Citrus Sinensis ID: 041624

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------46
Protein Sequence
GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIEIGR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccEEEEEcccccccccccccccccEEEEcccccccccccccccccccccEEEEEEEEccccEEEEEEEcccccccccccccccccEEcEEEEEEEccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHEEEEEccccccccccccccccccccEEcHHHHHHHHccccccccccccccccEEEEEEcccccEEEEEEccccccHHHHHHHHHHHHHHccccccccccccEEccccEEEEEEEccccccHHccccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccEEEccccccccccccccEEEccccccc
Secondary Structure Prediction (SSPRO)
ccEcccccHHHHEEEEEcccccccccEEEEEEEEcccccccccccccccEEEEEcccEEcccccccEEEcccccEEEEEEEccccEEEEEEEcccccccccccEcccccccccEEEEEEEEccccccccccccccccHEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHHcEEEEEEccccccEEEccHcccccccHcHHHHccccccccccEEEEcHHcccHHHHHccccccccccHHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccHHHHHHHHHHHccccccccccccccccc
Coil and Loop (DISEMBL)
gfqipsnspggflglfnsttaklssspivlvefdsfsnpewdpinvkddvginnsSIVSSVYTRwnasfhsgdtaHVKIKYNSAtknlsaswsygetpkysqenttstgryterhvlkswefnstldikeingreTIKIKVDVGVSIGGVVIMGILLLWKWKQRKetetftwvnddlsrdagprrfsyKDLASATnnfsnerklgqggfgaVYRGILIDLNMAVAVKKISRglkhgkneyiTEVKTCSQLRHRNLLQLIGLCHDRGEFMLVyefmpngsldfhlfskkstgtpltwtTRYKISLGLASALLYLHEEWKRCVVhrdikfsnimpdtdfnvklGDFGLALLvdhelgprttglagtlgymapeyistgrarldvnfdeqqTDCLMIVGLwcahpdrncrpSIRQAIQVLNfetkmpnlpskmpvaifeapassapcssepfitnscieigr
Flexible Loop (DISEMBL)
gfqipsnspggFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSAswsygetpkysqenttstgryterhvlkswefnstldikeingretiKIKVDVGVSIGGVVIMGILLLWKWKQRKETEtftwvnddlsrdagPRRFSYKDLAsatnnfsnerklgqggFGAVYRGILIDLNMAVAVKKISrglkhgkneyitevktcsqlrHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEApassapcssepfitnscieigr
Low Complexity Region (SEG)
GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGinnssivssvYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLKSWEFNSTLDIKEINGRETikikvdvgvsiggvvimgiLLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFeapassapcssepFITNSCIEIGR
Disordered region (IsUnstruct)
***********FLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSY***************RYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLS*********Y*************RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETK*************************************
Disordered Region (DISOPRED)
*FQ*PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLK********************IKVDVGVSIGGVVIMGILLLWKWKQRKET********DLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS******KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPV********************SCIE*G*
Disordered Region (DISEMBL)
GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYG*************GRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIEIGR
Disordered Region (DISPRO)
*FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSE************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIEIGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	459	2.2.26 [Sep-21-2011]
Q9LXA5	651	L-type lectin-domain cont	yes	no	0.938	0.662	0.512	1e-143
Q9LSL5	675	L-type lectin-domain cont	no	no	0.934	0.635	0.476	1e-125
Q9SZD5	669	L-type lectin-domain cont	no	no	0.965	0.662	0.309	8e-63
Q9FHG4	681	Probable L-type lectin-do	no	no	0.932	0.628	0.318	3e-62
Q9M2S4	684	L-type lectin-domain cont	no	no	0.906	0.608	0.318	1e-60
Q9M345	677	L-type lectin-domain cont	no	no	0.912	0.618	0.310	1e-60
O81292	674	L-type lectin-domain cont	no	no	0.888	0.605	0.295	6e-59
O04534	666	Putative L-type lectin-do	no	no	0.893	0.615	0.316	1e-57
O80939	675	L-type lectin-domain cont	no	no	0.901	0.613	0.295	2e-57
O04533	656	Putative L-type lectin-do	no	no	0.766	0.536	0.319	4e-57

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  509 bits (1311), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 266/519 (51%), Positives = 337/519 (64%), Gaps = 88/519 (16%)

Query: 3   QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVY 62
           Q+P NS GGFLGLFN T  + S+ P+V VEFD+F+NPEWDP++VK  VGINN+S+VSS Y
Sbjct: 111 QLPPNSAGGFLGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNY 170

Query: 63  TRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS--------------- 107
           T WNA+ H+ D   V I Y+SA +NLS SW+Y  T    + ++ S               
Sbjct: 171 TSWNATSHNQDIGRVLIFYDSARRNLSVSWTYDLTSDPLENSSLSYIIDLSKVLPSEVTI 230

Query: 108 -----TGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIM-----GILL 157
                +G  TE + L SWEF+S+L++ +I   +  K  + +G+S+ G V++      +++
Sbjct: 231 GFSATSGGVTEGNRLLSWEFSSSLELIDIKKSQNDKKGMIIGISVSGFVLLTFFITSLIV 290

Query: 158 LWKWKQRK----ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVY 213
             K KQ+K    ETE  T +N+DL R AGPR+F+YKDLASA NNF+++RKLG+GGFGAVY
Sbjct: 291 FLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVY 350

Query: 214 RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE 273
           RG L  L+M VA+KK + G K GK E++TEVK  S LRHRNL+QLIG CH++ EF+++YE
Sbjct: 351 RGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYE 410

Query: 274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP 333
           FMPNGSLD HLF KK     L W  R KI+LGLASALLYLHEEW++CVVHRDIK SN+M 
Sbjct: 411 FMPNGSLDAHLFGKKPH---LAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVML 467

Query: 334 DTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST------------------ 375
           D++FN KLGDFGLA L+DHELGP+TTGLAGT GYMAPEYIST                  
Sbjct: 468 DSNFNAKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLE 527

Query: 376 ---GRARLDV-----------------------------------NFDEQQTDCLMIVGL 397
              GR  +D                                     FDE+Q +CLMIVGL
Sbjct: 528 IVTGRKSVDRRQGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGL 587

Query: 398 WCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFE 436
           WCAHPD N RPSI+QAIQVLN E  +P+LP+KMPVA + 
Sbjct: 588 WCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATYH 626

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LSL5|LRK92_ARATH L-type lectin-domain containing receptor kinase IX.2 OS=Arabidopsis thaliana GN=LECRK92 PE=2 SV=1

 Score =  450 bits (1157), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 251/527 (47%), Positives = 322/527 (61%), Gaps = 98/527 (18%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           G Q+P+ S GGFL LF       SS P+V VEFD+F+NP WDP +V   VGINN+S+VSS
Sbjct: 126 GAQLPAYSVGGFLNLFTRKNNYSSSFPLVHVEFDTFNNPGWDPNDVGSHVGINNNSLVSS 185

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS------------- 107
            YT WNAS HS D  H KI Y+S TKNLS +W+Y  T     + ++S             
Sbjct: 186 NYTSWNASSHSQDICHAKISYDSVTKNLSVTWAYELTATSDPKESSSLSYIIDLAKVLPS 245

Query: 108 ---------TGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGILLL 158
                     G  TE H L SWE +S+LD  + + R    I + +G+S  G V +  +++
Sbjct: 246 DVMFGFIAAAGTNTEEHRLLSWELSSSLDSDKADSR----IGLVIGISASGFVFLTFMVI 301

Query: 159 -----WKWKQRK----ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGF 209
                W  KQRK    + E    +N DL R+AGPR+FSYKDL SATN FS+ RKLG+GGF
Sbjct: 302 TTVVVWSRKQRKKKERDIENMISINKDLEREAGPRKFSYKDLVSATNRFSSHRKLGEGGF 361

Query: 210 GAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM 269
           GAVY G L ++N  VAVKK+S   + GKNE++ EVK  S+LRHRNL+QLIG C+++ EF+
Sbjct: 362 GAVYEGNLKEINTMVAVKKLSGDSRQGKNEFLNEVKIISKLRHRNLVQLIGWCNEKNEFL 421

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
           L+YE +PNGSL+ HLF K+     L+W  RYKI LGLASALLYLHEEW +CV+HRDIK S
Sbjct: 422 LIYELVPNGSLNSHLFGKRPN--LLSWDIRYKIGLGLASALLYLHEEWDQCVLHRDIKAS 479

Query: 330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY----------------- 372
           NIM D++FNVKLGDFGLA L++HELG  TTGLAGT GYMAPEY                 
Sbjct: 480 NIMLDSEFNVKLGDFGLARLMNHELGSHTTGLAGTFGYMAPEYVMKGSASKESDIYSFGI 539

Query: 373 ----ISTGRA----------------------------------------RLDVNFDEQQ 388
               I TGR                                         +L  +FD+++
Sbjct: 540 VLLEIVTGRKSLERTQEDNSDTESDDEKSLVEKVWELYGKQELITSCVDDKLGEDFDKKE 599

Query: 389 TDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIF 435
            +CL+++GLWCAHPD+N RPSI+Q IQV+NFE+ +P+LP K PVA++
Sbjct: 600 AECLLVLGLWCAHPDKNSRPSIKQGIQVMNFESPLPDLPLKRPVAMY 646

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  241 bits (615), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 174/563 (30%), Positives = 266/563 (47%), Gaps = 120/563 (21%)

Query: 4   IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
           +P +S   +LGLFN T     S+ IV VEFD+F N E+D ++  + VGI+ +S+ S   +
Sbjct: 111 LPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMD-NNHVGIDINSLSSEKAS 169

Query: 64  RWNASFHSGDTAHVK-------------IKYNSATKNLSASWSYGETPK----------- 99
              A ++  D    K             I+Y+S+ + L+ +      PK           
Sbjct: 170 --TAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKD 227

Query: 100 ---YSQEN-----TTSTGRYTERHVLKSWEFN-----STLDIKEI-----NGRET-IKIK 140
              Y  ++     T++TGR    H +  W F      S +DI  +     + R T +K  
Sbjct: 228 LSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKI 287

Query: 141 VDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSN 200
           + + +S+  + I+ + L   +    + +    V +D     GP RF+YKDL  AT  F N
Sbjct: 288 LAISLSLTSLAIL-VFLTISYMLFLKRKKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRN 346

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
              LG+GGFG VY+G L   NM +AVKK+S   + G  E++ E+ T  +LRH NL++L+G
Sbjct: 347 SELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLG 406

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
            C  +GE  LVY+ MP GSLD  L+ +      L W+ R+KI   +AS L YLH +W + 
Sbjct: 407 YCRRKGELYLVYDCMPKGSLDKFLYHQPEQS--LDWSQRFKIIKDVASGLCYLHHQWVQV 464

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR- 379
           ++HRDIK +N++ D   N KLGDFGLA L +H   P+T+ +AGT GY++PE   TG+A  
Sbjct: 465 IIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKAST 524

Query: 380 ---------------------------------LDVNFDEQQTDCLMIV----------- 395
                                             D   D  + D L +V           
Sbjct: 525 SSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWEDDILQVVDERVKQDDKYL 584

Query: 396 ----------GLWCAHPDRNCRPSIRQAIQVLNFETKMPN-----LPSKMPVAIFE---- 436
                     GL+C+HP    RPS+   IQ L+   ++PN     + ++  V   E    
Sbjct: 585 EEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLPNNLFDIVKARENVGAIEGFGE 644

Query: 437 -APASSAPCS------SEPFITN 452
            A + + PCS      +EPF+++
Sbjct: 645 AAESLAEPCSVATLTFTEPFVSH 667

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  239 bits (610), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 177/556 (31%), Positives = 254/556 (45%), Gaps = 128/556 (23%)

Query: 8   SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPIN---VKDDVGINNSSIVSSVYTR 64
           SPGG+LGL NS+      +  V +EFD+  +P ++  N   +  DV   NS   S     
Sbjct: 126 SPGGYLGLVNSSQPM--KNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLS 183

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGE-------------------TPKYSQEN- 104
                 SG +    I Y +  + L+   SY +                   +P  + E  
Sbjct: 184 SQIDLKSGKSITSWIDYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMY 243

Query: 105 ---TTSTGRYTERHVLKSWEFNST-------------------------LDIKEINGRET 136
              + ST   TE H++++W F ++                         + I     R  
Sbjct: 244 VGFSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHR 303

Query: 137 IKIKVDVGVSIGGVV-----IMGILLLWKWKQRK-----ETETFTWVNDDLSRDAGPRRF 186
             + + +G+S   ++     + G   L KWK  K     +TE  T          G R F
Sbjct: 304 HNLAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELIT----------GLREF 353

Query: 187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKT 246
           SYK+L +AT  F + R +G+G FG VYR + +      AVK+       GK E++ E+  
Sbjct: 354 SYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSI 413

Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG-TPLTWTTRYKISLG 305
            + LRH+NL+QL G C+++GE +LVYEFMPNGSLD  L+ +  TG   L W+ R  I++G
Sbjct: 414 IACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIG 473

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LASAL YLH E ++ VVHRDIK SNIM D +FN +LGDFGLA L +H+  P +T  AGT+
Sbjct: 474 LASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTM 533

Query: 366 GYMAPEY---------------------ISTGRARLDVNFDEQQT--------------- 389
           GY+APEY                     ++ GR  +D   + Q+T               
Sbjct: 534 GYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGR 593

Query: 390 ------------------DCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP 431
                               L++VGL CAHPD N RPS+R+ +Q+LN E +   +P   P
Sbjct: 594 VLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKP 653

Query: 432 VAIFEAPASSAPCSSE 447
              F    S     SE
Sbjct: 654 TLSFSCGLSLDDIVSE 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  234 bits (597), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 167/525 (31%), Positives = 245/525 (46%), Gaps = 109/525 (20%)

Query: 9   PGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT----- 63
           P  +LGL NS+    SS     VEFD+  + E++ IN  + VGI+ +S+ SS+ T     
Sbjct: 119 PSQYLGLLNSSRVNFSSH-FFAVEFDTVRDLEFEDIN-DNHVGIDINSMESSISTPAGYF 176

Query: 64  -----RWNASFHSGDTAHVKIKYNSATKNLSASWS-YGETPKYSQEN------------- 104
                +       G      I Y+S  K L    S + E PK S  +             
Sbjct: 177 LANSTKKELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEM 236

Query: 105 ----TTSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVS-------IGGVVIM 153
               + STG     H +  W FN + +   ++     +I   +          I GV ++
Sbjct: 237 YVGFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLL 296

Query: 154 GILLLWKW----------KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERK 203
             LL++            K + E     W       D GP RFSY++L  ATN F ++  
Sbjct: 297 CSLLIFAVLVAASLFVVRKVKDEDRVEEW-----ELDFGPHRFSYRELKKATNGFGDKEL 351

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG GGFG VY+G L   +  VAVK+IS   + G  E+++EV +   LRHRNL+QL+G C 
Sbjct: 352 LGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCR 411

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
            R + +LVY+FMPNGSLD +LF +      LTW  R+KI  G+AS LLYLHE W++ V+H
Sbjct: 412 RRDDLLLVYDFMPNGSLDMYLFDENPE-VILTWKQRFKIIKGVASGLLYLHEGWEQTVIH 470

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY----------- 372
           RDIK +N++ D++ N ++GDFGLA L +H   P  T + GT GY+APE            
Sbjct: 471 RDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTD 530

Query: 373 ----------ISTGRA--------------------------------RLDVNFDEQQTD 390
                     ++ GR                                 RL+  FDE++  
Sbjct: 531 VYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVV 590

Query: 391 CLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIF 435
            ++ +GL C++     RP++RQ +  L  E + P+ P  +P   F
Sbjct: 591 MVIKLGLLCSNNSPEVRPTMRQVVMYL--EKQFPS-PEVVPAPDF 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  234 bits (596), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 161/518 (31%), Positives = 245/518 (47%), Gaps = 99/518 (19%)

Query: 4   IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
           +P   P  ++GLFN +     ++ I  VEFD+  + E+   N  + VGI+ + + S+ Y+
Sbjct: 115 LPFALPSQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPN-DNHVGIDLNGLRSANYS 173

Query: 64  R----------WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPK-------YSQE--- 103
                       N S  S     V I Y++ +  +  + +  ++ K       Y ++   
Sbjct: 174 TAGYRDDHDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSS 233

Query: 104 ---------NTTSTGRYTERHVLKSWEFN--------STLDIKEINGRETIKIK--VDVG 144
                     +++TG     H L  W F         S   + ++   E  +I     +G
Sbjct: 234 ILLEDMYVGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIG 293

Query: 145 VSIGGV-VIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERK 203
           + +  + +I  I+ L  +  R++ + +    DD   + G  RF +K+L  AT  F  +  
Sbjct: 294 MPLISLSLIFSIIFLAFYIVRRKKK-YEEELDDWETEFGKNRFRFKELYHATKGFKEKDL 352

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG GGFG VYRGIL    + VAVK++S   K G  E++ E+ +  ++ HRNL+ L+G C 
Sbjct: 353 LGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCR 412

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
            RGE +LVY++MPNGSLD +L++     T L W  R  I  G+AS L YLHEEW++ V+H
Sbjct: 413 RRGELLLVYDYMPNGSLDKYLYNNPE--TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIH 470

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA----- 378
           RD+K SN++ D DFN +LGDFGLA L DH   P+TT + GTLGY+APE+  TGRA     
Sbjct: 471 RDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTD 530

Query: 379 --------------RLDVNFDEQQTDCLMIV----------------------------- 395
                         R  + F     D  ++V                             
Sbjct: 531 VYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEE 590

Query: 396 -------GLWCAHPDRNCRPSIRQAIQVLNFETKMPNL 426
                  GL C+H D   RPS+RQ +Q L  +  +P L
Sbjct: 591 VEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPEL 628

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  228 bits (582), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 153/518 (29%), Positives = 251/518 (48%), Gaps = 110/518 (21%)

Query: 12  FLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGIN-NS--SIVSSVYTRW--- 65
           +LGLF+ST     ++ I+ VEFD+  NPE+D  N  + VGIN NS  S+ SS+   W   
Sbjct: 125 YLGLFSSTNNGNDTNHILAVEFDTIMNPEFDDTN-DNHVGININSLTSVKSSLVGYWDEI 183

Query: 66  ----NASFHSGDTAHVKIKYNSATKNLSASWS-YGET-PKYSQEN--------------- 104
               N +  S     V + Y+  T  +  + + +GE  P+ +  +               
Sbjct: 184 NQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYL 243

Query: 105 --TTSTGRYTERHVLKSWEF------NSTLDIKEINGRETI-----------KIKVDVGV 145
             + +TG     H +  W F         L + ++     +           ++ +   +
Sbjct: 244 GFSAATGYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLL 303

Query: 146 SIGGVVIMGILLLWKW---KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNER 202
            I  + ++ ++ L ++   ++RK  E F    +D   + G  R  +KDL  AT  F ++ 
Sbjct: 304 LIPVLFVVSLIFLVRFIVRRRRKFAEEF----EDWETEFGKNRLRFKDLYYATKGFKDKD 359

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
            LG GGFG VYRG++      +AVK++S   + G  E++ E+ +  ++ HRNL+ L+G C
Sbjct: 360 LLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYC 419

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
             R E +LVY++MPNGSLD +L+        L W  R+ + +G+AS L YLHEEW++ V+
Sbjct: 420 RRRDELLLVYDYMPNGSLDKYLYDCPEV--TLDWKQRFNVIIGVASGLFYLHEEWEQVVI 477

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA---- 378
           HRDIK SN++ D ++N +LGDFGLA L DH   P+TT + GT GY+AP+++ TGRA    
Sbjct: 478 HRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTAT 537

Query: 379 -------------------RLDVNFDE-------------------------------QQ 388
                               +++  DE                               ++
Sbjct: 538 DVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQRE 597

Query: 389 TDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL 426
            + ++ +GL C+H D   RP++RQ +Q L  +  +P+L
Sbjct: 598 VETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLPDL 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  224 bits (570), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 163/515 (31%), Positives = 250/515 (48%), Gaps = 105/515 (20%)

Query: 9   PGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSV-----YT 63
           P  +LGLFN +      + IV VE D+  + +++  +  + VGI+ +++VS       Y 
Sbjct: 115 PTTYLGLFNRSNMGDPKNHIVAVELDTKVDQQFEDKDA-NHVGIDINTLVSDTVALAGYY 173

Query: 64  RWNASF-----HSGDTAHVKIKYNSATKNLSASWSYGETPK-----YSQEN--------- 104
             N +F     +SG    + I+Y+S  K ++ +      PK      S E          
Sbjct: 174 MDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHPLYVPKPKIPLLSLEKDLSPYLLEL 233

Query: 105 -----TTSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIK-------------VDVGVS 146
                T++TG  T  H +  W F       +I+     KI              + + ++
Sbjct: 234 MYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLT 293

Query: 147 IGGVVIMGILLLWKW---KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERK 203
           + GV+I+ IL L  W   K++K  E    V +D     GP RF++KDL  AT  F +   
Sbjct: 294 VSGVIILIILSLSLWLFLKRKKLLE----VLEDWEVQFGPHRFAFKDLHIATKGFKDTEV 349

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG+GGFG VY+G L   N+ +AVK +S   + G  E+I E+ T  +LRH NL++L G C 
Sbjct: 350 LGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGYCR 409

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
            +GE  LVY+ M  GSLD  L+ ++ TG  L W+ R+KI   +AS L YLH++W + ++H
Sbjct: 410 HKGELYLVYDCMAKGSLDKFLYHQQ-TGN-LDWSQRFKIIKDVASGLYYLHQQWVQVIIH 467

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA--RLD 381
           RDIK +NI+ D + N KLGDFGLA L DH   P+T+ +AGTLGY++PE   TG+A  R D
Sbjct: 468 RDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTRSD 527

Query: 382 V---------------------------------------------------NFDEQQTD 390
           V                                                    + E+Q  
Sbjct: 528 VFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENEDIMQVLDHKIGQEYVEEQAA 587

Query: 391 CLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN 425
            ++ +GL+C+HP    RP++   IQ+L+   ++P+
Sbjct: 588 LVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLPH 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  224 bits (570), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 154/522 (29%), Positives = 245/522 (46%), Gaps = 108/522 (20%)

Query: 4   IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGIN-NS--SIVSS 60
           +P  +P  ++GLFN       ++ +  VE D+  + E++  N  + VGI+ NS  S+ SS
Sbjct: 115 LPYGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTN-DNHVGIDINSLKSVQSS 173

Query: 61  VYTRW-------NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS------ 107
               W       N +  S     V + Y+  T  +  + +     K ++   T+      
Sbjct: 174 PAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSS 233

Query: 108 -------------TGRYTERHVLKSWEFN----------------STLDIKEINGRETIK 138
                        TG     H +  W F                    + K I+  E  K
Sbjct: 234 VLLQDMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRIS--EFYK 291

Query: 139 IKVDVGVSIGGVVIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNF 198
           I + + +S+  +     L+ +  ++R++   F    ++  ++ G  RF +KDL  AT  F
Sbjct: 292 IGMPL-ISLFLIFSFIFLVCYIVRRRRK---FAEELEEWEKEFGKNRFRFKDLYYATKGF 347

Query: 199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
             +  LG GGFG+VY+G++    + +AVK++S   + G  E++ E+ +  ++ HRNL+ L
Sbjct: 348 KEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPL 407

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           +G C  RGE +LVY++MPNGSLD +L++       L W  R K+ LG+AS L YLHEEW+
Sbjct: 408 LGYCRRRGELLLVYDYMPNGSLDKYLYNTPEV--TLNWKQRIKVILGVASGLFYLHEEWE 465

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
           + V+HRD+K SN++ D + N +LGDFGLA L DH   P+TT + GTLGY+APE+  TGRA
Sbjct: 466 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRA 525

Query: 379 -------------------RLDVNFDEQQTDCLMIV----GLW----------------- 398
                              R  + F ++  +  ++V    GLW                 
Sbjct: 526 TMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSEC 585

Query: 399 --------------CAHPDRNCRPSIRQAIQVLNFETKMPNL 426
                         C+H D   RPS+RQ +  L  + K+P L
Sbjct: 586 DEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1

 Score =  222 bits (566), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 143/448 (31%), Positives = 215/448 (47%), Gaps = 96/448 (21%)

Query: 66  NASFHSGDTAHVKIKYNSATKNL-----SASWSYGETP-------------KYSQENTTS 107
           N    SG    V I+YN++TK L     S   S  + P             +Y     TS
Sbjct: 173 NLDIASGKPIQVWIEYNNSTKQLDVTMHSIKISKPKIPLLSMRKDLSPYLHEYMYIGFTS 232

Query: 108 TGRYTERHVLKSWEFNSTLDIKEINGRETIKIK------------VDVGVSIGGV----- 150
            G  T  H +  W FN+   + +IN     K+             + + +SI GV     
Sbjct: 233 VGSPTSSHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVIV 292

Query: 151 VIMGILLLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFG 210
           +I+G++L  K K+      F  V +D     GP +F+YKDL  AT  F N   LG+GGFG
Sbjct: 293 LILGVMLFLKRKK------FLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFG 346

Query: 211 AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML 270
            V++GIL   ++ +AVKKIS   + G  E++ E+ T  +LRH +L++L+G C  +GE  L
Sbjct: 347 KVFKGILPLSSIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYL 406

Query: 271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN 330
           VY+FMP GSLD  L+++ +    L W+ R+ I   +AS L YLH++W + ++HRDIK +N
Sbjct: 407 VYDFMPKGSLDKFLYNQPN--QILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPAN 464

Query: 331 IMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA------------ 378
           I+ D + N KLGDFGLA L DH +  +T+ +AGT GY++PE   TG++            
Sbjct: 465 ILLDENMNAKLGDFGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVF 524

Query: 379 -----------------------------------------RLDVNFDEQQTDCLMIVGL 397
                                                    +L   +  +Q   ++ +GL
Sbjct: 525 MLEITCGRRPIGPRGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGL 584

Query: 398 WCAHPDRNCRPSIRQAIQVLNFETKMPN 425
            C+HP    RPS+   IQ L+    +P+
Sbjct: 585 LCSHPVAATRPSMSSVIQFLDGVATLPH 612

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	459
224074307	651	predicted protein [Populus trichocarpa]	0.978	0.689	0.553	1e-160
255572599	652	kinase, putative [Ricinus communis] gi|2	0.986	0.694	0.551	1e-160
255572593	672	kinase, putative [Ricinus communis] gi|2	0.986	0.674	0.557	1e-158
255572603	632	kinase, putative [Ricinus communis] gi|2	0.989	0.718	0.533	1e-146
357517145	651	Cysteine-rich receptor-like protein kina	0.982	0.692	0.529	1e-146
357517131	655	Cysteine-rich receptor-like protein kina	0.984	0.690	0.523	1e-145
449484066	651	PREDICTED: LOW QUALITY PROTEIN: L-type l	0.980	0.691	0.529	1e-145
449460702	649	PREDICTED: L-type lectin-domain containi	0.980	0.693	0.529	1e-145
449460754	688	PREDICTED: L-type lectin-domain containi	0.980	0.654	0.525	1e-144
449531003	659	PREDICTED: LOW QUALITY PROTEIN: L-type l	0.980	0.682	0.525	1e-144

>gi|224074307|ref|XP_002304348.1| predicted protein [Populus trichocarpa] gi|222841780|gb|EEE79327.1| predicted protein [Populus trichocarpa]

 Score =  572 bits (1474), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 300/542 (55%), Positives = 361/542 (66%), Gaps = 93/542 (17%)

Query: 2   FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSV 61
           F IP NS GGFLGL+N TT+    + IV +EFDSF+NPEWDP     +VGINN+S+ S+ 
Sbjct: 119 FHIPPNSAGGFLGLYNITTSDSPQNHIVHIEFDSFANPEWDP--PIQNVGINNNSVSSAT 176

Query: 62  YTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT--------------- 106
           YT WN S HSGDTA V++ YNS TKNL+ SW Y +T    QENT+               
Sbjct: 177 YTYWNTSLHSGDTADVRVTYNSTTKNLTVSWKY-QTTSSPQENTSLSYIIDLREVLPEWV 235

Query: 107 ------STGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVIMGIL---- 156
                 +T    ERHVL SW+F+STL++ E +G+    IK+ V +++ G V++ ++    
Sbjct: 236 TIGFTAATSNLIERHVLHSWDFSSTLEMSETSGKSAKNIKLVVSLTVSGAVLIIVIAVVS 295

Query: 157 -LLWKWK----QRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGA 211
            +LW+ K    +  ET   T +NDDL R AGPRRFSYKDL SATNNFS ERKLG+GGFGA
Sbjct: 296 GILWRRKLVRKETAETVNLTSINDDLERRAGPRRFSYKDLVSATNNFSAERKLGEGGFGA 355

Query: 212 VYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV 271
           VY+G L  ++ AVAVKKISRG K GK EY+TEVK  SQLRHRNL+QLIG CHDRGEF+LV
Sbjct: 356 VYQGQLTGIDTAVAVKKISRGSKQGKKEYVTEVKVISQLRHRNLVQLIGWCHDRGEFLLV 415

Query: 272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI 331
           YEFM NGSLD HLF KK    PLTWT RY+I+LGLASALLYLHEEW++CVVHRD+K SNI
Sbjct: 416 YEFMSNGSLDSHLFGKK---IPLTWTARYRIALGLASALLYLHEEWEQCVVHRDVKSSNI 472

Query: 332 MPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA------------- 378
           M D+ FNVKLGDFGLA L+DHELGP+TTGLAGTLGY+APEYISTGRA             
Sbjct: 473 MLDSSFNVKLGDFGLARLMDHELGPQTTGLAGTLGYLAPEYISTGRASKESDVYSFGMVS 532

Query: 379 ----------------------------------------RLDVNFDEQQTDCLMIVGLW 398
                                                   +L   FDE Q +CLMIVGLW
Sbjct: 533 LEIATGRKAVDAIEQKSEMSLVEWIWDLYGTGKLNLAVDEKLQSEFDENQMECLMIVGLW 592

Query: 399 CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSS-EPFITNSCIEI 457
           CAHPDRN RPSIRQAI VLNFE  +PNLP+KMPV ++  P  + P SS EP I++S +++
Sbjct: 593 CAHPDRNIRPSIRQAIHVLNFEAPLPNLPTKMPVPLYHVP--TPPLSSGEPLISHS-MDV 649

Query: 458 GR 459
           GR
Sbjct: 650 GR 651

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572599|ref|XP_002527233.1| kinase, putative [Ricinus communis] gi|223533409|gb|EEF35159.1| kinase, putative [Ricinus communis]

 Score =  571 bits (1472), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 299/542 (55%), Positives = 363/542 (66%), Gaps = 89/542 (16%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GFQIP NS  GFLGLFN++T   S + IV+VEFDS+ N EWDP+   + VGINN+S+ S+
Sbjct: 117 GFQIPLNSASGFLGLFNTSTVDSSQNQIVMVEFDSYPNEEWDPL--VEHVGINNNSLASA 174

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS------------- 107
            YT WNAS+HSGDTA+V I YNS+TKNLS  W+Y  T    ++ + S             
Sbjct: 175 NYTHWNASYHSGDTANVWITYNSSTKNLSLLWTYQNTSNPLEKTSLSYVIDLMKVLPEWV 234

Query: 108 -------TGRYTERHVLKSWEFNSTLDIKEING----RETIKIKVDVGVSIGGV-VIMGI 155
                  TG   ERH L SWEFNSTLD+KE  G    R  I + + V V + G+ VI+GI
Sbjct: 235 TVGFSAATGANGERHQLLSWEFNSTLDVKETKGNTSQRTGITVGIAVSVCVVGIGVILGI 294

Query: 156 LLLWKWKQR-----KETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFG 210
           L  W+ K+      +E    T +N DL R AGPRRFSY+DL +ATNNFSNER LG+GGFG
Sbjct: 295 LFFWRRKKMMKRKGEEKMNLTSINKDLERGAGPRRFSYEDLVAATNNFSNERMLGKGGFG 354

Query: 211 AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML 270
           AVY+G LID++MA+AVKKISRG + GK EYI EVKT  QLRHRNL+QL+G CHD+GEF+L
Sbjct: 355 AVYKGYLIDMDMAIAVKKISRGSRQGKKEYIAEVKTIGQLRHRNLVQLLGWCHDKGEFLL 414

Query: 271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN 330
           VYEFMPNGSLD HLF KKS+   LTW  R+KISLGLASALLYLHEEW++CVVHRD+K SN
Sbjct: 415 VYEFMPNGSLDSHLFGKKSS---LTWAVRHKISLGLASALLYLHEEWEQCVVHRDVKSSN 471

Query: 331 IMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR----------- 379
           +M D++ + KLGDFGLA L+DHELGP+TTGLAGTLGY+APEYIST RA            
Sbjct: 472 VMLDSNCSAKLGDFGLARLMDHELGPQTTGLAGTLGYLAPEYISTRRASKESDVYSFGVV 531

Query: 380 ------------------------------------------LDVNFDEQQTDCLMIVGL 397
                                                     + + FDE++ +CLMIVGL
Sbjct: 532 ALEIVSGRRAIDHINDKNEMSLVEWIWELYGQGKLHLAVDRAIHMEFDEKEAECLMIVGL 591

Query: 398 WCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIEI 457
           WCAHPDRN RPS+ QAIQVL FET +PNLP+KMPV ++  P  SA  SSEP ITNS +++
Sbjct: 592 WCAHPDRNIRPSMSQAIQVLKFETALPNLPAKMPVPMYHVPLPSA-SSSEPSITNSSLDV 650

Query: 458 GR 459
           GR
Sbjct: 651 GR 652

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572593|ref|XP_002527230.1| kinase, putative [Ricinus communis] gi|223533406|gb|EEF35156.1| kinase, putative [Ricinus communis]

 Score =  566 bits (1458), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 304/545 (55%), Positives = 360/545 (66%), Gaps = 92/545 (16%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GFQIP NS GGFLGLFN++T+  S + IV VEFDSFSN EWDP      VGINN+SI S+
Sbjct: 134 GFQIPPNSAGGFLGLFNTSTSDSSKNQIVTVEFDSFSNEEWDP--PVGHVGINNNSIASA 191

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS------------- 107
           VYT WNASFHSGD A   I YNS TKNLS  W+Y ET    + ++ S             
Sbjct: 192 VYTPWNASFHSGDIADAWITYNSITKNLSVFWTYKETSNPGENSSLSYIIDLMKVLPEQV 251

Query: 108 -------TGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVS--------IGGVVI 152
                  TG+   RH L+SWEF+S+L +K  +G E  K +V VGVS        I   VI
Sbjct: 252 TIGFSAATGQNGARHSLQSWEFSSSLVVKGKHGNELKKTQVIVGVSASVSGCLLIAAAVI 311

Query: 153 MGILLLWKWKQ-----RKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQG 207
           + +++  + KQ     R E    + + +DL R AGPR+FSY+DL +ATNNFS  R LG+G
Sbjct: 312 LALVISRRRKQIMKKKRAEVAGISSIYEDLERGAGPRKFSYEDLVTATNNFSGVRNLGEG 371

Query: 208 GFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE 267
           GFGAVY+G L D++MA+AVKK SRG K GK EYITEVKT SQLRHRNL+QLIG CHDRGE
Sbjct: 372 GFGAVYKGYLNDIDMAIAVKKFSRGSKQGKKEYITEVKTISQLRHRNLVQLIGWCHDRGE 431

Query: 268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK 327
           F+LVYEFMPNGSLD HLF KKS   PL+W  RYKISLGLASALLYLHEEW++CVVHRD+K
Sbjct: 432 FLLVYEFMPNGSLDSHLFGKKS---PLSWAVRYKISLGLASALLYLHEEWEQCVVHRDVK 488

Query: 328 FSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA--------- 378
            SN+M D+ FNVKLGDFGLA L+DHELGP+TTGLAGTLGY+APEYISTGRA         
Sbjct: 489 SSNVMLDSSFNVKLGDFGLARLMDHELGPQTTGLAGTLGYLAPEYISTGRASKDSDVYSF 548

Query: 379 --------------------------------------------RLDVNFDEQQTDCLMI 394
                                                       RL +NFDE++ + L+I
Sbjct: 549 GVVCLEIASGRKAIDQIEQKSGICLVEWIWDLYGCGKIHCGIDKRLQINFDEKEVERLVI 608

Query: 395 VGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSC 454
           VGLWCAHPD + RPSIRQAIQVLNFE ++P+LP+KMPV  F AP+ S   S EP ITNS 
Sbjct: 609 VGLWCAHPDSSARPSIRQAIQVLNFEAEIPDLPAKMPVPAFYAPSPSV-YSGEPSITNSS 667

Query: 455 IEIGR 459
           I +GR
Sbjct: 668 IAVGR 672

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572603|ref|XP_002527235.1| kinase, putative [Ricinus communis] gi|223533411|gb|EEF35161.1| kinase, putative [Ricinus communis]

 Score =  525 bits (1352), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 289/542 (53%), Positives = 353/542 (65%), Gaps = 88/542 (16%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GFQIP NS  G+LGLFN++T   S + IV VEFDS+ N  WDP  + + VGIN +S+ S+
Sbjct: 96  GFQIPPNSASGYLGLFNTSTVDSSQNQIVFVEFDSYPNKAWDPKPLVEHVGININSLASA 155

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTS------------- 107
             T WNAS+HSGDTA+V I YNS+TKNLS  W+Y  T    ++ + S             
Sbjct: 156 NSTPWNASYHSGDTANVWITYNSSTKNLSLLWNYRNTSNPLEKTSLSYVIDLMKVLPEWV 215

Query: 108 -------TGRYTERHVLKSWEFNSTLDIKEINGRET----IKIKVDVGVSIGGV-VIMGI 155
                  TG Y ERH L SWEFNSTLD+ E NG+ +    I + V V V + G+ +I GI
Sbjct: 216 TVGFSAATGVYKERHQLLSWEFNSTLDV-ETNGKSSKRTGIVVGVSVSVCVAGIGMIAGI 274

Query: 156 LLLWKWK-----QRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFG 210
           +L  + K     +RKE    T +N DL R A PRRFSY++L SATNNFSNER LG+GGFG
Sbjct: 275 VLSQRRKTMIARKRKEKLNLTSINKDLERGAAPRRFSYEELVSATNNFSNERMLGKGGFG 334

Query: 211 AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML 270
           AVY+G LID++MA+AVKKISRG + GK EYITEVKT  QLRHRNL+QL+G CHD+GEF+L
Sbjct: 335 AVYKGYLIDMDMAIAVKKISRGSRQGKREYITEVKTIGQLRHRNLVQLLGWCHDKGEFLL 394

Query: 271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN 330
           VYEFMPNGSLD HLF KKS+   L W  R+KI+LGLAS LLYLHEEW++CVVHRD+K SN
Sbjct: 395 VYEFMPNGSLDSHLFGKKSS---LPWAVRHKIALGLASGLLYLHEEWEQCVVHRDVKSSN 451

Query: 331 IMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA------------ 378
           +M D++FN KLGDFGLA L DHELGP+TTGLAGTLGY+APEYI+T RA            
Sbjct: 452 VMLDSNFNAKLGDFGLARLTDHELGPQTTGLAGTLGYLAPEYITTRRASKESDVYSFGMV 511

Query: 379 ---------------------------------RLDVNFDEQ--------QTDCLMIVGL 397
                                             L +  D++        + + LMIVGL
Sbjct: 512 ALEIISGRRVIDHINDKYEMSLVEWIWELYGEGNLHLAVDKELYSKFNEKEAERLMIVGL 571

Query: 398 WCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIEI 457
           WCAHPD N RPSIRQAIQVL FE  +PNLP+KM V ++  P +S   SSEP IT S ++ 
Sbjct: 572 WCAHPDCNLRPSIRQAIQVLKFEIALPNLPAKMLVPVYHVPPASV-SSSEPSITYSSLDA 630

Query: 458 GR 459
           GR
Sbjct: 631 GR 632

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357517145|ref|XP_003628861.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355522883|gb|AET03337.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  524 bits (1349), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 288/544 (52%), Positives = 350/544 (64%), Gaps = 93/544 (17%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GF+IP NS GG +GLFN+TT   SS+ IV VEFDSF+N E+      + VGINN+SI SS
Sbjct: 116 GFEIPPNSSGGLMGLFNTTTMLSSSNHIVHVEFDSFANSEFS--ETTEHVGINNNSIKSS 173

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENT--------------- 105
           + T WNAS HSGDTA V I+YNS TKNL+ SW Y +T    QE T               
Sbjct: 174 ISTPWNASLHSGDTAEVWIRYNSTTKNLTVSWEY-QTTSSPQEKTNLSYQIDFKKVLPEW 232

Query: 106 ------TSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVI-MGILLL 158
                  +TG   E + L SWEFNS L+  + +  +  ++ V + VS+G V+I +G L+ 
Sbjct: 233 VTIGFSAATGYNGEVNNLLSWEFNSNLEKSDDSNSKDTRLVVILTVSLGAVIIGVGALVA 292

Query: 159 W---------KWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGF 209
           +           KQ++E    T +NDDL R AGPRRF+YK+L  ATNNFS +RKLGQGGF
Sbjct: 293 YVILKRKRKRSEKQKEEAMHLTSMNDDLERGAGPRRFTYKELELATNNFSKDRKLGQGGF 352

Query: 210 GAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM 269
           GAV++G   DL++ VAVKKISRG + GK EY+TEVK  SQLRHRNL++L+G CHD+GEF+
Sbjct: 353 GAVFKGYFADLDLQVAVKKISRGSRQGKKEYVTEVKVISQLRHRNLVKLLGWCHDKGEFL 412

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
           L+YEFMPNGSLD HLF K+   TPL+W  R+KI+LGLAS LLYLHEEW+RCVVHRDIK S
Sbjct: 413 LIYEFMPNGSLDSHLFGKR---TPLSWGVRHKITLGLASGLLYLHEEWERCVVHRDIKSS 469

Query: 330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR---------- 379
           N+M D+ FNVKLGDFGLA L+DHELGP+TTGLAGT GY+APEY+STGRA           
Sbjct: 470 NVMLDSSFNVKLGDFGLAKLMDHELGPQTTGLAGTFGYLAPEYVSTGRASKESDVYSFGI 529

Query: 380 ----------------------------------------LDVNF----DEQQTDCLMIV 395
                                                   +D N     DE+Q +CLMIV
Sbjct: 530 VVLEITSGKKATEVMKEKDEEKGMIEWVWDHYGKGELLVAMDENLRKDFDEKQVECLMIV 589

Query: 396 GLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCI 455
           GLWCAHPD + RPSIRQAIQVLNFE  MPNLP K PVA + AP  S   S E  ITNS +
Sbjct: 590 GLWCAHPDVSLRPSIRQAIQVLNFEVSMPNLPPKRPVATYHAPTPSV-SSVEASITNS-L 647

Query: 456 EIGR 459
           + GR
Sbjct: 648 QDGR 651

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357517131|ref|XP_003628854.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355522876|gb|AET03330.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  521 bits (1341), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 284/543 (52%), Positives = 344/543 (63%), Gaps = 91/543 (16%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GF IP NS   F+GLFN TT   SS+ IVLVEFDSF N EW      + VGIN +SI+SS
Sbjct: 120 GFDIPPNSATAFMGLFNMTTMVSSSNQIVLVEFDSFPNGEWG--ETTEHVGINVNSIMSS 177

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENT--------------- 105
           V+T WNAS HSGD A V I +NS TKNL+ SW Y  T    ++ +               
Sbjct: 178 VFTPWNASLHSGDIAEVWISFNSTTKNLTVSWKYQRTSNPEEKTSLSYEIDLMKVLPEWV 237

Query: 106 -----TSTGRYTERHVLKSWEFNSTLDIKEINGRETIKIKVDVGVSIGGVVI-MGILLLW 159
                 S G   E + L SWEFNS L+  + +  +  ++ V + VS+G V+I +G L+ +
Sbjct: 238 TIGFSASIGNIRELNNLLSWEFNSNLEKSDDSNSKDTRLVVILTVSLGAVIIGVGALVAY 297

Query: 160 ---------KWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFG 210
                      KQ++E    T +NDDL R AGPRRF+YK+L  ATNNFS +RKLGQGGFG
Sbjct: 298 VILKRKRKRSEKQKEEAMHLTSMNDDLERGAGPRRFTYKELELATNNFSKDRKLGQGGFG 357

Query: 211 AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML 270
           AV++G   DL++ VAVKKISRG + GK EY+TEVK  SQLRHRNL++L+G CHD+GEF+L
Sbjct: 358 AVFKGYFADLDLQVAVKKISRGSRQGKKEYVTEVKVISQLRHRNLVKLLGWCHDKGEFLL 417

Query: 271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN 330
           +YEFMPNGSLD HLF K+   TPL+W  R+KI+LGLAS LLYLHEEW+RCVVHRDIK SN
Sbjct: 418 IYEFMPNGSLDSHLFGKR---TPLSWGVRHKITLGLASGLLYLHEEWERCVVHRDIKSSN 474

Query: 331 IMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR----------- 379
           +M D+ FNVKLGDFGLA L+DHELGP+TTGLAGT GY+APEY+STGRA            
Sbjct: 475 VMLDSSFNVKLGDFGLAKLMDHELGPQTTGLAGTFGYLAPEYVSTGRASKESDVYSFGIV 534

Query: 380 ---------------------------------------LDVNF----DEQQTDCLMIVG 396
                                                  +D N     DE+Q +CLMIVG
Sbjct: 535 VLEITSGKKATEVMKEKDEEKGMIEWVWDHYGKGELLVAMDENLRKDFDEKQVECLMIVG 594

Query: 397 LWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNSCIE 456
           LWCAHPD + RPSIRQAIQVLNFE  MPNLP K PVA + AP  S   S E  ITNS ++
Sbjct: 595 LWCAHPDVSLRPSIRQAIQVLNFEVSMPNLPPKRPVATYHAPTPSV-SSVEASITNS-LQ 652

Query: 457 IGR 459
            GR
Sbjct: 653 DGR 655

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449484066|ref|XP_004156774.1| PREDICTED: LOW QUALITY PROTEIN: L-type lectin-domain containing receptor kinase IX.1-like [Cucumis sativus]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 289/546 (52%), Positives = 352/546 (64%), Gaps = 96/546 (17%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GFQIP NS GGFLGL+N T +   ++ IV VEFD+ SN  WDP      VGIN +S+ SS
Sbjct: 115 GFQIPPNSAGGFLGLYNKTYSNSVTNQIVHVEFDTGSNG-WDPPYAH--VGININSVTSS 171

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-------------- 106
             TRWN S HSGD A V I YNS  K LS SW Y +T     ENTT              
Sbjct: 172 NDTRWNVSLHSGDLAEVWISYNSTIKLLSVSWKYQKTSTL-LENTTLSYPIDLTTVLPQQ 230

Query: 107 -------STGRYTERHVLKSWEFNSTLDIK--EINGRETIKIKVDVGVSIGGVVIMGILL 157
                  +TG + ERH + SWEFNSTLD+K   I+    + + V V VS+GG++++GI++
Sbjct: 231 ATVGFSAATGAHLERHSVSSWEFNSTLDMKPTSISAGNKVSVIVGVTVSVGGLILVGIIV 290

Query: 158 L-----WKWKQRK------ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQ 206
                  K K+RK      E    T +NDDL R AGPRRFS+K LA ATNNFSNERKLG+
Sbjct: 291 FVTLSRLKEKKRKKDQENLEEVNLTSINDDLERGAGPRRFSHKLLAMATNNFSNERKLGE 350

Query: 207 GGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG 266
           GGFGAVYRG + DL++ +AVKKISRG + G+ EYITEVK  S+LRHRNL+QLIG CHD+G
Sbjct: 351 GGFGAVYRGYIQDLDLNIAVKKISRGSRQGRKEYITEVKIISRLRHRNLVQLIGWCHDKG 410

Query: 267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI 326
           EF+LVYEFM NGSLD HLF K+   TPL W+ RYKI+LGL SALLYLHEE ++CVVHRDI
Sbjct: 411 EFLLVYEFMSNGSLDSHLFGKR---TPLAWSVRYKIALGLGSALLYLHEEGEQCVVHRDI 467

Query: 327 KFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR--------- 377
           K SNIM D++FNVKLGDFGLA L+DHELG +TTGL GTLGY+APEYI+TGR         
Sbjct: 468 KSSNIMLDSNFNVKLGDFGLARLMDHELGAQTTGLVGTLGYLAPEYINTGRASKESDVFS 527

Query: 378 --------------------------------------------ARLDVNFDEQQTDCLM 393
                                                       A+L  NFD++Q +CLM
Sbjct: 528 FGVVALEIATGRVSRTSMEKESHKGLVEWVWDLYGSGQLLEGVDAKLQSNFDKKQVECLM 587

Query: 394 IVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNS 453
           +VGLW A+PD N RPSI+Q IQVLNFE  +PNLP+KMPV  + AP++S   S+EP  T S
Sbjct: 588 VVGLWSAYPDPNFRPSIKQVIQVLNFEAAVPNLPNKMPVPTYNAPSTSM-SSNEPSFTVS 646

Query: 454 CIEIGR 459
            +++GR
Sbjct: 647 -LDMGR 651

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449460702|ref|XP_004148084.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like, partial [Cucumis sativus]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 289/546 (52%), Positives = 352/546 (64%), Gaps = 96/546 (17%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GFQIP NS GGFLGL+N T +   ++ IV VEFD+ SN  WDP      VGIN +S+ SS
Sbjct: 113 GFQIPPNSAGGFLGLYNKTYSNSVTNQIVHVEFDTGSNG-WDPPYAH--VGININSVTSS 169

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-------------- 106
             TRWN S HSGD A V I YNS  K LS SW Y +T     ENTT              
Sbjct: 170 NDTRWNVSLHSGDLAEVWISYNSTIKLLSVSWKYQKTSTL-LENTTLSYPIDLTTVLPQQ 228

Query: 107 -------STGRYTERHVLKSWEFNSTLDIK--EINGRETIKIKVDVGVSIGGVVIMGILL 157
                  +TG + ERH + SWEFNSTLD+K   I+    + + V V VS+GG++++GI++
Sbjct: 229 ATVGFSAATGAHLERHSVSSWEFNSTLDMKPTSISAGNKVSVIVGVTVSVGGLILVGIIV 288

Query: 158 L-----WKWKQRK------ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQ 206
                  K K+RK      E    T +NDDL R AGPRRFS+K LA ATNNFSNERKLG+
Sbjct: 289 FVTLSRLKEKKRKKDQENLEEVNLTSINDDLERGAGPRRFSHKLLAMATNNFSNERKLGE 348

Query: 207 GGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG 266
           GGFGAVYRG + DL++ +AVKKISRG + G+ EYITEVK  S+LRHRNL+QLIG CHD+G
Sbjct: 349 GGFGAVYRGYIQDLDLNIAVKKISRGSRQGRKEYITEVKIISRLRHRNLVQLIGWCHDKG 408

Query: 267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI 326
           EF+LVYEFM NGSLD HLF K+   TPL W+ RYKI+LGL SALLYLHEE ++CVVHRDI
Sbjct: 409 EFLLVYEFMSNGSLDSHLFGKR---TPLAWSVRYKIALGLGSALLYLHEEGEQCVVHRDI 465

Query: 327 KFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR--------- 377
           K SNIM D++FNVKLGDFGLA L+DHELG +TTGL GTLGY+APEYI+TGR         
Sbjct: 466 KSSNIMLDSNFNVKLGDFGLARLMDHELGAQTTGLVGTLGYLAPEYINTGRASKESDVFS 525

Query: 378 --------------------------------------------ARLDVNFDEQQTDCLM 393
                                                       A+L  NFD++Q +CLM
Sbjct: 526 FGVVALEIATGRVSRTSMEKESHKGLVEWVWDLYGSGQLLEGVDAKLQSNFDKKQVECLM 585

Query: 394 IVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPFITNS 453
           +VGLW A+PD N RPSI+Q IQVLNFE  +PNLP+KMPV  + AP++S   S+EP  T S
Sbjct: 586 VVGLWSAYPDPNFRPSIKQVIQVLNFEAAVPNLPNKMPVPTYNAPSTSM-SSNEPSFTVS 644

Query: 454 CIEIGR 459
            +++GR
Sbjct: 645 -LDMGR 649

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449460754|ref|XP_004148110.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Cucumis sativus]

 Score =  518 bits (1334), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 289/550 (52%), Positives = 355/550 (64%), Gaps = 100/550 (18%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GF IP NS GG+LGLFN T  + S + IV VEFDS+ N EWDP N  + VGIN +S+ SS
Sbjct: 148 GFHIPPNSAGGYLGLFNKTYTESSINQIVHVEFDSYPN-EWDP-NF-EHVGININSVSSS 204

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-------------- 106
            +T+WN S HS DT  V I Y+S TK LS SW+Y +TP  S ENTT              
Sbjct: 205 NFTKWNVSLHSLDTVDVFISYDSTTKYLSVSWNYEKTP-ISLENTTLSYMVDLMKILPQW 263

Query: 107 -------STGRYTERHVLKSWEFNSTLDIKEINGRET------IKIKVDVGVSIGGVVIM 153
                  +TG Y ERH+L SWEFNS+L++KE  G  T      + + V V VS+G  ++M
Sbjct: 264 ATVGFSAATGAYLERHLLFSWEFNSSLEMKETVGVGTEKNGKKVDVIVGVTVSVGASILM 323

Query: 154 GILLL-----------WKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNER 202
            I+                K+  E    T +NDDL R AGPRRFS+K LA ATNNFSNER
Sbjct: 324 AIVAFVVRRRLKQKKRKSEKKVAEEINLTSINDDLERGAGPRRFSHKLLAMATNNFSNER 383

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           KLGQGGFGAVYRG + D+++AVAVKKISRG + G+ EYITEVK  S+LRHRNL+QL+G C
Sbjct: 384 KLGQGGFGAVYRGYIPDIDLAVAVKKISRGSRQGRKEYITEVKIISRLRHRNLVQLVGWC 443

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           HD+GEF+LVYEFMPNGSLD HLF K++    L W  RYK++LGLASALLYLHEE ++CVV
Sbjct: 444 HDKGEFLLVYEFMPNGSLDSHLFGKRAH---LAWAVRYKVALGLASALLYLHEEGEQCVV 500

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA---- 378
           HRDIK SN+M D++FNVKLGDFGLA L+DHELG +TTGL GTLGY+APEYI+TGRA    
Sbjct: 501 HRDIKSSNVMLDSNFNVKLGDFGLARLMDHELGAQTTGLVGTLGYLAPEYINTGRASKES 560

Query: 379 -------------------------------------------------RLDVNFDEQQT 389
                                                            ++  +FD++Q 
Sbjct: 561 DVFSFGVVALEIATGRMSRTSMEAESHKGLVEWVWNLYGSAQLIDGMDEKMQSDFDKKQV 620

Query: 390 DCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPF 449
           +CLM+VGLW A+PD N RPSI+Q IQVLNFET MPNLP+KMPV I+ AP +S   S+E  
Sbjct: 621 ECLMLVGLWSAYPDPNLRPSIKQVIQVLNFETTMPNLPNKMPVPIYSAPPTSM-SSNEAS 679

Query: 450 ITNSCIEIGR 459
           IT S +++GR
Sbjct: 680 ITVS-LDMGR 688

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449531003|ref|XP_004172477.1| PREDICTED: LOW QUALITY PROTEIN: L-type lectin-domain containing receptor kinase IX.1-like [Cucumis sativus]

 Score =  518 bits (1334), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 289/550 (52%), Positives = 353/550 (64%), Gaps = 100/550 (18%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
           GF IP NS GG+LGLFN T  + S + IV VEFDS+ N EWDP N  + VGIN +S+ SS
Sbjct: 119 GFHIPPNSAGGYLGLFNKTYTESSINQIVHVEFDSYPN-EWDP-NF-EHVGININSVSSS 175

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-------------- 106
            +T+WN   HS DT  V I Y+S TK LS SW+Y +TP  S ENTT              
Sbjct: 176 NFTKWNVGLHSLDTVDVFISYDSTTKYLSVSWNYEKTP-ISLENTTLSYMVDLMKILPQW 234

Query: 107 -------STGRYTERHVLKSWEFNSTLDIKEINGRET------IKIKVDVGVSIGGVVIM 153
                  +TG Y ERH+L SWEFNS+L++KE  G  T      + + V V VS+G  ++M
Sbjct: 235 ATVGFSAATGAYLERHLLFSWEFNSSLEMKETVGVGTEKNGKKVDVIVGVTVSVGASILM 294

Query: 154 GILLL-----------WKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNER 202
            I+                K+  E    T +NDDL R AGPRRFS+K LA ATNNFSNER
Sbjct: 295 AIVAFVVRRRLKQKKRKSEKKVAEEINLTSINDDLERGAGPRRFSHKLLAMATNNFSNER 354

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           KLGQGGFGAVYRG + D+++AVAVKKISRG + G+ EYITEVK  S+LRHRNL+QL+G C
Sbjct: 355 KLGQGGFGAVYRGYIPDIDLAVAVKKISRGSRQGRKEYITEVKIISRLRHRNLVQLVGWC 414

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           HD+GEF+LVYEFMPNGSLD HLF K++    L W  RYK++LGLASALLYLHEE ++CVV
Sbjct: 415 HDKGEFLLVYEFMPNGSLDSHLFGKRAH---LAWAVRYKVALGLASALLYLHEEGEQCVV 471

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA---- 378
           HRDIK SN+M D++FNVKLGDFGLA L+DHELG +TTGL GTLGY+APEYISTGRA    
Sbjct: 472 HRDIKSSNVMLDSNFNVKLGDFGLARLMDHELGAQTTGLVGTLGYLAPEYISTGRASKES 531

Query: 379 -------------------------------------------------RLDVNFDEQQT 389
                                                            ++  +FD +Q 
Sbjct: 532 DVFSFGVVALEIATGRMSRTSMEAESHKGLVEWVWNLYGSAQLIDGMDEKMQSDFDXKQV 591

Query: 390 DCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPF 449
           +CLM+VGLW A+PD N RPSI+Q IQVLNFET MPNLP+KMPV I+ AP +S   S+E  
Sbjct: 592 ECLMLVGLWSAYPDPNLRPSIKQVIQVLNFETTMPNLPNKMPVPIYSAPPTSM-SSNEAS 650

Query: 450 ITNSCIEIGR 459
           IT S +++GR
Sbjct: 651 ITVS-LDMGR 659

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	459
TAIR|locus:2142499	651	AT5G10530 [Arabidopsis thalian	0.590	0.416	0.590	4.5e-131
TAIR|locus:2155685	675	AT5G65600 [Arabidopsis thalian	0.588	0.4	0.559	4e-122
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.472	0.303	0.488	3e-72
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.468	0.315	0.493	1.1e-70
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.440	0.298	0.504	5.7e-68
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.429	0.288	0.5	3.4e-66
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.668	0.458	0.374	6.4e-66
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.459	0.313	0.442	4.9e-64
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.444	0.302	0.461	1.3e-63
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.461	0.316	0.457	2.1e-63

TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 4.5e-131, Sum P(3) = 4.5e-131
 Identities = 167/283 (59%), Positives = 209/283 (73%)

Query:   105 TTSTGRYTERHVLKSWEFNSTLDIKEI----NGRETXXXXXXXXXXXXXXXXXXXLLLW- 159
             + ++G  TE + L SWEF+S+L++ +I    N ++                    L+++ 
Sbjct:   233 SATSGGVTEGNRLLSWEFSSSLELIDIKKSQNDKKGMIIGISVSGFVLLTFFITSLIVFL 292

Query:   160 KWKQRK----ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRG 215
             K KQ+K    ETE  T +N+DL R AGPR+F+YKDLASA NNF+++RKLG+GGFGAVYRG
Sbjct:   293 KRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVYRG 352

Query:   216 ILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM 275
              L  L+M VA+KK + G K GK E++TEVK  S LRHRNL+QLIG CH++ EF+++YEFM
Sbjct:   353 YLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYEFM 412

Query:   276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT 335
             PNGSLD HLF KK     L W  R KI+LGLASALLYLHEEW++CVVHRDIK SN+M D+
Sbjct:   413 PNGSLDAHLFGKKPH---LAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDS 469

Query:   336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
             +FN KLGDFGLA L+DHELGP+TTGLAGT GYMAPEYISTGRA
Sbjct:   470 NFNAKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRA 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2155685 AT5G65600 [Arabidopsis thaliana (taxid:3702)]

 Score = 782 (280.3 bits), Expect = 4.0e-122, Sum P(3) = 4.0e-122
 Identities = 155/277 (55%), Positives = 193/277 (69%)

Query:   107 STGRYTERHVLKSWEFNSTLDIKEINGR-ETXXXXXXXXXXXXXXXXXXXLLLWKWKQRK 165
             + G  TE H L SWE +S+LD  + + R                      +++W  KQRK
Sbjct:   254 AAGTNTEEHRLLSWELSSSLDSDKADSRIGLVIGISASGFVFLTFMVITTVVVWSRKQRK 313

Query:   166 ----ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN 221
                 + E    +N DL R+AGPR+FSYKDL SATN FS+ RKLG+GGFGAVY G L ++N
Sbjct:   314 KKERDIENMISINKDLEREAGPRKFSYKDLVSATNRFSSHRKLGEGGFGAVYEGNLKEIN 373

Query:   222 MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD 281
               VAVKK+S   + GKNE++ EVK  S+LRHRNL+QLIG C+++ EF+L+YE +PNGSL+
Sbjct:   374 TMVAVKKLSGDSRQGKNEFLNEVKIISKLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLN 433

Query:   282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL 341
              HLF K+     L+W  RYKI LGLASALLYLHEEW +CV+HRDIK SNIM D++FNVKL
Sbjct:   434 SHLFGKRPN--LLSWDIRYKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKL 491

Query:   342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
             GDFGLA L++HELG  TTGLAGT GYMAPEY+  G A
Sbjct:   492 GDFGLARLMNHELGSHTTGLAGTFGYMAPEYVMKGSA 528

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 543 (196.2 bits), Expect = 3.0e-72, Sum P(4) = 3.0e-72
 Identities = 109/223 (48%), Positives = 144/223 (64%)

Query:   157 LLWKWKQR-KETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRG 215
             L W + ++ K  E       ++ +   P+ FSYK+L + T NF+  R +G G FG VYRG
Sbjct:   336 LFWVYSKKFKRVERSDSFASEIIK--APKEFSYKELKAGTKNFNESRIIGHGAFGVVYRG 393

Query:   216 ILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM 275
             IL +    VAVK+ S   +  KNE+++E+     LRHRNL++L G CH++GE +LVY+ M
Sbjct:   394 ILPETGDIVAVKRCSHSSQDKKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLM 453

Query:   276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT 335
             PNGSLD  LF  + T   L W  R KI LG+ASAL YLH E +  V+HRD+K SNIM D 
Sbjct:   454 PNGSLDKALFESRFT---LPWDHRKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDE 510

Query:   336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
              FN KLGDFGLA  ++H+  P  T  AGT+GY+APEY+ TGRA
Sbjct:   511 SFNAKLGDFGLARQIEHDKSPEATVAAGTMGYLAPEYLLTGRA 553

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 517 (187.1 bits), Expect = 1.1e-70, Sum P(4) = 1.1e-70
 Identities = 110/223 (49%), Positives = 144/223 (64%)

Query:   158 LWKWKQRK-ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGI 216
             L KWK  K E E  T    +L    G R FSYK+L +AT  F + R +G+G FG VYR +
Sbjct:   330 LKKWKSVKAEKELKT----ELI--TGLREFSYKELYTATKGFHSSRVIGRGAFGNVYRAM 383

Query:   217 LIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP 276
              +      AVK+       GK E++ E+   + LRH+NL+QL G C+++GE +LVYEFMP
Sbjct:   384 FVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMP 443

Query:   277 NGSLDFHLFSKKSTGT-PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT 335
             NGSLD  L+ +  TG   L W+ R  I++GLASAL YLH E ++ VVHRDIK SNIM D 
Sbjct:   444 NGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDI 503

Query:   336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
             +FN +LGDFGLA L +H+  P +T  AGT+GY+APEY+  G A
Sbjct:   504 NFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYGTA 546

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 543 (196.2 bits), Expect = 5.7e-68, Sum P(4) = 5.7e-68
 Identities = 103/204 (50%), Positives = 136/204 (66%)

Query:   175 DDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK 234
             DD   + G  RF +K+L  AT  F  +  LG GGFG VYRGIL    + VAVK++S   K
Sbjct:   324 DDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSK 383

Query:   235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
              G  E++ E+ +  ++ HRNL+ L+G C  RGE +LVY++MPNGSLD +L++   T   L
Sbjct:   384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPET--TL 441

Query:   295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
              W  R  I  G+AS L YLHEEW++ V+HRD+K SN++ D DFN +LGDFGLA L DH  
Sbjct:   442 DWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGS 501

Query:   355 GPRTTGLAGTLGYMAPEYISTGRA 378
              P+TT + GTLGY+APE+  TGRA
Sbjct:   502 DPQTTHVVGTLGYLAPEHSRTGRA 525

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 3.4e-66, Sum P(4) = 3.4e-66
 Identities = 99/198 (50%), Positives = 135/198 (68%)

Query:   180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE 239
             D GP RFSY++L  ATN F ++  LG GGFG VY+G L   +  VAVK+IS   + G  E
Sbjct:   328 DFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVRE 387

Query:   240 YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
             +++EV +   LRHRNL+QL+G C  R + +LVY+FMPNGSLD +LF +      LTW  R
Sbjct:   388 FMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPE-VILTWKQR 446

Query:   300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
             +KI  G+AS LLYLHE W++ V+HRDIK +N++ D++ N ++GDFGLA L +H   P  T
Sbjct:   447 FKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGAT 506

Query:   360 GLAGTLGYMAPEYISTGR 377
              + GT GY+APE   +G+
Sbjct:   507 RVVGTFGYLAPELTKSGK 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 526 (190.2 bits), Expect = 6.4e-66, Sum P(3) = 6.4e-66
 Identities = 121/323 (37%), Positives = 167/323 (51%)

Query:    66 NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERHVLKSWEFN-- 123
             N + H       KI   S TK+LS    Y     Y    T++TGR    H +  W F   
Sbjct:   206 NVTIHPIHLPKPKIPLLSLTKDLSP---YLFDSMYVGF-TSATGRLRSSHYILGWTFKLN 261

Query:   124 ---STLDIKEI-----NGRETXXXXXXXXXXXXXXXXXXXLLLWKWKQRKETETFTWVND 175
                S +DI  +     + R T                    L   +    + +    V +
Sbjct:   262 GTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLMEVLE 321

Query:   176 DLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH 235
             D     GP RF+YKDL  AT  F N   LG+GGFG VY+G L   NM +AVKK+S   + 
Sbjct:   322 DWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQ 381

Query:   236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT 295
             G  E++ E+ T  +LRH NL++L+G C  +GE  LVY+ MP GSLD  L+ +      L 
Sbjct:   382 GMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQS--LD 439

Query:   296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG 355
             W+ R+KI   +AS L YLH +W + ++HRDIK +N++ D   N KLGDFGLA L +H   
Sbjct:   440 WSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFD 499

Query:   356 PRTTGLAGTLGYMAPEYISTGRA 378
             P+T+ +AGT GY++PE   TG+A
Sbjct:   500 PQTSNVAGTFGYISPELSRTGKA 522

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 4.9e-64, Sum P(3) = 4.9e-64
 Identities = 96/217 (44%), Positives = 140/217 (64%)

Query:   162 KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN 221
             ++RK  E F    +D   + G  R  +KDL  AT  F ++  LG GGFG VYRG++    
Sbjct:   323 RRRKFAEEF----EDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTK 378

Query:   222 MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD 281
               +AVK++S   + G  E++ E+ +  ++ HRNL+ L+G C  R E +LVY++MPNGSLD
Sbjct:   379 KEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLD 438

Query:   282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL 341
              +L+        L W  R+ + +G+AS L YLHEEW++ V+HRDIK SN++ D ++N +L
Sbjct:   439 KYLYDCPEV--TLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRL 496

Query:   342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
             GDFGLA L DH   P+TT + GT GY+AP+++ TGRA
Sbjct:   497 GDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRA 533

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 528 (190.9 bits), Expect = 1.3e-63, Sum P(3) = 1.3e-63
 Identities = 95/206 (46%), Positives = 139/206 (67%)

Query:   175 DDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK 234
             ++  ++ G  RF +KDL  AT  F  +  LG GGFG+VY+G++    + +AVK++S   +
Sbjct:   324 EEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESR 383

Query:   235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
              G  E++ E+ +  ++ HRNL+ L+G C  RGE +LVY++MPNGSLD +L++       L
Sbjct:   384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEV--TL 441

Query:   295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
              W  R K+ LG+AS L YLHEEW++ V+HRD+K SN++ D + N +LGDFGLA L DH  
Sbjct:   442 NWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGS 501

Query:   355 GPRTTGLAGTLGYMAPEYISTGRARL 380
              P+TT + GTLGY+APE+  TGRA +
Sbjct:   502 DPQTTHVVGTLGYLAPEHTRTGRATM 527

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 522 (188.8 bits), Expect = 2.1e-63, Sum P(3) = 2.1e-63
 Identities = 98/214 (45%), Positives = 139/214 (64%)

Query:   165 KETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAV 224
             K    F    +D   + G  R  +KDL  AT  F ++  LG GGFG+VY+GI+      +
Sbjct:   317 KRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEI 376

Query:   225 AVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL 284
             AVK++S   + G  E++ E+ +  Q+ HRNL+ L+G C  R E +LVY++MPNGSLD +L
Sbjct:   377 AVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYL 436

Query:   285 FSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
             ++  S    L W  R+K+  G+ASAL YLHEEW++ V+HRD+K SN++ D + N +LGDF
Sbjct:   437 YN--SPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDF 494

Query:   345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA 378
             GLA L DH   P+TT + GT GY+AP++I TGRA
Sbjct:   495 GLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRA 528

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LXA5	LRK91_ARATH	2, ., 7, ., 1, 1, ., 1	0.5125	0.9389	0.6620	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_III000739 hypothetical protein (651 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	459
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-32
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	2e-30
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-25
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	6e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-05
cd01951	223	cd01951, lectin_L-type, legume lectins	9e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.003
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (385), Expect = 5e-43
 Identities = 73/264 (27%), Positives = 107/264 (40%), Gaps = 54/264 (20%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNE-YITEVKTCSQLRHRNL 255
           +   RKLG G FG VY+         VAVK +  R  K  K++    E++   +L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++LI    D+    LV E+   G L  +L    S G PL+     KI+L +   L YLH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
                ++HRD+K  NI+ D +  VK+ DFGLA  +  +     T   GT  YMAPE +  
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLG 172

Query: 376 GR---ARLDV-------------------------------------NFDEQQTDCLMIV 395
           G     ++DV                                      FDE +       
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232

Query: 396 GL----WCAHPDRNCRPSIRQAIQ 415
                  C + D + RP+  + +Q
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (383), Expect = 1e-42
 Identities = 62/176 (35%), Positives = 86/176 (48%), Gaps = 12/176 (6%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNLL 256
           +    KLG+G FG VY          VA+K I +       E I  E+K   +L+H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKISLGLASALLYLHE 315
           +L  +  D  +  LV E+   G L   L  +      L+    R+     + SAL YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG----RLSEDEARF-YLRQILSALEYLH- 114

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              + +VHRD+K  NI+ D D +VKL DFGLA  +D   G + T   GT  YMAPE
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPE 166

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  146 bits (371), Expect = 2e-41
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 31/230 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLC 262
           LG+GGFG VY          VA+K I +        E + E++   +L H N+++L G+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            D     LV E+   GSL   L   +     L+     +I L +   L YLH      ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 323 HRDIKFSNIMPD-TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLD 381
           HRD+K  NI+ D  +  VKL DFGL+ L+  +       + GT  YMAPE +      L 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVL------LG 167

Query: 382 VNFDEQQTD-----CLM---------IVGLWCAHPDRNCRPSIRQAIQVL 417
             +  +++D      ++         I  +     D   RPS ++ ++ L
Sbjct: 168 KGYYSEKSDIWSLGVILYELPELKDLIRKML--QKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  136 bits (345), Expect = 4e-37
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 13/186 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQ 257
           +KLG+G FG VY+G L   +     VAVK +        + +++ E +   +L H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST-----GTPLTWTTRYKISLGLASALLY 312
           L+G+C +     LV E+M  G L  +L   +        + L+       ++ +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPE 371
           L     +  VHRD+   N +   D  VK+ DFGL+  V  +   R        + +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 372 YISTGR 377
            +  G 
Sbjct: 178 SLKDGI 183

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (334), Expect = 1e-35
 Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 199 SNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGLKHG-----KNEYITEVKTCSQ 249
           +  +KLG+G FG VY+G L          VAVK     LK         E++ E +   +
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT----LKEDASEQQIEEFLREARIMRK 57

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           L H N+++L+G+C +    M+V E+MP G L  +L  +K+    L+ +     +L +A  
Sbjct: 58  LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARG 115

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           + YL    K   +HRD+   N +   +  VK+ DFGL+  +  +   +  G    + +MA
Sbjct: 116 MEYLES--KNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172

Query: 370 PEYISTGR 377
           PE +  G+
Sbjct: 173 PESLKEGK 180

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (332), Expect = 2e-35
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 19/188 (10%)

Query: 199 SNERKLGQGGFGAVYRGILIDLNMA----VAVKKISRGLKHGKN-----EYITEVKTCSQ 249
           +  +KLG+G FG VY+G L          VAVK     LK   +     E++ E +   +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT----LKEDASEQQIEEFLREARIMRK 57

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           L H N+++L+G+C +     +V E+M  G L  +L   +     L+ +     +L +A  
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARG 114

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           + YL    K   +HRD+   N +   +  VK+ DFGL+  +  +   R  G    + +MA
Sbjct: 115 MEYLES--KNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171

Query: 370 PEYISTGR 377
           PE +  G+
Sbjct: 172 PESLKEGK 179

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (331), Expect = 4e-35
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 16/184 (8%)

Query: 202 RKLGQGGFGAVYRGILIDL----NMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLL 256
           +KLG+G FG VY+G L          VAVK +  G     + E++ E     +L H N++
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L+G+C       +V E+MP G L   L   +  G  LT     +++L +A  + YL   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES- 120

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG---YMAPEYI 373
            K   VHRD+   N +   +  VK+ DFGL+  +  +   R  G  G      +MAPE +
Sbjct: 121 -KNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESL 176

Query: 374 STGR 377
             G+
Sbjct: 177 KDGK 180

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (310), Expect = 2e-32
 Identities = 60/177 (33%), Positives = 85/177 (48%), Gaps = 8/177 (4%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           F    K+G+GGFG VY+         VA+K I    K  K + I E++   + +H N+++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
             G    + E  +V EF   GSL   L   KST   LT +    +   L   L YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              ++HRDIK +NI+  +D  VKL DFGL+             + GT  +MAPE I+
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVIN 170

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  117 bits (296), Expect = 2e-30
 Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 27/146 (18%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
           P  S GG+LGLFNS+    SS+ IV VEFD+F NPE+   +  + VGI+ +S+VS     
Sbjct: 94  PPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDD-NHVGIDVNSLVSVKAGY 152

Query: 65  WNAS---FHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT--------------- 106
           W+       SG      I Y+S++K LS + +Y    K   +                  
Sbjct: 153 WDDDGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAK--PKKPLLSYPVDLSKVLPEEV 210

Query: 107 ------STGRYTERHVLKSWEFNSTL 126
                 STG  TE H + SW F+S  
Sbjct: 211 YVGFSASTGLLTELHYILSWSFSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (290), Expect = 2e-29
 Identities = 62/183 (33%), Positives = 87/183 (47%), Gaps = 18/183 (9%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
             LG+G FG+VY  +  D    +AVK +  S   +        E++  S L+H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 260 GLCHDRGE-----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           G   D  +     F+   E++  GSL   L  KK    P     +Y  +  +   L YLH
Sbjct: 66  GSERDEEKNTLNIFL---EYVSGGSLSSLL--KKFGKLPEPVIRKY--TRQILEGLAYLH 118

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
                 +VHRDIK +NI+ D+D  VKL DFG A  L D E G  T  + GT  +MAPE I
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 374 STG 376
              
Sbjct: 176 RGE 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 4e-28
 Identities = 58/175 (33%), Positives = 90/175 (51%), Gaps = 14/175 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISR-GLKHGK-NEYITEVKTCSQLRHRNLLQLIG 260
            +G+G FG VY+G+ ++    VA+K+IS   +K       + E+     L+H N+++ IG
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYLHEEWK 318
                    ++ E+  NGSL      KK    P +    Y  ++  GLA    YLHE+  
Sbjct: 67  SIETSDSLYIILEYAENGSL--RQIIKKFGPFPESLVAVYVYQVLQGLA----YLHEQ-- 118

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
             V+HRDIK +NI+   D  VKL DFG+A  ++ ++      + GT  +MAPE I
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 31/184 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE----YITEVKTCSQLRHRNLLQ 257
            ++G+G +G VY+         VA+KKI   +++ K       I E+K   +LRH N+++
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 258 LIGLC--HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG--------LA 307
           L  +     +G   +V+E+M +   D        TG  L  +   K +          L 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH---DL-------TG--LLDSPEVKFTESQIKCYMKQLL 110

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             L YLH      ++HRDIK SNI+ + D  +KL DFGLA           T    TL Y
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167

Query: 368 MAPE 371
             PE
Sbjct: 168 RPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 18/183 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG----KNEYITEVKTCSQLRH 252
            +   +++G+G FG VY            +K+I   L +     + + + EVK   +L H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++      ++G+  +V E+   G L   +  +K  G P          + L  AL Y
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA----GTLGYM 368
           LH    R ++HRDIK  NI   ++  VKLGDFG++ ++       T  LA    GT  Y+
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-----TVDLAKTVVGTPYYL 170

Query: 369 APE 371
           +PE
Sbjct: 171 SPE 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (264), Expect = 4e-25
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 23/257 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRH- 252
           ++   RKLG+G FG VY          VA+K +++ L+    E   ++ E++  + L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L     D G   LV E++  GSL   L  K     PL+ +    I   + SAL Y
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHELGP-----RTTGLAGTLG 366
           LH    + ++HRDIK  NI+ D D   VKL DFGLA L+             +   GT G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 367 YMAPEYIS-TGRARLDVNFDEQQTDCLMIVGL-----WCAHPDRNCRPSIRQAIQVLNFE 420
           YMAPE +     A    + D       +   L     +    + +      + I  L   
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 421 TKMPNLPSKMPVAIFEA 437
           +    L    P  I +A
Sbjct: 234 SLASPLSPSNPELISKA 250

Length = 384

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  102 bits (256), Expect = 6e-25
 Identities = 49/141 (34%), Positives = 71/141 (50%), Gaps = 25/141 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVY-- 62
           P  S GG+LGLFNS+    SS+ IV VEFD+F NPE++ I+  + VGI+ +SI+S     
Sbjct: 94  PGASSGGYLGLFNSSNNGNSSNHIVAVEFDTFLNPEFNDID-DNHVGIDVNSIISVASES 152

Query: 63  ---TRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT------------- 106
                 +   +SG    V I Y+ ++K LS + +Y   PK    + +             
Sbjct: 153 ASFVPLD--LNSGKPIQVWIDYDGSSKRLSVTLAYPNKPKRPLLSASVDLSTVLPEWVYV 210

Query: 107 ----STGRYTERHVLKSWEFN 123
               STG  TE H + SW F+
Sbjct: 211 GFSASTGGATESHYVLSWSFS 231

Length = 231

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 8/172 (4%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNLLQLIGL 261
            LGQG  G VY+          A+KKI         + +  E+KT        +++  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
            +  GE  +V E+M  GSL   L        P+      +I  GL     YLH   KR +
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD----YLHT--KRHI 121

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +HRDIK SN++ ++   VK+ DFG++ ++++ L    T + GT+ YM+PE I
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 57/193 (29%), Positives = 82/193 (42%), Gaps = 19/193 (9%)

Query: 189 KDLASA---TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVK 245
           KD+ S       + N  K+G+G  G VY+         VA+KK+ R  K  K   I E+ 
Sbjct: 9   KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEIL 67

Query: 246 TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL----DFHLFSKKSTGTPLTWTTRYK 301
                +H N++          E  +V E+M  GSL      +          +       
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV-------RMNEPQIAY 120

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +   +   L YLH    + V+HRDIK  NI+   D +VKL DFG A  +  E   R + +
Sbjct: 121 VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-V 176

Query: 362 AGTLGYMAPEYIS 374
            GT  +MAPE I 
Sbjct: 177 VGTPYWMAPEVIK 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 7e-22
 Identities = 62/188 (32%), Positives = 90/188 (47%), Gaps = 18/188 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYIT---EVKTCSQL 250
            N+   + LGQG FG VY    +D    +AVK++         K E      E++    L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +H  ++Q  G   D     +  E+MP GS+   L   K+ G  LT T   K +  +   +
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYG-ALTETVTRKYTRQILEGV 117

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG----LALLVDHELGPRTTGLAGTLG 366
            YLH      +VHRDIK +NI+ D+  NVKLGDFG    L  +     G ++  + GT  
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172

Query: 367 YMAPEYIS 374
           +M+PE IS
Sbjct: 173 WMSPEVIS 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 13/185 (7%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---RGLKHGKNEYITEVKTCSQLR 251
             NF  E+K+G+G F  VY+ I +     VA+KK+          + + + E+    QL 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++ +    +  E  +V E    G L   +   K     +   T +K  + L SAL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT---GLAGTLGYM 368
           ++H   KR ++HRDIK +N+       VKLGD GL          +TT    L GT  YM
Sbjct: 121 HMHS--KR-IMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPYYM 173

Query: 369 APEYI 373
           +PE I
Sbjct: 174 SPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 50/212 (23%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYIT-EVKTCSQL-R 251
           ++F   + +G+G F  V      + N   A+K + +    K  K +Y+  E +  ++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNG----------SLDFHLFSKKSTGTPLTWTTRYK 301
           H  +++L     D      V E+ PNG          SLD                TR+ 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-------------CTRF- 106

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP----- 356
            +  +  AL YLH    + ++HRD+K  NI+ D D ++K+ DFG A ++D    P     
Sbjct: 107 YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 357 --------------RTTGLAGTLGYMAPEYIS 374
                         R     GT  Y++PE ++
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 6/153 (3%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           F+ ERKLG G FG V+ G+  +  + VA+K +       + ++  EV+   +LRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L  +C       ++ E M  GSL    F +   G  L   +   ++  +A  + YL E  
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-- 122

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   NI+   D   K+ DFGLA L+
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 18/182 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGL-KHGKNEYITEVKTCSQLRHRN 254
           +F    K+G+G FG V++ +        A+K+I    + +  + E I E +  ++L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT----WTTRYKISLGLASAL 310
           +++      D+G+  +V E+  NG L  H   K   G PL     W    +I LGLA   
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLA--- 115

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMA 369
            +LH    + ++HRDIK  N+  D   NVK+GD G+A LL D+     T  + GT  Y++
Sbjct: 116 -HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLS 169

Query: 370 PE 371
           PE
Sbjct: 170 PE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.6 bits (226), Expect = 2e-20
 Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 18/180 (10%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE------YITEVKTCSQLR 251
           +    KLG+G +G VY+         VA+KKI    +    E       + E+    +L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELK 56

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L+ + H   +  LV+E+     +D   +  K  G PL+      I   L   L 
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLA 112

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H      ++HRD+K  NI+ + D  +KL DFGLA      L   T  +  TL Y APE
Sbjct: 113 YCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 11/173 (6%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEY-ITEVKTCSQLRHRNLLQLIG 260
           LG+G FG V      D     A+K + +   +K  + E+ +TE    S++ H  +++L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                 +  LV E+ P G L  HL   K           Y  +  +  AL YLH      
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFY--AAEIVLALEYLHS---LG 113

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +++RD+K  NI+ D D ++KL DFGLA  +  E G RT    GT  Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFCGTPEYLAPEVL 165

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 60/181 (33%), Positives = 86/181 (47%), Gaps = 12/181 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLN--MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
            K+G G FG VY  + +D    MAV   +I         E   E+K    L+H NL++  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G+   R +  +  E+   G+L+     +            Y  +L L   L YLH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLE--ELLEHGRILDEHVIRVY--TLQLLEGLAYLHSHG-- 119

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHE--LGPRTTGLAGTLGYMAPEYISTG 376
            +VHRDIK +NI  D +  +KLGDFG A+ L ++   +G     LAGT  YMAPE I+ G
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 377 R 377
           +
Sbjct: 179 K 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 7e-20
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 11/176 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG VY+G+ +      +AVAVK           E ++ E     Q  H ++++
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +   + +V E  P G L  +L   K     L   +    S  L++AL YL    
Sbjct: 72  LIGVITENPVW-IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES-- 125

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           KR V HRDI   N++  +   VKLGDFGL+  ++ E   + +     + +MAPE I
Sbjct: 126 KRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 9e-20
 Identities = 52/178 (29%), Positives = 73/178 (41%), Gaps = 9/178 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYITEVKTCSQLRHR 253
           N +     +G+G +G V +         VA+K  K S   +  K   + EVK   QLRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++ L      +G   LV+E++    L+  L      G P      Y     L  A+ Y 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSY--IWQLLQAIAYC 116

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           H      ++HRDIK  NI+      +KL DFG A  +        T    T  Y APE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 12/182 (6%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHR 253
           +F   R +G+G FG V      D     A+K +++     K      + E +   +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            L+ L     D     LV + +  G L +HL S+K   +      ++ I   +  AL YL
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQ--VKFWIC-EIVLALEYL 116

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H    + ++HRDIK  NI+ D   +V + DF +A  V       TT  +GT GYMAPE +
Sbjct: 117 HS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVL 171

Query: 374 ST 375
             
Sbjct: 172 CR 173

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 9/178 (5%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIG 260
            K+G+G FG VY+G+L   N  VAVK     L    K +++ E +   Q  H N+++LIG
Sbjct: 1   EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +C  +    +V E +P GSL   L  KK+    LT     ++SL  A+ + YL     + 
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLES---KN 113

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYISTGR 377
            +HRD+   N +   +  +K+ DFG++   +  +   + GL    + + APE ++ GR
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 64/188 (34%), Positives = 91/188 (48%), Gaps = 23/188 (12%)

Query: 199 SNERK-LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           + ER  LG+G +G VY    +   + +A+K+I             E+   S L+HRN++Q
Sbjct: 10  NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSK----KSTGTPLTWTTRYKISLGLASALLYL 313
            +G   + G F +  E +P GSL   L SK    K     + + T+ +I  GL     YL
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEGLK----YL 124

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFG----LALLVDHELGPRTTGLAGTLGYM 368
           H+     +VHRDIK  N++ +T   V K+ DFG    LA      + P T    GTL YM
Sbjct: 125 HDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-----GINPCTETFTGTLQYM 176

Query: 369 APEYISTG 376
           APE I  G
Sbjct: 177 APEVIDKG 184

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 8/144 (5%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           +G+G FG V  G        VAVK +          ++ E    + LRH NL+QL+G+  
Sbjct: 14  IGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
                 +V E+M  GSL  +L S+      +T   +   +L +   + YL EE     VH
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYL-EEKN--FVH 125

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLA 347
           RD+   N++   D   K+ DFGLA
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 60/175 (34%), Positives = 86/175 (49%), Gaps = 14/175 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-----EYITEVKTCSQLRHRNLLQL 258
           LG G FG+VY G+ +D     AVK++S             +   E+   S+L+H N++Q 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           +G   +     +  E +P GSL   L    S   P+      +I LGL     YLH+   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE----YLHD--- 120

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           R  VHRDIK +NI+ DT+  VKL DFG+A  V      ++    G+  +MAPE I
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHRNL 255
           +    K+G+G +G VY+         VA+KKI    +        + E+K   +L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++L+ +   +G+  LV+EFM        L   +  G P +    Y     L   L + H 
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSY--LYQLLQGLAFCHS 116

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                ++HRD+K  N++ +T+  +KL DFGLA      + P T  +  T  Y APE
Sbjct: 117 HG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPE 168

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 19/162 (11%)

Query: 202 RKLGQGGFGAVYRGILIDLN-----MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNL 255
           R+LG+G FG V+ G    L        VAVK +        + ++  E +  +  +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSL---------DFH-LFSKKSTGTPLTWTTRYKISLG 305
           ++  G+C +    ++V+E+M +G L         D   L S  S    LT +   +I++ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +AS ++YL  +     VHRD+   N +   D  VK+GDFG++
Sbjct: 131 IASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 61/182 (33%), Positives = 85/182 (46%), Gaps = 17/182 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRHRNLLQ 257
           ERKLG G FG V+ G   +    VAVK     LK G      ++ E +   +LRH  L+Q
Sbjct: 11  ERKLGAGQFGEVWMG-TWNGTTKVAVKT----LKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 258 LIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           L  +C +     +V E+M  GSL D   F K   G  L       ++  +A  + YL   
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLD---FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES- 121

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIST 375
             R  +HRD+   NI+   +   K+ DFGLA L+ D E   R  G    + + APE  + 
Sbjct: 122 --RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPEAANY 178

Query: 376 GR 377
           GR
Sbjct: 179 GR 180

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 24/184 (13%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRN 254
           F+    +G+G FG VY+ I    N  VA+K I   L+  ++E      E++  SQ R   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLASA 309
           + +  G      +  ++ E+   GS    L       +              I   +   
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAF---------ILREVLLG 110

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L YLHEE K   +HRDIK +NI+   + +VKL DFG++  +   +  R T   GT  +MA
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMA 166

Query: 370 PEYI 373
           PE I
Sbjct: 167 PEVI 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 9/172 (5%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQLI 259
            ++G+G  G V++    +    VA+KK++     G   N+ + E+K     +H  +++L+
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
            +      F+LV E+MP   L   L   +    PL           L   + Y+H     
Sbjct: 66  DVFPHGSGFVLVMEYMP-SDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            ++HRD+K +N++   D  +K+ DFGLA L   E     +    T  Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQL-RHRNLLQL 258
           ++LG G FG+VY     +    VA+KK+ +       E +   EVK+  +L  H N+++L
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKL 63

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
             +  +  E   V+E+M  G+L + L  K   G P + +    I   +   L ++H   K
Sbjct: 64  KEVFRENDELYFVFEYM-EGNL-YQLM-KDRKGKPFSESVIRSIIYQILQGLAHIH---K 117

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
               HRD+K  N++      VK+ DFGLA
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLA 146

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 7/178 (3%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            +G+G FG V +         +  K+I  G   +  K + ++EV    +L+H N+++   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 261 LCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH--EE 316
              DR      +V E+   G L   +   K     +     ++I   L  AL   H   +
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
               V+HRD+K +NI  D + NVKLGDFGLA ++ H+     T   GT  YM+PE ++
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQLN 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 17/181 (9%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           F    KLG+G +G+VY+ I  +    VA+K +   ++    E I E+    Q     +++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 258 LIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALL---YL 313
             G      +  +V E+   GS  D      K T   LT     +I+  L   L    YL
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDI----MKITNKTLT---EEEIAAILYQTLKGLEYL 115

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H   K   +HRDIK  NI+ + +   KL DFG++  +   +  R T + GT  +MAPE I
Sbjct: 116 HSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVI 171

Query: 374 S 374
            
Sbjct: 172 Q 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 21/179 (11%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           ++G G +G VY+   I     VA+K I             E+    + RH N++   G  
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 263 HDRGEFMLVYEFMPNGSLD--FHLFSKKSTGTPLT-----WTTRYKISLGLASALLYLHE 315
             R +  +V E+   GSL   + +     T  PL+     +  R  +  GLA    YLHE
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQV-----TRGPLSELQIAYVCRETL-KGLA----YLHE 119

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
             K   +HRDIK +NI+   D +VKL DFG++  +   +  R +   GT  +MAPE  +
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAA 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 65/180 (36%), Positives = 83/180 (46%), Gaps = 17/180 (9%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK---NEYITEVKTCSQLRHRN 254
           F++ R++G G FGAVY    +  N  VA+KK+S   K       + I EV+   QLRH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 255 LLQLIGLCHDRGEFM-LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            ++  G C+ R     LV E+    + D     KK    PL       I  G    L YL
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKK----PLQEVEIAAICHGALQGLAYL 131

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H       +HRDIK  NI+      VKL DFG A LV     P  +   GT  +MAPE I
Sbjct: 132 HS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS-FVGTPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 13/179 (7%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK---NEYITEVKTCSQLRHRNLLQL 258
           RKLG G FG V+ G L +    VAVK     LK G     +++ E +   +LRH  L+QL
Sbjct: 12  RKLGAGQFGEVWEG-LWNNTTPVAVKT----LKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
             +C       +V E M  GSL  +L  +   G  L       ++  +AS + YL     
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEA--- 121

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +  +HRD+   N++   +   K+ DFGLA ++  ++     G    + + APE     R
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 59/187 (31%), Positives = 93/187 (49%), Gaps = 24/187 (12%)

Query: 202 RKLGQGGFGAVYRGILIDLN---MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG+V +G+ +  +   + VAVK + +  +  GK E++ E    +QL H  +++
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 258 LIGLCHDRGE-FMLVYEFMPNGSLDFHLFSKKSTGTP----LTWTTRYKISLGLASALLY 312
           LIG+C  +GE  MLV E  P G L    + KK    P           ++++G+A    Y
Sbjct: 61  LIGVC--KGEPLMLVMELAPLGPL--LKYLKKRREIPVSDLKELAH--QVAMGMA----Y 110

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAP 370
           L  E K   VHRD+   N++       K+ DFG+  AL    +    TT     L + AP
Sbjct: 111 L--ESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167

Query: 371 EYISTGR 377
           E I+ G+
Sbjct: 168 ECINYGK 174

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 8/175 (4%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           ++G G FG V+ G  ++    VA+K I  G    + ++I E +   +L H  L+QL G+C
Sbjct: 11  EIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +R    LV+EFM +G L  +L +++      +  T   + L +   + YL       V+
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NVI 122

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           HRD+   N +   +  VK+ DFG+   V  +    +TG    + + +PE  S  +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 10/177 (5%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGFG V    +       A KK+ +     + G+   + E K   ++  R ++ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
               + +  LV   M  G L +H+++    G P      Y  +  +   L +LH+   R 
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQ---RR 115

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +V+RD+K  N++ D   NV++ D GLA  V+ + G +  G AGT GYMAPE +    
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 15/177 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLIG 260
            +LG G  G V + +       +AVK I   +      + + E+    +     ++   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYLHEEWK 318
             ++ G+  +  E+M  GSLD  +  +     P     R   KI++ +   L YLHE  K
Sbjct: 67  AFYNNGDISICMEYMDGGSLD-KILKEVQGRIP----ERILGKIAVAVLKGLTYLHE--K 119

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIS 374
             ++HRD+K SNI+ ++   +KL DFG++  LV+           GT  YMAPE I 
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQ 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 45/192 (23%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-----EVKTCSQLRHRNL 255
            +KLG+G +  VY+    +    VA+KKI  G +    + I      E+K   +L+H N+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 256 LQLIGLCHDRGEFMLVYEFMP--------NGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           + L+ +   +    LV+EFM         + S+       KS              L   
Sbjct: 65  IGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKS------------YMLMTL 112

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG---- 363
             L YLH  W   ++HRD+K +N++  +D  +KL DFGLA         R+ G       
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA---------RSFGSPNRKMT 160

Query: 364 ----TLGYMAPE 371
               T  Y APE
Sbjct: 161 HQVVTRWYRAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 27/187 (14%)

Query: 201 ERKLGQGGFGAVYRGIL-------IDLNMAVAVKKISRGLKHG-----KNEYITEVKTCS 248
           E+ +G G FG V RG L       ID    VA+K     LK G     + +++TE     
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEID----VAIKT----LKAGSSDKQRLDFLTEASIMG 60

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           Q  H N+++L G+       M++ E+M NGSLD  L   +      T      +  G+AS
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIAS 117

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT-GLAGTLGY 367
            + YL E      VHRD+   NI+ +++   K+ DFGL+  ++      TT G    + +
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174

Query: 368 MAPEYIS 374
            APE I+
Sbjct: 175 TAPEAIA 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 6/169 (3%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+QL+G+C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL    K+  +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 12/181 (6%)

Query: 203 KLGQGGFGAVYRGILIDLN---MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQL 258
           KLG G FG V RG         + VAVK +    L    ++++ E      L H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
            G+       M+V E  P GSL   L  +K        +T    ++ +A+ + YL    K
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLES--K 116

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           R + HRD+   NI+  +D  VK+GDFGL  AL  + +       L     + APE + T 
Sbjct: 117 RFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 377 R 377
            
Sbjct: 176 T 176

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 12/185 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLR 251
           ++ + ++ +G G FG V+RGIL       +AVA+K +  G  +  + ++++E     Q  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L G+       M++ E+M NG+LD +L       +        +   G+A+ + 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMA 369
           YL +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T+G    + + A
Sbjct: 122 YLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 370 PEYIS 374
           PE I+
Sbjct: 179 PEAIA 183

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 28/212 (13%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRH 252
           TN + + + +G G FG V           VA+KKI +          T  E+K    LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 253 RNLLQLIGLC----HDRGEFMLVYEFMPNGSLDFH-LFSKKSTGTPLTWTTRYKISLGLA 307
            N+   I L         +   V E +     D H L + +           Y+I  GL 
Sbjct: 69  ENI---ISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQILRGLK 122

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
               Y+H      VVHRD+K SNI+ + + ++K+ DFGLA + D    P+ TG   T  Y
Sbjct: 123 ----YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYY 171

Query: 368 MAPEYISTGRARLDVNFDEQQTDCL---MIVG 396
            APE + T + + DV  D     C+   M+ G
Sbjct: 172 RAPEIMLTWQ-KYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 20/189 (10%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLR 251
           N+   + LGQG FG VY    +D    +A K++     S       +    E++    L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 252 HRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H  ++Q  G   DR E    +  E+MP GS+   L   K+ G  LT +   K +  +   
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGA-LTESVTRKYTRQILEG 118

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG----LALLVDHELGPRTTGLAGTL 365
           + YLH      +VHRDIK +NI+ D+  NVKLGDFG    L  +     G R+  + GT 
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTP 173

Query: 366 GYMAPEYIS 374
            +M+PE IS
Sbjct: 174 YWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)

Query: 204 LGQGGFGAVYRGILIDLN----MAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           LG G FG VY+G+ I       + VA+K +      K    E + E    + + H ++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-ANKEILDEAYVMASVDHPHVVR 73

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP---LTWTTRYKISLGLASALLYLH 314
           L+G+C    +  L+ + MP G L  ++ + K        L W       + +A  + YL 
Sbjct: 74  LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD-HELGPRTTGLAGTLGYMAPEYI 373
           E   + +VHRD+   N++  T  +VK+ DFGLA L+D  E      G    + +MA E I
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 374 STGR 377
               
Sbjct: 184 LHRI 187

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 53/179 (29%), Positives = 75/179 (41%), Gaps = 14/179 (7%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK---NEYITEVKTCSQLRHRNLLQLI 259
            +G G    VY  I +  N  VA+K+I   L+  +   +E   EV+  SQ  H N+++  
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
                  E  LV  ++  GSL   +         L       +   +   L YLH     
Sbjct: 66  TSFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SN 121

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFG----LALLVDHELGPRTTGLAGTLGYMAPEYIS 374
             +HRDIK  NI+   D +VK+ DFG    LA   D     R T   GT  +MAPE + 
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVME 179

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 60/208 (28%), Positives = 85/208 (40%), Gaps = 45/208 (21%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YIT---EVKTC 247
           S   ++    KLG+G FG VY+   I     VA+KKI   L H + +   IT   E+K  
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKIL 61

Query: 248 SQLRHRNLLQLIGLC--------HDRGEFMLVYEFMP---NGSL---DFHLFSKKSTGTP 293
            +L+H N++ LI +           RG   +V  +M    +G L      L   +     
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-- 119

Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD-- 351
                     L L   + YLHE     ++HRDIK +NI+ D    +K+ DFGLA   D  
Sbjct: 120 --------YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 352 --------HELGPRTTGLAGTLGYMAPE 371
                        + T L  T  Y  PE
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 55/183 (30%), Positives = 82/183 (44%), Gaps = 22/183 (12%)

Query: 202 RKLGQGGFGAVYRGI---LIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           ++LG G FG V+ G     ID    VA+K I  G    ++++I E K   +L H NL+QL
Sbjct: 10  KELGSGQFGVVHLGKWRGKID----VAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQL 64

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS----ALLYLH 314
            G+C  +    +V E+M NG L  +L  +K            +  L + S    A+ YL 
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKL-------GTEWLLDMCSDVCEAMEYLE 117

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                  +HRD+   N +   D  VK+ DFGLA  V  +    + G    + +  PE   
Sbjct: 118 S---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD 174

Query: 375 TGR 377
             R
Sbjct: 175 YSR 177

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 23/196 (11%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           FS+ R++G G FGAVY    +  +  VA+KK+S   K    ++   I EV+   +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            +Q  G         LV E+    + D     KK    PL       ++ G    L YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRD+K  NI+      VKLGDFG A ++     P      GT  +MAPE I 
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANX-FVGTPYWMAPEVI- 183

Query: 375 TGRARLDVNFDEQQTD 390
                  +  DE Q D
Sbjct: 184 -------LAMDEGQYD 192

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 16/189 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRN 254
            R+LGQG FG VY G+   +        VA+K ++       + E++ E     +    +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST------GTPLTWTTRYKISLGLAS 308
           +++L+G+       ++V E M  G L  +L S++          P T     +++  +A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGY 367
            + YL     +  VHRD+   N M   D  VK+GDFG+   + + +   +       + +
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 188 MAPESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 7/172 (4%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG G FG VY+    +  +  A K I    +    +++ E+   S+ +H N++ L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
              +  ++ EF   G+LD  +         LT      +   +  AL +LH      V+H
Sbjct: 73  YENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIH 126

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
           RD+K  NI+   D +VKL DFG++      L  R T   GT  +MAPE ++ 
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVAC 177

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 59/182 (32%), Positives = 87/182 (47%), Gaps = 19/182 (10%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH---RNLLQLI 259
           +G+G +GAVYRG  +     VA+K I+          I  EV   SQLR     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS---ALLYLHEE 316
           G         ++ E+   GS+       ++         +Y IS+ +     AL Y+H  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKY-ISVIIREVLVALKYIH-- 118

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K  V+HRDIK +NI+     NVKL DFG+A L++     R+T   GT  +MAPE I+ G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEG 176

Query: 377 RA 378
           + 
Sbjct: 177 KY 178

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 10/176 (5%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLC 262
           LG+G FG V++G L D    VAVK     L    K ++++E +   Q  H N+++LIG+C
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
             R    +V E +P G  DF  F +K     L      K +L  A+ + YL  E K C +
Sbjct: 62  TQRQPIYIVMELVPGG--DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYL--ESKNC-I 115

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYISTGR 377
           HRD+   N +   +  +K+ DFG++   D  +   ++GL    + + APE ++ GR
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGR 170

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 17/162 (10%)

Query: 202 RKLGQGGFGAVYRGILIDLN----MAVAVKKISR-GLKHGKNEYITEVKTCSQLRHRNLL 256
           ++LG+G FG V       L       VAVK ++  G +  ++++  E++    L H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHL-FSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +  G+C   G     L+ E++P+GSL  +L   +               S  +   + YL
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK----RLLLFSSQICKGMDYL 125

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHE 353
               +R + HRD+   NI+ +++  VK+ DFGLA ++  D +
Sbjct: 126 GS--QRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 60/187 (32%), Positives = 88/187 (47%), Gaps = 16/187 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLR 251
           N+   + LG+G FG VY     D    +AVK++     S+      N    E++    LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 252 HRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H  ++Q  G   D  E    +  E+MP GS+   L   K+ G  LT     + +  +   
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGA-LTENVTRRYTRQILQG 118

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD--HELGPRTTGLAGTLGY 367
           + YLH      +VHRDIK +NI+ D+  NVKLGDFG +  +      G     + GT  +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 368 MAPEYIS 374
           M+PE IS
Sbjct: 176 MSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 56/184 (30%), Positives = 78/184 (42%), Gaps = 24/184 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLR----HRNLLQL 258
           +G+G +G VY+         VA+K +   +   + E I  E      LR    H N+   
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNI---LRKYSNHPNIATF 68

Query: 259 IGL--------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            G           D  +  LV E    GS+   +   +  G  L       I       L
Sbjct: 69  YGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLHE     V+HRDIK  NI+   +  VKL DFG++  +D  LG R T + GT  +MAP
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182

Query: 371 EYIS 374
           E I+
Sbjct: 183 EVIA 186

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 38/191 (19%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLI 259
           K+GQG FG V++         VA+KK+       +   IT   E+K    L+H N++ LI
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 260 GLCH--------DRGEFMLVYEF--------MPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
            +C          +G F LV+EF        + N ++ F L   K            K+ 
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK------------KVM 125

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA---LLVDHELGPRTTG 360
             L + L Y+H   +  ++HRD+K +NI+   D  +KL DFGLA    L  +    R T 
Sbjct: 126 KMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 361 LAGTLGYMAPE 371
              TL Y  PE
Sbjct: 183 RVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 58/191 (30%), Positives = 86/191 (45%), Gaps = 33/191 (17%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLRHRN 254
           +   + +G G +G V   +       VA+KKIS     L   K     E+K    LRH N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60

Query: 255 LLQLIGL-----CHDRGEFMLVYEFMPNGSLDFH--LFSKKSTGTPLT-----WTTRYKI 302
           ++ L+ +       D  +  +V E M     D H  + S +    PLT     +   Y+I
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQ----PLTDDHIQYFL-YQI 112

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT--TG 360
             GL     YLH      V+HRD+K SNI+ +++ ++K+ DFGLA  VD +   +   T 
Sbjct: 113 LRGLK----YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 361 LAGTLGYMAPE 371
              T  Y APE
Sbjct: 166 YVVTRWYRAPE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 9/172 (5%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+GQG  G VY  I +     VA+K+++   +  K   I E+    + +H N++  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
               E  +V E++  GSL     +   T T +       +      AL +LH      V+
Sbjct: 86  LVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVI 137

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRDIK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 63/180 (35%), Positives = 82/180 (45%), Gaps = 16/180 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           LGQG FG VY     D    +AVK++     S       N    E++    L H  ++Q 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 259 IGLCHDRGEFML--VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            G   D  E  L    E MP GS+   L   KS G  LT     K +  +   + YLH  
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGA-LTENVTRKYTRQILEGVSYLHSN 125

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELGPRTTGLAGTLGYMAPEYIS 374
               +VHRDIK +NI+ D+  NVKLGDFG +  L      G     + GT  +M+PE IS
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 64/196 (32%), Positives = 80/196 (40%), Gaps = 23/196 (11%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           F    ++G G FGAVY       N  VAVKK+S   K    ++   I EVK   QL+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            ++  G         LV E+    + D     KK    PL       I+ G    L YLH
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLH 138

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRDIK  NI+      VKL DFG A               GT  +MAPE I 
Sbjct: 139 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVI- 189

Query: 375 TGRARLDVNFDEQQTD 390
                  +  DE Q D
Sbjct: 190 -------LAMDEGQYD 198

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 18/159 (11%)

Query: 204 LGQGGFGAVYRGILIDL------NMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLL 256
           LG G FG VY G   D+       + VAVK + +G     K E++ E    S   H N++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK--STGTP-LTWTTRYKISLGLASALLYL 313
           +L+G+C       ++ E M  G L  +L   +    G P LT      I L +A   +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 314 HEEWKRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLA 347
               +   +HRD+   N +      D D  VK+GDFGLA
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 35/186 (18%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ---LR---HRNL 255
            ++G G  G VY+ I        A+K I     +G +E     + C +   LR   H N+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 256 LQLIGLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASA 309
           ++    CHD     GE  ++ EFM  GSL+         GT +    ++   ++  + S 
Sbjct: 135 VK----CHDMFDHNGEIQVLLEFMDGGSLE---------GTHI-ADEQFLADVARQILSG 180

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           + YLH   +R +VHRDIK SN++ ++  NVK+ DFG++ ++   + P  + + GT+ YM+
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMS 236

Query: 370 PEYIST 375
           PE I+T
Sbjct: 237 PERINT 242

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/185 (31%), Positives = 85/185 (45%), Gaps = 17/185 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---RGLKHGKNEYITEVKTCSQLRHR 253
           NF  E+K+G+G F  VYR   +     VA+KK+          + + + E+    QL H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLD--FHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           N+++ +    +  E  +V E    G L      F K+    P    T +K  + L SA+ 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP--ERTVWKYFVQLCSAVE 120

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYM 368
           ++H    R V+HRDIK +N+       VKLGD GL      +    TT    L GT  YM
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPYYM 173

Query: 369 APEYI 373
           +PE I
Sbjct: 174 SPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 33/162 (20%)

Query: 202 RKLGQGGFGAVYRGILID---LNMAVAVKKISRGLKHGKNEYITEVKTCSQ--------- 249
           R +G+G FG VY G LID     +  AVK ++R         IT+++   Q         
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---------ITDLEEVEQFLKEGIIMK 51

Query: 250 -LRHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL- 306
              H N+L L+G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL 
Sbjct: 52  DFSHPNVLSLLGICLPSEGSPLVVLPYMKHG--DLRNFIRSETHNP---TVKDLIGFGLQ 106

Query: 307 -ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            A  + YL     +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 107 VAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLA 145

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 58/183 (31%), Positives = 84/183 (45%), Gaps = 13/183 (7%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---RGLKHGKNEYITEVKTCSQLRHR 253
           NF  E+K+G+G F  VYR   +   + VA+KK+          + + I E+    QL H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++      +  E  +V E    G L   +   K     +   T +K  + L SAL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYMAP 370
           H    R V+HRDIK +N+       VKLGD GL          +TT    L GT  YM+P
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSP 175

Query: 371 EYI 373
           E I
Sbjct: 176 ERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 17/181 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLR 251
           NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELN 57

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L+ + H   +  LV+EF+ +  L   + +   +G PL     Y   L    A  
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAP 370
           + H      V+HRD+K  N++ +T+  +KL DFGLA      +  RT T    TL Y AP
Sbjct: 117 HSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAP 169

Query: 371 E 371
           E
Sbjct: 170 E 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 62/196 (31%), Positives = 85/196 (43%), Gaps = 23/196 (11%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           F++ R++G G FGAVY    +  N  VA+KK+S   K    ++   I EVK   +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            ++  G         LV E+    + D     KK    PL       I+ G    L YLH
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLH 142

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRDIK  NI+      VKL DFG A +             GT  +MAPE I 
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVI- 193

Query: 375 TGRARLDVNFDEQQTD 390
                  +  DE Q D
Sbjct: 194 -------LAMDEGQYD 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 14/182 (7%)

Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E  +G G FG V RG L       + VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+       M++ EFM NG+LD  L       T +      +   G+A+ + YL E 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE- 124

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAG---TLGYMAPEY 372
                VHRD+   NI+ +++   K+ DFGL+  L D    P  T   G    + + APE 
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 373 IS 374
           I+
Sbjct: 183 IA 184

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 9/151 (5%)

Query: 202 RKLGQGGFGAVYRG-ILIDLNMA-VAVK--KISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +++G G FG V  G +      A V VK  ++S  ++  + +++ E +    L+H NLLQ
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQ 59

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFS-KKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            +G C +   ++LV EF P G L  +L S +K+       TT  +++  +A  LL+LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            K   +H D+   N +   D  VK+GD+GL+
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 53/185 (28%), Positives = 77/185 (41%), Gaps = 11/185 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
                  +LG+G  G+V +  L +  M  A+K I+       + + + E++     +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 255 LLQLIGLCHDRGEFML--VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           +++  G   D     +    E+   GSLD      K  G  +      KI+  +   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPE 371
           LH    R ++HRDIK SNI+      VKL DFG    V  EL     G   GT  YMAPE
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSFYMAPE 173

Query: 372 YISTG 376
            I   
Sbjct: 174 RIQGK 178

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 62/190 (32%), Positives = 91/190 (47%), Gaps = 24/190 (12%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI---SRGLKHGKNEYIT---EVKTCSQLRHRNLLQ 257
           LG+G +G VY G L +    +AVK++   +  +   + EY     EV     L+H N++Q
Sbjct: 8   LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +G C D     +  EF+P GS+   L      G PL      K +  +   + YLH   
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL---NRFG-PLPEPVFCKYTKQILDGVAYLHNN- 121

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-------LLVDHELGPRTTGLAGTLGYMAP 370
             CVVHRDIK +N+M   +  +KL DFG A       L   H    ++  + GT  +MAP
Sbjct: 122 --CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYWMAP 177

Query: 371 EYIS-TGRAR 379
           E I+ +G  R
Sbjct: 178 EVINESGYGR 187

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 10/178 (5%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 11  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 69  VVSEE-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 122

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L+ D+E   R  G    + + APE    GR
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGR 179

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 59/181 (32%), Positives = 84/181 (46%), Gaps = 15/181 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNL 255
              N  K+G+G  G V           VAVKK+    K  + E +  EV      +H N+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-RKQQRRELLFNEVVIMRDYQHPNI 78

Query: 256 LQLIG--LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +++    L  D  E  +V EF+  G+L     +   T T +       + L +  AL +L
Sbjct: 79  VEMYSSYLVGD--ELWVVMEFLEGGAL-----TDIVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H    + V+HRDIK  +I+  +D  VKL DFG    V  E+ PR   L GT  +MAPE I
Sbjct: 132 H---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVI 187

Query: 374 S 374
           S
Sbjct: 188 S 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 25/182 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNE----YITEVKTCSQLRHRNLLQ 257
           LG G F + Y+   +     +AVK+++  R     + E       E++  ++L H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           ++G   +   F L  E+M  GS+  HL SK               +  L   L YLHE  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVS-HLLSKYG---AFKEAVIINYTEQLLRGLSYLHE-- 121

Query: 318 KRCVVHRDIKFSNIMPD-TDFNVKLGDFGLALLVDHELGPRTTG-------LAGTLGYMA 369
              ++HRD+K +N++ D T   +++ DFG A      L  + TG       L GT+ +MA
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRLRIADFGAAA----RLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 370 PE 371
           PE
Sbjct: 177 PE 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G V           VA+KK+SR      H K  Y  E++    + H N
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHEN 75

Query: 255 LLQLIGLCH------DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ L+ +        D  +  LV   M    L+  +  +K +   + +   Y+I  GL  
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLV-YQILRGLK- 132

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
              Y+H      ++HRD+K SNI  + D  +K+ DFGLA   D E+    TG   T  Y 
Sbjct: 133 ---YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 182

Query: 369 APEYI 373
           APE +
Sbjct: 183 APEIM 187

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 22/155 (14%)

Query: 204 LGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYIT----EVKTCSQLRHRNL 255
           LG+G FG+V    Y  +  +    VAVKK    L+H   E++     E++    L+H N+
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKK----LQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 256 LQLIGLCHDRG--EFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           ++  G+C+  G     LV E++P GSL D+    ++            +I  G+     Y
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME----Y 123

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           L    KR V HRD+   NI+ +++  VK+GDFGL 
Sbjct: 124 LGS--KRYV-HRDLATRNILVESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 26/195 (13%)

Query: 204 LGQGGFGAVYRGILIDLN-----MAVAVKKI-SRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           LG+G FG VY+G L   N      +VA+K +        + E+  E +  S L+H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSK------------KSTGTPLTWTTRYKISLG 305
           L+G+C       +++E++ +G L   L               ++  + L  +    I++ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV---DHELGPRTTGLA 362
           +A+ + YL        VHRD+   N +      VK+ DFGL+  +   D+      + L 
Sbjct: 133 IAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 363 GTLGYMAPEYISTGR 377
             + +M PE I  G+
Sbjct: 190 --VRWMPPEAILYGK 202

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 60/184 (32%), Positives = 86/184 (46%), Gaps = 27/184 (14%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY----ITEVKTCSQLRHRNLLQLI 259
           +G+G +G VY+    D    VA+KK+   L + K  +    I E+K   QL HRN++ L 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 260 GLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL--GLA 307
            +            D+G F LV+E+M     D  L     +G  + ++  +  S    L 
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGL-VHFSEDHIKSFMKQLL 126

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             L Y H   K+  +HRDIK SNI+ +    +KL DFGLA L + E     T    TL Y
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 368 MAPE 371
             PE
Sbjct: 184 RPPE 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 30/188 (15%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRN 254
           +F   +KLG+G +G+VY+   +  N   A+K++  G   +  + + + E++  + + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 255 LLQ-----LIG--LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           ++      L G  LC       +V E+ P G L   +  +K     +     ++I + L 
Sbjct: 61  IISYKEAFLDGNKLC-------IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA----G 363
             L  LHE   + ++HRD+K +NI+   +  VK+GD G++ ++          +A    G
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIG 163

Query: 364 TLGYMAPE 371
           T  YMAPE
Sbjct: 164 TPHYMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 16/159 (10%)

Query: 202 RKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + LG+G FG+V  G L       L +AV   K+         E+++E        H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 257 QLIGLC---HDRGEF---MLVYEFMPNGSLDFHLFSKKSTGTP--LTWTTRYKISLGLAS 308
           +LIG+C       +    M++  FM +G L   L   +  G P  L   T  K  + +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + YL     R  +HRD+   N M   D  V + DFGL+
Sbjct: 125 GMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 48/153 (31%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLL 256
           R LG+G FG V    Y          VAVK + R         +  E+     L H N++
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G C ++G     L+ E++P GSL  +L  K             +I  G+A    YLH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMA----YLH 124

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            +     +HRD+   N++ D D  VK+GDFGLA
Sbjct: 125 SQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 18/181 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQ 257
            +KLG G FG V+ G   + +  VA+K     LK G      ++ E     QL+H  L++
Sbjct: 11  VKKLGAGQFGEVWMG-YYNGHTKVAIKS----LKQGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 258 LIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           L  +   +    ++ E+M NGSL DF    K   G  LT      ++  +A  + ++   
Sbjct: 66  LYAVV-TQEPIYIITEYMENGSLVDF---LKTPEGIKLTINKLIDMAAQIAEGMAFIER- 120

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIST 375
             +  +HRD++ +NI+       K+ DFGLA L+ D+E   R  G    + + APE I+ 
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINY 177

Query: 376 G 376
           G
Sbjct: 178 G 178

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 14/185 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRN 254
           F   R LG+GGFG V    +       A KK+ +     + G++  + E +   ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLY 312
           ++ L      +    LV   M  G L FH++     G        Y  +I  GL      
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED---- 117

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH+E    +V+RD+K  NI+ D   ++++ D GLA+ V    G    G  GT+GYMAPE 
Sbjct: 118 LHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEV 172

Query: 373 ISTGR 377
           +   R
Sbjct: 173 VKNER 177

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 17/166 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQL 250
           +N   +R+LG+G FG V+     +L      + VAVK +     + + ++  E +  + L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL---------DFHLFSKKSTGTPLTWTTRYK 301
           +H ++++  G+C +    ++V+E+M +G L         D  L ++ +    LT +    
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           I+  +A+ ++YL  +     VHRD+   N +   +  VK+GDFG++
Sbjct: 125 IAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS 167

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 12/180 (6%)

Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G FG V  G L       + VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+       M+V E+M NGSLD   F +K  G   T      +  G+AS + YL + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLD--AFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSD- 124

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + APE I+
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 10/178 (5%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            +KLG G FG V+ G   + N  VAVK +  G       ++ E +   +LRH  L+QL  
Sbjct: 11  IKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL    F K   G  L       ++  +A+ + Y+    +  
Sbjct: 69  VVSEE-PIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMN 122

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGYMAPEYISTGR 377
            +HRD++ +NI+       K+ DFGLA L+ D+E   R  G    + + APE    GR
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGR 179

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 10/171 (5%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGFG V    + +     A KK+ +     K G+   + E +   ++    ++ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
               +    LV   M  G L +H+++    G  +     Y  S  +   +L+LH      
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SAQITCGILHLHS---MD 115

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +V+RD+K  N++ D   N +L D GLA  V+ + G   T  AGT GYMAPE
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 8/177 (4%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGL 261
           ++G+G FG V+ G L   N  VAVK     L    K +++ E +   Q  H N+++LIG+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C  +    +V E +  G  DF  F  ++ G  L      ++    A+ + YL     +  
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES---KHC 115

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYISTGR 377
           +HRD+   N +      +K+ DFG++   +  +   T G+    + + APE ++ GR
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.2 bits (166), Expect = 9e-13
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 9/177 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++   K+GQG  G V+  I +     VA+K+I+   +  K   I E+    +L++ N++ 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +       E  +V E++  GSL     +   T T +       +      AL +LH   
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSL-----TDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              V+HRDIK  N++   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 42/158 (26%), Positives = 65/158 (41%), Gaps = 15/158 (9%)

Query: 202 RKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNL 255
           R LG G FG VY G+    +     + VAVK +           ++ E    S+  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG---TPLTWTTRYKISLGLASALLY 312
           ++LIG+  +R    ++ E M  G L   L   +      + LT       +  +A    Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 313 LHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           L E      +HRDI   N +          K+ DFG+A
Sbjct: 132 LEE--NH-FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 18/184 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRH 252
           ++F   + LG G FG V            A+K +S+   +K  + E++  E +    +RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASAL 310
             L+ L G   D     LV E++P G L F    +KS   P      Y  ++ L    AL
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHL-RKSGRFPEPVARFYAAQVVL----AL 114

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLH      +V+RD+K  N++ D+D  +K+ DFG A  V      RT  L GT  Y+AP
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYLAP 167

Query: 371 EYIS 374
           E I 
Sbjct: 168 EIIL 171

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 26/180 (14%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH----GKNEYI-TEVKTCSQLRHRNLLQL 258
           LG GGFG V    +   N   A+K + +  +H    G+ E+I +E +   +  H  +++L
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 259 IGLCHDRGEFMLVYEFMPNGSL-----DFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
                D+    ++ E+   G L     D  LF +        +T R+ I+  +  A  YL
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--------YTARFYIA-CVVLAFEYL 109

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H    R +++RD+K  N++ D++  VKL DFG A  +  + G +T    GT  Y+APE I
Sbjct: 110 HN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEII 164

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 18/182 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHR 253
            F    ++G+G +G VYR         VA+KK+ R         I+   E+     LRH 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHP 66

Query: 254 NLLQLIGLCHDR--GEFMLVYEFMPN--GSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           N+++L  +   +      LV E+      SL        +  TP + +    + L L   
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRG 120

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L YLHE     ++HRD+K SN++      +K+ DFGLA        P T  +  TL Y A
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176

Query: 370 PE 371
           PE
Sbjct: 177 PE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 10/183 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRN 254
           F   R LG+GGFG V    +       A K++ +     + G++  + E +   ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      +    LV   M  G L FH+++  + G        Y   +     L  LH
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI--LCGLEDLH 119

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            E     V+RD+K  NI+ D   ++++ D GLA+ +    G    G  GT+GYMAPE ++
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRVGTVGYMAPEVLN 174

Query: 375 TGR 377
             R
Sbjct: 175 NQR 177

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 10/178 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHR 253
             + N   +G+G +G V +    +    VA+KK   S   K  K   + E++   QLRH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           NL+ LI +   +    LV+EF+ +  LD     K   G   +   +Y   +       + 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLD--DLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           H      ++HRDIK  NI+      VKL DFG A  +    G   T    T  Y APE
Sbjct: 119 HN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 19/182 (10%)

Query: 204 LGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNLLQLIG 260
           +G G FG V+  R  + +   A+ V  I   ++  + +++  E +   ++ H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGLASALLYLHEEWK 318
             HD+    ++ E++P G L  +L +    S  T L + +       +  AL YLH    
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE------IVCALEYLHS--- 119

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI-STGR 377
           + +V+RD+K  NI+ D + ++KL DFG A     +L  RT  L GT  Y+APE I S G 
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFA----KKLRDRTWTLCGTPEYLAPEVIQSKGH 175

Query: 378 AR 379
            +
Sbjct: 176 NK 177

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 6/152 (3%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNL 255
           NF    KLG+G +  VY+G        VA+K+I    + G  +  I E+    +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++L  + H   + MLV+E+M +  L  ++ +    G  L   T    +  L   + + HE
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCHE 118

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                V+HRD+K  N++ +    +KL DFGLA
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 27/176 (15%)

Query: 196 NNFSNERKLGQGGFGAVYR----GILIDLNMA-VAVKKISRGLK-HGKNEYITEVKTCSQ 249
           NN    R +GQG FG V++    G+L       VAVK +        + ++  E    ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT----------------- 292
             H N+++L+G+C       L++E+M  G L+  L  +                      
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 293 -PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            PL+ T +  I+  +A+ + YL E   R  VHRD+   N +   +  VK+ DFGL+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 177

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 39/273 (14%)

Query: 204 LGQGGFGAVYRGI--LIDLNMAVAVKKISRGLKHGKNEYIT-------EVKTCSQLRHRN 254
           +G G FG+VY G+       MAV   ++       K+   +       E+    +L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++Q +G   D     +  E++P GS+   L +  +    L      +I  GL     YLH
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN----YLH 123

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-----LAGTLGYMA 369
               R ++HRDIK +NI+ D    +K+ DFG++  ++       T      L G++ +MA
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 370 PEYI-STGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPS 428
           PE +  T   R     D     CL++  L   HP  +C  +  QAI  +  E   P +PS
Sbjct: 181 PEVVKQTSYTR---KADIWSLGCLVVEMLTGKHPFPDC--TQLQAIFKIG-ENASPEIPS 234

Query: 429 KMPVA-------IFEAPASSAPCSSE----PFI 450
            +           FE   +  P ++E    PF+
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 54/174 (31%), Positives = 91/174 (52%), Gaps = 13/174 (7%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-LK--HGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGFG V    +       A KK+++  LK   G    + E +  +++  R ++ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFS--KKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
               + +  LV   M  G L +H+++  +++ G P      Y  +  + S L +LH+   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY--TAQIISGLEHLHQ--- 115

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMAPE 371
           R +++RD+K  N++ D D NV++ D GLA+ L D +   +T G AGT G+MAPE
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPE 167

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 53/172 (30%), Positives = 77/172 (44%), Gaps = 9/172 (5%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+G+G  G V           VAVKK+    +  +     EV       H N++ +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
               E  +V EF+  G+L     +   T T +       + L +  AL YLH +    V+
Sbjct: 89  LVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VI 140

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRDIK  +I+  +D  +KL DFG    V  E+ P+   L GT  +MAPE IS
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVIS 191

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 54/172 (31%), Positives = 78/172 (45%), Gaps = 9/172 (5%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+G+G  G V    +      VAVKK+    +  +     EV      +H N++++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
               E  +V EF+  G+L     +   T T +       + L +  AL  LH +    V+
Sbjct: 87  LVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MAPE IS
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELIS 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 7/171 (4%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    +     A K I    +    +Y+ E++  +   H  +++L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +  G+  ++ EF P G++D  +         LT      I   +  AL YLH      ++
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHS---MKII 132

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  N++   D ++KL DFG++      L  R +   GT  +MAPE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-FIGTPYWMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 50/152 (32%), Positives = 63/152 (41%), Gaps = 14/152 (9%)

Query: 221 NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL 280
              V VK ++ G   G      E+     + HR ++ LI   H       V   MP    
Sbjct: 119 RKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLI---HAYRWKSTVCMVMPKYKC 170

Query: 281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK 340
           D  LF+      PL       I   L  AL YLH    R ++HRD+K  NI  D   N  
Sbjct: 171 D--LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225

Query: 341 LGDFGLAL-LVDHELGPRTTGLAGTLGYMAPE 371
           LGDFG A  L  H   P+  G +GTL   +PE
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPE 257

Length = 392

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 26/168 (15%)

Query: 203 KLGQGGFGAVY----RGILIDLNMA----------VAVKKI-SRGLKHGKNEYITEVKTC 247
           KLG+G FG V+     G+   L             VAVK + +   K  +N+++ E+K  
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL--------FSKKSTGTPLTWTTR 299
           S+L++ N+++L+G+C       ++ E+M NG L+  L        F+  +    ++    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +++ +AS + YL        VHRD+   N +    + +K+ DFG++
Sbjct: 132 LYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 18/156 (11%)

Query: 204 LGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLLQL 258
           LG G FG VY+GI +     + + VA+K ++       N E++ E    + + H +L++L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 259 IGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPL--TWTTRYKISLGLASALLYLHE 315
           +G+C       LV + MP+G L D+    K + G+ L   W  +      +A  ++YL E
Sbjct: 75  LGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
              R +VHRD+   N++  +  +VK+ DFGLA L++
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 7/171 (4%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    +  +  A K I    +    +Y+ E+   +   H N+++L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +      ++ EF   G++D  +   +    PLT      +      AL YLHE     ++
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHENK---II 125

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  NI+   D ++KL DFG++      +  R +   GT  +MAPE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 40/193 (20%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLR 251
           +++   K+G+G +G VY+G        VA+KKI       G+    +  I E+    +L+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKELQ 57

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFH-----LFSKKSTGTPLTWTTRYKISLGL 306
           H N++ L  +        L++EF+   S+D       L   +     L  +  Y+I  G+
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL----- 361
               L+ H    R V+HRD+K  N++ D    +KL DFGLA         R  G+     
Sbjct: 115 ----LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA---------RAFGIPVRVY 158

Query: 362 ---AGTLGYMAPE 371
                TL Y APE
Sbjct: 159 THEVVTLWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 25/164 (15%)

Query: 203 KLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +LG+G FG V+     +L      M VAVK +    +  + ++  E +  + L+H+++++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 258 LIGLCHDRGEFMLVYEFMPNGSL---------DFHLF--SKKSTGTPLTWTTRYKISLGL 306
             G+C +    ++V+E+M +G L         D  +    +      LT      I+  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 307 ASALLY---LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           AS ++Y   LH       VHRD+   N +      VK+GDFG++
Sbjct: 132 ASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 16/153 (10%)

Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K   +L H  L+Q
Sbjct: 10  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    +V E+M NG L  +L   +  G     +   ++   +   + YL  E 
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYL--ES 118

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           K+  +HRD+   N + D    VK+ DFGL+  V
Sbjct: 119 KQ-FIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 57/190 (30%), Positives = 89/190 (46%), Gaps = 20/190 (10%)

Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRN 254
           R+LGQG FG VY G   D+        VAVK +  S  L+  + E++ E          +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLNEASVMKGFTCHH 70

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS-----TGTPL-TWTTRYKISLGLAS 308
           +++L+G+       ++V E M +G L  +L S +       G P  T     +++  +A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--G 366
            + YL+    +  VHRD+   N M   DF VK+GDFG+   + +E      G  G L   
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVR 186

Query: 367 YMAPEYISTG 376
           +MAPE +  G
Sbjct: 187 WMAPESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 13/154 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-----EYITEVKTCSQLRHRNLL 256
            ++G G FG V  G      M+ A + + + L+          ++ EV+   +L H N+L
Sbjct: 1   DEIGNGWFGKVLLG-EAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASALLYLH 314
           Q +G C +   ++LV EF P G L  +L S +              +++  +AS LL+LH
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLH 117

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL 348
              +   +H D+   N     D +VK+GD+GLAL
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLAL 148

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 42/200 (21%)

Query: 198 FSNERKLGQGGFGAVYRGILID--LNMAVAVKKISRGLKHGKNEY-------ITEVKTCS 248
           +  E  +G+G +G VY+    +       A+KK     K  K +Y         E+    
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLR 57

Query: 249 QLRHRNLLQLIGLC--HDRGEFMLVYEFMPN---GSLDFHLFSKKSTGTP------LTWT 297
           +L+H N++ L+ +   H      L++++  +     + FH    K    P      L W 
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFH-RQAKRVSIPPSMVKSLLWQ 116

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN----VKLGDFGLALLVDHE 353
                   + + + YLH  W   V+HRD+K +NI+   +      VK+GD GLA L +  
Sbjct: 117 --------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 354 LGPRTTG--LAGTLGYMAPE 371
           L P      +  T+ Y APE
Sbjct: 166 LKPLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 54/174 (31%), Positives = 80/174 (45%), Gaps = 15/174 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK----NEYITEVKTCSQLRHRNLLQL 258
           K+G+G +G VY+         VA+KKI   L+       +  I E+    +L H N+++L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           + + H   +  LV+EF+    LD   +   S  T L           L   + Y H    
Sbjct: 64  LDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--- 117

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPE 371
             V+HRD+K  N++ D +  +KL DFGLA      +  RT T    TL Y APE
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 35/75 (46%), Positives = 46/75 (61%), Gaps = 6/75 (8%)

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTT 359
           K+++ +  AL YL E  K  V+HRD+K SNI+ D   NVKL DFG++  LVD +   R+ 
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174

Query: 360 GLAGTLGYMAPEYIS 374
             AG   YMAPE I 
Sbjct: 175 --AGCAAYMAPERID 187

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 37/190 (19%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLI---- 259
           + +G +G V+           A+K I +     KN+ + +V T      R++L       
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VDQVLT-----ERDILSQAQSPY 54

Query: 260 ------GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT-PLTWTTRY--KISLGLASAL 310
                      +  ++ V E++P G L   L   ++ G+        Y  +I L L    
Sbjct: 55  VVKLYYSFQGKKNLYL-VMEYLPGGDL-ASLL--ENVGSLDEDVARIYIAEIVLALE--- 107

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGP-----RTTGLAG 363
            YLH      ++HRD+K  NI+ D++ ++KL DFGL+   LV  ++           + G
Sbjct: 108 -YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 364 TLGYMAPEYI 373
           T  Y+APE I
Sbjct: 164 TPDYIAPEVI 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 33/193 (17%)

Query: 204 LGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNE-----YITEVKTCSQL-RH 252
           LG+G FG V +   + L+       VAVK     LK    E      ++E++    + +H
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKM----LKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------------PLTWTTRY 300
           +N++ L+G+C   G   +V E+  +G+L   L +++  G              LT     
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG 360
             +  +A  + +L    K+C+ HRD+   N++   D  +K+ DFGLA  + H    R T 
Sbjct: 136 SFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 361 LAGTLGY--MAPE 371
             G L    MAPE
Sbjct: 193 -NGRLPVKWMAPE 204

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 9/177 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++   K+GQG  G VY  I I     VA+K+++   +  K   I E+    + ++ N++ 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +       E  +V E++  GSL     +   T T +       +      AL +LH   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              V+HRDIK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 14/185 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V    +       A KK+ +     + G+   + E +   ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLY 312
           ++ L      +    LV   M  G L FH+++  + G        Y  +I+ GL      
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE----D 117

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH E    +V+RD+K  NI+ D   ++++ D GLA+ +    G    G  GT+GYMAPE 
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRVGTVGYMAPEV 172

Query: 373 ISTGR 377
           +   R
Sbjct: 173 VKNER 177

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 13/152 (8%)

Query: 206 QGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-----YITEVKTCSQLRHRNLLQLIG 260
           +G FG ++ GILID       +   + +K   +E      + E      L H+N+L ++ 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 261 LCHDRGEF-MLVYEFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGL--ASALLYLHE 315
           +C + GE   ++Y +M  G+L   L   +      P   +T+  + + +  A  + YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             KR V+H+DI   N + D +  VK+ D  L+
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALS 164

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 16/180 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMA-VAVKKIS-RGLKHGKN---------EYITEVKTC-SQLR 251
           LG G FG VY+    +     +A+K+I+      GK+         + ++EV     QLR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++      +     +V + +    L  H  S K      T    + I + +  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           YLH+E  + +VHRD+  +NIM   D  V + DFGLA     E   + T + GT+ Y  PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE--SKLTSVVGTILYSCPE 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +R+LG+G FG V+     +L+     M VAVK +       + ++  E +  + L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTP------LTWTTRYKIS 303
           ++  G+C D    ++V+E+M +G L+  L +          G P      L  +    I+
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +AS ++YL  +     VHRD+   N +   +  VK+GDFG++
Sbjct: 130 SQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 50/148 (33%), Positives = 71/148 (47%), Gaps = 18/148 (12%)

Query: 204 LGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG V    YRG        VAVK I          ++ E    +QLRH NL+QL+
Sbjct: 14  IGKGEFGDVMLGDYRGN------KVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 65

Query: 260 G-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           G +  ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL     
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
              VHRD+   N++   D   K+ DFGL
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGL 148

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 29/169 (17%)

Query: 202 RKLGQGGFGAVY-----RGILIDLNMA-----------VAVKKISRGL-KHGKNEYITEV 244
            KLG+G FG V+                          VAVK +      + + +++ EV
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 245 KTCSQLRHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLF-------SKKSTGTPLTW 296
           K  S+L   N+ +L+G+C  D    M + E+M NG L+  L                L++
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG 345
           +T   ++  +AS + YL        VHRD+   N +   ++ +K+ DFG
Sbjct: 130 STLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 10/145 (6%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
            +G+G FGAV +G        VAVK I   +      ++ E    ++L H+NL++L+G+ 
Sbjct: 13  IIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
              G   +V E M  G+L   L ++      +    ++  SL +A  + YL  E K+ +V
Sbjct: 69  LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGMEYL--ESKK-LV 122

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLA 347
           HRD+   NI+   D   K+ DFGLA
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 10/180 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V    +       A KK+ +     + G+   + E +   ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      +    LV   M  G L FH+++  + G        Y   L     L  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL--CCGLEDLQ 119

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            E    +V+RD+K  NI+ D   ++++ D GLA+ +    G    G  GT+GYMAPE I+
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRVGTVGYMAPEVIN 174

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN------- 238
           F+ +DL        +  ++G+G FG V + +       +AVK+I R     K        
Sbjct: 1   FTAEDL-------KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMD 52

Query: 239 -EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD-FHLFSKKSTGTPLTW 296
            + +     C       +++  G     G+  +  E M + SLD F+ +  +   + +  
Sbjct: 53  LDVVMRSSDCP-----YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE 106

Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELG 355
               KI++    AL YL EE K  ++HRD+K SNI+ D + N+KL DFG++  LVD    
Sbjct: 107 EILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164

Query: 356 PRTTGLAGTLGYMAPEYIST-GRARLDVNFD 385
            R    AG   YMAPE I    R   DV  D
Sbjct: 165 TRD---AGCRPYMAPERIDPSARDGYDVRSD 192

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 51/260 (19%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---------KNEYITEVKTC 247
           NF   R LG G +G V+            V+K+  G   G         K   + + KT 
Sbjct: 1   NFELLRVLGTGAYGKVF-----------LVRKVG-GHDAGKLYAMKVLKKATIVQKAKTA 48

Query: 248 SQLR-HRNLLQLIGLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
              R  R +L+ +  C              +  L+ +++  G L  HL+ ++        
Sbjct: 49  EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---- 104

Query: 297 TTRYKISLG-LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG 355
            +  ++ +  +  AL +LH   +  +++RDIK  NI+ D++ +V L DFGL+     E  
Sbjct: 105 -SEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160

Query: 356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP-----DRNCRPSI 410
            R     GT+ YMAPE I  G    D   D      L    L  A P     ++N +  I
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220

Query: 411 RQAIQVLNFETKMPNLPSKM 430
            + I         P  P  M
Sbjct: 221 SRRIL-----KSKPPFPKTM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 22/180 (12%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKIS-----RGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +G+G +G VY+   ++    VA+KK+       G+       I  +K      H N+++L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 259 IGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGLASALL 311
           + +CH    DR  +  LV+E +     D   +  K    G P   T +  +   L   + 
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLP-PETIK-DLMRQLLRGVD 121

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +LH      +VHRD+K  NI+  +D  VK+ DFGLA +   E+    T +  TL Y APE
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 20/180 (11%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLR-HRNLLQL 258
           +KLG+G +G V++ I       VA+KKI    ++  +   T  E+    +L  H N+++L
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 259 IGLC---HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + +    +D+ +  LV+E+M     D H   +           RY I   L  AL Y+H 
Sbjct: 73  LNVIKAENDK-DIYLVFEYMET---DLHAVIRA--NILEDVHKRY-IMYQLLKALKYIHS 125

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT----TGLAGTLGYMAPE 371
                V+HRD+K SNI+ ++D  VKL DFGLA  +            T    T  Y APE
Sbjct: 126 ---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 18/155 (11%)

Query: 204 LGQGGFGAVYRGILI----DLNMAVAVKKI-SRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           LG G FG V++GI I     + + VA+K I  R  +    E    +     L H  +++L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP---LTWTTRYKISLGLASALLYLHE 315
           +G+C       LV +  P GSL  H+   + +  P   L W  +      +A  + YL E
Sbjct: 75  LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
                +VHR++   NI+  +D  V++ DFG+A L+
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 32/183 (17%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---------YITEVKTCSQLRHR 253
           ++ +G +G VYR         VA+KK+       K E          + E+    +L+H 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQHP 64

Query: 254 NLLQL----IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT-PLTWTTRYKISLGLAS 308
           N++ +    +G   D+    +V E++     +  L S   T   P   +    + L L S
Sbjct: 65  NIVTVKEVVVGSNLDK--IYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
            + +LH+ W   ++HRD+K SN++ +    +K+ DFGLA      L P T  +  TL Y 
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173

Query: 369 APE 371
           APE
Sbjct: 174 APE 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 28/200 (14%)

Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRH 252
             LGQG F  +Y+G+L    DL++    +++S  LK           +       SQL H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           ++L++L G+C  R E ++V E++  G LD  L  +K     L W  +  ++  LASAL Y
Sbjct: 61  KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASALHY 116

Query: 313 LHEEWKRCVVHRDIKFSNIM-----PDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTL 365
           L +  K+  VH ++   NI+      +  +   +KL D G+ + V      R   +   +
Sbjct: 117 LED--KKL-VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV----LSREERVE-RI 168

Query: 366 GYMAPEYISTGRARLDVNFD 385
            ++APE I  G+A L +  D
Sbjct: 169 PWIAPECIRNGQASLTIAAD 188

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)

Query: 202 RKLGQGGFGAVYRGILID----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           + LG+G FG+V  G L      L +AV   KI+   +    ++++E     +  H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 258 LIGLCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASA 309
           LIG+C    E       +++  FM +G L   L   +    P    T+   K    +AS 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           + YL     +  +HRD+   N M + + NV + DFGL+
Sbjct: 125 MEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 18/189 (9%)

Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY GI   +        VA+K ++       + E++ E     +    ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYKISLGLASA 309
           ++L+G+       +++ E M  G L  +L S +          P +     +++  +A  
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 187

Query: 368 MAPEYISTG 376
           M+PE +  G
Sbjct: 188 MSPESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 18/183 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVA------VKKISRGLKHGKNEYI---TEVKTCSQLR 251
           +++LG+G FG VY   L+    AVA      +K+I  G +   NE +    E +  S+L 
Sbjct: 5   QQRLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVG-ELNPNETVQANQEAQLLSKLD 60

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H  +++      +R  F ++ E+     LD  L   K TG  L+     +  + L   + 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y+H+   R ++HRD+K  NI    +  +K+GDFG++ L+       TT   GT  YM+PE
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSPE 175

Query: 372 YIS 374
            + 
Sbjct: 176 ALK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 121 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 58/196 (29%), Positives = 81/196 (41%), Gaps = 44/196 (22%)

Query: 204 LGQGGFGAV----------YRGILIDLNMAVAVKKI--------SRGLKHGKNEYITEVK 245
           LG+G FG V          Y  + I L   V + K         SR L++ ++ ++T +K
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKI-LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 246 TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
              Q   R       LC        V E+   G L FHL  ++          R+     
Sbjct: 62  YSFQTHDR-------LC-------FVMEYANGGELFFHLSRERVFSED---RARF-YGAE 103

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           + SAL YLH      VV+RD+K  N+M D D ++K+ DFGL        G       GT 
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLC-KEGISDGATMKTFCGTP 159

Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 160 EYLAPEVLEDNDYGRA 175

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 18/180 (10%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQL-RHRNLLQ 257
           + LG+G FG V    L   +   AVK + + +    ++    +TE +  +   +H  L Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L      +     V E++  G L FH+  ++S          Y  +  +   L +LHE  
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFY--AAEIVLGLQFLHE-- 114

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA---LLVDHELGPRTTGLAGTLGYMAPEYIS 374
            R +++RD+K  N++ D++ ++K+ DFG+    +L     G  T+   GT  Y+APE +S
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----GVTTSTFCGTPDYIAPEILS 169

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 18/164 (10%)

Query: 198 FSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRH 252
           F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLASA 309
            ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A  
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
           + YL E   R +VHRD+   N++  T  +VK+ DFGLA L+  +
Sbjct: 122 MNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 11/177 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +KLG G FG V+ G   + +  VAVK +  G       ++ E      L+H  L++L  +
Sbjct: 12  KKLGAGQFGEVWMGYYNN-STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 262 CHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                   ++ E+M  GSL DF    K   G  +        S  +A  + Y+    ++ 
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDF---LKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKN 123

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGYMAPEYISTG 376
            +HRD++ +N++       K+ DFGLA ++ D+E   R  G    + + APE I+ G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFG 179

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 12/179 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           + KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+ L  
Sbjct: 11  DVKLGQGCFGEVWMGTW-NGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           +  +     +V EFM  GSL DF    K+  G  L       ++  +A  + Y+    + 
Sbjct: 69  VVSEE-PIYIVTEFMGKGSLLDF---LKEGDGKYLKLPQLVDMAAQIADGMAYIE---RM 121

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGYMAPEYISTGR 377
             +HRD++ +NI+   +   K+ DFGLA L+ D+E   R  G    + + APE    GR
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGR 179

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 8/149 (5%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           ++LG G FG V+ G      + VA+K I+ G    + ++I E K   +L H  L+QL G+
Sbjct: 10  KELGSGQFGVVHLGKW-RAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C  +    +V EFM NG L  +L  ++   +     +   +   +   + YL    +   
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS---MCQDVCEGMEYLE---RNSF 121

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           +HRD+   N +  +   VK+ DFG+   V
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYV 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 47/177 (26%), Positives = 87/177 (49%), Gaps = 35/177 (19%)

Query: 203 KLGQGGFGAVYRGILID----------LNMA------VAVKKI-SRGLKHGKNEYITEVK 245
           KLG+G FG V+   +++           N+       VAVK +     K+ +N+++ EVK
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 246 TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD-----FHLFSKKSTGTP------- 293
             S+L+  N+++L+G+C D     ++ E+M NG L+      HL  K+  G         
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 294 ---LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +++++   ++L +AS + YL        VHRD+   N +   +  +K+ DFG++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E+KLG G FG V+     + +  VAVK +  G       ++ E      L+H  L++L  
Sbjct: 11  EKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +   +    ++ EFM  GSL   L S + +  PL     +  S  +A  + ++    +R 
Sbjct: 69  VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIE---QRN 122

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTLGYMAPEYISTG 376
            +HRD++ +NI+       K+ DFGLA ++ D+E   R  G    + + APE I+ G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFG 178

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 9/177 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++   K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +       E  +V E++  GSL     +   T T +       +      AL +LH   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              V+HRDIK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 71/246 (28%), Positives = 102/246 (41%), Gaps = 43/246 (17%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL--- 258
            +LG+G +G V +   +     +AVK+I   +              SQ + R L+ L   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-------------SQEQKRLLMDLDIS 53

Query: 259 ------------IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISL 304
                        G     G+  +  E M + SLD   F KK     LT       KI++
Sbjct: 54  MRSVDCPYTVTFYGALFREGDVWICMEVM-DTSLD--KFYKKVYDKGLTIPEDILGKIAV 110

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAG 363
            +  AL YLH +    V+HRD+K SN++ + +  VKL DFG++  LVD       T  AG
Sbjct: 111 SIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAG 165

Query: 364 TLGYMAPEYIS--TGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET 421
              YMAPE I+    +   DV  D       MI       P  + +   +Q  QV+  E 
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EE 223

Query: 422 KMPNLP 427
             P LP
Sbjct: 224 PSPQLP 229

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 22/188 (11%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-----EYITEVKTCSQLR 251
           +F   +++G G +G VY+   ++     A+K I   L+ G++     + I  +K C   +
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDC---K 64

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLD--FHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H N++   G    R +  +  EF   GSL   +H+     TG PL+ +    +S      
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-----TG-PLSESQIAYVSRETLQG 118

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L YLH + K   +HRDIK +NI+   + +VKL DFG++  +   +  R +   GT  +MA
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMA 174

Query: 370 PEYISTGR 377
           PE  +  R
Sbjct: 175 PEVAAVER 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 48/194 (24%), Positives = 90/194 (46%), Gaps = 22/194 (11%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYI-----TEVKTCSQLRHR 253
           +G+G +G VY  + +     +AVK++       G    + + +     +E++T   L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++Q +G         +  E++P GS+   L +       L      ++  GLA    YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----YL 124

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEY 372
           H    + ++HRD+K  N++ D D   K+ DFG++   D      +   + G++ +MAPE 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 373 ISTGR----ARLDV 382
           I +      A++D+
Sbjct: 182 IHSYSQGYSAKVDI 195

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 14/179 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   ++G+G FG VY+GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDL------LKPGPLEETYIATILREILKGLDYLHS 119

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++     +VKL DFG+A  L D ++   T    GT  +MAPE I
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 42/169 (24%), Positives = 85/169 (50%), Gaps = 27/169 (15%)

Query: 203 KLGQGGFGAVY------------RGILIDLN----MAVAVKKI-SRGLKHGKNEYITEVK 245
           KLG+G FG V+            +   +D++    + VAVK +     K+ +N+++ E+K
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 246 TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS-------KKSTGTPLTWTT 298
             S+L+  N+++L+ +C       ++ E+M NG L+  L         +K+    ++++T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              ++  +AS + YL        VHRD+   N +   ++ +K+ DFG++
Sbjct: 132 LIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 14/177 (7%)

Query: 203 KLGQGGFGAVYRGI--LIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLI 259
           +LG G FG V +G+  +    + VA+K +     K  ++E + E +   QL +  ++++I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT-RYKISLGLASALLYLHEEWK 318
           G+C      MLV E    G L+  L  KK   T        +++S+G+     YL     
Sbjct: 62  GVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMK----YLEG--- 113

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +  VHRD+   N++       K+ DFGL  AL  D       +     L + APE I
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 19/163 (11%)

Query: 201 ERKLGQGGFGAVYRGILID--LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-RHRNLL 256
           E  +G+G FG V R ++    L M  A+K +     ++   ++  E++   +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSK---------KSTGTPLTWTTR--YKISL 304
            L+G C +RG   +  E+ P G+ LDF   S+         K  GT  T T++   + + 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            +A+ + YL E   +  +HRD+   N++   +   K+ DFGL+
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 32/188 (17%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLRH 252
           +    K+G+G +G VY+      N  +A+KKI       G+    +  I E+    +++H
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP---STAIREISLLKEMQH 60

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP-------LTWTTRYKISLG 305
            N+++L  + H      LV+E+     LD  L  K    +P       L  T  Y+I  G
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEY-----LDLDL-KKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHELGPRT-TGLAG 363
           +A    Y H      V+HRD+K  N++ D   N +KL DFGLA      +  RT T    
Sbjct: 115 IA----YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVV 165

Query: 364 TLGYMAPE 371
           TL Y APE
Sbjct: 166 TLWYRAPE 173

Length = 294

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 19/160 (11%)

Query: 204 LGQGGFGAVYRG-ILID-LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-RHRNLLQLI 259
           +G+G FG V +  I  D L M  A+K++     K    ++  E++   +L  H N++ L+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 260 GLCHDRGEFMLVYEFMPNGS-LDFHLFSK-----------KSTGTPLTWTTRYKISLGLA 307
           G C  RG   L  E+ P+G+ LDF   S+            ST + L+       +  +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + YL +   +  +HRD+   NI+   ++  K+ DFGL+
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 24/225 (10%)

Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKDLA--SATNNFSNERKLGQGGFGAVYRGI 216
           WK  +      + +++        P +  Y DL      NN S  + LG G FG V    
Sbjct: 5   WKVIESINGNEYVYID--------PTQLPY-DLKWEFPRNNLSFGKTLGAGAFGKVVEAT 55

Query: 217 LIDLN-----MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM 269
              L+     M VAVK +        +   ++E+K  S L  H N++ L+G C   G  +
Sbjct: 56  AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
           ++ E+   G L   L  K+ +   LT       S  +A  + +L    K C+ HRD+   
Sbjct: 116 VITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFL--ASKNCI-HRDLAAR 170

Query: 330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-TLGYMAPEYI 373
           N++      VK+ DFGLA  + ++      G A   + +MAPE I
Sbjct: 171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 18/177 (10%)

Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +K+G+G FG   + IL+   +      +K+I  S+     + E   EV   S ++H N++
Sbjct: 6   KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           Q      + G   +V ++   G L   + +++    P      + + + LA  L ++H+ 
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA--LKHVHD- 119

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH--ELGPRTTGLAGTLGYMAPE 371
             R ++HRDIK  NI    D  +KLGDFG+A +++   EL  RT    GT  Y++PE
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA-RTC--IGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 12/177 (6%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNL 255
           +F    +LG G  G V + +     + +A K I   +K   +N+ I E+K   +     +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +   G  +  GE  +  E M  GSLD  L  KK+   P       KIS+ +   L YL E
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILG--KISIAVLRGLTYLRE 117

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           + K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 9e-10
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 23/161 (14%)

Query: 222 MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG-LCHDRGEFML-------VYE 273
           +A  VK  SR     +NE +       +L H N+L++   L  +   +M+       +Y 
Sbjct: 196 IAKRVKAGSRAAIQLENEILA----LGRLNHENILKIEEILRSEANTYMITQKYDFDLYS 251

Query: 274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP 333
           FM + + D+          PL   TR  I   L  A+ Y+H+   + ++HRDIK  NI  
Sbjct: 252 FMYDEAFDW-------KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300

Query: 334 DTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           + D  + LGDFG A+  + E      G  GT+   +PE ++
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA 341

Length = 501

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 23/183 (12%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V       L   VAVKK+SR    L H +  Y  E++    ++H N
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHEN 75

Query: 255 LLQLIGL------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ L+ +        +  E  LV   M    L+  +  +K +   + +   Y++  GL  
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLI-YQLLRGLK- 132

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
              Y+H      ++HRD+K SN+  + D  +++ DFGLA   D E+    TG   T  Y 
Sbjct: 133 ---YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYR 182

Query: 369 APE 371
           APE
Sbjct: 183 APE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 15/172 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           LG G  G VY+   +     +AVK I   +    + + ++E++   +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                  +  EFM  GSLD +    +     +      +I++ +   L YL   W   ++
Sbjct: 69  FVENRISICTEFMDGGSLDVY----RKIPEHVLG----RIAVAVVKGLTYL---WSLKIL 117

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRD+K SN++ +T   VKL DFG++  + + +        GT  YMAPE IS
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---KTYVGTNAYMAPERIS 166

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVK 245
           K +      + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELR 68

Query: 246 TCSQLRHRNLLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRY 300
               ++H N++ L+ +        EF  VY    +    L+  +  +K T   + +   Y
Sbjct: 69  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-Y 127

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG 360
           +I  GL     Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG
Sbjct: 128 QILRGLK----YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TG 176

Query: 361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLM 393
              T  Y APE I       +   D     C+M
Sbjct: 177 YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIM 208

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)

Query: 202 RKLGQGGFG--AVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           R LG+G FG   +YR    + +  V  K++  +R  +  + + + E+   S L+H N++ 
Sbjct: 6   RVLGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
                 D    ++  E+   G+L   +  +K           Y   +   SA+ Y+H+  
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI--VSAVSYIHKA- 120

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              ++HRDIK  NI       +KLGDFG++ ++  E     T + GT  YM+PE
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 25/192 (13%)

Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKIS-RGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V R     ++       + VAVK +          + I+E++    + +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------------PLTWTTRY 300
           +N++ L+G+C   G   ++ E+   G+L   L +++  G              L++    
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL  E +RC +HRD+   N++   D  +K+ DFGLA  V   +   +T+
Sbjct: 138 SCAYQVARGMEYL--ESRRC-IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 360 GLAGTLGYMAPE 371
                + +MAPE
Sbjct: 195 NGRLPVKWMAPE 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 17/180 (9%)

Query: 202 RKLGQGGFGAVY------RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        G      +AV   K   G  H   +   E++    L H N+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENI 68

Query: 256 LQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G+C + G     L+ EF+P+GSL  +L   K+    +    + K ++ +   + YL
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYL 125

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPE 371
                R  VHRD+   N++ +++  VK+GDFGL  A+  D E       L   + + APE
Sbjct: 126 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 58/185 (31%), Positives = 80/185 (43%), Gaps = 22/185 (11%)

Query: 204 LGQGGFGAVYRGILID---LNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQ 257
           LG+G FG V   IL+         A+K + + +   K+E    +TE +     RH  L  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L            V E+   G L FHL  ++      T          + SAL YLH   
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHS-- 113

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL-VDHELGPRTTGLAGTLGYMAPEYIST- 375
            R VV+RDIK  N+M D D ++K+ DFGL    +      +T    GT  Y+APE +   
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDN 170

Query: 376 --GRA 378
             GRA
Sbjct: 171 DYGRA 175

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 14/179 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   K+G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDL------LEPGPLDETQIATILREILKGLDYLHS 119

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++      VKL DFG+A  L D ++  +     GT  +MAPE I
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 22/177 (12%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           K+G+G +G V++    +    VA+KK   S      K   + E++   QL+H NL+ LI 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------LTWTTRYKISLGLASALLYLH 314
           +   + +  LV+E+  +  L  +   K   G P      + W T          A+ + H
Sbjct: 68  VFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQT--------LQAVNFCH 117

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              K   +HRD+K  NI+      +KL DFG A ++       T  +A T  Y APE
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 9/180 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHR 253
           N F     +G+G +G V +    +    VA+KK   S   +  K   + E+K    L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L      RG+  LV+E++    L+  L  +   G P      Y   L    A+ + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQL--IKAIHWC 116

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H   K  +VHRDIK  N++   +  +KL DFG A  +        T    T  Y +PE +
Sbjct: 117 H---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 58/185 (31%), Positives = 90/185 (48%), Gaps = 25/185 (13%)

Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVK-----KISRGLK---HGKNEY-ITEVKTCSQ 249
           + LG+GG+G V++   +   D     A+K      I R  K   H K E  I E      
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-----A 56

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++H  ++ LI      G+  L+ E++  G L  HL   +  G  +  T  + +S  ++ A
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLS-EISLA 112

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L +LH   ++ +++RD+K  NI+ D   +VKL DFGL     HE G  T    GT+ YMA
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMA 168

Query: 370 PEYIS 374
           PE + 
Sbjct: 169 PEILM 173

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 19/160 (11%)

Query: 204 LGQGGFGAVYRGILID--LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-RHRNLLQLI 259
           +G+G FG V +  +    L M  A+K++     K    ++  E++   +L  H N++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 260 GLCHDRGEFMLVYEFMPNGS-LDFHLFSK---------KSTGTPLTWTTR--YKISLGLA 307
           G C  RG   L  E+ P+G+ LDF   S+          +  T  T +++     +  +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + YL +   +  +HRD+   NI+   ++  K+ DFGL+
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 12/178 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIG 260
             LG G  G+V +   I     +A K +  G K   + + + E++   + R   ++   G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
              +     +  EFM  GSLD     KK  G P+      KI++ +   L YL+   +  
Sbjct: 71  AFLNENNICMCMEFMDCGSLD--RIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL-GPRTTGLAGTLGYMAPEYISTGR 377
           ++HRDIK SNI+ ++   +KL DFG    V  EL         GT  YM+PE I  G+
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFG----VSGELINSIADTFVGTSTYMSPERIQGGK 178

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 12/174 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLR-HRNLLQ 257
           R LG+G FG V    L +     AVK + + +    ++    +TE +  S  R H  L Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L            V EF+  G L FH+   +          R+  +  + SAL++LH+  
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARF-YAAEITSALMFLHD-- 114

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            + +++RD+K  N++ D + + KL DFG+        G  T+   GT  Y+APE
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 18/179 (10%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++G G +G VY+         VA+K +       GL       +  +K      H N+++
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 258 LIGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           L+ +C     DR  +  LV+E +     D   +  K     L   T   +       L +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           LH     C+VHRD+K  NI+  +   VKL DFGLA +   ++    T +  TL Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPE 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 22/177 (12%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-----EYITEVKTCSQLRHRNLL 256
           +++G G +G VY+   +      AVK I   L+ G +     + I  VK C   +H N++
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKEC---KHCNIV 69

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLD--FHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
              G    R +  +  E+   GSL   +H+     TG PL+      +       L YLH
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHV-----TG-PLSELQIAYVCRETLQGLAYLH 123

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            + K   +HRDIK +NI+   + +VKL DFG+A  +   +  R +   GT  +MAPE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 12/178 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V +       + +A K I   +K   +N+ I E++   +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L   K     +      K+S+ +   L YL 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG----KVSIAVLRGLAYLR 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E  K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 9/172 (5%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+G+G  G V           VAVK +    +  +     EV      +H+N++++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
               E  ++ EF+  G+L     +   + T L       +   +  AL YLH +    V+
Sbjct: 88  LVGEELWVLMEFLQGGAL-----TDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRDIK  +I+   D  VKL DFG    +  ++ P+   L GT  +MAPE IS
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVIS 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 36/150 (24%), Positives = 70/150 (46%), Gaps = 15/150 (10%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKIS-----RGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           K+G+G +G V++    + +  VA+K++       G+    +  + E+    +L+H+N+++
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVR 63

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L  + H   +  LV+E+      D   +     G       +      L   L + H   
Sbjct: 64  LYDVLHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVK-SFMFQLLKGLAFCHSH- 118

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              V+HRD+K  N++ + +  +KL DFGLA
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 15/179 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLIGL 261
           +LG+G +G+VY+ +     + +A+K+I   L   K N+ I E+    +     ++   G 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
               G   +  E+M  GSLD  L++       +      +I+  +   L +L EE    +
Sbjct: 68  FFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA----GTLGYMAPEYISTG 376
           +HRD+K +N++ + +  VKL DFG++       G     LA    G   YMAPE I +G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS-------GNLVASLAKTNIGCQSYMAPERIKSG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 40/162 (24%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQLI 259
           KLG+G +  VY+G        VA+K+I   L+H +      I E      L+H N++ L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDLKHANIVTLH 69

Query: 260 GLCHDRGEFMLVYEFM-----------PNGSLDFH---LFSKKSTGTPLTWTTRYKISLG 305
            + H +    LV+E++             G L  H   LF              +++  G
Sbjct: 70  DIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-LSMHNVRLFL-------------FQLLRG 115

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           LA    Y H   +R V+HRD+K  N++      +KL DFGLA
Sbjct: 116 LA----YCH---QRRVLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 14/172 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQLI 259
           ++GQGG+G V+     D    VA+K++ + L    NE    +TE    +  +   L++L+
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
               D     L  E++P G  DF      + G       R+ ++     A+  LHE    
Sbjct: 68  YAFQDDEYLYLAMEYVPGG--DFRTLLN-NLGVLSEDHARFYMAEMFE-AVDALHE---L 120

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
             +HRD+K  N + D   ++KL DFGL+      +      + G+  YMAPE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLS----KGIVTYANSVVGSPDYMAPE 168

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 33/136 (24%), Positives = 68/136 (50%), Gaps = 13/136 (9%)

Query: 204 LGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           LGQG F  +++GI  ++          V +K + +  ++    +       SQL H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
              G+C    E ++V E++  GSLD +L   K+    ++W  + +++  LA AL +L + 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL-INISW--KLEVAKQLAWALHFLED- 118

Query: 317 WKRCVVHRDIKFSNIM 332
             + + H ++   N++
Sbjct: 119 --KGLTHGNVCAKNVL 132

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 24/179 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIG 260
           +G G +G+V   I       VA+KK+SR  +     K  Y  E+     ++H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81

Query: 261 L------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +        +  +F LV   MP    D     +K  G PL+      +   +   L Y+H
Sbjct: 82  VFTSAVSGDEFQDFYLV---MPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 ++HRD+K  N+  + D  +K+ DFGLA   D E+    TG   T  Y APE I
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVI 186

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 40/187 (21%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ------ 257
           +G+G FG VY+    D     A+K +S      K E + + +    +  RN+L       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 258 ---LIGL---CHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGL 306
              ++GL        +  LV ++M  G L +HL     FS+           ++ I+  L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA--------KFYIA-EL 105

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGT 364
             AL +LH   K  +V+RD+K  NI+ D   ++ L DFGL  A L D++    T    GT
Sbjct: 106 VLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGT 159

Query: 365 LGYMAPE 371
             Y+APE
Sbjct: 160 TEYLAPE 166

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 14/175 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCS-QLRHRNLLQ 257
           + LG+G FG V+   L   N   A+K + + +    ++    + E +  S    H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L      +     V E++  G L FH+ S      P       +I  GL     +LH   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQ----FLHS-- 114

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPE 371
            + +V+RD+K  NI+ DTD ++K+ DFG+    ++ LG  +T    GT  Y+APE
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 18/158 (11%)

Query: 202 RKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLL 256
           + LG G FG VY+GI I    ++ + VA+K +        N E + E    + +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLASALLYL 313
           +L+G+C       LV + MP G L D+   +K   G+   L W  +      +A  + YL
Sbjct: 73  RLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYL 125

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            E     +VHRD+   N++  +  +VK+ DFGLA L+D
Sbjct: 126 EEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 33/196 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW---------------- 296
           +N++ L+G C   G   ++ E+   G+L  +L +++  G    +                
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELG 355
           +  Y+++ G+     YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +  
Sbjct: 144 SCAYQVARGME----YLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196

Query: 356 PRTTGLAGTLGYMAPE 371
            +TT     + +MAPE
Sbjct: 197 KKTTNGRLPVKWMAPE 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 8/149 (5%)

Query: 202 RKLGQGGFGAVYRG-ILIDLNMA-VAVK--KISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +++G G FG V    I  D  +A V VK  K +   K  +NE++ +      L+H N+LQ
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQ 59

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +G C +   ++LV+E+   G L  +L  ++            +++  +A+ + ++H   
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--- 116

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           K   +H D+   N    +D  VK+GD+G+
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 14/180 (7%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRHRN 254
            +   R +G+G FG V+          V +K+I   +  K  +     E +    L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++      +    M+V E+ P G+L  ++  + ++         + + +     LL LH
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALH 115

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTG--LAGTLGYMAPE 371
               + ++HRD+K  NI+ D    V K+GDFG++      L  ++    + GT  Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS----KILSSKSKAYTVVGTPCYISPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 12/104 (11%)

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
           LV E++  G  D     K   G P  W  +Y   + L   +  LH   +R ++HRDIK  
Sbjct: 74  LVMEYLNGG--DCASLIKTLGGLPEDWAKQYIAEVVLG--VEDLH---QRGIIHRDIKPE 126

Query: 330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           N++ D   ++KL DFGL+       G       GT  Y+APE I
Sbjct: 127 NLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 54/182 (29%), Positives = 81/182 (44%), Gaps = 20/182 (10%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   ++G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 257 QLIGLCHDRGEFMLVYEFMPNGS----LDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           +  G      +  ++ E++  GS    L    F +    T L           +   L Y
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---------EILKGLDY 116

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           LH E K   +HRDIK +N++     +VKL DFG+A  L D ++   T    GT  +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 171

Query: 372 YI 373
            I
Sbjct: 172 VI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 18/180 (10%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +G G +G VY+G  +      A+K   ++   +      I  +K  S   HRN+    G 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH--HRNIATYYGA 81

Query: 262 C-------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
                   HD  +  LV EF   GS+      K + G  L       I   +   L +LH
Sbjct: 82  FIKKSPPGHD-DQLWLVMEFCGAGSVTD--LVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 V+HRDIK  N++   +  VKL DFG++  +D  +G R T   GT  +MAPE I+
Sbjct: 139 AHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIA 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 8/155 (5%)

Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRH 252
           A  ++ N  KLG+G +  VY+GI       VA+K IS   + G     I E      L+H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N++ L  + H +     V+E+M     D   +  +  G    +  R      L   L Y
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAY 118

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +H    + ++HRD+K  N++      +KL DFGLA
Sbjct: 119 IH---GQHILHRDLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 17/182 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMA-VAVKKI--SRGLKHGKNEYI-TEVKTCSQLRH 252
           +F+  R LG G FG V      + +   VA+K+   S+ +K  + +++ +E K  + + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              + L G   D     LV EF+  G  +F  F +++   P      Y      A+ ++ 
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFY------AAQIVL 142

Query: 313 LHEEWKRC-VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + E  +   +V+RD+K  N++ D D  +K+ DFG A +VD     RT  L GT  Y+APE
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPE 198

Query: 372 YI 373
            +
Sbjct: 199 IL 200

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 60/186 (32%), Positives = 85/186 (45%), Gaps = 23/186 (12%)

Query: 204 LGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNL-- 255
           LG+G FG V   IL+         A+K + + +   K+E    +TE +     RH  L  
Sbjct: 3   LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           L+     HDR     V E+   G L FHL  ++          R+     + SAL YLH 
Sbjct: 60  LKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSALDYLHS 113

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
           E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y+APE +  
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED 170

Query: 376 ---GRA 378
              GRA
Sbjct: 171 NDYGRA 176

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
           F+  R LG+G FG+V    L   +     VAVK +   +    +  E++ E     +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 253 RNLLQLIGLC-HDRGEF-----MLVYEFMPNGSLDFHLFSKKSTGTPLTWT--TRYKISL 304
            N+++LIG+    R +      M++  FM +G L   L   +    P T    T  +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            +AS + YL     +  +HRD+   N M + +  V + DFGL+
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 16/179 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +G G +G VY+G  +      A+K   ++   +    + I  +K  S   HRN+    G 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 71

Query: 262 CHDRG------EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
              +       +  LV EF   GS+   + + K       W     I   +   L +LH+
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                V+HRDIK  N++   +  VKL DFG++  +D  +G R T   GT  +MAPE I+
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIA 184

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 69/259 (26%), Positives = 101/259 (38%), Gaps = 49/259 (18%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK---------NEYITEVKTC 247
           NF   + LG G +G V+            V+K+S G   GK            + + KT 
Sbjct: 1   NFELLKVLGTGAYGKVF-----------LVRKVS-GHDSGKLYAMKVLKKATIVQKAKTT 48

Query: 248 SQLR-HRNLLQLIGLCHDRGEFMLV---YEFMPNGSLDFHLFSKKSTG----TPLTWTTR 299
              R  R +L+     H R    LV   Y F  +  L  HL      G    T L+   R
Sbjct: 49  EHTRTERQVLE-----HIRQSPFLVTLHYAFQTDTKL--HLILDYINGGELFTHLSQRER 101

Query: 300 YK---ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP 356
           +K   + +     +L L    K  +++RDIK  NI+ D++ +V L DFGL+     +   
Sbjct: 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Query: 357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP-----DRNCRPSIR 411
           R     GT+ YMAP+ +  G    D   D      LM   L  A P     ++N +  I 
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221

Query: 412 QAIQVLNFETKMPNLPSKM 430
           + I         P  P +M
Sbjct: 222 RRIL-----KSEPPYPQEM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 43/242 (17%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLI--G 260
           +G+GGFG VY     D     A+K + +  +K  + E +        L  R +L L+  G
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIMLSLVSTG 54

Query: 261 LC----------HDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLG 305
            C          H   +   + + M  G L +HL     FS+K      T     +I LG
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT-----EIILG 109

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L     ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     GT 
Sbjct: 110 LE----HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 159

Query: 366 GYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ--VLNFETKM 423
           GYMAPE +  G A  D + D     C++   L    P R  +   +  I    L    ++
Sbjct: 160 GYMAPEVLQKGTA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL 218

Query: 424 PN 425
           P+
Sbjct: 219 PD 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 23/185 (12%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRHRN 254
            +   +K+G+G FG +Y       +    +K+I   +     K     EV   ++++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFH-------LFSKKSTGTPLTWTTRYKISLGLA 307
           ++       + G   +V E+   G L          LFS+      L+W    +ISLGL 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSWFV--QISLGLK 115

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLG 366
               ++H+   R ++HRDIK  NI    +  V KLGDFG+A  ++  +    T   GT  
Sbjct: 116 ----HIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPY 167

Query: 367 YMAPE 371
           Y++PE
Sbjct: 168 YLSPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 10/149 (6%)

Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLL 256
           ER LG G FG + RG L       + VA+  +  G    +   ++ E  T  Q  H N++
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L G+       M+V E+M NG+LD   F +K  G  L       +  GLAS + YL E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYLSE- 125

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFG 345
                VH+ +    ++ ++D   K+  F 
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 25/143 (17%)

Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGE-----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
           E   C++L H N++ L+    D GE        V+E++P  +L   L    +    L   
Sbjct: 28  ETALCARLYHPNIVALL----DSGEAPPGLLFAVFEYVPGRTLREVL----AADGALPAG 79

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALL----- 349
              ++ L +  AL   H    + +VHRD+K  NIM        + K+ DFG+  L     
Sbjct: 80  ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136

Query: 350 -VDHELGPRTTGLAGTLGYMAPE 371
             D     RTT + GT  Y APE
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 53/191 (27%), Positives = 79/191 (41%), Gaps = 32/191 (16%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVK-------TCSQLRHRNLL 256
           LG+G FG V            A+K + +G    ++E +  +        T +  RH  L+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE-VESLMCEKRIFETANSERHPFLV 65

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHL----FSKKSTGTPLTWTTRYKISLGLASALLY 312
            L            V E+   G L  H+    FS+            Y   + L   L Y
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-------VFYAACVVLG--LQY 116

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAP 370
           LHE     +V+RD+K  N++ DT+  VK+ DFGL       +G   RT+   GT  ++AP
Sbjct: 117 LHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAP 170

Query: 371 EYI---STGRA 378
           E +   S  RA
Sbjct: 171 EVLTETSYTRA 181

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 30/65 (46%), Positives = 39/65 (60%), Gaps = 3/65 (4%)

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           AL +LH   K  +V+RDIK  NI+ D++ +V L DFGL+     E   RT    GT+ YM
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 369 APEYI 373
           APE I
Sbjct: 174 APEII 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 70/237 (29%), Positives = 109/237 (45%), Gaps = 36/237 (15%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL-- 261
           +G G FG VY  I ID +  VA+KK+ +  ++ KN    E+     L H N++ L     
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQY-KNR---ELLIMKNLNHINIIFLKDYYY 129

Query: 262 --CHDRGE---FM-LVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
             C  + E   F+ +V EF+P     +   +++ +   PL     Y  S  L  AL Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY--SYQLCRALAYIH 187

Query: 315 EEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLA--LLVDHELGPRTTGLAGTLGYMAPE 371
            ++   + HRD+K  N++ D +   +KL DFG A  LL     G R+     +  Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA----GQRSVSYICSRFYRAPE 240

Query: 372 YISTGRARLDVNFDEQQTDCL---MIVGLWCAHPDRNCRPSIRQ---AIQVLNFETK 422
            +  G      + D     C+   MI+G    +P  + + S+ Q    IQVL   T+
Sbjct: 241 LM-LGATNYTTHIDLWSLGCIIAEMILG----YPIFSGQSSVDQLVRIIQVLGTPTE 292

Length = 440

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 24/180 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG--- 260
           LG+G FG V    L   N   A+K     LK  K+  + +      +  R +L L     
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIK----ALK--KDVVLEDDDVECTMVERRVLALAWEHP 56

Query: 261 -LCH------DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            L H       +     V E++  G L FH+ S             Y   +     L +L
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD--EARARFYAAEI--ICGLQFL 112

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H++    +++RD+K  N++ D D ++K+ DFG+    +     + +   GT  Y+APE +
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEIL 168

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 17/178 (9%)

Query: 204 LGQGGFGAVY--RGIL-IDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRHRNLLQL 258
           LGQG FG V+  R I   D     A+K + +     ++   T  E    +++ H  +++L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG-LASALLYLHEEW 317
                  G+  L+ +F+  G L F   SK+   T        K  L  LA AL +LH   
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFT----EEDVKFYLAELALALDHLH--- 115

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMAPEYIS 374
              +++RD+K  NI+ D + ++KL DFGL+   +DHE   +     GT+ YMAPE ++
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVN 171

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQLI 259
           KLG+G +  VY+G     +  VA+K+I   L+H +      I EV     L+H N++ L 
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
            + H      LV+E++ +  L  +L      G  +           L   L Y H   +R
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCH---RR 123

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            V+HRD+K  N++ +    +KL DFGLA
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 14/175 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYITEVKTCSQ-LRHRNLLQLIG 260
           LG G FG V            A+K  K    LK  + +++ + K+    L H  ++ ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
              D      + EF+  G L  HL  +K+   P      Y   L LA    YLH    + 
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLA--FEYLHS---KD 138

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
           +++RD+K  N++ D   +VK+ DFG A  V      RT  L GT  Y+APE I +
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVIQS 189

Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 21/179 (11%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRNLLQL--I 259
           +G+G +G V   I       VA+KKI+   +H  +    + E+K    LRH +++++  I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 260 GLCHDRGEF---MLVYEFMPNGSLDFHLFSKKSTG-TPLTWTTRYKISL-GLASALLYLH 314
            L   R EF    +V+E M +   D H   K +   TP      ++  L  L  AL Y+H
Sbjct: 68  MLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP----EHHQFFLYQLLRALKYIH 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT--TGLAGTLGYMAPE 371
                 V HRD+K  NI+ + D  +K+ DFGLA +  ++       T    T  Y APE
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 18/179 (10%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-----RHRNLL 256
           R +G+G +  V    L       A+K + + L +  +E I  V+T   +      H  L+
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L            V E++  G L FH+  ++    P      Y   + LA  L YLHE 
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--LNYLHE- 114

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPEYI 373
             R +++RD+K  N++ D++ ++KL D+G+       L P   T+   GT  Y+APE +
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEIL 168

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 56/184 (30%), Positives = 83/184 (45%), Gaps = 20/184 (10%)

Query: 204 LGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQ 257
           LG+G FG V   IL+    +    A+K + + +   K+E    +TE +     RH  L  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L      +     V E++  G L FHL  ++         TR+     + SAL YLH   
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED---RTRF-YGAEIVSALDYLHSGK 115

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST-- 375
              +V+RD+K  N+M D D ++K+ DFGL      +     T   GT  Y+APE +    
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171

Query: 376 -GRA 378
            GRA
Sbjct: 172 YGRA 175

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 44/192 (22%), Positives = 92/192 (47%), Gaps = 25/192 (13%)

Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKIS-RGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------------PLTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  V++ +   +TT
Sbjct: 141 SCTYQVARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 360 GLAGTLGYMAPE 371
                + +MAPE
Sbjct: 198 NGRLPVKWMAPE 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 29/184 (15%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRHRNLLQL--I 259
           +G+G +G V      + N  VA+KKI+    +  +   T  E+K    L H N++ +  I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 260 GLCHDRGEF---MLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
                R  F    +VYE M     D H   + S    L+    +Y +   L   L Y+H 
Sbjct: 73  MPPPHREAFNDVYIVYELM---DTDLHQIIRSSQ--TLSDDHCQYFL-YQLLRGLKYIHS 126

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
                V+HRD+K SN++ + + ++K+ DFGLA         RTT  +    +M  EY+ T
Sbjct: 127 A---NVLHRDLKPSNLLLNANCDLKICDFGLA---------RTT--SEKGDFMT-EYVVT 171

Query: 376 GRAR 379
              R
Sbjct: 172 RWYR 175

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 37/193 (19%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---------RGLKHGKNEYITEVKTC 247
            + N   +G+G +G V         + VA+KKIS         R L+        E+K  
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR--------EIKIL 57

Query: 248 SQLRHRNLLQL--IGLCHDRGEFMLVY---EFMPNGSLDFH--LFSKKSTGTPLTWTTRY 300
            + +H N++ +  I        F  VY   E M     D +  + ++  +   + +   Y
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYFL-Y 113

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD--HELGPRT 358
           +I  GL     Y+H      V+HRD+K SN++ +T+ ++K+ DFGLA + D  H+     
Sbjct: 114 QILRGLK----YIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 359 TGLAGTLGYMAPE 371
           T    T  Y APE
Sbjct: 167 TEYVATRWYRAPE 179

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 18/179 (10%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ--LI 259
           R +G+G +  V    L   +   A+K + + L H  +E I  V+T   +  +      L+
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLV 59

Query: 260 GL--C-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           GL  C        LV E++  G L FH+  ++    P      Y   + +A  L +LHE 
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIA--LNFLHE- 114

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPEYI 373
             R +++RD+K  N++ D D ++KL D+G+       LGP   T+   GT  Y+APE +
Sbjct: 115 --RGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEGLGPGDTTSTFCGTPNYIAPEIL 168

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 18/177 (10%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL--RHRNLLQLI 259
           R +G+G +  V    L       A+K I + L +  +E I  V+T   +     N   L+
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLV 59

Query: 260 GL--C-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           GL  C         V EF+  G L FH+  ++    P      Y   + LA  L +LHE 
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLA--LNFLHE- 114

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
             R +++RD+K  N++ D + ++KL D+G+       + P   T+   GT  Y+APE
Sbjct: 115 --RGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 22/153 (14%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQLI 259
           KLG+G +  V++G        VA+K+I   L+H +      I EV     L+H N++ L 
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 260 GLCHDRGEFMLVYEFMPNGSLDF-----HLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            + H      LV+E++      +     ++ S  +    L     Y+I  GLA    Y H
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQILRGLA----YCH 121

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +R V+HRD+K  N++ +    +KL DFGLA
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 36/200 (18%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQL 258
           R +G+GG G VY       +  VA+KKI   L      K  ++ E K  + L H  ++ +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 259 IGLCHDRGEFMLVYEFMP--NG----SLDFHLFSKKSTGTPLTWTTRYK----ISLGLAS 308
             +C D G+   VY  MP   G    SL   ++ K+S    L   T       I   + +
Sbjct: 68  YSICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE------LGPRTTG-- 360
            + Y+H    + V+HRD+K  NI+      V + D+G A+    E      +        
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 361 ---------LAGTLGYMAPE 371
                    + GT  YMAPE
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE 201

Length = 932

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 23/183 (12%)

Query: 202 RKLGQGGFGAVY---------RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH 252
           R +G+G +G V          + ++  LN+  A ++  +  +        E +  SQL+H
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-------EAQLLSQLKH 58

Query: 253 RNLLQLIGLCH-DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
            N++        + G   +V  F   G L   L  +K    P      + + +  A AL 
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI--AMALQ 116

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           YLHE+    ++HRD+K  N+       +K+GD G+A +++++    +T L GT  YM+PE
Sbjct: 117 YLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPE 172

Query: 372 YIS 374
             S
Sbjct: 173 LFS 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 33/195 (16%)

Query: 188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEV 244
           Y+DL          +++G G +G V   +       VA+KK+ R  +     K  Y  E+
Sbjct: 17  YRDL----------KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-REL 65

Query: 245 KTCSQLRHRNLLQLIGL------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
           +    ++H N++ L+ +           +F LV  FM  G+    L   +          
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123

Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT 358
            Y++  GL     Y+H      ++HRD+K  N+  + D  +K+ DFGLA   D E+    
Sbjct: 124 VYQMLKGLK----YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---- 172

Query: 359 TGLAGTLGYMAPEYI 373
           TG   T  Y APE I
Sbjct: 173 TGYVVTRWYRAPEVI 187

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 27/193 (13%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--------YITEVKTCSQL-RH 252
           + LG+G FG V     I ++     K ++  +K  K++         ++E++    + +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------------PLTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              LT+    
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG--PRT 358
             +  +A  + YL    ++C +HRD+   N++   D  +K+ DFGLA  V H +    +T
Sbjct: 138 SCAYQVARGMEYLAS--QKC-IHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKT 193

Query: 359 TGLAGTLGYMAPE 371
           T     + +MAPE
Sbjct: 194 TNGRLPVKWMAPE 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 12/111 (10%)

Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
           DR  F  V E++  G L +H+        P       +I++GL     +LH    + +++
Sbjct: 74  DRLYF--VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL----FFLH---SKGIIY 124

Query: 324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT-GLAGTLGYMAPEYI 373
           RD+K  N+M D + ++K+ DFG+    ++  G +TT    GT  Y+APE I
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQLI 259
           KLG+G +  V++G        VA+K+I   L+H +      I EV     L+H N++ L 
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
            + H      LV+E++ +  L  +L    + G  ++          L   L Y H   KR
Sbjct: 70  DIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KR 122

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            ++HRD+K  N++ +    +KL DFGLA
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 27/185 (14%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+G+G +G VY+    +    VA+KK        + E   E    + LR  +LLQ++   
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKT-------RLEMDEEGIPPTALREISLLQMLSES 60

Query: 263 -------------HDRGEFM--LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
                           G+    LV+E++ +    F   + +  G PL   T       L 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLG 366
             + + H   K  V+HRD+K  N++ D    + K+ D GL       +   T  +  TL 
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176

Query: 367 YMAPE 371
           Y APE
Sbjct: 177 YRAPE 181

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 22/135 (16%)

Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY--- 240
           +  +  D+ S+      E  + +G  GA Y+G  I   M   VK+I        N+    
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEI--------NDVNSI 729

Query: 241 -ITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
             +E+    +L+H N+++LIGLC       L++E++   +L   L +       L+W  R
Sbjct: 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERR 782

Query: 300 YKISLGLASALLYLH 314
            KI++G+A AL +LH
Sbjct: 783 RKIAIGIAKALRFLH 797

Length = 968

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 26/140 (18%)

Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
           K  ++T++ +C Q   R                 V E++  G L +H+        P   
Sbjct: 59  KPPFLTQLHSCFQTVDR--------------LYFVMEYVNGGDLMYHIQQVGKFKEPQAV 104

Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHEL 354
               +IS+GL     +LH   +R +++RD+K  N+M D++ ++K+ DFG+    +VD   
Sbjct: 105 FYAAEISVGL----FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--- 154

Query: 355 GPRTTGLAGTLGYMAPEYIS 374
           G  T    GT  Y+APE I+
Sbjct: 155 GVTTRTFCGTPDYIAPEIIA 174

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 55/192 (28%), Positives = 80/192 (41%), Gaps = 43/192 (22%)

Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE 239
           D G R   Y DL          R LG G  G V+  +  D +  VAVKKI          
Sbjct: 2   DLGSR---YMDL----------RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKH 48

Query: 240 YITEVKTCSQLRHRNLLQLIGLCHDRG-----------EFMLVY---EFMPNGSLDFHLF 285
            + E+K   +L H N++++  +    G           E   VY   E+M     +  L 
Sbjct: 49  ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLA 103

Query: 286 SKKSTGTPLTWTTR---YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKL 341
           +    G       R   Y++  GL     Y+H      V+HRD+K +N+  +T D  +K+
Sbjct: 104 NVLEQGPLSEEHARLFMYQLLRGLK----YIHSA---NVLHRDLKPANVFINTEDLVLKI 156

Query: 342 GDFGLALLVDHE 353
           GDFGLA +VD  
Sbjct: 157 GDFGLARIVDPH 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 64/245 (26%), Positives = 98/245 (40%), Gaps = 42/245 (17%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLI--G 260
           +G+GGFG VY     D     A+K + +  +K  + E +        L  R +L L+  G
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIMLSLVSTG 54

Query: 261 LC----------HDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLG 305
            C          H   +   + + M  G L +HL     FS+             ++   
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------------EMRFY 102

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
            A  +L L     R VV+RD+K +NI+ D   +V++ D GLA     +  P  +   GT 
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS--VGTH 159

Query: 366 GYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN 425
           GYMAPE +  G A  D + D     C++   L    P R  +   +  I  +   T    
Sbjct: 160 GYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVE 217

Query: 426 LPSKM 430
           LP   
Sbjct: 218 LPDSF 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 21/214 (9%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
                 + L   T+ +     +G+G +G VY+ +    + ++A  KI   +     E   
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDEEIEA 67

Query: 243 EVKTCSQL-RHRNLLQLIGLCHDR-----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
           E      L  H N+++  G+ +       G+  LV E    GS+   +      G  L  
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP 356
                IS  L  ALL L       ++HRD+K +NI+  T+  VKL DFG++  +      
Sbjct: 128 AM---ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTD 390
           R T + GT  +MAPE I+           EQQ D
Sbjct: 185 RNTSV-GTPFWMAPEVIAC----------EQQYD 207

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 19/182 (10%)

Query: 203 KLGQGGFGAVYRGI-LIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++G+G +G V++   L +    VA+K++       G+       +  ++      H N++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 257 QLIGLCH----DR-GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           +L  +C     DR  +  LV+E + +  L  +L      G P    T   +   L   L 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLD 124

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++    T +  TL Y APE
Sbjct: 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 179

Query: 372 YI 373
            +
Sbjct: 180 VL 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 12/149 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMA--VAVKKISRGLKHG--KNEYITEVKTCSQLRHRNLLQL 258
           +LG G FG V +G+         VAVK +         K+E + E     QL +  ++++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           IG+C     +MLV E    G L+  L   K           +++S+G+     YL E   
Sbjct: 62  IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK----YLEET-- 114

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              VHRD+   N++  T    K+ DFGL+
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 21/186 (11%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRHRN 254
            +     +G G +G V   I       VA+KKI            T  E+K     +H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 255 LLQLIGLCHDRGEFM----LVYEFMPNGSLDFH--LFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ +  +    G       +V + M +   D H  + S +           Y++  GL  
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLTEEHIRYFLYQLLRGLK- 121

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH---ELGPRTTGLAGTL 365
              Y+H      V+HRD+K SN++ + D  +++GDFG+A  +     E     T    T 
Sbjct: 122 ---YIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 366 GYMAPE 371
            Y APE
Sbjct: 176 WYRAPE 181

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 24/178 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-------- 255
           LG+G FG V    L       AVK + + +       I +   C+ +  R L        
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV-----LIDDDVECTMVEKRVLALAWENPF 57

Query: 256 -LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
              L      +     V EF+  G L FH+  K      L   T Y   +     L +LH
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF--DLYRATFYAAEI--VCGLQFLH 113

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPE 371
            +    +++RD+K  N+M D D ++K+ DFG+    ++  G  R +   GT  Y+APE
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 52/199 (26%), Positives = 73/199 (36%), Gaps = 38/199 (19%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRNLLQLIG 260
           +G+G FG V+     D     A+K + +     +N+      E    +      +++L  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
              D     LV E+MP G L   L  +K           Y     +A  +L L    K  
Sbjct: 69  SFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPE-ETARFY-----IAELVLALDSVHKLG 121

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLA------------LLVDHELGPRTTGLA------ 362
            +HRDIK  NI+ D D ++KL DFGL             L   H L  R   L       
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 363 ----------GTLGYMAPE 371
                     GT  Y+APE
Sbjct: 182 QRRVRANSTVGTPDYIAPE 200

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 29/182 (15%)

Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQLRHR 253
           R +G+G FG   R +L+   + +   A+K+I     S  ++  + E +      ++++H 
Sbjct: 6   RVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKMKHP 58

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP----LTWTTRYKISLGLASA 309
           N++         G   +V E+   G L   +  ++    P    L W    ++ LG+   
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ-- 114

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             ++HE  KR V+HRDIK  NI    +  VKLGDFG A L+        T   GT  Y+ 
Sbjct: 115 --HIHE--KR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVP 168

Query: 370 PE 371
           PE
Sbjct: 169 PE 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 10/86 (11%)

Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
           PL       ++  L SA+ Y+H E    ++HRDIK  N++ +   ++ LGDFG A     
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR- 311

Query: 353 ELGPRTT----GLAGTLGYMAPEYIS 374
             G  +T    G+AGT+   APE ++
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLA 335

Length = 461

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 26/141 (18%)

Query: 236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT 295
           GK  ++T++ +C Q   R                 V E++  G L + +        P  
Sbjct: 58  GKPPFLTQLHSCFQTMDR--------------LYFVMEYVNGGDLMYQIQQVGRFKEPHA 103

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHE 353
                +I++GL     +LH    + +++RD+K  N+M D++ ++K+ DFG+    + D  
Sbjct: 104 VFYAAEIAIGL----FFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154

Query: 354 LGPRTTGLAGTLGYMAPEYIS 374
            G  T    GT  Y+APE I+
Sbjct: 155 -GVTTKTFCGTPDYIAPEIIA 174

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRN 254
           +++    KLG+G +  VY+G        VA+K I    + G     I E      L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L  + H +    LV+E++     D   +  K  G       +  +   L   L Y+H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +   R ++HRD+K  N++      +KL DFGLA
Sbjct: 121 Q---RYILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
            V +F+  G L FHL  ++S   P     R+  +  +ASAL YLH      +V+RD+K  
Sbjct: 73  FVLDFVNGGELFFHLQRERSFPEP---RARFYAA-EIASALGYLHS---INIVYRDLKPE 125

Query: 330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           NI+ D+  +V L DFGL           TT   GT  Y+APE I
Sbjct: 126 NILLDSQGHVVLTDFGLC-KEGIAQSDTTTTFCGTPEYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 12/174 (6%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YITEVKTC--SQLRHRNLLQLI 259
           +G+G FG V            AVK + +     K E  +I   +      ++H  L+ L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
                  +   V +++  G L FHL  ++S   P     R+  +  +ASAL YLH     
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARF-YAAEIASALGYLHS---L 115

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
            +++RD+K  NI+ D+  +V L DFGL      E    T+   GT  Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLC-KEGIEHSKTTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 22/183 (12%)

Query: 202 RKLGQGGFGAV--YRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKTCSQLR-HRNLL 256
           ++LGQG +G V   R         VA+KKI+     K      + E+K     R H+N+ 
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 257 QLIGL-CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT----WTTRYKISLGLASALL 311
            L  +     G F  +Y +      D H   +  +G PLT     +  Y+I  GL     
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQIIR--SGQPLTDAHFQSFIYQILCGLK---- 119

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELG-PRTTGLAGTLGYM 368
           Y+H      V+HRD+K  N++ + D  +K+ DFGLA     +        T    T  Y 
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 369 APE 371
           APE
Sbjct: 177 APE 179

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 24/159 (15%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKK-----ISRGLKHGKNEYI----------TEVKTCS 248
           LG+G +G V +         VA+KK     IS  +     + +           E+K  +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT-KDRQLVGMCGIHFTTLRELKIMN 75

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +++H N++ L+ +  +     LV + M    L      KK     +  T      + L  
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIM-ASDL------KKVVDRKIRLTESQVKCI-LLQ 127

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            L  L+   K   +HRD+  +NI  ++    K+ DFGLA
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166

Length = 335

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 8/121 (6%)

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++QL     D     +V E+MP G L  +L S      P  W   Y      A  +L L 
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDV--PEKWAKFYT-----AEVVLALD 156

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRD+K  N++ D   ++KL DFG  + +D     R     GT  Y++PE + 
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 375 T 375
           +
Sbjct: 217 S 217

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 11/190 (5%)

Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKT 246
           +DL     ++   + +G+G FG V            A+K +S+   +K   + +  E + 
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 247 CSQLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
                +   ++QL     D     +V E+MP G L  +L S      P  W   Y     
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDV--PEKWARFYT---- 148

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
            A  +L L        +HRD+K  N++ D   ++KL DFG  + ++ E   R     GT 
Sbjct: 149 -AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207

Query: 366 GYMAPEYIST 375
            Y++PE + +
Sbjct: 208 DYISPEVLKS 217

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 23/190 (12%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLRH 252
            +F  +  +G+G FG V            A+K + +     +   + +  E    S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK-------ISLG 305
             + QL     D+    LV E+ P G L             L+   RY+           
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDL-------------LSLLNRYEDQFDEDMAQFY 107

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA  +L +H   +   VHRDIK  N++ D   ++KL DFG A  +       +    GT 
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 366 GYMAPEYIST 375
            Y+APE ++T
Sbjct: 168 DYIAPEVLTT 177

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 50/186 (26%), Positives = 75/186 (40%), Gaps = 43/186 (23%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY--ITEVKTCSQLR-------HR 253
           K+G+G F  V +          A+K +       K  +  + +V    +++       H 
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58

Query: 254 NLLQLIGLCHDR--GEFMLVYEFMPNGSLDFHLFSK-KSTGTPLTWTTRYKISLGLASAL 310
           N+L+LI +  DR  G   LV+E M     D +L+   K    PL           L  +L
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 311 LYLHEEWKRC-VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            ++H    R  + HRDIK  NI+   D  +KL DFG    + +   P T           
Sbjct: 114 DHMH----RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPYT----------- 156

Query: 370 PEYIST 375
            EYIST
Sbjct: 157 -EYIST 161

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 15/177 (8%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKTCSQLRHRN---LLQL 258
           +G+G FG V            A+K +S+   +K   + +  E +    + H N   ++QL
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL 108

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
                D     +V E+MP G L  +L S  +   P  W   Y   + LA   ++      
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-VNLMS--NYDIPEKWARFYTAEVVLALDAIH-----S 160

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
              +HRD+K  N++ D   ++KL DFG  + +D     R     GT  Y++PE + +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 11/174 (6%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQLIG 260
           +G+G FG V +    D     A+K I +     ++E    + E    +Q+    ++ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                 +  LV  F+  G L  HL   +  G       R+  +  L  AL  LH+     
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTA-ELLCALENLHK---FN 113

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           V++RD+K  NI+ D   ++ L DFGL  L + +   +T    GT  Y+APE + 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLL 166

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 37/174 (21%)

Query: 204 LGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQ 257
           LG+G FG V +     L        VAVK +       +  + ++E     Q+ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT--------------------PLTW- 296
           L G C   G  +L+ E+   GSL   L   +  G                      LT  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 297 ---TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  ++IS G+     YL E     +VHRD+   N++      +K+ DFGL+
Sbjct: 128 DLISFAWQISRGMQ----YLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 21/185 (11%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           ++F   + +G+G FG V    +       A+K ++      K E +   +T      RN+
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN------KWEMLKRAETACFREERNV 54

Query: 256 L-----QLIGLCH----DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           L     Q I   H    D     LV ++   G L   L SK     P      Y     +
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY-----I 108

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
           A  +L +H   +   VHRDIK  N++ D + +++L DFG  L ++ +   +++   GT  
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168

Query: 367 YMAPE 371
           Y++PE
Sbjct: 169 YISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 40/170 (23%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH--- 252
            +F   + +G+G FG V      D     A+K + +          +E+    QL H   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLK----------SEMFKKDQLAHVKA 50

Query: 253 -RNLL---------QLIGLCHDRGEFMLVYEFMPNGSL-----DFHLFSKKSTGTPLTWT 297
            R++L          L     D     L+ EF+P G L      +  FS+          
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--------V 102

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           TR+ +    A  +L +    K   +HRDIK  NI+ D   ++KL DFGL+
Sbjct: 103 TRFYM----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLC 262
           +G+G +G V++ +L   N + A  KI   +     E   E      L  H N+++  G+ 
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 263 HDRG-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           + +      +  LV E    GS+   +      G  +       I+  L  AL+ L    
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---IAYILHEALMGLQHLH 141

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
               +HRD+K +NI+  T+  VKL DFG++  +      R T + GT  +MAPE I+   
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC-E 199

Query: 378 ARLDVNFDEQ 387
            +LD  +D +
Sbjct: 200 QQLDSTYDAR 209

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 48/217 (22%)

Query: 177 LSRDAGPRRFSYKDLASAT----NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           +SR      F   ++  +T      + N + +G G  G V       L   VA+KK+SR 
Sbjct: 1   MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60

Query: 233 LK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL----DFHLF 285
            +   H K  Y  E+     + H+N++ L+ +            F P  SL    D ++ 
Sbjct: 61  FQNQTHAKRAY-RELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIV 107

Query: 286 SKKSTGTPLTWTTRYKISLGLASALLY--------LHEEWKRCVVHRDIKFSNIMPDTDF 337
            +      L    + ++     S LLY        LH      ++HRD+K SNI+  +D 
Sbjct: 108 MELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163

Query: 338 NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            +K+ DFGLA         RT   AGT   M P  ++
Sbjct: 164 TLKILDFGLA---------RT---AGTSFMMTPYVVT 188

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 203 KLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLL 256
           +LG+  FG VY+G L      +   AVA+K +    +   + E+  E    S+L+H N++
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLF--------------SKKSTGTPLTWTTRYKI 302
            L+G+        +++ +  +   D H F                K+  + L       I
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL---------ALLVDHE 353
              +A+ + +L       VVH+D+   N++     NVK+ D GL           L+ + 
Sbjct: 130 VTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 354 LGPRTTGLAGTLGYMAPEYISTGRARLD 381
           L P        + +M+PE I  G+  +D
Sbjct: 187 LLP--------IRWMSPEAIMYGKFSID 206

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 13/109 (11%)

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           Q+ H++++ L G+C    E ++V EF+  G LD  LF  + +   LT   ++K++  LAS
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKS-DVLTTPWKFKVAKQLAS 116

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMP-----DTDFN--VKLGDFGLALLV 350
           AL YL +   + +VH ++   NI+      D +    +KL D G+ + V
Sbjct: 117 ALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 22/160 (13%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           ++F + + +G+G FG V      D     A+KK+       K+E + + +       R++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDI 54

Query: 256 L---------QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           L         +L     D     L+ E++P G +   L  KK T T     TR+ I    
Sbjct: 55  LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDM-MTLLMKKDTFT--EEETRFYI---- 107

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           A  +L +    K   +HRDIK  N++ D   ++KL DFGL
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 53/187 (28%), Positives = 76/187 (40%), Gaps = 34/187 (18%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQL 258
           + +G G  G V       L + VAVKK+SR  +   H K  Y  E+     + H+N++ L
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85

Query: 259 IGLCHDRGEFMLVYEFMPNGSL----DFHLFSKKSTGTPLTWTTRYKISLGLASALLY-- 312
           + +            F P  SL    D +L  +      L      ++     S LLY  
Sbjct: 86  LNV------------FTPQKSLEEFQDVYLVMELMDAN-LCQVIHMELDHERMSYLLYQM 132

Query: 313 ------LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                 LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRY 187

Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 188 YRAPEVI 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 4/64 (6%)

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL++LH   +  V++RD+K  NI+ D + + KL DFG+        G  TT   GT  Y
Sbjct: 107 LALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDY 162

Query: 368 MAPE 371
           +APE
Sbjct: 163 IAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 16/174 (9%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTC--SQLRHRNLLQLI 259
           +G+G FG V            AVK + +   LK  +  +I   +      L+H  L+ L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
                  +   V +++  G L FHL  ++    P     R+  +  +ASA+ YLH     
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARF-YAAEVASAIGYLHSL--- 115

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR--TTGLAGTLGYMAPE 371
            +++RD+K  NI+ D+  +V L DFGL       + P   T+   GT  Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 8/111 (7%)

Query: 275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD 334
           +P+ S D + +  K +  PL       I   +   L YLH +    ++HRD+K  NI  +
Sbjct: 136 LPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFIN 191

Query: 335 TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFD 385
               V +GD G A        P   GLAGT+   APE ++  R + +   D
Sbjct: 192 DVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLA--RDKYNSKAD 238

Length = 357

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 25/165 (15%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-----EYITEVKTCSQLRHRNLLQ 257
           +LG+  FG +Y+G L    M  A     + LK   N     E+  E    ++L H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLF------------SKKSTGT---PLTWTTRYKI 302
           L+G+        +++E++  G  D H F            S    GT    L       I
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           ++ +A+ + YL   +    VH+D+   NI+     +VK+ D GL+
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLS 171

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 14/154 (9%)

Query: 204 LGQGGFGAVY----RGILI-DLNMAVAVKKI-SRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           LG+G FG V+    +GI        V VK +     ++ ++E+  E+    +L H+N+++
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 258 LIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGT----PLTWTTRYKISLGLASALLY 312
           L+GLC +     ++ E+   G L  F   +K         PL+   +  +   +A  + +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           L        VHRD+   N +  +   VK+    L
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSL 163

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 26/123 (21%), Positives = 38/123 (30%), Gaps = 25/123 (20%)

Query: 26  SPIVLVEFDSFSNPE-WDP------INVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK 78
              V VEFD++ N +  DP      I+V  +      +               G+   V+
Sbjct: 102 GNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLG-SASLPNGTGLGNEHTVR 160

Query: 79  IKYNSATKNLSASWSYGETPKYSQENTT-----------------STGRYTERHVLKSWE 121
           I Y+  T  L+     G T                          STG  T  H + +W 
Sbjct: 161 ITYDPTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWS 220

Query: 122 FNS 124
           F S
Sbjct: 221 FTS 223

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 51/199 (25%), Positives = 79/199 (39%), Gaps = 50/199 (25%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N + +G G  G V           VA+KK+SR  +   H K  Y  E+     + H+N
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKN 76

Query: 255 LLQLIGL------CHDRGEFMLVYEFMP-------NGSLDFHLFSKKSTGTPLTWTTRYK 301
           ++ L+ +        +  +  LV E M           LD    S             Y+
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS----------YLLYQ 126

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +  G+     +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G 
Sbjct: 127 MLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGT 170

Query: 362 AGTLG-------YMAPEYI 373
           +  +        Y APE I
Sbjct: 171 SFMMTPYVVTRYYRAPEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 12/174 (6%)

Query: 204 LGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTC--SQLRHRNLLQLI 259
           +G+G FG V   R    +   AV V +    LK  + ++I   +      ++H  L+ L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
                  +   V +++  G L +HL  ++    P     R+  +  +ASAL YLH     
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARF-YAAEIASALGYLHS---L 115

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
            +V+RD+K  NI+ D+  ++ L DFGL    + E    T+   GT  Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLC-KENIEHNGTTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 10/106 (9%)

Query: 270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS 329
           LV ++   G L   + S+  T         ++  L     LL +H    + ++HRDIK +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFR---EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 330 NIMPDTDFNVKLGDFGL----ALLVDHELGPRTTGLAGTLGYMAPE 371
           NI+  ++  VKLGDFG     A  V  ++G RT    GT  Y+APE
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVG-RT--FCGTPYYVAPE 215

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 48/198 (24%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     + H+N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 77

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSL----DFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           ++ L+ +            F P  SL    D +L  +      L    + ++     S L
Sbjct: 78  IISLLNV------------FTPQKSLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYL 124

Query: 311 LY--------LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           LY        LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTS 172

Query: 363 GTLG-------YMAPEYI 373
             +        Y APE I
Sbjct: 173 FMMTPYVVTRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 25/192 (13%)

Query: 203 KLGQGGFGAVYRGILIDLN--MAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRNL--LQ 257
           K+G+G +G VY+    D       A+K+I   G+         E+    +L+H N+  LQ
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELKHPNVIALQ 64

Query: 258 LIGLCHDRGEFMLVYEFMPNG---SLDFHLFSKKSTGTPLTWTTRYKISL--GLASALLY 312
            + L H   +  L++++  +     + FH  SK +   P+        SL   +   + Y
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 313 LHEEWKRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLALLVDHELGPRT--TGLAGTL 365
           LH  W   V+HRD+K +NI+     P+    VK+ D G A L +  L P      +  T 
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 366 GYMAPEYISTGR 377
            Y APE +   R
Sbjct: 180 WYRAPELLLGAR 191

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 37/198 (18%)

Query: 203 KLGQGGFGAVYRGILID--LNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRNL--LQ 257
           K+G+G +G VY+    D   +   A+K+I   G+         E+    +L+H N+  LQ
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 64

Query: 258 LIGLCHDRGEFMLVYEFMPNG---SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY-- 312
            + L H   +  L++++  +     + FH  SK +   P+      ++  G+  +LLY  
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK-ANKKPV------QLPRGMVKSLLYQI 117

Query: 313 ------LHEEWKRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLALLVDHELGPRT--T 359
                 LH  W   V+HRD+K +NI+     P+    VK+ D G A L +  L P     
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLD 173

Query: 360 GLAGTLGYMAPEYISTGR 377
            +  T  Y APE +   R
Sbjct: 174 PVVVTFWYRAPELLLGAR 191

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 26/66 (39%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           A+ YLHE     ++HRDIK  NI  +   +V LGDFG A         +  G AGT+   
Sbjct: 194 AIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 369 APEYIS 374
           APE ++
Sbjct: 251 APELLA 256

Length = 391

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 22/158 (13%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL- 256
           F   + +G G FG V     +D N   A+K + +     +N+    VK       R++L 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ-AAHVKA-----ERDILA 56

Query: 257 --------QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
                   +L     D+     V +++P G +   L         L    R+ I+  L  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTC 112

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           A+  +H   K   +HRDIK  NI+ D D ++KL DFGL
Sbjct: 113 AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 7/84 (8%)

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            D+    L+ EF+P G +   L  KK T       T  +    +A  +L +    +   +
Sbjct: 71  QDKLNLYLIMEFLPGGDM-MTLLMKKDT------LTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGL 346
           HRDIK  N++ D+  +VKL DFGL
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 37/147 (25%), Positives = 58/147 (39%), Gaps = 13/147 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT----EVKTCSQLRHRNLLQ 257
           +         + +      N  VAVKKI+  L     E +     E+ T  QL+H N+L 
Sbjct: 8   KCFEDLMIVHLAKHK--PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +       E  +V   M  GS +  L +    G P      + I   + +AL Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAF-ILKDVLNALDYIH--- 118

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDF 344
            +  +HR +K S+I+   D  V L   
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 12/103 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNEY---ITEVKTCSQL-R 251
            + LG+G FG V +     +  +     VAVK +  G     +EY   +TE+K    +  
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGH 69

Query: 252 HRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
           H N++ L+G C    G  M++ E+   G+L  +L SK+   +P
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 24/195 (12%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +F   + +G+G FG V    L + +   A+K ++      K E +   +T      R++L
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN------KWEMLKRAETACFREERDVL 55

Query: 257 -----QLIGLCH----DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
                Q I   H    D     LV ++   G L   L SK     P      Y     LA
Sbjct: 56  VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY-----LA 109

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             ++ +    +   VHRDIK  NI+ D + +++L DFG  L +  +   +++   GT  Y
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 169

Query: 368 MAPEYIST---GRAR 379
           ++PE +     G+ +
Sbjct: 170 ISPEILQAMEDGKGK 184

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 4/106 (3%)

Query: 267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI 326
           + +L+ E+   G L+  +  +     P      Y++ L     +L L E   R ++HRD+
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYEVGLLFYQIVLALDEVHSRKMMHRDL 195

Query: 327 KFSNIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPE 371
           K +NI       +KLGDFG +      +     +   GT  Y+APE
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Length = 478

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.002
 Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 29/212 (13%)

Query: 188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKH-GKNEYITEVK 245
           Y D  S  N +   +K+G G FG V+             K IS RGLK   K++ + EV 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64

Query: 246 TCSQLRHRNLLQLIG--LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
              +L+H+N+++ I   L     +  ++ EF   G L  ++         +       I+
Sbjct: 65  VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124

Query: 304 LGLASALLYLHE-----EWKRCVVHRDIKFSNIMPDTDFN-----------------VKL 341
             L  AL Y H        +R V+HRD+K  NI   T                     K+
Sbjct: 125 RQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           GDFGL+  +  E         GT  Y +PE +
Sbjct: 184 GDFGLSKNIGIE--SMAHSCVGTPYYWSPELL 213

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 26/84 (30%), Positives = 39/84 (46%), Gaps = 7/84 (8%)

Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            D+    L+ EF+P G +   L  KK T       +       +A  +L +    +   +
Sbjct: 71  QDKRNLYLIMEFLPGGDM-MTLLMKKDT------LSEEATQFYIAETVLAIDAIHQLGFI 123

Query: 323 HRDIKFSNIMPDTDFNVKLGDFGL 346
           HRDIK  N++ D   +VKL DFGL
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 12/153 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKT----CSQLRHR 253
           F   + LG G FG V     +D +   A+K + +     +N+ +  VK      ++  + 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VAHVKAERDILAEADNE 61

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            +++L     D+     V +++P G +   L   +     L    R+ I+  L  A+  +
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAIESV 117

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           H   K   +HRDIK  NI+ D D ++KL DFGL
Sbjct: 118 H---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 8/100 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNM-----AVAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 13  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 72

Query: 255 LLQLIGLCHDRG-EFMLVYEFMPNGSLDFHLFSKKSTGTP 293
           ++ L+G C   G   M++ EF   G+L  +L SK+    P
Sbjct: 73  VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.1 bits (92), Expect = 0.003
 Identities = 38/135 (28%), Positives = 60/135 (44%), Gaps = 15/135 (11%)

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           + N ++L          +L+ +++ +G L F L  K+     L+     KI   L  AL 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL-FDLLKKE---GKLSEAEVKKIIRQLVEALN 123

Query: 312 YLHEEWKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            LH   K  ++H DIK  N++ D     + L D+GL  ++        +   GTL Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSP 175

Query: 371 EYISTGRARLDVNFD 385
           E I       DV+FD
Sbjct: 176 EKIK--GHNYDVSFD 188

Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 18/50 (36%), Positives = 30/50 (60%)

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           VHRDIK  N++ D + +++L DFG  L +  +   ++    GT  Y++PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 21/181 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKIS---RGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +R +G G FG V+          VA+KK+    + L   K  +  E+K     +H N+L 
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 258 LIGLCH--DRGEFMLVY---EFMPNGSLDFH--LFSKKSTGTPLTWTTRYKISLGLASAL 310
            + +        F  +Y   E M +   D H  + S +   +       Y+I  GL    
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQS---DLHKIIVSPQPLSSDHVKVFLYQILRGLK--- 117

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLH      ++HRDIK  N++ +++  +K+ DFGLA + + +     T    T  Y AP
Sbjct: 118 -YLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 371 E 371
           E
Sbjct: 174 E 174

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	459
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.98
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
PHA03207	392	serine/threonine kinase US3; Provisional	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.98
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	99.87
PLN00181	793	protein SPA1-RELATED; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
smart00090	237	RIO RIO-like kinase.	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.77
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	99.67
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.62
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.18
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
PRK09902	216	hypothetical protein; Provisional	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.37
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.24
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.13
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.11
COG4248	637	Uncharacterized protein with protein kinase and he	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
PRK10593	297	hypothetical protein; Provisional	97.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.93
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.87
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.81
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.63
PRK05231	319	homoserine kinase; Provisional	97.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	97.41
PLN02236	344	choline kinase	97.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.21
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.06
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.06
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.93
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.73
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
KOG2270	520	consensus Serine/threonine protein kinase involved	96.54
PLN02756	418	S-methyl-5-thioribose kinase	96.53
COG2334	331	Putative homoserine kinase type II (protein kinase	96.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.35
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.32
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.0
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.72
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.68
PRK11768	325	serine/threonine protein kinase; Provisional	95.65
PTZ00384	383	choline kinase; Provisional	95.6
PRK12396	409	5-methylribose kinase; Reviewed	95.59
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=384.45  Aligned_cols=213  Identities=48%  Similarity=0.786  Sum_probs=183.5

Q ss_pred             CCcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEE
Q 041624          182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL  261 (459)
Q Consensus       182 ~~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~  261 (459)
                      ..+.|+++|++.||++|...++||+|+||.||+|...+ +..||||++.....+..++|.+|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            46789999999999999999999999999999999988 58999998876543315669999999999999999999999


Q ss_pred             EeeCC-eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          262 CHDRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       262 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      |.+.+ +.+||||||++|||+++|+.....  +|+|.+|++|+.++|+||+|||+.+...|+||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99998 599999999999999999876543  799999999999999999999998888999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccc-cccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          341 LGDFGLALLVDHELGPRTTGL-AGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      |+|||+|+..... ....... .||.+|+|||++..+.  ++.++|+||+|+++.++++|.
T Consensus       218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~--lt~KsDVySFGVvllElitgr  275 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGK--LTEKSDVYSFGVVLLELITGR  275 (361)
T ss_pred             ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCC--cCcccccccchHHHHHHHhCC
Confidence            9999999765531 1111222 8999999999998764  466777777777776655533

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=344.79  Aligned_cols=218  Identities=27%  Similarity=0.390  Sum_probs=194.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|...+.||+|+||+||+|+++.++..||||.+.+.  .....+.+..|+.+|+.++|+|||+|++++..++.+|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            446788888999999999999999999999999999776  445567788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC------CCEEEeecC
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD------FNVKLGDFG  345 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kL~DFG  345 (459)
                      ||||.+|+|.++|+.++    .+++...+.++.|||.||++||+   ++||||||||.||||+..      -.+||+|||
T Consensus        88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999998876    49999999999999999999999   999999999999999875      458999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      +||.+..  .....+.+|++-|||||+++.++  |+.+.|+|++|+++|.++++..|+..  .|..|+....+......
T Consensus       161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~--YdAKADLWSiG~Ilyq~l~g~~Pf~a--~t~~eL~~~~~k~~~~~  233 (429)
T KOG0595|consen  161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQ--YDAKADLWSIGTILYQCLTGKPPFDA--ETPKELLLYIKKGNEIV  233 (429)
T ss_pred             hhhhCCc--hhHHHHhhCCccccCHHHHHhcc--ccchhhHHHHHHHHHHHHhCCCCccc--cCHHHHHHHHhcccccc
Confidence            9998874  34456789999999999998765  68999999999999999999998875  47788888777665433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-43  Score=349.49  Aligned_cols=214  Identities=30%  Similarity=0.496  Sum_probs=192.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..|...+.||+|||+.||++++..+|..||+|++.+.   .....+...+|+++.++|+|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999999899999999999764   2345677899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |+|++++|..++..++    ++++.+++.++.||+.||.|||+   .+|+|||||..|+||++++++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999887443    79999999999999999999999   9999999999999999999999999999998875


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC--------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA--------------------------------  400 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~--------------------------------  400 (459)
                      + .....+.+||+.|+|||++...  ..+.++|+||+||++|.+|.+.                                
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~d  247 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKD  247 (592)
T ss_pred             c-ccccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHH
Confidence            4 3456678999999999999843  4678899999999999998755                                


Q ss_pred             ------CCCCCCCCCHHHHHHHHhc
Q 041624          401 ------HPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       401 ------~p~p~~RPs~~~v~~~L~~  419 (459)
                            .++|.+|||+.+|+..-.+
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhh
Confidence                  4589999999999986544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=339.29  Aligned_cols=215  Identities=32%  Similarity=0.462  Sum_probs=186.3

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc--hHHHHHHHHHHhccCcCCceeEEEEEeeCC-eEEEEEEe
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHRNLLQLIGLCHDRG-EFMLVYEF  274 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~  274 (459)
                      +...+.||+|+||+||+|.+.. ...||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. .++|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g-~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRG-TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCC-ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3444569999999999999985 2339999997653222  569999999999999999999999999887 79999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eeecCCCCCCeeecCCC-CEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC-VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  352 (459)
                      |++|+|.++++..  ....+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++....
T Consensus       122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999874  12379999999999999999999999   77 99999999999999998 999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .. ...+...||+.|||||++.+.+..++.++|+||+|++++++++                                  
T Consensus       197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l  275 (362)
T KOG0192|consen  197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHL  275 (362)
T ss_pred             cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            32 2334478999999999998643357999999999999998876                                  


Q ss_pred             ------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                            ||+.+|..||++.+++.+|+.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence                  999999999999999999983

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=324.49  Aligned_cols=213  Identities=24%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|+..++||+|+||+||.++.+++++.+|+|++++..   ....+...+|..+|.+++||+||+++..|++.+.+||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4578999999999999999999999999999999998763   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |+||+.||.|..+|.++.    .+++..+.-++.+|+.||.|||+   ++||||||||+|||||.+|.++|+|||+|+..
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999997665    49999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ... +..+.+.+||+.|||||++.+.  .++..+|.||+|+++|+|++++.|+...  +..++.+.+.
T Consensus       176 ~~~-~~~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~--~~~~~~~~I~  238 (357)
T KOG0598|consen  176 LKD-GDATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAE--DVKKMYDKIL  238 (357)
T ss_pred             ccC-CCccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCc--cHHHHHHHHh
Confidence            433 3456668999999999999876  5789999999999999999999999865  3344444443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=328.88  Aligned_cols=219  Identities=25%  Similarity=0.317  Sum_probs=187.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-------chHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            345678889999999999999999999999999999765221       1233579999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEee
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGD  343 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~D  343 (459)
                      ..|+||||++||+|.+.+-.+.    .+.+.....++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999997765    47788889999999999999999   999999999999999866   7899999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCC-CCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDV-NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~-~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      ||+|+....  ...+.+.|||+.|.|||++.++...+.. ++|+||+||++|++|++..||.+.+-.+.-.-|++.+.-
T Consensus       323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            999998763  4567789999999999999877664444 889999999999999999999988854433335555543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-43  Score=319.59  Aligned_cols=226  Identities=28%  Similarity=0.366  Sum_probs=195.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEE-EeeCCe-EEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGL-CHDRGE-FMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~-~~~~~~-~~lV  271 (459)
                      .+|++.++||+|.||+|||+....+|..||.|.++-.  ..+..+....|+.+|++|+|||||+++++ +.++++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4567788999999999999999999999999999744  33456778999999999999999999994 445555 8999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||..|+|.+++...+.....+++..+++++.|++.||.++|+.++. -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999987666667899999999999999999999985533 4899999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLP  427 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p  427 (459)
                      ... .......+||+.||+||.+....  ++.++|+|++||++|+|+.-.+|+..+  +.-++.+.++.. ..|++|
T Consensus       179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qg-d~~~~p  249 (375)
T KOG0591|consen  179 SSK-TTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQG-DYPPLP  249 (375)
T ss_pred             cch-hHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcC-CCCCCc
Confidence            754 33456689999999999998764  688999999999999999999999887  888888877655 556666

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=318.30  Aligned_cols=226  Identities=27%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      .+++.||+.       .+.||+|..|+||++.++.+++.+|+|.+.... ....+++.+|++++.+.+||+||++||.|.
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            355666655       478999999999999999999999999996553 345688999999999999999999999999


Q ss_pred             eCC-eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          264 DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       264 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      .++ .+.|+||||.+|||++++...+    .+++...-+|+.+|++||.|||+  .++||||||||+|||++..|.+|||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEec
Confidence            998 5999999999999999987553    59999999999999999999996  3899999999999999999999999


Q ss_pred             ecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHhc
Q 041624          343 DFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP---SIRQAIQVLNF  419 (459)
Q Consensus       343 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP---s~~~v~~~L~~  419 (459)
                      |||.++.+...   ...+.+||..|||||.+.++.  ++...|+||+|..+.++..+.-|+|..++   ...+++..+-.
T Consensus       222 DFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  222 DFGVSGILVNS---IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             cccccHHhhhh---hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence            99999887653   456789999999999999875  56778999999999999999999998765   44444444433


Q ss_pred             CCCCCCCCCC
Q 041624          420 ETKMPNLPSK  429 (459)
Q Consensus       420 ~~~~p~~p~~  429 (459)
                      + +.|.+|..
T Consensus       297 ~-ppP~lP~~  305 (364)
T KOG0581|consen  297 E-PPPRLPEG  305 (364)
T ss_pred             C-CCCCCCcc
Confidence            2 33555554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-40  Score=300.60  Aligned_cols=233  Identities=28%  Similarity=0.433  Sum_probs=199.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-c-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-G-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .+|...+.||+|.||.||+|++..+|+.||||+++..... + ....++|++.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677789999999999999999999999999999866322 2 4567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||+. +|+..+++...   .|+..++..++.++++||+|||+   +.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus        82 fm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9965 99999987665   79999999999999999999998   99999999999999999999999999999998765


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------------------
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------------------  398 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------------------  398 (459)
                      ....+. .+-|..|.|||.+.+.+ .++..+|+|+.||++.+++.                                   
T Consensus       155 ~~~~~~-~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRIQTH-QVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Cccccc-ceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            444333 37799999999998776 58999999999999998886                                   


Q ss_pred             -------------------------------cCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCCcccccC
Q 041624          399 -------------------------------CAHPDRNCRPSIRQAIQVLNFE-TKMPNLPSKMPVAIFEA  437 (459)
Q Consensus       399 -------------------------------c~~p~p~~RPs~~~v~~~L~~~-~~~p~~p~~~p~~~~~~  437 (459)
                                                     .+..+|.+|.++.|++++=-+. .|.|..|.++|.+...+
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~~~  303 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPSTKS  303 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcccC
Confidence                                           3344788888888888765443 57777777777665533

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=323.86  Aligned_cols=201  Identities=28%  Similarity=0.341  Sum_probs=176.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV  271 (459)
                      +.|+..++||+|.||.||+|++..+|+.||+|+++...  .....-..+||.+|++|+||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            44666688999999999999999999999999998664  33345567999999999999999999998776  689999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      +|||+. +|.-++....-   .+++.++..++.||+.||.|||+   ++|+|||||.+|||||.+|.+||+|||||+++.
T Consensus       197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999987 88888865443   69999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .......+..+-|+.|.|||++.+.. .|+..+|+|+.||++.+|+.+...+|
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcC
Confidence            77666677778899999999998655 69999999999999999988554433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=299.26  Aligned_cols=217  Identities=26%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||.|+||+|..++.+.+|..+|+|++++..-   ...+...+|..+|+.+.||+++++++.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            466778999999999999999999999999999976532   33456779999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||.+||.|..+|++.+    .+++..++-++.||+.||+|||+   .+|++|||||+|||||.+|.+||+|||+|+.+..
T Consensus       124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998765    59999999999999999999999   9999999999999999999999999999997753


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL  426 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~  426 (459)
                          .+.+.|||+.|+|||.++..  .++..+|.|++|+++|+|+.+-.|+-..+| |.---+++++...+|..
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~  263 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSY  263 (355)
T ss_pred             ----cEEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcc
Confidence                37789999999999999876  468889999999999999999999999998 55555678887777754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=326.00  Aligned_cols=225  Identities=28%  Similarity=0.435  Sum_probs=191.4

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      ...+.||+|-||.||.|.++. ...||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            345789999999999999987 568999999765 344578999999999999999999999999998999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      +|.++|+...  +..+...+.+.++.|||+||+||++   +++|||||.++|||++++..+||+||||||...++.....
T Consensus       287 sLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  287 SLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            9999998732  2368999999999999999999999   9999999999999999999999999999997665544444


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCccc
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAI  434 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~~~  434 (459)
                      ....-...|.|||.+..++  ++.++|+||+|++++++++-- ..|-...+-.++++.|+....+|. |...|..+
T Consensus       362 ~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G-~~py~~msn~ev~~~le~GyRlp~-P~~CP~~v  433 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYG-RVPYPGMSNEEVLELLERGYRLPR-PEGCPDEV  433 (468)
T ss_pred             CCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccC-CCCCCCCCHHHHHHHHhccCcCCC-CCCCCHHH
Confidence            4555577999999999886  578899999999999998842 223334588888888888888777 55677554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-40  Score=302.47  Aligned_cols=219  Identities=25%  Similarity=0.286  Sum_probs=187.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      +.|+...++|+|+||.||++++++||+.||||++.....  ...+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357778899999999999999999999999999965432  335667899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||+..-| +-|.....   .++.....+++.|++.|+.|+|+   +++|||||||+||||+.++.+||||||+|+.+.. 
T Consensus        82 ~~dhTvL-~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHTVL-HELERYPN---GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchHHH-HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            9987444 44444433   58999999999999999999998   9999999999999999999999999999999874 


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      .+...+..+.|.+|.|||.+.+.. .++..+|+|++||++.+|+++...+|.+ -..+|+..+..-..+++
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHHHHHHHcccC
Confidence            344556678899999999998644 5899999999999999999999999975 47777766655444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=316.00  Aligned_cols=220  Identities=25%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCe
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  267 (459)
                      +...++|..++.||+|+|++|++|+.+.+++.+|||++.+..   ....+....|-.+|.+| .||.|++|+..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            345578888999999999999999999999999999997652   23344567889999999 89999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      +|+|+||+++|+|.++|.+.+    .+++...+.++.+|+.||+|||+   .|||||||||+|||||++|++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999998775    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC----------c--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC-------------
Q 041624          348 LLVDHELGP----------R--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP-------------  402 (459)
Q Consensus       348 ~~~~~~~~~----------~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p-------------  402 (459)
                      +.+......          .  ...++||..|.+||++..+..  +...|+|++||++|.|+.+..|             
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~--~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA--GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC--CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            988643221          1  145899999999999998754  6778999999999999998877             


Q ss_pred             -------------------------CCCCCCCHHHHHHHHhcC
Q 041624          403 -------------------------DRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       403 -------------------------~p~~RPs~~~v~~~L~~~  420 (459)
                                               +|.+|.+..||.+..-+.
T Consensus       300 ~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  300 QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence                                     788888888888776543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=316.42  Aligned_cols=194  Identities=27%  Similarity=0.371  Sum_probs=171.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHH--HHHHHHHHhccC-cCCceeEEEEEeeCC-eEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YITEVKTCSQLR-HRNLLQLIGLCHDRG-EFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~  269 (459)
                      ..++|...++||.|.||.||+|+.+.++..||||++++.... .++  -++|++.|++|+ ||||++|..++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            346788889999999999999999999999999999876433 333  368999999998 999999999999888 999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|||||+. +|++++..+..   .+++..++.|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+||.
T Consensus        87 fVfE~Md~-NLYqLmK~R~r---~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNR---LFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCC---cCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccc
Confidence            99999965 99999987744   89999999999999999999998   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +...  ...+..+.|..|+|||++..... |+...|+|++||+++++..
T Consensus       160 v~Sk--pPYTeYVSTRWYRAPEvLLrs~~-Ys~pvD~wA~GcI~aEl~s  205 (538)
T KOG0661|consen  160 VRSK--PPYTEYVSTRWYRAPEVLLRSGY-YSSPVDMWAVGCIMAELYS  205 (538)
T ss_pred             cccC--CCcchhhhcccccchHHhhhccc-cCCchHHHHHHHHHHHHHH
Confidence            7643  44567889999999999986554 8899999999999987665

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5e-39  Score=316.32  Aligned_cols=217  Identities=27%  Similarity=0.342  Sum_probs=193.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..  .+..+...+|++++++++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999999999999999997653  3446678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+.+ +|..+|....    .|+++.++.|+.+++.||.|||+   .+|+|||+||.|||++..+.+|+||||+|+.+...
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9976 9999997665    49999999999999999999999   99999999999999999999999999999987653


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                       ....+.+.||+.|||||.+.++  .++..+|.|++||++|++..+..||-..  ++.++++++..+...|+
T Consensus       154 -t~vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~~p  220 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVKPP  220 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCCCc
Confidence             3345678899999999999865  4677889999999999999999999876  88899988876654443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=303.52  Aligned_cols=230  Identities=27%  Similarity=0.380  Sum_probs=193.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC--eEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG--EFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  272 (459)
                      ..+|...+.||+|+||.||++.+.++|...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            455777899999999999999999989999999987653333677899999999999999999999855444  689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecCCccccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVD  351 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~  351 (459)
                      ||+++|||.+++.....   .|++..+.++..||++||.|||+   ++|+||||||+|||++. ++.+||+|||+++...
T Consensus        96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999987653   59999999999999999999998   99999999999999999 7999999999998776


Q ss_pred             C--CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          352 H--ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       352 ~--~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                      .  ..........||+.|||||++..+.. ....+|+|++||++.+|+++..|+....-.+..++...... ..|++|+.
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~-~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEV-ARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCc-CCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcc
Confidence            3  21222446789999999999986322 23588999999999999999999998544556666666555 67888887


Q ss_pred             CCc
Q 041624          430 MPV  432 (459)
Q Consensus       430 ~p~  432 (459)
                      ++.
T Consensus       248 ls~  250 (313)
T KOG0198|consen  248 LSD  250 (313)
T ss_pred             cCH
Confidence            764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=305.14  Aligned_cols=218  Identities=23%  Similarity=0.276  Sum_probs=187.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ...++|+....||+|+||.||.|+-++||..+|+|++++..   ....+....|-.+|...+++.||+|+..|++.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35689999999999999999999999999999999998763   234556788999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      |||||+|||++..+|....    .|++..++.++.+++.|+.-||.   .|+|||||||+|+|||..|++||+||||+.-
T Consensus       218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999997665    59999999999999999999998   9999999999999999999999999999854


Q ss_pred             ccC-----------------------CCCC----c-------------------cccccccccccccceeccCccccCCC
Q 041624          350 VDH-----------------------ELGP----R-------------------TTGLAGTLGYMAPEYISTGRARLDVN  383 (459)
Q Consensus       350 ~~~-----------------------~~~~----~-------------------~~~~~gt~~y~APE~~~~~~~~~~~~  383 (459)
                      +..                       +...    .                   ....+|||.|||||++.+..  ++..
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~  368 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKE  368 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCcc
Confidence            321                       0000    0                   01246999999999999764  6889


Q ss_pred             CCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          384 FDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       384 ~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      +|.||+||++|+||.+..||-.+-|  .+..+.+....
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp--~~T~rkI~nwr  404 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETP--QETYRKIVNWR  404 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHh
Confidence            9999999999999999999998855  56665554433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=311.68  Aligned_cols=232  Identities=27%  Similarity=0.394  Sum_probs=199.4

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEE
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLC  262 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  262 (459)
                      +.+.++++...+.+.+...||+|.||+||+|.+.+   .||||+++...  .+..+.|.+|+.++++-+|.||+-+.|||
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            34557888888888999999999999999999975   59999997653  34578899999999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       263 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      ..... .||+.+|+|-+|+.+|+..+.   .++..+.+.|+.|||+|+.|||.   ++|||||||..||+|.+++++||+
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEe
Confidence            98877 999999999999999997765   69999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCC-CCCccccccccccccccceeccCcc-ccCCCCCHHHHHHHHHHHHh----------------------
Q 041624          343 DFGLALLVDHE-LGPRTTGLAGTLGYMAPEYISTGRA-RLDVNFDEQQTDCLMIVGLW----------------------  398 (459)
Q Consensus       343 DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~-~~~~~~D~~~~g~ll~~~l~----------------------  398 (459)
                      |||++..-..- .........|...|||||++..+.. .++..+|+|++|+++|++++                      
T Consensus       531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l  610 (678)
T KOG0193|consen  531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL  610 (678)
T ss_pred             cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence            99998653321 1222344568889999999975433 57888999999999999987                      


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHhcCCC-CCCC
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLNFETK-MPNL  426 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~~~~~-~p~~  426 (459)
                                           ||..++++||.+.+|+..|+...+ +|.+
T Consensus       611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki  660 (678)
T KOG0193|consen  611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI  660 (678)
T ss_pred             CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence                                 889999999999999998876544 4443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.2e-38  Score=323.56  Aligned_cols=226  Identities=23%  Similarity=0.381  Sum_probs=192.8

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      ..+.+....+.||+|.||+||+|...+     ....||||.++..... ...+|.+|++++..++|+|||+|+|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            344556667899999999999998754     3478999999887655 7889999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCC----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKST----------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      .+++|+|||..|||.++|+.+...          ..+|+..+.+.||.|||.||.||-+   +.+|||||..+|+|+.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccc
Confidence            999999999999999999854321          2349999999999999999999999   999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCCCccc-cccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------
Q 041624          337 FNVKLGDFGLALLVDHELGPRTT-GLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------  398 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------  398 (459)
                      ..+||+|||++|.+......... ...-.++|||||.+..++  ++.++|+|++|++++++++                 
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            99999999999977554333322 233467999999999886  5889999999998876554                 


Q ss_pred             -----------------------cCCCCCCCCCCHHHHHHHHhcCCCC
Q 041624          399 -----------------------CAHPDRNCRPSIRQAIQVLNFETKM  423 (459)
Q Consensus       399 -----------------------c~~p~p~~RPs~~~v~~~L~~~~~~  423 (459)
                                             ||+..|.+||+++||-..|+.....
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                                   9999999999999999999865443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=320.04  Aligned_cols=233  Identities=29%  Similarity=0.477  Sum_probs=201.2

Q ss_pred             ccCHHHHHHHhcCC---------CCCceeccCCceEEEEEEEcCCC---cEEEEEEeccCC-ccchHHHHHHHHHHhccC
Q 041624          185 RFSYKDLASATNNF---------SNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLR  251 (459)
Q Consensus       185 ~~~~~el~~~~~~f---------~~~~~Lg~G~fg~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~  251 (459)
                      .++|+|--.|...|         .+.++||.|.||.||+|+++..+   ..||||.++... .+.+.+|+.|+.||.+++
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            36677665555444         56789999999999999998654   689999998774 456778999999999999


Q ss_pred             cCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       252 H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      ||||++|.|+.......+||+|||+||+|+.+|+.+..   .+++.+...++++||.|++||-+   .++|||||.++||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI  762 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI  762 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence            99999999999999999999999999999999998775   59999999999999999999998   9999999999999


Q ss_pred             eecCCCCEEEeecCCcccccCCCCCccccccc--cccccccceeccCccccCCCCCHHHHHHHH----------------
Q 041624          332 MPDTDFNVKLGDFGLALLVDHELGPRTTGLAG--TLGYMAPEYISTGRARLDVNFDEQQTDCLM----------------  393 (459)
Q Consensus       332 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~~D~~~~g~ll----------------  393 (459)
                      |++.+..+|++|||++|.+.++.....+...|  ..+|.|||.+...+  ++..+|+||+|+++                
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccch
Confidence            99999999999999999887665333333333  46899999998775  58889999998744                


Q ss_pred             ------------------------HHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          394 ------------------------IVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       394 ------------------------~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                                              .+|+.||+.+..+||.+.||+..|......|.
T Consensus       841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence                                    57889999999999999999999987665554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=303.45  Aligned_cols=204  Identities=27%  Similarity=0.315  Sum_probs=177.9

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC----Cc-cchHHHHHHHHHHhccC-cCCceeEEEEEeeCC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG----LK-HGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRG  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  266 (459)
                      ...++|...+.||+|+||.|+.|.+..++..||+|.+.+.    .. ...+...+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999977654    11 23445668999999998 999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFG  345 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG  345 (459)
                      .+++||||+.+|+|.+++.+..    .+.+.++.+++.|+++|++|||+   ++|+||||||+|||+|.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999998733    69999999999999999999999   999999999999999999 999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ++.... .........+||+.|+|||++.+....-+.+.|+||+|+++|.|+.+..||-
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~  224 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD  224 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence            998874 2234566789999999999999765223678999999999999998555543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.7e-37  Score=305.38  Aligned_cols=209  Identities=27%  Similarity=0.365  Sum_probs=169.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC-
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR-  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-  265 (459)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|+++.... ...+.+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4567899999999999999999852     3357899999975432 3356789999999999 899999999998764 


Q ss_pred             CeEEEEEEecCCCCcchhccccCCC-------------------------------------------------------
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKST-------------------------------------------------------  290 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------  290 (459)
                      +.+++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4689999999999999988753210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-cccccccccc
Q 041624          291 ---GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLG  366 (459)
Q Consensus       291 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~  366 (459)
                         ..++++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+...... ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               1358889999999999999999998   99999999999999999999999999999865432211 1223456788


Q ss_pred             ccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          367 YMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       367 y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      |+|||++.+..  ++.+.|+||+|++++++++ +..|++...
T Consensus       242 y~aPE~~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         242 WMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             ccCcHHhhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999997653  5778999999999999986 666666544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=287.74  Aligned_cols=214  Identities=23%  Similarity=0.292  Sum_probs=184.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l  270 (459)
                      .++|+..+.|++|+||.||+|+++.+++.||+|+++.....  -.--.++||.+|.+++|||||.+..+...  -+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            45677889999999999999999999999999999765321  12246899999999999999999988754  467999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |||||+. +|..++.....   ++...++..++.|+++||+|||.   ..|+|||||++|+|++..|.+||+|||+||.+
T Consensus       155 VMe~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999977 89999987664   79999999999999999999998   89999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ..... ..+..+-|..|.|||.+.+.+ .++..+|+||+||++.+++.....+|.+- .+.|+-++..
T Consensus       228 gsp~k-~~T~lVVTLWYRaPELLLG~~-tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~  292 (419)
T KOG0663|consen  228 GSPLK-PYTPLVVTLWYRAPELLLGAK-TYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFK  292 (419)
T ss_pred             cCCcc-cCcceEEEeeecCHHHhcCCc-ccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHH
Confidence            76533 345567799999999999766 58999999999999999999999999764 5666555443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=308.09  Aligned_cols=217  Identities=23%  Similarity=0.326  Sum_probs=190.3

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCe
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  267 (459)
                      ....++|...++||+|.||+|+++..+.+++.+|||.+++..   ..+.+..+.|.+++... +||.|+.|+.++++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345678999999999999999999999999999999998873   45567788899988887 59999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      +|.||||+.||++..+.+..     .+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccc
Confidence            99999999999965444322     59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      +..-. .+..+.+++||+.|||||++.+..  |+..+|.|++|+++|+||.|..|+|.+  +-.++.+.+-.+.
T Consensus       516 Ke~m~-~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~  584 (694)
T KOG0694|consen  516 KEGMG-QGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDE  584 (694)
T ss_pred             cccCC-CCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCC
Confidence            86542 345678899999999999999775  688999999999999999999999976  5577776555443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=305.08  Aligned_cols=202  Identities=27%  Similarity=0.368  Sum_probs=179.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ...|....+||+|..|.||.|....+++.||||++.......++-.++|+.+|+..+|+|||.++..|...+++|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45677778999999999999999999999999999877666677788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      |++|+|.+.+...     .+++.++..|+.++++||+|||.   ++|+|||||.+|||++.+|.+||+|||+|..+....
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999988554     49999999999999999999999   999999999999999999999999999998887553


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . ...+.+||+.|||||++...  .|+.+.|+||+|.+..+|..+-.|+-.++
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             C-ccccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCC
Confidence            3 45568899999999999865  46899999999999988887554444433

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=309.24  Aligned_cols=225  Identities=28%  Similarity=0.361  Sum_probs=187.2

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCC----cEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEee
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      +...++-...++||+|+||.||+|.++..+    ..||+|..+..   ......+|++|+++|++++|+|||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            334444555689999999999999987632    23899998752   35567899999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      ...++||||+|+||+|+++|.....   .++..++.+++.+.|.||+|||+   ++++||||.++|+|++.++.+||+||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcc
Confidence            9999999999999999999987764   59999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHH-----------------------------
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIV-----------------------------  395 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~-----------------------------  395 (459)
                      |+++.-... ........-...|+|||.+..+  .++.++|+|++|+++++                             
T Consensus       307 GLs~~~~~~-~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  307 GLSRAGSQY-VMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             ccccCCcce-eeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence            998754311 1111122345799999999988  46889999999986654                             


Q ss_pred             ------------HHhcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          396 ------------GLWCAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       396 ------------~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                                  +-.|+..+|++||+|.++.+.|+.......
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                        334999999999999999999986544333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=294.24  Aligned_cols=223  Identities=30%  Similarity=0.475  Sum_probs=183.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhc--cCcCCceeEEEEEeeCC----eEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ--LRHRNLLQLIGLCHDRG----EFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~  269 (459)
                      ...+..++||+|+||.||||.+.+  +.||||++.   .+..+.|.+|-++...  ++|+||++++++-....    +++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccC--ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            445566889999999999999975  999999996   3556778888877765  48999999999876555    899


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------CCCeeecCCCCCCeeecCCCCEEEee
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW------KRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      ||+||.+.|||.++|..+     .++|....+|+..+++||+|||++.      |.+|+|||||++|||+.+|+++.|+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999765     5899999999999999999999864      67899999999999999999999999


Q ss_pred             cCCcccccCCCCC-ccccccccccccccceeccCccccC-----CCCCHHHHHHHHHHHHh-cCCCCC------------
Q 041624          344 FGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLD-----VNFDEQQTDCLMIVGLW-CAHPDR------------  404 (459)
Q Consensus       344 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~-----~~~D~~~~g~ll~~~l~-c~~p~p------------  404 (459)
                      ||+|..+...... .+-..+||.+|||||++.+. ..+.     ...|+|++|.+++++.. |...+|            
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            9999888643222 23457899999999998753 2343     35799999999998876 555432            


Q ss_pred             --CCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          405 --NCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       405 --~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                        ..+||..++-+..-.++.-|.+|+.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~  465 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDA  465 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhh
Confidence              3578888888877777777777653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-36  Score=294.41  Aligned_cols=214  Identities=25%  Similarity=0.375  Sum_probs=171.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC----------------CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID----------------LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQL  258 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l  258 (459)
                      ++|...+.||+|+||.||+|.+..                ++..||+|.+.... .....+|.+|++++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578888999999999999998643                24579999987653 2345679999999999999999999


Q ss_pred             EEEEeeCCeEEEEEEecCCCCcchhccccCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeee
Q 041624          259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS---------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH  323 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH  323 (459)
                      ++++.+.+..++||||+++|+|.+++.....               ....+++..+++++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            9999999999999999999999998864321               11347889999999999999999998   89999


Q ss_pred             cCCCCCCeeecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       324 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      |||||+|||++.++.+||+|||+++.+....... .....++..|+|||++..+.  ++.+.|+||+|+++++++++..+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC--CCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999998654332111 22345578999999987654  57789999999999998765444


Q ss_pred             CCCCCCCHHHHH
Q 041624          403 DRNCRPSIRQAI  414 (459)
Q Consensus       403 ~p~~RPs~~~v~  414 (459)
                      .|-...+..+++
T Consensus       240 ~p~~~~~~~~~~  251 (304)
T cd05096         240 QPYGELTDEQVI  251 (304)
T ss_pred             CCCCcCCHHHHH
Confidence            443333333333

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=289.56  Aligned_cols=221  Identities=22%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .+|++.+.||+|.||.|-+|.....|+.||||.+++..-   ++.-.+.+|+++|..|+||||+.++.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            456777899999999999999988899999999987643   44456789999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||..+|.|++++..++    .|++.+.+.++.||.+|+.|+|.   ++++|||||.+|||||.++++||+|||++-++..
T Consensus       133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999998776    49999999999999999999997   9999999999999999999999999999988754


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN-FETKMPNLPS  428 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~-~~~~~p~~p~  428 (459)
                      .  ...++++|++-|.+||.+.+.. .-++++|.|++|+++|.+..+..||-..  ....+++.+. +...-|+-|+
T Consensus       206 ~--kfLqTFCGSPLYASPEIvNG~P-Y~GPEVDsWsLGvLLYtLVyGtMPFDG~--Dhk~lvrQIs~GaYrEP~~PS  277 (668)
T KOG0611|consen  206 K--KFLQTFCGSPLYASPEIVNGTP-YKGPEVDSWSLGVLLYTLVYGTMPFDGR--DHKRLVRQISRGAYREPETPS  277 (668)
T ss_pred             c--cHHHHhcCCcccCCccccCCCC-CCCCccchhhHHHHHHHHhhcccccCCc--hHHHHHHHhhcccccCCCCCc
Confidence            3  4567899999999999998654 3678999999999999999999998754  4566666554 4444455444

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.7e-36  Score=286.53  Aligned_cols=227  Identities=24%  Similarity=0.336  Sum_probs=181.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|++.+.||+|+||.||+|.++   ..+..||+|.++.... .....|.+|+.++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357888999999999999999875   3457899999976532 334678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++.+++.++.||+.||+|||+   .+++||||||+|||++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999876433   68999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                      ............++..|+|||.+.++.  ++...|+|++|+++++++. +..|+...+  ..++++.++.....| .|..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~~~~~-~~~~  232 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMS--GQDVIKAVEDGFRLP-APRN  232 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCC--ccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCCCCCC-CCCC
Confidence            322111122234567899999987654  5678899999999998764 777776553  345666665443333 4555


Q ss_pred             CCc
Q 041624          430 MPV  432 (459)
Q Consensus       430 ~p~  432 (459)
                      .|.
T Consensus       233 ~~~  235 (266)
T cd05064         233 CPN  235 (266)
T ss_pred             CCH
Confidence            554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-35  Score=297.55  Aligned_cols=204  Identities=24%  Similarity=0.257  Sum_probs=176.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....+++.||+|+++...   ......+.+|+.++.+++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999999999999999997532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999987543    58999999999999999999998   9999999999999999999999999999976532


Q ss_pred             CCC----------------------------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELG----------------------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ...                                  ......+||+.|+|||++.+..  ++..+|+|++|+++++|++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHHHHHHh
Confidence            110                                  0012457999999999997653  5778999999999999999


Q ss_pred             cCCCCCCCCC
Q 041624          399 CAHPDRNCRP  408 (459)
Q Consensus       399 c~~p~p~~RP  408 (459)
                      +..|+....|
T Consensus       232 G~~Pf~~~~~  241 (363)
T cd05628         232 GYPPFCSETP  241 (363)
T ss_pred             CCCCCCCCCH
Confidence            9999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-37  Score=289.96  Aligned_cols=210  Identities=25%  Similarity=0.330  Sum_probs=174.9

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-----eEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-----EFMLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV  271 (459)
                      .|...+++|+|+||.||+|....+++.||||++-.+..    .-.+|+++|+.++|||||+|.-+|....     .+.||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            45667899999999999999999999999999854422    2236999999999999999999886432     34689


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~  350 (459)
                      |||||. +|.+.++.....+..++...+.-+..||.+||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 9999887543333468888889999999999999999   999999999999999977 99999999999988


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ....  ......-|..|+|||.+.+.. .++...|+||.||++.+|+.+...+|.+ -+..|++.+++
T Consensus       177 ~~~e--pniSYicSRyYRaPELifga~-~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik  240 (364)
T KOG0658|consen  177 VKGE--PNISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIK  240 (364)
T ss_pred             ccCC--CceeEEEeccccCHHHHcCcc-ccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHH
Confidence            7543  234455689999999998765 5899999999999999999999999984 45555555544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-36  Score=282.01  Aligned_cols=216  Identities=25%  Similarity=0.305  Sum_probs=183.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCC-ceeEEEEEeeCC------
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRN-LLQLIGLCHDRG------  266 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------  266 (459)
                      ..|...++||+|+||+||+|+.+.+|+.||+|+++....+  ......+|+.++++++|+| |++|++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4455667899999999999999999999999999866442  3456789999999999999 999999998877      


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      .+++|+||+. -+|..++.........++...+..++.||+.||+|||+   ++|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            8899999995 49999998765322357778999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      |+.+.-... ..+..++|..|.|||++.+... ++..+|+|++||++.+|++....+|..-. .+|+..+.+
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~  235 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTS-YSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFR  235 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCc-CCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHH
Confidence            997654322 2455678999999999987764 89999999999999999998888887653 566655554

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.2e-36  Score=300.75  Aligned_cols=206  Identities=25%  Similarity=0.316  Sum_probs=168.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEE-----cCCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      ..++|+..+.||+|+||.||+|++     .+++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            455788899999999999999974     3456789999997543 23456788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCC---------------------------------------------------------
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKS---------------------------------------------------------  289 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  289 (459)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999998864321                                                         


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          290 --------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       290 --------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                                    ....+++..+++++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          11257899999999999999999998   9999999999999999999999999999986643322


Q ss_pred             Cc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          356 PR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       356 ~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      .. .....++..|+|||.+.+..  ++.+.|+|++|++++++++ +..|++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            11 12234567899999997654  5778999999999999886 444443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-35  Score=284.77  Aligned_cols=230  Identities=14%  Similarity=0.198  Sum_probs=182.0

Q ss_pred             CcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc---hHHHHHHHHHHhccCcCCceeEE
Q 041624          183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRHRNLLQLI  259 (459)
Q Consensus       183 ~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~  259 (459)
                      .+.++.+++.     ......|++|++|.||+|.+.  ++.||||+++......   .+.|.+|+.+|.+++||||++++
T Consensus        12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             ceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            3445666662     233368999999999999984  7899999997653333   46788999999999999999999


Q ss_pred             EEEee----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC
Q 041624          260 GLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT  335 (459)
Q Consensus       260 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~  335 (459)
                      |++.+    ....++||||+++|+|.+++....    .+++....+++.+++.||.|||+  ..+++||||||+|||+++
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~  158 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTE  158 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECC
Confidence            99876    357899999999999999997643    58999999999999999999997  248889999999999999


Q ss_pred             CCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 041624          336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       336 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~  415 (459)
                      ++.+||+|||+++.+...    .....|+..|+|||++.+....++.+.|+||+|+++++++++..|+...  +..++.+
T Consensus       159 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~  232 (283)
T PHA02988        159 NYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYD  232 (283)
T ss_pred             CCcEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHH
Confidence            999999999999865432    2235678999999998753234678899999999999999988887754  3456666


Q ss_pred             HHhcCCCCCCCCCCCC
Q 041624          416 VLNFETKMPNLPSKMP  431 (459)
Q Consensus       416 ~L~~~~~~p~~p~~~p  431 (459)
                      .+......+++|...|
T Consensus       233 ~i~~~~~~~~~~~~~~  248 (283)
T PHA02988        233 LIINKNNSLKLPLDCP  248 (283)
T ss_pred             HHHhcCCCCCCCCcCc
Confidence            5533333333443333

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=284.17  Aligned_cols=226  Identities=24%  Similarity=0.246  Sum_probs=198.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      -.+.|+..+.||.|..+.||+|+...++..||||++.-+. ....+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3467889999999999999999999999999999997653 334688999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      .||.+||+.+++...-..  .+++..+..|++++++||.|||.   +|.||||||+.||||+.+|.+||+|||.+..+-+
T Consensus       104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999875543  49999999999999999999998   9999999999999999999999999998766543


Q ss_pred             CCCCc---cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          353 ELGPR---TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       353 ~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                      .....   ....+||+.|||||++......|+.++|||++|+...++.++..|+.+- |-|+-++..|++..+.|.
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-PPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-ChHHHHHHHhcCCCCCcc
Confidence            32111   1567899999999997666667999999999999999999999998764 779999999988766544

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-35  Score=297.55  Aligned_cols=209  Identities=21%  Similarity=0.224  Sum_probs=179.4

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      ++....++|+..+.||+|+||.||++.+..+++.+|+|.+.+.   .....+.+.+|+.++..++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3444567899999999999999999999999999999998643   1223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++|+|.+++...     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999988543     47889999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ++.+............||+.|+|||++....  ..++...|+||+|+++++|+++..|+...
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            9876543322334567999999999987543  12567899999999999999999988654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-35  Score=294.02  Aligned_cols=193  Identities=25%  Similarity=0.347  Sum_probs=160.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++.+++|+||+++++++...+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            34556789999999999999998899999999965432 33567899999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|....        .+.+..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999986532        35677888999999999999998   999999999999999999999999999998765322 


Q ss_pred             CccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      .......||..|+|||++....   ...+.+.|+|++|+++++++++..
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~  271 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF  271 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence            1233467899999999885321   123457899999999988765433

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=319.56  Aligned_cols=219  Identities=29%  Similarity=0.430  Sum_probs=188.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC-----cEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      ..+....+.||+|.||.||+|...+..     ..||||.+++.. .+...+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345566789999999999999987643     349999998764 45678999999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +|++|||++|+|..+|++.+.   +...|+..+.+.++.|||+|+.||++   +.+|||||.++|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999987521   23469999999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCcccc-ccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------------
Q 041624          346 LALLVDHELGPRTTG-LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------------  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------------  398 (459)
                      +|+.+.......... ..-...|||||.+.++.  ++.++|+|++|++++++++                          
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i--FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~  925 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI--FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP  925 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcc--cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence            999554433333222 23356899999999864  6899999999999987665                          


Q ss_pred             --------------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 --------------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 --------------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                    ||+++|++||++..+++.+.
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence                          99999999999999999776

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-35  Score=292.64  Aligned_cols=188  Identities=27%  Similarity=0.319  Sum_probs=163.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||+|....+++.||+|+++...   ......+.+|+.++.+++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997542   233456889999999999999999999999999999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      +|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            9998886543    58999999999999999999998   99999999999999999999999999998754322 2223


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ....||+.|+|||++.+..  ++...|+|++|+++++|+++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg  191 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCG  191 (323)
T ss_pred             cceecCccccChhhhcCCC--CCccccCcccchhhhhhhcC
Confidence            4567999999999997653  57789999999999988763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-35  Score=296.71  Aligned_cols=211  Identities=24%  Similarity=0.328  Sum_probs=172.1

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      ...++|+..+.||+|+||.||+|....+     +..||+|+++.... ...+.+.+|+.+++.+ +|+||++++++|...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            3456788999999999999999986433     35799999975432 3345688999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCC--------------------------------------------------------
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKS--------------------------------------------------------  289 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------  289 (459)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999998864211                                                        


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc-c
Q 041624          290 ----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-T  358 (459)
Q Consensus       290 ----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~  358 (459)
                                ...++++.++++++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.+....... .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      11357889999999999999999999   999999999999999999999999999998664332111 1


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCC
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRP  408 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RP  408 (459)
                      ....++..|+|||++..+.  ++.+.|+||+|++++++++ |..|++...+
T Consensus       272 ~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         272 GNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             cCCCCccceeCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            2234567899999987553  6788999999999999986 7777766543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.9e-35  Score=281.82  Aligned_cols=204  Identities=25%  Similarity=0.387  Sum_probs=176.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999999889999999986542   2234467899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999888764332  258999999999999999999998   99999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS  409 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs  409 (459)
                        .......||..|+|||++.+..  ++...|+|++|+++++++++..|+...+..
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~  207 (285)
T cd05631         156 --ETVRGRVGTVGYMAPEVINNEK--YTFSPDWWGLGCLIYEMIQGQSPFRKRKER  207 (285)
T ss_pred             --CeecCCCCCCCccCHhhhcCCC--CCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence              2234457899999999998654  577889999999999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-35  Score=305.50  Aligned_cols=198  Identities=18%  Similarity=0.185  Sum_probs=170.4

Q ss_pred             CCCCCceeccCCceEEEEEEEcCC-CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDL-NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+.++..++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            388889999999999999998776 7889999876554445567888999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++........++++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999999886543334478999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             C-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          356 P-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       356 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      . .....+||+.|+|||++.+..  ++.+.|+|++|+++++++++
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg  267 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTL  267 (478)
T ss_pred             cccccccCCCccccCHhHhCCCC--CCcHHhHHHHHHHHHHHHhC
Confidence            1 234567999999999987653  57788999999999988764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-36  Score=296.30  Aligned_cols=213  Identities=27%  Similarity=0.367  Sum_probs=191.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe-EEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE-FMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~  272 (459)
                      ++|...+++|+|+||.++.++++..+..+++|.+.-..  ....+..++|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999999889999999997653  3345578899999999999999999999998888 99999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      +||+||+|.+.|...+  +..++++.+++++.|++.|+.|||+   ..|+|||||+.|||++.+..+||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998766  3478999999999999999999998   9999999999999999999999999999999876


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .. ....+.+||+.||.||.+.+.  .++.+.|+|++||++|+|++                                  
T Consensus       159 ~~-~~a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~  235 (426)
T KOG0589|consen  159 ED-SLASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR  235 (426)
T ss_pred             ch-hhhheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence            53 345678999999999999876  46889999999999999886                                  


Q ss_pred             -----cCCCCCCCCCCHHHHHHH
Q 041624          399 -----CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~  416 (459)
                           |+..+|..||++.+++.+
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhC
Confidence                 778899999999999875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.6e-35  Score=289.30  Aligned_cols=199  Identities=26%  Similarity=0.320  Sum_probs=173.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+..... ...+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            4688999999999999999999999999999999976532 335679999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+  +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999986543    48999999999999999999998  246999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                         ......||..|+|||++.+..  ++.+.|+|++|+++++++++..|++
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCC
Confidence               233457899999999997653  5778999999999999887766654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.2e-35  Score=295.17  Aligned_cols=212  Identities=21%  Similarity=0.225  Sum_probs=182.3

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      .+.++....++|+..+.||+|+||.||++.+..+++.+|+|.+...   .....+.+.+|+.++..++||||+++++++.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3556666779999999999999999999999999999999998642   1223456788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      +.+..++||||+++|+|.+++...     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999988543     47888999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ||+++.+............||+.|+|||++....  ..++.++|+||+|+++++|+++..|+...
T Consensus       186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            9999876543333334567999999999987532  23577899999999999999999988653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=308.66  Aligned_cols=224  Identities=25%  Similarity=0.293  Sum_probs=185.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEE-e---e---C
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLC-H---D---R  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~-~---~---~  265 (459)
                      ..-++++.+.|.+|||+.||.|.+...+..+|+|++-...+...+...+|+++|++|+ |+|||.+++.. .   .   .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3445677899999999999999999877999999998777788889999999999996 99999999932 1   1   2


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      -+.+|.||||++|+|-+++..+...  .|++.++++|++|+++|+++||. ++.+|||||||.+||||+.++..||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence            3679999999999999999876554  49999999999999999999997 35679999999999999999999999999


Q ss_pred             CcccccCCCCC-cc-------ccccccccccccceecc-CccccCCCCCHHHHHHHHHHHHh------------------
Q 041624          346 LALLVDHELGP-RT-------TGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGLW------------------  398 (459)
Q Consensus       346 la~~~~~~~~~-~~-------~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l~------------------  398 (459)
                      .|.-.-..... ..       -...-|+.|+|||++.. ....++.+.|||++||++|-++.                  
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y  271 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY  271 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc
Confidence            98644322211 10       01235899999999842 22357899999999999997664                  


Q ss_pred             ------------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ------------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ------------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                        |++++|.+||++.||+..+...
T Consensus       272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                              9999999999999999877543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=297.65  Aligned_cols=199  Identities=32%  Similarity=0.455  Sum_probs=178.4

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      .+-||+|+.|.||+|++.  ++.||||+++.-.       ..+|+-|++|+|+||+.+.|+|.....++||||||+.|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            467999999999999998  4899999985321       2578899999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      ...|...+    ++.......|..+||.|+.|||.   +.|||||||.-||||+.+..+||+|||.++.....  .....
T Consensus       200 ~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS  270 (904)
T KOG4721|consen  200 YEVLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS  270 (904)
T ss_pred             HHHHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence            99997655    58899999999999999999999   99999999999999999999999999999877543  23346


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------------cC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------------CA  400 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------------c~  400 (459)
                      ++||..|||||++...  ....++|+|++|+++++||+                                        ||
T Consensus       271 FaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence            8999999999999865  35889999999999999998                                        78


Q ss_pred             CCCCCCCCCHHHHHHHHhc
Q 041624          401 HPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       401 ~p~p~~RPs~~~v~~~L~~  419 (459)
                      +--|..||+++||+..|+-
T Consensus       349 ~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             hcCCCCCccHHHHHHHHhh
Confidence            8899999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-36  Score=267.59  Aligned_cols=215  Identities=27%  Similarity=0.365  Sum_probs=189.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +.++|++.+.||+|-||.||.|+.+.++-.||+|++.+..   .+..+++.+|+++-+.|+||||+++++|+.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3467889999999999999999999999999999996652   3446789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ++||.+.|+|...|...+.  ..+++.....++.|+|.||.|+|.   ++|+||||||+|+|++..+..||+|||.+-.-
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            9999999999999975443  368889999999999999999998   99999999999999999999999999998643


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      .   .....+.+||..|.+||+..+..  .+..+|+|++|++.++++.+..||.++-  ..+..+.+...
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~  237 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKV  237 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHc
Confidence            3   33456789999999999998653  5788999999999999999999998874  78888776543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.6e-35  Score=277.68  Aligned_cols=211  Identities=24%  Similarity=0.367  Sum_probs=172.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|+..+.||+|+||.||++.++. +..+|+|.+... ....++|.+|+.++++++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457788999999999999999876 568999988643 334567899999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.....   .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            99999998875433   58999999999999999999998   9999999999999999999999999999976543322


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .......++..|+|||++....  ++.+.|+|++|++++++++ +..|+...  +-.++++.+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~  215 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMIS  215 (256)
T ss_pred             eccCCCCCchhhCChhhcccCc--cchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHH
Confidence            2222334567899999987553  5678999999999999987 55555433  2334444443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=291.61  Aligned_cols=211  Identities=27%  Similarity=0.312  Sum_probs=187.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ..|...+.||+|.||.||+|.+..+++.||+|++.... ....++.++|+.+|.+++++||.++||.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35666789999999999999999999999999998663 44567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      |.+|++.+.|....    .+++..+.-|+.+++.||.|||+   .+.+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus        93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999986543    46888888999999999999999   999999999999999999999999999998776543


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------------
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------------  398 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------------  398 (459)
                      . ...+++||+.|||||++...  .|+.++|+|++|...++|.+                                    
T Consensus       166 ~-rr~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 K-RRKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF  242 (467)
T ss_pred             h-ccccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence            3 33778999999999999943  47899999999999998887                                    


Q ss_pred             ---cCCCCCCCCCCHHHHHHH
Q 041624          399 ---CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 ---c~~p~p~~RPs~~~v~~~  416 (459)
                         |+..+|+.||++.++++.
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhh
Confidence               777899999999998863

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.7e-35  Score=295.33  Aligned_cols=203  Identities=23%  Similarity=0.267  Sum_probs=174.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .|...+.||+|+||.||+|....+++.||+|++....   ....+.+.+|++++.+++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999999999999999997542   2335678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999986543    58899999999999999999998   99999999999999999999999999998643210


Q ss_pred             CC----------------------------------------------CccccccccccccccceeccCccccCCCCCHH
Q 041624          354 LG----------------------------------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQ  387 (459)
Q Consensus       354 ~~----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~  387 (459)
                      ..                                              ......+||+.|+|||++....  ++...|+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~Diw  232 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCCcccee
Confidence            00                                              0012357999999999987653  57789999


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC
Q 041624          388 QTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       388 ~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ++|+++++|+++..|+....+
T Consensus       233 SlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCH
Confidence            999999999999999876554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-35  Score=295.16  Aligned_cols=193  Identities=24%  Similarity=0.253  Sum_probs=167.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999999999999999753      23567899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +. ++|..++....    .+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 68888876543    58999999999999999999998   899999999999999999999999999997643322


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ........||+.|+|||++....  ++...|+|++|+++++++++..|+
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             ccccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCc
Confidence            23334567999999999997653  577899999999999999887654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-35  Score=290.42  Aligned_cols=199  Identities=25%  Similarity=0.319  Sum_probs=165.3

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----CeEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GEFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  269 (459)
                      +|+..+.||+|+||.||+|....++..||+|++....  .....++.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999999999999999987532  23345788999999999999999999988543     3589


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+. ++|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 68988886543    58999999999999999999999   9999999999999999999999999999976


Q ss_pred             ccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          350 VDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       350 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .......  ......||..|+|||++.+....++.+.|+|++|+++++++++..|+
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf  208 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF  208 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence            5322211  12346789999999998753335678899999999998887665443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=287.33  Aligned_cols=205  Identities=21%  Similarity=0.225  Sum_probs=176.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||++....+++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999999999999999999642   1223456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999865333   58999999999999999999998   9999999999999999999999999999976654


Q ss_pred             CCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..........||+.|+|||++...   ...++.+.|+|++|+++++|+++..|+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            333233345799999999998632   223567889999999999999999988654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.2e-35  Score=278.36  Aligned_cols=214  Identities=24%  Similarity=0.401  Sum_probs=178.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .+|...+.||+|+||.||+|....+++.||+|.+... ....+++.+|++++.+++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4577888999999999999999988999999998754 334568999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....  ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999865432  258999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .......++..|+|||.+.+..  ++...|+|++|++++++++ +..|++..  ...++.+.+..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~  220 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEK  220 (263)
T ss_pred             eccCCCCCccccCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHC
Confidence            2222233467899999887654  5677899999999999997 66676654  34555555543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=293.26  Aligned_cols=203  Identities=23%  Similarity=0.253  Sum_probs=174.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....+++.||||++....   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999999999999999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999986543    58999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CCCC-------------------------------------ccccccccccccccceeccCccccCCCCCHHHHHHHHHH
Q 041624          353 ELGP-------------------------------------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIV  395 (459)
Q Consensus       353 ~~~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~  395 (459)
                      ....                                     .....+||+.|+|||++....  ++...|+|++|+++++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~e  231 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC--CCCeeeeecchhHHHH
Confidence            1100                                     011246999999999987553  5788999999999999


Q ss_pred             HHhcCCCCCCCC
Q 041624          396 GLWCAHPDRNCR  407 (459)
Q Consensus       396 ~l~c~~p~p~~R  407 (459)
                      |+++..|+....
T Consensus       232 l~~G~~Pf~~~~  243 (364)
T cd05599         232 MLVGYPPFCSDN  243 (364)
T ss_pred             hhcCCCCCCCCC
Confidence            999998886543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=289.33  Aligned_cols=198  Identities=25%  Similarity=0.339  Sum_probs=175.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999999989999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999996543    58999999999999999999998   9999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                          ......||+.|+|||++.+.  .++.+.|+|++|+++++|+++..|+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             ----ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCC
Confidence                23456789999999999866  4678899999999999999999988654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=289.36  Aligned_cols=190  Identities=25%  Similarity=0.281  Sum_probs=165.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||.||+|.+..+++.||+|+++..   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999753   233456788999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  152 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT  152 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence            99986543    58999999999999999999998   99999999999999999999999999999764322 223345


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ..||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+
T Consensus       153 ~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf  193 (312)
T cd05585         153 FCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPF  193 (312)
T ss_pred             ccCCcccCCHHHHcCCC--CCCccceechhHHHHHHHhCCCCc
Confidence            67999999999997653  577899999999999988766554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-35  Score=288.68  Aligned_cols=192  Identities=29%  Similarity=0.333  Sum_probs=165.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||++....++..||+|+++...   ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999889999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      +|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~  152 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence            9988886543    58999999999999999999998   99999999999999999999999999998753222 1223


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ....||+.|+|||++.++.  ++...|+|++|+++++++++..|+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             ccccCCcCcCCcccccCCC--CCchhchhhhHHHHHHHHhCCCCC
Confidence            3467999999999997654  577889999999999998765554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-35  Score=288.65  Aligned_cols=200  Identities=24%  Similarity=0.262  Sum_probs=176.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|...+.||+|+||.||+|.+..+++.||+|.++...   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367888999999999999999999999999999997532   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999987543    58899999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ..    .....||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+....
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        170 DR----TFTLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             CC----cceecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            32    23457899999999998654  4678899999999999999999886543

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-35  Score=293.06  Aligned_cols=206  Identities=21%  Similarity=0.221  Sum_probs=177.6

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ...++|+..+.||+|+||.||++....+++.||+|+++..   .......+.+|+.++..++|+||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3567899999999999999999999999999999999643   1233455788999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|.+++...     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            999999999999988543     47888899999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .............||+.|+|||++....  ..++.++|+|++|+++++|+++..|+...
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence            6543222334567999999999987543  13567899999999999999999988765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=294.10  Aligned_cols=203  Identities=23%  Similarity=0.239  Sum_probs=173.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|...+.||+|+||.||++....+++.||||++....   ....+.+.+|++++.+++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999999999999999986532   233467889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999986543    58899999999999999999998   9999999999999999999999999999964321


Q ss_pred             CCCC----------------------------------------------ccccccccccccccceeccCccccCCCCCH
Q 041624          353 ELGP----------------------------------------------RTTGLAGTLGYMAPEYISTGRARLDVNFDE  386 (459)
Q Consensus       353 ~~~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~  386 (459)
                      ....                                              .....+||+.|+|||++.+..  ++..+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di  231 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CCCceee
Confidence            1000                                              001246999999999987653  5788999


Q ss_pred             HHHHHHHHHHHhcCCCCCCCC
Q 041624          387 QQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       387 ~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ||+|+++++|+++..|+....
T Consensus       232 wSlGvil~elltG~~Pf~~~~  252 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCC
Confidence            999999999999999986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.4e-35  Score=294.22  Aligned_cols=203  Identities=23%  Similarity=0.259  Sum_probs=174.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .|...+.||+|+||.||+|....+++.||+|++....   ......+.+|++++.+++|+||+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999999999999999997532   2334578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999986543    58899999999999999999998   99999999999999999999999999997533110


Q ss_pred             C----------------------------------------------CCccccccccccccccceeccCccccCCCCCHH
Q 041624          354 L----------------------------------------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQ  387 (459)
Q Consensus       354 ~----------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~  387 (459)
                      .                                              .......+||+.|+|||++.+..  ++..+|+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~Diw  232 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCCeeeEE
Confidence            0                                              00012357999999999997654  57789999


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC
Q 041624          388 QTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       388 ~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ++|+++++|+++..|+....|
T Consensus       233 SlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             echHHHHHHHhCCCCCCCCCH
Confidence            999999999999999886654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-35  Score=281.49  Aligned_cols=209  Identities=32%  Similarity=0.491  Sum_probs=167.4

Q ss_pred             CCceeccCCceEEEEEEEc----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          200 NERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ..+.||.|.||.||+|.+.    ..+..|+||.++.... ...++|.+|++.+.+++|+||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999998    3468899999965433 3478899999999999999999999999988889999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++|+|.++|.....  ..+++.++..|+.||+.||.|||+   .+++|+||+++|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999987622  269999999999999999999999   899999999999999999999999999998763221


Q ss_pred             CC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHH
Q 041624          355 GP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       355 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L  417 (459)
                      .. ..........|+|||.+....  .+.+.|+|++|++++++++ +..|+...  +..++.+.+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~  218 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKL  218 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHH
T ss_pred             cccccccccccccccccccccccc--cccccccccccccccccccccccccccc--ccccccccc
Confidence            11 123345678999999998765  5778899999999999887 33443333  444444444

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-34  Score=276.61  Aligned_cols=215  Identities=22%  Similarity=0.352  Sum_probs=177.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++.+++|+||+++++++.+.+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4578889999999999999999765 6789999986542 3467899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999865432  368899999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      ........++..|+|||++..+.  ++...|+|++|++++++++ +..|++...  ..++...+...
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~  220 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRG  220 (261)
T ss_pred             eeccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcC
Confidence            22223344677899999987654  5677899999999999997 777777653  23444444433

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=282.63  Aligned_cols=198  Identities=25%  Similarity=0.270  Sum_probs=174.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999999889999999986532   233456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999987543    58999999999999999999998   9999999999999999999999999999986643


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .    .....||+.|+|||++.+..  .+.+.|+|++|+++++++++..|+...
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~  201 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDD  201 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            2    23457899999999987653  577889999999999999999887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-34  Score=286.96  Aligned_cols=205  Identities=20%  Similarity=0.219  Sum_probs=176.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|...+.||+|+||.||++....+++.||+|.+.+.   .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4788899999999999999999998999999998653   1223455788999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999976433   58999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..........||+.|+|||++.+..   ..++...|+|++|+++++|+++..|+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            3332334467999999999986521   23567889999999999999999988654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-34  Score=285.84  Aligned_cols=199  Identities=26%  Similarity=0.328  Sum_probs=172.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+..... ...+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            4789999999999999999999998899999999876532 334678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+  +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999986543    58899999999999999999997  247999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                         ......|+..|+|||++.+..  ++...|+|++|+++++++++..|++
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               223457899999999997653  5677899999999998887766654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-34  Score=275.32  Aligned_cols=201  Identities=28%  Similarity=0.404  Sum_probs=168.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|.+..+   ...||+|.++... .....+|.+|+.++.+++|+||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35788999999999999999998643   4689999987553 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++.....   .+++.++++++.|++.||+|||+   .+|+||||||+|||+++++.++|+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999876543   68999999999999999999998   99999999999999999999999999999877


Q ss_pred             cCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          351 DHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       351 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      ....... .....++..|+|||.+....  ++...|+|++|++++++++ +..|+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Dv~slG~~l~~l~~~g~~p~  209 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCC--CccccchHHHHHHHHHHHccCCCCC
Confidence            5222211 22234567899999987654  5678899999999998775 44443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-34  Score=293.02  Aligned_cols=208  Identities=25%  Similarity=0.329  Sum_probs=170.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCc-cchHHHHHHHHHHhccC-cCCceeEEEEEeeCC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~  266 (459)
                      ..++|.+.++||+|+||.||+|++...     +..||||+++.... ...+.+.+|++++.++. ||||++++++|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            467888999999999999999987532     34799999975433 33567999999999996 999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCC---------------------------------------------------------
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKS---------------------------------------------------------  289 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  289 (459)
                      ..+||||||++|+|.++|.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998865321                                                         


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec
Q 041624          290 -----------------------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD  334 (459)
Q Consensus       290 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~  334 (459)
                                                         ....+++.++..++.||+.||+|||+   .+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence                                               01247888999999999999999998   9999999999999999


Q ss_pred             CCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          335 TDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       335 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      .++.+||+|||+++........ ......++..|+|||.+.+..  ++.+.|+|++|++++++++ +..|++..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999866433221 122345678899999987654  5778899999999998875 55665543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-35  Score=303.57  Aligned_cols=208  Identities=22%  Similarity=0.226  Sum_probs=174.2

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-  266 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-  266 (459)
                      +.....++|.+.+.||+|+||.||+|....+++.||||++....  ......+.+|+..+..++|+||++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34445679999999999999999999999889999999987542  334567889999999999999999988765432 


Q ss_pred             -------eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          267 -------EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       267 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                             .+++||||+++|+|.+++..+......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence                   3689999999999999997655444579999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          340 KLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ||+|||+++.+...... ......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~P  244 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRP  244 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999876533221 234567999999999998653  57889999999999988874433

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.9e-35  Score=291.70  Aligned_cols=204  Identities=23%  Similarity=0.261  Sum_probs=176.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||++....+++.||+|+++...   ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999999999999999997532   234567888999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999986543    58999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCC----------------------------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELG----------------------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ...                                  ......+||+.|+|||++.+..  ++..+|+|++|+++++|++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC--CCCcceeccccceeeeccc
Confidence            110                                  0012357999999999987653  5778999999999999999


Q ss_pred             cCCCCCCCCC
Q 041624          399 CAHPDRNCRP  408 (459)
Q Consensus       399 c~~p~p~~RP  408 (459)
                      |..|+....|
T Consensus       232 G~~Pf~~~~~  241 (360)
T cd05627         232 GYPPFCSETP  241 (360)
T ss_pred             CCCCCCCCCH
Confidence            9999876654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-34  Score=278.84  Aligned_cols=229  Identities=23%  Similarity=0.380  Sum_probs=180.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCC-----cEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+..... ....+|.+|+.++.+++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46788899999999999999986544     6899999875432 33567899999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC
Q 041624          270 LVYEFMPNGSLDFHLFSKKST------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF  337 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  337 (459)
                      ++|||+++++|.+++......            ...+++..++.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            999999999999998754211            1358899999999999999999998   9999999999999999999


Q ss_pred             CEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHH
Q 041624          338 NVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~  415 (459)
                      .+||+|||+++....... .......+++.|+|||.+.++.  ++.+.|+|++|++++++++ +..|+...  +..++.+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~p~~~~--~~~~~~~  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYYGF--SNQEVIE  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHH
Confidence            999999999976543221 1233445688999999987654  5778899999999999986 66665443  2345555


Q ss_pred             HHhcCCCCCCCCCCCCc
Q 041624          416 VLNFETKMPNLPSKMPV  432 (459)
Q Consensus       416 ~L~~~~~~p~~p~~~p~  432 (459)
                      .+.... .++.|...|.
T Consensus       238 ~i~~~~-~~~~~~~~~~  253 (283)
T cd05048         238 MIRSRQ-LLPCPEDCPA  253 (283)
T ss_pred             HHHcCC-cCCCcccCCH
Confidence            554332 2333444443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.2e-34  Score=285.68  Aligned_cols=205  Identities=21%  Similarity=0.227  Sum_probs=175.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||++..+.+++.+|+|.+.+.   .......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4688899999999999999999998999999998642   1223445888999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++.....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999976433   58999999999999999999998   9999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..........||+.|+|||++...   ...++.+.|+|++|+++++++++..|+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            333333446799999999998631   224677899999999999999999988654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-34  Score=284.23  Aligned_cols=217  Identities=25%  Similarity=0.368  Sum_probs=181.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.++... ....+++.+|+.++..++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468889999999999999999865554    48999987543 34456899999999999999999999999765 5789


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |+||+++|+|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999876543   58899999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------
Q 041624          351 DHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------  398 (459)
Q Consensus       351 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------  398 (459)
                      ....... .....++..|+|||++....  ++.+.|+|++|++++++++                               
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  237 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence            5432221 12233467899999987653  5778899999999987653                               


Q ss_pred             ---------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ---------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ---------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                               |+..+|..||++.++++.|....
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     77789999999999999887443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=273.67  Aligned_cols=215  Identities=25%  Similarity=0.375  Sum_probs=176.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|++|.||+|.+.. ++.||+|.++... ...+++.+|+.++.+++|+||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            34678889999999999999999865 5789999987543 346779999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++....  +..+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999987644  2368999999999999999999998   99999999999999999999999999999877533


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ..........+..|+|||++.+..  ++...|+|++|++++++++ +..|++...  ..+++..+..
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~  219 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQ  219 (261)
T ss_pred             cccccCCCcCceeccCccccccCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHc
Confidence            222222233346899999987654  5778899999999999998 666665543  2334444433

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-34  Score=272.90  Aligned_cols=189  Identities=24%  Similarity=0.378  Sum_probs=159.6

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      +.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999998889999999886543 23456799999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc-c
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-T  359 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~  359 (459)
                      .+++.....   .+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......... .
T Consensus        81 ~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEGP---RLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            999865432   58999999999999999999998   9999999999999999999999999999876543211111 1


Q ss_pred             cccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          360 GLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       360 ~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ....+..|+|||.+.++.  ++...|+|++|++++++++
T Consensus       155 ~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         155 MKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             CCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHh
Confidence            112345799999987664  5677899999999998775

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-35  Score=291.31  Aligned_cols=197  Identities=24%  Similarity=0.309  Sum_probs=175.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +-|+.++.||.|+-|.|-.|++..||+.+|||.+.+..   ........+|+.+|+-+.|||++++++++++..++|||+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            55778899999999999999999999999999997662   223456789999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|-|.++|..++    +|++.++.+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|.+-..
T Consensus        92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999998765    59999999999999999999998   9999999999999999999999999999976432


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                        +....+.||++.|.|||++.+..+ -+.+.|+|+.|++++-+|++.-|
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pY-dG~~sDVWSCGVILfALLtG~LP  211 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPY-DGRPSDVWSCGVILFALLTGKLP  211 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCC-CCCccccchhHHHHHHHHhCCCC
Confidence              344567899999999999997665 57789999999999999986655

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-34  Score=276.68  Aligned_cols=206  Identities=27%  Similarity=0.405  Sum_probs=176.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ....+|+..+.||.|+||.||+|.+.. +..+|+|.+.........++..|+.++..++|+||+++++++.+.+..++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            345678889999999999999999988 8999999998766556778999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.....  ..+++.+++.++.||+.||+|||+   .+|+|+||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999976432  368999999999999999999998   9999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      ... ......++..|+|||.+..+.  +..+.|+|++|++++.+++ +..|++...
T Consensus       157 ~~~-~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         157 DVY-LSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             ccc-cccCCCCceEecCHHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            321 122344577899999987653  5678899999999999987 666665443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.6e-34  Score=274.48  Aligned_cols=220  Identities=27%  Similarity=0.337  Sum_probs=185.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|+...+++.||+|.++...   ......+.+|++++++++|+||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999999889999999886432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998886533333468999999999999999999998   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      .. .......|+..|+|||.+.+..  .+...|+|++|+++++++++..|+.....+..++.+.+....
T Consensus       159 ~~-~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  224 (267)
T cd08228         159 KT-TAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD  224 (267)
T ss_pred             hh-HHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC
Confidence            21 1223456888999999987654  467789999999999999988888776666667777665443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.5e-34  Score=274.45  Aligned_cols=199  Identities=26%  Similarity=0.366  Sum_probs=167.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|...+.||+|+||.||+|.+.+ +..+|+|.+.... ...++|.+|+.++.+++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            457778899999999999998875 5679999987542 34567999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.....   .+++.+++.++.||+.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            99999999875433   58999999999999999999998   9999999999999999999999999999986643322


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      .......++..|+|||++..+.  ++.+.|+|++|++++++++ +..|+.
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~  203 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYE  203 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            2222334567899999997654  5678899999999999986 555544

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=279.60  Aligned_cols=210  Identities=22%  Similarity=0.274  Sum_probs=174.1

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--------------cchHHHHHHHHHHhccCcCCc
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--------------HGKNEYITEVKTCSQLRHRNL  255 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nI  255 (459)
                      +-....++|.+.+.||+|.||.|-+|+...+++.||||++.+...              ...+...+||.+|++++|+||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            334567899999999999999999999999999999999965311              113478899999999999999


Q ss_pred             eeEEEEEee--CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          256 LQLIGLCHD--RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       256 v~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      |+|+.+..+  .+.+|||+|||..|.+...=-.    ...|++.++++++.++..||.|||.   ++||||||||+|+||
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLL  243 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEE
Confidence            999999876  4689999999999888543211    1239999999999999999999999   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCC----CCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          334 DTDFNVKLGDFGLALLVDHEL----GPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +++|++||+|||.+.......    .......+||+.|+|||+..++.  ...+.+.|+|++|+.+|.++.+.-||-.+
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            999999999999997663221    11234578999999999998754  23456789999999999999988885443

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-34  Score=286.89  Aligned_cols=202  Identities=26%  Similarity=0.308  Sum_probs=175.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCC-cEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLN-MAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..+.||+|+||.||+|.+..++ ..||+|++....   ....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3457888999999999999999876654 689999986532   234567889999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999987553    58999999999999999999998   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      +...    .....||+.|+|||++.+..  ++...|+|++|+++++|+++..|+....+
T Consensus       181 ~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~  233 (340)
T PTZ00426        181 VDTR----TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANEP  233 (340)
T ss_pred             cCCC----cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCCH
Confidence            6432    23467999999999997653  46788999999999999999999876543

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-34  Score=274.50  Aligned_cols=206  Identities=23%  Similarity=0.296  Sum_probs=176.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|....+++.||+|++..........+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999999888999999999765545566788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.+....
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999999886443    58999999999999999999998   999999999999999999999999999998664321


Q ss_pred             CCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                       .......|+..|+|||.+... ...++...|+|++|+++++++++..|+....|
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~  214 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence             122345688999999987532 22356788999999999999999888765544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-34  Score=291.97  Aligned_cols=204  Identities=23%  Similarity=0.259  Sum_probs=174.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|....+++.||+|++....   ......+.+|++++.+++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999999999999999986532   223456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|..+..
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999986543    58899999999999999999998   9999999999999999999999999999853311


Q ss_pred             CC------------------------------------------CCccccccccccccccceeccCccccCCCCCHHHHH
Q 041624          353 EL------------------------------------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTD  390 (459)
Q Consensus       353 ~~------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g  390 (459)
                      ..                                          ........||+.|+|||++.+..  ++...|+|++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG  231 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCcceeeeecc
Confidence            00                                          00012357999999999997653  57788999999


Q ss_pred             HHHHHHHhcCCCCCCCCC
Q 041624          391 CLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       391 ~ll~~~l~c~~p~p~~RP  408 (459)
                      +++++|+++..|+....|
T Consensus       232 vilyell~G~~Pf~~~~~  249 (376)
T cd05598         232 VILYEMLVGQPPFLADTP  249 (376)
T ss_pred             ceeeehhhCCCCCCCCCH
Confidence            999999999999876554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.2e-34  Score=279.83  Aligned_cols=210  Identities=22%  Similarity=0.285  Sum_probs=177.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.++++++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999998899999999975432 234567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |++ ++|.+++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            995 678777765433   58999999999999999999998   99999999999999999999999999999754332


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQA  413 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v  413 (459)
                      . .......+|+.|+|||++.+.. .++..+|+||+|++++++++|..|++...+...++
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  214 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL  214 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence            1 2223456899999999986433 35677899999999999999999998766543333

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-35  Score=267.74  Aligned_cols=202  Identities=29%  Similarity=0.398  Sum_probs=176.9

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--------cchHHHHHHHHHHhcc-CcCCceeEEEEE
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--------HGKNEYITEVKTCSQL-RHRNLLQLIGLC  262 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  262 (459)
                      +..-++|...+.||+|..+.|-++.++.++..+|+|++.....        ...+.-.+|+.+|+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678888999999999999999999999999999864321        1134556899999998 799999999999


Q ss_pred             eeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       263 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      +.+..+++|+|.|+.|.|.++|...-    .++++...+|+.|+..|+.|||.   .+|+||||||+|||+|++.++||+
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEe
Confidence            99999999999999999999997654    59999999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccccCCCCCccccccccccccccceec----cCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          343 DFGLALLVDHELGPRTTGLAGTLGYMAPEYIS----TGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       343 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      |||+|+.+..  +......+||++|+|||.+.    .+.+.++.+.|+|+.|+++|.+|.++.|
T Consensus       166 DFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpP  227 (411)
T KOG0599|consen  166 DFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPP  227 (411)
T ss_pred             ccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCc
Confidence            9999998764  45667789999999999875    3445788999999999999988876655

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.5e-34  Score=274.24  Aligned_cols=212  Identities=29%  Similarity=0.378  Sum_probs=181.5

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++.+++|+||+++++++...+..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45567788888889999999999999998889999999987766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecCC
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPL--TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGL  346 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGl  346 (459)
                      +|+||+++++|.+++.....   .+  ++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.++|+|||+
T Consensus        82 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence            99999999999999976432   34  788899999999999999998   99999999999999986 67999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      +...... ........|+..|+|||++..+...++...|+|++|++++.++++..|+.....
T Consensus       156 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         156 SKRLAGI-NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             heecccC-CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            8765432 122233467899999999876655567889999999999999999988765443

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-34  Score=277.97  Aligned_cols=231  Identities=23%  Similarity=0.351  Sum_probs=180.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      .+++|+..+.||+|+||.||+|.+..     ++..||+|++.... .....++.+|+.++..++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            56789999999999999999998653     35679999986542 2345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCC------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKST------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                      .++||||+++++|.+++......      ...+++..++.++.|++.||.|||+   .+++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998653221      2246888999999999999999998   89999999999999999999999


Q ss_pred             eecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          342 GDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      +|||+++......... .....++..|+|||.+.++.  ++...|+|++|++++++++ +..|+....  ..++.+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~~--~~~~~~~~~~  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMS--NEQVLRFVME  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc
Confidence            9999987654322111 12234577899999987654  5778899999999999998 566665543  2444444332


Q ss_pred             CCCCCCCCCCCCc
Q 041624          420 ETKMPNLPSKMPV  432 (459)
Q Consensus       420 ~~~~p~~p~~~p~  432 (459)
                      . ..++.|...|.
T Consensus       237 ~-~~~~~~~~~~~  248 (277)
T cd05062         237 G-GLLDKPDNCPD  248 (277)
T ss_pred             C-CcCCCCCCCCH
Confidence            2 23444555553

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.2e-34  Score=277.70  Aligned_cols=204  Identities=23%  Similarity=0.376  Sum_probs=169.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888899999999999999863     3456799999876655566789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccC---------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          271 VYEFMPNGSLDFHLFSKK---------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                      ||||+++++|.+++....         .....+++.+++.++.|++.||+|||+   ++++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            999999999999986543         112358999999999999999999998   99999999999999999999999


Q ss_pred             eecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          342 GDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       342 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      +|||+++........ ......++..|+|||.+.+..  ++.+.|+|++|++++++++ +..|+.
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999865432211 122344577899999987653  5778999999999999886 554443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-34  Score=282.69  Aligned_cols=196  Identities=26%  Similarity=0.306  Sum_probs=170.6

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||++....+++.||+|++....   ......+.+|+.++.+++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997542   234567889999999999999999999999999999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      +|..++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            9988886543    58999999999999999999998   99999999999999999999999999998754322 1223


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ....||+.|+|||++.+..  ++...|+|++|+++++++++..|+....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             ccccCCcCccChhhhcCCC--CCccCCccccchHHHHHhhCCCCCCCCC
Confidence            4467999999999997654  5788999999999999999999886543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-34  Score=283.27  Aligned_cols=213  Identities=25%  Similarity=0.284  Sum_probs=178.4

Q ss_pred             CCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeE
Q 041624          197 NFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  268 (459)
                      +|++.+.||+|+||.||++...   .+++.||+|++.+..    ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998864   468999999986531    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++..+.    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999986543    58999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC--CCCCHHHHHHHH
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN--CRPSIRQAIQVL  417 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~--~RPs~~~v~~~L  417 (459)
                      .+............||+.|+|||++.+.. ..+...|+|++|+++++++++..|+..  .+....++.+.+
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  223 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI  223 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCC-CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH
Confidence            66443333344567999999999987533 356788999999999999999999863  344555555443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.9e-34  Score=276.77  Aligned_cols=203  Identities=22%  Similarity=0.263  Sum_probs=175.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++...  ....+.+.+|+.++.+++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999999989999999997542  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|..+... .   ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~-~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM-P---NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc-C---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998877654432 2   258999999999999999999998   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .........||..|+|||++.+..  ++...|+|++|+++++++++..|++...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             ccccccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            333334567899999999997654  5778999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=274.08  Aligned_cols=214  Identities=25%  Similarity=0.310  Sum_probs=183.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEee-----CC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-----RG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~  266 (459)
                      ....|...+.||+|+||.|..+.++.+|+.||||++...  .....++-.+|+++|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            445666678999999999999999999999999999744  34456788999999999999999999998865     35


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      .+|+|+|+| ..+|.+.+..+.    .|+......+++|+++||+|+|+   .+|+||||||+|+|++.+...||+|||+
T Consensus       100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence            789999999 568998887654    49999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCC-CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          347 ALLVDHE-LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       347 a~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      |+..+.. .....+..+.|..|.|||.+.... .++..+|+||.||++.+|+++...||.+. ...|+-.++
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~-~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~  241 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSS-EYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLIL  241 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccc-cccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHH
Confidence            9988643 122346778899999999997655 58999999999999999999999999876 344443333

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.5e-34  Score=276.99  Aligned_cols=203  Identities=23%  Similarity=0.289  Sum_probs=174.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|...+.||+|+||.||+|....++..||+|.++.... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            568889999999999999999999999999999975432 3345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++ +|.+++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 89888865433   58899999999999999999998   999999999999999999999999999997654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       .......+++.|+|||++.+.. .++...|+|++|+++++++++..|++...
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGST-EYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             -ccccCceecccccChHHhcCCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             1223456799999999987533 36778999999999999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=263.55  Aligned_cols=223  Identities=24%  Similarity=0.260  Sum_probs=190.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----CeE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GEF  268 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  268 (459)
                      ..++|.+.+.||+|||+-||.+..-.++..+|+|++.....++.+..++|++..++++|||++++++++..+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346789999999999999999999888999999999887778889999999999999999999999887543     358


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecCCCCEEEeecCC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ||+++|...|||.+.+......+..+++.+.+.|+.+|++||++||+   ..  ++||||||.|||+.+++.++|.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEeccC
Confidence            99999999999999998877777789999999999999999999998   55  99999999999999999999999999


Q ss_pred             cccccCCCCCc--------cccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHh-------------------
Q 041624          347 ALLVDHELGPR--------TTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLW-------------------  398 (459)
Q Consensus       347 a~~~~~~~~~~--------~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~-------------------  398 (459)
                      ++...-.....        .....-|..|.|||.+.-.. ..++.+.|+||+||++|.|+.                   
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            87653221111        11234589999999986332 247889999999999998774                   


Q ss_pred             -----------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 -----------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 -----------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                             |.+++|.+||++.+++..+..
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                                   888899999999999887754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-34  Score=289.09  Aligned_cols=194  Identities=25%  Similarity=0.335  Sum_probs=164.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-----eEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-----EFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  269 (459)
                      +|+..+.||+|+||.||++....+++.||+|++....  ....+++.+|++++..++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999998889999999986542  233567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+. ++|.+.+....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 57877775433    58999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      .............+|..|+|||++.+.. .++.+.|+|++|+++++|+++
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g  201 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGR  201 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCC-CCCcHHHHHhHHHHHHHHHcC
Confidence            6543333334456889999999987543 357788999999999887654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.9e-34  Score=275.44  Aligned_cols=206  Identities=24%  Similarity=0.371  Sum_probs=171.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|...+.||+|+||.||+|....     ++..||+|.++..... ..+.+.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3567888999999999999998753     3578999999765443 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKS----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ++||||+++++|.+++.....          ....+++.++..++.|++.||+|||+   ++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence            999999999999999975421          22358899999999999999999998   89999999999999999999


Q ss_pred             EEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      +||+|||+++........ ......+++.|+|||++.++.  ++.+.|+|++|++++++++ +..|+..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999765332111 122344578899999997654  5778999999999999997 6666544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=288.56  Aligned_cols=233  Identities=22%  Similarity=0.335  Sum_probs=191.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..+...+.++||+|-||.|..+.... +..||||.++.... ...++|.+|+++|.+|+||||++|+|+|..++.+++|+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            44556778999999999999999876 79999999998754 44589999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|.+++..+...  .+.-....+|+.|||+||+||.+   .+++||||.++|+|+|.++++||+|||++|-+..
T Consensus       615 EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999877542  24556677899999999999999   9999999999999999999999999999997665


Q ss_pred             CCCCcc-ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc------CCCCCC
Q 041624          353 ELGPRT-TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF------ETKMPN  425 (459)
Q Consensus       353 ~~~~~~-~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~------~~~~p~  425 (459)
                      ...... ...+-.++|||||.+..++  ++.++|+|++|..+++++.-+..-|-.--+-+|+++.+.+      .+-.+.
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            544443 3445578999999999886  5889999999999998887555555555566677765532      223444


Q ss_pred             CCCCCCccc
Q 041624          426 LPSKMPVAI  434 (459)
Q Consensus       426 ~p~~~p~~~  434 (459)
                      .|+-.|..+
T Consensus       768 ~P~~cp~~l  776 (807)
T KOG1094|consen  768 RPPACPQGL  776 (807)
T ss_pred             CCCcCcHHH
Confidence            555555443

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-33  Score=270.21  Aligned_cols=218  Identities=26%  Similarity=0.349  Sum_probs=184.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....+++.||+|.++...   ....+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67899999999999999999999889999999886432   233567899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.........+++.+++.++.+++.||.|||+   .+|+||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999987544334468999999999999999999998   9999999999999999999999999999876643


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .. .......++..|+|||.+.+..  ++...|+|++|+++++++++..|+.....+..++.+.+..
T Consensus       159 ~~-~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08224         159 KT-TAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK  222 (267)
T ss_pred             CC-cccceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc
Confidence            32 1223456888999999987543  5678899999999999998888776666666666665544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-34  Score=278.72  Aligned_cols=209  Identities=23%  Similarity=0.371  Sum_probs=170.0

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEe
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCH  263 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  263 (459)
                      +....++|+..+.||+|+||.||++.....     ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            344556788899999999999999998643     3789999987542 23445788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKK------------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      ..+..+++|||+++|+|.+++....            .....+++..++.++.|++.||+|||+   ++|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence            9999999999999999999986432            223468999999999999999999998   9999999999999


Q ss_pred             eecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          332 MPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       332 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      |++.++.+||+|||+++.+....... .....++..|+|||.+.+..  ++.+.|+|++|++++++++ +..|++
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC--cCcccceeehhhHHHHHhcCCCCCCC
Confidence            99999999999999998765432111 22233567899999886553  5678899999999998775 444433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.8e-34  Score=274.23  Aligned_cols=202  Identities=26%  Similarity=0.333  Sum_probs=164.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|+..+.||+|+||.||+|.+..++.    .+++|.+..... ....++..|+..+.+++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            467778999999999999999876665    477787754322 234678888989999999999999998864 45789


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ++||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++++||||||+|||++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999976543   68999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          351 DHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       351 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ...... ......++..|+|||.+..+.  ++.+.|+|++|++++++++ +..|+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            433221 223455778999999997654  5778899999999998886 54444443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-34  Score=271.47  Aligned_cols=212  Identities=26%  Similarity=0.373  Sum_probs=172.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .+|+..+.||+|+||.||+|.++. +..+|+|.+.... ...++|.+|++++.+++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            357788999999999999998875 6789999986432 23467889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....   .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            99999999875443   58999999999999999999998   9999999999999999999999999999976543222


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .......++..|+|||.+....  ++...|+|++|++++++++ +..|+...+  ..++...+..
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~  216 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSA  216 (256)
T ss_pred             cccCCCCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHHHc
Confidence            1222223456899999988654  5678899999999999987 555554432  3444444443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-33  Score=273.30  Aligned_cols=197  Identities=26%  Similarity=0.389  Sum_probs=170.0

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||+||++.+..+++.+|+|++.....   ...+.+..|++++.+++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999998899999999865422   2345678899999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      ..++.........+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+.... .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence            98876543333469999999999999999999998   999999999999999999999999999997664332 22344


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..||+.|+|||.+.++.  ++...|+|++|+++++++++..|+...
T Consensus       157 ~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         157 YAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             cCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            67899999999998664  567889999999999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-34  Score=285.50  Aligned_cols=192  Identities=27%  Similarity=0.333  Sum_probs=163.1

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||++....+++.||+|.++...   .....++..|++++..++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999899999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      +|..++....    .+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~  153 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATM  153 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccc
Confidence            9988886543    58999999999999999999996  269999999999999999999999999998754322 1223


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ....||+.|+|||++.++.  ++...|+|++|+++++++++..|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tG~~P  195 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLP  195 (325)
T ss_pred             ccccCCcccCCHHHHccCC--CCCccccccccceeeeeccCCCC
Confidence            3467999999999997654  57789999999998877764433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8e-34  Score=274.85  Aligned_cols=196  Identities=24%  Similarity=0.369  Sum_probs=163.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEc----CCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~  269 (459)
                      ++|+..+.||+|+||.||++...    .++..||+|++........+.+.+|++++.+++|+||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999853    4578999999977655666789999999999999999999998754  34689


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++++|.+++.....   .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            99999999999999865433   58999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          350 VDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       350 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ........  .....++..|+|||++.++.  ++...|+|++|+++++++++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~  207 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTY  207 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCC--cChHHHHHHHHHHHHHHhhc
Confidence            65432211  11223345699999987654  56788999999998877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-34  Score=284.73  Aligned_cols=205  Identities=23%  Similarity=0.229  Sum_probs=177.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|...+.||+|+||.||++....+++.||+|+++...   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47888999999999999999999999999999997542   234566889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++.....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999976533   69999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccC----ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTG----RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..........||+.|+|||++...    ...++.+.|+|++|+++++|+++..|+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            333333445789999999998632    223567889999999999999998887543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.2e-34  Score=272.82  Aligned_cols=218  Identities=28%  Similarity=0.348  Sum_probs=182.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....++..+|||.+....   .....++.+|+.++..++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999998889999999886532   223467889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.........+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999887533333468999999999999999999998   9999999999999999999999999999876643


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .. .......++..|+|||++.+..  .+...|+|++|+++++++++..|+....++..+..+.+..
T Consensus       159 ~~-~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08229         159 KT-TAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ  222 (267)
T ss_pred             CC-cccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc
Confidence            32 1223456889999999987654  5677899999999999998887776555555555555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=286.74  Aligned_cols=203  Identities=25%  Similarity=0.298  Sum_probs=178.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|...+.||+|+||.||+|....+++.||+|+++...   ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999999889999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999997652    58999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CC----------------------------CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          353 EL----------------------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       353 ~~----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ..                            ........||+.|+|||++.+.  .++...|+|++|+++++|+++..|+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCC
Confidence            32                            1122345789999999999866  46788999999999999999999887


Q ss_pred             CCC
Q 041624          405 NCR  407 (459)
Q Consensus       405 ~~R  407 (459)
                      ...
T Consensus       232 ~~~  234 (350)
T cd05573         232 SDT  234 (350)
T ss_pred             CCC
Confidence            654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.3e-34  Score=271.94  Aligned_cols=184  Identities=25%  Similarity=0.379  Sum_probs=154.9

Q ss_pred             ceeccCCceEEEEEEEcCC------------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          202 RKLGQGGFGAVYRGILIDL------------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      +.||+|+||.||+|.....            ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999986431            2368999887655555667889999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC-------EEEe
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-------VKLG  342 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kL~  342 (459)
                      +||||+++|+|+.++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999988865433   68999999999999999999998   99999999999999987664       8999


Q ss_pred             ecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH
Q 041624          343 DFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL  397 (459)
Q Consensus       343 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l  397 (459)
                      |||++.....     .....++..|+|||.+..+. .++...|+|++|+++++++
T Consensus       155 d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~  203 (262)
T cd05077         155 DPGIPITVLS-----RQECVERIPWIAPECVEDSK-NLSIAADKWSFGTTLWEIC  203 (262)
T ss_pred             CCCCCccccC-----cccccccccccChhhhcCCC-CCCchhHHHHHHHHHHHHH
Confidence            9999865432     22345788999999886443 3677889999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-33  Score=274.67  Aligned_cols=202  Identities=25%  Similarity=0.332  Sum_probs=166.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC-CCcEEEEEEeccCCc--cchHHHHHHHHHHhcc---CcCCceeEEEEEe-----e
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID-LNMAVAVKKISRGLK--HGKNEYITEVKTCSQL---RHRNLLQLIGLCH-----D  264 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~  264 (459)
                      ++|+..+.||+|+||.||+|.+.. +++.||+|+++....  .....+.+|+.++.++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368889999999999999999854 468899999875432  2234566777777665   6999999999985     3


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      ...+++||||++ ++|.+++.....  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 689888865432  258999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      |+++.....  .......||+.|+|||.+....  ++.+.|+|++|+++++++++..|+....
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            999866433  2334567899999999987553  5778899999999999999988877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-33  Score=275.50  Aligned_cols=217  Identities=23%  Similarity=0.318  Sum_probs=174.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC----------------cEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCcee
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN----------------MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQ  257 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~  257 (459)
                      .++|++.+.||+|+||.||+|.+..++                ..||+|.+.... ....+++.+|++++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467889999999999999999876533                568999987653 334668899999999999999999


Q ss_pred             EEEEEeeCCeEEEEEEecCCCCcchhccccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS-------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       258 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      +++++..++..+++|||+++++|.+++.....       ....+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            99999999999999999999999999876441       12258999999999999999999998   999999999999


Q ss_pred             eeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCC
Q 041624          331 IMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS  409 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs  409 (459)
                      |+++.++.++|+|||+++........ ......++..|+|||++..+.  ++.+.|+|++|++++++++.....|....+
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC--CCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999765432211 123445678999999987654  578889999999999887633333333333


Q ss_pred             HHHHHHH
Q 041624          410 IRQAIQV  416 (459)
Q Consensus       410 ~~~v~~~  416 (459)
                      ..++++.
T Consensus       239 ~~~~~~~  245 (296)
T cd05051         239 DQQVIEN  245 (296)
T ss_pred             hHHHHHH
Confidence            3444443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-33  Score=316.06  Aligned_cols=191  Identities=27%  Similarity=0.365  Sum_probs=159.2

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      ++++++   ...|...+.||+|+||.||+|....++..||+|+++.....    ...|++.+++++||||++++|+|.+.
T Consensus       683 ~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            444444   35677889999999999999999888999999998643222    23568899999999999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +..++||||+++|+|.+++.       .++|.++.+|+.|+|+||+|||+.+..+|+||||||+||+++.++.+++. ||
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence            99999999999999999984       38999999999999999999996555899999999999999999988876 66


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .+.....     .....+|..|+|||++.++.  ++.+.|+|++|++++++++
T Consensus       828 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~el~t  873 (968)
T PLN00113        828 LPGLLCT-----DTKCFISSAYVAPETRETKD--ITEKSDIYGFGLILIELLT  873 (968)
T ss_pred             ccccccc-----CCCccccccccCcccccCCC--CCcccchhhHHHHHHHHHh
Confidence            6543321     12336789999999988654  5788999999999988764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-33  Score=277.27  Aligned_cols=195  Identities=23%  Similarity=0.347  Sum_probs=166.5

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++..+ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997542   23344566677777654 899999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            99998886543    58999999999999999999999   999999999999999999999999999997643321 23


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             cccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            34567999999999997654  577899999999999999999887654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.5e-34  Score=276.31  Aligned_cols=220  Identities=23%  Similarity=0.379  Sum_probs=181.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|...+.||+|+||.||+|....     ++..+++|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            457778999999999999998642     356799999876655556789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          271 VYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ||||+++++|.+++.....            ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            9999999999999975431            12358999999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------
Q 041624          339 VKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------  398 (459)
                      ++|+|||+++........ ......++..|+|||.+....  ++.+.|+|++|++++++++                   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999765432211 123345678899999987654  5677899999999998875                   


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                           |++++|.+||++.+++++|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                                 6666777777777777777654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-33  Score=273.72  Aligned_cols=228  Identities=20%  Similarity=0.312  Sum_probs=180.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEc----CCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +.|+..+.||+|+||.||+|.+.    ..+..+|+|.+.... .....++.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46778899999999999999863    345789999997543 2334678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC
Q 041624          271 VYEFMPNGSLDFHLFSKKS-------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF  337 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  337 (459)
                      ||||+++++|.+++.....             ....+++.+.+.++.|++.||+|||+   ++++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            9999999999999853321             12258899999999999999999998   8999999999999999999


Q ss_pred             CEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHH
Q 041624          338 NVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~  415 (459)
                      .+||+|||+++....... .......++..|+|||++.++.  ++.+.|+|++|++++++++ +..|+...+  ..++.+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIE  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence            999999999986543221 1123344577899999987654  5778999999999999997 776766543  355666


Q ss_pred             HHhcCCCCCCCCCCCC
Q 041624          416 VLNFETKMPNLPSKMP  431 (459)
Q Consensus       416 ~L~~~~~~p~~p~~~p  431 (459)
                      ++..... ++.|...|
T Consensus       238 ~~~~~~~-~~~~~~~~  252 (283)
T cd05090         238 MVRKRQL-LPCSEDCP  252 (283)
T ss_pred             HHHcCCc-CCCCCCCC
Confidence            6554433 23344444

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-34  Score=282.13  Aligned_cols=192  Identities=27%  Similarity=0.328  Sum_probs=161.5

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHH-HHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|....+++.+|+|++....   .....++..|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999996542   223345566655 46778999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~  152 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT  152 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence            99988886543    58999999999999999999998   99999999999999999999999999998753221 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf  196 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             cccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCC
Confidence            34567999999999997654  567899999999999988766553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-34  Score=274.22  Aligned_cols=187  Identities=23%  Similarity=0.352  Sum_probs=158.5

Q ss_pred             ceeccCCceEEEEEEEcCCCc-------EEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          202 RKLGQGGFGAVYRGILIDLNM-------AVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +.||+|+||.||+|.....+.       .+|+|.+........+++.+|+.++..++|+||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998865443       4888888665555567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC--------EEEeecCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--------VKLGDFGL  346 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kL~DFGl  346 (459)
                      +++|+|.+++..+..   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999999976543   58999999999999999999998   99999999999999987765        69999998


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      +.....     .....++..|+|||++.+.. .++...|+||+|+++++++++.
T Consensus       155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~  202 (258)
T cd05078         155 SITVLP-----KEILLERIPWVPPECIENPQ-NLSLAADKWSFGTTLWEIFSGG  202 (258)
T ss_pred             ccccCC-----chhccccCCccCchhccCCC-CCCchhhHHHHHHHHHHHHcCC
Confidence            865432     23356788999999997643 3567889999999999888753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=268.65  Aligned_cols=225  Identities=29%  Similarity=0.415  Sum_probs=182.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-----cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-----HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|+..+.||+|++|.||+|....+++.+|+|.+.....     ...+.+.+|++++.+++|+||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            578999999999999999999988899999999865421     123568899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |+||+++++|.+++....    .+++..+..++.|++.||.|||+   .+|+||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999886543    58899999999999999999998   99999999999999999999999999999765


Q ss_pred             cCCCCCcc--ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 041624          351 DHELGPRT--TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPS  428 (459)
Q Consensus       351 ~~~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~  428 (459)
                      ........  ....++..|+|||++.+..  .+...|+|++|+++++++++..|+.... .+..+.+... ....+..|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~  230 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIAT-QPTNPQLPS  230 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccc-hHHHHHHHhc-cCCCCCCCc
Confidence            43211111  3356788999999998654  5778899999999999999988875542 2333333332 223344554


Q ss_pred             CCC
Q 041624          429 KMP  431 (459)
Q Consensus       429 ~~p  431 (459)
                      ..+
T Consensus       231 ~~~  233 (263)
T cd06625         231 HVS  233 (263)
T ss_pred             cCC
Confidence            444

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.1e-34  Score=275.36  Aligned_cols=218  Identities=22%  Similarity=0.252  Sum_probs=181.4

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEe-
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCH-  263 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-  263 (459)
                      +.++.+..+.++|+..+.||+|+||.||++....+++.+|+|.++.. .....++.+|+.++.++ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            55677788999999999999999999999999988999999988643 23346788899999999 6999999999874 


Q ss_pred             ----eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          264 ----DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       264 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                          ..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                3457899999999999999876433333468999999999999999999998   899999999999999999999


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ||+|||+++.+... ........|+..|+|||++....   ..++.+.|+|++|+++++++++..|+....+
T Consensus       164 kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         164 KLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             EEccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999866432 12233456899999999986432   2356788999999999999998888765543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.6e-34  Score=274.07  Aligned_cols=192  Identities=24%  Similarity=0.306  Sum_probs=156.6

Q ss_pred             eeccCCceEEEEEEEcCC------------------------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeE
Q 041624          203 KLGQGGFGAVYRGILIDL------------------------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL  258 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l  258 (459)
                      .||+|+||.||+|.+..+                        ...|++|.+.........+|.+|+.++++++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999986321                        24689999876544445678899999999999999999


Q ss_pred             EEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-
Q 041624          259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-  337 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-  337 (459)
                      +++|.+.+..++||||+++|+|+.++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998865433   58999999999999999999998   9999999999999998654 


Q ss_pred             ------CEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH-hcCCCCCCC
Q 041624          338 ------NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL-WCAHPDRNC  406 (459)
Q Consensus       338 ------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l-~c~~p~p~~  406 (459)
                            .+|++|||++......     ....++..|+|||.+.+. ..++...|+|++|+++++++ .+..|+...
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                  3899999988643221     223567889999998754 34678899999999998874 455544433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-33  Score=276.88  Aligned_cols=200  Identities=23%  Similarity=0.294  Sum_probs=171.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCc-CCceeEEEEEeeCCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRH-RNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +|+..+.||+|+||.||+|....+++.||+|+++...   ....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999999989999999997542   2345678889999999976 46888999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998886543    58999999999999999999998   9999999999999999999999999999875322


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      . ........||+.|+|||++.+..  ++...|+|++|+++++++++..|+...
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         154 G-GKTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             C-CCceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            1 12234567999999999998654  577889999999999999999887543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.2e-34  Score=274.62  Aligned_cols=202  Identities=22%  Similarity=0.323  Sum_probs=165.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .|...+.||+|+||.||+|....+     +..||+|+++..... ..+.+.+|+.++.+++|+||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            456678899999999999987543     578999999755332 34668899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          271 VYEFMPNGSLDFHLFSKK------------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ++||+++++|.+++....            .....+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            999999999999985321            112358899999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          339 VKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      +||+|||+++........ ......+++.|+|||.+..+.  ++.+.|+|++|++++++++ +..|+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~  227 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPY  227 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCC
Confidence            999999998865432211 122344578999999987654  5678899999999999886 44443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=279.92  Aligned_cols=215  Identities=27%  Similarity=0.329  Sum_probs=186.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  269 (459)
                      ....|+..+.||+|.||.||+++.+.+|+.+|+|.+.+....   ..+...+|+.+|+++. |||||.+++.+++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            456788889999999999999999999999999999876443   3468899999999998 999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC----CCEEEeecC
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD----FNVKLGDFG  345 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kL~DFG  345 (459)
                      +|||++.||.|.+.+...     .+++..+..++.|++.|++|||+   .+|+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999765     29999999999999999999999   999999999999998643    479999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      ++.....  .......+||+.|+|||++...  .++...|+||+|+++|+|+.+..|+-.+.. .....+++.+.-
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-~~~~~~i~~~~~  255 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETE-FEIFLAILRGDF  255 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCCh-hHHHHHHHcCCC
Confidence            9998765  4566788999999999999854  478899999999999999999999887752 223334555443

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=274.77  Aligned_cols=215  Identities=24%  Similarity=0.340  Sum_probs=170.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC--------------CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL--------------NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLI  259 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~  259 (459)
                      .++|++.+.||+|+||.||++....+              ...||+|.++... ....+.|.+|++++.+++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35788899999999999999987542              2358999987653 23456799999999999999999999


Q ss_pred             EEEeeCCeEEEEEEecCCCCcchhccccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       260 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      +++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence            999999999999999999999999864321        11247899999999999999999998   9999999999999


Q ss_pred             eecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCH
Q 041624          332 MPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSI  410 (459)
Q Consensus       332 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~  410 (459)
                      +++.++.+||+|||+++......... .....++..|+|||++..+.  ++.+.|+||+|++++++++...+.|....+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999997654322111 22334577899999987654  5788999999999998876444444333344


Q ss_pred             HHHH
Q 041624          411 RQAI  414 (459)
Q Consensus       411 ~~v~  414 (459)
                      .+++
T Consensus       239 ~~~~  242 (295)
T cd05097         239 EQVI  242 (295)
T ss_pred             HHHH
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.1e-34  Score=287.50  Aligned_cols=223  Identities=25%  Similarity=0.310  Sum_probs=176.3

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccC-cCCceeEEEEEe
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLR-HRNLLQLIGLCH  263 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~  263 (459)
                      +....++|.+.+.||+|+||.||+|++..     +++.||+|+++.... ...+.+.+|++++.++. |+||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34455678888999999999999999643     356899999976533 23457889999999997 999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCC------------------------------------------------------
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKS------------------------------------------------------  289 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------  289 (459)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCC
Q 041624          290 ----------------------------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS  329 (459)
Q Consensus       290 ----------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~  329 (459)
                                                              ....+++.....++.||+.||.|||+   .+|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence                                                    11247888899999999999999998   99999999999


Q ss_pred             CeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          330 NIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       330 NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      |||+++++.+||+|||+++.+...... ......++..|+|||.+....  ++...|+|++|++++++++ +..|++.. 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~~g~~P~~~~-  345 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPEL-  345 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHHcCCCCCCCC-
Confidence            999999999999999999865432211 122345678899999997654  5677899999999999887 55565543 


Q ss_pred             CCHHHHHHHHhc
Q 041624          408 PSIRQAIQVLNF  419 (459)
Q Consensus       408 Ps~~~v~~~L~~  419 (459)
                      |...+..+.+..
T Consensus       346 ~~~~~~~~~~~~  357 (401)
T cd05107         346 PMNEQFYNAIKR  357 (401)
T ss_pred             CchHHHHHHHHc
Confidence            333444444443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-33  Score=277.45  Aligned_cols=207  Identities=24%  Similarity=0.317  Sum_probs=172.0

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHH---hccCcCCceeEEEEEeeCCeEEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTC---SQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      |++.+.||+|+||.||+|.+..+++.||||+++...   ....+.+..|++++   .+++|+||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999999999999999997542   22345566676654   567899999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|..++...     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999998877432     58999999999999999999998   999999999999999999999999999987543


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      .. ........|++.|+|||.+.+..  ++.+.|+|++|+++++++++..|+...  +..++.+.+
T Consensus       153 ~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~G~~pf~~~--~~~~~~~~i  213 (324)
T cd05589         153 GF-GDRTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSI  213 (324)
T ss_pred             CC-CCcccccccCccccCHhHhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHHH
Confidence            22 22234567999999999997653  577889999999999999999987643  344444433

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.2e-33  Score=277.44  Aligned_cols=200  Identities=22%  Similarity=0.296  Sum_probs=172.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +|...+.||+|+||.||+|....+++.||+|.+++..   ....+.+..|..++..+ +|++|+++++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999999989999999997642   22344567788888777 6899999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998886543    58999999999999999999998   9999999999999999999999999999975432


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      . ........||+.|+|||++..+.  ++.++|+||+|+++++++++..|+...
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         154 D-GVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             C-CCccccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCC
Confidence            2 22234567999999999998654  578899999999999999999988654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-33  Score=269.13  Aligned_cols=213  Identities=26%  Similarity=0.363  Sum_probs=173.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|.+.++||+|+||.||+|.+.++ ..||+|+++... ...++|.+|++++.+++|+||+++++.+.+ +..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            35688899999999999999998764 569999987532 345678999999999999999999998754 567999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++|+|.+++.....  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.++.+....
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999975432  358999999999999999999998   999999999999999999999999999998765433


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ........++..|+|||+...+.  ++...|+|++|++++++++ +..|++...  ..++.+.+..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~  218 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER  218 (262)
T ss_pred             cccccCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhc
Confidence            22223345677899999887554  5778899999999999998 666665442  3444444433

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-33  Score=271.58  Aligned_cols=209  Identities=27%  Similarity=0.336  Sum_probs=176.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC------
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR------  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------  265 (459)
                      .+++.|+..+.||+|+||.||+|....+++.||+|++... ......+.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4677889999999999999999999998999999998654 34456788999999998 799999999998753      


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ...++||||+++++|.+++.....  ..+++..+..++.|++.||+|||+   ++|+|+||||+||++++++.+||+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCC
Confidence            468999999999999999876432  268999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      +++...... .......|+..|+|||++...   ...++...|+|++|+++++++++..|+....+
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~  221 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  221 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            998664322 223446789999999998633   22466789999999999999999888765443

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-33  Score=270.20  Aligned_cols=214  Identities=25%  Similarity=0.393  Sum_probs=173.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCC---cEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|++.+.||+|+||.||+|.+..++   ..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888899999999999999886433   479999987543 23356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++.....   .+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.++|+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999975543   58999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCcc--ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HELGPRT--TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .......  ....++..|+|||++.++.  ++.+.|+|++|++++++++ +..|+-...+  .+.++.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~  224 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEE  224 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCc--cCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhC
Confidence            4322111  1223356899999997654  5778899999999998775 6666554432  344444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-33  Score=281.11  Aligned_cols=208  Identities=27%  Similarity=0.356  Sum_probs=168.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEee-CC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHD-RG  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-~~  266 (459)
                      .++|++.+.||+|+||.||+|....     +++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4578889999999999999997543     357899999875432 2345678899999999 89999999998865 45


Q ss_pred             eEEEEEEecCCCCcchhccccCCC--------------------------------------------------------
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKST--------------------------------------------------------  290 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  290 (459)
                      .++++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            788999999999999988643210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc-ccccccccccc
Q 041624          291 -GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYM  368 (459)
Q Consensus       291 -~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~  368 (459)
                       ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             1268999999999999999999998   999999999999999999999999999998764332211 22345677899


Q ss_pred             ccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          369 APEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       369 APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      |||++.+..  ++.+.|+|++|++++++++ +..|++..+
T Consensus       243 aPE~~~~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         243 APESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CcHHhcCCC--CCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999987653  5778999999999999886 666665443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-33  Score=266.78  Aligned_cols=202  Identities=25%  Similarity=0.365  Sum_probs=176.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|++|.||+|....+++.|++|.+...  .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477789999999999999999988999999998643  234567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++.+....
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999976422  368999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       .......|+..|+|||++.++.  ++...|+|++|+++++++++..|+...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  204 (256)
T cd08529         156 -NFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDAN  204 (256)
T ss_pred             -chhhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCC
Confidence             2223456889999999998654  567889999999999999998887654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=283.18  Aligned_cols=195  Identities=22%  Similarity=0.256  Sum_probs=166.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ...+|.+.+.||+|+||.||+|....++..||+|.....      ....|+.++.+++|+||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            446799999999999999999999988999999975432      23569999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+. ++|.+++.....   .+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       138 ~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             ccC-CcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            995 688888865433   69999999999999999999998   89999999999999999999999999999754322


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                        .......||..|+|||++.+..  ++.+.|+|++|++++++++...+...
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             --cccccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCcccc
Confidence              2234467899999999997654  57889999999999999876555433

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=272.03  Aligned_cols=231  Identities=23%  Similarity=0.361  Sum_probs=184.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|...+.||+|+||.||+|.....     +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            46788889999999999999998643     3789999986543 23455788999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCC------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          269 MLVYEFMPNGSLDFHLFSKKST------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      ++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            9999999999999998754321      2247899999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          343 DFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       343 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      |||+++.+..... .......++..|+|||.+..+.  .+.+.|+|++|++++++++ +..|++..  +..++.+.+. .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~-~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVI-D  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCC--CCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHh-c
Confidence            9999986643321 1223345678999999987654  5678899999999999987 77777654  3455566555 2


Q ss_pred             CCCCCCCCCCCcc
Q 041624          421 TKMPNLPSKMPVA  433 (459)
Q Consensus       421 ~~~p~~p~~~p~~  433 (459)
                      ...+..|...|..
T Consensus       237 ~~~~~~~~~~~~~  249 (277)
T cd05032         237 GGHLDLPENCPDK  249 (277)
T ss_pred             CCCCCCCCCCCHH
Confidence            3334445555433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-33  Score=269.55  Aligned_cols=214  Identities=24%  Similarity=0.424  Sum_probs=173.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCc---EEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNM---AVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|....++.   .+|+|.++... ....+++.+|++++.+++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578888999999999999999875543   79999987553 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++.....   .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999865433   58999999999999999999998   89999999999999999999999999999766


Q ss_pred             cCCCCCcc--ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRT--TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ........  .....+..|+|||++..+.  ++.+.|+|++|++++++++ +..|+....+  .++.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~  224 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIN  224 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCC--cChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHh
Confidence            53322111  1122345799999987654  5778899999999999886 6666654432  34444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-34  Score=305.76  Aligned_cols=211  Identities=25%  Similarity=0.300  Sum_probs=172.7

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee--C
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--R  265 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~  265 (459)
                      +.....++|.+.+.||+|+||.||+|.+..++..+|+|.+....  ......|..|+.++.+|+||||+++++++..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34445678999999999999999999999999999999987542  2345678999999999999999999998854  4


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----CCCeeecCCCCCCeeecCC-----
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW----KRCVVHRDIKFSNIMPDTD-----  336 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----~~~iiHrDlkp~NILl~~~-----  336 (459)
                      ..+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+..    .++|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5789999999999999999764333346999999999999999999999732    1359999999999999642     


Q ss_pred             ------------CCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          337 ------------FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       337 ------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                                  ..+||+|||+++.+...  .......||+.|+|||++......++.++|+|++|+++++|+++..|
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                        34899999999876432  22344679999999999875544567889999999999998874444

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-33  Score=275.93  Aligned_cols=202  Identities=22%  Similarity=0.290  Sum_probs=172.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|...+.||+|+||.||+|+...+++.||+|.++.... .....+.+|+.++.+++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            568889999999999999999998899999999975432 3345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++ +|.+++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 88887765433   58999999999999999999998   999999999999999999999999999997654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       .......+|..|+|||.+.+.. .++...|+|++|+++++++++..|++..
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSS-EYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             -cccccccccccccCCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             1223346789999999986543 3577889999999999999998887654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-33  Score=265.66  Aligned_cols=197  Identities=27%  Similarity=0.422  Sum_probs=165.0

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ++||+|+||.||+|...+ +..+|+|.++.... .....+.+|++++.+++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            469999999999999764 78999999876543 2345788999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++.....   .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus        80 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          80 LSFLRKKKD---ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            998865433   58999999999999999999998   999999999999999999999999999997654332222222


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      ..++..|+|||++.++.  ++.+.|+|++|++++++++ +..|++..+
T Consensus       154 ~~~~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         154 KQIPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             CCCcccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            34467899999997654  5677899999999999887 666766553

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3e-33  Score=267.29  Aligned_cols=212  Identities=25%  Similarity=0.382  Sum_probs=172.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|.... +..+|+|.++... ...+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3568888999999999999998875 6779999987543 24567999999999999999999999885 4568999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++..+....
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999875432  358999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ........++..|+|||.+.+..  ++...|+|++|++++++++ +..|++...  ..++.+.+.
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~  217 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVE  217 (260)
T ss_pred             cccccCCCCCccccChHHHhcCC--CcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH
Confidence            22222334567899999887554  5678899999999999998 777766542  334444443

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-33  Score=268.09  Aligned_cols=185  Identities=27%  Similarity=0.417  Sum_probs=158.3

Q ss_pred             ceeccCCceEEEEEEEcCCC----------cEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLN----------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999998765          35888877654333 6789999999999999999999999988 778999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-------CEEEeec
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-------NVKLGDF  344 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kL~DF  344 (459)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999999976543   58999999999999999999998   9999999999999999888       7999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      |+++....     .....++..|+|||++......++...|+|++|+++++++++
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~  202 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN  202 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhC
Confidence            99976543     223456778999999876534567788999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-33  Score=275.83  Aligned_cols=203  Identities=26%  Similarity=0.349  Sum_probs=171.5

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.++.+++.||+|++++..   ....+.+..|..++..+ +|+||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999989999999997542   23456678898888877 699999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~  152 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT  152 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence            99998886543    58999999999999999999998   99999999999999999999999999998754322 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      .....||+.|+|||++.+..  ++...|+|++|+++++++++..|+...  +..++.+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~  207 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEA  207 (320)
T ss_pred             ccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHH
Confidence            34567999999999987553  577889999999999999999988654  33444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-33  Score=268.76  Aligned_cols=203  Identities=26%  Similarity=0.288  Sum_probs=174.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +.|+..+.||+|.-|+||++.+.+++..+|+|++.+..   .+...+...|-+||+.++||.++.||+.++.++..||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34555688999999999999999999999999998763   334557788999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||+||+|..+++++..  ..+++..++.++.+|+.||+|||.   .|||+|||||+||||.++|.+-|+||.|+.....
T Consensus       157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999888866544  479999999999999999999999   9999999999999999999999999999754210


Q ss_pred             ---------------------------------C-C---------------------CCccccccccccccccceeccCc
Q 041624          353 ---------------------------------E-L---------------------GPRTTGLAGTLGYMAPEYISTGR  377 (459)
Q Consensus       353 ---------------------------------~-~---------------------~~~~~~~~gt~~y~APE~~~~~~  377 (459)
                                                       . .                     ......++||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                     01123467999999999999764


Q ss_pred             cccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          378 ARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       378 ~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                        .+.++|+|.+|+++|+|+.+..|+-.
T Consensus       312 --HgsAVDWWtfGIflYEmLyG~TPFKG  337 (459)
T KOG0610|consen  312 --HGSAVDWWTFGIFLYEMLYGTTPFKG  337 (459)
T ss_pred             --CCchhhHHHHHHHHHHHHhCCCCcCC
Confidence              57889999999999999999999764

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-33  Score=270.69  Aligned_cols=214  Identities=24%  Similarity=0.355  Sum_probs=178.1

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      |++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|++++..++|+||+++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            55678899999999999999998999999999766555667899999999999999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      ++|..++.....   ++++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...... ...
T Consensus        87 ~~l~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~  159 (282)
T cd06643          87 GAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR  159 (282)
T ss_pred             CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc-ccc
Confidence            999888765332   69999999999999999999999   99999999999999999999999999998765432 122


Q ss_pred             cccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          358 TTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .....++..|+|||++...   ...++...|+|++|+++++++++..|+.... ....+.+....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~  223 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKS  223 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhc
Confidence            3345689999999998532   1235678899999999999999988876543 23344444433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.6e-33  Score=270.69  Aligned_cols=200  Identities=26%  Similarity=0.356  Sum_probs=164.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      .++|+..+.||+|+||.||+|.+..++.    .||+|.++... ....+++.+|+.++..++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3567888999999999999999876555    48999987543 33456788999999999999999999999754 578


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +++||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999999876443   58999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          350 VDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       350 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      ........ .....++..|+|||.+.++.  ++...|+|++|++++++++ |..|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~  212 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCC
Confidence            65332211 12234567899999987653  5778899999999999876 44443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-33  Score=278.55  Aligned_cols=190  Identities=25%  Similarity=0.352  Sum_probs=162.3

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|.+++..   ....+.+..|..++..+ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999989999999997542   23455677899999888 799999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~  152 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT  152 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence            99998886543    59999999999999999999998   99999999999999999999999999998753221 122


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      .....||..|+|||++.+..  ++.+.|+|++|+++++++++..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             ccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCC
Confidence            34457899999999997654  5678899999999998876433

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.1e-33  Score=271.33  Aligned_cols=194  Identities=26%  Similarity=0.367  Sum_probs=167.1

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||.||++..+.+++.+|+|++....   ....+.+..|++++.+++|+||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999999999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++.....  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||++......  .....
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~  153 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQ  153 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeec
Confidence            988865432  258999999999999999999998   99999999999999999999999999999766432  22234


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ..|+..|+|||++.++.  ++...|+||+|+++++++++..|+...
T Consensus       154 ~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         154 RAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             cCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            56899999999997664  677889999999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-33  Score=269.96  Aligned_cols=206  Identities=24%  Similarity=0.307  Sum_probs=177.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.++..++|+||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            34677788999999999999999988999999999766555556788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...... 
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-  159 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-  159 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence            99999999886543    58999999999999999999998   89999999999999999999999999998765432 


Q ss_pred             CCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ........|+..|+|||++... ...++.+.|+||+|+++++++++..|+....|
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~  214 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence            2223445789999999987421 22356789999999999999999988876654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.6e-33  Score=276.63  Aligned_cols=196  Identities=24%  Similarity=0.332  Sum_probs=168.8

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ++||+|+||.||+|....+++.||+|+++...   ....+.+..|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999989999999997542   23445677899988876 899999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~  152 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVT  152 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccc
Confidence            99998886543    58999999999999999999998   99999999999999999999999999998754322 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             ccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCC
Confidence            34567899999999987553  5778999999999999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-33  Score=273.86  Aligned_cols=200  Identities=23%  Similarity=0.357  Sum_probs=165.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc-------CCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI-------DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++|.+.+.||+|+||.||+|...       ..+..||+|.+.... ....+++.+|+.++..+ +|+||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567888899999999999999753       124579999987542 34456789999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKST------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      .+..++||||+++|+|.+++......            ...+++.++..++.||+.||.|||+   ++++||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence            99999999999999999999764321            2358899999999999999999998   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ++.++.+||+|||+++.+....... .....++..|+|||++.+..  ++.+.|+|++|++++++++
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~  234 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFT  234 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC--CCchhhHHHHHHHHHHHHc
Confidence            9999999999999998764322211 22344567899999987653  5678899999999998876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-33  Score=272.81  Aligned_cols=201  Identities=26%  Similarity=0.371  Sum_probs=164.1

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      ..+++|++.+.||+|+||.||+|..++     .+..||+|.++.... .....+.+|+.++++++|+||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            356789999999999999999997653     245899998865432 23456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCC------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      ..++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+   ++|+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975321      12346788899999999999999998   9999999999999999999999


Q ss_pred             EeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          341 LGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+|||+++......... .....++..|+|||.+.++.  ++.+.|+|++|++++++++
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHh
Confidence            99999998654322111 12234567899999987654  5678899999999987764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-33  Score=267.29  Aligned_cols=204  Identities=25%  Similarity=0.330  Sum_probs=165.7

Q ss_pred             CCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe-----
Q 041624          198 FSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE-----  267 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  267 (459)
                      |++.+.||+|+||.||+|.....   +..||+|+++...  ....+.+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56778999999999999998643   4789999987542  2335678999999999999999999999876554     


Q ss_pred             -EEEEEEecCCCCcchhccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          268 -FMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       268 -~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                       .++++||+++|+|..++.....  ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             7999999999999999865321  22368999999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          345 GLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       345 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      |+++......... .....++..|+|||.+...  .++...|+||+|++++++++ |..|++..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            9998764332211 1223346789999998654  35778999999999999987 66665544

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.9e-33  Score=273.74  Aligned_cols=199  Identities=27%  Similarity=0.322  Sum_probs=172.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|+||.||++.+..++..+|+|.+..... ...+++.+|++++.+++|+||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            468899999999999999999998899999999875432 2345688999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999999986543    58999999999999999999997  258999999999999999999999999998765332 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                        ......|+..|+|||++.+..  ++...|+|++|+++++++++..|++.
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCC
Confidence              223457889999999986543  56788999999999999998877653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-33  Score=270.57  Aligned_cols=206  Identities=25%  Similarity=0.363  Sum_probs=176.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +.|++.+.||.|+||.||+|....++..+++|.+........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888899999999999999999989999999998766566778999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|..++.+...   .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... .
T Consensus        92 ~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~  164 (292)
T cd06644          92 PGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-L  164 (292)
T ss_pred             CCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc-c
Confidence            99999888765433   58999999999999999999998   99999999999999999999999999998754322 1


Q ss_pred             CccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      .......++..|+|||++..+.   ..++...|+|++|+++++++++..|+....|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  220 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP  220 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence            2223456788999999986432   2356678999999999999998887765543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.2e-33  Score=272.54  Aligned_cols=215  Identities=23%  Similarity=0.337  Sum_probs=171.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC----------------CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCcee
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID----------------LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQ  257 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~  257 (459)
                      .++|+..+.||+|+||.||++....                ++..+|+|.++... ....++|.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3578899999999999999986432                24579999987543 334568999999999999999999


Q ss_pred             EEEEEeeCCeEEEEEEecCCCCcchhccccCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST-------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       258 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      +++++...+..++||||+++++|.+++......       ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence            999999999999999999999999998764321       1347889999999999999999998   899999999999


Q ss_pred             eeecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCC
Q 041624          331 IMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS  409 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs  409 (459)
                      ||++.++.++|+|||+++.+....... .....++..|+|||....+.  ++.+.|+||+|+++++++++....|....+
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC--ccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999997654322111 12234467899999887654  577899999999999998744333333334


Q ss_pred             HHHHH
Q 041624          410 IRQAI  414 (459)
Q Consensus       410 ~~~v~  414 (459)
                      ..+++
T Consensus       239 ~~~~~  243 (296)
T cd05095         239 DEQVI  243 (296)
T ss_pred             hHHHH
Confidence            34443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-33  Score=269.27  Aligned_cols=219  Identities=26%  Similarity=0.418  Sum_probs=174.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc---EEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM---AVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +.|+..+.||+|+||.||+|.+..+++   .||+|.++... ....++|..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999999876554   69999987652 33456899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++.....   .+++.+++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999999875433   58999999999999999999998   999999999999999999999999999987664


Q ss_pred             CCCCCc--ccccc--ccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          352 HELGPR--TTGLA--GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       352 ~~~~~~--~~~~~--gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      ......  .....  .+..|+|||++..+.  ++.+.|+|++|++++++++ +..|+...  +..++.+.+......|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~~~~~~~  231 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIEQDYRLP  231 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCc--ccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCCcCC
Confidence            332211  11111  245799999987654  5778899999999999775 66555433  2344555544443333

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.7e-33  Score=270.38  Aligned_cols=220  Identities=23%  Similarity=0.328  Sum_probs=176.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      .+++|...+.||+|+||.||+|.+..     ++..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45778999999999999999999976     67899999886543 2334579999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEE
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKL  341 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL  341 (459)
                      .++||||+++++|.+++.....   ....+++..+++++.||+.||+|||+   ++++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999875432   12358999999999999999999998   8999999999999998764   5999


Q ss_pred             eecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          342 GDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      +|||+++.+....... ......+..|+|||++.++.  ++.+.|+|++|++++++++ +..|++...  ..++++.+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~~~~  236 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEFVTG  236 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc
Confidence            9999998763221111 11223356899999997654  5788999999999999885 777766543  2445555544


Q ss_pred             C
Q 041624          420 E  420 (459)
Q Consensus       420 ~  420 (459)
                      .
T Consensus       237 ~  237 (277)
T cd05036         237 G  237 (277)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.9e-33  Score=274.13  Aligned_cols=204  Identities=23%  Similarity=0.330  Sum_probs=170.8

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997542   23445667788888764 899999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            99998886543    58999999999999999999998   99999999999999999999999999998743221 122


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+...  +..++.+.+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~--~~~~~~~~~  208 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESI  208 (316)
T ss_pred             eeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHH
Confidence            34567999999999998654  577899999999999999999887644  334444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.5e-33  Score=280.03  Aligned_cols=192  Identities=26%  Similarity=0.298  Sum_probs=161.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-----
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-----  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----  266 (459)
                      ..++|+..+.||+|+||.||++.+..++..||+|++....  ......+.+|+.++..++|+||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4588999999999999999999999889999999997542  234567889999999999999999999986543     


Q ss_pred             -eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          267 -EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       267 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                       ..++||||+++ +|.+.+..      .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence             57999999975 56555532      47889999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +++.....  .......||..|+|||++.+..  ++...|+|++|+++++|+++
T Consensus       169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg  218 (359)
T cd07876         169 LARTACTN--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKG  218 (359)
T ss_pred             CccccccC--ccCCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhC
Confidence            99765332  2234467899999999997654  57789999999999887654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=276.25  Aligned_cols=202  Identities=27%  Similarity=0.388  Sum_probs=181.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +.|..-++||+||||.||-++...||+.+|.|++.+.   ..++....++|-.+|.+++.+.||.+-..|++.+.++|||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5578889999999999999999999999999998654   2344556789999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ..|.||+|.-+|.+..+  ..+++..++.++.+|+.||++||.   .+||.|||||+|||||+.|+++|+|.|+|..+..
T Consensus       265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999988765  369999999999999999999998   9999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .  ......+||.+|||||++.+++  ++...|.|++||++|+|+.+..|+-..
T Consensus       340 g--~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  340 G--KPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             C--CccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhh
Confidence            3  3445569999999999999887  577779999999999999999997643

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-33  Score=275.93  Aligned_cols=195  Identities=28%  Similarity=0.361  Sum_probs=166.8

Q ss_pred             ceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +.||+|+||.||++...   .+++.||+|.++...    ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   467899999987532    22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+.+..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            99999999886543    58888999999999999999998   99999999999999999999999999998754322 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ........||+.|+|||++.+..  .+.+.|+|++|+++++++++..|+...
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             CCcccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCC
Confidence            22234467999999999997653  567899999999999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=287.73  Aligned_cols=207  Identities=33%  Similarity=0.488  Sum_probs=187.7

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD  281 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  281 (459)
                      -+||+|.||+||.|++.++...+|||.+.....+..+-+..|+.+-++|+|+|||+++|.+.+++.+-+.||-+|||||.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999999999999999999998777777788999999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-CCCCEEEeecCCcccccCCCCCcc
Q 041624          282 FHLFSKKSTGTPL--TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLALLVDHELGPRT  358 (459)
Q Consensus       282 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~  358 (459)
                      ++|+..-+   +|  .+.+.-.+..||++||.|||+   ..|||||||-.|||++ -.|.+||+|||.++.+. .....+
T Consensus       661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~T  733 (1226)
T KOG4279|consen  661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCT  733 (1226)
T ss_pred             HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCccc
Confidence            99987654   56  778888899999999999998   9999999999999997 46899999999998875 335567


Q ss_pred             ccccccccccccceeccCccccCCCCCHHHHHHHHH-----------------------------------------HHH
Q 041624          359 TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMI-----------------------------------------VGL  397 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~-----------------------------------------~~l  397 (459)
                      .++.||..|||||++..|...++...|+||+||.+.                                         .++
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence            789999999999999999889999999999999553                                         456


Q ss_pred             hcCCCCCCCCCCHHHHHH
Q 041624          398 WCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       398 ~c~~p~p~~RPs~~~v~~  415 (459)
                      .|-.|+|.+||+++++++
T Consensus       814 rcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHcCCCcccCccHHHhcc
Confidence            699999999999999997

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.1e-33  Score=275.50  Aligned_cols=200  Identities=23%  Similarity=0.300  Sum_probs=171.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +|+..+.||+|+||.||+|....+++.||+|+++...   ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999999999999999997542   233456788999988885 577888999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999886543    58999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      . ........||+.|+|||++.++.  ++...|+|++|+++++++++..|+...
T Consensus       154 ~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         154 D-GVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             C-CccccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCC
Confidence            2 12234467899999999987653  577899999999999999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-33  Score=289.48  Aligned_cols=201  Identities=24%  Similarity=0.307  Sum_probs=164.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC--------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--------  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------  265 (459)
                      ..++|+..+.||+|+||.||+|....+++.||||++...    .....+|+.++++++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            456799999999999999999999988999999998543    22345799999999999999999886432        


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeec
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDF  344 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  344 (459)
                      ..+++||||+++ +|.+++.........+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 7777765433333469999999999999999999999   9999999999999999665 7999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      |+|+.+...  .......||+.|+|||++.+.. .++.+.|+||+|+++++|+++..|+..
T Consensus       216 Gla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        216 GSAKNLLAG--QRSVSYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             ccchhccCC--CCcccCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999876432  2233457899999999986543 367889999999999999887766544

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.5e-33  Score=267.62  Aligned_cols=215  Identities=22%  Similarity=0.306  Sum_probs=169.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCc--EEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------Ce
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNM--AVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------GE  267 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~  267 (459)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.++...  ....+.+.+|+.++.+++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999877664  69999886542  33456789999999999999999999987532      25


Q ss_pred             EEEEEEecCCCCcchhccccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          268 FMLVYEFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      .+++|||+++|+|.+++....  .....+++.....++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998875322  122358999999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          346 LALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       346 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      +++.+....... .....++..|+|||++....  ++.+.|+|++|++++++++ |..|++...  ..++.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQ  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCC--cChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc
Confidence            998764332111 12234567899999987653  5778899999999999987 676766542  3455554443

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.7e-33  Score=275.80  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=167.9

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++.++ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642   23345688999999998 799999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            99988886543    59999999999999999999998   99999999999999999999999999998743221 223


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             cccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcc
Confidence            34567999999999998654  5678999999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.1e-33  Score=271.77  Aligned_cols=194  Identities=29%  Similarity=0.391  Sum_probs=165.3

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-----chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-----GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +|+..+.||+|+||.||+|....+++.||+|+++.....     ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999999988999999999765322     234577899999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+ +++|.+++....   ..+++..+..++.||++||+|||+   ++|+|+||||+|||++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999986543   259999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ... .......++..|+|||.+.+.. .++...|+|++|+++++++++
T Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~e~~~g  199 (298)
T cd07841         154 SPN-RKMTHQVVTRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLR  199 (298)
T ss_pred             CCC-ccccccccceeeeCHHHHhCCC-CCCcHHHHHHHHHHHHHHHcC
Confidence            432 2223345678899999886433 357788999999999877654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-33  Score=276.01  Aligned_cols=193  Identities=26%  Similarity=0.351  Sum_probs=167.1

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|....+++.+|+|.+++..   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642   23345677899888877 899999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~  152 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  152 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence            99988876543    58999999999999999999998   99999999999999999999999999999754322 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .....||..|+|||++.+..  ++...|+|++|+++++++++..|+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             cccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCc
Confidence            34567999999999998654  5678999999999999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=269.09  Aligned_cols=203  Identities=26%  Similarity=0.384  Sum_probs=174.5

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      +|+..+.||+|+||.||++....+++.||+|++....   ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999998889999999996542   1223467889999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++.....  ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988865432  358999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                        .......|+..|+|||++.+..  ++...|+|++|+++++++++..|+.....
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         156 --ETIRGRVGTVGYMAPEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             --CccccccCCCCccCcHHhcCCC--CCccccchhHHHHHHHHHHCCCCCCCCch
Confidence              1223457899999999997553  56778999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.1e-33  Score=267.42  Aligned_cols=194  Identities=24%  Similarity=0.318  Sum_probs=169.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+++.+|++++.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999999889999999987552 33456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|..+.        .+++..+..++.|++.||.|||+   .+|+|+||||+|||++.++.++|+|||++..+... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999996542        47888999999999999999998   99999999999999999999999999999765432 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                        ......||..|+|||++.+..  ++...|+|++|+++++++++..|+..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             --cccCCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhCCCCchh
Confidence              233457899999999998654  57789999999999999999888754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.9e-33  Score=273.98  Aligned_cols=197  Identities=23%  Similarity=0.368  Sum_probs=162.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCc--EEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNM--AVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|.+..++.  .+|+|.++... .....++.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578888999999999999999877664  45788776432 33456788999999999 89999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          271 VYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ||||+++++|.+++.....            ....+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence            9999999999999875431            12358999999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +||+|||+++.....  .......++..|+|||++....  ++.+.|+|++|++++++++
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt  218 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS  218 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHh
Confidence            999999998643211  1112223467899999886543  5678999999999998874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.7e-33  Score=267.38  Aligned_cols=205  Identities=25%  Similarity=0.339  Sum_probs=166.5

Q ss_pred             ceeccCCceEEEEEEEcC--CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILID--LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||+|....  ++..+|+|.++.... .....+.+|+.++.+++|+||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653  456899999876532 33457889999999999999999999999999999999999999


Q ss_pred             CcchhccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-
Q 041624          279 SLDFHLFSKKS-TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-  356 (459)
Q Consensus       279 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  356 (459)
                      +|.+++..... ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975432 22346788888999999999999998   99999999999999999999999999999754332211 


Q ss_pred             ccccccccccccccceeccCcc-----ccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRA-----RLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPS  409 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~-----~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs  409 (459)
                      ......++..|+|||++.....     .++.+.|+|++|++++++++ +..|++...+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  216 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE  216 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence            1223457888999999864321     34678999999999999985 88888776543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=270.92  Aligned_cols=206  Identities=24%  Similarity=0.332  Sum_probs=178.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.++.......+.|.+|++++++++|+||+++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46788889999999999999999888999999999766555667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....   .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++...... 
T Consensus        84 ~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-  156 (280)
T cd06611          84 CDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-  156 (280)
T ss_pred             cCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence            999999999876443   69999999999999999999998   99999999999999999999999999998765432 


Q ss_pred             CCccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ........++..|+|||.+..+.   ..++...|+|++|+++++++++..|+....
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence            12233456899999999986332   235667899999999999999988876553

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-33  Score=272.49  Aligned_cols=206  Identities=24%  Similarity=0.362  Sum_probs=172.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999989999999997642   23345667788888764 999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCc
Confidence            99999886543    58999999999999999999998   99999999999999999999999999998753221 122


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .....||..|+|||++.+..  ++.+.|+|++|+++++++++..|+...  +..++.+.+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~i~~  210 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIRM  210 (316)
T ss_pred             eeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHh
Confidence            34567899999999987653  578899999999999999999887543  34555555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.2e-33  Score=269.57  Aligned_cols=206  Identities=23%  Similarity=0.354  Sum_probs=170.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|...++||+|+||.||++...     .++..+|+|.+........+.+.+|++++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999753     2467899999877666667789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          271 VYEFMPNGSLDFHLFSKKS-----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      +|||+++++|.+++.....           ....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999875431           11358999999999999999999998   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          340 KLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ||+|||+++......... .....+++.|+|||.+.+..  ++.+.|+|++|++++++++ +..|+...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            999999997654321111 12234567899999987654  5778899999999999987 55555443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.2e-33  Score=267.60  Aligned_cols=204  Identities=26%  Similarity=0.341  Sum_probs=163.7

Q ss_pred             ceeccCCceEEEEEEEcC--CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILID--LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.||+|+||.||+|....  ....+++|.+.... ......|.+|+.+++.++|+||+++++.+.+.+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997643  34578889876543 233567889999999999999999999999999999999999999


Q ss_pred             CcchhccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-
Q 041624          279 SLDFHLFSKKST-GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-  356 (459)
Q Consensus       279 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  356 (459)
                      +|.+++...... ....++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999765421 2235688889999999999999998   99999999999999999999999999998654322111 


Q ss_pred             ccccccccccccccceeccCc-----cccCCCCCHHHHHHHHHHHHh-cCCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGR-----ARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRP  408 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~-----~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RP  408 (459)
                      ......++..|+|||++....     ...+.+.|+|++|++++++++ +..|++..++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD  215 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence            122334567899999875421     235678899999999999998 7777776654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.1e-33  Score=270.79  Aligned_cols=203  Identities=25%  Similarity=0.334  Sum_probs=176.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++..++|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35788889999999999999999888999999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++...     .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999988532     48899999999999999999998   999999999999999999999999999987654322


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                       .......+++.|+|||.+.+..  .+.+.|+|++|+++++++++..|+...-|
T Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~  221 (296)
T cd06654         171 -SKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENP  221 (296)
T ss_pred             -cccCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence             1223456889999999987653  46789999999999999999988765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-33  Score=285.12  Aligned_cols=211  Identities=22%  Similarity=0.257  Sum_probs=181.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-c-----CCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-H-----RNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l  270 (459)
                      +|.+.+.||+|.||.|.+|.+..|++.||||+++.. ..-.++-..|+.+|..|+ |     -|+|++++++...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            889999999999999999999999999999999754 334566778999999996 4     489999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC--CEEEeecCCcc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF--NVKLGDFGLAL  348 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kL~DFGla~  348 (459)
                      |+|.+. .+|.++|..+.-.  .++...++.|+.||+.||.+||+   .+|||+||||+||||..-.  .+||+|||.|+
T Consensus       266 VfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999994 5999999876543  59999999999999999999998   9999999999999997543  69999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      .....    ....+-+..|+|||++.+..  ++.++|+||+||++.+|++++..+|.+- -++|+..+.+-..
T Consensus       340 ~~~q~----vytYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~n-e~DQl~~I~e~lG  405 (586)
T KOG0667|consen  340 FESQR----VYTYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDN-EYDQLARIIEVLG  405 (586)
T ss_pred             ccCCc----ceeeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCC-HHHHHHHHHHHhC
Confidence            76543    22566788999999999774  6899999999999999999999999885 4556555555433

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-33  Score=263.98  Aligned_cols=208  Identities=24%  Similarity=0.357  Sum_probs=172.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|...  ++.||+|.++.... ..+++.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357888899999999999999876  68899999976543 567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.++......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            999999999875442  258999999999999999999998   999999999999999999999999999998663321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                          .....+..|+|||++..+.  .+...|+|++|++++++++ +..|+...  +..++.+.+.
T Consensus       157 ----~~~~~~~~~~ape~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~  213 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVE  213 (256)
T ss_pred             ----ccCCCcccccCchhhcCCc--CCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHh
Confidence                1234467899999987654  4677899999999998875 54444322  3344444443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-33  Score=276.00  Aligned_cols=222  Identities=24%  Similarity=0.365  Sum_probs=182.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC-------CcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      ..+|.+.+.||+|+||.||+|.....       +..||+|.++... ....+++.+|+.++.++ +|+||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            34688899999999999999986431       2478999887543 23456899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      +..+++|||+++|+|.+++.....            ....+++.++..++.|++.||.|||+   ++++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence            999999999999999999875421            12358899999999999999999998   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------
Q 041624          334 DTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------  398 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------  398 (459)
                      +.++.+||+|||+++........ ......++..|+|||.+....  ++.+.|+|++|++++++++              
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999866432211 122233456899999987654  5677899999999987764              


Q ss_pred             --------------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 --------------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 --------------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                                |++++|.+||++.++++.|+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                                      77779999999999999997543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.2e-33  Score=270.16  Aligned_cols=204  Identities=23%  Similarity=0.313  Sum_probs=165.9

Q ss_pred             CCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +|+..+.||+|+||.||+|+...     ....+++|.+..... ...+++.+|+.++..++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998753     235789998875432 335678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          271 VYEFMPNGSLDFHLFSKKS--------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      ++||+++++|.+++.....                    ....+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            9999999999998864221                    12358899999999999999999998   999999999999


Q ss_pred             eeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          331 IMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..  .+...|+|++|++++++++ +..|++.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999999765432221 122334567899999886553  5678899999999998886 5555443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.5e-33  Score=264.48  Aligned_cols=206  Identities=23%  Similarity=0.359  Sum_probs=163.7

Q ss_pred             eeccCCceEEEEEEEc--CCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          203 KLGQGGFGAVYRGILI--DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      .||+|+||.||+|.+.  +.+..||+|.+..... ...+++.+|+.++++++|+||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999875  3456799999876533 335679999999999999999999998864 57899999999999


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc--
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR--  357 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--  357 (459)
                      |.+++.....   .+++..+++++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.........  
T Consensus        81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999875443   68999999999999999999998   899999999999999999999999999998654332211  


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .....++..|+|||++..+.  ++.+.|+|++|++++++++ +..|+...  +..++...+..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~  213 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQ  213 (257)
T ss_pred             cCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHC
Confidence            12223357899999987554  5678899999999999885 55555433  23344444433

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=279.68  Aligned_cols=216  Identities=28%  Similarity=0.420  Sum_probs=188.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC----CcEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL----NMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      ........++||.|-||.||+|++.+.    .-.||||..+.+ .....+.|+.|..+|++++||||++|+|.|.+. ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            334445668999999999999998642    357999998875 445678899999999999999999999999765 78


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      +||||+++-|.|..+|..++.   .|+......++.||+.||.|||+   ++.|||||..+|||+.+..-+||+|||++|
T Consensus       466 WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence            999999999999999987766   69999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      .++++.....+...-...|||||.+.-.+  ++.++|+|-+|+++++++.                              
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC  617 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC  617 (974)
T ss_pred             hccccchhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence            99876655555555577999999997654  6889999999999988775                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                ||..+|.+||.+.++...|.
T Consensus       618 Pp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                      99999999999999888765

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-33  Score=277.83  Aligned_cols=207  Identities=27%  Similarity=0.355  Sum_probs=166.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC-C
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR-G  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~  266 (459)
                      .++|+..+.||+|+||.||+|.+.     .+++.||||+++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            467899999999999999999853     3468999999976432 3345788999999999 689999999988654 5


Q ss_pred             eEEEEEEecCCCCcchhccccCCC--------------------------------------------------------
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKST--------------------------------------------------------  290 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  290 (459)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            679999999999999988643210                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-cccccc
Q 041624          291 -------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLA  362 (459)
Q Consensus       291 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~  362 (459)
                             ...+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   1247888999999999999999998   99999999999999999999999999999765332111 122234


Q ss_pred             ccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          363 GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       363 gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ++..|+|||.+.+..  ++.+.|+|++|++++++++ |..|++..
T Consensus       243 ~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         243 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCcceECcHHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            567899999987653  5778899999999999885 66666554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.6e-33  Score=264.63  Aligned_cols=202  Identities=25%  Similarity=0.361  Sum_probs=167.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|...+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4678889999999999999998764 569999886542 34567899999999999999999999875 45689999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....  ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++.......
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999975432  358999999999999999999998   8999999999999999999999999999987643322


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      .......++..|+|||....+.  .+...|+|++|++++++++ |..|++...
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             cccCCCccchhhCCHHHhccCC--cChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            2222344677899999887554  5678899999999999998 777776543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-33  Score=263.03  Aligned_cols=211  Identities=27%  Similarity=0.432  Sum_probs=178.1

Q ss_pred             ceeccCCceEEEEEEEcCC---CcEEEEEEeccCCccc-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.....   +..+++|.++...... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999865   8899999997654433 67899999999999999999999999999999999999999


Q ss_pred             CCcchhccccCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          278 GSLDFHLFSKKST-----GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       278 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ++|.+++......     ...+++.+++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999775211     2469999999999999999999998   9999999999999999999999999999987754


Q ss_pred             CCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc-CCCCCCCCCCHHHHHHHHhc
Q 041624          353 ELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC-AHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       353 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c-~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ... .......++..|+|||.+...  .++.+.|+|++|+++++++++ ..|+...  +..++.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRK  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHc
Confidence            321 123345678899999998765  467788999999999999884 6666655  55666666654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.3e-33  Score=269.28  Aligned_cols=196  Identities=24%  Similarity=0.380  Sum_probs=163.7

Q ss_pred             cCCCCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      +.|+..+.||+|+||.||++.+    ..++..||+|.++... ....+.+.+|+.++++++|+||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999985    3457899999987553 33456789999999999999999999998775  568


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++.....   .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            999999999999999865432   58999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          349 LVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       349 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      .+......  ......++..|+|||++.++.  ++.+.|+|++|+++++++++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~ellt~  208 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSK--FYIASDVWSFGVTLYELLTY  208 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCC--CCccccchhhhhhhhhhhcC
Confidence            76533221  122345677899999987653  56788999999999887653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-33  Score=268.11  Aligned_cols=200  Identities=34%  Similarity=0.480  Sum_probs=170.8

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccch--HHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      |+..+.||+|+||.||++....+++.+|+|.+........  ....+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999999999999999987643322  23456999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++....    .+++..++.++.||+.||.+||+   .+|+|+||||+||++++++.++|+|||.+.... ...
T Consensus        81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             ccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccc
Confidence            9999999997333    58999999999999999999999   999999999999999999999999999997642 223


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .......++..|+|||++..+. ..+...|+|++|++++.|+++..|+...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGK-KYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTS-SBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccc-cccccccccccccccccccccccccccc
Confidence            3455677899999999987222 3678889999999999999866665544

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-33  Score=271.37  Aligned_cols=196  Identities=23%  Similarity=0.369  Sum_probs=161.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc--EEEEEEeccC-CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM--AVAVKKISRG-LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|+..+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999999877654  4788888643 233456789999999999 799999999999999999999


Q ss_pred             EEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          272 YEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      |||+++++|.+++.....            ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            999999999999865321            11358899999999999999999998   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ||+|||++......  ........+..|+|||++....  ++.+.|+||+|++++++++
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t  213 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVS  213 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHc
Confidence            99999998643221  1111223356799999887553  5678899999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.6e-33  Score=269.97  Aligned_cols=218  Identities=25%  Similarity=0.266  Sum_probs=182.3

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEe
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCH  263 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  263 (459)
                      .+++.++..++++|...+.||+|+||.||++....+++.+|+|.+... .....++.+|+.++.++ +|+|++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            356677888899999999999999999999999988999999998653 22345678899999999 8999999999987


Q ss_pred             eC-----CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          264 DR-----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       264 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ..     +..++||||+++++|.+++.........+++..++.++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence            54     35899999999999999886533333468999999999999999999998   89999999999999999999


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccCcc---ccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA---RLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      +||+|||+++...... .......|+..|+|||.+..+..   ..+.+.|+|++|+++++++++..|+....
T Consensus       167 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         167 VKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             EEEeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            9999999987654321 12234568899999999865431   24678999999999999999988877554

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.5e-33  Score=298.77  Aligned_cols=202  Identities=24%  Similarity=0.300  Sum_probs=169.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.++||+|+||.||+|.+..+++.||+|+++....   ...++|.+|++++.+++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            578899999999999999999999999999999975432   23567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          273 EFMPNGSLDFHLFSKKS-------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ||+++|+|.+++.....       ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211       12346778889999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCC-----------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          346 LALLVDHELG-----------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       346 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      +++.......                 .......||+.|+|||++.+..  .+.+.|+||+|+++++|+++..|
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCCCC
Confidence            9987621110                 0112356999999999987654  57788999999999998875443

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.8e-33  Score=273.62  Aligned_cols=195  Identities=26%  Similarity=0.303  Sum_probs=164.3

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHH-HHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ++||+|+||.||+|++..+++.||+|++.+..   .....++..|.. ++..++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999986532   222345555654 57788999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET  152 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence            99988876443    58889999999999999999998   99999999999999999999999999998753222 122


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             cccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCC
Confidence            34567899999999987653  577899999999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=286.43  Aligned_cols=209  Identities=32%  Similarity=0.371  Sum_probs=180.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc---hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      -|...+.||.|+||.||-|++..+...||||+++-..++.   ..++++|++.|.+++|||++.+-|+|......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4566788999999999999999999999999997654443   4578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      || -||-.+++.-++.   +|.+.++..|+.+.+.||+|||+   .+.||||||+.||||++.|.+||+|||.|.+... 
T Consensus       107 YC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            99 5688888876665   79999999999999999999999   9999999999999999999999999999976543 


Q ss_pred             CCCccccccccccccccceecc-CccccCCCCCHHHHHHHHHHHH-----------------------------------
Q 041624          354 LGPRTTGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGL-----------------------------------  397 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l-----------------------------------  397 (459)
                          ...++||+.|||||++.. ....|+.++|+||+|+...++.                                   
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F  254 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF  254 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence                456899999999998752 2235789999999998654332                                   


Q ss_pred             -----hcCCCCCCCCCCHHHHHHHH
Q 041624          398 -----WCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       398 -----~c~~p~p~~RPs~~~v~~~L  417 (459)
                           .|++.-|.+|||..++++.-
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhhcc
Confidence                 39999999999998887653

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.5e-33  Score=271.43  Aligned_cols=206  Identities=26%  Similarity=0.342  Sum_probs=170.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      ..++|...+.||+|+||.||++...     .++..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467889999999999999999852     345689999987553 23346789999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++|+|.+++.....  ..+++.++..++.|++.||+|||+   ++|+|+||||+|||++.++.++|+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999865432  248999999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          347 ALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       347 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ++.+...... ......++..|+|||.+..+.  ++...|+|++|++++++++ +..|++..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            9866433211 122234577899999987654  5678899999999999987 66665543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.3e-33  Score=264.68  Aligned_cols=212  Identities=23%  Similarity=0.296  Sum_probs=179.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +|+..+.||+|+||.||++....+++.+|+|.++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477889999999999999999989999999998643 2344567889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....  ..+++...+.++.|++.||.|||+   ++|+|+||||+||++++++.++|+|||+++..... .
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~  154 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-G  154 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc-c
Confidence            99999998865332  358899999999999999999998   99999999999999999999999999999766533 2


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .......|+..|+|||++.+..  .+...|+|++|++++.++++..|+...  +..+.+..+.
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~  213 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVC  213 (255)
T ss_pred             cccccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCC--CHHHHHHHHh
Confidence            2233456889999999987553  577889999999999999999887654  3344444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-33  Score=278.31  Aligned_cols=197  Identities=26%  Similarity=0.362  Sum_probs=165.6

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeC-----
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----  265 (459)
                      ...++|...+.||+|+||.||+|....+++.||+|++.....  ...+.+.+|+.++++++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            356789999999999999999999998899999999875422  2345678999999999999999999987543     


Q ss_pred             -CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          266 -GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       266 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                       ...++++|++ +++|.+++...     .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence             4578999988 77998777432     58999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      |+++.....    .....||..|+|||++.+.. .++.+.|+|++|+++++++++..|+
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf  216 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGKALF  216 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCc-cCCchhhhHhHHHHHHHHHHCCCCC
Confidence            999865432    33457899999999987533 3677899999999999887654443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.4e-33  Score=263.85  Aligned_cols=214  Identities=24%  Similarity=0.378  Sum_probs=176.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .+.|+..++||+|+||.||+|...+ ++.||+|.+.... ...+++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4678889999999999999999765 7889999987543 34568999999999999999999999874 4578999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999998865432  368999999999999999999998   999999999999999999999999999998765332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      ........++..|+|||++..+.  ++...|+|++|++++++++ +..|++..  +..++++.+...
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~  219 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGM--TNPEVIQNLERG  219 (260)
T ss_pred             cccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcC
Confidence            22223345677899999987654  5678899999999999998 77777654  345556665544

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=271.79  Aligned_cols=223  Identities=27%  Similarity=0.369  Sum_probs=175.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc--CcCCceeEEEEEeeCC----eE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL--RHRNLLQLIGLCHDRG----EF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~~----~~  268 (459)
                      .+.....+.||+|.||.||+|.+.  |+.||||++..   .+.+.+.+|.++.+.+  +|+||+.+++.-..++    ++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            456778899999999999999998  68999999963   4566788888888775  9999999998865443    68


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE-----WKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      +||++|.+.|||.++|...     .++....++++..+|.||+|||.+     .+..|.|||||+.|||+.+++.+.|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            9999999999999999763     599999999999999999999974     367899999999999999999999999


Q ss_pred             cCCcccccCCCCC---ccccccccccccccceeccCcc----ccCCCCCHHHHHHHHHHHHh-c---------CCCCC--
Q 041624          344 FGLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRA----RLDVNFDEQQTDCLMIVGLW-C---------AHPDR--  404 (459)
Q Consensus       344 FGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~----~~~~~~D~~~~g~ll~~~l~-c---------~~p~p--  404 (459)
                      +|||-..+.....   ..+..+||.+|||||++...-.    .--..+|+|++|.+++++.. |         ..|+-  
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            9999766544222   2456789999999999864321    11124699999999998765 2         22221  


Q ss_pred             -CCCCCHHHHHHHHhcCCCCCCCC
Q 041624          405 -NCRPSIRQAIQVLNFETKMPNLP  427 (459)
Q Consensus       405 -~~RPs~~~v~~~L~~~~~~p~~p  427 (459)
                       ..-|++.|..+..--..--|.+|
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ip  463 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIP  463 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCC
Confidence             23467777666665555445544

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.5e-33  Score=273.02  Aligned_cols=219  Identities=22%  Similarity=0.338  Sum_probs=174.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-------LNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      .++|.+.+.||+|+||.||++....       ....+|+|.++... .....++..|+.++.++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678999999999999999998643       23579999997642 33456788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      +..++||||+++|+|.+++..+..            ....+++.++++++.|++.||+|||+   .+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            999999999999999999976432            12358999999999999999999998   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHH
Q 041624          334 DTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIR  411 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~  411 (459)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..  ++...|+|++|++++++++ +..|++..  ...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC--CCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHH
Confidence            99999999999999765432111 122223457899999987653  5678899999999999987 55555433  235


Q ss_pred             HHHHHHhcC
Q 041624          412 QAIQVLNFE  420 (459)
Q Consensus       412 ~v~~~L~~~  420 (459)
                      ++.+.+...
T Consensus       250 ~~~~~~~~~  258 (307)
T cd05098         250 ELFKLLKEG  258 (307)
T ss_pred             HHHHHHHcC
Confidence            555555443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.2e-33  Score=268.01  Aligned_cols=202  Identities=25%  Similarity=0.299  Sum_probs=170.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|++|.||+|+...++..||+|+++...  ....+.+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999999889999999986542  22346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      ++ ++|.+++..... ...+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 688888764332 2368999999999999999999998   999999999999999999999999999997654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                       .......++..|+|||.+.+.. .++.+.|+|++|+++++++++..|+..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             -ccccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             1123345688999999886543 356778999999999999998777654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.9e-33  Score=264.02  Aligned_cols=218  Identities=24%  Similarity=0.350  Sum_probs=174.4

Q ss_pred             eeccCCceEEEEEEE--cCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          203 KLGQGGFGAVYRGIL--IDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      .||+|+||.||+|.+  ..++..+|+|+++....  ...+++.+|+.++.+++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975  34578999999865432  23567899999999999999999999885 45679999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc-
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-  357 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-  357 (459)
                      +|.+++....    .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999986543    58999999999999999999998   999999999999999999999999999998765432211 


Q ss_pred             -cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 041624          358 -TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVA  433 (459)
Q Consensus       358 -~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~~  433 (459)
                       .....++..|+|||.+..+.  ++...|+|++|++++++++ +..|+...  +..++.++++.... ++.|...|..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~  226 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGER-MECPQRCPPE  226 (257)
T ss_pred             ecCCCCCCccccCHhHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCC-CCCCCCCCHH
Confidence             12233457899999887543  5678899999999999997 77777654  34567777765433 4455555543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.1e-33  Score=266.37  Aligned_cols=205  Identities=22%  Similarity=0.299  Sum_probs=169.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ++|+..+.||+|+||.||+|+.+.     ..+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578889999999999999999754     3467999988654333 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTG-----TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      +||||+++|+|.+++.......     ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654211     258999999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      |+++..............++..|+|||.+.++.  .....|+|++|++++++++ +..|+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            998754332222233445677899999987654  4577899999999998886 5555543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6e-33  Score=269.37  Aligned_cols=218  Identities=25%  Similarity=0.344  Sum_probs=174.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|+..+.||+|+||.||+|....     ++..||+|.+..... ...+++.+|+.++.+++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4678899999999999999998753     578999999875532 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKS------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      ++||||+++|+|.+++.....                  ....+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            999999999999999864321                  11357899999999999999999998   999999999999


Q ss_pred             eeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCC
Q 041624          331 IMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRP  408 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RP  408 (459)
                      ||++.++.++|+|||+++.+...... .......+..|+|||.+.++.  ++.+.|+|++|++++++++ +..|+...  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~~~~p~~~~--  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPYYGM--  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence            99999999999999998765432111 122233467899999887654  5778899999999999886 55555432  


Q ss_pred             CHHHHHHHHhc
Q 041624          409 SIRQAIQVLNF  419 (459)
Q Consensus       409 s~~~v~~~L~~  419 (459)
                      +..++++.+..
T Consensus       237 ~~~~~~~~~~~  247 (288)
T cd05050         237 AHEEVIYYVRD  247 (288)
T ss_pred             CHHHHHHHHhc
Confidence            33455555543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.2e-33  Score=273.29  Aligned_cols=194  Identities=25%  Similarity=0.314  Sum_probs=164.4

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHH-HHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|++....   .....++..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999997542   222345555555 56778999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT  152 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence            99998886543    58999999999999999999998   99999999999999999999999999998754322 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             cccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCC
Confidence            34567999999999987653  57789999999999999998888754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-32  Score=273.18  Aligned_cols=193  Identities=25%  Similarity=0.337  Sum_probs=167.8

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|....+++.||+|+++...   ....+.+..|+.++.++ +|+||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999989999999997642   23345688999999888 699999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            99988886543    59999999999999999999999   99999999999999999999999999998753221 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             eecccCCcccCCHHHHCCCC--CCchheeehhHHHHHHHHhCCCCCC
Confidence            34567999999999997654  5778999999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.9e-33  Score=271.87  Aligned_cols=222  Identities=24%  Similarity=0.380  Sum_probs=179.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcC-------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILID-------LNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++|.+.+.||+|+||.||+|....       ....+|+|.++... .....++.+|+.++.++ +|+||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34677888999999999999998632       24579999987543 23456788999999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      .+..++||||+++|+|.+++.....            ....+++.++..++.||+.||.|||+   ++++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence            9999999999999999999976431            12358999999999999999999998   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------  398 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------  398 (459)
                      ++.++.+||+|||+++........ ......++..|+|||.+.++.  ++.+.|+|++|++++++++             
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC--cCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999866432111 112223456799999987653  5778899999999987764             


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ---------------------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ---------------------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                                 |+.++|++||++.++++.|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                                       6667788888888888777643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-32  Score=266.62  Aligned_cols=201  Identities=24%  Similarity=0.322  Sum_probs=174.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999998889999999997653  23356799999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      + +++|.+++.....   .+++.+++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 9999999865443   69999999999999999999998   999999999999999999999999999998765443


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ........++..|+|||.+.+.. .++.+.|+|++|+++++++++..+++.
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             CCccccccCcccccCceeeeccc-cCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            22234457899999999987543 357789999999999999999655544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.8e-33  Score=267.62  Aligned_cols=200  Identities=25%  Similarity=0.325  Sum_probs=164.9

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhcc---CcCCceeEEEEEee-----CC
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQL---RHRNLLQLIGLCHD-----RG  266 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~  266 (459)
                      +|+..+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++.++   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999999999999999999875422  2234566777777665   79999999998864     34


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++ +|.+++.....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            57999999974 88888765432  258999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ++.....  .......||..|+|||++.+..  ++.+.|+|++|+++++++++..++...
T Consensus       155 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         155 ARIYSCQ--MALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cccccCc--ccCCCccccccccCchHhhCCC--CCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            9876432  2223456899999999997653  578899999999999999888777544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.7e-33  Score=262.86  Aligned_cols=212  Identities=26%  Similarity=0.436  Sum_probs=173.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|.++... ....+|.+|++++.+++|+|++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467778999999999999998865 6789999986542 33567899999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....   .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            99999999875443   58999999999999999999998   8999999999999999999999999999976543322


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .......++..|+|||.+.++.  ++...|+|++|++++++++ +..|+..  ....++++.+..
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~  216 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYEN--RSNSEVVETINA  216 (256)
T ss_pred             cccCCCccchhhcCHhHhccCC--cChHHHHHHHHHHHHHHHcCCCCCCCc--CCHHHHHHHHhC
Confidence            2222334567899999987654  5677899999999999887 5555432  233555555543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-32  Score=264.14  Aligned_cols=199  Identities=21%  Similarity=0.294  Sum_probs=159.2

Q ss_pred             eeccCCceEEEEEEEcCC--CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          203 KLGQGGFGAVYRGILIDL--NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      .||+|+||.||+|.....  ...+++|.++... ....+.|.+|+.++..++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999976432  3456777776543 2346789999999999999999999999999999999999999999


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC-CCcc
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL-GPRT  358 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~  358 (459)
                      |.+++.........+++.....++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997654333357778888999999999999998   999999999999999999999999999986432211 1122


Q ss_pred             ccccccccccccceeccCc-----cccCCCCCHHHHHHHHHHHHhcCC-CCC
Q 041624          359 TGLAGTLGYMAPEYISTGR-----ARLDVNFDEQQTDCLMIVGLWCAH-PDR  404 (459)
Q Consensus       359 ~~~~gt~~y~APE~~~~~~-----~~~~~~~D~~~~g~ll~~~l~c~~-p~p  404 (459)
                      ....++..|+|||++....     ...+.+.|+|++|+++++++++.. |+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            3456788999999885321     124567899999999999997644 443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=282.10  Aligned_cols=222  Identities=24%  Similarity=0.394  Sum_probs=192.9

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      ++++.-..+....++||-|-||.||.|.|+.-...||||.++.+ .-..++|++|..+|+.++|||+|+|+|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            34444445666778999999999999999988899999999765 34578999999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      |||+|||..|+|.++|+.....  .++.-..+.++.||++|+.||..   +++|||||.++|+|+.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999875442  57778889999999999999997   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH-------------------------------
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL-------------------------------  397 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l-------------------------------  397 (459)
                      ++..+.........-.+.|.|||-+....  +..+.|+|++|++++++.                               
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNt--FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC  491 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNT--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC  491 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccc--cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC
Confidence            99866544444555578999999998664  567889999999887644                               


Q ss_pred             ---------hcCCCCCCCCCCHHHHHHHHh
Q 041624          398 ---------WCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       398 ---------~c~~p~p~~RPs~~~v~~~L~  418 (459)
                               .||+..|.+||++.++-+.++
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence                     499999999999999988775

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-33  Score=263.60  Aligned_cols=214  Identities=27%  Similarity=0.422  Sum_probs=177.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|.+.+.||+|+||.||+|...+ ++.+|+|.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            45688899999999999999999875 5789999987543 345789999999999999999999999999899999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++.....  ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++.+...
T Consensus        82 ~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999976432  368999999999999999999998   89999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .........++..|+|||.+.++.  ++...|+|++|++++++++ +..|+....  ..+.++.+.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~  218 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQVE  218 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence            211222333457899999987553  5678899999999999997 787776543  234444443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=261.56  Aligned_cols=207  Identities=26%  Similarity=0.407  Sum_probs=166.5

Q ss_pred             ceeccCCceEEEEEEEcCCC---cEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ++||+|+||.||+|.+..++   ..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999876544   7899999976543 34567999999999999999999999876 4568999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++..++.++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997654    58999999999999999999998   899999999999999999999999999998765432221


Q ss_pred             c--ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          358 T--TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       358 ~--~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      .  ....++..|+|||.+....  ++...|+|++|++++++++ +..|+...  +-.++.+.+...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~  214 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESG  214 (257)
T ss_pred             ccccCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcC
Confidence            1  1222356899999987654  5778999999999999986 55554433  224444444433

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-32  Score=268.87  Aligned_cols=200  Identities=26%  Similarity=0.332  Sum_probs=174.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788999999999999999999888999999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++...     .+++.++..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999988542     48899999999999999999998   999999999999999999999999999987654332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                       .......+++.|+|||.+.+..  .+...|+|++|++++.++++..|+..
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         170 -SKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             -cCcCcccCCccccCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             1223456888999999987654  46788999999999999987777543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-32  Score=265.92  Aligned_cols=203  Identities=23%  Similarity=0.285  Sum_probs=173.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++.+++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999999889999999986542  2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|..++....    .+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999998887765432    58999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .. ......++..|+|||.+.+.. .++.+.|+|++|+++++++++..|++..-
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCC-CcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            21 223345788999999986533 35678999999999999999998887543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-32  Score=262.75  Aligned_cols=223  Identities=25%  Similarity=0.413  Sum_probs=181.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---------chHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      +|.....||+|++|.||+|....+++.+|+|.+......         ..+.+.+|+.++.+++|+||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467788999999999999999888999999988654322         12468899999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999996543    58899999999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCCCC-----ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          348 LLVDHELGP-----RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       348 ~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                      +........     ......|+..|+|||.+.++.  ++...|+|++|+++++++++..|+.... ....+.+...  ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~  228 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGKHPFPDCT-QLQAIFKIGE--NA  228 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCC--CCchhhhHHHHHHHHHHhhCCCCCCCcc-HHHHHHHHhc--cC
Confidence            876532111     112345788999999987654  4677899999999999999999887542 3344444333  23


Q ss_pred             CCCCCCCCC
Q 041624          423 MPNLPSKMP  431 (459)
Q Consensus       423 ~p~~p~~~p  431 (459)
                      .|.+|...|
T Consensus       229 ~~~~~~~~~  237 (267)
T cd06628         229 SPEIPSNIS  237 (267)
T ss_pred             CCcCCcccC
Confidence            344455544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-32  Score=264.77  Aligned_cols=202  Identities=29%  Similarity=0.401  Sum_probs=166.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|...+.||+|+||.||+|.+.+.   ...||+|...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577889999999999999987653   3579999887654 3456689999999999999999999999875 457899


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.....   .+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999965433   58999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ...........++..|+|||.+....  ++...|+|++|++++++++ +..|+...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~  212 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGV  212 (270)
T ss_pred             cccceecCCCCccccccChhhhccCC--CCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            43222222334456899999886543  5778999999999999885 66666443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.6e-33  Score=278.05  Aligned_cols=192  Identities=26%  Similarity=0.308  Sum_probs=161.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----  265 (459)
                      ...++|+..+.||+|+||.||++....+++.||+|++....  ....+.+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35678999999999999999999999889999999997542  23346788999999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          266 -GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       266 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                       ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence             357999999965 66665532      48889999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+++.....  .......||..|+|||++.+..  ++.+.|+|++|+++++|++
T Consensus       164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~  213 (355)
T cd07874         164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVR  213 (355)
T ss_pred             cccccCCCc--cccCCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHh
Confidence            999865432  2234467899999999997653  5778999999999887654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-32  Score=267.69  Aligned_cols=202  Identities=26%  Similarity=0.356  Sum_probs=175.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .+|+..+.||.|++|.||+|....+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999998889999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|..++...     .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... 
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-  169 (296)
T cd06655          99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-  169 (296)
T ss_pred             CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence            999999988532     48999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      .......++..|+|||.+.+..  ++...|+|++|++++.++++..|+....+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~~lltg~~pf~~~~~  220 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            1223456889999999987654  56788999999999999998877755443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-32  Score=261.88  Aligned_cols=220  Identities=26%  Similarity=0.333  Sum_probs=176.1

Q ss_pred             ceeccCCceEEEEEEEcC-CC--cEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILID-LN--MAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|++|.||+|.+.. .+  ..||+|.++.... ...+.+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 23  3699999987655 566789999999999999999999999988 889999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||+++.+.......
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976542  368999999999999999999998   999999999999999999999999999998775432221


Q ss_pred             --cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          358 --TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       358 --~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                        .....++..|+|||++.+..  ++...|+|++|+++++|++ +..|+...  +..++++.+......+..|...|
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~  227 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLERPEACP  227 (257)
T ss_pred             ecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCcCCCCccCC
Confidence              12345678999999987654  5677899999999999987 77666444  33445554443333333344444

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=262.55  Aligned_cols=207  Identities=26%  Similarity=0.333  Sum_probs=179.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|....+++.+++|.+........+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            36788899999999999999999888899999999876555678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....   .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999998876532   58999999999999999999998   999999999999999999999999999997665321


Q ss_pred             CCccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                       .......++..|+|||.+.... ...+..+|+|++|+++++|+++..|+....+
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~  209 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP  209 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence             1223456888999999987541 1356778999999999999999988876553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-32  Score=266.26  Aligned_cols=200  Identities=24%  Similarity=0.327  Sum_probs=164.8

Q ss_pred             CC-CCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          197 NF-SNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       197 ~f-~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      +| +..+.||+|+||.||++..    ..++..||+|.++.... .....|.+|++++++++|+||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7889999999999988653    34578999999876532 3456788999999999999999999988653  468


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++...     .+++.+++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccc
Confidence            9999999999999998543     48999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          349 LVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       349 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .........  .....++..|+|||.+..+.  ++.+.|+|++|+++++++++..|+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENK--FSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccC--CCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            765432111  12234566799999987653  577889999999999999887765443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=279.61  Aligned_cols=214  Identities=22%  Similarity=0.301  Sum_probs=189.6

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .-.+.|.+...||+|.|+.|..|++..++..||||.+.+..-.  ....+.+|+++|..|+|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            3457899999999999999999999999999999999876432  33558899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+.+|.+.++|..+..    +.+..+..++.|+.+|++|||+   ++|+|||||++||||+.+.++||+|||++..+
T Consensus       133 V~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence            9999999999999987764    6668899999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC------------------------------
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA------------------------------  400 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~------------------------------  400 (459)
                      ..  .......+|++.|.|||++.+.+ ...+++|+|++|.++|.++.+.                              
T Consensus       206 ~~--~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dc  282 (596)
T KOG0586|consen  206 DY--GLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDC  282 (596)
T ss_pred             cc--cccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechh
Confidence            74  34566789999999999999776 4788999999999998776533                              


Q ss_pred             --------CCCCCCCCCHHHHHHH
Q 041624          401 --------HPDRNCRPSIRQAIQV  416 (459)
Q Consensus       401 --------~p~p~~RPs~~~v~~~  416 (459)
                              -++|.+|++++++++.
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhh
Confidence                    3588888888888764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-32  Score=272.14  Aligned_cols=195  Identities=25%  Similarity=0.300  Sum_probs=163.7

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHH-HHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|.. ++..++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999889999999987532   122334445544 56778999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~  152 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT  152 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence            99999886543    47888899999999999999998   99999999999999999999999999999754322 222


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .....||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             cccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCC
Confidence            34567999999999998653  577889999999999999988887643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-32  Score=260.47  Aligned_cols=225  Identities=26%  Similarity=0.428  Sum_probs=180.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCC----cEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      |++.+.||+|+||.||++.....+    ..||+|.++..... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999999998766    89999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++......  .+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999998764431  28999999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      ..........++..|+|||.+.+..  .+.+.|+|++|++++++++ +..|+..  .+..++.+.+..... ++.|...|
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~-~~~~~~~~  230 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGK--FTSKSDVWSFGVLLWEIFTLGESPYPG--MSNEEVLEYLKKGYR-LPKPENCP  230 (258)
T ss_pred             ccccccccCCCcccccChHHhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCC-CCCCCcCC
Confidence            4222222233678999999986543  5778899999999999987 5555443  344555655554433 23344444


Q ss_pred             c
Q 041624          432 V  432 (459)
Q Consensus       432 ~  432 (459)
                      .
T Consensus       231 ~  231 (258)
T smart00219      231 P  231 (258)
T ss_pred             H
Confidence            3

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-32  Score=262.90  Aligned_cols=196  Identities=30%  Similarity=0.420  Sum_probs=158.5

Q ss_pred             ceeccCCceEEEEEEEcC---CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEe-eCCeEEEEEEecC
Q 041624          202 RKLGQGGFGAVYRGILID---LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCH-DRGEFMLVYEFMP  276 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~  276 (459)
                      +.||+|+||.||+|.+.+   ....+|+|++.... ....+.+.+|+.+++.++|+||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   24679999986432 334568889999999999999999999876 4556899999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +|+|.+++.....   .+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.+......
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999875433   47788889999999999999998   89999999999999999999999999999765432111


Q ss_pred             ---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          357 ---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       357 ---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                         ......++..|+|||.+....  ++.+.|+|++|++++++++ +..|++.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             eecccccCcCCccccChhHhccCc--cchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence               112334577899999987653  5678899999999999887 3444443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-32  Score=262.24  Aligned_cols=203  Identities=25%  Similarity=0.313  Sum_probs=177.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|....+++.+++|.++....  .+++.+|++++++++|+||+++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678889999999999999999998889999999865432  67899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            999999999865443   68999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                       .......++..|+|||++.+.  .++.+.|+|++|++++.++++..|+....+
T Consensus       154 -~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~  204 (256)
T cd06612         154 -AKRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHP  204 (256)
T ss_pred             -cccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence             123345578899999998765  357788999999999999999888776544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-32  Score=260.48  Aligned_cols=203  Identities=22%  Similarity=0.307  Sum_probs=175.9

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||.|+||.||.+....+++.+++|.+...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999999998999999998654  234456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999876532  368999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . ......++..|+|||++.+..  .+...|+|++|+++++++++..|+....
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence            2 233456899999999987553  4667899999999999999888776543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=263.85  Aligned_cols=195  Identities=24%  Similarity=0.373  Sum_probs=159.4

Q ss_pred             ceeccCCceEEEEEEEcCCCc--EEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNM--AVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+.+++.  .+++|.++... ....+.+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999987665  56888887543 34456788999999999 899999999999999999999999999


Q ss_pred             CCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          278 GSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       278 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      |+|.+++.....            ....+++.++..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            999999875431            12358899999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      +++.....  ........+..|+|||++....  ++.+.|+|++|++++++++ +..|+
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf  212 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPY  212 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCc
Confidence            98633211  1111223356799999986543  5778899999999999985 55554

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-32  Score=272.93  Aligned_cols=201  Identities=18%  Similarity=0.123  Sum_probs=166.2

Q ss_pred             CCceeccC--CceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          200 NERKLGQG--GFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       200 ~~~~Lg~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ..++||+|  +|++||++....+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  789999999999999999999975432  23456778999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++..+..  ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999865432  258999999999999999999998   9999999999999999999999999986543321111


Q ss_pred             C------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          356 P------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       356 ~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .      ......++..|+|||++......++.+.|+|++|+++++++++..|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0      0122356778999999976544567889999999999999888777653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.6e-33  Score=269.51  Aligned_cols=203  Identities=26%  Similarity=0.293  Sum_probs=172.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|++++.+++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468888999999999999999998899999999865432  235678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|..+.....    .+++.+++.++.||+.||+|||+   .+++|+||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999987765432    48999999999999999999998   89999999999999999999999999999876443


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . .......++..|+|||++.+.. .++.+.|+|++|+++++++++..+++...
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             c-cccCcccceeeccCcHHhcccc-ccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            2 2233456789999999986433 35677899999999999999877776543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-32  Score=265.48  Aligned_cols=220  Identities=21%  Similarity=0.261  Sum_probs=175.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcC----CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEee-CCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILID----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~  267 (459)
                      ..++|+..+.||+|+||.||+|.+..    ++..|++|++.... ....+.+.+|+.++.+++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678889999999999999999876    35889999987543 2345678899999999999999999998776 567


Q ss_pred             EEEEEEecCCCCcchhccccCCC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKST----GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      .++++||+++++|.+++......    ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998654321    1468999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          344 FGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       344 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      ||+++.+....... .....++..|+|||++....  ++.+.|+|++|++++++++ +..|+....|  .++...+...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~  235 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDG  235 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCC--CCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcC
Confidence            99998654322211 12234577899999987543  5778899999999999987 6666655433  3444444433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-32  Score=263.17  Aligned_cols=204  Identities=22%  Similarity=0.352  Sum_probs=173.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---c-------chHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---H-------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      +|...+.||+|+||.||+|....+++.+|+|.++....   .       ..+.+.+|+.++.+++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46778899999999999999988899999998854211   1       1246788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++++|.+++....    .+++..+..++.||+.||.|||+   ++++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            9999999999999999986652    58999999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          347 ALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       347 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ++........ ......|+..|+|||.+......++.+.|+|++|+++++++++..|+...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  216 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE  216 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence            9765432211 123456889999999987654346788999999999999999998876443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-32  Score=264.83  Aligned_cols=216  Identities=24%  Similarity=0.345  Sum_probs=175.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|+..+.||+|+||.||+|.++.++.    .+|+|.+..... ....++.+|+.++.+++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567788999999999999999876554    689998876533 345678999999999999999999999987 78899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++.+
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999976543   58999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCCcc-ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          351 DHELGPRT-TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       351 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                      ........ ....++..|+|||.+..+.  ++...|+|++|++++++++ +..|+...+  ..++.+.+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLLEKGER  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCC--cCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhCCCC
Confidence            53322111 1222356899999887543  5678899999999999987 777765543  4555655554333

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-32  Score=261.43  Aligned_cols=214  Identities=24%  Similarity=0.374  Sum_probs=174.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||++.... +..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+ ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            4678889999999999999998765 567999988654 2345678999999999999999999999887 778999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..+....
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999976432  358899999999999999999998   899999999999999999999999999997664332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      ........++..|+|||++..+.  ++...|+|++|++++++++ +..|++..  +..++.+.+...
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~  219 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERG  219 (260)
T ss_pred             cccccCCcccccccCHhHhccCC--cCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhCC
Confidence            22223344567899999997653  5778899999999999997 67776643  334455555443

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-32  Score=269.50  Aligned_cols=198  Identities=23%  Similarity=0.294  Sum_probs=160.9

Q ss_pred             CceeccCCceEEEEEEEcC--CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEEEEEecC
Q 041624          201 ERKLGQGGFGAVYRGILID--LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFMLVYEFMP  276 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~  276 (459)
                      .++||+|+||.||+|...+  +++.+|+|.+...  .....+.+|+.++++++|+||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4689999999999999763  5689999998643  233567889999999999999999998854  456899999995


Q ss_pred             CCCcchhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee----cCCCCEEEeecCCc
Q 041624          277 NGSLDFHLFSKK-----STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP----DTDFNVKLGDFGLA  347 (459)
Q Consensus       277 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla  347 (459)
                       ++|.+++....     .....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             47877765321     112358999999999999999999998   999999999999999    45678999999999


Q ss_pred             ccccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          348 LLVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       348 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      +.+......  ......||+.|+|||++.+.. .++...|+||+|+++++++++..|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            876543221  234567899999999987643 367789999999999999999888753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-32  Score=281.52  Aligned_cols=210  Identities=24%  Similarity=0.279  Sum_probs=178.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .+|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++|+||+++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36889999999999999999999999999999642      234678999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      . ++|..++.....   .+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       243 ~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        243 R-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             C-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            5 688888865433   69999999999999999999998   9999999999999999999999999999987643322


Q ss_pred             C-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC------CCCCCCCCHHHHHHHHhcC
Q 041624          356 P-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH------PDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       356 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~------p~p~~RPs~~~v~~~L~~~  420 (459)
                      . ......||..|+|||++.+..  ++...|+|++|+++++++.+..      ..+..+|...++.++++..
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            1 123467999999999997654  5778899999999999987543      3466788889988888754

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-32  Score=261.31  Aligned_cols=225  Identities=28%  Similarity=0.390  Sum_probs=180.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-----cchHHHHHHHHHHhccCcCCceeEEEEEee--CCeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-----HGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~  268 (459)
                      .+|+..+.||+|+||.||+|....++..||+|++.....     +..+.+.+|+.++++++|+||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            478899999999999999999998899999999864321     234568899999999999999999998865  3678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++++||+++++|.+++....    .+++...+.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            99999999999999986543    48899999999999999999998   999999999999999999999999999997


Q ss_pred             cccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 041624          349 LVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL  426 (459)
Q Consensus       349 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~  426 (459)
                      .+.....  .......++..|+|||++.+..  .+.+.|+|++|++++++++|..|+... ....++.+. ......|.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~~~~~~-~~~~~~~~~  230 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKI-ATQPTNPQL  230 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCC--CCchhhhHHHHHHHHHHHHCCCCcccc-chHHHHHHH-hcCCCCCCC
Confidence            6543211  1123356889999999987653  567889999999999999998887654 333444433 333334555


Q ss_pred             CCCCC
Q 041624          427 PSKMP  431 (459)
Q Consensus       427 p~~~p  431 (459)
                      |...+
T Consensus       231 ~~~~~  235 (266)
T cd06651         231 PSHIS  235 (266)
T ss_pred             chhcC
Confidence            54443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=301.39  Aligned_cols=217  Identities=24%  Similarity=0.242  Sum_probs=192.9

Q ss_pred             cccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEE
Q 041624          184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       184 ~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      ..-...++.-..++|.+.++||+|+||.|..++++.+++.+|+|++++.   .......|..|-.+|..-+.+-|+.++.
T Consensus        63 ~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   63 IVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            3345667777889999999999999999999999999999999999874   2334556888999999999999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      .|++.+++|+|||||+||+|-.++.+..    ++++..++.++..|+.||.-||+   .|+|||||||+|||||..|++|
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEe
Confidence            9999999999999999999999997654    58999999999999999999998   9999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceecc---CccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST---GRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      |+|||.+-.++.+........+|||.|++||+++.   ++..|+.++|.||+|+++|+|+.+..||-.+.
T Consensus       216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            99999998888776677788999999999999863   33468999999999999999999998866553

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-32  Score=267.84  Aligned_cols=202  Identities=24%  Similarity=0.294  Sum_probs=172.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|...+.||+|+||.||+|....+++.||+|.++... ......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999999889999999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      ++ ++|.+++.....   .+++..+..++.||+.||+|||+   .+|+|+||||+|||++.++.+||+|||+++......
T Consensus        86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 589888865433   58899999999999999999998   999999999999999999999999999997654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       .......++..|+|||.+.+.. .++.+.|+|++|+++++|+++..|++..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             -CcccccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             1223345688999999886543 3567789999999999999999888754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=285.19  Aligned_cols=202  Identities=28%  Similarity=0.347  Sum_probs=175.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------CeEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------GEFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~  269 (459)
                      .|...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|+|||++++.-++.      +...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455678999999999999999999999999998753 45677889999999999999999999986554      3568


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec--CCC--CEEEeecC
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD--TDF--NVKLGDFG  345 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kL~DFG  345 (459)
                      +|||||.+|||...|.+..+ ...|++.+.+.++.+++.||.|||+   ++|+||||||.||++-  .+|  ..||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            99999999999999976543 3469999999999999999999998   9999999999999974  334  48999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .||.++++  ......+||..|.+||++...+ .++..+|.||+|+++|+..++.-||-.
T Consensus       170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~-~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  170 AARELDDN--SLFTSLVGTEEYLHPELYERQK-KYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccccCCCC--CeeeeecCchhhcChHHHhhcc-CcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99988764  3567789999999999998633 478889999999999999999999843

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-32  Score=259.92  Aligned_cols=219  Identities=26%  Similarity=0.350  Sum_probs=175.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEe-eCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH-DRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~  274 (459)
                      ++|...+.||+|+||.||++...  +..+|+|.++..  ...+.+.+|+.++++++|+|++++++++. +.+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888899999999999999876  678999998643  33567899999999999999999999764 45678999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++..... 
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            999999999875433  258999999999999999999998   99999999999999999999999999998755332 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                         .....++..|+|||++....  ++...|+|++|++++++++ +..|++  .....++...+..... +..|+..|.
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~~g~~p~~--~~~~~~~~~~~~~~~~-~~~~~~~~~  226 (256)
T cd05082         156 ---QDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYK-MDAPDGCPP  226 (256)
T ss_pred             ---CCCCccceeecCHHHHccCC--CCchhhhHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHhcCCC-CCCCCCCCH
Confidence               12334467899999987553  5678899999999999986 666554  3456777776654322 333444443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3e-32  Score=259.47  Aligned_cols=211  Identities=23%  Similarity=0.307  Sum_probs=176.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee-CCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E  273 (459)
                      +|+..+.||+|++|.||++....+++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. .+.++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999999889999999986542  2345678899999999999999999998764 446899999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++.....  ..+++.++..++.+++.||+|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999875432  368999999999999999999998   99999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      . .......+++.|+|||.+.+..  ++.+.|+|++|+++++++++..|+...  +..++.+.+
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~  214 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRI  214 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCC--CCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHH
Confidence            2 2233456889999999987654  567789999999999999998887643  344444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-32  Score=264.43  Aligned_cols=214  Identities=24%  Similarity=0.298  Sum_probs=176.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++++|...+.||+|+||.||+|....++..||+|.+..... .....+.+|+.++.+++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            46789999999999999999999998899999999875533 23346789999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||++ ++|.+++.....   .+.+..+..++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 677777654332   57888899999999999999998   8999999999999999999999999999976533


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      .. .......++..|+|||++.+.. .++...|+|++|+++++++++..|+....+...++.+.
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~  217 (291)
T cd07870         156 PS-QTYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI  217 (291)
T ss_pred             CC-CCCCCccccccccCCceeecCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Confidence            21 1123345788999999987533 35667899999999999999999987666544444443

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.4e-33  Score=267.53  Aligned_cols=198  Identities=21%  Similarity=0.326  Sum_probs=168.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||+|.+..+|+.+|+|.++....  .....+.+|+.++.+++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            47788999999999999999998999999999865422  2345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      ++ ++|.+++.....   .+++..++.++.||++||.|||+   ++|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 578777765433   58999999999999999999998   999999999999999999999999999998654322


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                       .......++..|+|||++.+.. .++...|+|++|+++++|+++..|.
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~tg~~p~  200 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPL  200 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCc-ccCcHHHHHHHHHHHHHHHhcCCCC
Confidence             1223346788999999987543 3567889999999999999987774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.8e-32  Score=262.97  Aligned_cols=202  Identities=25%  Similarity=0.373  Sum_probs=174.2

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+.....   .....+.+|++++.+++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            6677899999999999999999899999999865421   2234578899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||++...... 
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            999999988865432  259999999999999999999998   99999999999999999999999999999765432 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                       .......|+..|+|||++.+..  ++...|+|++|+++++++++..|+...++
T Consensus       156 -~~~~~~~g~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~P~~~~~~  206 (285)
T cd05632         156 -ESIRGRVGTVGYMAPEVLNNQR--YTLSPDYWGLGCLIYEMIEGQSPFRGRKE  206 (285)
T ss_pred             -CcccCCCCCcCccChHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence             2223457899999999997654  56778999999999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-32  Score=258.28  Aligned_cols=197  Identities=28%  Similarity=0.426  Sum_probs=165.7

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ++||+|+||.||++.+.. ++.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999988 899999998765433 456899999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcc-c
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-T  359 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~  359 (459)
                      .+++.....   .+++..+..++.+++.||+|||+   ++++||||||+|||++.++.+||+|||+++.......... .
T Consensus        80 ~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          80 LTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999865433   58899999999999999999998   9999999999999999999999999999976542211111 1


Q ss_pred             cccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          360 GLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       360 ~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      ...++..|+|||.+.++.  ++...|+|++|++++++++ +..|++...
T Consensus       154 ~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         154 LKQIPIKWTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             cCcceeccCChHhhccCC--CCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            223456799999987654  5778899999999999997 555555443

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=263.45  Aligned_cols=221  Identities=26%  Similarity=0.290  Sum_probs=181.5

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC-----
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG-----  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-----  266 (459)
                      .++++|+..+.||+|++|.||+|....+++.+++|.+..... ..+++.+|+.++.++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            467899999999999999999999988889999999875432 456789999999999 7999999999997644     


Q ss_pred             -eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          267 -EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       267 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                       ..++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999887544233478999999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ++...... ........|+..|+|||.+....   ..++.+.|+|++|+++++++++..|+....+ +..+.+++..
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~  233 (275)
T cd06608         159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRALFKIPRN  233 (275)
T ss_pred             cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHHHHhhcc
Confidence            98765432 22233456889999999886432   2356678999999999999999888865432 3444444443

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.5e-32  Score=264.12  Aligned_cols=216  Identities=26%  Similarity=0.319  Sum_probs=181.6

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      .++.++..+.+.|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            567788888899999999999999999999999889999999986542 3446788899999998 79999999999853


Q ss_pred             ------CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          265 ------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       265 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                            .+..+++|||+++|+|.+++.....  ..+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence                  4678999999999999998875433  258888999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ++|+|||++....... .......|+..|+|||.+...   ...++...|+|++|+++++++++..|+...+|
T Consensus       160 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         160 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             EEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence            9999999987654321 123345689999999988632   22456778999999999999999998876654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-32  Score=260.74  Aligned_cols=229  Identities=25%  Similarity=0.325  Sum_probs=183.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  272 (459)
                      +|+..+.||.|+||.||++....++..+|+|.+....  ....+++..|++++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999999889999999986542  3345678899999999999999999998754  45689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW--KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||+++++|.+++.........+++..++.++.||+.||.|||..+  ..+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999765444457999999999999999999999221  289999999999999999999999999999877


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKM  430 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~  430 (459)
                      ..... ......++..|+|||.+....  .+...|+|++|++++.++++..|+....  ..++.+.+.. ...+.+|...
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~  234 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE-GKFRRIPYRY  234 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc-CCCCCCcccc
Confidence            54322 133456899999999987654  5677899999999999999887766543  3444444432 2334445444


Q ss_pred             C
Q 041624          431 P  431 (459)
Q Consensus       431 p  431 (459)
                      +
T Consensus       235 ~  235 (265)
T cd08217         235 S  235 (265)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-32  Score=261.36  Aligned_cols=201  Identities=26%  Similarity=0.372  Sum_probs=168.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcC-CCcEEEEEEeccCC----------ccchHHHHHHHHHHhc-cCcCCceeEEEEEee
Q 041624          197 NFSNERKLGQGGFGAVYRGILID-LNMAVAVKKISRGL----------KHGKNEYITEVKTCSQ-LRHRNLLQLIGLCHD  264 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~  264 (459)
                      +|+..+.||+|+||.||+|.+.. +++.+|+|.+....          .....++.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999987 67899999885331          1223457788888875 799999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      .+..++||||+++++|.+++.........+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999999886433333469999999999999999999996  268999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      |++.......  ......|+..|+|||.+.++.  ++...|+|++|+++++++++..|+
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~ll~~l~~g~~p~  213 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPF  213 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCC--CchHHHHHHHHHHHHHHHhCCCcc
Confidence            9998765432  334567889999999998654  577889999999999988765554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=262.31  Aligned_cols=201  Identities=27%  Similarity=0.286  Sum_probs=176.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||.|++|.||+|....+++.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999999889999999987553 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++...     .+++..+..++.|++.||.|||+   ++++|+||+|+||++++++.++|+|||+++.+....
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998643     58999999999999999999998   999999999999999999999999999998776432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       .......++..|+|||++.+..  ++.+.|+|++|+++++++++..|+-...
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             -cccccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence             2234457888999999998665  6788999999999999999988875544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-33  Score=272.23  Aligned_cols=194  Identities=26%  Similarity=0.286  Sum_probs=166.0

Q ss_pred             ceeccCCceEEEEEEE---cCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          202 RKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      +.||+|+||.||++..   ..+++.+|+|++....  ......+..|++++.+++|+||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   3568999999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +|+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~  153 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EK  153 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CC
Confidence            999999886543    58999999999999999999999   99999999999999999999999999999765432 12


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ......||+.|+|||.+....  .+.+.|+|++|+++++++++..|+..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             ceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCC
Confidence            234567999999999987643  46788999999999999988777653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-32  Score=267.82  Aligned_cols=217  Identities=25%  Similarity=0.405  Sum_probs=178.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      .++|+..+.||+|+||.||+|.+..++.    .+|+|.+..... ....++.+|+.++.+++|+||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3567778899999999999999876665    578888865432 2344788999999999999999999998764 467


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +++||+++|+|.+++.....   .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence            99999999999999876543   58999999999999999999998   9999999999999999999999999999987


Q ss_pred             ccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          350 VDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       350 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      +...... ......++..|+|||++.+..  ++...|+|++|++++++++                              
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC  236 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence            6533221 122344577899999987543  5677899999999887653                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |+..+|.+||++.++++.|+..
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      6677899999999999988754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-32  Score=262.95  Aligned_cols=200  Identities=29%  Similarity=0.393  Sum_probs=165.1

Q ss_pred             ceeccCCceEEEEEEEcCCC------cEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          202 RKLGQGGFGAVYRGILIDLN------MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +.||+|+||.||+|...+..      ..+|+|.+.... .....++.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999986533      689999886543 24466899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-----CEEEeecCC
Q 041624          275 MPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-----NVKLGDFGL  346 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kL~DFGl  346 (459)
                      +++++|.+++.....   ....+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975322   12358899999999999999999998   8999999999999999887     899999999


Q ss_pred             cccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          347 ALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       347 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      ++........ ......++..|+|||++.++.  ++.+.|+|++|++++++++ +..|++..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            9765432111 112334567899999998664  5778999999999999987 77776644

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=285.41  Aligned_cols=215  Identities=22%  Similarity=0.352  Sum_probs=186.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +.|.+...||.|+||.||+|..+.++...|.|.+........++|+-||+||..++||+||+|++.|+..+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34556678999999999999999988888999998777788899999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      .||-.+..+..-..   +|.+.++..+++|++.||.|||+   ++|||||||+.|||++-+|.++|+|||.+...... .
T Consensus       112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            99999988876554   79999999999999999999999   99999999999999999999999999998644321 2


Q ss_pred             CccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          356 PRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .....+.||+.|||||++....   .+|+...|+||+|+.+.+|..                                  
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~  264 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS  264 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence            2345689999999999886432   257788999999998766543                                  


Q ss_pred             -------cCCCCCCCCCCHHHHHHHH
Q 041624          399 -------CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 -------c~~p~p~~RPs~~~v~~~L  417 (459)
                             |+..+|..||+..++++.-
T Consensus       265 F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             HHHHHHHHHhcCCccCCCHHHHhhCc
Confidence                   8888999999999888753

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-32  Score=258.72  Aligned_cols=224  Identities=27%  Similarity=0.374  Sum_probs=184.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-----ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +|+..+.||+|+||.||+|....++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999998789999999986543     22456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++..+..++.||+.||+|||+   .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999986543    58999999999999999999998   999999999999999999999999999987664


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      ...  ......|+..|+|||.+.... .++...|+|++|++++.++++..|+.... ....+.+ .......|..|...+
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~-~~~~~~~~~~~~~~~  228 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFK-IGRSKELPPIPDHLS  228 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHH-HHhcccCCCcCCCcC
Confidence            332  234566889999999987554 35778899999999999999998876543 3333333 333344555555444


Q ss_pred             c
Q 041624          432 V  432 (459)
Q Consensus       432 ~  432 (459)
                      .
T Consensus       229 ~  229 (258)
T cd06632         229 D  229 (258)
T ss_pred             H
Confidence            3

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-32  Score=261.78  Aligned_cols=199  Identities=22%  Similarity=0.343  Sum_probs=165.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC----CCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEee--CCeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID----LNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~  268 (459)
                      +.|+..+.||+|+||.||+|.+..    ++..+|+|.++..... ..++|.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            356777899999999999998753    3789999999765443 46789999999999999999999999887  5678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++.....   .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999999976543   59999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          349 LVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       349 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      .........  .....++..|+|||.+.+..  ++...|+|++|+++++++++..|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~el~tg~~p  211 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSK--FSSASDVWSFGVTLYELFTYGDP  211 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCC--CCcccchHHHhhhhheeeccCCC
Confidence            765322211  11234456799999987653  56778999999988776665444

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.3e-32  Score=266.26  Aligned_cols=200  Identities=26%  Similarity=0.331  Sum_probs=165.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++.....  ....+.+|+.++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46789999999999999999999999999999998754322  233567899999999999999999998754  56899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+. ++|.+++.....   .+++.++..++.||+.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999996 488888765432   68999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .... .......++..|+|||.+.+.. .++.+.|+|++|+++++++++..|+
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~~f  209 (309)
T cd07845         159 GLPA-KPMTPKVVTLWYRAPELLLGCT-TYTTAIDMWAVGCILAELLAHKPLL  209 (309)
T ss_pred             CCcc-CCCCcccccccccChhhhcCCC-CcCchHHHHHHHHHHHHHHhCCCCC
Confidence            5432 1223334578899999987543 3677899999999998887655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=267.76  Aligned_cols=206  Identities=22%  Similarity=0.305  Sum_probs=170.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcC--CCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~  269 (459)
                      +|+..+.||+|+||.||+|....  ++..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788899999999999999988  78999999998643   33456788999999999999999999999988  8899


Q ss_pred             EEEEecCCCCcchhccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC----CCCEEEeec
Q 041624          270 LVYEFMPNGSLDFHLFSKKST-GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT----DFNVKLGDF  344 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL~DF  344 (459)
                      +||||+++ +|.+++...... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 676666543322 2368999999999999999999998   99999999999999999    899999999


Q ss_pred             CCcccccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          345 GLALLVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       345 Gla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      |+++........  ......++..|+|||.+.+.. .++...|+|++|+++++++++..|+....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            999876543221  123456789999999886543 35678899999999999999887765443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-32  Score=264.43  Aligned_cols=205  Identities=23%  Similarity=0.315  Sum_probs=174.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|+||.||++.+..++..+|+|.++... ......+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999999889999999987542 23356789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|..++.... ....+++..+..++.|++.||.|||+  ..+|+|+||||+||+++.++.+||+|||++..+... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999998886532 12368999999999999999999996  258999999999999999999999999999765432 


Q ss_pred             CCccccccccccccccceeccCcc----ccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRA----RLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~----~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                        ......++..|+|||.+.+...    .++...|+|++|+++++++++..|++..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence              2233567889999999865432    3467789999999999999998887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-32  Score=263.17  Aligned_cols=202  Identities=25%  Similarity=0.326  Sum_probs=171.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|++|.||+|....+++.||||+++...  ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788899999999999999999889999999987543  22345788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +. ++|.+++.....  ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 688888865432  368999999999999999999998   899999999999999999999999999997664332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       .......++..|+|||++.+.. .++...|+|++|+++++++++..|++..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             -cccccccccccccCCeEEecCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence             1223345688999999987543 2466789999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-32  Score=265.05  Aligned_cols=197  Identities=27%  Similarity=0.321  Sum_probs=167.9

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555678999999999999998889999999987543 334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++...     .+++..+..++.|++.||.|||+   ++++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            999999888532     58999999999999999999998   999999999999999999999999999997665321 


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .......++..|+|||++.+..  ++.+.|+|++|+++++++++..|+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSA--YDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCC--CchhhhHHHHHHHHHHHHhCCCCCc
Confidence            1223356789999999997654  5678899999999998887655543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.7e-32  Score=261.60  Aligned_cols=202  Identities=26%  Similarity=0.380  Sum_probs=174.0

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      |+..+.||+|+||.||++....+++.+|+|.+.....   ...+.+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6777899999999999999999999999999865422   2234678899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998865332  258999999999999999999998   999999999999999999999999999987654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                        ......|+..|+|||++.++.  ++.+.|+|++|+++++++++..|+.....
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~  206 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKK  206 (285)
T ss_pred             --cccCCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence              223457899999999997654  57788999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.3e-32  Score=272.60  Aligned_cols=195  Identities=25%  Similarity=0.281  Sum_probs=163.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  265 (459)
                      ..++|+..+.||+|+||.||++....+++.||||++....  ....+.+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4678999999999999999999999889999999997542  23456788999999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999965 67666632      47889999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      +++.....  .......||..|+|||++.+..  ++.+.|+||+|+++++|+++..|
T Consensus       172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             CccccCCC--CcccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCC
Confidence            99865432  2234467899999999997653  57789999999999887765433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.9e-32  Score=257.13  Aligned_cols=203  Identities=22%  Similarity=0.310  Sum_probs=173.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||++....+++.+|+|.+....  ....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788899999999999999999889999999987542  23456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecCCcccccCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~  353 (459)
                      +++++|.+++.....  ..+++..+..++.+++.||.|||+   ++++|+||||+||+++.+ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999976432  358999999999999999999998   999999999999999865 46899999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      .  ......++..|+|||.+....  .+.+.|+|++|++++.++++..|+....+
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  206 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANL  206 (256)
T ss_pred             c--cccccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhCCCCcccCch
Confidence            1  223456889999999987543  56788999999999999998887765543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-32  Score=258.16  Aligned_cols=203  Identities=22%  Similarity=0.322  Sum_probs=174.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.+|++....+++.||+|.+...  .....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999999988999999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....  ..+++.+++.++.|++.||.|||+   .+++|+||+|+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999998865432  257899999999999999999998   899999999999999999999999999997664321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       .......|+..|+|||++.++.  .+.+.|+|++|+++++++++..|+....
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08218         156 -ELARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGN  205 (256)
T ss_pred             -hhhhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCC
Confidence             1223456888999999987654  5678899999999999999888876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=257.25  Aligned_cols=218  Identities=24%  Similarity=0.362  Sum_probs=185.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .+++|++.+.||+|.|+.||++.+..+|+.+|+|.+...  ...+.+++.+|+++...|+||||++|...+.+....|||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            346778888999999999999999999999999988644  345678889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~  348 (459)
                      +|+|.|++|..-|-.+.    .+++..+-.++.||++||.|+|.   ++|+|||+||.|+||-+.   --+||+|||+|.
T Consensus        89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999977665543    58889999999999999999999   999999999999999643   359999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN-FETKMP  424 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~-~~~~~p  424 (459)
                      .+.  .+....+.+||++|||||++...  +++..+|+|+.|++++++|.+..|+-.+  +-..+.+.+. +...+|
T Consensus       162 ~l~--~g~~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd~~  232 (355)
T KOG0033|consen  162 EVN--DGEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYDYP  232 (355)
T ss_pred             EeC--CccccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccCCC
Confidence            887  24445678999999999999854  5788999999999999999999998874  4455665443 333443

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.2e-32  Score=265.79  Aligned_cols=197  Identities=23%  Similarity=0.305  Sum_probs=159.6

Q ss_pred             CceeccCCceEEEEEEEcC--CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEEEEEecC
Q 041624          201 ERKLGQGGFGAVYRGILID--LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFMLVYEFMP  276 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~  276 (459)
                      ..+||+|+||.||+|...+  ++..||+|.+...  .....+.+|+.++.+++|+||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999999764  4688999998653  233467899999999999999999999853  567899999996


Q ss_pred             CCCcchhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee----cCCCCEEEeecCCc
Q 041624          277 NGSLDFHLFSKK-----STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP----DTDFNVKLGDFGLA  347 (459)
Q Consensus       277 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla  347 (459)
                      + +|.+++....     .....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 7777664221     112358899999999999999999998   999999999999999    56678999999999


Q ss_pred             ccccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          348 LLVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       348 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      +........  ......||..|+|||++.+.. .++.+.|+||+|+++++++++..|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCC-ccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            876543221  233457899999999987543 35778899999999999999988764

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=236.36  Aligned_cols=231  Identities=22%  Similarity=0.303  Sum_probs=185.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..++||+|.||+||+|+..++++.||+|+++...  .......++|+.+++.++|+|||++++....++.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666788999999999999999999999999997653  23356789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      |.. +|..+...-..   .++.+....++.|+++||.|+|+   ++++||||||.|.||+.+|..||+|||+++.+.-..
T Consensus        83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            954 88877765443   69999999999999999999999   999999999999999999999999999999876542


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc--------CCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF--------ETKMPN  425 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~--------~~~~p~  425 (459)
                      .. .+..+-|..|.+|.++.+.+. ++...|+||.||++.++.. ++..+|..- -..|+.++..-        ...+..
T Consensus       156 rc-ysaevvtlwyrppdvlfgakl-y~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  156 RC-YSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             Ee-eeceeeeeeccCcceeeeeeh-hccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCcccc
Confidence            22 234456899999999997775 8899999999999987665 666677653 23333333321        113344


Q ss_pred             CCCCCCcccccC
Q 041624          426 LPSKMPVAIFEA  437 (459)
Q Consensus       426 ~p~~~p~~~~~~  437 (459)
                      +|+-.|.+.+++
T Consensus       233 lpdyk~yp~ypa  244 (292)
T KOG0662|consen  233 LPDYKPYPIYPA  244 (292)
T ss_pred             CCCCcccCCccc
Confidence            555555555543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-32  Score=266.90  Aligned_cols=194  Identities=28%  Similarity=0.357  Sum_probs=167.2

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ...||+|+||.||++....++..||||.+........+.+.+|+.++.+++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            46799999999999999888999999998765555567789999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++...     .+++.++..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++....... .....
T Consensus       107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  177 (292)
T cd06658         107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS  177 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence            9887432     48899999999999999999999   899999999999999999999999999997654332 22234


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ..|+..|+|||.+....  .+...|+|++|+++++++++..|+..
T Consensus       178 ~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         178 LVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             eecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            56889999999986543  56788999999999998886665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-32  Score=282.98  Aligned_cols=203  Identities=20%  Similarity=0.207  Sum_probs=164.2

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc------CCceeEEEEE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH------RNLLQLIGLC  262 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~g~~  262 (459)
                      +++...+++|++.++||+|+||.||+|.+..+++.||||+++... ...+++..|+.++..++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            445556789999999999999999999999889999999996432 233455667777777654      4588999988


Q ss_pred             eeC-CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----
Q 041624          263 HDR-GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----  337 (459)
Q Consensus       263 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----  337 (459)
                      ... +.+++|||++ +++|.+++....    .+++..+..|+.||+.||.|||+  +.+|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccc
Confidence            764 5789999988 778888886543    59999999999999999999997  25999999999999998765    


Q ss_pred             ------------CEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          338 ------------NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       338 ------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                                  .+||+|||.+....    ......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+..
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                        49999999886432    2234568999999999998654  57788999999999999887776643

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-32  Score=262.84  Aligned_cols=201  Identities=25%  Similarity=0.316  Sum_probs=173.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|+||.||++....+++.||+|++.... ....+.+.+|++++..++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56777889999999999999999889999999886543 33467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..+..++.+++.||.|||+  ..+++||||||+||+++.++.++|+|||++...... 
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            99999998886533    58999999999999999999997  268999999999999999999999999998754322 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                        ......|+..|+|||++.++  .++...|+|++|++++.++++..|+....
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             --ccCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence              12345789999999998765  35678899999999999998888876443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.4e-32  Score=265.10  Aligned_cols=211  Identities=21%  Similarity=0.219  Sum_probs=176.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||++.+..+++.|++|.+....   ....+.+.+|++++..++|+||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999999999999999987653   233457889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999996543    58999999999999999999998   8999999999999999999999999999874211


Q ss_pred             CCC--------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          353 ELG--------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       353 ~~~--------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      ...              .......++..|+|||.+..+.  ++.+.|+|++|+++++++++..|+....  ..++.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~~~~~~  228 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQV  228 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence            100              0112345788999999987643  5788899999999999999888876543  34444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-32  Score=263.20  Aligned_cols=203  Identities=26%  Similarity=0.301  Sum_probs=174.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46888999999999999999999889999999987542  3345788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |++++.|..++....    .+++.++..++.||+.||.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999877766554322    58999999999999999999998   89999999999999999999999999999877654


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .........++..|+|||++.+.. ..+.+.|+|++|++++.++++..+++..
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            332334467789999999997652 3577899999999999999998777643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.98  E-value=7.8e-32  Score=260.18  Aligned_cols=201  Identities=24%  Similarity=0.303  Sum_probs=172.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999998889999999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++...     ++++.+...++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999988532     58899999999999999999998   999999999999999999999999999997664332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       .......++..|+|||++.+..  .+...|+|++|+++++++++..|+....
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             -cccccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence             2233456788999999987654  5678899999999999998877765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2e-32  Score=271.38  Aligned_cols=202  Identities=24%  Similarity=0.247  Sum_probs=166.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc---CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL---RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ||+|+||.||+|....+++.||+|++....   ......+..|..++.++   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999986532   12233455677777665   699999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~  152 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKT  152 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCC
Confidence            99998886543    58999999999999999999998   99999999999999999999999999998754322 122


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      .....||..|+|||++.+.. .++...|+|++|+++++|+++..|+...  +..++.+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~elltG~~Pf~~~--~~~~~~~~  208 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEK-GYTKHVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRN  208 (330)
T ss_pred             ccCccCCccccCHHHHcCCC-CCCCccceeccccEEEEeccCCCCCCCC--CHHHHHHH
Confidence            34567999999999987543 3577899999999999999999887543  33444433

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.7e-32  Score=259.15  Aligned_cols=201  Identities=28%  Similarity=0.377  Sum_probs=173.3

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.++... .....++.+|+.++++++   |+|++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999998889999999987543 344567889999999996   999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++...     .+++...+.++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999888542     58999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .. .......|+..|+|||.+.++. .++...|+|++|++++.++++..|+....
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         154 NS-SKRSTFVGTPYWMAPEVITEGK-YYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             Cc-cccccccCCcceeCHHHhccCC-ccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32 2233456899999999987654 35678899999999999999888775543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4e-32  Score=275.54  Aligned_cols=199  Identities=24%  Similarity=0.245  Sum_probs=168.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC--CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..+|.+.+.||+|+||.||++...+  ++..||+|.+...     +...+|++++.+++|+||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4579999999999999999998653  4678999988543     34568999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |++. ++|.+++...    ..+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9995 6888888433    269999999999999999999998   9999999999999999999999999999976654


Q ss_pred             CCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          353 ELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       353 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      .... ......||+.|+|||++....  +..+.|+|++|+++++++++..|+...++
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence            3222 233567999999999997654  57789999999999999999988865543

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=8.1e-32  Score=262.09  Aligned_cols=205  Identities=22%  Similarity=0.267  Sum_probs=170.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccC-cCCceeEEEEEeeCCe-----
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGE-----  267 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~-----  267 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++.+++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468889999999999999999998899999999865432  23467889999999995 6999999999887665     


Q ss_pred             EEEEEEecCCCCcchhccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecC
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKST-GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFG  345 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG  345 (459)
                      .++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+   ++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 888887654322 3468999999999999999999998   99999999999999998 8899999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +++.+..... ......+++.|+|||++.+.. .++...|+|++|+++++++++..|++..
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9976543211 122345688999999886543 3677899999999999999999888754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.98  E-value=2e-34  Score=264.77  Aligned_cols=201  Identities=26%  Similarity=0.351  Sum_probs=180.8

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      -|++..+||+|+||.||+|.++.+|+.+|||++..  ..+.++..+|+.+|.+++.+++|++||.|.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            36677899999999999999999999999999864  4578899999999999999999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      .||..+.++.+..   +|++.++..++.+.++||+|||.   ..-+|||||+.||||+.+|.+||+|||.|-.+.+. ..
T Consensus       112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA  184 (502)
T KOG0574|consen  112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA  184 (502)
T ss_pred             CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence            9999999987765   79999999999999999999998   88899999999999999999999999999776532 23


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ...++.||+.|||||++..  ..++...|+||+|....+|..+..|..+--|
T Consensus       185 KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence            3467899999999999974  4578889999999999999998888776655

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=264.33  Aligned_cols=201  Identities=26%  Similarity=0.292  Sum_probs=170.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||+|....+++.+|+|.+.....   ...+.+..|++++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468888999999999999999998899999999976532   24567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+.+++|.+++.....  ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999865432  368999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CCCC----------------------------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          353 ELGP----------------------------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       353 ~~~~----------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ....                            ......||..|+|||++.+..  .+...|+|++|++++.++++..|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC--CCchHHHHHHHHHHHHHhhCCCCC
Confidence            2110                            112346788999999997653  577889999999999888755543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=4.5e-32  Score=264.88  Aligned_cols=193  Identities=26%  Similarity=0.328  Sum_probs=167.0

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ...||+|+||.||+|....+++.||+|.+........+.+.+|+.++..++|+||+++++.+..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            45799999999999999888999999999765555567788999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      ..++...     .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..+.... .....
T Consensus       106 ~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  176 (297)
T cd06659         106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS  176 (297)
T ss_pred             HHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence            9877432     48999999999999999999998   999999999999999999999999999997654332 22234


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ..|+..|+|||++.+..  .+.+.|+|++|+++++++++..|+.
T Consensus       177 ~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         177 LVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             eecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            56899999999997654  5778899999999999988766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=1.5e-31  Score=262.28  Aligned_cols=194  Identities=34%  Similarity=0.378  Sum_probs=163.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .+.|+..+.||+|+||.||+|....+++.||+|.+.....   ...+++.+|++++..++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            3568888999999999999999988899999999865432   2345788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||++ |+|.+++.....   .+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.+||+|||++....
T Consensus        94 ~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            99997 577776654333   58999999999999999999998   999999999999999999999999999987553


Q ss_pred             CCCCCccccccccccccccceecc-CccccCCCCCHHHHHHHHHHHHhcC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      ..     ....++..|+|||++.+ ....++.+.|+|++|+++++++++.
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~  211 (307)
T cd06607         167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (307)
T ss_pred             CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence            22     23567889999998853 1223677899999999998876543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.1e-31  Score=261.45  Aligned_cols=203  Identities=26%  Similarity=0.343  Sum_probs=175.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.++.+++|+||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36888899999999999999998888899999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++...     .+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999998643     47899999999999999999998   999999999999999999999999999987654332


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      . ......+++.|+|||.+..+.  ++...|+|++|++++.++++..|+...++
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~ll~~ll~g~~pf~~~~~  220 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (293)
T ss_pred             c-ccccccCChhhcCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            1 223456888999999987653  56789999999999999988777765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1e-31  Score=261.35  Aligned_cols=201  Identities=23%  Similarity=0.300  Sum_probs=170.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV  271 (459)
                      ++|+..+.||+|+||.||+|.+..+++.+|+|.++....  .....+.+|+.++.+++|+||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            578888999999999999999998899999999975432  2234577899999999999999999998877  899999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||++ ++|.+++.....   .+++..++.++.||+.||+|||+   .+++|+||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 489888865443   58999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ... .......++..|+|||.+.+.. ..+...|+|++|+++++++++..|+..
T Consensus       158 ~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         158 SPL-KPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             CCc-cccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            432 1223345788999999987543 256789999999999999998877754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=9.7e-32  Score=257.60  Aligned_cols=227  Identities=22%  Similarity=0.347  Sum_probs=181.4

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +|+..+.||+|++|.||+|....+++.+|+|.++....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            57888999999999999999988899999999865421      134678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALL  349 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~  349 (459)
                      ||||+++++|.+++....    ++++..+..++.||+.||.|||+   ++++|+||||+||+++.++ .+||+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999986543    58999999999999999999998   9999999999999998776 599999999977


Q ss_pred             ccCCCCC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcCCCCCC
Q 041624          350 VDHELGP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP-SIRQAIQVLNFETKMPN  425 (459)
Q Consensus       350 ~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP-s~~~v~~~L~~~~~~p~  425 (459)
                      .......   ......++..|+|||.+.+..  .+...|+|++|++++.++++..|+..... ...+...........++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS  231 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence            6543111   122356889999999987543  56788999999999999999988764432 22222222222233455


Q ss_pred             CCCCCCc
Q 041624          426 LPSKMPV  432 (459)
Q Consensus       426 ~p~~~p~  432 (459)
                      .|...+.
T Consensus       232 ~~~~~~~  238 (268)
T cd06630         232 IPEHLSP  238 (268)
T ss_pred             CchhhCH
Confidence            5555543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=1.2e-31  Score=259.30  Aligned_cols=203  Identities=26%  Similarity=0.363  Sum_probs=172.4

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +|+..+.||.|++|.||+|++..++..||+|+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            57888999999999999999998899999999976533 33567788999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++.......
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 88888765432 2368999999999999999999998   8999999999999999999999999999976543321


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       ......++..|+|||++.+.. .++...|+|++|+++++++++..|+...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             -ccccccccccccChHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             123345788999999986543 3567889999999999999998887643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=254.55  Aligned_cols=205  Identities=29%  Similarity=0.399  Sum_probs=177.1

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      +++|+.+.|+     +.||+|+|+.|--+....++..+|||++.+.......+..+|++++.+. .|+||++|+.||+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            4678888876     6799999999999999999999999999888777788999999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEEe
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLG  342 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~  342 (459)
                      ...|||||-|.||+|..+|.++.    -+++.++.++..+|+.||.|||.   ++|.||||||+|||-....   -+||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence            99999999999999999998776    49999999999999999999998   9999999999999986554   38999


Q ss_pred             ecCCcccccC--C----CCCccccccccccccccceec---cCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          343 DFGLALLVDH--E----LGPRTTGLAGTLGYMAPEYIS---TGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       343 DFGla~~~~~--~----~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ||.++.-+..  +    ......+.+|+..|||||+..   +...-|+...|.||+|+++|+||.+..|+
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            9998754321  1    122234578999999999753   33335788999999999999999977774

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=2e-31  Score=254.91  Aligned_cols=218  Identities=25%  Similarity=0.264  Sum_probs=183.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||.|+||.||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47888999999999999999998889999999987543 33567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++..... ...+++.....++.|++.||+|||+   .+++||||||+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999875422 1258999999999999999999998   999999999999999999999999999998765432


Q ss_pred             CC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          355 GP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       355 ~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ..   ......|+..|+|||++.... ..+...|+|++|+++++++++..|+.... .+..+.+.+..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~  222 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVH-GYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN  222 (267)
T ss_pred             cccccccccccCChhhcChHHHcccc-CcCcccchHhHhHHHHHHHhCCCCccccC-hhhhHHHHhcC
Confidence            22   123456889999999987652 35778899999999999999999876543 34444444443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.98  E-value=3.5e-31  Score=253.71  Aligned_cols=202  Identities=30%  Similarity=0.364  Sum_probs=171.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-----ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+....     ....+.+.+|+.++.+++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999999999999999886432     12245788899999999999999999988763  468


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++....    .+++...++++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999886543    48889999999999999999998   999999999999999999999999999997


Q ss_pred             cccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          349 LVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       349 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .......  .......|+..|+|||.+.+..  .+...|+|++|+++++++++..|+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCC--CCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            6543211  1123356889999999987643  577889999999999999999987655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=2.6e-31  Score=256.55  Aligned_cols=198  Identities=27%  Similarity=0.312  Sum_probs=169.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      -|+..+.||+|+||.||+|....++..+|+|.+.... ....+.+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999998889999999986442 233467889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++...     .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+... .
T Consensus        85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~  155 (277)
T cd06641          85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-Q  155 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc-h
Confidence            999999888532     58999999999999999999998   99999999999999999999999999998766432 1


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .......++..|+|||.+.+..  .+...|+|++|++++.++++..|+..
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             hhhccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            1223456788999999987653  46678999999999999887766543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=3.9e-31  Score=257.07  Aligned_cols=199  Identities=28%  Similarity=0.319  Sum_probs=175.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+....   ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999999889999999986542   233567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++|+||+|+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999986653    58999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .    .....+++.|+|||.+.+..  .+.+.|+|++|++++.++++..|+....
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            3    33456889999999987653  5677899999999999999988876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=2.2e-31  Score=258.46  Aligned_cols=215  Identities=24%  Similarity=0.273  Sum_probs=177.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  272 (459)
                      ++|...+.||.|++|.||++.+..+++.+|+|.+..... ....++.+|++++++++|+||+++++++.+  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            467888999999999999999998899999999875433 345678999999999999999999999865  34789999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.........+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999998876433333468999999999999999999998   9999999999999999999999999999875543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHh
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR---PSIRQAIQVLN  418 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R---Ps~~~v~~~L~  418 (459)
                      ..   .....++..|+|||.+.+..  ++...|+|++|+++++++++..|+....   ....++.+.+.
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV  221 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence            21   12345788999999987654  5677899999999999999998877653   34444444443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.98  E-value=1.5e-31  Score=254.69  Aligned_cols=207  Identities=24%  Similarity=0.353  Sum_probs=169.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|...+.||+|+||.||++..  +++.||+|.++..  ...+.+.+|+.++.+++|+||+++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            5688889999999999999875  4688999998653  2346789999999999999999999998664 479999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....  
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            99999999875432  258999999999999999999998   99999999999999999999999999998754322  


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                        ......+..|+|||.+.++.  ++...|+|++|++++++++ +..|++...  ..++.+.+...
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~  213 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKECVEKG  213 (254)
T ss_pred             --CCCCCCCceecCHHHhccCC--cCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhCC
Confidence              12233456899999987654  5678899999999999986 777777654  34555554433

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=2.4e-31  Score=256.85  Aligned_cols=198  Identities=26%  Similarity=0.292  Sum_probs=165.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccC-cCCceeEEEEEeeC--CeEEEEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLR-HRNLLQLIGLCHDR--GEFMLVYE  273 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E  273 (459)
                      |+..+.||+|+||.||+|....++..+|+|+++.... .......+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5667899999999999999998899999999876422 22334567899999985 99999999999987  88999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |++ ++|.+.+.....   .+++.+++.++.|++.||+|||+   .+++||||||+||+++. +.+||+|||+++.+...
T Consensus        81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 588777765432   68999999999999999999998   89999999999999999 99999999999876432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .  ......++..|+|||++..+. ..+...|+|++|+++++++++..|++..
T Consensus       153 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         153 P--PYTEYISTRWYRAPECLLTDG-YYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             C--CcCCCCCCcccCChhHhhcCC-CCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            2  122345788999999875443 2567889999999999999998888764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-33  Score=269.92  Aligned_cols=196  Identities=26%  Similarity=0.349  Sum_probs=170.7

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      .++||+|-||+||-|.++.+|+.||||++.+..  .....++.+|+.+|.+++||.||.+...|++.+..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            478999999999999999999999999997652  3445788999999999999999999999999999999999995 5


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEeecCCcccccCCCC
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~  355 (459)
                      ++.++|.....  ..|++..-..++.||+.||.|||.   ++|+|+||||+||||.+.   -.+||||||+||++...  
T Consensus       648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            65555544332  269999999999999999999998   999999999999999754   36999999999998754  


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .....++||+.|+|||++.+..  +....|+||.|+++|+-|.++-|+-++
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCc
Confidence            3345689999999999998764  678889999999999999999998876

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5e-32  Score=282.78  Aligned_cols=201  Identities=21%  Similarity=0.257  Sum_probs=157.1

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCC-cEEEEEE--------------ecc---CCccchHHHHHHHHHHhccCcCC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLN-MAVAVKK--------------ISR---GLKHGKNEYITEVKTCSQLRHRN  254 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~H~n  254 (459)
                      ...++|++.+.||+|+||.||+|..+... ...+.|.              +.+   ........+.+|+.++.+++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34678999999999999999998765422 1222221              110   11223456889999999999999


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS-TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      |+++++++...+..|+|+|++. ++|..++..... ........+...|+.||+.||+|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999995 567666654321 11123456778899999999999998   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          334 DTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +.++.+||+|||+++.+............||..|+|||++.+..  ++...|+|++|+++++|+++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~  364 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSH  364 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999877644333344567999999999998653  57788999999999988864

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-31  Score=257.83  Aligned_cols=201  Identities=26%  Similarity=0.314  Sum_probs=170.3

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      |+..+.||.|++|.||+|.+..++..||+|++....  ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999999889999999987543  223467889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      + ++|.+++.....  ..+++..++.++.|++.||+|||+   ++++||||+|+||+++.++.++|+|||+++.......
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 689988865442  258999999999999999999998   8999999999999999999999999999976543321


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       ......++..|+|||++.+.. .++...|+|++|+++++++++..|++..
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             -ccCccccccCCCCCceeecCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             122335688999999887543 2567789999999999999998877643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=2.3e-31  Score=259.75  Aligned_cols=206  Identities=29%  Similarity=0.332  Sum_probs=171.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC----
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----  266 (459)
                      ...++|++.+.||+|+||.||+|..+.+++.||+|.++...  ......+.+|++++++++|+||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999999889999999997543  223456778999999999999999999987654    


Q ss_pred             ------eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          267 ------EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       267 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                            ..++|+||+++ +|...+.....   .+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV---HFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 67666654422   68999999999999999999998   8999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      |+|||++...............++..|+|||.+.+.. ..+...|+|++|+++++++++..|+...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999876543322223345678899999886433 3567899999999999999988777543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=256.55  Aligned_cols=202  Identities=28%  Similarity=0.337  Sum_probs=172.4

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEEEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFMLVYE  273 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  273 (459)
                      |+..+.||+|+||.||+|....+++.+|+|++....  ......+.+|++++.+++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999999889999999998653  33346788999999999999999999999888  89999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++ +|.+++....   ..+++..++.++.||+.||+|||+   .+++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 8888886543   268999999999999999999998   89999999999999999999999999999877554


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .........++..|+|||.+.+.. .++.+.|+|++|+++++++++..|+....
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             CcccccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            322234456788999999876432 35778999999999999999988876554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.4e-31  Score=260.30  Aligned_cols=206  Identities=28%  Similarity=0.370  Sum_probs=169.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCC-----
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-----  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----  266 (459)
                      ..++|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+.++++++|+||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34578999999999999999999998999999999865422  22345678999999999999999999987654     


Q ss_pred             ---eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          267 ---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       267 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                         ..++||||+. ++|.+++.....   .+++.+++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNV---KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence               4599999996 478777754432   58999999999999999999998   8999999999999999999999999


Q ss_pred             cCCcccccCCCCC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          344 FGLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       344 FGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ||++..+......   ......++..|+|||.+.+.. .++.+.|+|++|+++++++++..++....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-DYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCc-ccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            9999876433221   123345788999999886543 35678899999999999999887776544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=5.1e-31  Score=249.08  Aligned_cols=201  Identities=31%  Similarity=0.378  Sum_probs=177.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      .|...+.||+|++|.||++....+++.+++|++........+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36778899999999999999988899999999977655567789999999999999999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +++|.+++....   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987653   268999999999999999999998   9999999999999999999999999999987654321 


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       .....++..|+|||.+....  .+.+.|+|++|++++.++++..|+....
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~  201 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELP  201 (253)
T ss_pred             -ccceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence             34556889999999987654  5678899999999999999888776543

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=4.7e-31  Score=256.04  Aligned_cols=201  Identities=29%  Similarity=0.357  Sum_probs=173.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      .|...+.||+|++|.||++....+++.+++|++........+.+.+|+.++.+++|+||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            34455799999999999999988899999999875544556678899999999999999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +++|.+++...     .+++..+..++.|++.||+|||+   ++++||||+|+||+++.++.++|+|||++....... .
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~  170 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-P  170 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-c
Confidence            99999988652     58999999999999999999998   999999999999999999999999999887654332 1


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ......|+..|+|||.+.+..  ++.+.|+|++|+++++++++..|+....|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~  220 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPP  220 (285)
T ss_pred             ccccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence            223356889999999987653  56788999999999999998888766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=5.8e-31  Score=259.35  Aligned_cols=194  Identities=32%  Similarity=0.379  Sum_probs=163.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .|+..+.||+|+||.||+|....++..+|+|++.....   .....+.+|++++++++|+|++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            36677899999999999999988899999999875422   234578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |++ |+|.+.+.....   ++++.++..++.|++.||.|||+   .+|+||||+|+||+++.++.+||+|||++..... 
T Consensus       106 ~~~-g~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         106 YCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             CCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            997 577777754433   68999999999999999999998   9999999999999999999999999999865432 


Q ss_pred             CCCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                          .....|+..|+|||++... ....+.+.|+|++|+++++++++..|
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  223 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  223 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                2345688899999997431 12357788999999999988765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=9.8e-31  Score=249.89  Aligned_cols=212  Identities=29%  Similarity=0.400  Sum_probs=181.0

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||+|....+++.|++|.++.....  ..+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            478889999999999999999888999999999765443  567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..+..++.+++.||.|||+   .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999986543    48899999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCcc---ccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 041624          355 GPRT---TGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       355 ~~~~---~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~  415 (459)
                      ....   ....++..|+|||++.... .....+.|+|++|+++++++++..|+...........+
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~  218 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH  218 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH
Confidence            2221   2356788999999997654 23677899999999999999999998766544444433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-31  Score=265.21  Aligned_cols=198  Identities=24%  Similarity=0.335  Sum_probs=162.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++.+++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999999889999999986432 23456788999999999999999999987644     35


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++|+||+++ +|.+++...     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence            7999999964 787776432     58999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          348 LLVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       348 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      +........  ......||..|+|||.+.+.. ..+...|+|++|+++++++++..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGvil~el~~G~~  208 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKAIDIWSVGCILAEMLSNRP  208 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence            766432211  123456889999999876433 35678899999999887665443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.4e-31  Score=256.13  Aligned_cols=212  Identities=25%  Similarity=0.326  Sum_probs=179.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|++|.||++.+..+++.+|+|.+.... ....+++.+|++++++++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999999889999999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+  ..+++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999987653   268999999999999999999997  3799999999999999999999999999987654321


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHH
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR---PSIRQAIQVL  417 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R---Ps~~~v~~~L  417 (459)
                         .....++..|+|||.+.+.  .++.+.|+|++|++++.++++..|++...   ....+.++.+
T Consensus       156 ---~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  216 (265)
T cd06605         156 ---AKTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI  216 (265)
T ss_pred             ---hhcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH
Confidence               1126788899999998765  45778899999999999999998876542   3444444433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=6.9e-31  Score=253.88  Aligned_cols=217  Identities=25%  Similarity=0.322  Sum_probs=176.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHH-HhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKT-CSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|+++... .....++..|+.. ++.++|+||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999999999999999997653 2334556667665 555689999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |++ |+|.+++.........+++..++.++.||+.||+|||+   + +++||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 68888876543333579999999999999999999998   5 899999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .  .......++..|+|||.+.+..  ..++...|+|++|+++++++++..|+.........+.+.+.
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            2  1123356788999999886422  23567789999999999999999988654445555555554

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=3.7e-31  Score=254.42  Aligned_cols=202  Identities=23%  Similarity=0.311  Sum_probs=160.9

Q ss_pred             CCCCceeccCCceEEEEEEEcC---CCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC------
Q 041624          198 FSNERKLGQGGFGAVYRGILID---LNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------  266 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  266 (459)
                      |.+.+.||+|+||.||+|.+..   +++.||+|++....  ....+++.+|++++++++|+||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5667899999999999998653   46899999987542  234567899999999999999999999886532      


Q ss_pred             eEEEEEEecCCCCcchhccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      ..++++||+++|+|.+++.....  ....+++...+.++.|++.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            24789999999999888754321  12257899999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          345 GLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       345 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      |+++........ ......++..|++||.+..+.  ++...|+|++|++++++++ +..|+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~  217 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYA  217 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCC
Confidence            999866432211 122334567899999887553  5678899999999998876 444443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=253.96  Aligned_cols=201  Identities=27%  Similarity=0.335  Sum_probs=177.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchH---HHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..++||+|.||+|..++.+.+++.+|+|++++..--.++   .-+.|-++|...+||.+..|-..++..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999999999999999999887443333   356789999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||..||.|.-+|...+    .+++...+.+..+|+.||.|||+   .+||.||||.+|.|||.+|.+||+|||+++.--
T Consensus       247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999998886654    58999999999999999999999   999999999999999999999999999997533


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                       ..+..+.+++||+.|+|||++....  ++..+|.|.+|+++|+|+.+.-|+-.
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnD--YgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDND--YGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             -cccceeccccCChhhcCchhhcccc--ccceeehhhhhHHHHHHHhccCcccc
Confidence             2344567899999999999998764  68889999999999999998877543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=262.19  Aligned_cols=203  Identities=24%  Similarity=0.286  Sum_probs=177.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .+-|+..+.||+|.|..|-.|++--+|..||||++.+..-.  ....+.+|++.|+.++|||||+||.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            35577788999999999999999999999999999876332  3457889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee-cCCCCEEEeecCCccccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP-DTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kL~DFGla~~~~  351 (459)
                      |+=.+|+|.++|.++..   .+.+....++++||+.|+.|+|.   ..+|||||||+||.+ ..-|.+||.|||++-.+.
T Consensus        97 ELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            99999999999988765   69999999999999999999998   899999999999976 456899999999997765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .  +...++.+|++.|-|||.+.+..+ -.+.+|+|++|+++|.+..+..||.+.
T Consensus       171 P--G~kL~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeA  222 (864)
T KOG4717|consen  171 P--GKKLTTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEA  222 (864)
T ss_pred             C--cchhhcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccc
Confidence            4  455677899999999999998765 467889999999999888766665443

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=8.7e-31  Score=254.45  Aligned_cols=214  Identities=25%  Similarity=0.285  Sum_probs=177.5

Q ss_pred             CCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeE
Q 041624          197 NFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  268 (459)
                      +|+..+.||+|+||.||++...   .++..||+|+++...    ....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999874   368999999987542    22346788999999999 699999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999986543    58899999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC--CCHHHHHHHH
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR--PSIRQAIQVL  417 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R--Ps~~~v~~~L  417 (459)
                      ..............|+..|+|||.+..+...++...|+|++|++++.++++..|+...+  .+..++.+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  224 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI  224 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh
Confidence            76543222333456899999999987655456778999999999999999998876432  2344444433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=249.35  Aligned_cols=225  Identities=28%  Similarity=0.382  Sum_probs=180.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC-----CccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-----LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788899999999999999999988999999987532     123345788999999999999999999998764  468


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++|+||+++++|.+++....    .+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999986543    48899999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 041624          349 LVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL  426 (459)
Q Consensus       349 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~  426 (459)
                      .......  .......++..|+|||++.+..  .+.+.|+|++|+++++++++..|+.... .+.++.+.. .....|.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~  230 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYE-AMAAIFKIA-TQPTKPML  230 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccC-HHHHHHHHH-cCCCCCCC
Confidence            6543211  1123456889999999987653  5677899999999999999999886553 344444443 22233444


Q ss_pred             CCCCC
Q 041624          427 PSKMP  431 (459)
Q Consensus       427 p~~~p  431 (459)
                      |...+
T Consensus       231 p~~~~  235 (264)
T cd06653         231 PDGVS  235 (264)
T ss_pred             CcccC
Confidence            54443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=2.7e-31  Score=252.73  Aligned_cols=202  Identities=22%  Similarity=0.333  Sum_probs=172.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||+|..+.++..+|+|.+....  ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999999989999999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCcccccCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  353 (459)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999865432  258999999999999999999998   9999999999999999885 4699999999876533


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      . .......|++.|+|||++....  .+.+.|+|++|+++++++++..|+...
T Consensus       156 ~-~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         156 M-ELAYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             c-ccccccCCCccccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            2 2223356889999999887553  567889999999999999988887544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-31  Score=254.89  Aligned_cols=204  Identities=23%  Similarity=0.295  Sum_probs=172.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|++|.||+|..+.+++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            3678889999999999999999988899999999875432 233567789999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++ +|.+++.....   .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9975 89888865443   68999999999999999999998   99999999999999999999999999998754322


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .. ......++..|+|||.+.+.. .++...|+|++|+++++++++..|++...
T Consensus       157 ~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         157 SK-TYSNEVVTLWYRPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             Cc-cccccccccccCCcHHhhcCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            11 112234688999999887533 35678899999999999999999887554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=6.6e-31  Score=254.76  Aligned_cols=206  Identities=27%  Similarity=0.328  Sum_probs=178.3

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..+++|+..+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|++++.+++|+|++++++.+...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456778888999999999999999998889999999976544 5678899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999998754   269999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ... ......++..|+|||.+.+..  ++.+.|+|++|++++.++++..|+-...|
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~  221 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPP  221 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence            321 223345788999999987553  57789999999999999998877665544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=7.3e-31  Score=249.17  Aligned_cols=227  Identities=24%  Similarity=0.373  Sum_probs=189.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|+||.||++.+..++..+++|++.....  ...+++.+|++++.+++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            57788999999999999999998899999999976533  4567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.........+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997754333479999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                       .......|++.|+|||.+....  .+...|+|++|++++.++++..|+...  +..++.+.+... ..+++|...|.
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~-~~~~~~~~~~~  229 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELALKILKG-QYPPIPSQYSS  229 (258)
T ss_pred             -ceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCC--cHHHHHHHHhcC-CCCCCCCCCCH
Confidence             2233456889999999887554  567889999999999999888776543  456666666543 34555555553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=4.3e-31  Score=262.50  Aligned_cols=195  Identities=29%  Similarity=0.387  Sum_probs=162.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC--CeE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~  268 (459)
                      ..++|+..+.||+|+||.||+|.+..++..+|+|++...  .......+.+|+.++.++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            457788899999999999999999888999999998643  223345677899999999 999999999998653  468


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||++ ++|..++...     .+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 5898887543     58899999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCC----ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          349 LVDHELGP----RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       349 ~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ........    ......|+..|+|||.+.... ..+...|+|++|++++.+++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~el~t  208 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLL  208 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccc-cccccchHHHHHHHHHHHHh
Confidence            76543221    233456899999999886543 35678999999999886654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=248.60  Aligned_cols=201  Identities=29%  Similarity=0.411  Sum_probs=175.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|+..+.||+|++|.||++....+++.+++|.+.....  ...+.+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999998899999999976643  4556899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999986552    69999999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . ......++..|+|||.+.+..  .+...|+|++|++++.++++..|+....
T Consensus       154 ~-~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         154 K-DDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             c-cccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            2 123456789999999987554  5778999999999999999888876543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=9e-31  Score=254.87  Aligned_cols=213  Identities=23%  Similarity=0.312  Sum_probs=173.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|++|.||+|....+++.||+|.+.....  ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578889999999999999999998899999999865422  334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecCCcccccC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDH  352 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~  352 (459)
                      |++ ++|.+++.....  ..+++.....++.||+.||+|||+   ++++||||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 578777754332  246888889999999999999998   89999999999999985 55799999999976543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      .. .......++..|+|||++.+.. .++...|+|++|++++.++++..|++... ...++.+++
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~i~~~l~tg~~pf~~~~-~~~~~~~~~  217 (294)
T PLN00009        156 PV-RTFTHEVVTLWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDS-EIDELFKIF  217 (294)
T ss_pred             Cc-cccccCceeecccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Confidence            21 1123346788999999986543 35678899999999999999988887653 334444433

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.8e-30  Score=248.72  Aligned_cols=225  Identities=27%  Similarity=0.384  Sum_probs=182.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4778899999999999999875 588999999864321      123568899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++.+..    .+++..+..++.|++.||+|||+   .+|+|+||+|+||++++++.++|+|||+++..
T Consensus        80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999999996543    58899999999999999999998   89999999999999999999999999998765


Q ss_pred             cCCC-----CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          351 DHEL-----GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       351 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                      ....     ........|+..|+|||++.+..  ++...|+|++|++++.++++..|+...+ ...+...........|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~  229 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMD-RLAAMFYIGAHRGLMPR  229 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCC-hHHHHHHhhhccCCCCC
Confidence            3211     11123456889999999987654  5678899999999999999999887544 33444444444455666


Q ss_pred             CCCCCCc
Q 041624          426 LPSKMPV  432 (459)
Q Consensus       426 ~p~~~p~  432 (459)
                      +|...+.
T Consensus       230 ~~~~~~~  236 (265)
T cd06631         230 LPDSFSA  236 (265)
T ss_pred             CCCCCCH
Confidence            6655543

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=5e-31  Score=251.49  Aligned_cols=222  Identities=27%  Similarity=0.306  Sum_probs=185.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      +|+..+.||.|+||.||+|.+..++..||+|.+....   ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999999889999999997542   2346789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++....    ++++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999986552    68999999999999999999998   99999999999999999999999999998766432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhcCCCCCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS-IRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs-~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      .  ......|+..|+|||.+.+..  .+.+.|+|++|++++.++++..|+...+.. ..++++....  ..+..|...|
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWS  226 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCc
Confidence            1  233456888999999987654  577899999999999999999998776653 3333333332  3344444444

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=4e-31  Score=251.23  Aligned_cols=202  Identities=25%  Similarity=0.387  Sum_probs=174.6

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|++.+.||+|+||.||++....+++.+++|.+....  .....++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999999889999999987542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.........+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999987644333468999999999999999999998   99999999999999999999999999999877543 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                        ......++..|+|||.+.+..  ++...|+|++|+++++++++..|+...
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             --CcccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              223356788999999987653  466789999999999999888776543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=6.4e-31  Score=255.15  Aligned_cols=213  Identities=27%  Similarity=0.298  Sum_probs=175.3

Q ss_pred             CCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeE
Q 041624          197 NFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  268 (459)
                      +|+..+.||+|++|.||++...   .++..||+|.++...    ....+.+.+|+.++.++ +|+||+++++.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4777899999999999999864   356889999987532    22345788999999999 699999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++....    .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999886543    58999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC--RPSIRQAIQV  416 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~--RPs~~~v~~~  416 (459)
                      .+............|+..|+|||.+.+.....+...|+|++|+++++++++..|+...  .++..++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  223 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR  223 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence            7654433333345688999999998765544567889999999999999988887532  2334444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.1e-32  Score=269.43  Aligned_cols=207  Identities=22%  Similarity=0.344  Sum_probs=178.2

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccC----CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe--EEEEEEe
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG----LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEF  274 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E~  274 (459)
                      ..+||+|+|-+||||.+..+|..||--.++..    .....++|..|+.+|+.|+|+||++++.++.+...  +-+|+|+
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            46799999999999999999988886444321    23445789999999999999999999999887654  7899999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecCCcccccCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~  353 (459)
                      |..|+|..|+.+.+.    ++.+....|++||++||.|||+. ..+|||||||..||+|+.+ |.+||+|+|||.+....
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999988764    88999999999999999999985 4789999999999999865 89999999999987643


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                         ....+.|||.|||||++..   .|+..+|+|++|+++.+|.+|-.|..+.+ ...||.+....
T Consensus       200 ---~aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQIYKKV~S  258 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQIYKKVTS  258 (632)
T ss_pred             ---ccceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHHHHHHHc
Confidence               2344899999999999974   47899999999999999999999999888 66777776544

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.2e-30  Score=258.97  Aligned_cols=203  Identities=23%  Similarity=0.249  Sum_probs=166.5

Q ss_pred             hcCCCC-CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc--------------hHHHHHHHHHHhccCcCCceeEE
Q 041624          195 TNNFSN-ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--------------KNEYITEVKTCSQLRHRNLLQLI  259 (459)
Q Consensus       195 ~~~f~~-~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~  259 (459)
                      .++|.. .+.||+|+||.||+|.+..+++.||+|+++......              ...+.+|++++.+++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345543 467999999999999999889999999986542211              12577999999999999999999


Q ss_pred             EEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       260 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      +++...+..++||||++ |+|.+++....    .+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCE
Confidence            99999999999999996 68988886433    58999999999999999999998   999999999999999999999


Q ss_pred             EEeecCCcccccCCC-------------CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          340 KLGDFGLALLVDHEL-------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       340 kL~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ||+|||+++......             ........++..|+|||.+.+.. .++...|+|++|+++++++++..|++..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999997664110             11122345688999999987543 3577889999999999998877666544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=7.4e-31  Score=260.89  Aligned_cols=196  Identities=24%  Similarity=0.339  Sum_probs=163.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      .++|...+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.++..++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999999999999999998754  233455778899999999999999999987654     35


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+. ++|.+++....    .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 68888876443    59999999999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      +...... .......++..|+|||.+.... .++...|+|++|+++++++++.
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~  206 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRK  206 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCC
Confidence            8664321 2233456788999999886533 2677899999999987665433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.2e-31  Score=284.29  Aligned_cols=201  Identities=24%  Similarity=0.329  Sum_probs=163.5

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEee------
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD------  264 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------  264 (459)
                      .+...+|+..+.||+||||.||+++++-+|+.+|||++.... ........+|+..|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            566788999999999999999999999999999999997653 3344567899999999999999998653210      


Q ss_pred             -------------------------------------------------C------------------------------
Q 041624          265 -------------------------------------------------R------------------------------  265 (459)
Q Consensus       265 -------------------------------------------------~------------------------------  265 (459)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 041624          266 ----------------------------------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL  311 (459)
Q Consensus       266 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~  311 (459)
                                                        ..+||-||||+..+|.+++..+.-.   -.....++++.+|++||.
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence                                              1257889999988888777655421   146778999999999999


Q ss_pred             HhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc-----------------CCCCCccccccccccccccceec
Q 041624          312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD-----------------HELGPRTTGLAGTLGYMAPEYIS  374 (459)
Q Consensus       312 yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~APE~~~  374 (459)
                      |+|+   ++||||||||.||+||++..+||+|||+|+...                 .......+..+||.-|+|||++.
T Consensus       712 YIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            9999   999999999999999999999999999998721                 01111346678999999999997


Q ss_pred             cCcc-ccCCCCCHHHHHHHHHHHHh
Q 041624          375 TGRA-RLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       375 ~~~~-~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +... .++.++|+||+|+++++|+.
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc
Confidence            5542 58999999999999998874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=6e-31  Score=261.16  Aligned_cols=195  Identities=24%  Similarity=0.371  Sum_probs=163.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~  268 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.++.+++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378899999999999999999999999999999987642  2345678889999999999999999998753    3568


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+. ++|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 68988885443    48999999999999999999998   999999999999999999999999999997


Q ss_pred             cccCCCCCc---cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          349 LVDHELGPR---TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       349 ~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .........   .....|+..|+|||.+.... .++.+.|+|++|++++++++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~el~~  207 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLG  207 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCc-ccccccchHHHHHHHHHHHc
Confidence            664332211   23457889999999986533 36788999999999876643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=243.07  Aligned_cols=219  Identities=27%  Similarity=0.378  Sum_probs=184.5

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccC-CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ....||.|..|.|++++.+.+|..+|||.+.+. ..+..++++..++++..- +.|.||+.+|||..+...++.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            346799999999999999999999999999876 345567788888887766 48999999999999999999999994 


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      .-++.++..-..   ++++...-++...+++||.||.+  +++|+|||+||+|||+|+.|++||||||++-.+-+.  ..
T Consensus       175 ~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kA  247 (391)
T KOG0983|consen  175 TCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KA  247 (391)
T ss_pred             HHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc--cc
Confidence            356666655444   68998899999999999999999  799999999999999999999999999999766543  23


Q ss_pred             cccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPS  428 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~  428 (459)
                      .+..+|-+.|||||.+.-. +..++..+|+||+|+.++++.++..|++...-.+.-+-++|+.+.  |-+|.
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~L~~  317 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PLLPG  317 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CCCCc
Confidence            3456788999999998754 556788889999999999999999999999888888888888543  44444

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2.8e-30  Score=249.81  Aligned_cols=195  Identities=26%  Similarity=0.356  Sum_probs=161.5

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHh---ccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCS---QLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      .||+|+||.||++....+++.+|+|.+.....   .....+.+|..++.   ..+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999998899999999865422   12233445544333   3479999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +++|.+++..+.    .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.++|+|||++......   
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---  150 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence            999998886543    59999999999999999999999   99999999999999999999999999998755432   


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ......|+..|+|||.+.++. .++.+.|+|++|+++++++++..|+....+
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  201 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGT-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence            123356899999999886543 357788999999999999999999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=260.17  Aligned_cols=191  Identities=26%  Similarity=0.384  Sum_probs=158.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------C
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------G  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~  266 (459)
                      .++|...+.||+|+||.||+|....+++.||+|++....  ......+.+|+.++.+++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999998889999999987542  22345688999999999999999999998654      3


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++|+||+.. +|..++.      ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46999999964 6665541      158899999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      ++....    ......++..|+|||.+.+.. .++.+.|+|++|+++++++++.
T Consensus       164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slGvil~el~~g~  212 (342)
T cd07879         164 ARHADA----EMTGYVVTRWYRAPEVILNWM-HYNQTVDIWSVGCIMAEMLTGK  212 (342)
T ss_pred             CcCCCC----CCCCceeeecccChhhhcCcc-ccCchHHHHHHHHHHHHHHhCC
Confidence            976432    123456788999999987533 3567889999999998776543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.3e-30  Score=256.18  Aligned_cols=195  Identities=21%  Similarity=0.147  Sum_probs=160.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcchhcc
Q 041624          208 GFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLF  285 (459)
Q Consensus       208 ~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  285 (459)
                      ++|.||.++...+++.||+|+++..  .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455555556667899999999764  23455789999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC------Cccc
Q 041624          286 SKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG------PRTT  359 (459)
Q Consensus       286 ~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~  359 (459)
                      ....  ..+++.....++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||.+........      ....
T Consensus        92 ~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          92 THFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             Hhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            6432  258899999999999999999998   9999999999999999999999999998875532211      1123


Q ss_pred             cccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          360 GLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       360 ~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ...++..|+|||++......++.+.|+|++|+++++++++..|+....
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            345778899999987654456778999999999999998877776543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.2e-30  Score=254.11  Aligned_cols=193  Identities=29%  Similarity=0.355  Sum_probs=167.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD  281 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  281 (459)
                      ..||+|+||.||++....++..||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999999889999999986555555667899999999999999999999999999999999999999999


Q ss_pred             hhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCccccc
Q 041624          282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL  361 (459)
Q Consensus       282 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  361 (459)
                      +++...     .+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....... ......
T Consensus       106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~  176 (292)
T cd06657         106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL  176 (292)
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence            877432     48899999999999999999998   899999999999999999999999999987654332 122345


Q ss_pred             cccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          362 AGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       362 ~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .|+..|+|||.+.+..  .+.+.|+|++|++++.++++..|+..
T Consensus       177 ~~~~~y~~pE~~~~~~--~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         177 VGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             ccCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            6889999999887543  46788999999999999987777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=6.5e-32  Score=249.41  Aligned_cols=204  Identities=24%  Similarity=0.343  Sum_probs=171.1

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCC----cEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEee-C
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHD-R  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~  265 (459)
                      .....|+....||+|.||.||+|.-++++    +.+|+|+++....  .......+|+.+++.++|+||+.|..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34567888899999999999999776543    3789999976532  224567899999999999999999999877 7


Q ss_pred             CeEEEEEEecCCCCcchhccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC----CCEE
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKK-STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD----FNVK  340 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~k  340 (459)
                      ..++|++||.+. +|.+.|+-++ .....++...+..|+.||+.|+.|||+   +=|+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeE
Confidence            889999999977 8888876433 223468999999999999999999999   779999999999999887    8999


Q ss_pred             EeecCCcccccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          341 LGDFGLALLVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      |+|||++|++.......  ...++-|..|.|||.+.+.+ .++.++|+|++||++.++++-..
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-hYT~AiDvWAiGCIfaElLtl~P  238 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-HYTKAIDVWAIGCIFAELLTLEP  238 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccc-cccchhhhHHHHHHHHHHHccCc
Confidence            99999999987654433  34567799999999999776 59999999999999999997443

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=6.5e-31  Score=250.72  Aligned_cols=204  Identities=24%  Similarity=0.286  Sum_probs=172.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||.||++....+++.+++|.+.....   ...+.+.+|++++.+++|+||+++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999875433   3456788999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC-----
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-----  355 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----  355 (459)
                      .+++....    .+++..+..++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99987543    58999999999999999999998   9999999999999999999999999999876543211     


Q ss_pred             --CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          356 --PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       356 --~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                        .......++..|+|||.+....  .+...|+|++|+++++++++..|+....  ..++.+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~  214 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNIL  214 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh
Confidence              1223456788999999987654  5677899999999999999988876554  344444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.5e-30  Score=257.58  Aligned_cols=201  Identities=18%  Similarity=0.147  Sum_probs=165.5

Q ss_pred             ceeccC--CceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQG--GFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ..||+|  +||+||++.+..+++.||+|.+.....  ...+.+.+|+.++..++|+||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  999999999998899999999875432  2346788999999999999999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      ++|.+++.....  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999998876432  258999999999999999999998   999999999999999999999999998654332211111


Q ss_pred             ------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          358 ------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       358 ------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                            .....++..|+|||++.++...++...|+|++|++++++++|..|+...+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                  11123466799999997654556788999999999999999888876654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=272.45  Aligned_cols=217  Identities=26%  Similarity=0.385  Sum_probs=185.2

Q ss_pred             CCCceeccCCceEEEEEEEcCCC----cEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ...++||+|+||+||+|.+--.+    .+||+|++... ..+..+++++|+.+|.+++|+||++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34579999999999999885433    57899988765 3455789999999999999999999999998776 889999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |||.|+|.++++.++.   .+-....+.|..|||+||.|||+   ++++||||.++|||+.+-..+||.|||+++.+..+
T Consensus       778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999998766   68899999999999999999998   99999999999999999999999999999998765


Q ss_pred             CCCcc-ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          354 LGPRT-TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       354 ~~~~~-~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      ..... ....-.+.|||-|.+....  ++.+.|+|++|+.++++++                                  
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence            43332 2333467899999998654  6888999999998877665                                  


Q ss_pred             ------cCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          399 ------CAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       399 ------c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                            ||..++..||.++++...+..-..-|
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence                  99999999999999998876544433

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-30  Score=249.39  Aligned_cols=200  Identities=27%  Similarity=0.379  Sum_probs=165.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhcc---CcCCceeEEEEEeeCCe-----
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQL---RHRNLLQLIGLCHDRGE-----  267 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----  267 (459)
                      |++.+.||+|+||.||+|.++.+++.+|+|+++.....  ....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            56778999999999999999988999999999754222  234566787777666   69999999999988776     


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .+++|||+. ++|.+++.....  ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            999999997 488888765432  258999999999999999999998   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ..+....  ......++..|+|||.+.+..  .+.+.|+|++|++++.++++..++....
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         155 RIYSFEM--ALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             eeccCCc--ccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            8765432  223345788999999997654  5678899999999999998877766544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.7e-30  Score=254.94  Aligned_cols=197  Identities=32%  Similarity=0.360  Sum_probs=164.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +.|+..+.||+|+||.||+|....++..+|+|.+....   ....+++.+|+++++.++|+|++++++++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999999889999999986432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+. |+|.+++.....   ++++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 688777754433   58999999999999999999998   8999999999999999999999999999876542


Q ss_pred             CCCCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                           .....++..|+|||.+... ....+.+.|+|++|+++++++++..|+.
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence                 2335678899999997531 1235678999999999999887666543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.9e-30  Score=259.63  Aligned_cols=194  Identities=25%  Similarity=0.282  Sum_probs=162.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  265 (459)
                      ..++|+..+.||+|+||.||+|....+++.||+|.+....  ....+++.+|+.++.+++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999999899999999986532  23345778899999999999999999998643      


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ...++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999996 588777642      27888999999999999999998   899999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      +++.....  .......++..|+|||.+.+..  ++.+.|+|++|++++.++++..
T Consensus       164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~  215 (353)
T cd07850         164 LARTAGTS--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTV  215 (353)
T ss_pred             cceeCCCC--CCCCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCC
Confidence            99876432  1223456789999999987653  5778899999999877765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=5.4e-30  Score=244.90  Aligned_cols=203  Identities=24%  Similarity=0.250  Sum_probs=173.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||.|++|.||+|.+..+++.+|+|.+.....   ...+.+.+|+.++++++|+||+++++.+.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999998899999999975432   3456789999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++....    .+++..+..++.||+.||+|||+   .+++|+||+|+||+++.++.++|+|||+++......  ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            99996543    48999999999999999999998   999999999999999999999999999998765432  2334


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      ..++..|+|||.+....  ++...|+|++|++++.++++..|+........++.+..
T Consensus       152 ~~~~~~~~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         152 FCGTPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             ccCCcCccChhHhcCCC--CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence            56889999999987543  56778999999999999999998876653334444433

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=5.3e-30  Score=252.13  Aligned_cols=197  Identities=34%  Similarity=0.352  Sum_probs=165.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      |...+.||+|+||.||+|....++..|++|++.....   ...+.+.+|++++.+++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5556789999999999999988899999999875432   2335688999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +. |+|.+++.....   ++++.++..++.||+.||.|||+   .+++|+||+|+||+++.++.+||+|||++....   
T Consensus       103 ~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---  172 (313)
T cd06633         103 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---  172 (313)
T ss_pred             CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence            96 577777754433   68999999999999999999998   899999999999999999999999999986432   


Q ss_pred             CCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                        ......|+..|+|||++... ....+...|+|++|+++++++++..|+...
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              22345688999999998532 223567889999999999998877766544

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-30  Score=257.53  Aligned_cols=208  Identities=25%  Similarity=0.330  Sum_probs=173.2

Q ss_pred             cccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEE
Q 041624          184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGL  261 (459)
Q Consensus       184 ~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~  261 (459)
                      ++....++...+++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.++.+++|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            34556778888999999999999999999999998889999999997542  2234668899999999999999999998


Q ss_pred             EeeC------CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC
Q 041624          262 CHDR------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT  335 (459)
Q Consensus       262 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~  335 (459)
                      +...      ...+++++++ +++|.+++...     .+++..+..++.|++.||+|||+   .+|+||||||+||++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~  155 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence            8643      3468888887 78998877432     48999999999999999999998   99999999999999999


Q ss_pred             CCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       336 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ++.+||+|||+++....    ......++..|+|||.+.+.. .++.+.|+|++|+++++++++..|++.
T Consensus       156 ~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         156 DCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             CCCEEEecccccccccc----cccccccCCCccCHHHHhCcc-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999876432    223456788999999886432 356788999999999998877666654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=9.4e-30  Score=242.95  Aligned_cols=215  Identities=26%  Similarity=0.328  Sum_probs=184.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468888999999999999999999999999999976543 4467899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++....    .+++..++.++.|++.||+|||+.  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999997652    689999999999999999999962  799999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhc
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR-PSIRQAIQVLNF  419 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R-Ps~~~v~~~L~~  419 (459)
                      . ......++..|+|||.+.++  ..+...|+|++|++++.++++..|+.... +...++++.+..
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  217 (264)
T cd06623         155 D-QCNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD  217 (264)
T ss_pred             C-cccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc
Confidence            2 22345678999999998766  35678899999999999999999886554 466666666553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-30  Score=257.51  Aligned_cols=193  Identities=28%  Similarity=0.380  Sum_probs=164.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-----eEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-----EFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~  269 (459)
                      +|++.+.||+|++|.||+|....++..||+|++....  ....+.+.+|+.++++++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999999889999999997653  344567899999999999999999999988775     789


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||++ ++|.+++....    .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 58888886443    69999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          350 VDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       350 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ......  .......++..|+|||.+.+.. ..+.+.|+|++|++++.+++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~  202 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLT  202 (330)
T ss_pred             ecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHc
Confidence            654321  1233456788999999998653 46788999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-30  Score=246.41  Aligned_cols=200  Identities=22%  Similarity=0.210  Sum_probs=165.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHH-hccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTC-SQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|....+++.||+|.++....   .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999988899999999865422   1223344554443 455899999999999999999999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      ++|.+++....    .+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++....     
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999986543    58999999999999999999998   8999999999999999999999999999875432     


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      .....++..|+|||.+.+..  ++...|+|++|+++++++++..|+....  -.++.+.+
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~  205 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNI  205 (260)
T ss_pred             cccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH
Confidence            23356788999999987654  5778899999999999999999886543  34444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=230.84  Aligned_cols=224  Identities=25%  Similarity=0.299  Sum_probs=187.9

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeE
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  268 (459)
                      ++...+.......||+|++|.|-+-++..+|...|+|+++... .+..++.++|+.+..+. .+|.+|+++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3334444555678999999999999999999999999998663 45567788999887776 799999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++.||.|. -||+.+..+--..+..+++...-+|+..+..||.|||+  +..++|||+||+||||+.+|++|+||||.+-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999994 58887776544455579999999999999999999999  6899999999999999999999999999997


Q ss_pred             cccCCCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .+.+.  -..+...|-..|||||.+..+.  ..++.++|+||+|..+.++.....|.+.-+--+.|+-|..+.
T Consensus       198 ~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  198 YLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             eehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            66543  2233456778999999886432  257888999999999999999999999999888888888754

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1e-29  Score=245.72  Aligned_cols=194  Identities=26%  Similarity=0.354  Sum_probs=161.5

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHH---HHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVK---TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      .||+|+||.||+|....+++.||+|.+.....   .....+..|..   .+....|+||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988899999999875422   11223444443   3444579999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +++|.+++....    .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+...   
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---  150 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence            999998886432    59999999999999999999998   99999999999999999999999999998765432   


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ......|+..|+|||.+.++. .++...|+|++|+++++++++..|+....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence            123357899999999987543 35678899999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=290.55  Aligned_cols=229  Identities=26%  Similarity=0.324  Sum_probs=188.9

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..+-+|+....||.|.||.||-|.+.++|...|+|-++-.  .........+|+.++..|+|||+|+.+|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3456778889999999999999999999999999988643  34456678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      .||||++|+|.+.+...+    .+++.....+..|++.|+.|||+   ++||||||||.||+|+.+|.+|++|||.|..+
T Consensus      1312 FMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEe
Confidence            999999999999986544    47777788889999999999998   99999999999999999999999999999887


Q ss_pred             cCCCC---CccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 041624          351 DHELG---PRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL  426 (459)
Q Consensus       351 ~~~~~---~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~  426 (459)
                      .....   .......||+.|||||.+.+.+ .....+.|+||+||+..+|.++..|+.+-- +-.+|+-.. +....|++
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V-~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHV-AAGHKPQI 1462 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHH-hccCCCCC
Confidence            65421   1235678999999999998655 345677899999999999999888877543 223333332 34456666


Q ss_pred             CCCC
Q 041624          427 PSKM  430 (459)
Q Consensus       427 p~~~  430 (459)
                      |..+
T Consensus      1463 P~~l 1466 (1509)
T KOG4645|consen 1463 PERL 1466 (1509)
T ss_pred             chhh
Confidence            6654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=265.90  Aligned_cols=192  Identities=25%  Similarity=0.330  Sum_probs=164.6

Q ss_pred             CCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          199 SNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ...++||+|.||.|++|.|...   ...||||+++..... ...+|++|+.+|.+|+|+|+++|||+..+ ..+.+|+|+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            3457899999999999999753   357999999876543 68899999999999999999999999988 678999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      ++.|||.+.|++..  ...|-......++.|||.||+||.+   +++|||||..+|+||-..-.+||+||||.+-+....
T Consensus       192 aplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999998732  2368888999999999999999999   999999999999999999999999999999887554


Q ss_pred             CCcc--ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          355 GPRT--TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       355 ~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ....  ....-...|.|||.+..++  ++.++|+|.+|+.+++|++
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFt  310 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFT  310 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhc
Confidence            3332  2233456899999999876  5788899999999988776

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-30  Score=248.78  Aligned_cols=200  Identities=25%  Similarity=0.331  Sum_probs=171.0

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      |+..+.||+|++|.||+|....+++.+++|+++....  .....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5667899999999999999988899999999876533  24567889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++ +|.+++.....   .+++.+++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 88888766432   69999999999999999999998   999999999999999999999999999997765432 


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .......++..|+|||.+.+.. ..+.+.|+|++|++++.++++..+++..
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~  202 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDK-GYSTPVDIWSVGCIFAELLSRRPLFPGK  202 (283)
T ss_pred             ccccCccCcccccCcHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            1223345788999999987542 3678899999999999999988777654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=8.8e-30  Score=245.82  Aligned_cols=195  Identities=27%  Similarity=0.403  Sum_probs=168.1

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||.||++....+++.+|+|.+....   ......+..|++++.+++|+||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999889999999986542   22345678899999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++.....  ..+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......  .....
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence            999876543  258999999999999999999998   99999999999999999999999999999766432  22334


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ..++..|+|||.+.++.  ++...|+|++|++++.++++..|+....
T Consensus       154 ~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         154 RAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             ccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            56788999999987654  5678899999999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.8e-30  Score=252.91  Aligned_cols=203  Identities=30%  Similarity=0.355  Sum_probs=166.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccCcCCceeEEEEEeeC-------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGLCHDR-------  265 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------  265 (459)
                      .++|+..+.||+|+||.||+|.+..+++.+|+|++......  ....+.+|++++.+++|+||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57899999999999999999999988999999998654322  234677899999999999999999987543       


Q ss_pred             -CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          266 -GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       266 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                       ..+++||||+.+ +|...+....   ..+++..+..++.|+++||+|||+   .+|+|+||||+||++++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence             346999999965 6766665433   269999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCCCC----------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          345 GLALLVDHELGP----------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       345 Gla~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      |+++........          ......+++.|+|||.+.+.. .++...|+|++|+++++++++..|+..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC-ccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            999865432211          112345688899999886543 367789999999999999999877653

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=248.37  Aligned_cols=201  Identities=25%  Similarity=0.342  Sum_probs=170.6

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEEec
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      |++.+.||+|++|.||+|....+++.|++|++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677899999999999999998899999999875432 22334567999999998 999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                       +|+|.+++.....  ..+++.++..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||+++...... 
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             8899888876541  368999999999999999999998   999999999999999999999999999998664321 


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       ......++..|+|||++.... .++...|+|++|+++++++++..+++...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             -CcCCCCCcccccCceeeecCc-CcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence             223456788999999886543 36778999999999999999988887654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=4.8e-30  Score=254.16  Aligned_cols=203  Identities=29%  Similarity=0.350  Sum_probs=171.0

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee-CC
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RG  266 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~  266 (459)
                      ++...+++|+..+.||+|+||.||+|....+++.||+|++....  ....+.+..|++++.+++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            44557889999999999999999999999889999999886532  2345678899999999999999999999865 56


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++|+||+ +++|.+++...     .+++.....++.|+++||+|||+   .+|+||||+|+|||++.++.+||+|||+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence            789999998 56888877532     47888889999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ++....    ......++..|+|||.+.++. .++...|+|++|+++++++++..|++..
T Consensus       155 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         155 ARIQDP----QMTGYVSTRYYRAPEIMLTWQ-KYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             ccccCC----CcCCCcccccccCceeeeccC-CcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            975432    223346788999999886533 3577899999999999999988777654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=6.9e-30  Score=249.06  Aligned_cols=203  Identities=19%  Similarity=0.121  Sum_probs=154.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCCccch-----------HHHHHHHHHHhccCcCCceeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKHGK-----------NEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      .++|.+.++||+|+||.||+|....+   +..+|+|..........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36789999999999999999998876   56677776433221111           11233445566779999999999


Q ss_pred             EEeeCC----eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          261 LCHDRG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       261 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      ++....    ..++++|++.. ++.+.+....    ..++..+..|+.|++.||+|||+   .+|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            876543    34778887743 5655554322    35788889999999999999998   899999999999999999


Q ss_pred             CCEEEeecCCcccccCCCC------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          337 FNVKLGDFGLALLVDHELG------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      +.++|+|||+|+.+.....      .......||+.|+|||++.+..  ++...|+||+|+++++++++..|+....
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999987643211      1123356999999999987654  5788899999999999999999987663

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.5e-30  Score=250.63  Aligned_cols=202  Identities=25%  Similarity=0.364  Sum_probs=173.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ....+.+.+|..++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999999889999999986532   233467889999999998 99999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999997653    59999999999999999999998   999999999999999999999999999997664


Q ss_pred             CCCC-------------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELG-------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~-------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ....                   .......++..|+|||.+....  .+...|+|++|++++.++++..|+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3321                   1123346789999999887654  567889999999999999987776644

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=2.4e-29  Score=241.70  Aligned_cols=202  Identities=25%  Similarity=0.265  Sum_probs=167.2

Q ss_pred             HHHHHHHhcCCCCCcee--ccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          188 YKDLASATNNFSNERKL--GQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~L--g~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++....++|+..+.+  |+|+||.||++..+.++..+|+|.+........     |+.....+ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34555566777777776  999999999999999899999999865422111     22222222 79999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGD  343 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~D  343 (459)
                      .+..++||||+++++|.+++....    .+++.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999986543    69999999999999999999998   8999999999999999998 999999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ||+++.....     ....++..|+|||++.+..  ++.+.|+|++|+++++++++..|+....+
T Consensus       154 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~  211 (267)
T PHA03390        154 YGLCKIIGTP-----SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDED  211 (267)
T ss_pred             CccceecCCC-----ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence            9998765432     2346789999999997654  56788999999999999999998875443

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=2.8e-30  Score=257.30  Aligned_cols=197  Identities=26%  Similarity=0.351  Sum_probs=161.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC----------
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR----------  265 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----------  265 (459)
                      ++|...+.||.|+||.||+|....+++.||+|++........+.+.+|++++++++|+||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6788999999999999999999999999999999766556667889999999999999999999776543          


Q ss_pred             ----CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEE
Q 041624          266 ----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVK  340 (459)
Q Consensus       266 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~k  340 (459)
                          ...++||||++ ++|.+++...     .+++..++.++.||+.||.|||+   .+|+||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence                35799999997 5888777432     48899999999999999999998   89999999999999984 56789


Q ss_pred             EeecCCcccccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          341 LGDFGLALLVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      |+|||+++.+.......  .....++..|+|||.+..+. .++.+.|+|++|+++++++++..|
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~p  218 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKPL  218 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCcc-ccCchhhHHHHHHHHHHHHhCCCC
Confidence            99999997664321111  22345788999999876433 367789999999999876544433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.3e-30  Score=255.42  Aligned_cols=196  Identities=25%  Similarity=0.354  Sum_probs=164.0

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC----
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----  266 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----  266 (459)
                      ...++|+..+.||+|+||.||+|....++..||||++....  ....+.+.+|+.++.+++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999999889999999986532  223456889999999999999999999987553    


Q ss_pred             --eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          267 --EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       267 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                        ..++||||+ +++|.+++...     .+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence              458999999 77898877532     58999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      |++......    .....++..|+|||.+.+.. .++...|+|++|++++.+++|..|
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  215 (343)
T cd07880         163 GLARQTDSE----MTGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPL  215 (343)
T ss_pred             ccccccccC----ccccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999765432    23446788999999987532 356778999999999877765544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=3e-29  Score=237.94  Aligned_cols=226  Identities=27%  Similarity=0.327  Sum_probs=187.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  272 (459)
                      +|+..+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47778999999999999999998899999999876542  4567889999999999999999999999988  8999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999987654    68999999999999999999998   9999999999999999999999999999987764


Q ss_pred             CCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          353 ELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       353 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      .... ......++..|+|||.+....  .....|+|++|++++.++++..|+.... ...+.+..+......+.+|...|
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPEIPEHLS  230 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCCcCCCcccC
Confidence            4221 123456889999999987664  5778899999999999999998887665 33333344433344555555544


Q ss_pred             c
Q 041624          432 V  432 (459)
Q Consensus       432 ~  432 (459)
                      .
T Consensus       231 ~  231 (260)
T cd06606         231 E  231 (260)
T ss_pred             H
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=9.1e-30  Score=252.49  Aligned_cols=198  Identities=26%  Similarity=0.310  Sum_probs=161.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCC--CcEEEEEEeccCC--ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeC----Ce
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDL--NMAVAVKKISRGL--KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR----GE  267 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~  267 (459)
                      +|+..+.||+|+||.||++....+  +..||+|++....  ....+.+.+|+.++.++ +|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477788999999999999999887  8899999987532  22356788999999999 599999999975432    45


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++++||+. ++|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788999885 68988885433    58999999999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          348 LLVDHELGP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       348 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      +.+......   ......||..|+|||.+.+.. ..+...|+|++|++++.++.+..|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~~l~~g~~pf  210 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ-SYTKAIDVWSVGCILAELLGRKPVF  210 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCcCC
Confidence            866432211   123457899999999886533 3577889999999998776655443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.3e-30  Score=246.09  Aligned_cols=203  Identities=25%  Similarity=0.332  Sum_probs=167.8

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-----ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +|.+.+.||+|+||.||++.+...+..+++|.++...     .....++..|+.++.+++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999998766667777665421     22334577899999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++.........+++.+++.++.|++.||.|||+   .+++|+||||+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999887544344579999999999999999999998   99999999999999975 569999999997764


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ... .......|+..|+|||.+.+..  ++.+.|+|++|++++.++++..|+...
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~  208 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQ  208 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            332 2233456788999999886543  466789999999999999988887543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-30  Score=256.51  Aligned_cols=194  Identities=23%  Similarity=0.312  Sum_probs=161.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..|++.++||+||.+.||++...+ .+.+|+|++...  ..+...-|.+|+..|.+| .|.+|++|++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            568889999999999999998876 567788776533  345577899999999999 5999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||= ..+|..+|.+....  ...| .++.+..|++.|+.++|.   .||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            976 55999999776542  3345 778889999999999999   99999999999999875 5899999999988765


Q ss_pred             CCCCc-cccccccccccccceeccCcc---------ccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELGPR-TTGLAGTLGYMAPEYISTGRA---------RLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~~~-~~~~~gt~~y~APE~~~~~~~---------~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +...- ....+||+.||+||.+.....         ..+..+|+||+||++|.|+.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY  567 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY  567 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence            43322 346789999999999864433         36778999999999998886

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=9.5e-30  Score=245.48  Aligned_cols=200  Identities=27%  Similarity=0.342  Sum_probs=170.8

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      |+..+.||+|++|.||+|....+++.+|+|.+....  ....+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999999989999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      + ++|.+++.....   .+++..++.++.|++.||+|||+   .+|+||||+|+||++++++.+||+|||+++.......
T Consensus        81 ~-~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 599999876532   59999999999999999999999   8999999999999999999999999999987654321


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       ......++..|+|||.+.+.. ..+.+.|+|++|+++++++++..|+...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSK-HYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCc-CCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence             223345678899999987552 3677889999999999999987776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3.1e-29  Score=244.45  Aligned_cols=218  Identities=26%  Similarity=0.358  Sum_probs=175.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||.++.... ....++..|+.++.+. .|+||+++++++.+....++|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678888999999999999999998899999999975432 3345677788777777 499999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||++ ++|.+++.....   .+++..+..++.|++.||+|||+  ..+|+||||+|+||++++++.+||+|||++..+.
T Consensus        93 ~e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 477776654332   69999999999999999999997  2589999999999999999999999999997664


Q ss_pred             CCCCCccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ...  ......++..|+|||++.+..  ..++...|+|++|+++++++++..|+....+....+.+.+..
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  234 (296)
T cd06618         167 DSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE  234 (296)
T ss_pred             CCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence            322  122345788999999987553  335678899999999999999999987654444434444444

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.3e-29  Score=266.64  Aligned_cols=197  Identities=22%  Similarity=0.238  Sum_probs=141.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC----CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEE------Ee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL------CH  263 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~  263 (459)
                      ..++|...+.||+|+||.||+|++..+    +..||+|++.....  .+.+..|  .+....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999988    89999999864321  1112221  1112222222222111      34


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCC
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKST----------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK  327 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk  327 (459)
                      .....+|||||+++++|.+++......                ........+..++.||+.||.|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            567899999999999999988653210                0011234466899999999999998   899999999


Q ss_pred             CCCeeecC-CCCEEEeecCCcccccCCCCCccccccccccccccceeccCcc--------------------ccCCCCCH
Q 041624          328 FSNIMPDT-DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA--------------------RLDVNFDE  386 (459)
Q Consensus       328 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--------------------~~~~~~D~  386 (459)
                      |+|||++. ++.+||+|||+|+.+............+++.|+|||.+.....                    .+..++|+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 5799999999998765444444456788999999996543221                    12345699


Q ss_pred             HHHHHHHHHHH
Q 041624          387 QQTDCLMIVGL  397 (459)
Q Consensus       387 ~~~g~ll~~~l  397 (459)
                      ||+|+++++|+
T Consensus       363 wSlGviL~el~  373 (566)
T PLN03225        363 YSAGLIFLQMA  373 (566)
T ss_pred             HHHHHHHHHHH
Confidence            99999998876

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=269.71  Aligned_cols=225  Identities=25%  Similarity=0.399  Sum_probs=188.4

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcC-------CCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILID-------LNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIG  260 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g  260 (459)
                      .++...++..+.+.||+|.||.|++|....       ....||||.++.... ...+.+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            455566666777799999999999998652       146899999986643 4567899999999999 6999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCC
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKK---ST-------G--TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKF  328 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp  328 (459)
                      +|.+.+.+++|+||+..|+|.++|+..+   ..       .  ..|+..+.+.++.|||.|++||++   .+++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            9999999999999999999999998776   00       0  248999999999999999999999   8999999999


Q ss_pred             CCeeecCCCCEEEeecCCcccccCCCCCccccccc--cccccccceeccCccccCCCCCHHHHHHHHHHHHh--------
Q 041624          329 SNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG--TLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------  398 (459)
Q Consensus       329 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------  398 (459)
                      +|||+.++..+||+|||+|+...+..........|  ...|||||.+...  .++.++|+||+|++++++++        
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999765543333232232  3469999999874  46888899999999987665        


Q ss_pred             ---------------------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ---------------------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ---------------------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                                       ||+.+|++||++.++++.+..
T Consensus       525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence                                             999999999999999988876

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=247.07  Aligned_cols=211  Identities=22%  Similarity=0.302  Sum_probs=180.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..+|....+||+|+||.|.+|..+.+.+.+|||++++..   ..+.+--+.|-++|... +-|.+++++.++++.+.+|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356888999999999999999999999999999998763   23344456777777766 67899999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+.||+|-.++.+-.    .+.+..+..++.+||-||-+||+   ++||.||||..|||||.+|.+||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999988887655    47788889999999999999999   99999999999999999999999999999754


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      -.+ ...+.+.+||+.|+|||.+..+  .++..+|.|++|+++|+|+.+..|+-.+  .-.++.+.+
T Consensus       501 i~~-~~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI  562 (683)
T KOG0696|consen  501 IFD-GVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAI  562 (683)
T ss_pred             ccC-CcceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHH
Confidence            322 3346679999999999999865  4688899999999999999999998766  445555544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=2.3e-29  Score=244.08  Aligned_cols=215  Identities=25%  Similarity=0.305  Sum_probs=171.8

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      +|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999999999999999987543 234567889999999996 99999999999999999999999


Q ss_pred             cCCCCcchhccc-cCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          275 MPNGSLDFHLFS-KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      +.. +|.++... .......+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55544321 11112368999999999999999999997  259999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      .  ......|+..|+|||.+.... ..++...|+|++|++++++++|..|+........++.+.
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  223 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV  223 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh
Confidence            1  123346789999999987552 236778999999999999999999988766434444333

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=5.3e-30  Score=255.41  Aligned_cols=196  Identities=26%  Similarity=0.341  Sum_probs=165.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe----
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE----  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----  267 (459)
                      ..++|...+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999999889999999986532  2334567889999999999999999988766554    


Q ss_pred             --EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          268 --FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       268 --~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                        .++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999999 6699888854     258999999999999999999998   899999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ++......    .....++..|+|||.+.+.. .++...|+|++|+++++++++..|+
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCC
Confidence            99765432    33456788999999986533 4677889999999998877655444

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=259.53  Aligned_cols=223  Identities=26%  Similarity=0.332  Sum_probs=188.9

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++.+...++-|.+.+.||.|.+|.||+++...+++.+|+|++... ....++...|.++++.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            44556666788899999999999999999999999999999988654 34456778899999888 79999999999864


Q ss_pred             -----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          265 -----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       265 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                           ++++|||||||.+||.-+++..-.  +..+.|..+..|++.++.||.+||.   ..++|||||-.|||++.++.+
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcE
Confidence                 578999999999999999997655  4579999999999999999999998   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCc---cccCCCCCHHHHHHHHH----------------------
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMI----------------------  394 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~----------------------  394 (459)
                      ||+|||++..++.. .....+..||+.|||||++....   +.++..+|+|++|++..                      
T Consensus       163 KLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip  241 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  241 (953)
T ss_pred             EEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence            99999999888754 34456789999999999996543   35677789999997443                      


Q ss_pred             -------------------HHHhcCCCCCCCCCCHHHHHH
Q 041624          395 -------------------VGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       395 -------------------~~l~c~~p~p~~RPs~~~v~~  415 (459)
                                         .+..|+..+...||++.++++
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                               455588888888888877665

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-31  Score=243.13  Aligned_cols=230  Identities=25%  Similarity=0.270  Sum_probs=188.7

Q ss_pred             cccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEE
Q 041624          184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGL  261 (459)
Q Consensus       184 ~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~  261 (459)
                      ..|+-++|+.       ...||.|+||+|+|-.++.+|+..|||+++.... ..+++++.|.+...+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            3465555544       4679999999999999999999999999987644 5677899999876665 79999999999


Q ss_pred             EeeCCeEEEEEEecCCCCcchhccc-cCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          262 CHDRGEFMLVYEFMPNGSLDFHLFS-KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       262 ~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      +..++..|+.||+|. -||+.+... ...+...+++...-.|....+.||.||-.  +..|||||+||+|||||..|.+|
T Consensus       132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence            999999999999994 577655432 11112358888888899999999999998  48999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      |||||++-.+...  ...+..+|-..|||||.+......++..+|+||+|..++++.++.-|.+.----+.|+.+...++
T Consensus       209 LCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd  286 (361)
T KOG1006|consen  209 LCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD  286 (361)
T ss_pred             eecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC
Confidence            9999999765432  23455678899999999987766788899999999999999999999887666788888888887


Q ss_pred             CCCCC
Q 041624          421 TKMPN  425 (459)
Q Consensus       421 ~~~p~  425 (459)
                      .|...
T Consensus       287 pp~l~  291 (361)
T KOG1006|consen  287 PPILL  291 (361)
T ss_pred             CCeec
Confidence            65443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.3e-29  Score=255.36  Aligned_cols=204  Identities=21%  Similarity=0.291  Sum_probs=154.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc----------------CCCcEEEEEEeccCCccchHH--------------HHHH
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI----------------DLNMAVAVKKISRGLKHGKNE--------------YITE  243 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  243 (459)
                      ..++|++.++||+|+||.||+|...                ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                234679999986543322233              4457


Q ss_pred             HHHHhccCcCCc-----eeEEEEEee--------CCeEEEEEEecCCCCcchhccccCC--------------------C
Q 041624          244 VKTCSQLRHRNL-----LQLIGLCHD--------RGEFMLVYEFMPNGSLDFHLFSKKS--------------------T  290 (459)
Q Consensus       244 ~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~  290 (459)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876655     677787753        3568999999999999999874321                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccccccccccccc
Q 041624          291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP  370 (459)
Q Consensus       291 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~AP  370 (459)
                      ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            1235778899999999999999998   8999999999999999999999999999976543322222223457899999


Q ss_pred             ceeccCcc--------------------ccCCCCCHHHHHHHHHHHHhcC
Q 041624          371 EYISTGRA--------------------RLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       371 E~~~~~~~--------------------~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      |.+.....                    .....+|+|++|++++.|+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~  429 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE  429 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence            98864321                    1123479999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-30  Score=245.76  Aligned_cols=214  Identities=26%  Similarity=0.363  Sum_probs=179.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccc----hHHHHHHHHHHhccCcCCceeEEEEEe-eCCe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHG----KNEYITEVKTCSQLRHRNLLQLIGLCH-DRGE  267 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~----~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~  267 (459)
                      ++|-...+||+|||+.||+|.+....+.||+|+-..+.   .+.    .+...+|.++-+.|+||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            55667789999999999999998888999999864331   111    234678999999999999999999986 5667


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeec
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDF  344 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DF  344 (459)
                      +|-|+|||+|.+|+-+|..++    .+++.+++.|+.||+.||.||.+- +.+|||-||||.||||..   .|.+||.||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            899999999999999997765    599999999999999999999973 578999999999999854   478999999


Q ss_pred             CCcccccCCCCC------ccccccccccccccceeccCc--cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 041624          345 GLALLVDHELGP------RTTGLAGTLGYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       345 Gla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~--~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~  415 (459)
                      |++++++.+...      .+....||.+|++||++.-++  +.++.++|+|++|+++|..+.+..||-..- +-.+|++
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-sQQdILq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-SQQDILQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-hHHHHHh
Confidence            999999765433      245678999999999998763  456778999999999999999999987664 5556665

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=234.26  Aligned_cols=200  Identities=25%  Similarity=0.329  Sum_probs=178.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|...++||+|+|++|..++++.|.+.+|+|++++..   .++.+-.+.|-.+..+. +||.+|-|+.++++...++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3478999999999999999999999999999999998763   34455677888888887 7999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|.||+++|+|--++.+++    .|+++.++.+..+|..||.|||+   .|||.||||..|||+|..|.+||.|+|+++.
T Consensus       328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence            9999999999988886665    49999999999999999999999   9999999999999999999999999999975


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      --. .+..+++++||+.|+|||.+.+..  ++..+|.|++|+++++|+.+..|+
T Consensus       401 ~l~-~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspf  451 (593)
T KOG0695|consen  401 GLG-PGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPF  451 (593)
T ss_pred             CCC-CCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCc
Confidence            432 344577899999999999999875  567789999999999999999986

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=233.46  Aligned_cols=199  Identities=24%  Similarity=0.262  Sum_probs=166.5

Q ss_pred             HhcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee----CCe
Q 041624          194 ATNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD----RGE  267 (459)
Q Consensus       194 ~~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~  267 (459)
                      .+++|++. ++||-|-.|.|-.+..+.|++.+|+|++..     .....+|++.--.. .|+|||.++++|+.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45555443 689999999999999999999999999853     23445677765554 69999999999864    457


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEeec
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDF  344 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DF  344 (459)
                      +++|||.|+||.|.+-+.+++..  .+++.++-.|+.||+.|++|||+   .+|.||||||+|+|....   -.+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence            89999999999999999876653  79999999999999999999999   999999999999998654   46999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      |+|+.-..  .....+.+-|+.|.|||++-..+  ++...|+|++|+++|++|.+-.||-+.
T Consensus       209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ccccccCC--CccccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhhcCCCccccc
Confidence            99986543  23345678899999999997665  688899999999999999999887654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.1e-28  Score=229.85  Aligned_cols=203  Identities=27%  Similarity=0.293  Sum_probs=172.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      ||+|+||.||++....+++.+|+|.+.....   .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccc
Q 041624          281 DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG  360 (459)
Q Consensus       281 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  360 (459)
                      .+++....    .+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            99986553    58999999999999999999998   999999999999999999999999999997764321 22345


Q ss_pred             ccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          361 LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       361 ~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ..++..|+|||.+.+..  .+...|+|++|++++.++++..|+....  ..++.+.+.
T Consensus       153 ~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~  206 (250)
T cd05123         153 FCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKIL  206 (250)
T ss_pred             CcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHh
Confidence            66888999999987654  5677899999999999999998885442  244444443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.4e-28  Score=232.22  Aligned_cols=180  Identities=19%  Similarity=0.107  Sum_probs=152.8

Q ss_pred             CCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccc
Q 041624          207 GGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS  286 (459)
Q Consensus       207 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  286 (459)
                      |.+|.||++.+..+++.+|+|+++...     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999997542     233455555566799999999999999999999999999999999865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccccccccc
Q 041624          287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG  366 (459)
Q Consensus       287 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~  366 (459)
                      ..    .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++++|||.+......    .....++..
T Consensus        79 ~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 FL----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             hc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            43    48999999999999999999998   99999999999999999999999999988655432    223455778


Q ss_pred             ccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          367 YMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       367 y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      |+|||.+..+.  ++...|+|++|+++++++++..++.
T Consensus       148 y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         148 YCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhh
Confidence            99999886543  4677899999999999999876543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.6e-29  Score=248.63  Aligned_cols=205  Identities=22%  Similarity=0.258  Sum_probs=175.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .-|..++.||-|+||+|.++.-.+|...+|+|.+++..-   ........|-+||...+.+-||+|+..|++++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457788999999999999999999999999999976532   22334668899999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||++||++-.+|.+..    .+.+..++.++.++..|+++.|.   .|+|||||||.|||||.+|.+||.||||+.-+..
T Consensus       709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence            9999999999987665    58899999999999999999997   9999999999999999999999999999854311


Q ss_pred             --------CCCC---------------------------------ccccccccccccccceeccCccccCCCCCHHHHHH
Q 041624          353 --------ELGP---------------------------------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDC  391 (459)
Q Consensus       353 --------~~~~---------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~  391 (459)
                              ...+                                 .....+||..|+|||++...  .++..+|.|+.|+
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGV  859 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhH
Confidence                    0000                                 00125699999999999744  5688899999999


Q ss_pred             HHHHHHhcCCCCCCCCCC
Q 041624          392 LMIVGLWCAHPDRNCRPS  409 (459)
Q Consensus       392 ll~~~l~c~~p~p~~RPs  409 (459)
                      ++++|+.+..||-.+-|.
T Consensus       860 il~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHHHHhhCCCCccCCCCC
Confidence            999999999998887774

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=250.68  Aligned_cols=225  Identities=22%  Similarity=0.245  Sum_probs=188.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..+++....||-||||.|-.+..+.....+|+|++++..   ....+....|-.+|...+.+.||++|..|.+....|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345566678999999999999988755568999987652   33455677899999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||-|-||.|...|+++.    .++......++..+++|++|||.   ++||+|||||+|.|||.+|-+||.|||+|+.+.
T Consensus       499 mEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999999998776    48888999999999999999998   999999999999999999999999999999986


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      .  +..+.+++||+.|.|||.+.+..  .+..+|.|++|.++++++++..|+..--| |..--.+|++. ..-+.|+.++
T Consensus       572 ~--g~KTwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGi-d~i~~Pr~I~  645 (732)
T KOG0614|consen  572 S--GRKTWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGI-DKIEFPRRIT  645 (732)
T ss_pred             c--CCceeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhh-hhhhcccccc
Confidence            5  45677899999999999998764  47788999999999999999999987765 33333344433 2333455444


Q ss_pred             c
Q 041624          432 V  432 (459)
Q Consensus       432 ~  432 (459)
                      .
T Consensus       646 k  646 (732)
T KOG0614|consen  646 K  646 (732)
T ss_pred             h
Confidence            3

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-30  Score=234.17  Aligned_cols=203  Identities=29%  Similarity=0.416  Sum_probs=168.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee--------C
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--------R  265 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~  265 (459)
                      +.|....+||+|.||.||+|+.+++++.||+|++--..  ..-....++|+++|..|+|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999999999999998764321  2223456899999999999999999988753        2


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ..+|||+++|+. +|..+|.+...   .++..++.+++.++..||.|+|.   ..|+|||+||.|+||+.++.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence            358999999976 88888876544   69999999999999999999998   999999999999999999999999999


Q ss_pred             CcccccCCCC---CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          346 LALLVDHELG---PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       346 la~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +++.+.....   ...+..+-|..|.+||.+.+.+ .++...|+|..||++.+|.+..+.....
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCC
Confidence            9987754322   2234456699999999999766 4899999999999999998876665543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.9e-27  Score=219.75  Aligned_cols=220  Identities=29%  Similarity=0.384  Sum_probs=186.1

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      |...+.||+|++|.||++....+++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            55678999999999999999988899999999866544 67789999999999999999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +++|.+++.....   .+++.....++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999999876432   28899999999999999999998   89999999999999999999999999999877544211


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      ......++..|++||.+. +...++...|+|++|+++++++++..|++.++-...++.+.+....+.|
T Consensus       155 ~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL  221 (225)
T ss_pred             cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence            233456788999999985 3334566899999999999999999999774445567777776655433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=6.6e-29  Score=245.68  Aligned_cols=197  Identities=25%  Similarity=0.302  Sum_probs=168.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--------cchHHHHHHHHHHhccC---cCCceeEEEEEee
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--------HGKNEYITEVKTCSQLR---HRNLLQLIGLCHD  264 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~  264 (459)
                      ..|...+.||+|+||.|+.|.++.....|+||.+.+..-        ...-..-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            457888999999999999999999899999999976521        11223557999999997   9999999999999


Q ss_pred             CCeEEEEEEec-CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          265 RGEFMLVYEFM-PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       265 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      ++.+||+||-. ++-+|.++|..+.    .+++.++..|+.||+.|+++||+   ++|+|||||-+||.++.+|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence            99999999976 4568888886554    59999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ||.|.....+   .-..++||.+|.|||++.+.++ .+..-|+|++|.++|.+..-.+|+
T Consensus       714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCC---CcceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCC
Confidence            9998765432   3346789999999999987765 778889999999999876555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=247.53  Aligned_cols=206  Identities=26%  Similarity=0.265  Sum_probs=173.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .+..|.....+|.|+|+.|-++.+..+++..++|++.+..    .+-.+|+.++... +|+||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3677888889999999999999999999999999997652    2334577666666 7999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee-cCCCCEEEeecCCccccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP-DTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kL~DFGla~~~~  351 (459)
                      |++.++-|.+.+....     ....++..|+++|+.|+.|||+   ++|+||||||+|||+ ++.+.++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999988877765543     2337777899999999999999   999999999999999 588999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..    ....+-|..|.|||++.  ...++..+|+||+|+++|+||+                                 
T Consensus       468 ~~----~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKd  541 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKD  541 (612)
T ss_pred             hh----hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHH
Confidence            43    33446689999999998  3458999999999999999998                                 


Q ss_pred             ----cCCCCCCCCCCHHHHHHHH
Q 041624          399 ----CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 ----c~~p~p~~RPs~~~v~~~L  417 (459)
                          |++.+|.+||+|.++...-
T Consensus       542 Ll~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  542 LLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             HHHHhccCChhhCcChhhhccCc
Confidence                5566888888888887643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4e-30  Score=233.72  Aligned_cols=200  Identities=27%  Similarity=0.335  Sum_probs=169.6

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeC-----CeEEEEE
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GEFMLVY  272 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~  272 (459)
                      ..+-||-|+||.||.+++..+|+.||+|++..-..  ...+.+.+|+++|..++|.|++..++...-.     .++|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            34679999999999999999999999999864322  3456888999999999999999998877543     3578999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |+|. .+|...|-...    .|+...+.-+++||++||+|||+   .+|+||||||.|.|++++..+||||||+++.-+.
T Consensus       137 ELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            9995 48888776544    68999999999999999999999   9999999999999999999999999999998776


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      +.....+..+-|..|.|||.+.+.+ .++...|+||.||++.+++.-.-.+...-|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            6555666677799999999999766 589999999999999988876555554443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=6.4e-27  Score=219.36  Aligned_cols=202  Identities=27%  Similarity=0.322  Sum_probs=172.3

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccCCccc-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccc
Q 041624          208 GFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS  286 (459)
Q Consensus       208 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  286 (459)
                      +||.||+|....+++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999997665444 78899999999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccccccccc
Q 041624          287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG  366 (459)
Q Consensus       287 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~  366 (459)
                      ..    .+++..++.++.+++.+|.|||+   .+++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            43    28999999999999999999998   899999999999999999999999999998765432  3345567889


Q ss_pred             ccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          367 YMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       367 y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      |++||.+....  ++.+.|+|++|++++.++++..|+... .....+.+.+....
T Consensus       152 ~~~pE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~  203 (244)
T smart00220      152 YMAPEVLLGKG--YGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPK  203 (244)
T ss_pred             CCCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccC
Confidence            99999987543  567899999999999999988777653 35566666665443

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.3e-26  Score=210.10  Aligned_cols=205  Identities=30%  Similarity=0.424  Sum_probs=175.6

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcch
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDF  282 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  282 (459)
                      ||+|.+|.||++....+++.+++|++...... ..+.+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888899999999765332 35779999999999999999999999999999999999999999999


Q ss_pred             hccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecCCcccccCCCCCccccc
Q 041624          283 HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDHELGPRTTGL  361 (459)
Q Consensus       283 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~  361 (459)
                      ++....   ..+++..+..++.+++++|++||+   .+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987543   258999999999999999999998   89999999999999999 89999999999986654321 23335


Q ss_pred             cccccccccceeccCccccCCCCCHHHHHHHHH-------HHHhcCCCCCCCCCCHHHHHHH
Q 041624          362 AGTLGYMAPEYISTGRARLDVNFDEQQTDCLMI-------VGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       362 ~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~-------~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      .+...|++||.+... ...+...|+|++|++++       ++..|+.++|.+||++.++++.
T Consensus       154 ~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         154 VGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             cCCCCccChhHhccc-CCCCchhhhHHHHHHHHHHHHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            578899999998764 23567789999997764       5667999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-28  Score=250.20  Aligned_cols=191  Identities=27%  Similarity=0.304  Sum_probs=152.1

Q ss_pred             CCCCCceeccCCce-EEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEe
Q 041624          197 NFSNERKLGQGGFG-AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      -|...+++|.|+-| .||+|...  ++.||||++-..   ......+|+..|..- +|||||++++.-.++...||..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            35566789999887 58999997  589999998532   234456899999887 699999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---C--CCEEEeecCCccc
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---D--FNVKLGDFGLALL  349 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kL~DFGla~~  349 (459)
                      |. .+|++++...........-...+.++.|+++||++||+   .+||||||||.||||+.   +  .+++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            95 59999997741111111114457788999999999999   99999999999999976   2  5799999999999


Q ss_pred             ccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          350 VDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       350 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +..+....  ..+..||.+|+|||++...+.  ...+|++++||++|..++
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~--~~avDiFslGCvfyYvlt  709 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRK--TQAVDIFSLGCVFYYVLT  709 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhcccc--CcccchhhcCceEEEEec
Confidence            87654332  456789999999999987654  558899999998765444

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=3.2e-26  Score=246.58  Aligned_cols=188  Identities=20%  Similarity=0.208  Sum_probs=157.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++....   .....+..|+.++..++|+||+++++++...+..|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3678899999999999999999998899999999975422   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++..++.|+.||+.||+|||.   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            99999999999986543    48899999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHH
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDC  391 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~  391 (459)
                      .. ........+|+.|++||....... .....++|++|.
T Consensus       156 ~~-~~~~~~~~~t~~~~~pe~~~~~~~-~~~~s~~~s~g~  193 (669)
T cd05610         156 NR-ELNMMDILTTPSMAKPKNDYSRTP-GQVLSLISSLGF  193 (669)
T ss_pred             CC-cccccccccCccccCccccccCCC-CceeeeeeecCc
Confidence            33 223345678999999997653322 223345555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-26  Score=218.62  Aligned_cols=226  Identities=23%  Similarity=0.216  Sum_probs=183.3

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEE
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGL  261 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~  261 (459)
                      .+||.....+++...++-+|.||.||+|.+.+.     .+.|-+|.++.... -....++.|.-.+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            456666778899999999999999999977642     35677787765433 345678899999999999999999999


Q ss_pred             Eee-CCeEEEEEEecCCCCcchhccccC----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          262 CHD-RGEFMLVYEFMPNGSLDFHLFSKK----STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       262 ~~~-~~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      +.+ ....+++|.++.-|+|+.+|...+    .....++..+...++.|++.|++|||.   ++|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence            865 456799999999999999998432    222357778888999999999999998   999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------
Q 041624          337 FNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------  398 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------  398 (459)
                      .++||+|=.++|.+-...... ....-....||+||.+....  +...+|+|++|++++++++                 
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999999998653322211 11223356899999998764  6888999999999987665                 


Q ss_pred             -----------------------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 -----------------------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 -----------------------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                             ||...|++||++.|++.-|.
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence                                   99999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-27  Score=238.89  Aligned_cols=192  Identities=23%  Similarity=0.306  Sum_probs=167.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|.....+|+|.||.|||++++.+++..|+|.++.....+..-..+|+-+++..+|+||+.++|-+...+.+++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            44678888999999999999999999999999999988777777778899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||.+|+|++.-+-..    +|++.++..++++.++||+|||+   ++-+|||||-.|||+++.|.+|++|||.+..+...
T Consensus        93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence            999999998876543    79999999999999999999999   89999999999999999999999999998766532


Q ss_pred             CCCccccccccccccccceeccCc-cccCCCCCHHHHHHHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLM  393 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll  393 (459)
                       -.....+.||+.|||||+..-++ ..+...+|+|+.|...
T Consensus       166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitA  205 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITA  205 (829)
T ss_pred             -hhhhhcccCCccccchhHHHHHhcccccccccccccccch
Confidence             22345678999999999875332 3567888999988643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.5e-25  Score=221.80  Aligned_cols=169  Identities=18%  Similarity=0.156  Sum_probs=132.0

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcC-CCcEEEEEEeccCC-----ccchHHHHHHHHHHhccCcCCceeEEEEEee
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILID-LNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      .....++|...+.||+|+||+||+|.+.. +++.+|||++....     ....+.|.+|+++|.+++|+|+++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            33456789999999999999999999875 57788999875331     1234568999999999999999853332   


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCC-CCCCeeecCCCCEEEee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI-KFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kL~D  343 (459)
                      .+..+|||||+++++|.. +.  .     ..   ...++.++++||.|||+   ++|+|||| ||+|||++.++.+||+|
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~--~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-AR--P-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hC--c-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence            246799999999999962 21  1     11   14678899999999998   99999999 99999999999999999


Q ss_pred             cCCcccccCCCCC-------ccccccccccccccceeccC
Q 041624          344 FGLALLVDHELGP-------RTTGLAGTLGYMAPEYISTG  376 (459)
Q Consensus       344 FGla~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~  376 (459)
                      ||+|+.+......       ......+++.|+|||++...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999877543211       12456788999999987543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-26  Score=219.22  Aligned_cols=199  Identities=21%  Similarity=0.245  Sum_probs=168.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc--C----CceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH--R----NLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~g~~~~~~~~  268 (459)
                      +++|.+...+|+|.||.|-++.+..++..||||+++.- ..-.+..+-|+++|.++.+  |    -+|++.+|+.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            78999999999999999999999999999999998643 3345566789999999932  2    368888999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-------------
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-------------  335 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-------------  335 (459)
                      +||+|.+ |-|+.++|..+..  .+++..+++.|+.|++++++|||+   .+++|-||||+|||+.+             
T Consensus       167 Civfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999998 6699999977554  378999999999999999999999   99999999999999742             


Q ss_pred             -------CCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          336 -------DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       336 -------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                             +..+||+|||.|+.....    .+..+.|..|.|||++.+-  .++...|+||+||++.++.++...++..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecccC
Confidence                   234899999999765432    3567889999999999865  4678899999999999999999888754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=2e-26  Score=204.88  Aligned_cols=208  Identities=23%  Similarity=0.327  Sum_probs=176.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeC--CeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDR--GEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV  271 (459)
                      .++|++.+++|+|-+++||.|....+++.++||.+++   -..+...+|+.+|..|. |+||++|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678888999999999999999888889999999974   34567889999999996 99999999998764  467899


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~  350 (459)
                      +||+.+.+...+..       .|+...+..++.+++.||.|+|+   +||.|||+||.|++||.. -.++|+|+|+|.+.
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999987765542       47788899999999999999999   999999999999999965 46999999999887


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ....  .....+.+..|.-||.+-.-+. ++-..|+||+||++..|..-..|+....-.-+|++++-.
T Consensus       184 Hp~~--eYnVRVASRyfKGPELLVdy~~-YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  184 HPGK--EYNVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             CCCc--eeeeeeehhhcCCchheeechh-ccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            6432  2333456778899999876543 677889999999999999999999999999999887643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=210.90  Aligned_cols=223  Identities=24%  Similarity=0.358  Sum_probs=176.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEE-EeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGL-CHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lV  271 (459)
                      ..+.|.+.+.||+|.||.+-++.++.++..+++|-+... ....++|.+|...--.| .|.||+.-++. |+..+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            346788899999999999999999999999999998654 34578899998876666 69999988765 6778889999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee-cCC-CCEEEeecCCccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP-DTD-FNVKLGDFGLALL  349 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl-~~~-~~~kL~DFGla~~  349 (459)
                      +||+|.|+|.+-+...     .+-+....+++.|+++||.|+|+   +++||||||.+|||| +.+ .++||||||+.+.
T Consensus       101 qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccc
Confidence            9999999998887543     47888899999999999999999   999999999999998 333 4799999999875


Q ss_pred             ccCCCCCccccccccccccccceec---cCccccCCCCCHHHHHHHHHHHHhcCCCCCCC---CCCHHHHHHHHhcCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYIS---TGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC---RPSIRQAIQVLNFETKM  423 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~---RPs~~~v~~~L~~~~~~  423 (459)
                      .+.    ......-+..|.|||...   +++....+..|+|++|++++..+++..|+...   -|.-.+-++-+.+.  .
T Consensus       173 ~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk--~  246 (378)
T KOG1345|consen  173 VGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK--N  246 (378)
T ss_pred             cCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc--C
Confidence            542    222233466799999764   34445677889999999999999999988743   34555555555443  3


Q ss_pred             CCCCCCCC
Q 041624          424 PNLPSKMP  431 (459)
Q Consensus       424 p~~p~~~p  431 (459)
                      |.+|+..-
T Consensus       247 ~~~P~~F~  254 (378)
T KOG1345|consen  247 PALPKKFN  254 (378)
T ss_pred             ccCchhhc
Confidence            45555443

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=99.92  E-value=4.5e-25  Score=207.01  Aligned_cols=118  Identities=42%  Similarity=0.688  Sum_probs=102.6

Q ss_pred             CCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeeccc---CCCCCceEEEEEEe
Q 041624            6 SNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNA---SFHSGDTAHVKIKY   81 (459)
Q Consensus         6 ~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~---~~~~g~~~~~~i~y   81 (459)
                      +++.|+||||++.++++...+++|||||||++|.+| ||++  ||||||+|++.|..+..|+.   .+.+|+.++|||+|
T Consensus        95 ~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~--nHigIdvn~~~S~~~~~~~~~~~~l~~g~~~~v~I~Y  172 (236)
T cd06899          95 PASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDD--NHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDY  172 (236)
T ss_pred             CCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCC--CeEEEEcCCcccceeeccccccccccCCCeEEEEEEE
Confidence            367899999999877777788999999999999877 8988  99999999999998888754   36799999999999


Q ss_pred             cCCcceEEEEEeeCCCCCcCC-------------------CCcCCCCceecceeccccccccc
Q 041624           82 NSATKNLSASWSYGETPKYSQ-------------------ENTTSTGRYTERHVLKSWEFNST  125 (459)
Q Consensus        82 ~~~~~~l~v~~~~~~~~~~~~-------------------~fsastG~~~~~h~i~swsfss~  125 (459)
                      |+.+++|.|+|.+....++..                   +|+|+||...+.|++++|+|+++
T Consensus       173 ~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~  235 (236)
T cd06899         173 DSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN  235 (236)
T ss_pred             cCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence            999999999998865422221                   59999999999999999999875

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=3e-25  Score=206.38  Aligned_cols=196  Identities=27%  Similarity=0.310  Sum_probs=166.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------C
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------G  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~  266 (459)
                      ..+|.....+|.|.- .|..+.+.-++++||+|++....  ....++..+|...+..+.|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777788999988 78888888789999999986542  23456778999999999999999999998533      4


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      +.|+||||| ..+|.+.+..      .++-.....|..|++.|++|||+   .+|+||||||+||++..+..+||.|||+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence            679999999 4589888862      47888899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      |+.-+..  -..+..+.|..|.|||++.+..  +...+|+||.||++.+|+++.-.+|.
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecC
Confidence            9865432  3456778899999999998765  78899999999999999998877773

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=2.5e-24  Score=211.00  Aligned_cols=226  Identities=22%  Similarity=0.192  Sum_probs=183.8

Q ss_pred             ccccCCCCCcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---
Q 041624          175 DDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---  251 (459)
Q Consensus       175 ~~~~~~~~~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---  251 (459)
                      +.|....|--++-+.|+.  -++|.+....|+|-|++|.+|.+...|..||||+|+.+ ....+.-+.|+++|.+|.   
T Consensus       413 DNWdDaEGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD  489 (752)
T KOG0670|consen  413 DNWDDAEGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDAD  489 (752)
T ss_pred             cCcccccceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccC
Confidence            445444555555566654  46899999999999999999999988999999999764 333455678999999994   


Q ss_pred             ---cCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCC
Q 041624          252 ---HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKF  328 (459)
Q Consensus       252 ---H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp  328 (459)
                         -.+.++|+..|...+++|||+|-+ ..+|.++|...+. ...|....+..++.|+.-||..|-.   .+|+|.||||
T Consensus       490 ~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKP  564 (752)
T KOG0670|consen  490 PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKP  564 (752)
T ss_pred             chhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCc
Confidence               357899999999999999999988 4589998876543 3458899999999999999999998   8999999999


Q ss_pred             CCeeecCC-CCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          329 SNIMPDTD-FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       329 ~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .|||+++. ..+||||||.|......   ..+...-+..|.|||++.+-  +++...|+||+||++|++.++.-.||.. 
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~-  638 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGR-  638 (752)
T ss_pred             cceEeccCcceeeeccCccccccccc---cccHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCC-
Confidence            99999876 56899999999765432   33445557789999999975  4677889999999999999999999986 


Q ss_pred             CCHHHHHH
Q 041624          408 PSIRQAIQ  415 (459)
Q Consensus       408 Ps~~~v~~  415 (459)
                       |-.+.++
T Consensus       639 -TNN~MLr  645 (752)
T KOG0670|consen  639 -TNNQMLR  645 (752)
T ss_pred             -CcHHHHH
Confidence             4445444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=8.2e-24  Score=203.65  Aligned_cols=211  Identities=24%  Similarity=0.293  Sum_probs=172.3

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcC---CCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILID---LNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      +....+.|...++||+|.|+.||++++..   ..+.||+|.+...  .......+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44566789999999999999999999876   6889999998654  3456688999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFG  345 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG  345 (459)
                      ...+|+||++.-+..+++.       .++..++..+++.++.||+++|.   +|||||||||+|+|.+.. ++-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEech
Confidence            9999999999988888774       47788999999999999999998   999999999999999854 678999999


Q ss_pred             CcccccCCC------C-------------------------------------CccccccccccccccceeccCccccCC
Q 041624          346 LALLVDHEL------G-------------------------------------PRTTGLAGTLGYMAPEYISTGRARLDV  382 (459)
Q Consensus       346 la~~~~~~~------~-------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~  382 (459)
                      +|...+...      .                                     ......+||++|.|||++..-. .-+.
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~Qtt  257 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQTT  257 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-CcCC
Confidence            997221000      0                                     0011246999999999987432 4577


Q ss_pred             CCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 041624          383 NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI  414 (459)
Q Consensus       383 ~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~  414 (459)
                      ++|+|+.|+++.-+++...|+-..--+..-++
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~  289 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALA  289 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHH
Confidence            89999999999999999998865543333333

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-22  Score=197.55  Aligned_cols=134  Identities=23%  Similarity=0.316  Sum_probs=114.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-----c---CCceeEEEEEee--
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-----H---RNLLQLIGLCHD--  264 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~~~~--  264 (459)
                      .++|.+.++||-|.|++||+|.+....+.||+|+.+.. ..-.+..+.||++|++++     |   ..||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            37889999999999999999999999999999998643 344566789999999983     2   469999999874  


Q ss_pred             --CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec
Q 041624          265 --RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD  334 (459)
Q Consensus       265 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~  334 (459)
                        +.++++|+|++ |-+|..+|......  .++...+.+|+.||+.||.|||.+  .+|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence              45899999999 66888888765443  588889999999999999999994  7999999999999963

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.9e-22  Score=183.56  Aligned_cols=140  Identities=16%  Similarity=0.158  Sum_probs=108.9

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--c-------hHH-----------------HHHHHHHHhccCcCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--G-------KNE-----------------YITEVKTCSQLRHRN  254 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~n  254 (459)
                      ...||+|+||.||+|... +|+.||||+++.....  .       ...                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 6999999999764211  1       112                 234999999998877


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeeecCCCCCCeee
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL-HEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDlkp~NILl  333 (459)
                      +.....+...  ..+|||||+++++|...+...    ..+++.+...++.|++.+|.|| |+   .+|+||||||+|||+
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence            6443332222  238999999988776543322    2588999999999999999999 56   899999999999999


Q ss_pred             cCCCCEEEeecCCccccc
Q 041624          334 DTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~  351 (459)
                      + ++.++|+|||+|...+
T Consensus       152 ~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             E-CCcEEEEEccccccCC
Confidence            8 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=99.87  E-value=6.3e-23  Score=192.98  Aligned_cols=117  Identities=38%  Similarity=0.576  Sum_probs=99.9

Q ss_pred             CCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeee------cccCCCCCceEE
Q 041624            4 IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTR------WNASFHSGDTAH   76 (459)
Q Consensus         4 ~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~------~~~~~~~g~~~~   76 (459)
                      +|.++.|++||+++.++++...++.|||||||++|+++ ||++  ||||||+|++.|..+.+      ...++.+|+.++
T Consensus        94 ~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~--nHIgI~~n~~~s~~~~~~~~~~~~~~~l~~g~~~~  171 (236)
T PF00139_consen   94 LPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDD--NHIGIDVNSVVSNKTASAGYYSSPSFSLSDGKWHT  171 (236)
T ss_dssp             STTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSS--SEEEEEESSSSESEEEE----EEEEHHHGTTSEEE
T ss_pred             cccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCC--CEEEEECCCCcccccccccccccccccccCCcEEE
Confidence            45668999999999877766678999999999999876 8888  99999999999988743      355788999999


Q ss_pred             EEEEecCCcceEEEEEeeCCCCCcCC-------------------CCcCCCCceecceeccccccc
Q 041624           77 VKIKYNSATKNLSASWSYGETPKYSQ-------------------ENTTSTGRYTERHVLKSWEFN  123 (459)
Q Consensus        77 ~~i~y~~~~~~l~v~~~~~~~~~~~~-------------------~fsastG~~~~~h~i~swsfs  123 (459)
                      |||+||+.+++|.|++.... .++..                   +|||+||...+.|.|++|+|+
T Consensus       172 v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~  236 (236)
T PF00139_consen  172 VWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS  236 (236)
T ss_dssp             EEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred             EEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence            99999999999999998873 11211                   599999999999999999995

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.87  E-value=5.6e-23  Score=226.27  Aligned_cols=159  Identities=17%  Similarity=0.177  Sum_probs=119.8

Q ss_pred             ccCc-CCceeEEEEE-------eeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 041624          249 QLRH-RNLLQLIGLC-------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC  320 (459)
Q Consensus       249 ~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  320 (459)
                      .++| .||.+++++|       .+.+.+++++||+ +++|.++|.....   .+++.+++.++.||++||.|||+   ++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR---SVDAFECFHVFRQIVEIVNAAHS---QG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc---cccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            4456 6888888887       2334677888988 5699999975432   69999999999999999999998   99


Q ss_pred             eeecCCCCCCeeecC-------------------CCCEEEeecCCcccccCCCC---------------Ccccccccccc
Q 041624          321 VVHRDIKFSNIMPDT-------------------DFNVKLGDFGLALLVDHELG---------------PRTTGLAGTLG  366 (459)
Q Consensus       321 iiHrDlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~  366 (459)
                      |+||||||+||||+.                   ++.+|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999964                   44566666676654221000               00112468899


Q ss_pred             ccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------------cCCCCCCCCCC
Q 041624          367 YMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------------CAHPDRNCRPS  409 (459)
Q Consensus       367 y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------------c~~p~p~~RPs  409 (459)
                      |||||++.+..  ++.++|+|++|+++++|++                                     |++++|.+||+
T Consensus       181 Y~APE~~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        181 YTSPEEDNGSS--SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             eEChhhhccCC--CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            99999988654  5788999999999998875                                     56677777777


Q ss_pred             HHHHHHH
Q 041624          410 IRQAIQV  416 (459)
Q Consensus       410 ~~~v~~~  416 (459)
                      |.|+++.
T Consensus       259 ~~eil~h  265 (793)
T PLN00181        259 MSELLQS  265 (793)
T ss_pred             hHHHhhc
Confidence            7777664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.4e-21  Score=175.62  Aligned_cols=142  Identities=18%  Similarity=0.100  Sum_probs=112.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc--------------------------hHHHHHHHHHHhccCcCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--------------------------KNEYITEVKTCSQLRHRN  254 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~n  254 (459)
                      ...||+|+||.||+|.+. +|+.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 69999999997652110                          112357899999999998


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD  334 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~  334 (459)
                      +.....+....  .+|||||++++++.......    ..++..+...++.|++.+|.+||+  ..+|+||||||+|||++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence            85544443332  48999999988654432222    147888999999999999999997  37999999999999999


Q ss_pred             CCCCEEEeecCCcccccC
Q 041624          335 TDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       335 ~~~~~kL~DFGla~~~~~  352 (459)
                       ++.++|+|||+++.+..
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=7.3e-21  Score=178.02  Aligned_cols=225  Identities=20%  Similarity=0.215  Sum_probs=182.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      -+|.+.++||+|+||.++.|+..-+++.||||.-..  +...-++..|.+..+.| ..++|..++.+..++.+-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999999988899999997543  23344677788888888 579999999888888888999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-----CCEEEeecCCccc
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-----FNVKLGDFGLALL  349 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kL~DFGla~~  349 (459)
                      + |.||+++..-...   .++.+++..+|.|++.-++|+|+   +.+|.|||||+|+||..-     ..+.|+|||+|+.
T Consensus       106 L-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9 8899998765544   69999999999999999999999   999999999999999754     3589999999998


Q ss_pred             ccCCCCCc------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhcCC-
Q 041624          350 VDHELGPR------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN-CRPSIRQAIQVLNFET-  421 (459)
Q Consensus       350 ~~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~-~RPs~~~v~~~L~~~~-  421 (459)
                      +.+.....      .....||.+||+--...+.+.  +..-|..++|-++...|.+.-|+.. +-|+.++-.+.+-..+ 
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ--SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchh--hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            86543332      345679999999888876654  3334999999999999999999986 4578888887775443 


Q ss_pred             --CCCCCCCCCC
Q 041624          422 --KMPNLPSKMP  431 (459)
Q Consensus       422 --~~p~~p~~~p  431 (459)
                        ++-++....|
T Consensus       257 ~T~i~~Lc~g~P  268 (449)
T KOG1165|consen  257 STPIEVLCEGFP  268 (449)
T ss_pred             cCCHHHHHhcCH
Confidence              2333444444

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.5e-20  Score=185.55  Aligned_cols=201  Identities=23%  Similarity=0.220  Sum_probs=161.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCC-cEEEEEEeccCCccchHHHHHHHHHHhccCc----CCceeEEEEE-eeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLN-MAVAVKKISRGLKHGKNEYITEVKTCSQLRH----RNLLQLIGLC-HDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l  270 (459)
                      +|.+.+.||+|+||.||.+....++ ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999988754 5788888765533333367789998888863    6889999988 47778899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-----CCEEEeecC
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-----FNVKLGDFG  345 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kL~DFG  345 (459)
                      ||+.+ |.+|.++.....  ...++..+.++|+.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 789999775544  3479999999999999999999998   999999999999999765     469999999


Q ss_pred             Ccc--cccCCCC-----Cc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          346 LAL--LVDHELG-----PR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       346 la~--~~~~~~~-----~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      +++  .+.....     ..  .....||..|+++.+..+..  .+..-|.|++..++.+++.+.-|+..
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCcc
Confidence            998  3322211     11  23456999999999887665  45666999999999999888777644

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-21  Score=173.87  Aligned_cols=208  Identities=22%  Similarity=0.235  Sum_probs=169.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc-CCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..++|...++||+|+||.+|.|....+|..||||.-+....  .-++.-|.++...|++ ..|..+..+..+.+.-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34789999999999999999999999999999998654432  3456778899988864 67888888888888999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~  349 (459)
                      |++ |.||+++..-...   .++..+.+-++-|++.-++|+|.   ++++||||||+|+|..-   ..++.|+|||+|+.
T Consensus        91 dLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence            999 8899988764443   58999999999999999999998   99999999999999753   35699999999988


Q ss_pred             ccCCCCCc------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 041624          350 VDHELGPR------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQ  412 (459)
Q Consensus       350 ~~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~  412 (459)
                      +.+.....      .....||.+|.+--...+-..  +..-|+.|+|.++.....+.-|+..-++..++
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq--SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~  230 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ--SRRDDMESVGYVLMYFNRGSLPWQGLKAATKK  230 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhh--hhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence            75432221      234679999998777664433  23349999999999999999999998886544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=7.1e-20  Score=177.79  Aligned_cols=217  Identities=31%  Similarity=0.388  Sum_probs=177.2

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccCcC-CceeEEEEEeeCCeEEEEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHR-NLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E  273 (459)
                      |...+.||.|+||.||++...   ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            566789999999999999987   78899999766433   367899999999999988 79999999977777899999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCcccccC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDH  352 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  352 (459)
                      ++.+++|.+++...... ..+.......++.|++.++.|+|.   .+++|||+||+||+++... .++++|||.++.+..
T Consensus        79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            99999999666544311 258899999999999999999998   8999999999999999998 799999999986654


Q ss_pred             CCCC-----ccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCC
Q 041624          353 ELGP-----RTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP--SIRQAIQVLNFET  421 (459)
Q Consensus       353 ~~~~-----~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP--s~~~v~~~L~~~~  421 (459)
                      ....     ......||..|+|||.+.... .......|+|++|++++.++....|+.....  ...+..+.+....
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            3322     235678999999999998642 3467788999999999999999988555443  2566666665443

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.4e-20  Score=170.57  Aligned_cols=137  Identities=18%  Similarity=0.145  Sum_probs=109.2

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-----CcCCceeEEEEEeeCC---eEE
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-----RHRNLLQLIGLCHDRG---EFM  269 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~~  269 (459)
                      +...+.||+|+||.||.  ++.++.. +||++........+++.+|+.++.++     .||||++++|+++++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996  6665555 69988765455667899999999999     5799999999998873   433


Q ss_pred             -EEEEe--cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHH-HHhhhccCCCeeecCCCCCCeeecC----CCCEEE
Q 041624          270 -LVYEF--MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL-LYLHEEWKRCVVHRDIKFSNIMPDT----DFNVKL  341 (459)
Q Consensus       270 -lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL  341 (459)
                       +|+||  +++|+|.+++.+.     .+++.  ..++.+++.++ +|||+   ++|+||||||+|||++.    +..++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  6689999999542     25554  35678888888 99999   99999999999999974    347999


Q ss_pred             eecCCc
Q 041624          342 GDFGLA  347 (459)
Q Consensus       342 ~DFGla  347 (459)
                      +||+-+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995434

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2.9e-20  Score=171.82  Aligned_cols=170  Identities=10%  Similarity=0.071  Sum_probs=130.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHH---------HHHHHHHHhccCcCCceeEEEEEee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---------YITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      ..++|...++||.|+||.||.... + +..+|+|.+++........         +.+|+..+.++.|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            568999999999999999999655 3 6689999997654333222         6899999999999999999988654


Q ss_pred             C--------CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          265 R--------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       265 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      .        +..+|||||++|.+|.++.        .++.    ....+++.+|..||.   .+++|||+||+||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCC
Confidence            3        3579999999999997763        2332    245699999999998   999999999999999998


Q ss_pred             CCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHH
Q 041624          337 FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVG  396 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~  396 (459)
                      + ++|+|||..+.........             .++...  .+....|+|++|..+.+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d-------------~~vler--~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKD-------------RIDLER--HYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             C-EEEEECCCcccccchhhHH-------------HHHHHh--HhcccccccceeEeehHH
Confidence            8 9999999886543221100             022222  234578999999876554

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=3.2e-19  Score=167.83  Aligned_cols=144  Identities=18%  Similarity=0.145  Sum_probs=113.2

Q ss_pred             CCCCCceeccCCceEEEEEE-EcCCCcEEEEEEeccCCcc------------------------chHHHHHHHHHHhccC
Q 041624          197 NFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKISRGLKH------------------------GKNEYITEVKTCSQLR  251 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  251 (459)
                      .|++.+.||+|+||.||+|. ...+|+.||+|+++.....                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6567999999998754210                        0123568999999997


Q ss_pred             cCC--ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eeecCCCC
Q 041624          252 HRN--LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC-VVHRDIKF  328 (459)
Q Consensus       252 H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-iiHrDlkp  328 (459)
                      +..  +.+++++    ...++||||+++.+|...+....    .+...+...++.|++.+|++||+   .+ |+||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence            533  4455543    23589999999988876653322    35666778999999999999998   88 99999999


Q ss_pred             CCeeecCCCCEEEeecCCcccccC
Q 041624          329 SNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       329 ~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      +||+++ ++.++|+|||.+.....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCC
Confidence            999999 88999999999875543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.9e-19  Score=158.42  Aligned_cols=189  Identities=13%  Similarity=-0.074  Sum_probs=133.3

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc----chHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH----GKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .....|++|+||+||.+..  .+..++.+.+.....-    ....|.+|+++|.+|. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997765  3677887777544221    1225789999999995 5889999987    35699999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCC-CCCCeeecCCCCEEEeecCCcccccC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI-KFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |+.|.+|.+.+.        .   ....++.|++.+|.++|.   .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus        79 yI~G~~L~~~~~--------~---~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         79 YLAGAAMYQRPP--------R---GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             eecCccHHhhhh--------h---hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999988865431        1   113577899999999998   99999999 79999999999999999999985543


Q ss_pred             CCCC----c--------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          353 ELGP----R--------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       353 ~~~~----~--------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ....    .        ..-...++.|++|+...--...--...+..+.|+.+|-+++..-++-.++
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            2210    0        01122466777777543211000122356677888888888766655443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.7e-18  Score=160.24  Aligned_cols=134  Identities=19%  Similarity=0.254  Sum_probs=113.6

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--------chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      +.||+|++|.||+|...  +..+++|+.......        ....+.+|+.++..+.|+++.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            57999999999999883  678999986543211        12457889999999999999887878777788899999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      |+++++|.+++...       .+ .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999888532       22 788999999999999998   9999999999999999 78999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.77  E-value=6.4e-20  Score=167.35  Aligned_cols=207  Identities=19%  Similarity=0.279  Sum_probs=159.7

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      ..+|.+...|+.|+|++..  ..+++|++.-.  .....++|..|.-.|+-+.||||+.++|.|.....+.++..|||.|
T Consensus       195 ~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3468899999999999985  55667776433  3455678999999999999999999999999999999999999999


Q ss_pred             CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe-eecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV-VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       279 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i-iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      ||...|+....  ...+..++.+++.++|+|++|||+.  .++ .---|.+..+++|++.+++|+- +-+++     +.+
T Consensus       273 slynvlhe~t~--vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad~kf-----sfq  342 (448)
T KOG0195|consen  273 SLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQ  342 (448)
T ss_pred             HHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cccee-----eee
Confidence            99999987544  3678889999999999999999984  333 3446889999999999888751 11111     112


Q ss_pred             cccccccccccccceeccCcccc-CCCCCHHHHHHHHHHHHh--------------------------------------
Q 041624          358 TTGLAGTLGYMAPEYISTGRARL-DVNFDEQQTDCLMIVGLW--------------------------------------  398 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~-~~~~D~~~~g~ll~~~l~--------------------------------------  398 (459)
                      .....-.+.||+||.++...... -...|+||+..+++++.+                                      
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm  422 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM  422 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence            22334578999999998654422 235799999999987765                                      


Q ss_pred             --cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 --CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 --c~~p~p~~RPs~~~v~~~L~~  419 (459)
                        |.+.+|.+||.++.|+-+|+.
T Consensus       423 ~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  423 NICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             HHHhcCCCCcCCCcceehhhHHH
Confidence              667777777777777766653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.77  E-value=1e-18  Score=156.86  Aligned_cols=108  Identities=25%  Similarity=0.138  Sum_probs=92.1

Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |||.+++..+..   .+++.+++.|+.||+.||+|||+   .+      ||+|||++.++.+|+  ||+++.....    
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc----
Confidence            689999876443   69999999999999999999998   54      999999999999999  9999876532    


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                        ...||+.|+|||++.+..  ++.++|+||+|+++++++++..|+....
T Consensus        63 --~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             --cCCCcccccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccc
Confidence              126889999999998664  5778999999999999999998876544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=4.4e-18  Score=179.23  Aligned_cols=142  Identities=20%  Similarity=0.242  Sum_probs=115.0

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEe-ccCCc-------cchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-SRGLK-------HGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      ......|...+.||+|+||.||+|.+...  .+++|+. .+...       ...+++.+|++++.+++|++++....++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            33445567789999999999999988653  3444432 21111       12356889999999999999998888888


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      +....++||||+++++|.+++.            ....++.+++.+|.|||+   .+++||||||+|||+ .++.++|+|
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEe
Confidence            8778899999999999988773            356789999999999998   999999999999999 677999999


Q ss_pred             cCCccccc
Q 041624          344 FGLALLVD  351 (459)
Q Consensus       344 FGla~~~~  351 (459)
                      ||+++..+
T Consensus       471 FGla~~~~  478 (535)
T PRK09605        471 FGLGKYSD  478 (535)
T ss_pred             CcccccCC
Confidence            99997653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.7e-18  Score=156.62  Aligned_cols=145  Identities=17%  Similarity=0.127  Sum_probs=112.8

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc----------------------chHHHHHHHHHH
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH----------------------GKNEYITEVKTC  247 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  247 (459)
                      ++...-..|...+.||+|+||.||++... +++.||||+++.....                      ....+..|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            44444445788899999999999999886 5899999987643210                      112366789999


Q ss_pred             hccCcC--CceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecC
Q 041624          248 SQLRHR--NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRD  325 (459)
Q Consensus       248 ~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD  325 (459)
                      .++.|+  .+++.++.    ...++||||+++++|......          .....++.+++.++.++|+   .+|+|||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D  150 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD  150 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence            999877  44555542    355899999999999765421          2346788999999999998   9999999


Q ss_pred             CCCCCeeecCCCCEEEeecCCcccccC
Q 041624          326 IKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       326 lkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||+||++++++.++|+|||++.....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=5.8e-18  Score=155.27  Aligned_cols=131  Identities=20%  Similarity=0.237  Sum_probs=106.9

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCCc-c-------chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-H-------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .||+|+||.||+|.+.  +..+++|....... .       ...++.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            4899999999999854  67899998654321 1       135677899999999988766555566667778999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      +++++|.+++....     .      .++.+++.+|.+||+   .+++|+|++|.||+++ ++.+++.|||+++..
T Consensus        79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988774321     0      789999999999998   9999999999999999 889999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.6e-19  Score=188.61  Aligned_cols=195  Identities=21%  Similarity=0.266  Sum_probs=150.8

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEec----cC-Cccc-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----RG-LKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ....++|.|.+|.|+...........+.|..+    .. .... ...+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988887766545555555443    11 1111 112667888888899999988887777776666669


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++ +|..++....    .+...++..++.|++.|++|||+   .||.|||||++|++++.++.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 9998886552    48888999999999999999999   9999999999999999999999999999977654


Q ss_pred             CCC---CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          353 ELG---PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       353 ~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ...   ......+|+..|+|||.+...++. ....|+|+.|.++..|.....|
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCc
Confidence            433   235678899999999999877663 3456999998877655554333

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=9.2e-17  Score=139.31  Aligned_cols=135  Identities=21%  Similarity=0.119  Sum_probs=115.1

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc--CCceeEEEEEeeCCeEEEEEEecCC
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+.+|+.++..++|  .++++++++....+..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35689999999999999864  7899999865433  5678899999999976  5999999998888889999999998


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +++..+           +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            877543           4566778899999999999984445799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=5e-18  Score=171.70  Aligned_cols=187  Identities=25%  Similarity=0.207  Sum_probs=155.7

Q ss_pred             eeccCCceEEEEEEE---cCCCcEEEEEEeccCCcc--chHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEEecC
Q 041624          203 KLGQGGFGAVYRGIL---IDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      .+|+|.||.|+.+.-   .+.+..+|+|.+++....  .......|-.++..++ |+.++++...++.+..++++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999987532   344788899988765321  1224556778888886 9999999999999999999999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  356 (459)
                      +|.|...+.+..    .+++.....+...++-|++++|.   .+|+|||+|++||+++.+|.+++.|||+++..-...  
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            999988776544    47777888888999999999998   999999999999999999999999999998764321  


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                         ..+||..|||||++.+    .....|.|++|.+++.++++..|+..
T Consensus       152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch
Confidence               1289999999999982    35678999999999999999999887

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=4.3e-17  Score=175.55  Aligned_cols=197  Identities=17%  Similarity=0.178  Sum_probs=152.2

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---cCCceeEEEEEeeC
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDR  265 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~  265 (459)
                      .+.+..-..|.+.+.||+|+||.||+|...+ |+.||+|+-+....-.   |.-=.+++.+|+   -+.|..+...+.-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3445556788999999999999999999988 9999999876653321   111122333333   23455555555667


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-------CCC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-------DFN  338 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-------~~~  338 (459)
                      +.-+||+||.+.|+|.+++...    +.++|...+.++.|++.-+++||.   .+|||+||||+|.||..       +..
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccc
Confidence            7789999999999999999633    369999999999999999999998   99999999999999843       345


Q ss_pred             EEEeecCCcccccCCC-CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          339 VKLGDFGLALLVDHEL-GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ++|+|||.+-.+.--. +..-...++|-.+-.+|+..+.  +.+-.+|.+.+..++++||.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLF  898 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLF  898 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHH
Confidence            9999999986543211 2234567889999999998865  36777899999999999986

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.9e-16  Score=142.48  Aligned_cols=139  Identities=23%  Similarity=0.247  Sum_probs=100.7

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--chHHH----------------------HHHHHHHhccCcCC--
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEY----------------------ITEVKTCSQLRHRN--  254 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--  254 (459)
                      .+.||+|+||.||+|... +++.||||+++.....  ....+                      ..|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 5899999998754221  11111                      35666666664443  


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD  334 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~  334 (459)
                      +.+.+++    ...++||||++++++.........    .. .+...++.+++.++.++|.  ..+|+|+||||+||+++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence            4555543    245899999999655322111111    11 5678899999999999997  37999999999999999


Q ss_pred             CCCCEEEeecCCcccccC
Q 041624          335 TDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       335 ~~~~~kL~DFGla~~~~~  352 (459)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd01951 lectin_L-type legume lectins

Probab=99.67  E-value=1.8e-16  Score=148.12  Aligned_cols=105  Identities=28%  Similarity=0.364  Sum_probs=82.3

Q ss_pred             CccccccCCCCCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCcee-------eeeeecccCCCCCceEEEEEEec
Q 041624           11 GFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVS-------SVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus        11 ~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s-------~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      ++||.-       ..++.+||||||++|.++ ||+.  ||||||+|+..+       .....++....+|+.++|||+|+
T Consensus        94 ~~lG~~-------~~~~~~aVefDT~~N~~~~dp~~--~higi~~n~~~~~~~~~~~~~~~~~~~~~~~g~~~~v~I~Y~  164 (223)
T cd01951          94 GGLGYG-------GIGNSVAVEFDTYKNDDNNDPNG--NHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITYD  164 (223)
T ss_pred             CccCcc-------ccCCeEEEEEeccccCCCCCCCC--CEEEEEcCCCCCCcccccccceeeCCCccCCCCEEEEEEEEe
Confidence            777752       345789999999999874 9988  999999999964       33344443333499999999999


Q ss_pred             CCcceEEEEEeeCCCCC-cC----------------CCCcCCCCceecceecccccccc
Q 041624           83 SATKNLSASWSYGETPK-YS----------------QENTTSTGRYTERHVLKSWEFNS  124 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~-~~----------------~~fsastG~~~~~h~i~swsfss  124 (459)
                      +.++.|+|++.+...+. +.                .+|||+||...+.|.|++|+|+.
T Consensus       165 ~~~~~L~v~l~~~~~~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~  223 (223)
T cd01951         165 PTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS  223 (223)
T ss_pred             CCCCEEEEEECCCCccccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence            99999999998754310 00                15999999999999999999963

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=3.1e-16  Score=149.39  Aligned_cols=199  Identities=22%  Similarity=0.239  Sum_probs=130.8

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccC----------cCCceeEEEEEe-
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLR----------HRNLLQLIGLCH-  263 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~nIv~l~g~~~-  263 (459)
                      +...+.||.|+++.||.+++..|++.+|+|......   ....+++.+|.-....+.          |-.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999999999999999885432   234566777765555532          222332222221 


Q ss_pred             --------eC---C-----eEEEEEEecCCCCcchhcc---ccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeec
Q 041624          264 --------DR---G-----EFMLVYEFMPNGSLDFHLF---SKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHR  324 (459)
Q Consensus       264 --------~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr  324 (459)
                              ..   .     ..+++|+-+ .++|.+++.   ........+....++.+..|+++.+++||+   .|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence                    11   1     236788877 568887754   222222235566677888999999999999   999999


Q ss_pred             CCCCCCeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceecc------CccccCCCCCHHHHHHHHHHHHh
Q 041624          325 DIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST------GRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       325 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ||||+|++++.+|.++|+||+.....+..    ......+..|.+||....      ....++.+.|.|++|+++|.+.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999877654321    111334578999997643      23356778899999999999887


Q ss_pred             cCCCCC
Q 041624          399 CAHPDR  404 (459)
Q Consensus       399 c~~p~p  404 (459)
                      ...|+.
T Consensus       246 ~~lPf~  251 (288)
T PF14531_consen  246 GRLPFG  251 (288)
T ss_dssp             SS-STC
T ss_pred             ccCCCC
Confidence            766654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.8e-15  Score=142.73  Aligned_cols=135  Identities=21%  Similarity=0.196  Sum_probs=105.5

Q ss_pred             Cceec-cCCceEEEEEEEcCCCcEEEEEEeccCC-------------ccchHHHHHHHHHHhccCcCCc--eeEEEEEee
Q 041624          201 ERKLG-QGGFGAVYRGILIDLNMAVAVKKISRGL-------------KHGKNEYITEVKTCSQLRHRNL--LQLIGLCHD  264 (459)
Q Consensus       201 ~~~Lg-~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~  264 (459)
                      ...|| .||.|+||++...  +..++||.+....             ......+.+|++++.+|+|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35787 8999999998875  5789999885321             1223467889999999998885  677776543


Q ss_pred             CC----eEEEEEEecCC-CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          265 RG----EFMLVYEFMPN-GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       265 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      ..    ..++|||++++ .+|.+++...     .++..    .+.+|+.+|.+||+   .||+||||||.|||++.++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence            32    23599999997 6898887432     35543    35689999999998   999999999999999999999


Q ss_pred             EEeecCCccc
Q 041624          340 KLGDFGLALL  349 (459)
Q Consensus       340 kL~DFGla~~  349 (459)
                      +|+|||.++.
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=3.6e-16  Score=149.86  Aligned_cols=171  Identities=25%  Similarity=0.320  Sum_probs=122.6

Q ss_pred             CcCCceeEEEEEee---------------------------CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHH
Q 041624          251 RHRNLLQLIGLCHD---------------------------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS  303 (459)
Q Consensus       251 ~H~nIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  303 (459)
                      +|||||++.++|.+                           ...+||||.-++. +|.+++-.+.     .+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence            69999999988743                           2357999998865 8988886543     5667778899


Q ss_pred             HHHHHHHHHhhhccCCCeeecCCCCCCeee--cCCC--CEEEeecCCcccccCC-----CCCccccccccccccccceec
Q 041624          304 LGLASALLYLHEEWKRCVVHRDIKFSNIMP--DTDF--NVKLGDFGLALLVDHE-----LGPRTTGLAGTLGYMAPEYIS  374 (459)
Q Consensus       304 ~~ia~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kL~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~~~  374 (459)
                      .|+++|+.|||.   ++|.|||+|++|||+  |+|.  ...|+|||++---+..     .....-...|...-||||+..
T Consensus       348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            999999999998   999999999999997  4444  4788999987432210     011122345778899999876


Q ss_pred             cCcc-----ccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 041624          375 TGRA-----RLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVA  433 (459)
Q Consensus       375 ~~~~-----~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~~  433 (459)
                      ...-     .+ .+.|.|+.|.+.|+++.-.+||-.+ -.|---.+. -.+..+|++|+..|+.
T Consensus       425 a~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~-Yqe~qLPalp~~vpp~  485 (598)
T KOG4158|consen  425 AVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRT-YQESQLPALPSRVPPV  485 (598)
T ss_pred             cCCCCceeecc-chhhhhhhhhhHHHHhccCCccccc-chheechhh-hhhhhCCCCcccCChH
Confidence            4221     12 3579999999999999999999872 221110111 2345788888887753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.62  E-value=1.3e-16  Score=169.36  Aligned_cols=211  Identities=21%  Similarity=0.170  Sum_probs=160.8

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHH---HHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYI---TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++...+.||++.|=+|.+|.+.+ |. |+||++-+.. .-..+.|.   .|++ ...++|||.+++.-+-..+...|||=
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            67778899999999999999886 55 8899986543 33344444   4444 44558999999988877788889998


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc-
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD-  351 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-  351 (459)
                      +|..+ +|.+-|..+.    -|...+..-|+.|++.||..+|.   .+|+|||||.+||||+.-.-+.|+||..-+... 
T Consensus       101 qyvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence            99855 8888775543    58888999999999999999998   999999999999999999999999998654321 


Q ss_pred             -CCCCCccc----cccccccccccceeccCc---------cccCCCCCHHHHHHHHHHHHh-------------------
Q 041624          352 -HELGPRTT----GLAGTLGYMAPEYISTGR---------ARLDVNFDEQQTDCLMIVGLW-------------------  398 (459)
Q Consensus       352 -~~~~~~~~----~~~gt~~y~APE~~~~~~---------~~~~~~~D~~~~g~ll~~~l~-------------------  398 (459)
                       .+....-+    +...-..|+|||.+..+.         ..+.+++|++|+||++.++++                   
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~  252 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA  252 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence             11111111    111224699999875422         137788999999999987765                   


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                           +.+.+|+.|-++.+.++.-.
T Consensus       253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence                                 56678999999988888743

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.60  E-value=2.8e-15  Score=151.61  Aligned_cols=176  Identities=25%  Similarity=0.288  Sum_probs=141.0

Q ss_pred             HhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe-eecC
Q 041624          247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV-VHRD  325 (459)
Q Consensus       247 l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i-iHrD  325 (459)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.....   .+++.-...++++|+.||.|||+   ..| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHN---SPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence            4578999999999999999999999999999999999987443   69999999999999999999998   444 9999


Q ss_pred             CCCCCeeecCCCCEEEeecCCcccccCC-CCCccccccccccccccceeccCcc-----ccCCCCCHHHHHHHHHHHHhc
Q 041624          326 IKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPEYISTGRA-----RLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       326 lkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~-----~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ++++|+++|....+||+|||+..+.... .........-..-|.|||.+.....     ..+...|+|++|.++++++.-
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998776421 0011112223467999999986422     146678999999999999999


Q ss_pred             CCCCCC--CCCCHHHHHHHHhcCCCCCCCCC
Q 041624          400 AHPDRN--CRPSIRQAIQVLNFETKMPNLPS  428 (459)
Q Consensus       400 ~~p~p~--~RPs~~~v~~~L~~~~~~p~~p~  428 (459)
                      ..|++.  ..++-.+++..++....-|..|.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~  185 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPS  185 (484)
T ss_pred             cCccccccccCChHHHHHHHHhcCCCCcCcc
Confidence            999887  44455788888877444333343

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.56  E-value=4.2e-15  Score=157.76  Aligned_cols=175  Identities=23%  Similarity=0.265  Sum_probs=126.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ...+|..++.|..|+||.||..+++.+.+++|+| +++...     .++-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-----------------
Confidence            3468889999999999999999999999999994 432211     0010  22222333333                 


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                          |+-...+....    +++-        +++.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+++..-..
T Consensus       136 ----gDc~tllk~~g----~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG----PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhcccCC----CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                34444443322    2332        22788999999   99999999999999999999999999998764211


Q ss_pred             CC--------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 041624          354 LG--------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       354 ~~--------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~  416 (459)
                      ..              -....++||+.|+|||++...  .|+..+|+|+||.++|+.+-++.|+-.+-|  .+++..
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtp--eelfg~  269 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQ  269 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCH--HHHHhh
Confidence            10              012457899999999999855  478999999999999999999999888854  455543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=4.3e-14  Score=144.60  Aligned_cols=142  Identities=22%  Similarity=0.214  Sum_probs=101.9

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccch----------------------------------------HHH
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK----------------------------------------NEY  240 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  240 (459)
                      .+.||+|++|.||+|++++ |+.||||+.++......                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            3689999999999999976 89999999866421110                                        025


Q ss_pred             HHHHHHHhccC----cCCceeEEEEEe-eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHH-HHHHhh
Q 041624          241 ITEVKTCSQLR----HRNLLQLIGLCH-DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS-ALLYLH  314 (459)
Q Consensus       241 ~~E~~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH  314 (459)
                      .+|.+.+.+++    |.+-+.+-..+. .....+|||||++|++|.++......   ..   .+.+++..++. .+..+|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH
Confidence            56666666652    333333333332 23456999999999999887653221   12   24456666666 477888


Q ss_pred             hccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       315 ~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      .   .|++|+|++|.||+++.+++++++|||++..++.
T Consensus       275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7   8999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.52  E-value=3.4e-15  Score=148.63  Aligned_cols=123  Identities=27%  Similarity=0.355  Sum_probs=106.0

Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      .+|+.|++|...+|.+||..++. ....++...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999975443 3457888999999999999999      6899999999999999999999999999


Q ss_pred             cccccCCC-----CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          347 ALLVDHEL-----GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       347 a~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ........     ....+...||..||+||.+.+..  +..+.|+|++|.++++++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHH
Confidence            87766543     22456678999999999999764  6888999999999998887

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=4.9e-13  Score=138.63  Aligned_cols=147  Identities=19%  Similarity=0.143  Sum_probs=98.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc----------------------------------h---
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG----------------------------------K---  237 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~---  237 (459)
                      -..|+. +.||+|++|.||+|+++++|+.||||++++.....                                  .   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 78999999999999999889999999997652110                                  0   


Q ss_pred             ---HHHHHHHHHHhccC----cCCceeEEEEEee-CCeEEEEEEecCCCCcchhcc--ccCCCCCCCCHHHHHHHHHHHH
Q 041624          238 ---NEYITEVKTCSQLR----HRNLLQLIGLCHD-RGEFMLVYEFMPNGSLDFHLF--SKKSTGTPLTWTTRYKISLGLA  307 (459)
Q Consensus       238 ---~~~~~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~--~~~~~~~~l~~~~~~~i~~~ia  307 (459)
                         -+|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.|.++-.  ........+.......++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence               12455666666553    4444444344432 346789999999999977432  11110001222222223333  


Q ss_pred             HHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEeecCCcccccC
Q 041624          308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGDFGLALLVDH  352 (459)
Q Consensus       308 ~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~~~  352 (459)
                           ++.   .|++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       276 -----if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 333   7999999999999999988    999999999977653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=1.6e-12  Score=115.80  Aligned_cols=131  Identities=19%  Similarity=0.084  Sum_probs=96.6

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCce-eEEEEEeeCCeEEEEEEecCCCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL-QLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      .+.|+.|.++.||++...  +..+++|....... ....+..|+.++..+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            357889999999999875  67899998765432 233567899999998665554 5555433  34589999999988


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW--KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +....         .   ....++.+++++|+.||...  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            86430         1   11345678999999999821  12359999999999999 66899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=5e-14  Score=148.69  Aligned_cols=202  Identities=25%  Similarity=0.259  Sum_probs=158.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-CCcEEEEEEeccCC--ccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-LNMAVAVKKISRGL--KHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~l  270 (459)
                      ...|...+.||+|.|+.|-...... ....+|+|.+....  ....+....|..+-..+. |+|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456777889999999999887743 34667777765443  222333445777777776 9999999999999999999


Q ss_pred             EEEecCCCCcchhcc-ccCCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCeeecCCCCCCeeecCCC-CEEEeecCCc
Q 041624          271 VYEFMPNGSLDFHLF-SKKSTGTPLTWTTRYKISLGLASALLYLH-EEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLA  347 (459)
Q Consensus       271 V~E~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla  347 (459)
                      +++|..++++...+. ...   ...+....-.++.|+..++.|+| +   .++.|+|+||+|.+++..+ ..+++|||+|
T Consensus        99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhh
Confidence            999999999988883 222   13556667788999999999999 6   9999999999999999999 9999999999


Q ss_pred             ccccC--CCCCccccccc-cccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          348 LLVDH--ELGPRTTGLAG-TLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       348 ~~~~~--~~~~~~~~~~g-t~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ..+..  +........+| ++.|+|||...+.. ......|+|+.|+++..++.+-.|+
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~  230 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPW  230 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCc
Confidence            87765  22223345678 99999999988643 3567789999999998888766543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1.8e-11  Score=110.96  Aligned_cols=139  Identities=16%  Similarity=0.132  Sum_probs=100.5

Q ss_pred             ceeccCCceEEEEEEEcC------CCcEEEEEEeccCCc----------------------cchHHH----HHHHHHHhc
Q 041624          202 RKLGQGGFGAVYRGILID------LNMAVAVKKISRGLK----------------------HGKNEY----ITEVKTCSQ  249 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~  249 (459)
                      ..||.|--+.||.|...+      .+..+|||..+....                      ...+.+    .+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      257999998743210                      001122    389999999


Q ss_pred             cCc--CCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeeecCC
Q 041624          250 LRH--RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL-HEEWKRCVVHRDI  326 (459)
Q Consensus       250 l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDl  326 (459)
                      +..  -++.+++++    ..-+|||||+.+..+..-....    ..++..+...+..+++.+|..| |.   .+|+|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            853  466677764    4568999999765442211111    1355566778889999999999 76   89999999


Q ss_pred             CCCCeeecCCCCEEEeecCCcccccC
Q 041624          327 KFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       327 kp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ++.|||++ ++.+.|+|||.+-..++
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.6e-12  Score=122.30  Aligned_cols=171  Identities=21%  Similarity=0.228  Sum_probs=130.1

Q ss_pred             HHHHHHhccCcCCceeEEEEEeeC-----CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 041624          242 TEVKTCSQLRHRNLLQLIGLCHDR-----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE  316 (459)
Q Consensus       242 ~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~  316 (459)
                      .-+..|.++.|.|||+++.|+.+.     .+..+++|||..|+|.++|++.......+......+|+.||..||.|||+ 
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-  194 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence            334556677899999999987653     35788999999999999999876666678999999999999999999998 


Q ss_pred             cCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC---CCCCccccccccccccccceeccCccccCCCCCHHHHHHHH
Q 041624          317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH---ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLM  393 (459)
Q Consensus       317 ~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll  393 (459)
                      |...|+|+++..+-|++..++-+|++--.-...-..   ..........+-++|.|||+=...  ......|++.+|.+.
T Consensus       195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGASDIYKFGMCA  272 (458)
T ss_pred             cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccchhhhhhhHHH
Confidence            568899999999999999999999863221111000   000112223467899999975543  346788999999765


Q ss_pred             HHHHh------------------------------------cCCCCCCCCCCHHHHHH
Q 041624          394 IVGLW------------------------------------CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       394 ~~~l~------------------------------------c~~p~p~~RPs~~~v~~  415 (459)
                      ..|.-                                    |.++.|..||+|++++.
T Consensus       273 lemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  273 LEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence            54432                                    99999999999998765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=8.5e-11  Score=109.13  Aligned_cols=142  Identities=21%  Similarity=0.245  Sum_probs=112.5

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCc--CCceeEEEEEeeCC---eEEEEEEec
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRG---EFMLVYEFM  275 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~E~~  275 (459)
                      +.|+.|..+.+|++...+ |..+++|....... ....++..|.+++..+.+  .++.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998865 67899999765432 245678899999999976  44677888876643   568999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE---------------------------------------  316 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------  316 (459)
                      ++.+|.+.+..     ..++..++..++.+++++|..||+.                                       
T Consensus        83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99988876532     1477888888999999999999852                                       


Q ss_pred             --------------cCCCeeecCCCCCCeeecC--CCCEEEeecCCccc
Q 041624          317 --------------WKRCVVHRDIKFSNIMPDT--DFNVKLGDFGLALL  349 (459)
Q Consensus       317 --------------~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~  349 (459)
                                    ....++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          1256899999999999998  56789999998853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.18  E-value=1.3e-10  Score=119.42  Aligned_cols=170  Identities=20%  Similarity=0.157  Sum_probs=130.4

Q ss_pred             EEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCC
Q 041624          214 RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP  293 (459)
Q Consensus       214 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  293 (459)
                      .|..+.++.+|.|...+...........+-++.|+.++||||++++..++..+.+|||+|-+.  .|..++..       
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence            466677788999998876655334556778899999999999999999999999999999884  46666643       


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCcccccccccccccccee
Q 041624          294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI  373 (459)
Q Consensus       294 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~  373 (459)
                      +......-.+.||+.||.|||+  +.+++|++|.-..|++++.|.-||++|.++........ ......--..|..|+.+
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI  177 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence            3455667778999999999998  48999999999999999999999999998865432211 11111122356777765


Q ss_pred             ccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          374 STGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       374 ~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ....    -..|.|.+|++++.++.+
T Consensus       178 ~~s~----~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  178 DPSE----WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             Cccc----cchhhhhHHHHHHHHhCc
Confidence            4221    346999999999999988

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=4.5e-10  Score=98.77  Aligned_cols=132  Identities=20%  Similarity=0.228  Sum_probs=100.7

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEe-ccCCc-c------chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKI-SRGLK-H------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~-~~~~~-~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..+++|+-+.+|.+.+.  |..+++|.= ++.-. .      ..++-.+|++++.+++--.|..-+=+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45789999999999775  345666643 22211 1      12356789999999976666555556667788899999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |+++-.|.+.+...           ...++..+-.-+.-||.   .+|+|+||.++||++..+. +.++|||++..-
T Consensus        80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99998888887533           25667778888889998   9999999999999998775 999999999743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=5e-11  Score=121.16  Aligned_cols=192  Identities=21%  Similarity=0.204  Sum_probs=149.0

Q ss_pred             CCCCCceecc--CCceEEEEEEE--cCCCcEEEEEEeccCCc--cchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          197 NFSNERKLGQ--GGFGAVYRGIL--IDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       197 ~f~~~~~Lg~--G~fg~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      .|...+.+|.  |.+|.||.+..  ..++..+|+|+-+....  .....=.+|+....++ .|+|.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556688999  99999999998  77789999998543322  3333445677777777 5999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHH----HHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeec
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS----ALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDF  344 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DF  344 (459)
                      +-+|++. .+|.++......   .++....+.+..+..+    ||.++|+   ..++|-|+||.||++..+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence            9999995 688777765443   4666677777777777    9999999   999999999999999999 88999999


Q ss_pred             CCcccccCCCCCcc----ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          345 GLALLVDHELGPRT----TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       345 Gla~~~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+...+....-...    ....|...|++||...+-   .+...|++++|.++.+...
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l  322 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAIL  322 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHh
Confidence            99988765432221    223577789999998753   4566788998887765554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.09  E-value=9.5e-10  Score=96.33  Aligned_cols=143  Identities=20%  Similarity=0.184  Sum_probs=106.7

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEe-ccCC-------ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKI-SRGL-------KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ....|-+|+-+.|+++.+.  |+...||.- .+.-       .-..++..+|++.|.+++--.|.--.=++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999887  577667642 2221       11245678999999998766665555556677777899


Q ss_pred             EEecCC-CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEEeecCCc
Q 041624          272 YEFMPN-GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLGDFGLA  347 (459)
Q Consensus       272 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla  347 (459)
                      |||+++ .++.+++......  ..........+..|-+.+.-||.   .+|+|+||..+||+|..++   .+.++|||++
T Consensus        89 ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence            999976 4778887664432  22223336788899999999998   9999999999999997665   3589999998


Q ss_pred             cc
Q 041624          348 LL  349 (459)
Q Consensus       348 ~~  349 (459)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            53

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=6.1e-09  Score=99.56  Aligned_cols=141  Identities=12%  Similarity=0.014  Sum_probs=102.1

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-----------cchHHHHHHHHHHhccCcCCc--eeEEEEEee----
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-----------HGKNEYITEVKTCSQLRHRNL--LQLIGLCHD----  264 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~----  264 (459)
                      +.+-.-....|++....  |+.+.||+......           .....+.+|...+.+|...+|  ++++++...    
T Consensus        28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            44554445567777664  67899997743321           111247899999988854444  455556543    


Q ss_pred             -CCeEEEEEEecCCC-CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-------
Q 041624          265 -RGEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-------  335 (459)
Q Consensus       265 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-------  335 (459)
                       ...-+||||++++. +|.+++.....  .+.+...+..++.+++..+.-||.   .||+|+|++++|||++.       
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence             23578999999886 78888753211  245667788999999999999999   99999999999999985       


Q ss_pred             CCCEEEeecCCccc
Q 041624          336 DFNVKLGDFGLALL  349 (459)
Q Consensus       336 ~~~~kL~DFGla~~  349 (459)
                      +..+.|+||+.++.
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46899999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=6.7e-09  Score=93.77  Aligned_cols=126  Identities=21%  Similarity=0.205  Sum_probs=82.6

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCCc-------------c-------------chHHHHHHHHHHhccCcC--CceeEEEEE
Q 041624          211 AVYRGILIDLNMAVAVKKISRGLK-------------H-------------GKNEYITEVKTCSQLRHR--NLLQLIGLC  262 (459)
Q Consensus       211 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~H~--nIv~l~g~~  262 (459)
                      .||.|...+ +..+|||..+....             .             ......+|.+.|.++...  ++.+++.+.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            489998876 78999998743210             0             012357899999999765  566776553


Q ss_pred             eeCCeEEEEEEecC--CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeeecCCCCCCeeecCCCCE
Q 041624          263 HDRGEFMLVYEFMP--NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL-HEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       263 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                          .-+|||||++  +..+..+....      ++......++.+++..+..+ |.   .+|+|+||.+.|||++++ .+
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence                3479999998  55554433211      22345567778888866664 66   999999999999999988 99


Q ss_pred             EEeecCCccccc
Q 041624          340 KLGDFGLALLVD  351 (459)
Q Consensus       340 kL~DFGla~~~~  351 (459)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=3e-10  Score=115.54  Aligned_cols=204  Identities=20%  Similarity=0.179  Sum_probs=148.1

Q ss_pred             ccCHHH-HHHHhcCCCCCceeccCCceEEEEEEEc-CCCcEEEEEEeccCCccchH--HHHHHHHHHhcc-CcCCceeEE
Q 041624          185 RFSYKD-LASATNNFSNERKLGQGGFGAVYRGILI-DLNMAVAVKKISRGLKHGKN--EYITEVKTCSQL-RHRNLLQLI  259 (459)
Q Consensus       185 ~~~~~e-l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~  259 (459)
                      .|.-++ ....+.+|.....||.|.|+.|++.... .++..+++|.+.+.......  .-+.|+.+...+ .|.+++...
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            344555 5567788999999999999999998765 56788999988765433222  223455555555 588888877


Q ss_pred             EEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CC
Q 041624          260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FN  338 (459)
Q Consensus       260 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~  338 (459)
                      ..+...+..|+-.|||.++++...+...    ..+++..++++..|++.++.++|+   +.++|+|+||+||++..+ +.
T Consensus       333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  333 SSWSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhh
Confidence            7777777788999999999887665222    247888999999999999999998   999999999999999886 88


Q ss_pred             EEEeecCCcccccCCCCCcccccccccccc-ccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYM-APEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~-APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      .+++|||++..+.-.    ........+++ .+|.+.... .+....|+++++.-+..+.+..
T Consensus       406 ~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~-~~~~~~~~~sl~~~~~e~~~~~  463 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDY-PHLSKADIFSLGLSVDEAITGS  463 (524)
T ss_pred             hhcccccccccccee----cccccccccccccchhhcccc-ccccccccccccccccccccCc
Confidence            999999988643211    11222333444 355554333 3567788888887766665543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=2e-08  Score=100.49  Aligned_cols=143  Identities=14%  Similarity=0.214  Sum_probs=115.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEe----eCCeEEEEEEecCC-CCcch
Q 041624          208 GFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH----DRGEFMLVYEFMPN-GSLDF  282 (459)
Q Consensus       208 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~  282 (459)
                      .-.+.||++..-+|..+++|++.....+.......-++.++++.|.|+|++..++.    .+..+++||+|+|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34688999999889999999995444444434456678899999999999999876    34578999999986 57777


Q ss_pred             hccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          283 HLFSKKS-----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       283 ~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      +-+....           .+...++...|.++.|+..||.++|+   .|+.-+-|.+.+||++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6654321           23457889999999999999999999   899999999999999999999999888776655


Q ss_pred             CC
Q 041624          352 HE  353 (459)
Q Consensus       352 ~~  353 (459)
                      .+
T Consensus       445 ~d  446 (655)
T KOG3741|consen  445 ED  446 (655)
T ss_pred             CC
Confidence            43

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=1e-09  Score=117.51  Aligned_cols=230  Identities=19%  Similarity=0.166  Sum_probs=163.0

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ...+.|.+.+-+-+|.++.++.+.-..++...+.|.....   .....+....+-.++-..+||-++....-+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            4556777778888999999998877766655555544322   1122223333333333334566655544445567889


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      ||++|+.+++|...|+.-.    .++..-....+..+..+++|||+   ..+.|+|++|.|.|+..++..+++|||....
T Consensus       881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccc
Confidence            9999999999999887654    35555666777888999999998   6699999999999999999999999984332


Q ss_pred             ccC---------------------CC-----C----CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          350 VDH---------------------EL-----G----PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       350 ~~~---------------------~~-----~----~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ...                     ..     .    .......||+.|.+||...+...  ....|.|+.|.++.+.++|
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h--gs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH--GSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC--CCcchhhhhhhhhhhhhcC
Confidence            210                     00     0    00123568999999999987654  5667999999999999999


Q ss_pred             CCCCCCCCCCHHHHHH-HHhcCCCCCCCCCCCCcc
Q 041624          400 AHPDRNCRPSIRQAIQ-VLNFETKMPNLPSKMPVA  433 (459)
Q Consensus       400 ~~p~p~~RPs~~~v~~-~L~~~~~~p~~p~~~p~~  433 (459)
                      ..|+-..+|  +++.+ +++...+.|.-|..++..
T Consensus      1032 ~pp~na~tp--q~~f~ni~~~~~~~p~g~~~~s~~ 1064 (1205)
T KOG0606|consen 1032 IPPFNAETP--QQIFENILNRDIPWPEGPEEGSYE 1064 (1205)
T ss_pred             CCCCCCcch--hhhhhccccCCCCCCCCccccChh
Confidence            999988876  45554 666777777777665543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=9.2e-08  Score=88.19  Aligned_cols=107  Identities=22%  Similarity=0.221  Sum_probs=85.5

Q ss_pred             hHHHHHHHHHHhccCcC--CceeEEEEEeeCC----eEEEEEEecCCC-CcchhccccCCCCCCCCHHHHHHHHHHHHHH
Q 041624          237 KNEYITEVKTCSQLRHR--NLLQLIGLCHDRG----EFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASA  309 (459)
Q Consensus       237 ~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a  309 (459)
                      .....+|...+.+|...  ..++.+++.....    ..+||+|++++. +|.+++.....    ++......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence            44678898888888543  4456777765532    458999999874 79888865332    5667788999999999


Q ss_pred             HHHhhhccCCCeeecCCCCCCeeecCCC---CEEEeecCCcccc
Q 041624          310 LLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLGDFGLALLV  350 (459)
Q Consensus       310 L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~~  350 (459)
                      ++-||.   .+|+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   9999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=2.7e-07  Score=84.06  Aligned_cols=139  Identities=17%  Similarity=0.086  Sum_probs=103.9

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeccCC------ccchHHHHHHHHHHhccCcCC--ceeEEEEEee----CCeEEEE
Q 041624          204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL------KHGKNEYITEVKTCSQLRHRN--LLQLIGLCHD----RGEFMLV  271 (459)
Q Consensus       204 Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~----~~~~~lV  271 (459)
                      -|+||.+.|++-...+  ..+-+|+-....      ......|.+|+..|.+|...+  +.++......    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            4678999999977764  468888865221      335668999999999995333  4455422222    1246899


Q ss_pred             EEecCC-CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC--EEEeecCCcc
Q 041624          272 YEFMPN-GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~  348 (459)
                      +|-+++ -+|.+++.+...  .+.+...+..++.+++..++-||.   .++.|+|+.+.|||++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998764 588888755322  256788889999999999999998   99999999999999986666  9999998765


Q ss_pred             c
Q 041624          349 L  349 (459)
Q Consensus       349 ~  349 (459)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=2.1e-07  Score=86.83  Aligned_cols=136  Identities=21%  Similarity=0.149  Sum_probs=95.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc----------------------chHHHHHHHHHHhccCcC--
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH----------------------GKNEYITEVKTCSQLRHR--  253 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--  253 (459)
                      ..+...||-|--+.||.|.... |.++|||.-+.....                      ......+|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3456889999999999999986 899999965332100                      112356899999999654  


Q ss_pred             CceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       254 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      .+.+.+++    +.-.+||||+++-.|...-         ++....-.++..|+.-+.-+-.   .||+|+|+.+-||++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV  235 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence            67777755    4567999999886664332         1222233334444444433334   899999999999999


Q ss_pred             cCCCCEEEeecCCcccc
Q 041624          334 DTDFNVKLGDFGLALLV  350 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~  350 (459)
                      +++|.+.++||--+...
T Consensus       236 ~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ecCCCEEEEeCcccccC
Confidence            99999999999765433

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=2.9e-07  Score=95.27  Aligned_cols=145  Identities=20%  Similarity=0.236  Sum_probs=96.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccch------------------------------H-------
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK------------------------------N-------  238 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~-------  238 (459)
                      ..|+. +-|+.++-|.||+|++++ |+.||||+.+++.....                              +       
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            44443 689999999999999998 99999999865422110                              0       


Q ss_pred             ---HHHHHHHHHhccC-----cCCceeEEEEEe-eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHH
Q 041624          239 ---EYITEVKTCSQLR-----HRNLLQLIGLCH-DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA  309 (459)
Q Consensus       239 ---~~~~E~~~l~~l~-----H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a  309 (459)
                         +|.+|...+.+++     .+++ ++=..|. -.....|+|||++|-.+.+.......   ..+...   ++..++++
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~---ia~~~~~~  276 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKE---LAELLVRA  276 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHH---HHHHHHHH
Confidence               2455666666552     2332 2222332 24566899999999999888543332   244332   33333322


Q ss_pred             -HHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          310 -LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       310 -L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                       +..+-.   .++.|.|..|.||+++.++++.+.|||+...++.
T Consensus       277 f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 FLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             222222   6899999999999999999999999999876653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=1.1e-06  Score=82.18  Aligned_cols=132  Identities=18%  Similarity=0.174  Sum_probs=86.4

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      ..||+|..+.||+..    +..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            578999999999841    4467788876532  3345688999999986544  4677888877788889999998863


Q ss_pred             -cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------ccC
Q 041624          280 -LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE----------------------------------------EWK  318 (459)
Q Consensus       280 -L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~----------------------------------------~~~  318 (459)
                       +...+.        .+......++.++++.+.-||+                                        ...
T Consensus        81 ~~~~~~~--------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        81 SFSRIIS--------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             chhhhhc--------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence             221111        0111111112222222222221                                        113


Q ss_pred             CCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       319 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ..++|+|+.|.||++++++ +.++||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            4678999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=4.8e-06  Score=76.29  Aligned_cols=138  Identities=12%  Similarity=0.099  Sum_probs=93.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHH---------HHHHHHHHhccC---cCCceeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---------YITEVKTCSQLR---HRNLLQLIGL  261 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---H~nIv~l~g~  261 (459)
                      ..++|...+++-......|.+-...  +..+++|..+.......+.         ..+++..+.+++   -...+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4577888888888777777766554  6889999887654333222         233444444443   2333333333


Q ss_pred             Eee-----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          262 CHD-----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       262 ~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      ...     ....+|+|||++|..|.++..        ++.    .++..+++++.-||.   .|+.|+|..|.|++++.+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence            322     234578999999988866541        332    245667788999998   999999999999999965


Q ss_pred             CCEEEeecCCccc
Q 041624          337 FNVKLGDFGLALL  349 (459)
Q Consensus       337 ~~~kL~DFGla~~  349 (459)
                       .+++.||+..+.
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.37  E-value=7.8e-06  Score=75.76  Aligned_cols=155  Identities=20%  Similarity=0.154  Sum_probs=104.6

Q ss_pred             ccCHHHHHHHhcCCCCCceec---cCCceEEEEEEEcCCCcEEEEEEeccCCccc-------------------hH----
Q 041624          185 RFSYKDLASATNNFSNERKLG---QGGFGAVYRGILIDLNMAVAVKKISRGLKHG-------------------KN----  238 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg---~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~~----  238 (459)
                      ..+++.+....++..+....|   +|--+.||+|...+ +..+|+|+++......                   .+    
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~-~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD-GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC-CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            356677777777777666655   56666899998754 7899999986432111                   11    


Q ss_pred             -HHHHHHHHHhccC--cCCceeEEEEEeeCCeEEEEEEecCCCCc-chhccccCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 041624          239 -EYITEVKTCSQLR--HRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH  314 (459)
Q Consensus       239 -~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH  314 (459)
                       -..+|+..|.++.  +-.+.+-+++.    .-.|||||+....+ .-.|.     ..++...+...+..++++.+.-|-
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH
Confidence             1346777787773  44555555543    34799999965311 11111     112334467777788888887777


Q ss_pred             hccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       315 ~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      .  ..++||+||+.-|||+. ++.+.++|||-|-..++
T Consensus       184 ~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         184 K--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             H--hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            5  37999999999999999 88999999998866554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=2.5e-06  Score=88.14  Aligned_cols=145  Identities=20%  Similarity=0.214  Sum_probs=96.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccch-------------------------------------H
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-------------------------------------N  238 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~  238 (459)
                      ..|+ .+.||.-+.|.||+|+.++ |+.||||+-++..+...                                     -
T Consensus       162 ~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  162 SEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             HhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            3443 3689999999999999998 99999998765432210                                     0


Q ss_pred             HHHHHHHHHhcc----CcCC------ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHH
Q 041624          239 EYITEVKTCSQL----RHRN------LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS  308 (459)
Q Consensus       239 ~~~~E~~~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  308 (459)
                      +|.+|.+...++    +|-+      |.+++-.+  .....|+||||+|..+.+.-.-...   .++...+..-+.+   
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~---  311 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVE---  311 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHH---
Confidence            356666655554    3555      33333222  2356899999999988776543332   3555544333333   


Q ss_pred             HHHHhhhccCCCeeecCCCCCCeeecC----CCCEEEeecCCcccccC
Q 041624          309 ALLYLHEEWKRCVVHRDIKFSNIMPDT----DFNVKLGDFGLALLVDH  352 (459)
Q Consensus       309 aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL~DFGla~~~~~  352 (459)
                      +.  ++.-.+.|++|+|=.|.||+++.    ++.+.+-|||+...+.+
T Consensus       312 ~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  312 AY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22  12111268999999999999984    67899999999876654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=4.5e-06  Score=77.76  Aligned_cols=144  Identities=22%  Similarity=0.176  Sum_probs=85.5

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeEEEEEee---CCeEEEEEEecC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQLIGLCHD---RGEFMLVYEFMP  276 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~---~~~~~lV~E~~~  276 (459)
                      +.|+.|..+.||+....+  ..+++|.....  ........|..++..+....  +.+++.++..   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            578999999999999876  48899987543  45567788999988885443  5677765433   335789999999


Q ss_pred             CCCcch----------------hcc---ccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHhhh
Q 041624          277 NGSLDF----------------HLF---SKKSTGTPLTWTTR---------YKI------------SLGLAS-ALLYLHE  315 (459)
Q Consensus       277 ~gsL~~----------------~l~---~~~~~~~~l~~~~~---------~~i------------~~~ia~-aL~yLH~  315 (459)
                      +..+..                .+.   ........+.+...         ...            ...+.. .++.++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                111   11000011111110         000            111222 2333332


Q ss_pred             c----cCCCeeecCCCCCCeeec-CCCCEEEeecCCccc
Q 041624          316 E----WKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLALL  349 (459)
Q Consensus       316 ~----~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~  349 (459)
                      .    ....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    246799999999999999 666668999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.24  E-value=1.8e-05  Score=87.84  Aligned_cols=80  Identities=15%  Similarity=0.246  Sum_probs=59.2

Q ss_pred             CceeccCCceEEEEEEEcCCC--cEEEEEEeccCC-ccchHHHHHHHHHHhccC-cCCc--eeEEEEEeeC---CeEEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLN--MAVAVKKISRGL-KHGKNEYITEVKTCSQLR-HRNL--LQLIGLCHDR---GEFMLV  271 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV  271 (459)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|+++|..+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467899999999998776432  467788765432 223457889999999995 6665  7888888764   467999


Q ss_pred             EEecCCCCc
Q 041624          272 YEFMPNGSL  280 (459)
Q Consensus       272 ~E~~~~gsL  280 (459)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.8e-05  Score=74.78  Aligned_cols=142  Identities=19%  Similarity=0.129  Sum_probs=86.3

Q ss_pred             eeccCCc-eEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          203 KLGQGGF-GAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       203 ~Lg~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      .|..|.. ..||+....  +..+.+|......   ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455555 789998754  3678888775432   345678999888883 44566888887776778999999999887


Q ss_pred             chhcc-------------------ccCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHhhh----
Q 041624          281 DFHLF-------------------SKKSTGTPLTW--TTRYKISL--------------------GLASALLYLHE----  315 (459)
Q Consensus       281 ~~~l~-------------------~~~~~~~~l~~--~~~~~i~~--------------------~ia~aL~yLH~----  315 (459)
                      .....                   .......++..  ........                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64421                   00000001110  00000000                    01111122211    


Q ss_pred             ccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       316 ~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      .....++|+|+.|.|||++++....|+||+.+..
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            0125699999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=8.8e-06  Score=73.71  Aligned_cols=105  Identities=25%  Similarity=0.195  Sum_probs=81.9

Q ss_pred             HHHHHHhccCc-CCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 041624          242 TEVKTCSQLRH-RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC  320 (459)
Q Consensus       242 ~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  320 (459)
                      .|.-++..+.+ +++++++|+|-    .++|.||.+.+++...-.. -..-..-+|..|.+|+.++++.+.+|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            57888888865 69999999993    3679999987766432000 000014689999999999999999999855456


Q ss_pred             eeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       321 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      +.-.|++++|+-+++++++|+.|...+...+
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999998775443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.13  E-value=4.5e-05  Score=69.50  Aligned_cols=133  Identities=22%  Similarity=0.239  Sum_probs=93.7

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCC----------------ccchHHHHHHHHHHhccC------cCCcee
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL----------------KHGKNEYITEVKTCSQLR------HRNLLQ  257 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~  257 (459)
                      ....||+|+.-.||.  ++. .....||++....                ....+++.+|+.-..++.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            456899999999997  443 4557789887654                223567778887766665      889999


Q ss_pred             EEEEEeeCCeEEEEEEecCC--C----CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          258 LIGLCHDRGEFMLVYEFMPN--G----SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       258 l~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      ++|+.+++..+-+|+|.+.+  |    +|.+++...     .++. ...+.+.++   .+||-.   ..|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccE
Confidence            99999999999999998754  2    466666332     3554 333333433   455655   7899999999999


Q ss_pred             eecCCC----CEEEee-cCCc
Q 041624          332 MPDTDF----NVKLGD-FGLA  347 (459)
Q Consensus       332 Ll~~~~----~~kL~D-FGla  347 (459)
                      ++....    .+.|+| ||-.
T Consensus       150 v~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEEecCCCceEEEEEeCCCCc
Confidence            986432    477777 4533

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.11  E-value=3.9e-06  Score=91.13  Aligned_cols=100  Identities=16%  Similarity=0.112  Sum_probs=71.0

Q ss_pred             eecCCCCC-CeeecCCCCEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          322 VHRDIKFS-NIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       322 iHrDlkp~-NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      .|++.+|. |++++.....++.|||.++....... .......||+.|+|||++.+..  ++...|+|++||++++++++
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~--~~~~~DiwSlG~il~ElltG  576 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKP--HGPAVDWWALGVCLFEFLTG  576 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCC--CCcHHHHHHHHHHHHHHHHC
Confidence            34555555 67777777889999999887654322 2234568999999999998653  67889999999999999999


Q ss_pred             CCCCCCCCCCHHHHH-HHHhcCCCCCC
Q 041624          400 AHPDRNCRPSIRQAI-QVLNFETKMPN  425 (459)
Q Consensus       400 ~~p~p~~RPs~~~v~-~~L~~~~~~p~  425 (459)
                      ..|+...++  .+++ ++|....+.|.
T Consensus       577 ~~pf~~~~~--~~~~~~il~~~~~~p~  601 (669)
T cd05610         577 IPPFNDETP--QQVFQNILNRDIPWPE  601 (669)
T ss_pred             CCCCCCCCH--HHHHHHHHhcCCCCCc
Confidence            999876543  3333 34444444343

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.98  E-value=8.4e-05  Score=73.41  Aligned_cols=194  Identities=19%  Similarity=0.160  Sum_probs=125.9

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEe------eC-CeEEEE
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCH------DR-GEFMLV  271 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~------~~-~~~~lV  271 (459)
                      ....||+|+-+.+|-.-.-   ...+.|++.........+.   +..|... .||-+..=+.|=.      +. ...-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4577999999999974322   2234576655433322222   2233333 5664443222211      12 225677


Q ss_pred             EEecCCCCcchhccc---cCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      |..+++..=-..+.+   ++..-...+|...++.+..+|.+.+-||+   .|.+-+|+.++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence            777766422112221   22233457999999999999999999999   999999999999999999999999855333


Q ss_pred             cccCCCCCccccccccccccccceeccCcc---ccCCCCCHHHHHHHHHHHHhc-CCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRA---RLDVNFDEQQTDCLMIVGLWC-AHPDR  404 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~~~~D~~~~g~ll~~~l~c-~~p~p  404 (459)
                      +..  .+......+|...|.+||.-.-+..   .-+...|.+.++++++.+|.+ .+|+.
T Consensus       166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            222  2233445678999999997652221   235678999999999888776 77764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=0.00012  Score=66.34  Aligned_cols=125  Identities=23%  Similarity=0.274  Sum_probs=91.0

Q ss_pred             cCCCCCceeccCCc-eEEEEEEEcCCCcEEEEEEeccC---C--------c----------cchHHHHHHHHHHhccC--
Q 041624          196 NNFSNERKLGQGGF-GAVYRGILIDLNMAVAVKKISRG---L--------K----------HGKNEYITEVKTCSQLR--  251 (459)
Q Consensus       196 ~~f~~~~~Lg~G~f-g~Vy~~~~~~~~~~vavK~~~~~---~--------~----------~~~~~~~~E~~~l~~l~--  251 (459)
                      .+++..+.||.|.- |.||++...  |+.+|+|.++..   .        .          .-..-|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78888999999999 999999997  579999994221   0        0          11235889999998884  


Q ss_pred             -cCCc--eeEEEEEeeC------------------CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHH
Q 041624          252 -HRNL--LQLIGLCHDR------------------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL  310 (459)
Q Consensus       252 -H~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL  310 (459)
                       +.++  |+++||..-.                  ....||.||.+...             .+....    +.+|.+-|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl  177 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDL  177 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHH
Confidence             4566  9999997322                  12357777775532             123233    45666678


Q ss_pred             HHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       311 ~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      ..+|.   .+|+-+|+++.|..     .-||+|||.+
T Consensus       178 ~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            88997   99999999999987     5689999864

>PRK10593 hypothetical protein; Provisional

Probab=97.97  E-value=0.00022  Score=69.60  Aligned_cols=78  Identities=13%  Similarity=0.033  Sum_probs=57.7

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc---CCceeEEEEEee---CCeEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH---RNLLQLIGLCHD---RGEFMLVY  272 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~---~~~~~lV~  272 (459)
                      ...+.||.|..+.||+....+ + .+.+|..+.  ......|..|.+.|+.|.-   -.+.+++++|..   .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            335679999999999986654 3 466676432  1234688899999998843   368899988864   36689999


Q ss_pred             EecCCCCc
Q 041624          273 EFMPNGSL  280 (459)
Q Consensus       273 E~~~~gsL  280 (459)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.93  E-value=9.2e-05  Score=69.61  Aligned_cols=74  Identities=15%  Similarity=0.115  Sum_probs=47.7

Q ss_pred             ceeccCCce-EEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcC---CceeEEEEEeeC---CeEEEEEEe
Q 041624          202 RKLGQGGFG-AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHR---NLLQLIGLCHDR---GEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~E~  274 (459)
                      +.|+.||.. .||+.     +..+++|..+.  ......+.+|.+++..+...   -+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467777776 59985     23466776543  22345788999999888532   345555544332   234889999


Q ss_pred             cCCCCcch
Q 041624          275 MPNGSLDF  282 (459)
Q Consensus       275 ~~~gsL~~  282 (459)
                      ++|.++.+
T Consensus        76 i~G~~l~~   83 (235)
T cd05155          76 LEGETATA   83 (235)
T ss_pred             ecCCCCCc
Confidence            99987753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.91  E-value=7.6e-05  Score=65.66  Aligned_cols=130  Identities=18%  Similarity=0.122  Sum_probs=89.2

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCce-eEEEEEeeCCeEEEEEEecCC
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL-QLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ...+.|++|++|.||+|.+.  +..+|+|+-+.+  .....+..|+++|..+.-.++. +++.|-.    .++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            34578999999999999997  468999987653  3456788999999998777665 4444432    2455999998


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCC-CCCeeecCCCCEEEeecCCcccc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK-FSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~kL~DFGla~~~  350 (459)
                      -.|.++-..       .+..+.    ..++++---|-.   .||-|+.|. |...+|..+..+.|+||.-|+.-
T Consensus        97 ~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIG-------GDRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhc-------ccHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            888665421       122233    334444333443   888898886 44555555559999999988743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.87  E-value=0.00011  Score=70.14  Aligned_cols=140  Identities=18%  Similarity=0.117  Sum_probs=80.4

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEecCCCCcc
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEFMPNGSLD  281 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~  281 (459)
                      .+..|-...+|+...  .+..+++|..........-...+|.+++..+....+ .++++.+.    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            355677889998873  356788887654322211235788889988864434 44554432    36899999987764


Q ss_pred             hh-----------------ccccCCCCCCCCHHHH-HHHHHH---------HHHHHHHhhh-----ccCCCeeecCCCCC
Q 041624          282 FH-----------------LFSKKSTGTPLTWTTR-YKISLG---------LASALLYLHE-----EWKRCVVHRDIKFS  329 (459)
Q Consensus       282 ~~-----------------l~~~~~~~~~l~~~~~-~~i~~~---------ia~aL~yLH~-----~~~~~iiHrDlkp~  329 (459)
                      ..                 |+.......+++.... ..+..+         +...+..+-.     ..+..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            32                 1111111112222211 111111         1111111111     11246899999999


Q ss_pred             CeeecCCCCEEEeecCCccc
Q 041624          330 NIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       330 NILl~~~~~~kL~DFGla~~  349 (459)
                      ||++++++ +.|.||..|..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.0002  Score=67.21  Aligned_cols=75  Identities=17%  Similarity=0.205  Sum_probs=48.6

Q ss_pred             ceeccCCceEEEEEEEcC-CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC-ceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          202 RKLGQGGFGAVYRGILID-LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      +.|..|-...+|+....+ .+..+++|........ .-...+|+.++..+...+ .+++++.+. .   .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            567778888999987653 2467888876543222 123347888888885433 445544432 2   47999999877


Q ss_pred             cc
Q 041624          280 LD  281 (459)
Q Consensus       280 L~  281 (459)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            64

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.81  E-value=3.1e-06  Score=87.14  Aligned_cols=175  Identities=16%  Similarity=0.121  Sum_probs=119.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC-ceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN-LLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~  274 (459)
                      +-+...+-++++++++++|.+...+.. ...+.+...     ....-++++|.+++||| .+..++-+..+...++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            333344567899999999977665333 335555332     44556889999999999 66666667777888999999


Q ss_pred             cCCC-CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          275 MPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      +..+ +-.......   ...+..-+...+...-.++|++||+   ..-+|+|    ||+..+ +..|.+||+....+...
T Consensus       316 ~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCChh---hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence            9877 221111100   0123334445566677789999998   4457888    777665 68999999998776543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDC  391 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~  391 (459)
                      .  ......+|+.++|||....+.  +....|.|+.+.
T Consensus       385 ~--~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~  418 (829)
T KOG0576|consen  385 M--KPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAV  418 (829)
T ss_pred             c--ccccCCCCCCCCCchhhcccc--cccCCCccCCCc
Confidence            2  345678999999999887664  455667777664

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.77  E-value=0.00029  Score=68.52  Aligned_cols=144  Identities=18%  Similarity=0.096  Sum_probs=86.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeEEEE------EeeCCeEEEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQLIGL------CHDRGEFMLVY  272 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~  272 (459)
                      .+.|..|....+|+....  +..+++|+...   ....+...|++++..+.+.+  +.+++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            456777877899998654  34688898754   23455667888888875433  4454432      12345678999


Q ss_pred             EecCCCCcchh----c----------cccC-C--C----CCCCCHHHHH----------HHHHHHHHHHHHhhh----cc
Q 041624          273 EFMPNGSLDFH----L----------FSKK-S--T----GTPLTWTTRY----------KISLGLASALLYLHE----EW  317 (459)
Q Consensus       273 E~~~~gsL~~~----l----------~~~~-~--~----~~~l~~~~~~----------~i~~~ia~aL~yLH~----~~  317 (459)
                      +|++|..+...    +          +... .  .    .....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99998776430    0          0000 0  0    0111222211          011123334444442    12


Q ss_pred             CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       318 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      ..+++|+|+.|.|||++++..+.|.||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999987789999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.63  E-value=0.0017  Score=65.67  Aligned_cols=76  Identities=16%  Similarity=0.111  Sum_probs=54.8

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCC-------ccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-------KHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +.||.|.+..||++...+.++.++||.-.+..       ....+++..|.+.|..+.   -..+++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            57899999999999987643689999854221       124566778888888762   2457777777  44557899


Q ss_pred             EEecCCCC
Q 041624          272 YEFMPNGS  279 (459)
Q Consensus       272 ~E~~~~gs  279 (459)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0011  Score=65.14  Aligned_cols=158  Identities=16%  Similarity=0.116  Sum_probs=85.5

Q ss_pred             cCHHHHHHHhcCCCC-----CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeE
Q 041624          186 FSYKDLASATNNFSN-----ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQL  258 (459)
Q Consensus       186 ~~~~el~~~~~~f~~-----~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l  258 (459)
                      .+.+++......|..     .+.|+.|....+|+....+ | .+++|++..   ...+....|+.++..|...+  +.+.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence            455566555556644     3456677778999987653 3 688898752   12333444555555553222  3333


Q ss_pred             EEE------EeeCCeEEEEEEecCCCCcch-----------hcc---ccCC-------CCCCCCH-HHHHH---------
Q 041624          259 IGL------CHDRGEFMLVYEFMPNGSLDF-----------HLF---SKKS-------TGTPLTW-TTRYK---------  301 (459)
Q Consensus       259 ~g~------~~~~~~~~lV~E~~~~gsL~~-----------~l~---~~~~-------~~~~l~~-~~~~~---------  301 (459)
                      +..      ....+..++++||++|..+..           .|.   ....       ....+.| .....         
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            321      123456799999999875421           110   0000       0001111 11111         


Q ss_pred             ---HHHH-HHHHHHHhhh----ccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          302 ---ISLG-LASALLYLHE----EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       302 ---i~~~-ia~aL~yLH~----~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                         .+.+ +...+..+..    ....+++|+|+.|.|||++.+...-|.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence               1111 1112222221    124689999999999999977666899999885

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.51  E-value=0.00078  Score=65.79  Aligned_cols=143  Identities=25%  Similarity=0.258  Sum_probs=84.8

Q ss_pred             ceeccCCceEEEEEEEcC------CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEe
Q 041624          202 RKLGQGGFGAVYRGILID------LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~  274 (459)
                      +.|..|-...+|+.....      .++.+++|...... ....+..+|.+++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777999987654      25788899876543 223445678888888854333 456665542    358999


Q ss_pred             cCCCCcchh-c----------------cccCCC--C-----CCCCHHHHHH--------------------------HHH
Q 041624          275 MPNGSLDFH-L----------------FSKKST--G-----TPLTWTTRYK--------------------------ISL  304 (459)
Q Consensus       275 ~~~gsL~~~-l----------------~~~~~~--~-----~~l~~~~~~~--------------------------i~~  304 (459)
                      ++|.++... +                +.....  .     .+.-+.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776432 1                010000  0     0011111111                          111


Q ss_pred             HHHHHHHHhhh------ccCCCeeecCCCCCCeeecCC----CCEEEeecCCccc
Q 041624          305 GLASALLYLHE------EWKRCVVHRDIKFSNIMPDTD----FNVKLGDFGLALL  349 (459)
Q Consensus       305 ~ia~aL~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~  349 (459)
                      .+..-+++|-.      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334431      134689999999999999985    8899999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0028  Score=62.07  Aligned_cols=158  Identities=16%  Similarity=0.140  Sum_probs=89.5

Q ss_pred             CHHHHHHHhcCCCC-----CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeEE
Q 041624          187 SYKDLASATNNFSN-----ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQLI  259 (459)
Q Consensus       187 ~~~el~~~~~~f~~-----~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~  259 (459)
                      +.++|....+.|..     .+.++.|....+|+....  +..+++|+.....  ..++...|.+++..|....  +.+++
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            33455555445543     355667777899998654  3357788765421  2344556777777774322  34444


Q ss_pred             EEE------eeCCeEEEEEEecCCCCcchh--------------ccccCC---CCC-----CCCHHHHH-----------
Q 041624          260 GLC------HDRGEFMLVYEFMPNGSLDFH--------------LFSKKS---TGT-----PLTWTTRY-----------  300 (459)
Q Consensus       260 g~~------~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~---~~~-----~l~~~~~~-----------  300 (459)
                      ...      ...+..++++||++|..+...              ++....   ...     .-.|....           
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            421      224567899999998655311              110000   000     01111110           


Q ss_pred             -HHHHHHHHHHHHhhh----ccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          301 -KISLGLASALLYLHE----EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       301 -~i~~~ia~aL~yLH~----~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                       .....+...++++..    ....+++|+|+.+.||+++.++...|.||+.+.
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             011123344555532    224789999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=97.41  E-value=0.00039  Score=64.64  Aligned_cols=94  Identities=16%  Similarity=0.152  Sum_probs=56.4

Q ss_pred             CCEEEEEeeCCCCCCC-CCCCCCCceeEecCCc--------eeeeeeecccCCCCCceEEEEEEecCCcceEEEEEeeCC
Q 041624           26 SPIVLVEFDSFSNPEW-DPINVKDDVGINNSSI--------VSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGE   96 (459)
Q Consensus        26 ~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~--------~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~~~~~~   96 (459)
                      .+-+||||||+.|... +|.- .-|++...++.        .+.....++.. .++..++++|.|+  .+.|.|.+.+..
T Consensus        99 ~~Glai~fdt~~n~~~~~p~i-~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~-~~~~~~~~~I~y~--~~~l~v~i~~~~  174 (218)
T cd07308          99 FKGLAIFFDTYDNDGKGFPSI-SVFLNDGTKSYDYETDGEKLELASCSLKFR-NSNAPTTLRISYL--NNTLKVDITYSE  174 (218)
T ss_pred             CCEEEEEEEcCCCCCCCCCeE-EEEEeCCCceecccCCCccccccceeEecc-cCCCCeEEEEEEE--CCEEEEEEeCCC
Confidence            4679999999999511 2211 01333333221        11111222221 1278999999999  678888886431


Q ss_pred             CCCc---------------CCCCcCCCCceecceeccccccc
Q 041624           97 TPKY---------------SQENTTSTGRYTERHVLKSWEFN  123 (459)
Q Consensus        97 ~~~~---------------~~~fsastG~~~~~h~i~swsfs  123 (459)
                      ....               ..+|||+||...+.|.+++|.+.
T Consensus       175 ~~~~~~c~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         175 GNNWKECFTVEDVILPSQGYFGFSAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             CCCccEEEEcCCcccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence            1110               01599999999999999998653

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>PLN02236 choline kinase

Probab=97.28  E-value=0.0025  Score=63.56  Aligned_cols=143  Identities=19%  Similarity=0.197  Sum_probs=84.0

Q ss_pred             ceeccCCceEEEEEEEcC----CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCce-eEEEEEeeCCeEEEEEEecC
Q 041624          202 RKLGQGGFGAVYRGILID----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL-QLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~  276 (459)
                      ..|-.|-.-.+|+.....    .++.+++|..........+ -.+|..++..+...++. ++++.+...    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345557778899987543    2467889987655433322 36789998888655554 566655332    5899998


Q ss_pred             CCCcchh-----------------ccccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHh----hh-
Q 041624          277 NGSLDFH-----------------LFSKKSTGT--PLTWTTRYKISLGL-----------------ASALLYL----HE-  315 (459)
Q Consensus       277 ~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i-----------------a~aL~yL----H~-  315 (459)
                      +.+|...                 ++.......  ...+.+..++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422                 111110000  12233333332211                 1112222    11 


Q ss_pred             ccCCCeeecCCCCCCeeecC-CCCEEEeecCCccc
Q 041624          316 EWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALL  349 (459)
Q Consensus       316 ~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~  349 (459)
                      .....++|+|+++.|||+++ ++.++++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12357899999999999986 46899999998864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.21  E-value=0.00011  Score=76.80  Aligned_cols=90  Identities=22%  Similarity=0.249  Sum_probs=66.8

Q ss_pred             HHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc--------cccccccccccccceecc
Q 041624          304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR--------TTGLAGTLGYMAPEYIST  375 (459)
Q Consensus       304 ~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~y~APE~~~~  375 (459)
                      .+++.||.|+|.  ..++||++|.|++|.+++++..||+.|+.+..........        ..-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            455699999998  4899999999999999999999999999875543311100        111234567999999976


Q ss_pred             CccccCCCCCHHHHHHHHHHHH
Q 041624          376 GRARLDVNFDEQQTDCLMIVGL  397 (459)
Q Consensus       376 ~~~~~~~~~D~~~~g~ll~~~l  397 (459)
                      .  ..+.+.|.+++|++++.+.
T Consensus       184 ~--~~~~~sd~fSlG~li~~i~  203 (700)
T KOG2137|consen  184 T--TNTPASDVFSLGVLIYTIY  203 (700)
T ss_pred             c--cccccccceeeeeEEEEEe
Confidence            3  3567889999988765433

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0053  Score=59.96  Aligned_cols=137  Identities=18%  Similarity=0.146  Sum_probs=84.3

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEecc--CCccchHHHHHHHHHHhccCc--CCceeEEEEEeeCC--eEEEEEEec
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRG--EFMLVYEFM  275 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~E~~  275 (459)
                      +.+..|..-.+|.....  ++.+++. ...  ..........+|..+++.+.-  --....+++|.++.  ..|.||+|+
T Consensus        31 ~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          31 EEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            33434444455554443  5777777 321  122334445577777777632  33456677777665  679999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHH-HHHHHHHHHhhh---------------------------------------
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKIS-LGLASALLYLHE---------------------------------------  315 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~ia~aL~yLH~---------------------------------------  315 (459)
                      +|..+.+.+...       +..  .+++ ..++..|.-||+                                       
T Consensus       108 eGe~~~~~~~~~-------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         108 EGEVVWSALPPE-------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             cceeccCcCCcc-------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            986554433211       111  1222 255555555554                                       


Q ss_pred             ----------------ccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          316 ----------------EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       316 ----------------~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                                      ..+..++|+|+.+.|++++.+..+=+.||+++..-
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                            11357999999999999999988999999998654

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.06  E-value=0.0044  Score=60.00  Aligned_cols=74  Identities=19%  Similarity=0.218  Sum_probs=49.6

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEEEEecC
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      ..+.++.|....+|+..  .+++.+.||.-.   ......|..|.+-|+.|.   --.+.+++++....+..+|||||++
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            34678889999999977  457889999875   344567888998888883   4567899999887778899999998


Q ss_pred             CC
Q 041624          277 NG  278 (459)
Q Consensus       277 ~g  278 (459)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.06  E-value=0.0063  Score=58.70  Aligned_cols=32  Identities=28%  Similarity=0.304  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCCeeecCCCC-EEEeecCCcccc
Q 041624          319 RCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLV  350 (459)
Q Consensus       319 ~~iiHrDlkp~NILl~~~~~-~kL~DFGla~~~  350 (459)
                      ..++|+|+.+.|||++++++ .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 569999988643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.93  E-value=0.0015  Score=63.09  Aligned_cols=145  Identities=19%  Similarity=0.169  Sum_probs=95.8

Q ss_pred             cCHHHHHHHhc---CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc----------------c------chHHH
Q 041624          186 FSYKDLASATN---NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK----------------H------GKNEY  240 (459)
Q Consensus       186 ~~~~el~~~~~---~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------------~------~~~~~  240 (459)
                      ++|-.|+..++   -+...++||-|--+.||.+-+.. |.+.++|.-+....                .      ..-..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            44444544443   35778999999999999999876 78888885422100                0      01134


Q ss_pred             HHHHHHHhccC-cC-CceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 041624          241 ITEVKTCSQLR-HR-NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK  318 (459)
Q Consensus       241 ~~E~~~l~~l~-H~-nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~  318 (459)
                      .+|+..|+.|. |. -+.+.++    .+..++|||++.+..|.+.-+       ..+..+++.-+.++.   --|-.   
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~I---v~la~---  220 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLI---VRLAN---  220 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHH---HHHHH---
Confidence            57888888874 22 2344443    346689999999988865432       233344443333332   23333   


Q ss_pred             CCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       319 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      +|+||+|..-=||+++++..++++||--.-
T Consensus       221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cCceecccchheeEEecCCCEEEeechHhh
Confidence            899999999999999999999999996543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.73  E-value=0.014  Score=57.94  Aligned_cols=143  Identities=15%  Similarity=0.239  Sum_probs=81.5

Q ss_pred             ceeccCCceEEEEEEEcCC---CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.|..|-...+|+....+.   +..|++|........ .-.-.+|..++..+...++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            3455577778998876542   237889987654332 2233578888888866555 45666653 22   58999987


Q ss_pred             CCcchh-------c----------cccCCCC--CCCCHHHHHHHHHHH----------------------HHHHHHhhh-
Q 041624          278 GSLDFH-------L----------FSKKSTG--TPLTWTTRYKISLGL----------------------ASALLYLHE-  315 (459)
Q Consensus       278 gsL~~~-------l----------~~~~~~~--~~l~~~~~~~i~~~i----------------------a~aL~yLH~-  315 (459)
                      .+|...       +          +......  .+--|....++..++                      ..-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1111000  011233222222211                      111111111 


Q ss_pred             ----ccCCCeeecCCCCCCeeecC-CCCEEEeecCCccc
Q 041624          316 ----EWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALL  349 (459)
Q Consensus       316 ----~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~  349 (459)
                          ......+|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11235899999999999975 57899999998854

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.02  Score=56.81  Aligned_cols=73  Identities=14%  Similarity=0.069  Sum_probs=48.0

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccC-------CccchHHHHHHHHHHhccC--cC-CceeEEEEEeeCCeEEEEE
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKNEYITEVKTCSQLR--HR-NLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~  272 (459)
                      .||-|....||++...+.++.|+||.-.+.       -.-..++..-|...|....  -| .+.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999998654468999975321       1223445556777776652  23 45555544  555567999


Q ss_pred             EecCC
Q 041624          273 EFMPN  277 (459)
Q Consensus       273 E~~~~  277 (459)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.54  E-value=0.026  Score=55.66  Aligned_cols=142  Identities=17%  Similarity=0.168  Sum_probs=95.5

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCC---------------------ccc-hH----HHHHHHHHHhccCcCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---------------------KHG-KN----EYITEVKTCSQLRHRN  254 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------------~~~-~~----~~~~E~~~l~~l~H~n  254 (459)
                      ..+|..|--+.||.|+..+ |..+|||+++...                     ... .+    -...|++.|.+|+...
T Consensus       149 nGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            4578889999999998877 7889999875321                     000 01    2356888888886655


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD  334 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~  334 (459)
                      |.----...  ..-.|||+|+....   +-.-. -....++...+..+-.+++.-+.-|...  .++||.||.--|+|+-
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPK-LKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCC---CcCcc-cccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence            432111111  12479999995321   21111 1112577778888888999989888873  6799999999999986


Q ss_pred             CCCCEEEeecCCcccccC
Q 041624          335 TDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       335 ~~~~~kL~DFGla~~~~~  352 (459)
                      + |.+.|+|.+-+-..++
T Consensus       300 d-G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  300 D-GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             C-CEEEEEEccccccCCC
Confidence            4 5899999987765544

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.53  E-value=0.044  Score=55.39  Aligned_cols=73  Identities=10%  Similarity=0.138  Sum_probs=50.2

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-------cchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-------HGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l  270 (459)
                      .+.||.|....||+....  +..++||+-.....       ....+-..|.+.|..+.   ...+.+++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            467899999999998864  45688997652211       13344445566666553   3578889988874  4578


Q ss_pred             EEEecCC
Q 041624          271 VYEFMPN  277 (459)
Q Consensus       271 V~E~~~~  277 (459)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.44  E-value=0.05  Score=53.66  Aligned_cols=141  Identities=21%  Similarity=0.226  Sum_probs=82.4

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc------eeEEEEE--eeCC--eEEEEE
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL------LQLIGLC--HDRG--EFMLVY  272 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI------v~l~g~~--~~~~--~~~lV~  272 (459)
                      .|.+ .-..+|+....+ |+. ++|.....  ....+...|+..+..|.-..|      ..+-|-.  .-.+  ..+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~-g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED-GRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC-CCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 456789988766 444 88888765  445566667777777632222      2222211  1123  778899


Q ss_pred             EecCCCCcch-hc--------------c----c----cCCCCCCCCHHH-------------HHHHHHHHHHHHHHhhhc
Q 041624          273 EFMPNGSLDF-HL--------------F----S----KKSTGTPLTWTT-------------RYKISLGLASALLYLHEE  316 (459)
Q Consensus       273 E~~~~gsL~~-~l--------------~----~----~~~~~~~l~~~~-------------~~~i~~~ia~aL~yLH~~  316 (459)
                      +|++|..+.. .-              +    .    +........|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999988873 11              0    0    111111233431             011233444445554442


Q ss_pred             c----CCC---eeecCCCCCCeeecCCCC-EEEeecCCcc
Q 041624          317 W----KRC---VVHRDIKFSNIMPDTDFN-VKLGDFGLAL  348 (459)
Q Consensus       317 ~----~~~---iiHrDlkp~NILl~~~~~-~kL~DFGla~  348 (459)
                      .    ...   +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2    233   999999999999999875 8999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.35  E-value=0.0085  Score=66.56  Aligned_cols=169  Identities=18%  Similarity=0.057  Sum_probs=114.4

Q ss_pred             HHHHHHHHhccCcCCceeEEEEEeeCCe----EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 041624          240 YITEVKTCSQLRHRNLLQLIGLCHDRGE----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE  315 (459)
Q Consensus       240 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~  315 (459)
                      ..-|+..+.++.|+|++.++.|..+...    ..+..|++..-++...+..-.    ..+....+.+..++.+||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence            3457778888899999999999765432    234557888878877775443    57888999999999999999998


Q ss_pred             ccCCCeeecCCCCC---CeeecCCCCEEEe--ecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHH
Q 041624          316 EWKRCVVHRDIKFS---NIMPDTDFNVKLG--DFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTD  390 (459)
Q Consensus       316 ~~~~~iiHrDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g  390 (459)
                         ....|.-|..+   +--.+.++...++  ||+.++.+......  ....-+..|.|||.............|+|++|
T Consensus       305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHH
Confidence               55555555544   4445566667776  89888766543222  22233556888888776555444456888887


Q ss_pred             HHHHHHH-----------------------------hcCCCCCCCCCCHHHHHHHH
Q 041624          391 CLMIVGL-----------------------------WCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       391 ~ll~~~l-----------------------------~c~~p~p~~RPs~~~v~~~L  417 (459)
                      ....-+.                             .|...++++|++..+++...
T Consensus       380 ll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            6554333                             35556677777777776643

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.32  E-value=0.0091  Score=55.03  Aligned_cols=124  Identities=22%  Similarity=0.190  Sum_probs=60.6

Q ss_pred             CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEecCCCCcchh-ccc------------
Q 041624          221 NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEFMPNGSLDFH-LFS------------  286 (459)
Q Consensus       221 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~------------  286 (459)
                      ++.|++|+.... ....-.-..|..+++.+...++ .++++.+...    .|+||+++.+|... +..            
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            457888887655 2334455678888888865555 5566654332    57799977665331 100            


Q ss_pred             ------c-CCCCCCCCHHHHHHH----------------------HHHHHHHHHHhhh-----ccCCCeeecCCCCCCee
Q 041624          287 ------K-KSTGTPLTWTTRYKI----------------------SLGLASALLYLHE-----EWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       287 ------~-~~~~~~l~~~~~~~i----------------------~~~ia~aL~yLH~-----~~~~~iiHrDlkp~NIL  332 (459)
                            . ......--|.....+                      ...+..-+..+..     .....++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence                  0 000001112222121                      0111111222111     01256899999999999


Q ss_pred             e-cCCCCEEEeecCCccc
Q 041624          333 P-DTDFNVKLGDFGLALL  349 (459)
Q Consensus       333 l-~~~~~~kL~DFGla~~  349 (459)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.00  E-value=0.074  Score=52.14  Aligned_cols=31  Identities=19%  Similarity=0.246  Sum_probs=28.4

Q ss_pred             CCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       318 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      +.+++|+|+.+.|+|+++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4689999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.72  E-value=0.13  Score=50.22  Aligned_cols=29  Identities=28%  Similarity=0.403  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       319 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            68999999999999998 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.68  E-value=0.11  Score=48.13  Aligned_cols=75  Identities=20%  Similarity=0.261  Sum_probs=53.4

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.+.-|-.-..|...+.  ..++-||+-.   ......|..|+.-|..|.   .-++.+++.+-.+.++.||||||++-|
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            34444555555554443  4678888642   344567889988777773   456788888888999999999999988


Q ss_pred             Ccc
Q 041624          279 SLD  281 (459)
Q Consensus       279 sL~  281 (459)
                      .++
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            776

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.65  E-value=0.6  Score=46.13  Aligned_cols=94  Identities=13%  Similarity=0.053  Sum_probs=54.0

Q ss_pred             ccCHHHHHHHhcCCCCC---c-eeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeE
Q 041624          185 RFSYKDLASATNNFSNE---R-KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQL  258 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~---~-~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l  258 (459)
                      .++.+.+..+...+-..   + ..=.+.-..||+....+ +..+++|..+.. .....+...|.+.+..|....  ++..
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~-~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p   87 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDED-GRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP   87 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCC-CCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            45556666665555332   1 22234556899987654 667888987533 234556667777777663221  2221


Q ss_pred             E---E--EEeeCCeEEEEEEecCCCCc
Q 041624          259 I---G--LCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       259 ~---g--~~~~~~~~~lV~E~~~~gsL  280 (459)
                      .   |  ...-++..+.++++++|...
T Consensus        88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         88 LAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            1   1  12234567889999987654

>PTZ00384 choline kinase; Provisional

Probab=95.60  E-value=0.17  Score=51.22  Aligned_cols=75  Identities=21%  Similarity=0.274  Sum_probs=45.7

Q ss_pred             ceeccCCceEEEEEEEcCCC-c-----EEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEe
Q 041624          202 RKLGQGGFGAVYRGILIDLN-M-----AVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~  274 (459)
                      +.|..|-...+|++...... .     .|.++...... ...-.-.+|++++..+...++ .++++.+..    ++|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            45556888899998765421 2     24444332221 111223578999999966555 455555532    599999


Q ss_pred             cCCCCcc
Q 041624          275 MPNGSLD  281 (459)
Q Consensus       275 ~~~gsL~  281 (459)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998775

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.59  E-value=0.064  Score=53.97  Aligned_cols=75  Identities=19%  Similarity=0.150  Sum_probs=50.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccC------CccchHHHHHHHHHHhccC--cC-CceeEEEEEeeCCeEEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG------LKHGKNEYITEVKTCSQLR--HR-NLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lV  271 (459)
                      .+.||-|.-..||++.+...++.|+||.-...      -.-..++..-|.+.|+...  -| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            35789999999999998543567999974321      1233456666777777652  34 45556654  45556789


Q ss_pred             EEecCC
Q 041624          272 YEFMPN  277 (459)
Q Consensus       272 ~E~~~~  277 (459)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.58  E-value=0.047  Score=53.76  Aligned_cols=74  Identities=23%  Similarity=0.176  Sum_probs=58.3

Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      ....|++|++- +++|...-        .-.+++...++.+.+.-+.-+..  +...-|||+.-.||||+ +|++-|+||
T Consensus       298 ~~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         298 TLYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             ceEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence            34557777765 55553221        35688999999998888888876  57889999999999999 999999999


Q ss_pred             CCcccc
Q 041624          345 GLALLV  350 (459)
Q Consensus       345 Gla~~~  350 (459)
                      -++|+-
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999853

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	459
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-26
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
3soa_A	444	Full-Length Human Camkii Length = 444		6e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-08
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		9e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
2b7y_A	182	Fava Bean Lectin-Glucose Complex Length = 182		3e-07
2lal_A	181	Crystal Structure Determination And Refinement At 2		3e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-07
1ofs_A	187	Pea Lectin-sucrose Complex Length = 187		1e-06
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		1e-06
2ltn_A	181	Design, Expression, And Crystallization Of Recombin		1e-06
1rin_A	180	X-Ray Crystal Structure Of A Pea Lectin-Trimannosid		1e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
1loa_A	181	Three-Dimensional Structures Of Complexes Of Lathyr		2e-06
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		2e-06
1fat_A	252	Phytohemagglutinin-L Length = 252		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		3e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
1lof_C	181	X-Ray Structure Of A Biantennary Octasaccharide-Lec		3e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-06
1lgb_A	181	Interaction Of A Legume Lectin With The N2 Fragment		4e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-06
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		4e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
1lgc_A	181	Interaction Of A Legume Lectin With The N2 Fragment		6e-06
1fx5_A	242	Crystal Structure Analysis Of Ulex Europaeus Lectin		6e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-05
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		2e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-05
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		6e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-04
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		2e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-04
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		3e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-04
1gsl_A	243	Lectin (Fourth Isolated From (Griffonia Simplicifol		3e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-04
2pel_A	236	Peanut Lectin Length = 236		8e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-04
1bzw_A	232	Peanut Lectin Complexed With C-Lactose Length = 232		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 84/196 (42%), Positives = 124/196 (63%), Gaps = 2/196 (1%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-EYIT 242
           +RFS ++L  A++NFSN+  LG+GGFG VY+G L D  + VAVK++      G   ++ T
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQT 84
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           EV+  S   HRNLL+L G C    E +LVY +M NGS+   L  +  +  PL W  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +LG A  L YLH+     ++HRD+K +NI+ D +F   +GDFGLA L+D++       + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 363 GTLGYMAPEYISTGRA 378
           GT+G++APEY+STG++
Sbjct: 205 GTIGHIAPEYLSTGKS 220

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 82/196 (41%), Positives = 121/196 (61%), Gaps = 2/196 (1%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-EYIT 242
           +RFS ++L  A++NF N+  LG+GGFG VY+G L D    VAVK++      G   ++ T
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGELQFQT 76
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           EV+  S   HRNLL+L G C    E +LVY +M NGS+   L  +  +  PL W  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +LG A  L YLH+     ++HRD+K +NI+ D +F   +GDFGLA L+D++       + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 363 GTLGYMAPEYISTGRA 378
           G +G++APEY+STG++
Sbjct: 197 GXIGHIAPEYLSTGKS 212

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/211 (39%), Positives = 119/211 (56%), Gaps = 11/211 (5%)
Query: 173 VNDDLSRDAGPRRFSYK----DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKK 228
           +ND LS        SY+    DL  ATNNF ++  +G G FG VY+G+L D    VA+K+
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKR 70
Query: 229 ISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK 288
            +     G  E+ TE++T S  RH +L+ LIG C +R E +L+Y++M NG+L  HL+   
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 289 STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL 348
                ++W  R +I +G A  L YLH    R ++HRD+K  NI+ D +F  K+ DFG++ 
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS- 186
Query: 349 LVDHELGPR--TTGLAGTLGYMAPEYISTGR 377
               ELG       + GTLGY+ PEY   GR
Sbjct: 187 KKGTELGQTHLXXVVKGTLGYIDPEYFIKGR 217

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/210 (38%), Positives = 118/210 (56%), Gaps = 9/210 (4%)
Query: 173 VNDDLSRDAGPRRFSYK----DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKK 228
           +ND LS        SY+    DL  ATNNF ++  +G G FG VY+G+L D    VA+K+
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKR 70
Query: 229 ISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK 288
            +     G  E+ TE++T S  RH +L+ LIG C +R E +L+Y++M NG+L  HL+   
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 289 STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL 348
                ++W  R +I +G A  L YLH    R ++HRD+K  NI+ D +F  K+ DFG++ 
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 349 L-VDHELGPRTTGLAGTLGYMAPEYISTGR 377
              + +       + GTLGY+ PEY   GR
Sbjct: 188 KGTELDQTHLXXVVKGTLGYIDPEYFIKGR 217

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 113/200 (56%), Gaps = 19/200 (9%)
Query: 186 FSYKDLASATNNFSNER-------KLGQGGFGAVYRGILIDLNMAVAVKKISRGL----K 234
           FS+ +L + TNNF +ER       K+G+GGFG VY+G +   N  VAVKK++  +    +
Sbjct: 15  FSFYELKNVTNNF-DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTE 71
Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K ++  E+K  ++ +H NL++L+G   D  +  LVY +MPNGSL   L     T  PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 130
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-E 353
           +W  R KI+ G A+ + +LHE      +HRDIK +NI+ D  F  K+ DFGLA   +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 354 LGPRTTGLAGTLGYMAPEYI 373
                + + GT  YMAPE +
Sbjct: 188 QTVMXSRIVGTTAYMAPEAL 207

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 112/200 (56%), Gaps = 19/200 (9%)
Query: 186 FSYKDLASATNNFSNER-------KLGQGGFGAVYRGILIDLNMAVAVKKISRGL----K 234
           FS+ +L + TNNF +ER       K+G+GGFG VY+G +   N  VAVKK++  +    +
Sbjct: 15  FSFYELKNVTNNF-DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTE 71
Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K ++  E+K  ++ +H NL++L+G   D  +  LVY +MPNGSL   L     T  PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 130
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-E 353
           +W  R KI+ G A+ + +LHE      +HRDIK +NI+ D  F  K+ DFGLA   +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 354 LGPRTTGLAGTLGYMAPEYI 373
                  + GT  YMAPE +
Sbjct: 188 QTVMXXRIVGTTAYMAPEAL 207

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 112/200 (56%), Gaps = 19/200 (9%)
Query: 186 FSYKDLASATNNFSNER-------KLGQGGFGAVYRGILIDLNMAVAVKKISRGL----K 234
           FS+ +L + TNNF +ER       K+G+GGFG VY+G +   N  VAVKK++  +    +
Sbjct: 9   FSFYELKNVTNNF-DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTE 65
Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K ++  E+K  ++ +H NL++L+G   D  +  LVY +MPNGSL   L     T  PL
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPL 124
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-E 353
           +W  R KI+ G A+ + +LHE      +HRDIK +NI+ D  F  K+ DFGLA   +   
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 354 LGPRTTGLAGTLGYMAPEYI 373
                  + GT  YMAPE +
Sbjct: 182 QXVMXXRIVGTTAYMAPEAL 201

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 75/200 (37%), Positives = 110/200 (55%), Gaps = 19/200 (9%)
Query: 186 FSYKDLASATNNFSNER-------KLGQGGFGAVYRGILIDLNMAVAVKKISRGL----K 234
           FS+ +L + TNNF +ER       K G+GGFG VY+G +   N  VAVKK++  +    +
Sbjct: 6   FSFYELKNVTNNF-DERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTE 62
Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K ++  E+K  ++ +H NL++L+G   D  +  LVY + PNGSL   L     T  PL
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPL 121
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-E 353
           +W  R KI+ G A+ + +LHE      +HRDIK +NI+ D  F  K+ DFGLA   +   
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 354 LGPRTTGLAGTLGYMAPEYI 373
                + + GT  Y APE +
Sbjct: 179 QXVXXSRIVGTTAYXAPEAL 198

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-------EVKT 246
           A N    E+++G+GGFG V++G L+     VA+K +  G   G+ E I        EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
            S L H N+++L GL H+     +V EF+P G L   L  K     P+ W+ + ++ L +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDI 131
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNI-MPDTDFN----VKLGDFGLALLVDHELGPRTTGL 361
           A  + Y+  +    +VHRD++  NI +   D N     K+ DFGL+    H +    +GL
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGL 186
Query: 362 AGTLGYMAPEYIST 375
            G   +MAPE I  
Sbjct: 187 LGNFQWMAPETIGA 200

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 22/194 (11%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-------EVKT 246
           A N    E+++G+GGFG V++G L+     VA+K +  G   G+ E I        EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
            S L H N+++L GL H+     +V EF+P G L   L  K     P+ W+ + ++ L +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDI 131
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNI-MPDTDFN----VKLGDFGLALLVDHELGPRTTGL 361
           A  + Y+  +    +VHRD++  NI +   D N     K+ DFG +    H +    +GL
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV----SGL 186
Query: 362 AGTLGYMAPEYIST 375
            G   +MAPE I  
Sbjct: 187 LGNFQWMAPETIGA 200

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 22/194 (11%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-------EVKT 246
           A N    E+++G+GGFG V++G L+     VA+K +  G   G+ E I        EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
            S L H N+++L GL H+     +V EF+P G L   L  K     P+ W+ + ++ L +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDI 131
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNI-MPDTDFN----VKLGDFGLALLVDHELGPRTTGL 361
           A  + Y+  +    +VHRD++  NI +   D N     K+ DF L+    H +    +GL
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV----SGL 186
Query: 362 AGTLGYMAPEYIST 375
            G   +MAPE I  
Sbjct: 187 LGNFQWMAPETIGA 200

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 93/192 (48%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVY------RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY      R  ++ L +    +    G++H   +   EV+  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 59
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 112
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 113 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 164
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 165 GTLDYLPPEMIE 176

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 36/203 (17%)
Query: 182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKH 235
           GPR+++ +D       F   R LG+G FG VY         ++ L +    +    G++H
Sbjct: 1   GPRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 53
Query: 236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKST 290
              +   EV+  S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T
Sbjct: 54  ---QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            T +T          LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++  
Sbjct: 111 ATYIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 156
Query: 351 DHELGPRTTGLAGTLGYMAPEYI 373
            H    R T L GTL Y+ PE I
Sbjct: 157 -HAPSSRRTTLCGTLDYLPPEMI 178

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 36/203 (17%)
Query: 182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKH 235
           GPR+++ +D       F   R LG+G FG VY         ++ L +    +    G++H
Sbjct: 1   GPRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 53
Query: 236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKST 290
              +   EV+  S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T
Sbjct: 54  ---QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            T +T          LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++  
Sbjct: 111 ATYIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 156
Query: 351 DHELGPRTTGLAGTLGYMAPEYI 373
            H    R T L GTL Y+ PE I
Sbjct: 157 -HAPSSRRTELCGTLDYLPPEMI 178

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGTPLTWTTRYKISLG 305
           S LRH N+L+L G  HD     L+ E+ P G +  +    SK       T+ T       
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE------ 121
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L GTL
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 175
Query: 366 GYMAPEYI 373
            Y+ PE I
Sbjct: 176 DYLPPEMI 183

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 79
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 132
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 133 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 184
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 185 GTLDYLPPEMI 195

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 88
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGTPLTWTTRYKISLG 305
           S LRH N+L+L G  HD     L+ E+ P G++  +    SK       T+ T       
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE------ 142
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L GTL
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 196
Query: 366 GYMAPEYI 373
            Y+ PE I
Sbjct: 197 DYLPPEMI 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 63
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 116
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 117 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC 168
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 169 GTLDYLPPEMI 179

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 116 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC 167
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 168 GTLDYLPPEMIE 179

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 118
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 119 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 170
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 171 GTLDYLPPEMI 181

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 120
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 121 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC 172
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 173 GTLDYLPPEMI 183

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 120
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 121 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 172
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 173 GTLDYLPPEXI 183

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 120
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 121 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 172
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 173 GTLDYLPPEMI 183

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 116 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC 167
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 168 GTLDYLPPEMIE 179

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRH 252
           ++F   R LG+G FG VY  R       MA+ V   S+  K G +++   E++  S LRH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLA 307
            N+L++    HDR    L+ EF P G L   L     F ++ + T +           LA
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------ELA 124
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL Y HE   R V+HRDIK  N++      +K+ DFG ++   H    R   + GTL Y
Sbjct: 125 DALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDY 178
Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA 400
           + PE I           DE+       V LWCA
Sbjct: 179 LPPEMIEGK------THDEK-------VDLWCA 198

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 63
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 116
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG +    H    R T L+
Sbjct: 117 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSC---HAPSSRRTTLS 168
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 169 GTLDYLPPEMI 179

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 61
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 114
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 115 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 166
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 167 GTLDYLPPEMIE 178

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 118
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 119 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 170
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 171 GTLDYLPPEMIE 182

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRH 252
           ++F   R LG+G FG VY  R       MA+ V   S+  K G +++   E++  S LRH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLA 307
            N+L++    HDR    L+ EF P G L   L     F ++ + T +           LA
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------ELA 125
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL Y HE   R V+HRDIK  N++      +K+ DFG ++   H    R   + GTL Y
Sbjct: 126 DALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDY 179
Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA 400
           + PE I           DE+       V LWCA
Sbjct: 180 LPPEMIEGK------THDEK-------VDLWCA 199

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 116 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLC 167
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 168 GTLDYLPPEMIE 179

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 66
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 119
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R T L 
Sbjct: 120 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLC 171
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 172 GTLDYLPPEMI 182

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 93/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR------GLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY     +    +A+K + +      G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 116 --ELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALC 167
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 168 GTLDYLPPEMI 178

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGTPLTWTTRYKISLG 305
           S LRH N+L+L G  HD     L+ E+ P G++  +    SK       T+ T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE------ 119
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L GTL
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTL 173
Query: 366 GYMAPEYI 373
            Y+ PE I
Sbjct: 174 DYLPPEMI 181

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 116 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALC 167
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 168 GTLDYLPPEMIE 179

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 88/188 (46%), Gaps = 23/188 (12%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGTPLTWTTRYKISLG 305
           S LRH N+L+L G  HD     L+ E+ P G +  +    SK       T+ T       
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE------ 121
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L GTL
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTL 175
Query: 366 GYMAPEYI 373
            Y+ PE I
Sbjct: 176 DYLPPEMI 183

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 88
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGTPLTWTTRYKISLG 305
           S LRH N+L+L G  HD     L+ E+ P G++  +    SK       T+ T       
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE------ 142
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L GTL
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTL 196
Query: 366 GYMAPEYI 373
            Y+ PE I
Sbjct: 197 DYLPPEMI 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 196 NNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
            +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  S 
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH---QLRREVEIQSH 68
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISL 304
           LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T         
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT--------- 119
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            LA+AL Y H    + V+HRDIK  N++  ++  +K+ DFG ++   H    R T L GT
Sbjct: 120 ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGT 173
Query: 365 LGYMAPEYI 373
           L Y+ PE I
Sbjct: 174 LDYLPPEMI 182

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 64
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 117
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ +FG ++   H    R T L 
Sbjct: 118 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLC 169
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 170 GTLDYLPPEMI 180

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 91/191 (47%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 64
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 117
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 118 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLC 169
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 170 GTLDYLPPEMI 180

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +         E++ E     +++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 90
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F +V E+MP G+L  +L  ++     +T      ++  ++SA+ YL  
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLE- 147
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++
Sbjct: 148 --KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 118
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ +FG ++   H    R T L 
Sbjct: 119 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLC 170
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 171 GTLDYLPPEMIE 182

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 91/191 (47%), Gaps = 29/191 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 63
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 116
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 117 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLC 168
Query: 363 GTLGYMAPEYI 373
           GTL Y+ PE I
Sbjct: 169 GTLDYLPPEMI 179

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G FG VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 126
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 376 GR 377
            +
Sbjct: 185 NK 186

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    ++++I E +   +L H  L+QL G+
Sbjct: 33  QEIGSGQFGLVHLGYWLNKD-KVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV+EFM +G L  +L +++         T   + L +   + YL E    CV
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 144
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 118
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 119 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLC 170
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 171 GTLDYLPPEMIE 182

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 62
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 115
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 116 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLC 167
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 168 GTLDYLPPEMIE 179

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L+QL G+
Sbjct: 11  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV+EFM +G L  +L +++         T   + L +   + YL E    CV
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 122
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L+QL G+
Sbjct: 16  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV+EFM +G L  +L +++         T   + L +   + YL E    CV
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 127
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 183

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 194 ATNNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTC 247
           A  +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH---QLRREVEIQ 65
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKI 302
           S LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T       
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------- 118
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              LA+AL Y H    + V+HRDIK  N++  +   +K+ DFG ++   H    R   L 
Sbjct: 119 --ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLC 170
Query: 363 GTLGYMAPEYIS 374
           GTL Y+ PE I 
Sbjct: 171 GTLDYLPPEMIE 182

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L+QL G+
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV+EFM +G L  +L +++         T   + L +   + YL E    CV
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 124
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 180

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 126
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 376 GR 377
            +
Sbjct: 185 NK 186

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 63
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L  ++     ++      +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM 121
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 363 GTLGYMAPEYISTGR 377
             + + APE ++  +
Sbjct: 179 FPIKWTAPESLAYNK 193

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 63
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L  ++     +       +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYM 121
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 363 GTLGYMAPEYISTGR 377
             + + APE ++  +
Sbjct: 179 FPIKWTAPESLAYNK 193

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 376 GR 377
            +
Sbjct: 187 NK 188

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 63
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L  ++     +       +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYM 121
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 363 GTLGYMAPEYISTGR 377
             + + APE ++  +
Sbjct: 179 FPIKWTAPESLAYNK 193

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN 188
Query: 377 R 377
           +
Sbjct: 189 K 189

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 376 GR 377
            +
Sbjct: 187 NK 188

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 376 GR 377
            +
Sbjct: 187 NK 188

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 63
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L  ++     +       +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYM 121
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 363 GTLGYMAPEYISTGR 377
             + + APE ++  +
Sbjct: 179 FPIKWTAPESLAYNK 193

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 63
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L  ++     +       +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYM 121
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 363 GTLGYMAPEYISTGR 377
             + + APE ++  +
Sbjct: 179 FPIKWTAPESLAYNK 193

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 29/190 (15%)
Query: 196 NNFSNERKLGQGGFGAVYRG------ILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
            +F   R LG+G FG VY         ++ L +    +    G++H   +   EV+  S 
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH---QLRREVEIQSH 68
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISL 304
           LRH N+L+L G  HD     L+ E+ P G++   L     F ++ T T +T         
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT--------- 119
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            LA+AL Y H    + V+HRDIK  N++  ++  +K+ DFG ++   H    R   L GT
Sbjct: 120 ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGT 173
Query: 365 LGYMAPEYIS 374
           L Y+ PE I 
Sbjct: 174 LDYLPPEMIE 183

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 376 GR 377
            +
Sbjct: 187 NK 188

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 3/173 (1%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           + K+G G FG V+R      ++AV +           NE++ EV    +LRH N++  +G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                    +V E++  GSL + L  K      L    R  ++  +A  + YLH      
Sbjct: 102 AVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +VHRD+K  N++ D  + VK+ DFGL+ L        +   AGT  +MAPE +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVL 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYN 188
Query: 377 R 377
           +
Sbjct: 189 K 189

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRHRNLLQLIG 260
           LG+G F  VYR   I   + VA+K I +    K G  + +  EVK   QL+H ++L+L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
              D     LV E   NG ++ +L   K+   P +          + + +LYLH      
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELGPRTTGLAGTLGYMAPE 371
           ++HRD+  SN++   + N+K+ DFGLA  L + HE   +   L GT  Y++PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPE 182

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 6/182 (3%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE- 126
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++ 
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 376 GR 377
            +
Sbjct: 185 NK 186

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYN 189
Query: 377 R 377
           +
Sbjct: 190 K 190

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 377 R 377
           +
Sbjct: 188 K 188

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 76
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 132
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 377 R 377
           +
Sbjct: 192 K 192

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L+QL G+
Sbjct: 14  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV EFM +G L  +L +++         T   + L +   + YL E    CV
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 181

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 377 R 377
           +
Sbjct: 190 K 190

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 85
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 200
Query: 377 R 377
           +
Sbjct: 201 K 201

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 377 R 377
           +
Sbjct: 188 K 188

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 189
Query: 377 R 377
           +
Sbjct: 190 K 190

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 3/173 (1%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           + K+G G FG V+R      ++AV +           NE++ EV    +LRH N++  +G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                    +V E++  GSL + L  K      L    R  ++  +A  + YLH      
Sbjct: 102 AVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +VHR++K  N++ D  + VK+ DFGL+ L        +   AGT  +MAPE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVL 211

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 92/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 279
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL   
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HR++   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 377 R 377
           +
Sbjct: 395 K 395

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           + + + KLG G +G VY G+    ++ VAVK +       + E++ E     +++H NL+
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 318
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           QL+G+C     F ++ EFM  G+L  +L  ++     +       ++  ++SA+ YL   
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            K+  +HR++   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  
Sbjct: 375 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 377 R 377
           +
Sbjct: 434 K 434

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 87/176 (49%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L+QL G+
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C ++    LV+EFM +G L  +L +++         T   + L +   + YL E     V
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---SV 124
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 180

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 23/196 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           FS+ R++G G FGAVY    +  +  VA+KK+S   K    ++   I EV+   +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            +Q  G         LV E+    + D     KK    PL       ++ G    L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 171
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRD+K  NI+      VKLGDFG A +    + P      GT  +MAPE I 
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAP-ANXFVGTPYWMAPEVI- 222
Query: 375 TGRARLDVNFDEQQTD 390
                  +  DE Q D
Sbjct: 223 -------LAMDEGQYD 231

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           FS+ R++G G FGAVY    +  +  VA+KK+S   K    ++   I EV+   +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            +Q  G         LV E+    + D     KK    PL       ++ G    L YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 ++HRD+K  NI+      VKLGDFG A +    + P      GT  +MAPE I
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAP-ANXFVGTPYWMAPEVI 183

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 26  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 84  TQEPIYIIT-EYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 137
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 191

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 78  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 185

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 29  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 87  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 140
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 194

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 28  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 86  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 139
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 193

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASA 309
           H N+++L+ + H   +  LV+EF+   S+D   F   S  TG PL     Y   L    A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 121 FCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLA 153

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 22  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 80  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 133
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 187

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 21  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 79  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 132
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 186

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 78  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG 185

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASA 309
           H N+++L+ + H   +  LV+EF+   S+D   F   S  TG PL     Y   L    A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 119 FCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKN 238
           GP  F     A  ++ +  +R LG+G FG V            AVK IS+     K  K 
Sbjct: 18  GPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 239 EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
             + EV+   QL H N+++L     D+G F LV E    G L   + S+K      +   
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVD 133
Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELG 355
             +I   + S + Y+H   K  +VHRD+K  N++ ++   D N+++ DFGL+     E  
Sbjct: 134 AARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEAS 188
Query: 356 PRTTGLAGTLGYMAPEYI 373
            +     GT  Y+APE +
Sbjct: 189 KKMKDKIGTAYYIAPEVL 206

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 25  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 83  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 136
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 190

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 26  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 84  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 137
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 191

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L+ + H   +  LV+EF+     DF + +   TG PL     Y   L    A  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDF-MDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 HSHR-----VLHRDLKPENLLINTEGAIKLADFGLA 150

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASA 309
           H N+++L+ + H   +  LV+EF+   S+D   F   S  TG PL     Y   L    A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 FCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASA 309
           H N+++L+ + H   +  LV+EF+   S+D   F   S  TG PL     Y   L    A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 121 FCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 187 SYKDLASATNNFSNE---------RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL- 233
           +Y+D   A + F+ E         R +G G FG V  G L      ++AVA+K +  G  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 234 KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
           +  + +++ E     Q  H N++ L G+       M+V EFM NG+LD   F +K  G  
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALD--AFLRKHDGQ- 141
Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--D 351
            T      +  G+A+ + YL +      VHRD+   NI+ +++   K+ DFGL+ ++  D
Sbjct: 142 FTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 352 HELGPRTTGLAGTLGYMAPEYIS 374
            E    TTG    + + APE I 
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQ 221

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 8/189 (4%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLR 251
           S+++ F    KLG G +  VY+G+     + VA+K++    + G  +  I E+    +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP--LTWTTRYKISLGLASA 309
           H N+++L  + H   +  LV+EFM N  L  ++ S+    TP  L           L   
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L + HE     ++HRD+K  N++ +    +KLGDFGLA      +   ++ +  TL Y A
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 370 PEYISTGRA 378
           P+ +   R 
Sbjct: 177 PDVLMGSRT 185

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 78  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 30  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 88  TQEPIYIIT-EYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 141
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 195

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG+G +G VY G  +   + +A+K+I             E+     L+H+N++Q +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 264 DRGEFMLVYEFMPNGSLDFHLFSK----KSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           + G   +  E +P GSL   L SK    K     + + T+      +   L YLH+    
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDNQ-- 142
Query: 320 CVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            +VHRDIK  N++ +T   V K+ DFG +  +   + P T    GTL YMAPE I  G
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEIIDKG 198

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGK 237
           A P  F     A  ++ +  +R LG+G FG V            AVK IS+     K  K
Sbjct: 11  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 70
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
              + EV+   QL H N+++L     D+G F LV E    G L   + S+K      +  
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEV 126
Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHEL 354
              +I   + S + Y+H   K  +VHRD+K  N++ ++   D N+++ DFGL+     E 
Sbjct: 127 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEA 181
Query: 355 GPRTTGLAGTLGYMAPEYI 373
             +     GT  Y+APE +
Sbjct: 182 SKKMKDKIGTAYYIAPEVL 200

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 200 NER-----KLGQGGFGAVYRGILIDLNMAVAVKKI---SRGLKHGKNEYITEVKTCSQLR 251
           NER     KLG GG   VY      LN+ VA+K I    R  +     +  EV   SQL 
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H+N++ +I +  +   + LV E++   +L  ++   +S G PL+  T    +  +   + 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG-PLSVDTAINFTNQILDGIK 125
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + H+     +VHRDIK  NI+ D++  +K+ DFG+A  +      +T  + GT+ Y +PE
Sbjct: 126 HAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---RGLKHGKNEYITEVKTCSQLRHR 253
           NF  E+K+G+G F  VYR   +   + VA+KK+          + + I E+    QL H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++      +  E  +V E    G L   +   K     +   T +K  + L SAL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYMAP 370
           H    R V+HRDIK +N+       VKLGD GL          +TT    L GT  YM+P
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSP 205
Query: 371 EYI 373
           E I
Sbjct: 206 ERI 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 15  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 73  TQEPIYIIT-EYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 180

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGK 237
           A P  F     A  ++ +  +R LG+G FG V            AVK IS+     K  K
Sbjct: 34  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 93
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
              + EV+   QL H N+++L     D+G F LV E    G L   + S+K      +  
Sbjct: 94  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEV 149
Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHEL 354
              +I   + S + Y+H   K  +VHRD+K  N++ ++   D N+++ DFGL+     E 
Sbjct: 150 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEA 204
Query: 355 GPRTTGLAGTLGYMAPEYI 373
             +     GT  Y+APE +
Sbjct: 205 SKKMKDKIGTAYYIAPEVL 223

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 199 SNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHR 253
           + ++ +G G FG VY+G+L        + VA+K +  G    +  +++ E     Q  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L G+       M++ E+M NG+LD  L  K    + L      +   G+A+ + YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL 163
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPE 371
                   VHRD+   NI+ +++   K+ DFGL+ ++  D E    T+G    + + APE
Sbjct: 164 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 372 YIS 374
            IS
Sbjct: 221 AIS 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGK 237
           A P  F     A  ++ +  +R LG+G FG V            AVK IS+     K  K
Sbjct: 35  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 94
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
              + EV+   QL H N+++L     D+G F LV E    G L   + S+K      +  
Sbjct: 95  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEV 150
Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHEL 354
              +I   + S + Y+H   K  +VHRD+K  N++ ++   D N+++ DFGL+     E 
Sbjct: 151 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEA 205
Query: 355 GPRTTGLAGTLGYMAPEYI 373
             +     GT  Y+APE +
Sbjct: 206 SKKMKDKIGTAYYIAPEVL 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 89/192 (46%), Gaps = 36/192 (18%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--------EVKTCSQLRH 252
           E  +G GGFG VYR   I   +AV      +  +H  +E I+        E K  + L+H
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAV------KAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKISLGLASALL 311
            N++ L G+C       LV EF   G L+  L  K+     L  W  +      +A  + 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMN 119
Query: 312 YLHEEWKRCVVHRDIKFSNIM-----PDTDFN---VKLGDFGLALLVDHELGPRTTGL-- 361
           YLH+E    ++HRD+K SNI+      + D +   +K+ DFGLA         RTT +  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----REWHRTTKMSA 174
Query: 362 AGTLGYMAPEYI 373
           AG   +MAPE I
Sbjct: 175 AGAYAWMAPEVI 186

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y 
Sbjct: 118 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 171
Query: 369 APEYI 373
           APE +
Sbjct: 172 APEIL 176

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 63
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 123 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 176
Query: 371 EYI 373
           E +
Sbjct: 177 EIL 179

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG+G +G VY G  +   + +A+K+I             E+     L+H+N++Q +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 264 DRGEFMLVYEFMPNGSLDFHLFSK----KSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           + G   +  E +P GSL   L SK    K     + + T+      +   L YLH+    
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDNQ-- 128
Query: 320 CVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            +VHRDIK  N++ +T   V K+ DFG +  +   + P T    GTL YMAPE I  G
Sbjct: 129 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-INPCTETFTGTLQYMAPEIIDKG 184

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 13/181 (7%)
Query: 202 RKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           R LG+G FG VY G+  +     +N+AV   K    L + K ++++E      L H +++
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLDHPHIV 72
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+  +   ++++ E  P G L  +L   K++   LT       SL +  A+ YL  E
Sbjct: 73  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLY---SLQICKAMAYL--E 126
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              CV HRDI   NI+  +   VKLGDFGL+  ++ E   + +     + +M+PE I+  
Sbjct: 127 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 377 R 377
           R
Sbjct: 186 R 186

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 59
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 119 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 371 EYI 373
           E +
Sbjct: 173 EIL 175

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 58
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 118 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 371 EYI 373
           E +
Sbjct: 172 EIL 174

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 9/180 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
            NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A  + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y APE +
Sbjct: 121 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 59
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 119 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 371 EYI 373
           E +
Sbjct: 173 EIL 175

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 66
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 126 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 179
Query: 371 EYI 373
           E +
Sbjct: 180 EIL 182

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E  +G G FG V RG L         VA+K +  G  +  + E+++E     Q  H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L G+  +    M++ EFM NG+LD  L       T +      +   G+AS + YL E 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAE- 136
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGP-RTTGLAGTLG--YMAPEY 372
                VHRD+   NI+ +++   K+ DFGL+  L ++   P  T+ L G +   + APE 
Sbjct: 137 --MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 373 IS 374
           I+
Sbjct: 195 IA 196

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 66
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 126 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 179
Query: 371 EYI 373
           E +
Sbjct: 180 EIL 182

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 59
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 119 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 371 EYI 373
           E +
Sbjct: 173 EIL 175

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 13/181 (7%)
Query: 202 RKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           R LG+G FG VY G+  +     +N+AV   K    L + K ++++E      L H +++
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLDHPHIV 88
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+  +   ++++ E  P G L  +L   K++   LT       SL +  A+ YL  E
Sbjct: 89  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLY---SLQICKAMAYL--E 142
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              CV HRDI   NI+  +   VKLGDFGL+  ++ E   + +     + +M+PE I+  
Sbjct: 143 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 377 R 377
           R
Sbjct: 202 R 202

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 13/181 (7%)
Query: 202 RKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           R LG+G FG VY G+  +     +N+AV   K    L + K ++++E      L H +++
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLDHPHIV 76
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+  +   ++++ E  P G L  +L   K++   LT       SL +  A+ YL  E
Sbjct: 77  KLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLY---SLQICKAMAYL--E 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              CV HRDI   NI+  +   VKLGDFGL+  ++ E   + +     + +M+PE I+  
Sbjct: 131 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 377 R 377
           R
Sbjct: 190 R 190

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 60
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 13  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 71  VVSEE-PIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 124
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 181

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 20  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       +S  +AS + Y+    +  
Sbjct: 78  VVSEEPIY-IVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMN 131
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGR 188

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 59
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 119 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 59
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 119 AFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLA 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 57
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 117 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E  +G G FG V RG L         VA+K +  G  +  + E+++E     Q  H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L G+  +    M++ EFM NG+LD  L       T +      +   G+AS + YL E 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAE- 134
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPR-TTGLAGTLG--YMAPEY 372
                VHRD+   NI+ +++   K+ DFGL+  L ++   P  T+ L G +   + APE 
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 373 IS 374
           I+
Sbjct: 193 IA 194

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 57
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 117 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 60
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 59
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 119 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 187 SYKDLASATNNFSNE---------RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL- 233
           +Y+D   A + F+ E         R +G G FG V  G L       + VA+K +  G  
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 234 KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
           +  + +++ E     Q  H N++ L G+       M+V E+M NGSLD   F KK+ G  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKNDGQ- 120
Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--D 351
            T      +  G+++ + YL +      VHRD+   NI+ +++   K+ DFGL+ ++  D
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 352 HELGPRTTGLAGTLGYMAPEYIS 374
            E    T G    + + APE I+
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIA 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 118 AFCHSHR-----VLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 60
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 118 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 57
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 117 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLR 251
           +  NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 HSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 61
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 121 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 247 VVSEEPIY-IVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 300
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 247 VVSEEPIY-IVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 300
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGLA ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 58
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 118 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 20  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       +S  +AS + Y+    +  
Sbjct: 78  VVSEEPIY-IVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMN 131
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 188

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 60
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
            NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A  + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 121 HR-----VLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 7/171 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    + ++  A K I    +    +Y+ E+   +   H N+++L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +      ++ EF   G++D  +   +    PLT +    +      AL YLH+     ++
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKII 157
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  NI+   D ++KL DFG++      +  R     GT  +MAPE +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ-RRDSFIGTPYWMAPEVV 207

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGK 237
           A P  F     A  ++ +  +R LG+G FG V            AVK IS+     K  K
Sbjct: 11  ATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 70
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
              + EV+   QL H N+ +L     D+G F LV E    G L   + S+K      +  
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEV 126
Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHEL 354
              +I   + S + Y H   K  +VHRD+K  N++ ++   D N+++ DFGL+     E 
Sbjct: 127 DAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEA 181
Query: 355 GPRTTGLAGTLGYMAPEYI 373
             +     GT  Y+APE +
Sbjct: 182 SKKXKDKIGTAYYIAPEVL 200

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQL 250
           +N   +R+LG+G FG V+     +L      + VAVK +     + + ++  E +  + L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL---------DFHLFSKKSTGTPLTWTTRYK 301
           +H ++++  G+C +    ++V+E+M +G L         D  L ++ +  T LT +    
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           I+  +A+ ++YL  +     VHRD+   N +   +  VK+GDFG++
Sbjct: 133 IAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS 175

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 272 EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 330 VVSEE-PIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 383
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G  G V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 20  RLGAGQAGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 78  TQEPIYIIT-EYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYG 185

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 9/180 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
            NF    K+G+G +G VY+         VA+KKI    +     +  I E+    +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    +  + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y APE +
Sbjct: 122 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 7/171 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    + ++  A K I    +    +Y+ E+   +   H N+++L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +      ++ EF   G++D  +   +    PLT +    +      AL YLH+     ++
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKII 157
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  NI+   D ++KL DFG++      +  R     GT  +MAPE +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVV 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 16  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 74  VVSEEPIY-IVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 127
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 184

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K  TG  L       ++  +AS + Y+    +  
Sbjct: 247 VVSEEPIY-IVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 300
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+ G   + +  VAVK + +G     + ++ E     QL+H+ L++L  + 
Sbjct: 16  RLGAGQFGEVWMGYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
                +++  E+M NGSL    F K  +G  LT      ++  +A  + ++ E   R  +
Sbjct: 74  TQEPIYIIT-EYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           HR+++ +NI+     + K+ DFGLA L++        G    + + APE I+ G
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 181

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 23/187 (12%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHG-KNEYITEVKTCSQLRH 252
           ++F   R LG+G FG VY       +  VA+K +  S+  K G +++   E++  + L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLA 307
            N+L+L    +DR    L+ E+ P G L   L     F ++ T T         I   LA
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTAT---------IMEELA 133
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL+Y H    + V+HRDIK  N++      +K+ DFG ++   H    R   + GTL Y
Sbjct: 134 DALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDY 187
Query: 368 MAPEYIS 374
           + PE I 
Sbjct: 188 LPPEMIE 194

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 7/171 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    + ++  A K I    +    +Y+ E+   +   H N+++L+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +      ++ EF   G++D  +   +    PLT +    +      AL YLH+     ++
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKII 157
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  NI+   D ++KL DFG++      +  R     GT  +MAPE +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ-RRDXFIGTPYWMAPEVV 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 133
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 134 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 371 EYIS 374
           E I+
Sbjct: 191 EAIA 194

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 186 FSYKDLASATNNFSNE---------RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL 233
           F+++D   A   F+ E         + +G G FG V  G L       + VA+K +  G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 234 -KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
               + ++++E     Q  H N++ L G+       M++ E+M NGSLD   F +K+ G 
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
             T      +  G+ S + YL +      VHRD+   NI+ +++   K+ DFG++ ++  
Sbjct: 128 -FTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 351 DHELGPRTTGLAGTLGYMAPEYIS 374
           D E    T G    + + APE I+
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIA 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 141
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 142 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 200 FEV--DVWSIGCIM 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 12/186 (6%)
Query: 195 TNNFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
             N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q 
Sbjct: 32  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS +
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 148
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYM 368
            YL +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + 
Sbjct: 149 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 369 APEYIS 374
           +PE I+
Sbjct: 206 SPEAIA 211

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 137
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 196 FEV--DVWSIGCIM 207

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 137
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 196 FEV--DVWSIGCIM 207

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
            NF    K+G+G +G VY+         VA+ KI    +     +  I E+    +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A  + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y APE +
Sbjct: 122 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 9/180 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
            NF    K+G+G +G VY+         VA+ KI    +     +  I E+    +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L+ + H   +  LV+EF+ +  L   + +   TG PL     Y   L    A  + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y APE +
Sbjct: 121 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 160
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 161 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 371 EYIS 374
           E I+
Sbjct: 218 EAIA 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 159
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 160 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 218 FEV--DVWSIGCIM 229

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 161
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 220 FEV--DVWSIGCIM 231

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   ++++ E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIYIVI-EYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 191

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E+M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL  ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG 260
           LG+GGF   +     D     A K + + L    H + +   E+     L H++++   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 261 LCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
              D     +V E     SL + H   K  T     +  R +I LG      YLH     
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRNR-- 135
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            V+HRD+K  N+  + D  VK+GDFGLA  V+++ G R   L GT  Y+APE +S     
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 380 LDVNFDEQQTDCLM 393
            +V  D     C+M
Sbjct: 194 FEV--DVWSIGCIM 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 150
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 151 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 151
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 116 GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 169
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 170 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 198

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 170
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 171 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 199

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 148
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 149 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 177

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 205 GQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD 264
            +G FG V++  L++  +AV +  I +  +  +NEY  EV +   ++H N+LQ IG    
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPI-QDKQSWQNEY--EVYSLPGMKHENILQFIG-AEK 88
Query: 265 RG-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-- 317
           RG     +  L+  F   GSL   L         ++W     I+  +A  L YLHE+   
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 318 -----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTTGLAGTLGYMAPE 371
                K  + HRDIK  N++   +    + DFGLAL  +  +    T G  GT  YMAPE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 372 YIS 374
            + 
Sbjct: 204 VLE 206

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
            NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    +L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL 58
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L+ + H   +  LV+E + +  L   + +   TG PL     Y   L    A 
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y AP
Sbjct: 118 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 371 EYI 373
           E +
Sbjct: 172 EIL 174

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 143
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 144 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 172

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 96  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 149
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 150 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 178

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 146
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 175

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 150
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 151 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 91/184 (49%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 150
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  ++D E       TG    + +MA E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 374 STGR 377
            T +
Sbjct: 211 QTQK 214

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYLAS- 151
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  VHRD+   N M D  F VK+ DFGLA
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   ++++ E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIYIVI-EYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 20/188 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           LG+G FG   +    +    + +K++ R  +  +  ++ EVK    L H N+L+ IG+ +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVH 323
                  + E++  G+L   +   KS  +   W+ R   +  +AS + YLH      ++H
Sbjct: 78  KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 324 RDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGP------------RTTGLAGTLGYMAP 370
           RD+   N +   + NV + DFGLA L+VD +  P            +   + G   +MAP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 371 EYISTGRA 378
           E I+ GR+
Sbjct: 192 EMIN-GRS 198

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 12  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 70  VVSEEPIY-IVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 123
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 180

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 14  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 72  VVSEEPIY-IVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 125
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 182

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI-------SRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +G+G F  V R I  +     AVK +       S GL     +   E   C  L+H +++
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL--STEDLKREASICHMLKHPHIV 89
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L+      G   +V+EFM    L F +  +   G   +          +  AL Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 317 WKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
               ++HRD+K  N++  +  N   VKLGDFG+A+ +  E G    G  GT  +MAPE +
Sbjct: 149 --NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 133
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 134 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 371 EYIS 374
           E I+
Sbjct: 191 EAIA 194

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 12/185 (6%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           D  S  +NF    K+G+G  G V    +      VAVKK+    +  +     EV     
Sbjct: 148 DPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 204
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            +H N++++        E  +V EF+  G+L     +   T T +       + L +  A
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQA 259
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L  LH +    V+HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MA
Sbjct: 260 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMA 315
Query: 370 PEYIS 374
           PE IS
Sbjct: 316 PELIS 320

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 149
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 374 STGR 377
            T +
Sbjct: 210 QTQK 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           +  NF    K+G+G +G VY+         VA+KKI     + G+    +  I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLK 60
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +L H N+++L+ + H   +  LV+E + +  L   + +   TG PL     Y   L    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A  + H      V+HRD+K  N++ +T+  +KL DFGLA
Sbjct: 120 AFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 186 FSYKDLASATNNFSNE---------RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL 233
           F+++D   A   F+ E         + +G G FG V  G L       + VA+K +  G 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 234 -KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
            +  + ++++E     Q  H N++ L G+       M++ EFM NGSLD  L       T
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVD 351
            +      +   G+A+ + YL +      VHRD+   NI+ +++   K+ DFGL+  L D
Sbjct: 134 VIQLVGMLR---GIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 352 HELGPR-TTGLAGTLG--YMAPEYI 373
               P  T+ L G +   + APE I
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAI 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG----LKHGKNE-YITEV 244
           D+ S    +     LG+G F  VY+    + N  VA+KKI  G     K G N   + E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           K   +L H N++ L+     +    LV++FM     D  +  K ++   LT +      L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLV-LTPSHIKAYML 119
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                L YLH+ W   ++HRD+K +N++ D +  +KL DFGLA
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFLAS- 149
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 150 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 374 STGR 377
            T +
Sbjct: 208 QTQK 211

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 150
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 374 STGR 377
            T +
Sbjct: 211 QTQK 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 83/171 (48%), Gaps = 7/171 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    +     A K I    +    +YI E++  +   H  +++L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +  G+  ++ EF P G++D  +         LT      +   +  AL +LH    + ++
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFLH---SKRII 139
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  N++   + +++L DFG++      L  R + + GT  +MAPE +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           N S ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L G+       M+V E M NGSLD  L    +  T +      +   G+AS + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAP 370
           L +      VHRD+   NI+ +++   K+ DFGL+ ++  D E    T G    + + +P
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 371 EYIS 374
           E I+
Sbjct: 220 EAIA 223

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 10/185 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRH 252
           N F   R LG+GGFG V    +       A KK+ +       G+   + E +   ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           R ++ L      +    LV   M  G L FH++     G P      Y   +     L  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI--CCGLED 301
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH E    +V+RD+K  NI+ D   ++++ D GLA+ V    G    G  GT+GYMAPE 
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEV 356
Query: 373 ISTGR 377
           +   R
Sbjct: 357 VKNER 361

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 157 GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 208
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 374 STGR 377
            T +
Sbjct: 269 QTQK 272

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 103 GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 154
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 374 STGR 377
            T +
Sbjct: 215 QTQK 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGL 261
           ++G+G FG V+ G L   N  VAVK     L    K +++ E +   Q  H N+++LIG+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C  +    +V E +  G  DF  F  ++ G  L   T  ++    A+ + YL     +C 
Sbjct: 181 CTQKQPIYIVMELVQGG--DFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYISTGR 377
           +HRD+   N +      +K+ DFG++      +   + GL    + + APE ++ GR
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 10/185 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRH 252
           N F   R LG+GGFG V    +       A KK+ +       G+   + E +   ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           R ++ L      +    LV   M  G L FH++     G P      Y   +     L  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI--CCGLED 301
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH E    +V+RD+K  NI+ D   ++++ D GLA+ V    G    G  GT+GYMAPE 
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEV 356
Query: 373 ISTGR 377
           +   R
Sbjct: 357 VKNER 361

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 183 PRRFSYKDLASAT----------NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           P+R S++   +A           +   N  K+G+G  G V    +      VAVKK+   
Sbjct: 8   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR 67
Query: 233 LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
            +  +     EV      +H N++++        E  +V EF+  G+L     +   T T
Sbjct: 68  KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHT 122
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
            +       + L +  AL  LH +    V+HRDIK  +I+   D  VKL DFG    V  
Sbjct: 123 RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 353 ELGPRTTGLAGTLGYMAPEYIS 374
           E+ PR   L GT  +MAPE IS
Sbjct: 180 EV-PRRKXLVGTPYWMAPELIS 200

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 204 LGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGK-NEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG VY G L+D +   +  AVK ++R    G+ ++++TE        H N+L L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 260 GLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLYLHEE 316
           G+C    G  ++V  +M +G  D   F +  T  P   T +  I  GL  A  + +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHG--DLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--- 149
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGP--RTTGLAGTLGYMAPEYI 373
             +  VHRD+   N M D  F VK+ DFGLA  + D E       TG    + +MA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 374 STGR 377
            T +
Sbjct: 210 QTQK 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 12/185 (6%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           D  S  +NF    K+G+G  G V    +      VAVKK+    +  +     EV     
Sbjct: 26  DPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 82
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            +H N++++        E  +V EF+  G+L     +   T T +       + L +  A
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQA 137
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L  LH +    V+HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MA
Sbjct: 138 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMA 193
Query: 370 PEYIS 374
           PE IS
Sbjct: 194 PELIS 198

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 7/171 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG VY+    +     A K I    +    +YI E++  +   H  +++L+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
           +  G+  ++ EF P G++D  +         LT      +   +  AL +LH    + ++
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---SKRII 131
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HRD+K  N++   + +++L DFG++      L  R +   GT  +MAPE +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVV 181

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 12/185 (6%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           D  S  +NF    K+G+G  G V    +      VAVKK+    +  +     EV     
Sbjct: 17  DPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            +H N++++        E  +V EF+  G+L     +   T T +       + L +  A
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQA 128
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L  LH +    V+HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MA
Sbjct: 129 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMA 184
Query: 370 PEYIS 374
           PE IS
Sbjct: 185 PELIS 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQL 258
           R LG+GGF   Y    +D     A K + + +    H K +  TE+     L + +++  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 259 IGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            G   D     +V E     SL + H   K  T     +  R  I       + YLH   
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ-----GVQYLHNNR 162
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
              V+HRD+K  N+  + D +VK+GDFGLA  ++ + G R   L GT  Y+APE +    
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCKKG 218
Query: 378 ARLDVNF 384
              +V+ 
Sbjct: 219 HSFEVDI 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE--VKTCSQLRHRNLLQLIG- 260
           +G+G +GAVY+G L +  +AV V   +      +  +I E  +     + H N+ + I  
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 261 ----LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
                   R E++LV E+ PNGSL  +L    S      W +  +++  +   L YLH E
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHTE 130
Query: 317 ------WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-------LLVDHELGPRTTGLAG 363
                 +K  + HRD+   N++   D    + DFGL+       L+   E         G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTD 390
           T+ YMAPE +       D     +Q D
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVD 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQL 258
           R LG+GGF   Y    +D     A K + + +    H K +  TE+     L + +++  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 259 IGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            G   D     +V E     SL + H   K  T     +  R  I       + YLH   
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ-----GVQYLHNNR 146
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
              V+HRD+K  N+  + D +VK+GDFGLA  ++ + G R   L GT  Y+APE +    
Sbjct: 147 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCKKG 202
Query: 378 ARLDVNF 384
              +V+ 
Sbjct: 203 HSFEVDI 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 190 EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 248 VVSEE-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 301
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGL  L++        G    + + APE    GR
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR 358

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 178 SRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK 237
           S D+ P +F  +D+   T+       LG+G +  V   + +      AVK I +   H +
Sbjct: 2   STDSLPGKF--EDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR 54
Query: 238 NEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
           +    EV+T  Q + ++N+L+LI    D   F LV+E +  GS+  H+  +K        
Sbjct: 55  SRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH----FNE 110
Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDF--GLALLVD 351
               ++   +A+AL +LH    + + HRD+K  NI+   P+    VK+ DF  G  + ++
Sbjct: 111 REASRVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLN 167
Query: 352 HELGPRT----TGLAGTLGYMAPEYIST 375
           +   P T    T   G+  YMAPE +  
Sbjct: 168 NSCTPITTPELTTPCGSAEYMAPEVVEV 195

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   ++RH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 202 RKLGQGGFGAVYRGILID----LNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLL 256
           + LG G FG VY+GI +     + + VA+K ++       N E++ E    + + H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYL 313
           +L+G+C       LV + MP+G L  ++   K    +   L W  +      +A  ++YL
Sbjct: 104 RLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 156
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            E   R +VHRD+   N++  +  +VK+ DFGLA L++
Sbjct: 157 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 191

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 12/185 (6%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           D  S  +NF    K+G+G  G V    +      VAVKK+    +  +     EV     
Sbjct: 21  DPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 77
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            +H N++++        E  +V EF+  G+L     +   T T +       + L +  A
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQA 132
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L  LH +    V+HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MA
Sbjct: 133 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMA 188
Query: 370 PEYIS 374
           PE IS
Sbjct: 189 PELIS 193

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 205 GQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD 264
            +G FG V++  L  +N  VAVK      K        E+ +   ++H NLLQ I     
Sbjct: 24  ARGRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIA-AEK 79
Query: 265 RG-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           RG     E  L+  F   GSL  +L      G  +TW     ++  ++  L YLHE+   
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 320 C--------VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAP 370
           C        + HRD K  N++  +D    L DFGLA+  +    P  T G  GT  YMAP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 371 EYIS 374
           E + 
Sbjct: 195 EVLE 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 21/242 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 124
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  +  E+        GT  YM+PE   
Sbjct: 125 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM---ANEFVGTRSYMSPE--- 176
Query: 375 TGRARLDVNFDEQQTDC-LMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVA 433
               RL       Q+D   M + L      R  RP +    ++L++    P  P K+P A
Sbjct: 177 ----RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM-AIFELLDYIVNEP--PPKLPSA 229
Query: 434 IF 435
           +F
Sbjct: 230 VF 231

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  GSL    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD+  +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQL 258
           R LG+GGF   Y    +D     A K + + +    H K +  TE+     L + +++  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 259 IGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            G   D     +V E     SL + H   K  T     +  R  I       + YLH   
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ-----GVQYLHNNR 162
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
              V+HRD+K  N+  + D +VK+GDFGLA  ++ + G R   L GT  Y+APE +    
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYIAPEVLCKKG 218
Query: 378 ARLDVNF 384
              +V+ 
Sbjct: 219 HSFEVDI 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 12/185 (6%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           D  S  +NF    K+G+G  G V    +      VAVKK+    +  +     EV     
Sbjct: 71  DPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 127
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            +H N++++        E  +V EF+  G+L     +   T T +       + L +  A
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLQA 182
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L  LH +    V+HRDIK  +I+   D  VKL DFG    V  E+ PR   L GT  +MA
Sbjct: 183 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMA 238
Query: 370 PEYIS 374
           PE IS
Sbjct: 239 PELIS 243

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQL 258
           R LG+GGF   Y    +D     A K + + +    H K +  TE+     L + +++  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 259 IGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            G   D     +V E     SL + H   K  T     +  R  I       + YLH   
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ-----GVQYLHNNR 162
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
              V+HRD+K  N+  + D +VK+GDFGLA  ++ + G R   L GT  Y+APE +    
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKTLCGTPNYIAPEVLCKKG 218
Query: 378 ARLDVNF 384
              +V+ 
Sbjct: 219 HSFEVDI 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 202 RKLGQGGFGAVYRGILID----LNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLL 256
           + LG G FG VY+GI +     + + VA+K ++       N E++ E    + + H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYL 313
           +L+G+C       LV + MP+G L  ++   K    +   L W  +      +A  ++YL
Sbjct: 81  RLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 133
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            E   R +VHRD+   N++  +  +VK+ DFGLA L++
Sbjct: 134 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 168

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 9/191 (4%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE 243
           RR S  D        +  +++G G FG VY+G     ++AV +  ++         +  E
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 82
Query: 244 VKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
           V    + RH N+L  +G    + +  +V ++    SL  HL   +   T         I+
Sbjct: 83  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIA 138
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLA 362
              A  + YLH    + ++HRD+K +NI    D  VK+GDFGLA +     G      L+
Sbjct: 139 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 363 GTLGYMAPEYI 373
           G++ +MAPE I
Sbjct: 196 GSILWMAPEVI 206

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGL 261
           ++G+G FG V+ G L   N  VAVK     L    K +++ E +   Q  H N+++LIG+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C  +    +V E +  G  DF  F  ++ G  L   T  ++    A+ + YL     +C 
Sbjct: 181 CTQKQPIYIVMELVQGG--DFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYISTGR 377
           +HRD+   N +      +K+ DFG++      +   + GL    + + APE ++ GR
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 9/191 (4%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE 243
           RR S  D        +  +++G G FG VY+G     ++AV +  ++         +  E
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 81
Query: 244 VKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
           V    + RH N+L  +G    + +  +V ++    SL  HL   +   T         I+
Sbjct: 82  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIA 137
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLA 362
              A  + YLH    + ++HRD+K +NI    D  VK+GDFGLA +     G      L+
Sbjct: 138 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 363 GTLGYMAPEYI 373
           G++ +MAPE I
Sbjct: 195 GSILWMAPEVI 205

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRW 198
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 199 MAPESLKDG 207

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   +      R  G  G L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRW 198
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 199 MAPESLKDG 207

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   +      R  G  G L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRW 198
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 199 MAPESLKDG 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 12/180 (6%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G FG V  G L       + VA+K +  G     + ++++E     Q  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+       M++ E+M NGSLD   F +K+ G   T      +  G+ S + YL + 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIGSGMKYLSD- 134
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   NI+ +++   K+ DFG++ ++  D E    T G    + + APE I+
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  G L    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   +      R  G  G L   +
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG-KGLLPVRW 195
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 196 MAPESLKDG 204

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 18  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL + +   T         I+   A  + YLH    + +
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSI 129
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 12/180 (6%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G FG V  G L       + VA+K +  G     + ++++E     Q  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+       M++ E+M NGSLD   F +K+ G   T      +  G+ S + YL + 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGR-FTVIQLVGMLRGIGSGMKYLSD- 128
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   NI+ +++   K+ DFG++ ++  D E    T G    + + APE I+
Sbjct: 129 --MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 198
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 199 MAPESLKDG 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G   +    VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 23  EVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +   + +V E+M  G L    F K   G  L       ++  +AS + Y+    +  
Sbjct: 81  VVSEEPIY-IVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN 134
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 191

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 13/177 (7%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           ++ LG+G F    + +    N A AVK IS+ ++    + IT +K C    H N+++L  
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHE 73
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           + HD+    LV E +  G     LF +       + T    I   L SA+ ++H+     
Sbjct: 74  VFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--- 126
Query: 321 VVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           VVHRD+K  N++    + +  +K+ DFG A L   +  P  T    TL Y APE ++
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLN 182

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 33/253 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 121
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE  
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE-- 173
Query: 374 STGRARLDVNFDEQQTD--------CLMIVGLWCAHP---DRNCRPSIRQAIQVLNFETK 422
                RL       Q+D          M VG +   P     + RP +    ++L++   
Sbjct: 174 -----RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPM-AIFELLDYIVN 227
Query: 423 MPNLPSKMPVAIF 435
            P  P K+P  +F
Sbjct: 228 EP--PPKLPSGVF 238

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V+   +     L     + K     + G    + E K  +++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      + +  LV   M  G + +H+++                +  + S L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYI 373
           +   R +++RD+K  N++ D D NV++ D GLA  V+ + G  +T G AGT G+MAPE +
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V+   +     L     + K     + G    + E K  +++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      + +  LV   M  G + +H+++                +  + S L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYI 373
           +   R +++RD+K  N++ D D NV++ D GLA  V+ + G  +T G AGT G+MAPE +
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V+   +     L     + K     + G    + E K  +++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      + +  LV   M  G + +H+++                +  + S L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYI 373
           +   R +++RD+K  N++ D D NV++ D GLA  V+ + G  +T G AGT G+MAPE +
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           F + R LG+GGFG V+   +     L     + K     + G    + E K  +++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L      + +  LV   M  G + +H+++                +  + S L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYI 373
           +   R +++RD+K  N++ D D NV++ D GLA  V+ + G  +T G AGT G+MAPE +
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 9/177 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
            +N  K+G+G  G V           VAVKK+    +  +     EV       H N++ 
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +        E  +V EF+  G+L     +   T T +       + L +  AL YLH + 
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG 161
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              V+HRDIK  +I+  +D  +KL DFG    V  E+ P+   L GT  +MAPE IS
Sbjct: 162 ---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKXLVGTPYWMAPEVIS 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI---------SRGLKHGKNEYITEVKT 246
            N+  +  LG+G    V R I        AVK I         +  ++  +   + EV  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 247 CSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
             ++  H N++QL         F LV++ M  G L F   ++K T   L+     KI   
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVT---LSEKETRKIMRA 132
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L   +  LH   K  +VHRD+K  NI+ D D N+KL DFG +  +D   G +   + GT 
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLRSVCGTP 187
Query: 366 GYMAPEYIS 374
            Y+APE I 
Sbjct: 188 SYLAPEIIE 196

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 9/177 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           F    KLG+G +G+VY+ I  +    VA+K++   ++    E I E+    Q    ++++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVK 88
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
             G      +  +V E+   GS+   +  +  T T     T  + +L     L YLH   
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           K   +HRDIK  NI+ +T+ + KL DFG+A  +   +  R   + GT  +MAPE I 
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX-VIGTPFWMAPEVIQ 198

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 9/191 (4%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE 243
           RR S  D        +  +++G G FG VY+G     ++AV +  ++         +  E
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 74
Query: 244 VKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
           V    + RH N+L  +G    + +  +V ++    SL  HL   +   T         I+
Sbjct: 75  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIA 130
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLA 362
              A  + YLH    + ++HRD+K +NI    D  VK+GDFGLA       G      L+
Sbjct: 131 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 363 GTLGYMAPEYI 373
           G++ +MAPE I
Sbjct: 188 GSILWMAPEVI 198

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 16  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 127
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 19  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 130
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 19  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 130
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHRD+   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 197
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 198 MAPESLKDG 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNLL 256
           F  +RKLG G FG V+        +   +K I++       E I  E++    L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++  +  D     +V E    G L   + S ++ G  L+     ++   + +AL Y H +
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 317 WKRCVVHRDIKFSNIM-PDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
               VVH+D+K  NI+  DT  +  +K+ DFGLA L   +    +T  AGT  YMAPE
Sbjct: 144 H---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE 196

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 9/191 (4%)
Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE 243
           RR S  D        +  +++G G FG VY+G     ++AV +  ++         +  E
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 82
Query: 244 VKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
           V    + RH N+L  +G    + +  +V ++    SL  HL   +   T         I+
Sbjct: 83  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIA 138
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLA 362
              A  + YLH    + ++HRD+K +NI    D  VK+GDFGLA       G      L+
Sbjct: 139 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 363 GTLGYMAPEYI 373
           G++ +MAPE I
Sbjct: 196 GSILWMAPEVI 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 177 LSRDAGPRRFSYKDLASATNNFSNE----RKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           ++ +  P+    + LA+    +S +      LG G FG V+  +  + N  V VK I + 
Sbjct: 1   MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE 60
Query: 233 -------LKHGKNEYIT-EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL 284
                  ++  K   +T E+   S++ H N+++++ +  ++G F LV E   +G LD   
Sbjct: 61  KVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFA 119
Query: 285 FSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
           F  +     L       I   L SA+ YL     + ++HRDIK  NI+   DF +KL DF
Sbjct: 120 FIDRHPR--LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 345 GLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           G A  +  E G       GT+ Y APE +
Sbjct: 175 GSAAYL--ERGKLFYTFCGTIEYCAPEVL 201

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                E  +V E++  GSL     +   T T +       +      AL +LH      V
Sbjct: 86  YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +HRDIK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 189

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 14  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +R+LG+G FG V+     +L+     M VAVK +       + ++  E +  + L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTP------LTWTTRYKIS 303
           ++  G+C D    ++V+E+M +G L+  L +          G P      L  +    I+
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +AS ++YL  +     VHRD+   N +   +  VK+GDFG++
Sbjct: 140 SQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS 180

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI---------SRGLKHGKNEYITEVKT 246
            N+  +  LG+G    V R I        AVK I         +  ++  +   + EV  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 247 CSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
             ++  H N++QL         F LV++ M  G L F   ++K T   L+     KI   
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVT---LSEKETRKIMRA 132
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L   +  LH   K  +VHRD+K  NI+ D D N+KL DFG +  +D   G +   + GT 
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 187
Query: 366 GYMAPEYIS 374
            Y+APE I 
Sbjct: 188 SYLAPEIIE 196

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 17/244 (6%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH 252
           +  N+  N  ++G G  G V++         +AVK++ R     +N+ I          H
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81
Query: 253 RN--LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
               ++Q  G      +  +  E M  G+    L  KK    P+      K+++ +  AL
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKAL 137
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMA 369
            YL E  K  V+HRD+K SNI+ D    +KL DFG++  LVD +   R+ G A    YMA
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA---AYMA 192
Query: 370 PEYI---STGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNL 426
           PE I      +   D+  D       ++       P +NC+       +VL  E   P L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--PLL 250
Query: 427 PSKM 430
           P  M
Sbjct: 251 PGHM 254

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 12/180 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 183
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE +
Sbjct: 184 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 237

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI---------SRGLKHGKNEYITEVKT 246
            N+  +  LG+G    V R I        AVK I         +  ++  +   + EV  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 247 CSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
             ++  H N++QL         F LV++ M  G L F   ++K T   L+     KI   
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVT---LSEKETRKIMRA 119
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L   +  LH   K  +VHRD+K  NI+ D D N+KL DFG +  +D   G +   + GT 
Sbjct: 120 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 174
Query: 366 GYMAPEYIS 374
            Y+APE I 
Sbjct: 175 SYLAPEIIE 183

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 30  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL + +   T         I+   A  + YLH    + +
Sbjct: 89  S-TKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA       G      L+G++ +MAPE I
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 8/176 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E+KLG G FG V+     + +  VAVK +  G       ++ E      L+H  L++L  
Sbjct: 20  EKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +   +    ++ EFM  GSL   L S + +  PL     +  S  +A  + ++ +   R 
Sbjct: 78  VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQ---RN 131
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            +HRD++ +NI+       K+ DFGLA +++        G    + + APE I+ G
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 187

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           ++ F  E +LG+G    VYR          A+K + + +   K    TE+    +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +     E  LV E +  G L F    +K   +        K  L    A+ YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-FDRIVEKGYYSERDAADAVKQIL---EAVAYLH 165
Query: 315 EEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           E     +VHRD+K  N++   P  D  +K+ DFGL+ +V+H++  +T  + GT GY APE
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPE 220
Query: 372 YI 373
            +
Sbjct: 221 IL 222

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           ++LG G FG V+ G   + N  VA+K +  G    ++ ++ E +   +L+H  L+QL  +
Sbjct: 15  KRLGNGQFGEVWMGTW-NGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAV 72
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
             +   + +V E+M  GSL    F K   G  L       ++  +A+ + Y+    +   
Sbjct: 73  VSEEPIY-IVTEYMNKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 126
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           +HRD++ +NI+       K+ DFGLA L++        G    + + APE    GR
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 182

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           R+LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ EF+P GSL  +L   K     +      + +  +   + YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 133
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 374 STGR 377
           +  +
Sbjct: 193 TESK 196

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  MAVA+K           E ++ E  T  Q  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--ES 129
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 130 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 8/176 (4%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E+KLG G FG V+     + +  VAVK +  G       ++ E      L+H  L++L  
Sbjct: 193 EKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +   +    ++ EFM  GSL   L S + +  PL     +  S  +A  + ++ +   R 
Sbjct: 251 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQ---RN 304
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            +HRD++ +NI+       K+ DFGLA +++        G    + + APE I+ G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHR++   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 198
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 199 MAPESLKDG 207

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNL 255
           R+LGQG FG VY G   D+        VAVK ++       + E++ E          ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYKISLGLASA 309
           ++L+G+       ++V E M +G L  +L S +          P T     +++  +A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG--Y 367
           + YL+    +  VHR++   N M   DF VK+GDFG+   + +E      G  G L   +
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRW 199
Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 200 MAPESLKDG 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 121
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G  G V  G L      ++ VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 257 QLIGLCHDRGEF-MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +L G+   RG   M+V E+M NGSLD  L +     T +      +   G+ + + YL +
Sbjct: 114 RLEGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSD 169
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYI 373
                 VHRD+   N++ D++   K+ DFGL+ ++  D +    TTG    + + APE I
Sbjct: 170 ---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 374 S 374
           +
Sbjct: 227 A 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 121
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 121
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 12/181 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 148
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE +
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 374 S 374
Sbjct: 203 Q 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 121
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 183 PRRFSYKDL------ASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISR 231
           P  FS  D+        A    +  R+LGQG FG VY G+   +        VA+K ++ 
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 232 GLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST 290
                 + E++ E     +    ++++L+G+       +++ E M  G L  +L S +  
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 291 GT------PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
                   P + +   +++  +A  + YL+       VHRD+   N M   DF VK+GDF
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 345 GLALLVDHELGPRTTGLAGTLG--YMAPEYISTG 376
           G+   + +E      G  G L   +M+PE +  G
Sbjct: 183 GMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDG 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 181 AGPRRFSYKDLASAT-----NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---G 232
           +GPR   Y+   + T           R +G G +G+V       L   VAVKK+SR    
Sbjct: 8   SGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQS 67
Query: 233 LKHGKNEYITEVKTCSQLRHRNLLQLIGL------CHDRGEFMLVYEFMPNGSLDFHLFS 286
           L H +  Y  E++    L+H N++ L+ +        D  E  LV   M  G+   ++  
Sbjct: 68  LIHARRTY-RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVK 124
Query: 287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
            ++          Y++  GL     Y+H      ++HRD+K SN+  + D  +++ DFGL
Sbjct: 125 SQALSDEHVQFLVYQLLRGLK----YIH---SAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 347 ALLVDHELGPRTTGLAGTLGYMAPEYI 373
           A   D E+    TG   T  Y APE +
Sbjct: 178 ARQADEEM----TGYVATRWYRAPEIM 200

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 14  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 73  S-TAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA +     G      L+G++ +MAPE I
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 183 PRRFSYKDL------ASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISR 231
           P  FS  D+        A    +  R+LGQG FG VY G+   +        VA+K ++ 
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 232 GLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST 290
                 + E++ E     +    ++++L+G+       +++ E M  G L  +L S +  
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 125
Query: 291 G------TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
                   P + +   +++  +A  + YL+       VHRD+   N M   DF VK+GDF
Sbjct: 126 MENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 345 GLALLVDHELGPRTTGLAGTLG--YMAPEYISTG 376
           G+   + +E      G  G L   +M+PE +  G
Sbjct: 183 GMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDG 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 14  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
              + +  +V ++    SL  HL   +   T         I+   A  + YLH    + +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA       G      L+G++ +MAPE I
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 8   WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 59
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 60  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 119
Query: 271 VYEFMPNGSLDFHLFSK------KSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHR 324
           + E+   G L   L  K      K  G PL        S  +A  + +L    K C+ HR
Sbjct: 120 ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS--KNCI-HR 176
Query: 325 DIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-TLGYMAPEYI 373
           D+   N++       K+GDFGLA  + ++      G A   + +MAPE I
Sbjct: 177 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 174 NDDLSRDAGPRRFSYKDL------ASATNNFSNERKLGQGGFGAVYRGILIDL-----NM 222
           N  L     P  FS  D+        A    +  R+LGQG FG VY G+   +       
Sbjct: 19  NGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPET 78
Query: 223 AVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD 281
            VA+K ++       + E++ E     +    ++++L+G+       +++ E M  G L 
Sbjct: 79  RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 138
Query: 282 FHLFSKKS------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT 335
            +L S +          P + +   +++  +A  + YL+       VHRD+   N M   
Sbjct: 139 SYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 195
Query: 336 DFNVKLGDFGLALLVDHELGPRTTGLAGTLG--YMAPEYISTG 376
           DF VK+GDFG+   + +E      G  G L   +M+PE +  G
Sbjct: 196 DFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDG 237

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+L  +G 
Sbjct: 30  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                +  +V ++    SL  HL + +   T         I+   A  + YLH    + +
Sbjct: 89  S-TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLAGTLGYMAPEYI 373
           +HRD+K +NI    D  VK+GDFGLA       G      L+G++ +MAPE I
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 16  WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127
Query: 271 VYEFMPNGSLDFHLFSK------KSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHR 324
           + E+   G L   L  K      K  G PL        S  +A  + +L    K C+ HR
Sbjct: 128 ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS--KNCI-HR 184
Query: 325 DIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-TLGYMAPEYI 373
           D+   N++       K+GDFGLA  + ++      G A   + +MAPE I
Sbjct: 185 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  MAVA+K           E ++ E  T  Q  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 129
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 130 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L  KK+   P       K+S+ +   L YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 140
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YM+PE
Sbjct: 141 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 192

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------TPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   +      R  G 
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG- 183
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 184 KGLLPVRWMSPESLKDG 200

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 166 ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILI---DLNM 222
           ET+ +  + D+      P   S +D           R +G+G FG V++GI +   +  M
Sbjct: 363 ETDDYAEIIDEEDTYTMP---STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAM 419
Query: 223 AVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD 281
           AVA+K          + +++ E  T  Q  H ++++LIG+  +     ++ E    G L 
Sbjct: 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELR 478
Query: 282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL 341
             L  +K +   L   +    +  L++AL YL  E KR  VHRDI   N++  ++  VKL
Sbjct: 479 SFLQVRKFS---LDLASLILYAYQLSTALAYL--ESKR-FVHRDIAARNVLVSSNDCVKL 532
Query: 342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           GDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G  G V  G L      ++ VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 257 QLIGLCHDRGEF-MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +L G+   RG   M+V E+M NGSLD  L +     T +      +   G+ + + YL +
Sbjct: 114 RLEGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSD 169
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYI 373
                 VHRD+   N++ D++   K+ DFGL+ ++  D +    TTG    + + APE I
Sbjct: 170 ---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 374 S 374
           +
Sbjct: 227 A 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------TPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   +      R  G 
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG- 192
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 193 KGLLPVRWMSPESLKDG 209

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT------PLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 188
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 189 KGLLPVRWMSPESLKDG 205

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 201 ERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G FG V  G L       + VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+       M++ EFM NGSLD  L       T +      +   G+A+ + YL + 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLAD- 127
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPR-TTGLAGTLG--YMAPEY 372
                VHR +   NI+ +++   K+ DFGL+  L D    P  T+ L G +   + APE 
Sbjct: 128 --MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 373 I 373
           I
Sbjct: 186 I 186

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                E  +V E++  GSL     +   T T +       +      AL +LH      V
Sbjct: 86  YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +HRDIK  NI+   D +VKL DFG    +  E   R+  + GT  +MAPE ++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX-MVGTPYWMAPEVVT 189

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                E  +V E++  GSL     +   T T +       +      AL +LH      V
Sbjct: 86  YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +HRDIK  NI+   D +VKL DFG    +  E   R+  + GT  +MAPE ++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSE-MVGTPYWMAPEVVT 189

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------TPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 192
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 193 KGLLPVRWMSPESLKDG 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 7/175 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +KLG G FG V+ G   + +  VAVK +  G       ++ E      L+H  L++L  +
Sbjct: 18  KKLGAGQFGEVWMGYYNN-STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                   ++ EFM  GSL    F K   G  +        S  +A  + Y+    ++  
Sbjct: 76  VTKEEPIYIITEFMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 130
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           +HRD++ +N++       K+ DFGLA +++        G    + + APE I+ G
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++  +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                E  +V E++  GSL     +   T T +       +      AL +LH      V
Sbjct: 87  YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---V 138
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +HRDIK  NI+   D +VKL DFG    +  E   R+  + GT  +MAPE ++
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX-MVGTPYWMAPEVVT 190

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 191
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 192 KGLLPVRWMSPESLKDG 208

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++  +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                E  +V E++  GSL     +   T T +       +      AL +LH      V
Sbjct: 87  YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---V 138
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +HR+IK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 190

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------TPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 189
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 190 KGLLPVRWMSPESLKDG 206

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------TPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 185
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 186 KGLLPVRWMSPESLKDG 202

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 181 AGPRRFSYKDLASAT-----NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---G 232
           +GPR   Y+   + T           R +G G +G+V       L   VAVKK+SR    
Sbjct: 8   SGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQS 67
Query: 233 LKHGKNEYITEVKTCSQLRHRNLLQLIGL------CHDRGEFMLVYEFMPNGSLDFHLFS 286
           L H +  Y  E++    L+H N++ L+ +        D  E  LV   M  G+   ++  
Sbjct: 68  LIHARRTY-RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVK 124
Query: 287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
            ++          Y++  GL     Y+H      ++HRD+K SN+  + D  +++ DFGL
Sbjct: 125 CQALSDEHVQFLVYQLLRGLK----YIH---SAGIIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 347 ALLVDHELGPRTTGLAGTLGYMAPEYI 373
           A   D E+    TG   T  Y APE +
Sbjct: 178 ARQADEEM----TGYVATRWYRAPEIM 200

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N M   DF VK+GDFG+   + +E      G 
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGG 191
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 192 KGLLPVRWMSPESLKDG 208

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 79  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 174

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 76  DNPHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 76  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 78  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 77  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  +AVA+K           E ++ E  T  Q  H ++++
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 73  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 126
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 127 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 100 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 153 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 191 LASATNNFSNERK-------LGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE- 239
           + S+T ++  +R+       +G+G FG V++GI +   +  +AVA+K           E 
Sbjct: 26  MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 85
Query: 240 YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           ++ E  T  Q  H ++++LIG+  +     ++ E    G L   L  +K +   L   + 
Sbjct: 86  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASL 141
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
              +  L++AL YL  E KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +
Sbjct: 142 ILYAYQLSTALAYL--ESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 198
Query: 360 GLAGTLGYMAPEYISTGR 377
                + +MAPE I+  R
Sbjct: 199 KGKLPIKWMAPESINFRR 216

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  +AVA+K          + +++ E  T  Q  H ++++
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 78  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 131
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 132 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLRHRNLLQL 258
           R +G G +G+V       L   VAVKK+SR    L H +  Y  E++    L+H N++ L
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 84
Query: 259 IGL------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           + +        D  E  LV   M  G+   ++   ++          Y++  GL     Y
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLK----Y 138
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           +H      ++HRD+K SN+  + D  +++ DFGLA   D E+    TG   T  Y APE 
Sbjct: 139 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRWYRAPEI 191
Query: 373 I 373
           +
Sbjct: 192 M 192

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 11/158 (6%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQL 250
            +   + N   +G+G +G V +    D    VA+KK   S   K  K   + E+K   QL
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           RH NL+ L+ +C  +  + LV+EF+ +  L D  LF        L +    K    + + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIING 136
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           + + H      ++HRDIK  NI+      VKL DFG A
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 78  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 178 SRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAV----YRGILIDLNMAVAVKKISRGL 233
           S D  P +F  + L          ++LG+G FG+V    Y  +  +    VAVKK+    
Sbjct: 2   SEDRDPTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 54
Query: 234 KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTG 291
           +    ++  E++    L+H N+++  G+C+  G     L+ E++P GSL  +L   K   
Sbjct: 55  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER- 113
Query: 292 TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALL 349
             +      + +  +   + YL     +  +HRD+   NI+ + +  VK+GDFGL   L 
Sbjct: 114 --IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 168
Query: 350 VDHELGPRTTGLAGTLGYMAPEYISTGR 377
            D E           + + APE ++  +
Sbjct: 169 QDKEXXKVKEPGESPIFWYAPESLTESK 196

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 85  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 138 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 78  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 82  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 202 RKLGQGGFGAVYRGILIDLN------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        N      +AV   K   G +H ++ +  E+     L H ++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH-RSGWKQEIDILRTLYHEHI 78
Query: 256 LQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G C D+GE    LV E++P GSL  +L  + S G         +I  G+A    YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMA----YL 133
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           H +     +HR++   N++ D D  VK+GDFGLA  V
Sbjct: 134 HSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 191 LASATNNFSNERK-------LGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE- 239
           + S+T ++  +R+       +G+G FG V++GI +   +  +AVA+K           E 
Sbjct: 3   MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 240 YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           ++ E  T  Q  H ++++LIG+  +     ++ E    G L   L  +K +   L   + 
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASL 118
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
              +  L++AL YL  E KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +
Sbjct: 119 ILYAYQLSTALAYL--ESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 360 GLAGTLGYMAPEYISTGR 377
                + +MAPE I+  R
Sbjct: 176 KGKLPIKWMAPESINFRR 193

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 81  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 134 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 77  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  +AVA+K          + +++ E  T  Q  H ++++
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 79  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 132
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 133 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  +AVA+K           E ++ E  T  Q  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 129
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 130 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 78  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 178 SRDAGPRRFSYKDLASAT--NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH 235
           ++  GP   S     SAT  + +    KLG+G +G VY+ I    N  VA+K+I   L+H
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEH 71
Query: 236 GKN----EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
            +       I EV    +L+HRN+++L  + H      L++E+  N   D   +  K+  
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMDKNPD 128
Query: 292 TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-----VKLGDFGL 346
             +     +     L + + + H   +RC +HRD+K  N++           +K+GDFGL
Sbjct: 129 VSMRVIKSFLYQ--LINGVNFCHS--RRC-LHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
Query: 347 A 347
           A
Sbjct: 184 A 184

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 72  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 125 EGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 167

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 166 ETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILI---DLNM 222
           ET+ +  + D+      P   S +D           R +G+G FG V++GI +   +  M
Sbjct: 363 ETDDYAEIIDEEDTYTMP---STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAM 419
Query: 223 AVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD 281
           AVA+K          + +++ E  T  Q  H ++++LIG+  +     ++ E    G L 
Sbjct: 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELR 478
Query: 282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL 341
             L  +K +   L   +    +  L++AL YL  E KR  VHRDI   N++      VKL
Sbjct: 479 SFLQVRKFS---LDLASLILYAYQLSTALAYL--ESKR-FVHRDIAARNVLVSATDCVKL 532
Query: 342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           GDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 202 RKLGQGGFGAVYRGILIDLN------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        N      +AV   K   G +H ++ +  E+     L H ++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH-RSGWKQEIDILRTLYHEHI 78
Query: 256 LQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G C D+GE    LV E++P GSL  +L  + S G         +I  G+A    YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMA----YL 133
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           H +     +HR++   N++ D D  VK+GDFGLA  V
Sbjct: 134 HAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 154 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 211 NGRLPVKWMAPEAL 224

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 202 RKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQ 257
           R +G+G FG V++GI +   +  MAVA+K           E ++ E  T  Q  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+  +     ++ E    G L   L  +K +   L   +    +  L++AL YL  E 
Sbjct: 76  LIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--ES 129
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           KR  VHRDI   N++      VKLGDFGL+  ++     + +     + +MAPE I+  R
Sbjct: 130 KR-FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 88/202 (43%), Gaps = 28/202 (13%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITE 243
           D     N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 60
Query: 244 VKTCSQLRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            +     RH  L  L+     HDR     V E+   G L FHL    S     T      
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL----SRERVFTEERARF 114
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTT 359
               + SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G    
Sbjct: 115 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMK 168
Query: 360 GLAGTLGYMAPEYIST---GRA 378
              GT  Y+APE +     GRA
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRA 190

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL    S     T          + 
Sbjct: 62  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 115
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTP 169
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 170 EYLAPEVLEDNDYGRA 185

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLR 251
           N+   + LG+G FG V           VA+K I++ +       G+ E   E+     LR
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++L  +   + E ++V E+  N   D+ +   K     ++     +    + SA+ 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVE 127
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H   +  +VHRD+K  N++ D   NVK+ DFGL+ ++      +T+   G+  Y APE
Sbjct: 128 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 182
Query: 372 YIS 374
            IS
Sbjct: 183 VIS 185

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRN 254
           ++F    +LG G  G V +       + +A K I   +K   +N+ I E++   +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD  L   K     +      K+S+ +   L YL 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG----KVSIAVLRGLAYLR 131
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E  K  ++HRD+K SNI+ ++   +KL DFG++  L+D           GT  YMAPE +
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERL 185
Query: 374 S 374
Sbjct: 186 Q 186

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLR 251
           N+   + LG+G FG V           VA+K I++ +       G+ E   E+     LR
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++L  +   + E ++V E+  N   D+ +   K     ++     +    + SA+ 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVE 117
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H   +  +VHRD+K  N++ D   NVK+ DFGL+ ++      +T+   G+  Y APE
Sbjct: 118 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 172
Query: 372 YIS 374
            IS
Sbjct: 173 VIS 175

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLR 251
           N+   + LG+G FG V           VA+K I++ +       G+ E   E+     LR
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++L  +   + E ++V E+  N   D+ +   K     ++     +    + SA+ 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVE 126
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H   +  +VHRD+K  N++ D   NVK+ DFGL+ ++      +T+   G+  Y APE
Sbjct: 127 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 181
Query: 372 YIS 374
            IS
Sbjct: 182 VIS 184

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 202 RKLGQGGFGAVYRGILIDLN------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        N      +AV   K   G +H ++ +  E+     L H ++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEIDILRTLYHEHI 95
Query: 256 LQLIGLCHDRG--EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G C D G     LV E++P GSL  +L  + S G         +I  G+A    YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMA----YL 150
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           H +     +HRD+   N++ D D  VK+GDFGLA  V
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 135
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 374 STGR 377
           +  +
Sbjct: 195 TESK 198

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 137
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 374 STGR 377
           +  +
Sbjct: 197 TESK 200

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 161
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 374 STGR 377
           +  +
Sbjct: 221 TESK 224

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL    S     T          + 
Sbjct: 62  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 115
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTP 169
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 170 EYLAPEVLEDNDYGRA 185

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 143 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 200 NGRLPVKWMAPEAL 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 8/170 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           ++LG G FG V  G        VAVK I  G    ++E+  E +T  +L H  L++  G+
Sbjct: 14  KELGSGQFGVVKLGKWKG-QYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
           C       +V E++ NG L  +L   +S G  L  +   ++   +   + +L        
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---F 125
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +HRD+   N + D D  VK+ DFG+   V  +    + G    + + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLR 251
           N+   + LG+G FG V           VA+K I++ +       G+ E   E+     LR
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++L  +   + E ++V E+  N   D+ +   K     ++     +    + SA+ 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-----MSEQEARRFFQQIISAVE 121
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H   +  +VHRD+K  N++ D   NVK+ DFGL+ ++      +T+   G+  Y APE
Sbjct: 122 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 176
Query: 372 YIS 374
            IS
Sbjct: 177 VIS 179

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 147 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 204 NGRLPVKWMAPEAL 217

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 154 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 211 NGRLPVKWMAPEAL 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++ L+G C    G  M++ EF   G+L  +L SK++   P      YK  L L   + Y 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 314 HEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-TL 365
            +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A   L
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 366 GYMAPEYI 373
            +MAPE I
Sbjct: 215 KWMAPETI 222

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 130
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 374 STGR 377
           +  +
Sbjct: 190 TESK 193

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 8   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL    S     T          + 
Sbjct: 65  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 118
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 119 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTP 172
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 173 EYLAPEVLEDNDYGRA 188

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 134
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 374 STGR 377
           +  +
Sbjct: 194 TESK 197

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           + +G+G FG V    YRG        VAVK I          ++ E    +QLRH NL+Q
Sbjct: 199 QTIGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 250
Query: 258 LIG-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           L+G +  ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL   
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE-- 306
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
                VHRD+   N++   D   K+ DFGL
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 130
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 374 STGR 377
           +  +
Sbjct: 190 TESK 193

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 129
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 374 STGR 377
           +  +
Sbjct: 189 TESK 192

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 146 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 203 NGRLPVKWMAPEAL 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 128
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 374 STGR 377
           +  +
Sbjct: 188 TESK 191

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 130
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 374 STGR 377
           +  +
Sbjct: 190 TESK 193

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL    S     T          + 
Sbjct: 62  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 115
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCGTP 169
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 170 EYLAPEVLEDNDYGRA 185

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++      T          + 
Sbjct: 62  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIV 115
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTP 169
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 170 EYLAPEVLEDNDYGRA 185

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 136
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 374 STGR 377
           +  +
Sbjct: 196 TESK 199

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   ++    +      + +  +   + YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYI 373
              +  +HRD+   NI+ + +  VK+GDFGL   L  D E           + + APE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 374 STGR 377
           +  +
Sbjct: 193 TESK 196

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 203 KLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +LG+G FG V+     +L      M VAVK +    +  + ++  E +  + L+H+++++
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT-----------PLTWTTRYKISLGL 306
             G+C +    ++V+E+M +G L+  L S                 PL       ++  +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A+ ++YL        VHRD+   N +      VK+GDFG++
Sbjct: 168 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 7/175 (4%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           ++LG G FG V+ G   + +  VAVK +  G       ++ E      L+H  L++L  +
Sbjct: 19  KRLGAGQFGEVWMGYYNN-STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
                   ++ E+M  GSL    F K   G  +        S  +A  + Y+    ++  
Sbjct: 77  VTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 131
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           +HRD++ +N++       K+ DFGLA +++        G    + + APE I+ G
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 186

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           + +G+G FG V    YRG        VAVK I          ++ E    +QLRH NL+Q
Sbjct: 18  QTIGKGEFGDVMLGDYRG------NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 69
Query: 258 LIG-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           L+G +  ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL   
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE-- 125
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
                VHRD+   N++   D   K+ DFGL
Sbjct: 126 -GNNFVHRDLAARNVLVSEDNVAKVSDFGL 154

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 71/148 (47%), Gaps = 18/148 (12%)
Query: 204 LGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG V    YRG        VAVK I          ++ E    +QLRH NL+QL+
Sbjct: 29  IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 80
Query: 260 G-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           G +  ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL     
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---G 135
Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
              VHRD+   N++   D   K+ DFGL
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGL 163

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N+F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++      T          + 
Sbjct: 62  TRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIV 115
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTL 365
           SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL    + D   G       GT 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTP 169
Query: 366 GYMAPEYIST---GRA 378
            Y+APE +     GRA
Sbjct: 170 EYLAPEVLEDNDYGRA 185

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 203 KLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +LG+G FG V+     +L      M VAVK +    +  + ++  E +  + L+H+++++
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT-----------PLTWTTRYKISLGL 306
             G+C +    ++V+E+M +G L+  L S                 PL       ++  +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A+ ++YL        VHRD+   N +      VK+GDFG++
Sbjct: 139 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMS 176

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++ L+G C    G  M++ EF   G+L  +L SK++   P  +   YK  L L   + Y 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP--YKDLYKDFLTLEHLIXYS 150
Query: 314 HEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
            +  K       R  +HRD+   NI+      VK+ DFGLA  +                
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDI---------------- 194
Query: 367 YMAPEYISTGRARLDVNFDEQQT 389
           Y  P+Y+  G ARL + +   +T
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPET 217

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 154 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 211 NGRLPVKWMAPEAL 224

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 203 KLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +LG+G FG V+     +L      M VAVK +    +  + ++  E +  + L+H+++++
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT-----------PLTWTTRYKISLGL 306
             G+C +    ++V+E+M +G L+  L S                 PL       ++  +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           A+ ++YL        VHRD+   N +      VK+GDFG++
Sbjct: 145 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMS 182

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 71/148 (47%), Gaps = 18/148 (12%)
Query: 204 LGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
           +G+G FG V    YRG        VAVK I          ++ E    +QLRH NL+QL+
Sbjct: 14  IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 65
Query: 260 G-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           G +  ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL     
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---G 120
Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
              VHRD+   N++   D   K+ DFGL
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGL 148

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 12/186 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           ++F   R +G+G FG V      D     A+K +++     +NE      E++    L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             L+ L     D  +  +V + +  G L +HL             T       L  AL Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDY 130
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           L  +    ++HRD+K  NI+ D   +V + DF +A ++  E   + T +AGT  YMAPE 
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEM 185
Query: 373 ISTGRA 378
            S+ + 
Sbjct: 186 FSSRKG 191

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 148
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +HRD+   NI+ + +  VK+GDFGL 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLT 179

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 11/187 (5%)
Query: 187 SYKDLASATNNFSNERKLGQGGFGAV--YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           S  D      N+  ++ +G+G F  V   R +L    +AV +   ++       +   EV
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREV 65
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    L H N+++L  +        LV E+   G +  +L +    G       R K   
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR- 121
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            + SA+ Y H+++   +VHRD+K  N++ D D N+K+ DFG +   +  +G +     G+
Sbjct: 122 QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFS--NEFTVGNKLDTFCGS 176
Query: 365 LGYMAPE 371
             Y APE
Sbjct: 177 PPYAAPE 183

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 144
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 145 --YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRA 195
Query: 370 PEYI 373
           PE +
Sbjct: 196 PEIM 199

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G   ++   +            
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 195 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 252 NGRLPVKWMAPEAL 265

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 148
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +HRD+   NI+ + +  VK+GDFGL 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLT 179

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 16/180 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI-------SRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +G+G F  V R I  +     AVK +       S GL     +   E   C  L+H +++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL--STEDLKREASICHMLKHPHIV 89
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L+      G   +V+EFM    L F +  +   G   +          +  AL Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 317 WKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
               ++HRD+K   ++  +  N   VKLG FG+A+ +  E G    G  GT  +MAPE +
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++ L+G C    G  M++ EF   G+L  +L SK++   P  +   YK  L L   + Y 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP--YKDLYKDFLTLEHLICYS 150
Query: 314 HEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
            +  K       R  +HRD+   NI+      VK+ DFGLA  +                
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDI---------------- 194
Query: 367 YMAPEYISTGRARLDVNFDEQQT 389
           Y  P+Y+  G ARL + +   +T
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPET 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 16/180 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKI-------SRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +G+G F  V R I  +     AVK +       S GL     +   E   C  L+H +++
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS--TEDLKREASICHMLKHPHIV 91
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L+      G   +V+EFM    L F +  +   G   +          +  AL Y H+ 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 151
Query: 317 WKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
               ++HRD+K   ++  +  N   VKLG FG+A+ +  E G    G  GT  +MAPE +
Sbjct: 152 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 207

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 200 NERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNL 255
           ++R +G+G FG VY G  ID     +  A+K +SR  +  + E ++ E      L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 256 LQLIG-LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL--ASALLY 312
           L LIG +    G   ++  +M +G  D   F +     P   T +  IS GL  A  + Y
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHG--DLLQFIRSPQRNP---TVKDLISFGLQVARGMEY 139
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           L E+     VHRD+   N M D  F VK+ DFGLA
Sbjct: 140 LAEQK---FVHRDLAARNCMLDESFTVKVADFGLA 171

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G    +   +            
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 139 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 196 NGRLPVKWMAPEAL 209

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 144
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 145 --YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRA 195
Query: 370 PEYI 373
           PE +
Sbjct: 196 PEIM 199

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 10/196 (5%)
Query: 179 RDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN 238
           R  G R  SY     A+    + R +G G FG VY+G     ++AV + K+         
Sbjct: 20  RPRGQRDSSYYWEIEASEVMLSTR-IGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQ 77
Query: 239 EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
            +  EV    + RH N+L  +G    +    +V ++    SL  HL  ++   T      
Sbjct: 78  AFRNEVAVLRKTRHVNILLFMGYM-TKDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQ 133
Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT 358
              I+   A  + YLH    + ++HRD+K +NI       VK+GDFGLA +     G + 
Sbjct: 134 LIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 359 TGL-AGTLGYMAPEYI 373
                G++ +MAPE I
Sbjct: 191 VEQPTGSVLWMAPEVI 206

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 33/245 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRN 254
           N+FS  R +G+GGFG VY     D     A+K + +  +K  + E +        L  R 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERI 241
Query: 255 LLQLI--GLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           +L L+  G C          H   +   + + M  G L +HL                +I
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
            LGL     ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     
Sbjct: 302 ILGLE----HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 363 GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI--QVLNFE 420
           GT GYMAPE +  G A  D + D     C++   L    P R  +   +  I    L   
Sbjct: 352 GTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 421 TKMPN 425
            ++P+
Sbjct: 411 VELPD 415

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 33/245 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRN 254
           N+FS  R +G+GGFG VY     D     A+K + +  +K  + E +        L  R 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERI 240
Query: 255 LLQLI--GLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           +L L+  G C          H   +   + + M  G L +HL                +I
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 300
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
            LGL     ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     
Sbjct: 301 ILGLE----HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 350
Query: 363 GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI--QVLNFE 420
           GT GYMAPE +  G A  D + D     C++   L    P R  +   +  I    L   
Sbjct: 351 GTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 409
Query: 421 TKMPN 425
            ++P+
Sbjct: 410 VELPD 414

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 10/178 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +++    +LG G FG V+R          A K +    +  K     E++T S LRH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + L     D  E +++YEFM  G L F   + +           Y     +   L ++HE
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNKMSEDEAVEYMRQ--VCKGLCHMHE 167
Query: 316 EWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                 VH D+K  NIM  T  +  +KL DFGL   +D +   + T   GT  + APE
Sbjct: 168 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPE 220

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTC 247
           A    +  R+LGQG FG VY G+   +        VA+K ++       + E++ E    
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYK 301
            +    ++++L+G+       +++ E M  G L  +L S +          P + +   +
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           ++  +A  + YL+       VHRD+   N     DF VK+GDFG+   + +E      G 
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI-YETDYYRKGG 185
Query: 362 AGTLG--YMAPEYISTG 376
            G L   +M+PE +  G
Sbjct: 186 KGLLPVRWMSPESLKDG 202

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 93
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 150
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 151 --YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRA 201
Query: 370 PEYI 373
           PE +
Sbjct: 202 PEIM 205

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 10/178 (5%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +++    +LG G FG V+R          A K +    +  K     E++T S LRH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + L     D  E +++YEFM  G L F   + +           Y     +   L ++HE
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNKMSEDEAVEYMRQ--VCKGLCHMHE 273
Query: 316 EWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                 VH D+K  NIM  T  +  +KL DFGL   +D +   + T   GT  + APE
Sbjct: 274 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPE 326

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 12/189 (6%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN---LLQLI 259
           ++G+G +G+V + +       +AVK+I   +   + + +  +     +R  +   ++Q  
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL-MDLDVVMRSSDCPYIVQFY 87
Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G     G+  +  E M      F+ +        +      KI+L    AL +L E  K 
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI--STG 376
            ++HRDIK SNI+ D   N+KL DFG++  LVD     R    AG   YMAPE I  S  
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSAS 202
Query: 377 RARLDVNFD 385
           R   DV  D
Sbjct: 203 RQGYDVRSD 211

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDL-NMAVAVKKISRGLKHGK---------- 237
           K+     N++   R L QG F  +   IL +  N   A+KK  + L   K          
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKI---ILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 238 -------NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL---DFHLFSK 287
                  +++  E++  + +++   L   G+  +  E  ++YE+M N S+   D + F  
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 288 KSTGTPLTWTTRYK-ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
               T        K I   + ++  Y+H E   C  HRD+K SNI+ D +  VKL DFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGE 198
Query: 347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGR----ARLDV 382
           +   ++ +  +  G  GT  +M PE+ S       A++D+
Sbjct: 199 S---EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 147 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 197
Query: 370 PEYI 373
           PE +
Sbjct: 198 PEIM 201

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 144
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 145 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 195
Query: 370 PEYI 373
           PE +
Sbjct: 196 PEIM 199

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 81
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 82  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 138
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 139 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 189
Query: 370 PEYI 373
           PE +
Sbjct: 190 PEIM 193

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     I L+         VAVK + S   +   ++ I+E++    + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------------ 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G    +   +            
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA  + H +   +TT
Sbjct: 154 SCAYQVARGMEYLAS--KKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 211 NGRLPVKWMAPEAL 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 77  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + L  G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 82  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 77  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 151
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 152 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 202
Query: 370 PEYI 373
           PE +
Sbjct: 203 PEIM 206

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 145
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 146 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 196
Query: 370 PEYI 373
           PE +
Sbjct: 197 PEIM 200

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 141
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 142 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 192
Query: 370 PEYI 373
           PE +
Sbjct: 193 PEIM 196

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 151
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 152 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 202
Query: 370 PEYI 373
           PE +
Sbjct: 203 PEIM 206

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  + S+K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGL    D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRN 254
           N+   + +G+G F  V     I     VAVK I +   +  +  +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G   Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDAFCGAPPYAAPE 182

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 79  DNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 174

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 79
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 136
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 137 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 187
Query: 370 PEYI 373
           PE +
Sbjct: 188 PEIM 191

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 195 TNNFSNERKLGQGGFGAVY--RGILIDLNMAVAV-KKISRGLKHGKNEYITEVKTCSQLR 251
           ++ +   +KLG G +G V   +  L     A+ + KK S          + EV    QL 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L     D+  + LV E    G     LF +       +      I   + S   
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           YLH   K  +VHRD+K  N++ ++   D  +K+ DFGL+     E+G +     GT  Y+
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVGGKMKERLGTAYYI 190
Query: 369 APEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           APE +   R + D   D      ++ + L C +P
Sbjct: 191 APEVL---RKKYDEKCDVWSCGVILYI-LLCGYP 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 141
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 142 --YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYRA 192
Query: 370 PEYI 373
           PE +
Sbjct: 193 PEIM 196

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 135
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 136 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 186
Query: 370 PEYI 373
           PE +
Sbjct: 187 PEIM 190

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 141
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 142 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 192
Query: 370 PEYI 373
           PE +
Sbjct: 193 PEIM 196

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 84
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 141
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 142 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 192
Query: 370 PEYI 373
           PE +
Sbjct: 193 PEIM 196

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           R LG+G FG V    Y          VAVK +  G     ++ +  E++    L H +++
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G C D+GE    LV E++P GSL  +L  +   G         +I  G+A    YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMA----YLH 129
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +     +HR +   N++ D D  VK+GDFGLA  V
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAV 162

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 195 TNNFSNERKLGQGGFGAVY--RGILIDLNMAVAV-KKISRGLKHGKNEYITEVKTCSQLR 251
           ++ +   +KLG G +G V   +  L     A+ + KK S          + EV    QL 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L     D+  + LV E    G     LF +       +      I   + S   
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           YLH   K  +VHRD+K  N++ ++   D  +K+ DFGL+     E+G +     GT  Y+
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVGGKMKERLGTAYYI 173
Query: 369 APEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           APE +   R + D   D      ++ + L C +P
Sbjct: 174 APEVL---RKKYDEKCDVWSCGVILYI-LLCGYP 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 33/245 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRN 254
           N+FS  R +G+GGFG VY     D     A+K + +  +K  + E +        L  R 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERI 241
Query: 255 LLQLI--GLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           +L L+  G C          H   +   + + M  G L +HL                +I
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
            LGL     ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     
Sbjct: 302 ILGLE----HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 363 GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI--QVLNFE 420
           GT GYMAPE +  G A  D + D     C++   L    P R  +   +  I    L   
Sbjct: 352 GTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 421 TKMPN 425
            ++P+
Sbjct: 411 VELPD 415

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 33/245 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRN 254
           N+FS  R +G+GGFG VY     D     A+K + +  +K  + E +        L  R 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERI 241
Query: 255 LLQLI--GLC----------HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           +L L+  G C          H   +   + + M  G L +HL                +I
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
            LGL     ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     
Sbjct: 302 ILGLE----HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 363 GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI--QVLNFE 420
           GT GYMAPE +  G A  D + D     C++   L    P R  +   +  I    L   
Sbjct: 352 GTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 421 TKMPN 425
            ++P+
Sbjct: 411 VELPD 415

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 87
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 144
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 145 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 195
Query: 370 PEYI 373
           PE +
Sbjct: 196 PEIM 199

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 93
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 150
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 151 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 201
Query: 370 PEYI 373
           PE +
Sbjct: 202 PEIM 205

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 178 SRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--- 234
           SR    R+   K +      + N   +G G +G+V         + VAVKK+SR  +   
Sbjct: 2   SRPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKS 289
           H K  Y  E++    ++H N++ L+ +        EF  VY    +    L+  +  +K 
Sbjct: 62  HAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 290 TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL 349
           T   + +   Y+I  GL     Y+H      ++HRD+K SN+  + D  +K+ DFGLA  
Sbjct: 121 TDDHVQFLI-YQILRGLK----YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 172
Query: 350 VDHELGPRTTGLAGTLGYMAPEYI 373
            D E+    TG   T  Y APE +
Sbjct: 173 TDDEM----TGYVATRWYRAPEIM 192

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 79
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 136
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 137 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 187
Query: 370 PEYI 373
           PE +
Sbjct: 188 PEIM 191

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 159
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 160 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 210
Query: 370 PEYI 373
           PE +
Sbjct: 211 PEIM 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 45/257 (17%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 16  WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127
Query: 271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA-LLYLHEEW---------KRC 320
           + E+   G L   L  K+  G   ++   +     L+S  LL+   +          K C
Sbjct: 128 ITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC 187
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARL 380
           + HRD+   N++       K+GDFGLA  + ++                  YI  G ARL
Sbjct: 188 I-HRDVAARNVLLTNGHVAKIGDFGLARDIMND----------------SNYIVKGNARL 230
Query: 381 DVNF--DEQQTDCLMIV 395
            V +   E   DC+  V
Sbjct: 231 PVKWMAPESIFDCVYTV 247

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKI-------------SRGLKHGKNEYITEVKTCS 248
           RKLG G +G V      + +   A+K I             ++ ++    E   E+    
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
            L H N+++L  +  D+  F LV EF   G     LF +              I   + S
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDECDAANIMKQILS 157
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDFGLALLV--DHELGPRTTGLAG 363
            + YLH   K  +VHRDIK  NI+ +      N+K+ DFGL+     D++L  R     G
Sbjct: 158 GICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----G 210
Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           T  Y+APE +   + + +   D      +M + L C +P
Sbjct: 211 TAYYIAPEVL---KKKYNEKCDVWSCGVIMYI-LLCGYP 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + L  G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +              
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------------- 198
Query: 365 LGYMAPEYISTGRARLDVNFDEQQT 389
             Y  P+Y+  G ARL + +   +T
Sbjct: 199 --YKDPDYVRKGDARLPLKWMAPET 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 101
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 158
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 159 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 209
Query: 370 PEYI 373
           PE +
Sbjct: 210 PEIM 213

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           R LG+G FG V    Y          VAVK +  G     ++ +  E++    L H +++
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G C D+GE    LV E++P GSL  +L  +   G         +I  G+A    YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMA----YLH 128
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +     +HR +   N++ D D  VK+GDFGLA  V
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAV 161

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKIS----RGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +LG+G F  V R + +      A K I+        H K E   E + C  L+H N+++L
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE--REARICRLLKHPNIVRL 86
Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
                + G   L+++ +  G L   + +++            +I      A+L+ H+   
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI----LEAVLHCHQ--- 139
Query: 319 RCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
             VVHRD+K  N++  +      VKL DFGLA+ V+ E      G AGT GY++PE +
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVL 196

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + L  G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 82  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRN 254
           N+   + +G+G F  V     I     VAVK I +   +  +  +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH---GRXKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G   Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFS--NEFTFGNKLDAFCGAPPYAAPE 182

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 77  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +              
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------------- 235
Query: 365 LGYMAPEYISTGRARLDVNFDEQQT 389
             Y  P+Y+  G ARL + +   +T
Sbjct: 236 --YKDPDYVRKGDARLPLKWMAPET 258

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+ ++        N E + E    + +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 109 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFGLA L+  E
Sbjct: 162 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 145
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 146 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 196
Query: 370 PEYI 373
           PE +
Sbjct: 197 PEIM 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRN 254
           N+   + +G+G F  V     I     VAVK I +   +  +  +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G+  Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAPE 182

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +              
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------------- 200
Query: 365 LGYMAPEYISTGRARLDVNFDEQQT 389
             Y  P+Y+  G ARL + +   +T
Sbjct: 201 --YKDPDYVRKGDARLPLKWMAPET 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 145
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 146 --YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYRA 196
Query: 370 PEYI 373
           PE +
Sbjct: 197 PEIM 200

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRN 254
           N+   + +G+G F  V     I     VAVK I +   +  +  +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G+  Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAPE 182

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 105
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 162
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 163 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 213
Query: 370 PEYI 373
           PE +
Sbjct: 214 PEIM 217

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E+KLG G FG V+     + +  VAVK +  G       ++ E      L+H  L++L  
Sbjct: 187 EKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 244
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +   +    ++ EFM  GSL   L S + +  PL     +  S  +A  + ++ +   R 
Sbjct: 245 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQ---RN 298
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            +HRD++ +NI+       K+ DFGLA            G    + + APE I+ G
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLA----------RVGAKFPIKWTAPEAINFG 344

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YITEVKTCSQLRHRNLLQLIGL 261
           LG+G FG V +          AVK I++     K+    + EV+   +L H N+++L  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
             D   F +V E    G L   +  +K      +     +I   + S + Y+H   K  +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 322 VHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           VHRD+K  NI+ ++   D ++K+ DFGL+         +     GT  Y+APE +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVL 195

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 202 RKLGQGGFGAVY------RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        G      +AV   K   G  H  +    E++    L H N+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENI 85
Query: 256 LQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G+C + G     L+ EF+P+GSL  +L   K+    +    + K ++ +   + YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPE 371
                R  VHRD+   N++ +++  VK+GDFGL  A+  D E           + + APE
Sbjct: 143 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 372 -------YISTGRARLDVNFDEQQTDC 391
                  YI++      V   E  T C
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYC 226

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQL 250
             F   + LG G FG VY+G+ I     + + VA+K++        N E + E    + +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            + ++ +L+G+C       L+ + MP G L D+    K + G+   L W  +      +A
Sbjct: 82  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             + YL +   R +VHRD+   N++  T  +VK+ DFG A L+  E
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAV--YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           N+   + +G+G F  V   R IL    +AV +   ++       +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G+  Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAPE 182

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 93
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL-TWTTRYKISLGLASALLY 312
           ++ L+G C    G  M++ EF   G+L  +L SK++   P  T    YK  L L   + Y
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 313 LHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-T 364
             +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A   
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 365 LGYMAPEYI 373
           L +MAPE I
Sbjct: 214 LKWMAPETI 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 23/179 (12%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIG 260
           +G G +G+V     +   + +AVKK+SR  +   H K  Y  E++    ++H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 261 L------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +        +  +  LV   M    L+  +  +K T   + +   Y+I  GL     Y+H
Sbjct: 118 VFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI-YQILRGLK----YIH 171
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y APE +
Sbjct: 172 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIM 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 198 FSNERKLGQGGFGAVYR-----GILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQL 250
           F   R LG+GG+G V++     G       A+ V K +  +++ K+   T  E     ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +H  ++ LI      G+  L+ E++  G L   L   +  G  +  T  + ++  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLA-EISMAL 134
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +LH+   + +++RD+K  NIM +   +VKL DFGL     H+ G  T    GT+ YMAP
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHXFCGTIEYMAP 190
Query: 371 EYI 373
           E +
Sbjct: 191 EIL 193

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +              
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------------- 189
Query: 365 LGYMAPEYISTGRARLDVNFDEQQT 389
             Y  P+Y+  G ARL + +   +T
Sbjct: 190 --YKDPDYVRKGDARLPLKWMAPET 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 33/205 (16%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +              
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------------- 189
Query: 365 LGYMAPEYISTGRARLDVNFDEQQT 389
             Y  P+Y+  G ARL + +   +T
Sbjct: 190 --YKDPDYVRKGDARLPLKWMAPET 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAV--YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           N+   + +G+G F  V   R IL    +AV +   ++       +   EV+    L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAKFR-QIVSAVQYCH 130
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G+  Y APE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDEFCGSPPYAAPE 182

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 202 RKLGQGGFGAVY------RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           R LG+G FG V        G      +AV   K   G  H  +    E++    L H N+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENI 73
Query: 256 LQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           ++  G+C + G     L+ EF+P+GSL  +L   K+    +    + K ++ +   + YL
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 130
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPE 371
                R  VHRD+   N++ +++  VK+GDFGL  A+  D E           + + APE
Sbjct: 131 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 372 -------YISTGRARLDVNFDEQQTDC 391
                  YI++      V   E  T C
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLTYC 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 102/266 (38%), Gaps = 56/266 (21%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 1   WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 52
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 53  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 112
Query: 271 VYEFMPNGSLDFHLFSK-------------------KSTGTPLTWTTRYKISLGLASALL 311
           + E+   G L   L  K                   K  G PL        S  +A  + 
Sbjct: 113 ITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMA 172
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +L    K C+ HRD+   N++       K+GDFGLA  + ++                  
Sbjct: 173 FLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND----------------SN 213
Query: 372 YISTGRARLDVNF--DEQQTDCLMIV 395
           YI  G ARL V +   E   DC+  V
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTV 239

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 198 FSNERKLGQGGFGAVYR-----GILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQL 250
           F   R LG+GG+G V++     G       A+ V K +  +++ K+   T  E     ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +H  ++ LI      G+  L+ E++  G L   L   +  G  +  T  + ++  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLA-EISMAL 134
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +LH+   + +++RD+K  NIM +   +VKL DFGL     H+ G  T    GT+ YMAP
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAP 190
Query: 371 EYI 373
           E +
Sbjct: 191 EIL 193

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG+G FG+V    Y  +  +    VAVKK+    +    ++  E++    L+H N+++
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 258 LIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
             G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 131
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +HR++   NI+ + +  VK+GDFGL 
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLT 162

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-R 251
           N+   +  +G+G FG V +  +    L M  A+K++     K    ++  E++   +L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSK-----------KSTGTPLTWTTR 299
           H N++ L+G C  RG   L  E+ P+G+ LDF   S+            ST + L+    
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +A  + YL +   +  +HRD+   NI+   ++  K+ DFGL+
Sbjct: 135 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 179

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-R 251
           N+   +  +G+G FG V +  +    L M  A+K++     K    ++  E++   +L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSK-----------KSTGTPLTWTTR 299
           H N++ L+G C  RG   L  E+ P+G+ LDF   S+            ST + L+    
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +A  + YL +   +  +HRD+   NI+   ++  K+ DFGL+
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 189

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++          R+     + 
Sbjct: 205 SRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIV 258
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           SAL YLH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y
Sbjct: 259 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEY 315
Query: 368 MAPEYIST---GRA 378
           +APE +     GRA
Sbjct: 316 LAPEVLEDNDYGRA 329

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGLKHGKNEYITE 243
           +D+    N     + LG+G FG+V  G L       L +AV   K+    +    E+++E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 244 VKTCSQLRHRNLLQLIGLCHDRG-----EFMLVYEFMPNGSLD-FHLFSKKSTG---TPL 294
                   H N+++L+G+C +       + M++  FM  G L  + L+S+  TG    PL
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
               ++ + + L    L       R  +HRD+   N M   D  V + DFGL+
Sbjct: 147 QTLLKFMVDIALGMEYLS-----NRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++          R+     + 
Sbjct: 208 SRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIV 261
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           SAL YLH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y
Sbjct: 262 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEY 318
Query: 368 MAPEYIST---GRA 378
           +APE +     GRA
Sbjct: 319 LAPEVLEDNDYGRA 332

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL-- 261
           +G+G +G V+RG     N+AV +   SR  K    E  TE+     LRH N+L  I    
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 262 --CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-- 317
              H   +  L+  +   GSL  +L       T L   +  +I L +AS L +LH E   
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 318 ---KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYMAPE 371
              K  + HRD+K  NI+   +    + D GLA++          G     GT  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 372 YI 373
            +
Sbjct: 188 VL 189

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ D+GLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQL 250
             +NF   R LG+G FG V    + +     AVK + + +    ++    +TE +  S  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 251 R-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           R H  L QL            V EF+  G L FH+  +KS          Y   +   SA
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEI--ISA 136
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHELGPRTTGLAGTLGY 367
           L++LH+   + +++RD+K  N++ D + + KL DFG+    + +   G  T    GT  Y
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN---GVTTATFCGTPDY 190
Query: 368 MAPEYIS 374
           +APE + 
Sbjct: 191 IAPEILQ 197

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNEYITEVKTCSQ 249
           T  +    +LG+G F  V R + +        M +  KK+S    H K E   E + C  
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLE--REARICRL 66
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           L+H N+++L     + G   L+++ +  G L   + +++            +I      A
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI----LEA 122
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLG 366
           +L+ H+     VVHR++K  N++  +      VKL DFGLA+ V+ E      G AGT G
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPG 178
Query: 367 YMAPEYI 373
           Y++PE +
Sbjct: 179 YLSPEVL 185

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG+G FG V           VA+K ISR L    + ++    E+     LRH ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +     + ++V E+      D+ +  K+     +T     +    +  A+ Y H   +  
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEYCH---RHK 128
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +VHRD+K  N++ D + NVK+ DFGL+ ++ D   G       G+  Y APE I+
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVIN 180

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL-- 261
           +G+G +G V+RG     N+AV +   SR  K    E  TE+     LRH N+L  I    
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 262 --CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-- 317
              H   +  L+  +   GSL  +L       T L   +  +I L +AS L +LH E   
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 318 ---KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYMAPE 371
              K  + HRD+K  NI+   +    + D GLA++          G     GT  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 372 YI 373
            +
Sbjct: 188 VL 189

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YITEVKTCSQLRHRNLLQLIGL 261
           LG+G FG V +          AVK I++     K+    + EV+   +L H N+++L  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
             D   F +V E    G L   +  +K      +     +I   + S + Y+H   K  +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 322 VHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           VHRD+K  NI+ ++   D ++K+ DFGL+         +     GT  Y+APE +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVL 195

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+S+  +   H K  Y  E++    ++H N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHEN 94
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 151
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 152 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 202
Query: 370 PEYI 373
           PE +
Sbjct: 203 PEIM 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 18/190 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           AT+ +    ++G G +G VY+         VA+K +       GL       +  ++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 249 QLRHRNLLQLIGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
              H N+++L+ +C     DR  +  LV+E +     D   +  K+    L   T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
                 L +LH     C+VHRD+K  NI+  +   VKL DFGLA +  +++      +  
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LAPVVV 173
Query: 364 TLGYMAPEYI 373
           TL Y APE +
Sbjct: 174 TLWYRAPEVL 183

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 92
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 93  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 149
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 150 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 200
Query: 370 PEYI 373
           PE +
Sbjct: 201 PEIM 204

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC- 262
           +G+G +G V+RG     N+AV +   SR  K    E  TE+     LRH N+L  I    
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 263 ---HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-- 317
              H   +  L+  +   GSL  +L       T L   +  +I L +AS L +LH E   
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 318 ---KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG---LAGTLGYMAPE 371
              K  + HRD+K  NI+   +    + D GLA++          G     GT  YMAPE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 372 YI 373
            +
Sbjct: 217 VL 218

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   ++G+G FG VY+GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDL------LKPGPLEETYIATILREILKGLDYLHS 134
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++     +VKL DFG+A  L D ++  +     GT  +MAPE I
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVI 188

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH 263
           +G+G    V R +        AVK +    +    E + EV+  ++     L Q+ G  H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 264 --------DRGEFM-LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
                   +   FM LV++ M  G L    F   +    L+      I   L  A+ +LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 +VHRD+K  NI+ D +  ++L DFG +  +  E G +   L GT GY+APE +
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE--YITEVKTCSQLRHRNLLQLIGL 261
           LG+G FG V +          AVK I++     K+    + EV+   +L H N+++L  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
             D   F +V E    G L   +  +K      +     +I   + S + Y+H   K  +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 322 VHRDIKFSNIMPDT---DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           VHRD+K  NI+ ++   D ++K+ DFGL+         +     GT  Y+APE +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVL 195

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 364 TLGYMAPEYI 373
            L +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A  
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 364 TLGYMAPEYI 373
            L +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +G K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-KAFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 188
Query: 368 MAPEYI 373
            APE I
Sbjct: 189 RAPELI 194

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQLIGL 261
           +LG GGFG V R I  D    VA+K+  + L     E +  E++   +L H N++    +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 262 CHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
                +       +L  E+   G L  +L   ++         R  +S  ++SAL YLHE
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHE 140
Query: 316 EWKRCVVHRDIKFSNIM--PDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
                ++HRD+K  NI+  P     + K+ D G A  +D   G   T   GTL Y+APE 
Sbjct: 141 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAPEL 195
Query: 373 ISTGRARLDVNF 384
           +   +  + V++
Sbjct: 196 LEQKKYTVTVDY 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 88
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 145
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 146 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 196
Query: 370 PEYI 373
           PE +
Sbjct: 197 PEIM 200

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 135
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 136 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 186
Query: 370 PEYI 373
           PE +
Sbjct: 187 PEIM 190

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 101
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 158
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 159 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 209
Query: 370 PEYI 373
           PE +
Sbjct: 210 PEIM 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQLRHRNLLQLIGL 261
           +LG GGFG V R I  D    VA+K+  + L     E +  E++   +L H N++    +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 262 CHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
                +       +L  E+   G L  +L   ++         R  +S  ++SAL YLHE
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHE 139
Query: 316 EWKRCVVHRDIKFSNIM--PDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
                ++HRD+K  NI+  P     + K+ D G A  +D   G   T   GTL Y+APE 
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAPEL 194
Query: 373 ISTGRARLDVNF 384
           +   +  + V++
Sbjct: 195 LEQKKYTVTVDY 206

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +G K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-KAFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA 347
           L Y+H      + HRDIK  N++ D D  V KL DFG A
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 159
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 160 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 210
Query: 370 PEYI 373
           PE +
Sbjct: 211 PEIM 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHRN 254
           N+   + +G+G F  V     I     VAVK I +   +  +  +   EV+    L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        LV E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GWMKEKEARAKFR-QIVSAVQYCH 123
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +++   +VHRD+K  N++ D D N+K+ DFG +   +   G +     G+  Y APE
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAPE 175

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 18/190 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           AT+ +    ++G G +G VY+         VA+K +       GL       +  ++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 249 QLRHRNLLQLIGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
              H N+++L+ +C     DR  +  LV+E +     D   +  K+    L   T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
                 L +LH     C+VHRD+K  NI+  +   VKL DFGLA +  +++      +  
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDPVVV 173
Query: 364 TLGYMAPEYI 373
           TL Y APE +
Sbjct: 174 TLWYRAPEVL 183

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +G K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-KAFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA 347
           L Y+H      + HRDIK  N++ D D  V KL DFG A
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 105
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 162
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+     G   T  Y A
Sbjct: 163 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGYVATRWYRA 213
Query: 370 PEYI 373
           PE +
Sbjct: 214 PEIM 217

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++          R+     + 
Sbjct: 67  SRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIV 120
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           SAL YLH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y
Sbjct: 121 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTPEY 177
Query: 368 MAPEYIST---GRA 378
           +APE +     GRA
Sbjct: 178 LAPEVLEDNDYGRA 191

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++          R+     + 
Sbjct: 66  SRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIV 119
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           SAL YLH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y
Sbjct: 120 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTPEY 176
Query: 368 MAPEYIST---GRA 378
           +APE +     GRA
Sbjct: 177 LAPEVLEDNDYGRA 190

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNEY---ITEVKTCSQ 249
           N F   + LG+G FG V   IL+         A+K + + +   K+E    +TE +    
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 250 LRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            RH  L  L+     HDR     V E+   G L FHL  ++          R+     + 
Sbjct: 65  SRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIV 118
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           SAL YLH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y
Sbjct: 119 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTPEY 175
Query: 368 MAPEYIST---GRA 378
           +APE +     GRA
Sbjct: 176 LAPEVLEDNDYGRA 189

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 14  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 154

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 30  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
            +  +HRD+   N + +    VK+ DFGL+  V  +    + G    + +  PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVL 193

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 21/190 (11%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----RGLKHGKNEYITEVKTCS 248
           S T+ +     +G+G F  V R + +      A K I+        H K E   E + C 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
            L+H N+++L     + G   LV++ +  G L   + +++            +I      
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----LE 114
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTT--GLAG 363
           A+L+ H+     VVHRD+K  N++  +      VKL DFGLA+ V    G +    G AG
Sbjct: 115 AVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ---GDQQAWFGFAG 168
Query: 364 TLGYMAPEYI 373
           T GY++PE +
Sbjct: 169 TPGYLSPEVL 178

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A  
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 364 TLGYMAPEYI 373
            L +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+     G   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+     G   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 29/194 (14%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----RGLKHGKNEYITEVKTCS 248
           S T+ +    +LG+G F  V R + I      A K I+        H K E   E + C 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
            L+H N+++L     + G   LV++ +  G L   + +++           Y      + 
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-----------YYSEADASH 107
Query: 309 ALLYLHEEWKRC----VVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTT-- 359
            +  + E    C    +VHRD+K  N++  +      VKL DFGLA+ V    G +    
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ---GDQQAWF 164
Query: 360 GLAGTLGYMAPEYI 373
           G AGT GY++PE +
Sbjct: 165 GFAGTPGYLSPEVL 178

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 180 DAGPRRFSYKDLASAT---NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----RG 232
           D G     ++ +A+ T   +++    +LG+G F  V R +        A K I+      
Sbjct: 12  DLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA 71
Query: 233 LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
             H K E   E + C  L+H N+++L     + G   LV++ +  G L   + +++    
Sbjct: 72  RDHQKLE--REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---- 125
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALL 349
              + +    S  +   L  ++   +  +VHRD+K  N++  +      VKL DFGLA+ 
Sbjct: 126 ---YYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE 182
Query: 350 VDHELGPRTTGLAGTLGYMAPEYI 373
           V  E      G AGT GY++PE +
Sbjct: 183 VQGE-QQAWFGFAGTPGYLSPEVL 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 10  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-----YITEVKTCSQLRHRNLLQ 257
           K+GQG FG V++         VA+KK+   L   + E      + E+K    L+H N++ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 258 LIGLCHDR--------GEFMLVYEFMPN--GSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           LI +C  +        G   LV++F  +    L  ++  K       T +   ++   L 
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL---LVDHELGPRTTGLAGT 364
           + L Y+H   +  ++HRD+K +N++   D  +KL DFGLA    L  +    R      T
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 365 LGYMAPEYI 373
           L Y  PE +
Sbjct: 193 LWYRPPELL 201

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 18/190 (9%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCS 248
           AT+ +    ++G G +G VY+         VA+K +       GL       +  ++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 249 QLRHRNLLQLIGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
              H N+++L+ +C     DR  +  LV+E +     D   +  K+    L   T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
                 L +LH     C+VHRD+K  NI+  +   VKL DFGLA +  +++      +  
Sbjct: 119 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LFPVVV 173
Query: 364 TLGYMAPEYI 373
           TL Y APE +
Sbjct: 174 TLWYRAPEVL 183

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 15  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 30  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 135
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+     G   T  Y A
Sbjct: 136 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRA 186
Query: 370 PEYI 373
           PE +
Sbjct: 187 PEIM 190

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 21  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 161

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 202 RKLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++LG G FG V    +RG        VA+K I  G    ++E+I E K    L H  L+Q
Sbjct: 15  KELGTGQFGVVKYGKWRG-----QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL    
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            +  +HRD+   N + +    VK+ DFGL+  V
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 202 RKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKNE-YITEVKTCSQL-RHRN 254
           + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 255 LLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALL 311
           ++ L+G C    G  M++ EF   G+L  +L SK++   P        YK  L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 312 YLHEEWK-------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
           Y  +  K       R  +HRD+   NI+      VK+ DFGLA  +  +      G A  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 364 TLGYMAPEYI 373
            L +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 255 LLQLIGL---CHDRGEFMLVYEFMPNGSLDFHLFSK--KSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY        D +   K  K T   + +   Y+I  GL   
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQILRGLK-- 135
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+    TG   T  Y A
Sbjct: 136 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRA 186
Query: 370 PEYI 373
           PE +
Sbjct: 187 PEIM 190

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 125
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 126 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 372 YISTGRA 378
            ++   A
Sbjct: 183 LLTEKSA 189

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 145
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 372 YISTGRA 378
            ++   A
Sbjct: 203 LLTEKSA 209

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 21/193 (10%)
Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYITEVKTCSQLR 251
           AT+ +    ++G G +G VY+         VA+K  ++  G   G    I+ V+  + LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 252 ------HRNLLQLIGLCH----DRG-EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY 300
                 H N+++L+ +C     DR  +  LV+E +     D   +  K+    L   T  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIK 123
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG 360
            +       L +LH     C+VHRD+K  NI+  +   VKL DFGLA +  +++    T 
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 361 LAGTLGYMAPEYI 373
           +  TL Y APE +
Sbjct: 179 VVVTLWYRAPEVL 191

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 18/175 (10%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E  +G+G FG V +      +  VA+K+I    +  +  +I E++  S++ H N+++L G
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKD--VAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKIS--LGLASALLYLHEEW 317
            C +     LV E+   GS    L++      PL  +T  + +S  L  +  + YLH   
Sbjct: 70  ACLN--PVCLVMEYAEGGS----LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 318 KRCVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            + ++HRD+K  N++      V K+ DFG A  +   +    T   G+  +MAPE
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPE 174

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 124
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 125 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 372 YISTGRA 378
            ++   A
Sbjct: 182 LLTEKSA 188

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 122
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 123 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 372 YISTGRA 378
            ++   A
Sbjct: 180 LLTEKSA 186

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 123
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 372 YISTGRA 378
            ++   A
Sbjct: 181 LLTEKSA 187

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 29/194 (14%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----RGLKHGKNEYITEVKTCS 248
           S T+ +    +LG+G F  V R + I      A K I+        H K E   E + C 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE--REARICR 58
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
            L+H N+++L     + G   LV++ +  G L   + +++           Y      + 
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-----------YYSEADASH 107
Query: 309 ALLYLHEEWKRC----VVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTT-- 359
            +  + E    C    +VHRD+K  N++  +      VKL DFGLA+ V    G +    
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ---GDQQAWF 164
Query: 360 GLAGTLGYMAPEYI 373
           G AGT GY++PE +
Sbjct: 165 GFAGTPGYLSPEVL 178

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 144
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 372 YISTGRA 378
            ++   A
Sbjct: 202 LLTEKSA 208

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA     E+    TG   T  Y A
Sbjct: 147 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRA 197
Query: 370 PEYI 373
           PE +
Sbjct: 198 PEIM 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 11/187 (5%)
Query: 187 SYKDLASATNNFSNERKLGQGGFGAV--YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           S  D      N+   + +G+G F  V   R IL    +A+ +   ++       +   EV
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    L H N+++L  +        L+ E+   G +  +L +    G       R K   
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFR- 121
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            + SA+ Y H+   + +VHRD+K  N++ D D N+K+ DFG +   +  +G +     G 
Sbjct: 122 QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLDAFCGA 176
Query: 365 LGYMAPE 371
             Y APE
Sbjct: 177 PPYAAPE 183

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 148
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 149 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 372 YISTGRA 378
            ++   A
Sbjct: 206 LLTEKSA 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   K+G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDL------LEPGPLDETQIATILREILKGLDYLHS 137
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++      VKL DFG+A  L D ++  +     GT  +MAPE I
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVI 191

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 18/175 (10%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E  +G+G FG V +      +  VA+K+I    +  +  +I E++  S++ H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKD--VAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKIS--LGLASALLYLHEEW 317
            C +     LV E+   GS    L++      PL  +T  + +S  L  +  + YLH   
Sbjct: 69  ACLN--PVCLVMEYAEGGS----LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 318 KRCVVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            + ++HRD+K  N++      V K+ DFG A  +   +    T   G+  +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPE 173

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 196 NNFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISR-GLKHGKNEYITEVKTCSQL-R 251
           N+   +  +G+G FG V +  +    L M  A+K++     K    ++  E++   +L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSK-----------KSTGTPLTWTTR 299
           H N++ L+G C  RG   L  E+ P+G+ LDF   S+            ST + L+    
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +  +A  + YL +   +  +HR++   NI+   ++  K+ DFGL+
Sbjct: 142 LHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLS 186

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   K+G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDL------LEPGPLDETQIATILREILKGLDYLHS 122
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++      VKL DFG+A  L D ++   T    GT  +MAPE I
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 176

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA     E+    TG   T  Y A
Sbjct: 147 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRA 197
Query: 370 PEYI 373
           PE +
Sbjct: 198 PEIM 201

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA     E+    TG   T  Y A
Sbjct: 147 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRA 197
Query: 370 PEYI 373
           PE +
Sbjct: 198 PEIM 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 16  WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127
Query: 271 VYEFMPNGSLDFHLFSKKS-----------TGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           + E+   G L  +   +KS             + L+       S  +A  + +L    K 
Sbjct: 128 ITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS--KN 184
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYI 373
           C+ HRD+   N++       K+GDFGLA  + ++      G A   + +MAPE I
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ D GLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   K+G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDL------LEPGPLDETQIATILREILKGLDYLHS 122
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++      VKL DFG+A  L D ++  +     GT  +MAPE I
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVI 176

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 129
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 130 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 372 YISTGRA 378
            ++   A
Sbjct: 187 LLTEKSA 193

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+  FGLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 194 ATNNFSNERKLGQGGFGAVY----RGILIDLNMAVAVKKISRGLK---HGKNEYITEVKT 246
           +  +F   R LG G FG V+    R       M V  K+I   LK   H  +E +     
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM---- 59
Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
            S + H  ++++ G   D  +  ++ +++  G L F L  +KS   P      Y   + L
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLL-RKSQRFPNPVAKFYAAEVCL 117
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
           A  L YLH    + +++RD+K  NI+ D + ++K+ DFG A  V       T  L GT  
Sbjct: 118 A--LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPD 168
Query: 367 YMAPEYIST 375
           Y+APE +ST
Sbjct: 169 YIAPEVVST 177

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 110
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 168
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 222
Query: 368 MAPEYI 373
            APE I
Sbjct: 223 RAPELI 228

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 26/199 (13%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-----YITEVKTCSQ 249
            + +    K+GQG FG V++         VA+KK+   L   + E      + E+K    
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQL 72
Query: 250 LRHRNLLQLIGLCHDR--------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
           L+H N++ LI +C  +        G   LV++F  +      L S  +     T +   +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLS--NVLVKFTLSEIKR 128
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL---LVDHELGPRT 358
           +   L + L Y+H   +  ++HRD+K +N++   D  +KL DFGLA    L  +    R 
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 359 TGLAGTLGYMAPEYISTGR 377
                TL Y  PE +   R
Sbjct: 186 XNRVVTLWYRPPELLLGER 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLL 256
           F+   K+G+G FG V++GI       VA+K I       + E I  E+   SQ     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 257 QLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +  G      +  ++ E++  GS LD           PL  T    I   +   L YLH 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDL------LEPGPLDETQIATILREILKGLDYLHS 142
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
           E K   +HRDIK +N++      VKL DFG+A  L D ++   T    GT  +MAPE I
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 196

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 152
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 153 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 372 YISTGRA 378
            ++   A
Sbjct: 210 LLTEKSA 216

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 145
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 372 YISTGRA 378
            ++   A
Sbjct: 203 LLTEKSA 209

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 84
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 142
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 143 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 196
Query: 368 MAPEYI 373
            APE I
Sbjct: 197 RAPELI 202

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           K+G+G +G V++    D    VA+KK   S      K   + E++   QL+H NL+ L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------LTWTTRYKISLGLASALLYLH 314
           +   +    LV+E+  +  L  H   +   G P      +TW T          A+ + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQT--------LQAVNFCH 119
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
              K   +HRD+K  NI+      +KL DFG A L+
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 88
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 200
Query: 368 MAPEYI 373
            APE I
Sbjct: 201 RAPELI 206

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQL 258
            E  LG+G    V   I +  +   AVK I +   H ++    EV+   Q + HRN+L+L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           I    +   F LV+E M  GS+  H+  ++             +   +ASAL +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLH---N 129
Query: 319 RCVVHRDIKFSNIM---PDTDFNVKLGDFGL--ALLVDHELGPRTT----GLAGTLGYMA 369
           + + HRD+K  NI+   P+    VK+ DFGL   + ++ +  P +T       G+  YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 370 PEYIST 375
           PE +  
Sbjct: 190 PEVVEA 195

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 145
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 372 YISTGRA 378
            ++   A
Sbjct: 203 LLTEKSA 209

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 30/201 (14%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-----YITEVKTCSQ 249
            + +    K+GQG FG V++         VA+KK+   L   + E      + E+K    
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 250 LRHRNLLQLIGLCHDR--------GEFMLVYEFMPN--GSLDFHLFSKKSTGTPLTWTTR 299
           L+H N++ LI +C  +        G   LV++F  +    L  ++  K       T +  
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEI 127
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL---LVDHELGP 356
            ++   L + L Y+H   +  ++HRD+K +N++   D  +KL DFGLA    L  +    
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 357 RTTGLAGTLGYMAPEYISTGR 377
           R      TL Y  PE +   R
Sbjct: 185 RYXNRVVTLWYRPPELLLGER 205

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 144
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 372 YISTGRA 378
            ++   A
Sbjct: 202 LLTEKSA 208

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 95
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 153
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 154 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 207
Query: 368 MAPEYI 373
            APE I
Sbjct: 208 RAPELI 213

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ D GLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 188
Query: 368 MAPEYI 373
            APE I
Sbjct: 189 RAPELI 194

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 148
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 149 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 372 YISTGRA 378
            ++   A
Sbjct: 206 LLTEKSA 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVK--TCSQL 250
           + F   + LGQG FG V+    I   D     A+K + +     ++   T+++     ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  +++L       G+  L+ +F+  G L    F++ S     T          LA AL
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMA 369
            +LH      +++RD+K  NI+ D + ++KL DFGL+   +DHE   +     GT+ YMA
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMA 194
Query: 370 PEYIS 374
           PE ++
Sbjct: 195 PEVVN 199

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 177 LSRDAGPRRFSYKDLASATNN---FSNERKLGQGGFGAVYRGILIDLNMAVAVK--KISR 231
           ++ D+  R     DL++  +    F     +G G +G VY+G  +      A+K   ++ 
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 232 GLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------EFMLVYEFMPNGSLDFHLF 285
             +    + I  +K  S   HRN+    G    +       +  LV EF   GS+   + 
Sbjct: 62  DEEEEIKQEINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 286 SKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG 345
           + K       W     I   +   L +LH+     V+HRDIK  N++   +  VKL DFG
Sbjct: 120 NTKGNTLKEEWIAY--ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 346 LALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           ++  +D  +G R T   GT  +MAPE I+
Sbjct: 175 VSAQLDRTVGRRNT-FIGTPYWMAPEVIA 202

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQL- 250
             +F   + LG+G FG V+       N   A+K + + +    ++    + E +  S   
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L  +      +     V E++  G L +H+  +      L+  T Y   + L   L
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG--L 132
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMA 369
            +LH    + +V+RD+K  NI+ D D ++K+ DFG+    ++ LG  +T    GT  Y+A
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNEFCGTPDYIA 187
Query: 370 PEYI 373
           PE +
Sbjct: 188 PEIL 191

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 88
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 146
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 200
Query: 368 MAPEYI 373
            APE I
Sbjct: 201 RAPELI 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 203 KLGQGGFGAVYRGI--LIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLI 259
           +LG G FG+V +G+  +    + VA+K + +G  K    E + E +   QL +  +++LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALLYLHEEW 317
           G+C      MLV E    G L   L  K+    P++      +++S+G+     YL E  
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMK----YLEE-- 128
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT--LGYMAPEYIS 374
            +  VHRD+   N++       K+ DFGL+  +  +    T   AG   L + APE I+
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 188
Query: 368 MAPEYI 373
            APE I
Sbjct: 189 RAPELI 194

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 188
Query: 368 MAPEYI 373
            APE I
Sbjct: 189 RAPELI 194

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 11/177 (6%)
Query: 197 NFSNERKLGQGGFGAV--YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           N+   + +G+G F  V   R IL    +A+ +   ++       +   EV+    L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L  +        L+ E+   G +  +L +    G       R K    + SA+ Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFR-QIVSAVQYCH 128
Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +   + +VHRD+K  N++ D D N+K+ DFG +   +  +G +     G+  Y APE
Sbjct: 129 Q---KRIVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLDTFCGSPPYAAPE 180

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 77
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 135
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 136 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 189
Query: 368 MAPEYI 373
            APE I
Sbjct: 190 RAPELI 195

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 23/185 (12%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRN 254
           + + + +G G +GAV   +       VA+KK+ R  +     K  Y  E++    +RH N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 85
Query: 255 LLQLIGL------CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ L+ +        D  +F LV  FM  G+    L   +  G        Y++  GL  
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR- 142
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
              Y+H      ++HRD+K  N+  + D  +K+ DFGLA   D E+     G   T  Y 
Sbjct: 143 ---YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----XGXVVTRWYR 192
Query: 369 APEYI 373
           APE I
Sbjct: 193 APEVI 197

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 9   QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 65
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 120
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 178
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 179 YMAPEVL 185

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 147
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 372 YISTGRA 378
            ++   A
Sbjct: 205 LLTEKSA 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 103
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 158
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 216
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 217 YMAPEVL 223

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 104
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 162
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 216
Query: 368 MAPEYI 373
            APE I
Sbjct: 217 RAPELI 222

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F  V   R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 150
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 151 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 372 YISTGRA 378
            ++   A
Sbjct: 208 LLTEKSA 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 102
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 159
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DFGLA   D E+     G   T  Y A
Sbjct: 160 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGXVATRWYRA 210
Query: 370 PEYI 373
           PE +
Sbjct: 211 PEIM 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 64
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 119
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 177
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 178 YMAPEVL 184

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVK--TCSQL 250
           + F   + LGQG FG V+    I   D     A+K + +     ++   T+++     ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  +++L       G+  L+ +F+  G L    F++ S     T          LA AL
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMA 369
            +LH      +++RD+K  NI+ D + ++KL DFGL+   +DHE   +     GT+ YMA
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMA 194
Query: 370 PEYIS 374
           PE ++
Sbjct: 195 PEVVN 199

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 80
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 138
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 139 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-Y 192
Query: 368 MAPEYI 373
            APE I
Sbjct: 193 RAPELI 198

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 34  QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 90
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 145
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 203
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 204 YMAPEVL 210

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 110
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 168
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 222
Query: 368 MAPEYI 373
            APE I
Sbjct: 223 RAPELI 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVK--TCSQL 250
           + F   + LGQG FG V+    I   D     A+K + +     ++   T+++     ++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  +++L       G+  L+ +F+  G L    F++ S     T          LA AL
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMA 369
            +LH      +++RD+K  NI+ D + ++KL DFGL+   +DHE   +     GT+ YMA
Sbjct: 141 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMA 195
Query: 370 PEYIS 374
           PE ++
Sbjct: 196 PEVVN 200

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 14  QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 70
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 125
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 183
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 184 YMAPEVL 190

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V         + VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ D GLA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 112
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 170
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 224
Query: 368 MAPEYI 373
            APE I
Sbjct: 225 RAPELI 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 114
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 172
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 226
Query: 368 MAPEYI 373
            APE I
Sbjct: 227 RAPELI 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 81
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 140 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 193
Query: 368 MAPEYI 373
            APE I
Sbjct: 194 RAPELI 199

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           +  +G+G FG V+RG      +AV +   SR  +    E   E+     LRH N+L  I 
Sbjct: 11  QESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFRE--AEIYQTVMLRHENILGFIA 67
Query: 261 LCH-DRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             + D G   +  LV ++  +GSL F   ++ +    +T     K++L  AS L +LH E
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT----VTVEGMIKLALSTASGLAHLHME 122
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA-----GTLG 366
                 K  + HRD+K  NI+   +    + D GLA  V H+    T  +A     GT  
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 180
Query: 367 YMAPEYI 373
           YMAPE +
Sbjct: 181 YMAPEVL 187

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 89
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 147
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 148 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 201
Query: 368 MAPEYI 373
            APE I
Sbjct: 202 RAPELI 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 76
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 134
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 188
Query: 368 MAPEYI 373
            APE I
Sbjct: 189 RAPELI 194

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 159 WKWKQRKETETFTWVNDDLSRDAGPRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGIL 217
           WK  +  E  ++T+++        P +  Y +      NN    + LG G FG V     
Sbjct: 16  WKIIESYEGNSYTFID--------PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 218 IDLNMAVAVKKIS----RGLKHG--KNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML 270
             L    AV K++    +   H   K   ++E+K  S L +H N++ L+G C   G  ++
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127
Query: 271 VYEFMPNGSLDFHLFSKKSTGTPL---------TWTTR--YKISLGLASALLYLHEEWKR 319
           + E+   G L  +   +KS              T +TR     S  +A  + +L    K 
Sbjct: 128 ITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KN 184
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG-TLGYMAPEYI 373
           C+ HRD+   N++       K+GDFGLA  + ++      G A   + +MAPE I
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 181 AGPRRFSYKDLAS---ATNNF---SNERKLGQGGFGAVYRGILIDLNMAVAVKKI-SRGL 233
           A P  F ++ + +   A N+F   S    LG G FG V++       + +A K I +RG+
Sbjct: 68  APPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 234 KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
           K  K E   E+   +QL H NL+QL      + + +LV E++  G L   +  +    T 
Sbjct: 128 K-DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM-PDTDF-NVKLGDFGLALLVD 351
           L      K    +   + ++H+ +   ++H D+K  NI+  + D   +K+ DFGLA    
Sbjct: 187 LDTILFMK---QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA---- 236
Query: 352 HELGPRTTGLA--GTLGYMAPEYIS 374
               PR       GT  ++APE ++
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPEVVN 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLR-HRNLLQL 258
           +KLG+G +G V++ I       VAVKKI    ++  +   T  E+   ++L  H N++ L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 259 IGLC---HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + +    +DR  + LV+++M     D H   + +   P+    +  +   L   + YLH 
Sbjct: 75  LNVLRADNDRDVY-LVFDYM---ETDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHS 127
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                ++HRD+K SNI+ + + +VK+ DFGL+
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLS 156

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQL- 250
             +F   + LG+G FG V+       N   A+K + + +    ++    + E +  S   
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L  +      +     V E++  G L +H+  +      L+  T Y   + L   L
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG--L 131
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMA 369
            +LH    + +V+RD+K  NI+ D D ++K+ DFG+    ++ LG  +T    GT  Y+A
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNXFCGTPDYIA 186
Query: 370 PEYI 373
           PE +
Sbjct: 187 PEIL 190

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  K  KN    E++   +L H N++
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMRKLDHCNIV 155
Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASA 309
           +L    +  GE        LV +++P         +S+     P+ +   Y     L  +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--LFRS 213
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGY 367
           L Y+H      + HRDIK  N++ D D  V KL DFG A  LV  E  P  + +     Y
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-Y 267
Query: 368 MAPEYI 373
            APE I
Sbjct: 268 RAPELI 273

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 202 RKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +K+G+G FG   + IL+          +    ISR     + E   EV   + ++H N++
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST----GTPLTWTTRYKISLGLASALLY 312
           Q      + G   +V ++   G L   + ++K         L W  +      +  AL +
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLALKH 140
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +H+   R ++HRDIK  NI    D  V+LGDFG+A +++  +        GT  Y++PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPE 195

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 10/173 (5%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           +LG G FG V+R +          K I+      K     E+   +QL H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            D+ E +L+ EF+  G L F   + +           Y         L ++HE     +V
Sbjct: 118 EDKYEMVLILEFLSGGEL-FDRIAAEDYKMSEAEVINY--MRQACEGLKHMHE---HSIV 171
Query: 323 HRDIKFSNIMPDTD--FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H DIK  NIM +T    +VK+ DFGLA  ++ +   + T    T  + APE +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIV 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIG 260
           +G G +G+V   I       VA+KK+SR  +     K  Y  E+     ++H N++ L+ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 261 LCHDRGEFMLVYEF---MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +          Y+F   MP    D     +K  G   +      +   +   L Y+H   
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDL----QKIMGLKFSEEKIQYLVYQMLKGLKYIHSA- 145
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
              VVHRD+K  N+  + D  +K+ DFGLA   D E+    TG   T  Y APE I
Sbjct: 146 --GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVI 195

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIG 260
           +G G +G+V   I       VA+KK+SR  +     K  Y  E+     ++H N++ L+ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 108
Query: 261 LCHDRGEFMLVYEF---MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +          Y+F   MP    D     +K  G   +      +   +   L Y+H   
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDL----QKIMGMEFSEEKIQYLVYQMLKGLKYIHSA- 163
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
              VVHRD+K  N+  + D  +K+ DFGLA   D E+    TG   T  Y APE I
Sbjct: 164 --GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVI 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 79  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 131
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 132 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 137
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 138 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
           ++N+  + +LG+G F  V R +     +  A K I+      ++  +   E + C +L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L     +     LV++ +  G L   + +++            +I   +A    Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----Y 120
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            H      +VHR++K  N++  +      VKL DFGLA+ V+        G AGT GY++
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 175
Query: 370 PEYI 373
           PE +
Sbjct: 176 PEVL 179

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 137
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 138 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 45/245 (18%)
Query: 203 KLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +LG+G FG+V    Y  +  +    VAVK++       + ++  E++    L    +++ 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 259 IGLCHDRG--EFMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            G+ +  G  E  LV E++P+G L DF                R++  L  +  LLY  +
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDF--------------LQRHRARLDASRLLLYSSQ 119
Query: 316 EWK--------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT--L 365
             K        RCV HRD+   NI+ +++ +VK+ DFGLA L+  +         G   +
Sbjct: 120 ICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 366 GYMAPEYISTGRARLDVNFDEQQTDC----LMIVGLWCAHPDRNCRPSIRQAIQVLNFET 421
            + APE +S        N   +Q+D     +++  L+  + D++C PS  + ++++  E 
Sbjct: 179 FWYAPESLSD-------NIFSRQSDVWSFGVVLYELF-TYCDKSCSPSA-EFLRMMGCER 229
Query: 422 KMPNL 426
            +P L
Sbjct: 230 DVPAL 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
           ++N+  + +LG+G F  V R +     +  A K I+      ++  +   E + C +L+H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L     +     LV++ +  G L   + +++            +I   +A    Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----Y 119
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            H      +VHR++K  N++  +      VKL DFGLA+ V+        G AGT GY++
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 174
Query: 370 PEYI 373
           PE +
Sbjct: 175 PEVL 178

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
             +    K+G+G +G VY+         VA+K+I    +     +  I E+    +L H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++ LI + H      LV+EFM        +  +  TG   +    Y   L    A  + 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLK--KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      ++HRD+K  N++ ++D  +KL DFGLA      +   T  +  TL Y AP+ +
Sbjct: 138 HR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 374 STGRARLDVNFDEQQTDCL---MIVG 396
             G  +   + D     C+   MI G
Sbjct: 192 -MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 196 NNFSNERKLGQGGFG--AVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRH 252
            +F   + LG+G F    + R +      A+ + +    +K  K  Y+T E    S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRF-YTAEIVSALEY 145
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 372 YISTGRA 378
            ++   A
Sbjct: 203 LLTEKSA 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
           ++N+  + +LG+G F  V R +     +  A K I+      ++  +   E + C +L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L     +     LV++ +  G L   + +++            +I   +A    Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----Y 120
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            H      +VHR++K  N++  +      VKL DFGLA+ V+        G AGT GY++
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 175
Query: 370 PEYI 373
           PE +
Sbjct: 176 PEVL 179

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 75  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 127
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 128 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 75  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 127
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 128 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 5/142 (3%)
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLF--SKKSTGT 292
           K   ++EV    +L+H N+++      DR      +V E+   G L   +   +K+    
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
              +  R    L LA    +   +    V+HRD+K +N+  D   NVKLGDFGLA +++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 353 ELGPRTTGLAGTLGYMAPEYIS 374
           +     T   GT  YM+PE ++
Sbjct: 169 DTSFAKT-FVGTPYYMSPEQMN 189

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
           ++N+  + +LG+G F  V R +     +  A K I+      ++  +   E + C +L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++L     +     LV++ +  G L   + +++            +I   +A    Y
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----Y 143
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            H      +VHR++K  N++  +      VKL DFGLA+ V+        G AGT GY++
Sbjct: 144 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 198
Query: 370 PEYI 373
           PE +
Sbjct: 199 PEVL 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHR 253
             +    K+G+G +G VY+         VA+K+I    +     +  I E+    +L H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++ LI + H      LV+EFM        +  +  TG   +    Y   L    A  + 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLK--KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H      ++HRD+K  N++ ++D  +KL DFGLA      +   T  +  TL Y AP+ +
Sbjct: 138 HR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 374 STGRARLDVNFDEQQTDCL---MIVG 396
             G  +   + D     C+   MI G
Sbjct: 192 -MGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKISR-GLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 207 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 264 NGRLPVKWMAPEAL 277

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 79  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 131
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 132 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N   +G G +G+V           VAVKK+SR  +   H K  Y  E++    ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 82
Query: 255 LLQLIGL---CHDRGEFMLVY--EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++ L+ +        EF  VY    +    L+  +  +K T   + +   Y+I  GL   
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK-- 139
Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
             Y+H      ++HRD+K SN+  + D  +K+ DF LA   D E+    TG   T  Y A
Sbjct: 140 --YIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM----TGYVATRWYRA 190
Query: 370 PEYI 373
           PE +
Sbjct: 191 PEIM 194

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 9/172 (5%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC 262
           K+G+G  G V           VAVK +    +  +     EV      +H N++++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
               E  ++ EF+  G+L     +   +   L       +   +  AL YLH +    V+
Sbjct: 112 LVGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           HRDIK  +I+   D  VKL DFG    +  ++ P+   L GT  +MAPE IS
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKXLVGTPYWMAPEVIS 214

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 22/159 (13%)
Query: 202 RKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKNEY--ITE-VKTCSQLRHRN 254
           + LG G FG V++G+ I     + + V +K I    K G+  +  +T+ +     L H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP---LTWTTRYKISLGLASALL 311
           +++L+GLC       LV +++P GSL  H+   +    P   L W  +      +A  + 
Sbjct: 95  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           YL E     +VHR++   N++  +   V++ DFG+A L+
Sbjct: 148 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 183

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 203 KLGQGGFGAVYRG---ILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLL 256
           KLG G FG V RG         ++VAVK +   +       +++I EV     L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGLASALLYLHE 315
           +L G+        +V E  P GSL   L  +K  G  L  T +RY + +  A  + YL  
Sbjct: 75  RLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV--AEGMGYL-- 127
Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
           E KR  +HRD+   N++  T   VK+GDFGL
Sbjct: 128 ESKR-FIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 202 RKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLL 256
           + LG G FG VY+GI I    ++ + VA+K +        N E + E    + +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYL 313
           +L+G+C       LV + MP G L  H+   +    +   L W  +      +A  + YL
Sbjct: 83  RLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYL 135
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            +     +VHRD+   N++  +  +VK+ DFGLA L+D
Sbjct: 136 EDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 170

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G     LF +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYI 373
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           K+G+G +G VY+    +     A+KKI   +  +   +  I E+    +L+H N+++L  
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           + H +   +LV+E +     D         G  L   T     L L + + Y H+   R 
Sbjct: 68  VIHTKKRLVLVFEHLDQ---DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARL 380
           V+HRD+K  N++ + +  +K+ DFGLA      +   T  +  TL Y AP+ +  G  + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD-VLMGSKKY 178
Query: 381 DVNFDEQQTDCL 392
               D     C+
Sbjct: 179 STTIDIWSVGCI 190

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+   + L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 24/143 (16%)
Query: 4   IPSNSPGGFLGLFNSTTA-KLSSSPIVLVEFDSF---SNPEWDPINVKDDVGXXXXXXXX 59
           IPS S GG LGLFN  TA   S++ ++ VEFD+F   ++  WDP N +  +G        
Sbjct: 108 IPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDP-NYQ-HIGIDVNSIRS 165
Query: 60  XXYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN--------------- 104
               RW      G T +V + YN +T+ +    +Y +  +Y   +               
Sbjct: 166 SKVVRWER--REGKTLNVLVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVG 223
Query: 105 -TTSTGRYTERHVLKSWEFNSTL 126
            + ++G   + H L+SW F STL
Sbjct: 224 FSAASGEQFQTHNLESWSFTSTL 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 150 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 207 NGRLPVKWMAPEAL 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQLIG 260
           LG+G FG V            A+K + + +    ++    + E +  + L     L  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 261 LCH---DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            C    DR  F  V E++  G L +H+        P       +IS+GL     +LH   
Sbjct: 87  SCFQTVDRLYF--VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGL----FFLH--- 137
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL-GPRTTGLAGTLGYMAPEYIS 374
           KR +++RD+K  N+M D++ ++K+ DFG+    +H + G  T    GT  Y+APE I+
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMMDGVTTREFCGTPDYIAPEIIA 193

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCS 248
           ++A     F+   ++G+G FG V++GI       VA+K I       + E I  E+   S
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGS-LDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           Q     + +  G      +  ++ E++  GS LD           P        +   + 
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDL------LRAGPFDEFQIATMLKEIL 130
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLG 366
             L YLH E K   +HRDIK +N++     +VKL DFG+A  L D ++   T    GT  
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPF 185
Query: 367 YMAPEYI 373
           +MAPE I
Sbjct: 186 WMAPEVI 192

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G     LF +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYI 373
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 148 SCTYQLARGMEYLASQ--KC-IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 205 NGRLPVKWMAPEAL 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +++ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL----- 250
            +F   R +G+G +  V    L   +   A+K + + L +  +E I  V+T   +     
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQAS 78
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L+ L            V E++  G L FH+  ++    P      Y   + LA  L
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--L 134
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLHE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+AP
Sbjct: 135 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSXFCGTPNYIAP 190
Query: 371 EYI 373
           E +
Sbjct: 191 EIL 193

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +    TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 30/201 (14%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE-----YITEVKTCSQ 249
            + +    K+GQG FG V++         VA+KK+   L   + E      + E+K    
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 250 LRHRNLLQLIGLCHDRGE--------FMLVYEFMPN--GSLDFHLFSKKSTGTPLTWTTR 299
           L+H N++ LI +C  +            LV++F  +    L  ++  K       T +  
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK------FTLSEI 127
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL---LVDHELGP 356
            ++   L + L Y+H   +  ++HRD+K +N++   D  +KL DFGLA    L  +    
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 357 RTTGLAGTLGYMAPEYISTGR 377
           R      TL Y  PE +   R
Sbjct: 185 RYXNRVVTLWYRPPELLLGER 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++ E+   G+L  +L +++  G              +T+    
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 153 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 210 NGRLPVKWMAPEAL 223

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIG 260
           R L +GGF  VY    +      A+K++    +      I EV    +L  H N++Q   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 261 LCH--------DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
                       + EF+L+ E      ++F    K  +  PL+  T  KI      A+ +
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEF--LKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
           +H + K  ++HRD+K  N++      +KL DFG A  + H
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQLIG 260
           LG G FG V  G        VAVK ++R      +   +   E++     RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +     +F +V E++  G L F    K      +     ++  L   SA+ Y H   +  
Sbjct: 79  VISTPTDFFMVMEYVSGGEL-FDYICKHGRVEEMEARRLFQQIL---SAVDYCH---RHM 131
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           VVHRD+K  N++ D   N K+ DFGL+ ++      RT+   G+  Y APE IS
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 196 NNFSNERKLGQGGFGAVY---RGILIDLNMAVAVKKISRGLKHGKNEYITEVK--TCSQL 250
           ++F   + LGQG FG V+   +    D     A+K + +     ++   T+++    + +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  +++L       G+  L+ +F+  G L F   SK+         T   +   LA   
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDL-FTRLSKE------VMFTEEDVKFYLAELA 140
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMA 369
           L L       +++RD+K  NI+ D + ++KL DFGL+   +DHE   +     GT+ YMA
Sbjct: 141 LGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE--KKAYSFCGTVEYMA 198
Query: 370 PEYIS 374
           PE ++
Sbjct: 199 PEVVN 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 22/159 (13%)
Query: 202 RKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLKHGKNEY--ITE-VKTCSQLRHRN 254
           + LG G FG V++G+ I     + + V +K I    K G+  +  +T+ +     L H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP---LTWTTRYKISLGLASALL 311
           +++L+GLC       LV +++P GSL  H+   +    P   L W  +      +A  + 
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
           YL E     +VHR++   N++  +   V++ DFG+A L+
Sbjct: 130 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 5/142 (3%)
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLF--SKKSTGT 292
           K   ++EV    +L+H N+++      DR      +V E+   G L   +   +K+    
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
              +  R    L LA    +   +    V+HRD+K +N+  D   NVKLGDFGLA +++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 353 ELGPRTTGLAGTLGYMAPEYIS 374
           +         GT  YM+PE ++
Sbjct: 169 DTS-FAKAFVGTPYYMSPEQMN 189

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL----- 250
            +F   R +G+G +  V    L   +   A+K + + L +  +E I  V+T   +     
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQAS 63
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L+ L            V E++  G L FH+  ++    P      Y   + LA  L
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--L 119
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLHE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+AP
Sbjct: 120 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSXFCGTPNYIAP 175
Query: 371 EYI 373
           E +
Sbjct: 176 EIL 178

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           K+G+G +G VY+    +     A+KKI   +  +   +  I E+    +L+H N+++L  
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           + H +   +LV+E +     D         G  L   T     L L + + Y H+   R 
Sbjct: 68  VIHTKKRLVLVFEHLDQ---DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARL 380
           V+HRD+K  N++ + +  +K+ DFGLA      +   T  +  TL Y AP+ +  G  + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPD-VLMGSKKY 178
Query: 381 DVNFDEQQTDCL 392
               D     C+
Sbjct: 179 STTIDIWSVGCI 190

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           K+G+G +G VY+    +     A+KKI   +  +   +  I E+    +L+H N+++L  
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           + H +   +LV+E +     D         G  L   T     L L + + Y H+   R 
Sbjct: 68  VIHTKKRLVLVFEHLDQ---DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARL 380
           V+HRD+K  N++ + +  +K+ DFGLA      +   T  +  TL Y AP+ +  G  + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPD-VLMGSKKY 178
Query: 381 DVNFDEQQTDCL 392
               D     C+
Sbjct: 179 STTIDIWSVGCI 190

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL----- 250
            +F   R +G+G +  V    L   +   A+K + + L +  +E I  V+T   +     
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQAS 67
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L+ L            V E++  G L FH+  ++    P      Y   + LA  L
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--L 123
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLHE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+AP
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSXFCGTPNYIAP 179
Query: 371 EYI 373
           E +
Sbjct: 180 EIL 182

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 30/202 (14%)
Query: 197 NFSNERKLGQGGFGAVY--RGILIDLNMAVA-VKKISRGLKHGKNEYITEVKTCSQLRHR 253
           +F   + LG+GGFG V+  +  + D N A+  ++  +R L   + + + EVK  ++L H 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHP 63
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----------FSKKSTGTPLTWTTRYKI 302
            +++      ++     +    P   L   +            + + T      +    I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE------LGP 356
            L +A A+ +LH    + ++HRD+K SNI    D  VK+GDFGL   +D +      L P
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 357 -----RTTGLAGTLGYMAPEYI 373
                R TG  GT  YM+PE I
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQI 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYI 373
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYI 373
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 9/172 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYI 373
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 20/232 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILID------LNMAVAVKKISRGLKHGKNEYI-TEVKTCS 248
            NF   + LG G +G V+    I       L     +KK +   K    E+  TE +   
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 249 QLRHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            +R    L  +        +  L+ +++  G L  HL  ++         T +++ + + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-------TEHEVQIYVG 166
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             +L L    K  +++RDIK  NI+ D++ +V L DFGL+     +   R     GT+ Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP-----DRNCRPSIRQAI 414
           MAP+ +  G +  D   D      LM   L  A P     ++N +  I + I
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G +G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQL 258
            E  LG+G    V   I +  +   AVK I +   H ++    EV+   Q + HRN+L+L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           I    +   F LV+E M  GS+  H+  ++             +   +ASAL +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLH---N 129
Query: 319 RCVVHRDIKFSNIM---PDTDFNVKLGDF--GLALLVDHELGPRTT----GLAGTLGYMA 369
           + + HRD+K  NI+   P+    VK+ DF  G  + ++ +  P +T       G+  YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 370 PEYIST 375
           PE +  
Sbjct: 190 PEVVEA 195

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 203 KLGQGGFGAVYRGI--LIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLI 259
           +LG G FG+V +G+  +    + VA+K + +G  K    E + E +   QL +  +++LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLASALLYLHEEW 317
           G+C      MLV E    G L   L  K+    P++      +++S+G+     YL E  
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMK----YLEE-- 454
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG--TLGYMAPEYIS 374
            +  VHR++   N++       K+ DFGL+  +  +    T   AG   L + APE I+
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+L
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 209 PVKWMPPEAFMEG 221

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 191 LASATNNFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKI-----SRGLKHGKNEYITEV 244
           L  A   +    ++G+G +G V++   L +    VA+K++       G+       +  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 245 KTCSQLRHRNLLQLIGLCH----DR-GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           +      H N+++L  +C     DR  +  LV+E + +  L  +L      G P T T +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP-TETIK 123
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
             +   L   L +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++    T
Sbjct: 124 -DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LT 177
Query: 360 GLAGTLGYMAPEYI 373
            +  TL Y APE +
Sbjct: 178 SVVVTLWYRAPEVL 191

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 29/178 (16%)
Query: 196 NNFSNERKLGQGGFGAVYR----GIL-IDLNMAVAVKKI-SRGLKHGKNEYITEVKTCSQ 249
           NN    R +G+G FG V++    G+L  +    VAVK +        + ++  E    ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK-------------------ST 290
             + N+++L+G+C       L++E+M  G L+  L S                     S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 291 GTP-LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           G P L+   +  I+  +A+ + YL E   R  VHRD+   N +   +  VK+ DFGL+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 221

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 14/198 (7%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKN 238
           A P  F        +  +   +KLG G +G V   R  +  +  A+ + + +       +
Sbjct: 22  ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS 81
Query: 239 EYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
           + + EV     L H N+++L     D+  + LV E    G     LF +           
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVD 137
Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELG 355
              I   + S + YLH   K  +VHRD+K  N++    + D  +K+ DFGL+ + +++  
Sbjct: 138 AAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192
Query: 356 PRTTGLAGTLGYMAPEYI 373
            +     GT  Y+APE +
Sbjct: 193 KKMKERLGTAYYIAPEVL 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL----- 250
            +F   R +G+G +  V    L   +   A++ + + L +  +E I  V+T   +     
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQAS 110
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  L+ L            V E++  G L FH+  ++    P      Y   + LA  L
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--L 166
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            YLHE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+AP
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSTFCGTPNYIAP 222
Query: 371 EYI 373
           E +
Sbjct: 223 EIL 225

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 3   QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXY 62
           +IPS S G  LGLF S+    S + +V VEFD++ N +    N +  +G           
Sbjct: 98  KIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYR-HIGIDVNSIRSKAA 156
Query: 63  TRWNASFHSGDTAHVKIKYNSATKNLSASWSYGET---------------PKYSQEN-TT 106
           ++W+  + +G TA   I YNSA+K LS   SY  +               P + +   + 
Sbjct: 157 SKWD--WQNGKTATAHISYNSASKRLSVVSSYPNSSPVVVSFDVELNNVXPXWVRVGFSA 214
Query: 107 STGRYTERHVLKSWEFNSTL 126
           +TG+YT+ + + +W F S+L
Sbjct: 215 TTGQYTQTNNILAWSFRSSL 234

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+L
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 223 PVKWMPPEAFMEG 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 11/190 (5%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKT 246
           +DL     ++   + +G+G FG V            A+K +S+   +K   + +  E + 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 247 CSQLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
                +   ++QL     D     +V E+MP G L  +L S  +   P  W   Y     
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYT---- 174
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
            A  +L L        +HRD+K  N++ D   ++KL DFG  + ++ E   R     GT 
Sbjct: 175 -AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 366 GYMAPEYIST 375
            Y++PE + +
Sbjct: 234 DYISPEVLKS 243

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 191 LASATNNFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKI-----SRGLKHGKNEYITEV 244
           L  A   +    ++G+G +G V++   L +    VA+K++       G+       +  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 245 KTCSQLRHRNLLQLIGLCH----DR-GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           +      H N+++L  +C     DR  +  LV+E + +  L  +L      G P T T +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP-TETIK 123
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
             +   L   L +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++    T
Sbjct: 124 -DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LT 177
Query: 360 GLAGTLGYMAPEYI 373
            +  TL Y APE +
Sbjct: 178 SVVVTLWYRAPEVL 191

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++  +   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 11/190 (5%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKT 246
           +DL     ++   + +G+G FG V            A+K +S+   +K   + +  E + 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 247 CSQLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
                +   ++QL     D     +V E+MP G L  +L S  +   P  W   Y     
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYT---- 179
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
            A  +L L        +HRD+K  N++ D   ++KL DFG  + ++ E   R     GT 
Sbjct: 180 -AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 366 GYMAPEYIST 375
            Y++PE + +
Sbjct: 239 DYISPEVLKS 248

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN-EYITEVKTCSQLRHRNLLQLIGL 261
           KLG+G +  VY+G     +  VA+K+I    + G     I EV     L+H N++ L  +
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
            H      LV+E++ +  L  +L      G  +           L   L Y H   ++ V
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +HRD+K  N++ +    +KL DFGLA
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLA 147

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 5/142 (3%)
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLF--SKKSTGT 292
           K   ++EV    +L+H N+++      DR      +V E+   G L   +   +K+    
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
              +  R    L LA    +   +    V+HRD+K +N+  D   NVKLGDFGLA +++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 353 ELGPRTTGLAGTLGYMAPEYIS 374
           +         GT  YM+PE ++
Sbjct: 169 D-EDFAKEFVGTPYYMSPEQMN 189

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 191 LASATNNFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKI-----SRGLKHGKNEYITEV 244
           L  A   +    ++G+G +G V++   L +    VA+K++       G+       +  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 245 KTCSQLRHRNLLQLIGLCH----DR-GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           +      H N+++L  +C     DR  +  LV+E + +  L  +L      G P T T +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP-TETIK 123
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
             +   L   L +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++    T
Sbjct: 124 -DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LT 177
Query: 360 GLAGTLGYMAPEYI 373
            +  TL Y APE +
Sbjct: 178 SVVVTLWYRAPEVL 191

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 11/190 (5%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKT 246
           +DL     ++   + +G+G FG V            A+K +S+   +K   + +  E + 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 247 CSQLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
                +   ++QL     D     +V E+MP G L  +L S  +   P  W   Y     
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYT---- 179
Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
            A  +L L        +HRD+K  N++ D   ++KL DFG  + ++ E   R     GT 
Sbjct: 180 -AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 366 GYMAPEYIST 375
            Y++PE + +
Sbjct: 239 DYISPEVLKS 248

>pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FN       ++  V VEFD+F N  WDP N K  +G             WN   
Sbjct: 99  GGYLGVFNGKDYD-KTAQTVAVEFDTFYNAAWDPSNGKRHIGIDVNTIKSISTKSWN--L 155
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ AHV I +N+ T  LS +  Y
Sbjct: 156 QNGEEAHVAISFNATTNVLSVTLLY 180

>pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      +S  V VEFD+F N  WDP N +  +G             WN   
Sbjct: 98  GGYLGVFNSKEYD-KTSQTVAVEFDTFYNAAWDPSNKERHIGIDVNSIKSVNTKSWN--L 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A+V I +N+AT  L+ + +Y
Sbjct: 155 QNGERANVVIAFNAATNVLTVTLTY 179

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 49/247 (19%)
Query: 203 KLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +LG+G FG+V    Y  +  +    VAVK++       + ++  E++    L    +++ 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 259 IGLCHDRGE--FMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            G+ +  G     LV E++P+G L DF                R++  L  +  LLY  +
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDF--------------LQRHRARLDASRLLLYSSQ 122
Query: 316 EWK--------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV----DHELGPRTTGLAG 363
             K        RCV HRD+   NI+ +++ +VK+ DFGLA L+    D+ +  R  G + 
Sbjct: 123 ICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSP 180
Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTDC----LMIVGLWCAHPDRNCRPSIRQAIQVLNF 419
              Y APE +S        N   +Q+D     +++  L+  + D++C PS  + ++++  
Sbjct: 181 IFWY-APESLSD-------NIFSRQSDVWSFGVVLYELF-TYCDKSCSPSA-EFLRMMGS 230
Query: 420 ETKMPNL 426
           E  +P L
Sbjct: 231 ERDVPAL 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 49/247 (19%)
Query: 203 KLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +LG+G FG+V    Y  +  +    VAVK++       + ++  E++    L    +++ 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 259 IGLCHDRGE--FMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            G+ +  G     LV E++P+G L DF                R++  L  +  LLY  +
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDF--------------LQRHRARLDASRLLLYSSQ 123
Query: 316 EWK--------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV----DHELGPRTTGLAG 363
             K        RCV HRD+   NI+ +++ +VK+ DFGLA L+    D+ +  R  G + 
Sbjct: 124 ICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSP 181
Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTDC----LMIVGLWCAHPDRNCRPSIRQAIQVLNF 419
              Y APE +S        N   +Q+D     +++  L+  + D++C PS  + ++++  
Sbjct: 182 IFWY-APESLSD-------NIFSRQSDVWSFGVVLYELF-TYCDKSCSPSA-EFLRMMGC 231
Query: 420 ETKMPNL 426
           E  +P L
Sbjct: 232 ERDVPAL 238

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 12/174 (6%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQLIG 260
           LG G FG V  G        VAVK ++R      +   +   E++     RH ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +     +  +V E++  G L    F        L      ++   + S + Y H   +  
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---RHM 136
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           VVHRD+K  N++ D   N K+ DFGL+ ++    G       G+  Y APE IS
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPEVIS 188

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 49/247 (19%)
Query: 203 KLGQGGFGAV----YRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +LG+G FG+V    Y  +  +    VAVK++       + ++  E++    L    +++ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 259 IGLCHDRGE--FMLVYEFMPNGSL-DFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            G+ +  G     LV E++P+G L DF                R++  L  +  LLY  +
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDF--------------LQRHRARLDASRLLLYSSQ 135
Query: 316 EWK--------RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV----DHELGPRTTGLAG 363
             K        RCV HRD+   NI+ +++ +VK+ DFGLA L+    D+ +  R  G + 
Sbjct: 136 ICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSP 193
Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTDC----LMIVGLWCAHPDRNCRPSIRQAIQVLNF 419
              Y APE +S        N   +Q+D     +++  L+  + D++C PS  + ++++  
Sbjct: 194 IFWY-APESLSD-------NIFSRQSDVWSFGVVLYELF-TYCDKSCSPSA-EFLRMMGC 243
Query: 420 ETKMPNL 426
           E  +P L
Sbjct: 244 ERDVPAL 250

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQLIG 260
           LG G FG V  G        VAVK ++R      +   +   E++     RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +     +F +V E++  G L F    K      +     ++  L   SA+ Y H   +  
Sbjct: 79  VISTPTDFFMVMEYVSGGEL-FDYICKHGRVEEMEARRLFQQIL---SAVDYCH---RHM 131
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           VVHRD+K  N++ D   N K+ DFGL+ ++    G       G+  Y APE IS
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRDSCGSPNYAAPEVIS 183

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 10/149 (6%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRHRNLLQLIGL 261
           +G G +G V           VA+KKI        N   T  E+K     +H N++ +  +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 262 CHDR---GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
                  GEF  VY  +     D H     S   PLT          L   L Y+H    
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ- 179
Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             V+HRD+K SN++ + +  +K+GDFG+A
Sbjct: 180 --VIHRDLKPSNLLVNENCELKIGDFGMA 206

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 202 RKLGQGGFGAVYRGILIDLN-------MAVAVKKI-SRGLKHGKNEYITEVKTCSQL-RH 252
           + LG+G FG V     + ++       + VAVK +     +   ++ ++E++    + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LTWTTRY 300
           +N++ L+G C   G   ++  +   G+L  +L +++  G              +T+    
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH-ELGPRTT 359
             +  LA  + YL  +  +C +HRD+   N++   +  +K+ DFGLA  +++ +   +TT
Sbjct: 161 SCTYQLARGMEYLASQ--KC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 360 GLAGTLGYMAPEYI 373
                + +MAPE +
Sbjct: 218 NGRLPVKWMAPEAL 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 44/210 (20%)
Query: 197 NFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +F     +G GGFG V++    ID    V      R +K+   +   EVK  ++L H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVI-----RRVKYNNEKAEREVKALAKLDHVNI 67
Query: 256 LQLIGLCHDRGEF------------------------------MLVYEFMPNGSLDFHLF 285
           +   G C D  ++                               +  EF   G+L+   +
Sbjct: 68  VHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE--QW 124
Query: 286 SKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG 345
            +K  G  L      ++   +   + Y+H    + ++HRD+K SNI       VK+GDFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 346 LALLVDHELGPRTTGLAGTLGYMAPEYIST 375
           L   + ++ G RT    GTL YM+PE IS+
Sbjct: 182 LVTSLKND-GKRTRS-KGTLRYMSPEQISS 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNE-YITEVKTCSQL 250
           N    + LG G FG V       ++     + VAVK +       + E  ++E+K  +QL
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 251 -RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP---------------- 293
             H N++ L+G C   G   L++E+   G L  +L SK+   +                 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 294 ---LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
              LT+      +  +A  + +L  E+K C VHRD+   N++      VK+ DFGLA  +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFL--EFKSC-VHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 351 DHELGPRTTGLAGT-LGYMAPEYISTG 376
             +      G A   + +MAPE +  G
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEG 249

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 12/191 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRN 254
           +++  +  +G G    V           VA+K+I+    +   +E + E++  SQ  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGS-LDF--HLFSK-KSTGTPLTWTTRYKISLGLASAL 310
           ++        + E  LV + +  GS LD   H+ +K +     L  +T   I   +   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV----DHELGPRTTGLAGTLG 366
            YLH   K   +HRD+K  NI+   D +V++ DFG++  +    D           GT  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 367 YMAPEYISTGR 377
           +MAPE +   R
Sbjct: 192 WMAPEVMEQVR 202

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 209 PVKWMPPEAFMEG 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 36/204 (17%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL-- 261
           +G+G +G V+RG+    ++AV +   SR  +    E  TE+     LRH N+L  I    
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFS-SRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 262 --CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-- 317
              +   +  L+  +  +GSL  + F ++ T  P       ++++  A  L +LH E   
Sbjct: 73  TSRNSSTQLWLITHYHEHGSL--YDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFG 127
Query: 318 ---KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL-----AGTLGYMA 369
              K  + HRD K  N++  ++    + D GLA++  H  G     +      GT  YMA
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM--HSQGSDYLDIGNNPRVGTKRYMA 185
Query: 370 PEYISTGRARLDVNFDEQ-QTDCL 392
           PE +           DEQ +TDC 
Sbjct: 186 PEVL-----------DEQIRTDCF 198

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++ E  +G+G +G V   +     +  A KKI +      + +  E++    L H N+++
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L     D  +  LV E    G     LF +         +   +I   + SA+ Y H   
Sbjct: 88  LYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 318 KRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           K  V HRD+K  N +     PD+   +KL DFGLA     + G       GT  Y++P+ 
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQV 196
Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           +           DE     +M V L C +P
Sbjct: 197 LE---GLYGPECDEWSAGVMMYV-LLCGYP 222

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 151 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 208 PVKWMPPEAFMEG 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 209 PVKWMPPEAFMEG 221

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 10/149 (6%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRHRNLLQLIGL 261
           +G G +G V           VA+KKI        N   T  E+K     +H N++ +  +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 262 CHDR---GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
                  GEF  VY  +     D H     S   PLT          L   L Y+H    
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ- 178
Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             V+HRD+K SN++ + +  +K+GDFG+A
Sbjct: 179 --VIHRDLKPSNLLVNENCELKIGDFGMA 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 9/173 (5%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLIGLC 262
           LG+G  G V   +      AVAVK +         E I  E+     L H N+++  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVV 322
            +     L  E+   G L    F +      +      +    L + ++YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 323 HRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG-LAGTLGYMAPEYIS 374
           HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE + 
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++ E  +G+G +G V   +     +  A KKI +      + +  E++    L H N+++
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L     D  +  LV E    G     LF +         +   +I   + SA+ Y H   
Sbjct: 71  LYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 318 KRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           K  V HRD+K  N +     PD+   +KL DFGLA     + G       GT  Y++P+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQV 179
Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           +           DE     +M V L C +P
Sbjct: 180 LE---GLYGPECDEWSAGVMMYV-LLCGYP 205

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 16/194 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQ 249
            N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGL 306
             H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
           A    YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A 
Sbjct: 157 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 364 -TLGYMAPEYISTG 376
             + +M PE    G
Sbjct: 214 LPVKWMPPEAFMEG 227

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 151 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 208 PVKWMPPEAFMEG 220

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 16/194 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQ 249
            N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGL 306
             H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
           A    YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A 
Sbjct: 142 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 364 -TLGYMAPEYISTG 376
             + +M PE    G
Sbjct: 199 LPVKWMPPEAFMEG 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 12/191 (6%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRN 254
           +++  +  +G G    V           VA+K+I+    +   +E + E++  SQ  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGS-LDF--HLFSK-KSTGTPLTWTTRYKISLGLASAL 310
           ++        + E  LV + +  GS LD   H+ +K +     L  +T   I   +   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV----DHELGPRTTGLAGTLG 366
            YLH   K   +HRD+K  NI+   D +V++ DFG++  +    D           GT  
Sbjct: 130 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 367 YMAPEYISTGR 377
           +MAPE +   R
Sbjct: 187 WMAPEVMEQVR 197

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 16/194 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQ 249
            N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGL 306
             H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
           A    YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A 
Sbjct: 177 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 364 -TLGYMAPEYISTG 376
             + +M PE    G
Sbjct: 234 LPVKWMPPEAFMEG 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 16/194 (8%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQ 249
            N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGL 306
             H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
           A    YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A 
Sbjct: 167 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 364 -TLGYMAPEYISTG 376
             + +M PE    G
Sbjct: 224 LPVKWMPPEAFMEG 237

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 223 PVKWMPPEAFMEG 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +F     +G GGFG V++           +K++    K+   +   EVK  ++L H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67
Query: 257 QLIGLCHDRGEF-----------------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
              G C D  ++                  +  EF   G+L+   + +K  G  L     
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE--QWIEKRRGEKLDKVLA 124
Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
            ++   +   + Y+H    + +++RD+K SNI       VK+GDFGL   + ++ G R  
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRXR 180
Query: 360 GLAGTLGYMAPEYIST 375
              GTL YM+PE IS+
Sbjct: 181 S-KGTLRYMSPEQISS 195

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
               YL E      +HRDI   N +   P      K+GDFG+A
Sbjct: 192 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 16/172 (9%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGKN--EYITE 243
           +D+      F+  R LG+G FG+V    L   +   + VAVK +   +    +  E++ E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 244 VKTCSQLRHRNLLQLIGLC---HDRGEF---MLVYEFMPNGSLDFHLFSKKSTGTP--LT 295
                +  H ++ +L+G+      +G     M++  FM +G L   L + +    P  L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             T  +  + +A  + YL     R  +HRD+   N M   D  V + DFGL+
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 15/164 (9%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQ 249
            N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGL 306
             H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           A    YL E      +HRDI   N +   P      K+GDFG+A
Sbjct: 168 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 208

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 197 NFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQL 250
           N +  R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+ 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLA 307
            H+N+++ IG+        ++ E M  G L   L     + S  + L       ++  +A
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG- 363
               YL E      +HRDI   N +   P      K+GDFG+A  +      R  G A  
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 364 TLGYMAPEYISTG 376
            + +M PE    G
Sbjct: 223 PVKWMPPEAFMEG 235

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++N + +G G FG V++  L++ +  VA+KK+ +  K  KN    E++    ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQD-KRFKNR---ELQIMRIVKHPNVVD 96
Query: 258 LIGLCHDRGE------FMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRYKISLGLASAL 310
           L    +  G+        LV E++P         ++K     P+     Y     L  +L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--LLRSL 154
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNV-KLGDFGLA-LLVDHELGPRTTGLAGTLGYM 368
            Y+H      + HRDIK  N++ D    V KL DFG A +L+  E  P  + +     Y 
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-YR 208
Query: 369 APEYISTGRARLDVNFDEQQTDCLM 393
           APE I  G      N D   T C+M
Sbjct: 209 APELI-FGATNYTTNIDIWSTGCVM 232

>pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      ++  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSAEYD-KTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A+V I +N+AT  L+ S +Y
Sbjct: 155 QNGEEANVVIAFNAATNVLTVSLTY 179

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 58/139 (41%), Gaps = 25/139 (17%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      ++  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSAEYD-KTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY------GETPKYSQENTTS---------------- 107
            +G+ A+V I +N+AT  L+ S +Y       E   Y+  +  S                
Sbjct: 155 QNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSAT 214
Query: 108 TGRYTERHVLKSWEFNSTL 126
           TG     H + SW F+S L
Sbjct: 215 TGAEYAAHEVLSWSFHSEL 233

>pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      ++  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSAEYD-KTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A+V I +N+AT  L+ S +Y
Sbjct: 155 QNGEEANVVIAFNAATNVLTVSLTY 179

>pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      ++  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSAEYD-KTTETVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A+V I +N+AT  L+ S +Y
Sbjct: 155 QNGEEANVVIAFNAATNVLTVSLTY 179

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           + F  ER  GQG FG V  G      M+VA+KK+ +  +  +N  +  ++  + L H N+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNI 81
Query: 256 LQLIGLCHDRGE-------FMLVYEFMPNGSLDFHL----FSKKSTGTPLTWTTRYKISL 304
           +QL    +  GE         +V E++P+     H     + ++    P      +   L
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDT---LHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMP-DTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
             +   L+L       V HRDIK  N++  + D  +KL DFG A     +L P    +A 
Sbjct: 139 IRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSA----KKLSPSEPNVAY 191
Query: 364 TLG--YMAPEYI 373
                Y APE I
Sbjct: 192 ICSRYYRAPELI 203

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 20/166 (12%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-- 252
            ++F     LGQG FG V +      +   A+KKI R  +   +  ++EV   + L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 253 -----------RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
                      RN ++ +     +    +  E+  NG+L + L   ++          ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQ--QRDEYWR 120
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +   +  AL Y+H +    ++HRD+K  NI  D   NVK+GDFGLA
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY 300
           E+    +L H N+++L+ +  D  E    +V+E +  G +      +  T  PL+     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----MEVPTLKPLSEDQAR 140
Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG 360
                L   + YLH +    ++HRDIK SN++   D ++K+ DFG    V +E       
Sbjct: 141 FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG----VSNEFKGSDAL 193
Query: 361 LAGTLG---YMAPEYISTGR 377
           L+ T+G   +MAPE +S  R
Sbjct: 194 LSNTVGTPAFMAPESLSETR 213

>pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      +S  V VEFD+F N  WDP N    +G             W  + 
Sbjct: 98  GGYLGVFNSKDYD-KTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW--AL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G  A+V I +N+AT  L+ S +Y
Sbjct: 155 QNGKEANVVIAFNAATNVLTVSLTY 179

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 66/146 (45%), Gaps = 27/146 (18%)
Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXX 60
           G +  SNS  GFLG+F+S     +S+  V VEFD+FSN +WDP      +G         
Sbjct: 95  GSEPKSNS--GFLGVFDSDVYD-NSAQTVAVEFDTFSNTDWDP--TSRHIGIDVNSIKSI 149
Query: 61  XYTRWNASFHSGDTAHVKIKYNSATKNLSASW-------SY---------GETPKY-SQE 103
               W     +G  A + I YN+AT  L AS        SY          E P+Y S  
Sbjct: 150 RTASWG--LANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIG 207
Query: 104 NTTSTGR---YTERHVLKSWEFNSTL 126
            + +TG    YTE H + SW F S L
Sbjct: 208 FSATTGLSEGYTETHDVLSWSFASKL 233

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GGFLGLF+ + +   +   V VEFD+  N +WDP   +  +G           TRW+  F
Sbjct: 103 GGFLGLFDGSNSNFHT---VAVEFDTLYNKDWDP--TERHIGIDVNSIRSIKTTRWD--F 155
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A V I Y+S+T  L AS  Y
Sbjct: 156 VNGENAEVLITYDSSTNLLVASLVY 180

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 92  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 146
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 92  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 146
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/82 (41%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GGFLGLF+S     SS+  V VEFD+F N  WDP   +  +G           T W+  F
Sbjct: 125 GGFLGLFDSKNYA-SSNQTVAVEFDTFYNGGWDP--TERHIGIDVNSIKSIKTTSWD--F 179
Query: 70  HSGDTAHVKIKYNSATKNLSAS 91
            +G+ A V I Y+S+T  L AS
Sbjct: 180 ANGENAEVLITYDSSTNLLVAS 201

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 11/176 (6%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL---LQLI 259
           +LG+G +G V +   +     +AVK+I R   + + +    +     +R  +    +   
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G     G+  +  E M + SLD         G  +      KI++ +  AL +LH   K 
Sbjct: 117 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 173
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIS 374
            V+HRD+K SN++ +    VK+ DFG++  LVD       T  AG   YMAPE I+
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV---AKTIDAGCKPYMAPERIN 226

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFGLA  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG----RTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + +G G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+MP G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +K+ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 90  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 144
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 145 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
             +    K+G+G +G V++    + +  VA+K++       G+    +  + E+    +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL 58
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +H+N+++L  + H   +  LV+EF      D   +     G  L           L   L
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGD-LDPEIVKSFLFQLLKGL 114
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + H    R V+HRD+K  N++ + +  +KL DFGLA
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLA 148

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + +G G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+MP G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +K+ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GGFLGLF+ + +   +   V VEFD+  N +WDP   +  +G           TRW+  F
Sbjct: 103 GGFLGLFDGSNSNFHT---VAVEFDTLYNKDWDP--TERHIGIDVNSIRSIKTTRWD--F 155
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A V I Y+S+T  L AS  Y
Sbjct: 156 VNGENAEVLITYDSSTNLLVASLVY 180

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQ 249
               +N+  +  +G+G +G VY     + N  VA+KK++R  +        + E+   ++
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 250 LRHRNLLQLIGLC--HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           L+   +++L  L    D  +F  +Y  +     D     KK   TP+  T ++ +   L 
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDL----KKLFKTPIFLTEQH-VKTILY 138
Query: 308 SALL---YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           + LL   ++HE     ++HRD+K +N + + D +VK+ DFGLA
Sbjct: 139 NLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKX 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 126
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 136
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

>pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      +S  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSKDYD-KTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G  A+V I +N+AT  L+ S +Y
Sbjct: 155 QNGKEANVVIAFNAATNVLTVSLTY 179

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 76  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 70  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 124
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 125 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR----------HR 253
           LG+GGFG V+ G  +   + VA+K I R    G +     V    ++           H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            +++L+     +  FMLV E  P  + D  LF   +   PL           + +A+ + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           H    R VVHRDIK  NI+ D      KL DFG   L+  E     T   GT  Y  PE+
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEW 209
Query: 373 IS 374
           IS
Sbjct: 210 IS 211

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKX 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      +S  V VEFD+F N  WDP N    +G             W  + 
Sbjct: 98  GGYLGVFNSKDYD-KTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW--AL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G  A+V I +N AT  L+ S +Y
Sbjct: 155 QNGKEANVVIAFNGATNVLTVSLTY 179

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 76  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 130
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 187

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 65/148 (43%), Gaps = 24/148 (16%)
Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGXXXXXXXX 59
           G +IP NS GG+LG+ +S+    S +  V VEFDS  N  WDP +++   +G        
Sbjct: 90  GTEIPPNSQGGYLGITDSSN---SQNQFVAVEFDSHPN-VWDPKSLRSSHIGIDVNSIMS 145
Query: 60  XXYTRWNASFHSGDTAHVKIKYNSATKNLSASWSY--GETPKYSQE-------------- 103
                WN    SG      I Y+S TK L+   ++  G+    SQE              
Sbjct: 146 LKAVNWNRV--SGSLEKATIIYDSDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVG 203
Query: 104 -NTTSTGRYTERHVLKSWEFNSTLDIKE 130
            + T+     ERH + SW F STL   E
Sbjct: 204 FSATTWNPERERHDIYSWSFTSTLKEPE 231

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 434 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 488
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 489 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 201 ERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   +AV + K        K+E + E     QL +  ++
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +           +++S+G+     YL E 
Sbjct: 435 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK----YLEES 489
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGL--ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL  AL  D       T     + + APE I+
Sbjct: 490 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 546

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   R LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +K+ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +++ +LG+G FG V+R          AVKK+   L+  + E   E+  C+ L    ++ L
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR--LEVFRAE---ELMACAGLTSPRIVPL 150
Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA-SALLYLHEEW 317
            G   +     +  E +  GSL      K+    P      Y   LG A   L YLH   
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLG--QLVKEQGCLPEDRALYY---LGQALEGLEYLH--- 202
Query: 318 KRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHE-LGPR-TTG--LAGTLGYMAPEY 372
            R ++H D+K  N++  +D  +  L DFG A+ +  + LG    TG  + GT  +MAPE 
Sbjct: 203 SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           +  GR+  D   D   + C+M+  L   HP
Sbjct: 263 V-LGRS-CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKV 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++ +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+FNS      +S  V VEFD+F N  WDP N    +G             W    
Sbjct: 98  GGYLGVFNSKDYD-KTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW--KL 154
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G  A+V I +N AT  L+ S +Y
Sbjct: 155 QNGKEANVVIAFNGATNVLTVSLTY 179

>pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 13/125 (10%)
Query: 2   FQIPSNSP----GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPE--WDPINVKDDVGXXXX 55
           F  P +SP    GG+ GLFN T    SS   V VEFD+  +P   WDP      +G    
Sbjct: 92  FLAPPDSPLRRAGGYFGLFNDTKCD-SSYQTVAVEFDTIGSPVNFWDP--GFPHIGIDVN 148
Query: 56  XXXXXXYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGRYTERH 115
                   RWN  +   + A+V+I Y +++K L+AS +Y       Q + + T     + 
Sbjct: 149 CVKSINAERWNKRYGLNNVANVEIIYEASSKTLTASLTYPS----DQTSISVTSIVDLKE 204
Query: 116 VLKSW 120
           +L  W
Sbjct: 205 ILPEW 209

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 12/185 (6%)
Query: 193 SATNNFSNERKLGQGGFGAVY--RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTC--S 248
           +  ++F   + +G+G FG V   R    ++  AV V +    LK  + ++I   +     
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
            ++H  L+ L        +   V +++  G L +HL  ++    P     R+  +  +AS
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARF-YAAEIAS 150
Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           AL YLH      +V+RD+K  NI+ D+  ++ L DFGL    + E    T+   GT  Y+
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC-KENIEHNSTTSTFCGTPEYL 206
Query: 369 APEYI 373
           APE +
Sbjct: 207 APEVL 211

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 40  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 85
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  LV   M  G+  + L   +    
Sbjct: 86  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSN 143
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 144 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 196
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 197 DHDHTGFLTEYVATRWYRAPE 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           +++ +LG+G FG V+R          AVKK+   L+  + E   E+  C+ L    ++ L
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR--LEVFRAE---ELMACAGLTSPRIVPL 131
Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA-SALLYLHEEW 317
            G   +     +  E +  GSL      K+    P      Y   LG A   L YLH   
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLG--QLVKEQGCLPEDRALYY---LGQALEGLEYLH--- 183
Query: 318 KRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHE-LGPR-TTG--LAGTLGYMAPEY 372
            R ++H D+K  N++  +D  +  L DFG A+ +  + LG    TG  + GT  +MAPE 
Sbjct: 184 SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           +  GR+  D   D   + C+M+  L   HP
Sbjct: 244 V-LGRS-CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +++ DFGLA  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKX 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 72
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 133 K----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLA---------RTAGTSFMMT 176
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 177 PYVVTRYYRAPEVI 190

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGK-NEYITEVKTCSQ 249
            N    + LG+G FG V +     L        VAVK +       +  + ++E     Q
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT----------------- 292
           + H ++++L G C   G  +L+ E+   GSL   L   +  G                  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 293 ---PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
               LT       +  ++  + YL E     +VHRD+   NI+      +K+ DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLS 197

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 16/182 (8%)
Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRN 254
           + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     + H+N
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 122
Query: 255 LLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           ++ L+ +   +    EF  VY  M     +     +            Y++  G+     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK---- 178
Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  Y APE
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPE 233
Query: 372 YI 373
            I
Sbjct: 234 VI 235

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 11/188 (5%)
Query: 191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKNEYITEVKTCS 248
           L     ++   + +G+G FG V            A+K +S+   +K   + +  E +   
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 249 QLRHRN-LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
              +   ++QL     D     +V E+MP G L  +L S  +   P  W   Y      A
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMS--NYDVPEKWAKFYT-----A 181
Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             +L L       ++HRD+K  N++ D   ++KL DFG  + +D           GT  Y
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 368 MAPEYIST 375
           ++PE + +
Sbjct: 242 ISPEVLKS 249

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT   AGT  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RT---AGTSF 180
Query: 367 YMAPEYIS 374
            M PE ++
Sbjct: 181 MMTPEVVT 188

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQ 249
               +N+  +  +G+G +G VY     +    VA+KK++R  +        + E+   ++
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 250 LRHRNLLQLIGLC--HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           L+   +++L  L    D  +F  +Y  +     D     KK   TP+  T  + I   L 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDL----KKLFKTPIFLTEEH-IKTILY 136
Query: 308 SALL---YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-------------- 350
           + LL   ++HE     ++HRD+K +N + + D +VK+ DFGLA  +              
Sbjct: 137 NLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 351 DHELGPRTTGLAGTLG-------YMAPEYI 373
           + E GP    L   L        Y APE I
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 196 NNFSNERKLGQGGFGAV-----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQ 249
           N  S  + LG G FG V     Y  I  D  M VAVK +       + E  ++E+K  S 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------DFHLFSKKSTGT------PL 294
           L  H N++ L+G C   G  +++ E+   G L        D  + SK S          L
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L    K C+ HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 159 DLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 355 GPRTTGLAG-TLGYMAPEYI 373
                G A   + +MAPE I
Sbjct: 216 NYVVKGNARLPVKWMAPESI 235

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT   AGT  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RT---AGTSF 180
Query: 367 YMAPEYIS 374
            M PE ++
Sbjct: 181 MMEPEVVT 188

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 196 NNFSNERKLGQGGFGAV-----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQ 249
           N  S  + LG G FG V     Y  I  D  M VAVK +       + E  ++E+K  S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------DFHLFSKKSTGT------PL 294
           L  H N++ L+G C   G  +++ E+   G L        D  + SK S          L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L    K C+ HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 355 GPRTTGLAG-TLGYMAPEYI 373
                G A   + +MAPE I
Sbjct: 223 NYVVKGNARLPVKWMAPESI 242

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 24/171 (14%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           + + + + LG GG G V+  +  D +  VA+KKI           + E+K   +L H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 256 LQL--------------IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
           +++              +G   +     +V E+M          +      PL       
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD------LANVLEQGPLLEEHARL 124
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVD 351
               L   L Y+H      V+HRD+K +N+  +T D  +K+GDFGLA ++D
Sbjct: 125 FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 117
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 178 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 228
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 229 YRAPEVI 235

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKV 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++ +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT   AGT  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RT---AGTSF 180
Query: 367 YMAPEYIS 374
            M PE ++
Sbjct: 181 MMEPEVVT 188

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 190
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 191 YRAPEVI 197

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 73
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 184
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 185 YRAPEVI 191

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 78
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 139 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 189
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 190 YRAPEVI 196

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 80
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 141 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 191
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 192 YRAPEVI 198

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 9/175 (5%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL---LQLI 259
           +LG+G +G V +   +     +AVK+I R   + + +    +     +R  +    +   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G     G+  +  E M + SLD         G  +      KI++ +  AL +LH   K 
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 129
Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            V+HRD+K SN++ +    VK+ DFG++  +  ++       AG   YMAPE I+
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERIN 182

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 80
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 141 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 191
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 192 YRAPEVI 198

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 73
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 184
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 185 YRAPEVI 191

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + +G G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +K+ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L+  VA+KK+SR  +   H K  Y  E+     
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 72
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 133 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 183
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 184 YRAPEVI 190

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKV 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++ +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 196 NNFSNERKLGQGGFGAV-----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQ 249
           N  S  + LG G FG V     Y  I  D  M VAVK +       + E  ++E+K  S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------DFHLFSKKSTGT------PL 294
           L  H N++ L+G C   G  +++ E+   G L        D  + SK S          L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L    K C+ HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 355 GPRTTGLAG-TLGYMAPEYI 373
                G A   + +MAPE I
Sbjct: 223 NYVVKGNARLPVKWMAPESI 242

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI-----SRGLKHGKNEYITEVKTCSQL 250
             +    K+G+G +G V++    + +  VA+K++       G+    +  + E+    +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL 58
Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +H+N+++L  + H   +  LV+EF      D   +     G  L           L   L
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGD-LDPEIVKSFLFQLLKGL 114
Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + H    R V+HRD+K  N++ + +  +KL +FGLA
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLA 148

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 196 NNFSNERKLGQGGFGAV-----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQ 249
           N  S  + LG G FG V     Y  I  D  M VAVK +       + E  ++E+K  S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------DFHLFSKKSTGT------PL 294
           L  H N++ L+G C   G  +++ E+   G L        D  + SK S          L
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L    K C+ HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 161 DLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 355 GPRTTGLAG-TLGYMAPEYI 373
                G A   + +MAPE I
Sbjct: 218 NYVVKGNARLPVKWMAPESI 237

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGK-NEYITEVKTCSQ 249
            N    + LG+G FG V +     L        VAVK +       +  + ++E     Q
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT----------------- 292
           + H ++++L G C   G  +L+ E+   GSL   L   +  G                  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 293 ---PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
               LT       +  ++  + YL E     +VHRD+   NI+      +K+ DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS 197

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 177 LSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG 236
           L+    P  + Y++     +  +++ +LG+G FG V+R          AVKK+   +   
Sbjct: 56  LTEKLKPVDYEYRE---EVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR- 111
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
               + E+  C+ L    ++ L G   +     +  E +  GSL      K+    P   
Sbjct: 112 ----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG--QLIKQMGCLPEDR 165
Query: 297 TTRYKISLGLA-SALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHE- 353
              Y   LG A   L YLH    R ++H D+K  N++  +D +   L DFG AL +  + 
Sbjct: 166 ALYY---LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 219
Query: 354 LGPR-TTG--LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           LG    TG  + GT  +MAPE +  G+   D   D   + C+M+  L   HP
Sbjct: 220 LGKSLLTGDYIPGTETHMAPEVV-MGKP-CDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 72/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L +L     D     +V E+ P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 196 NNFSNERKLGQGGFGAV-----YRGILIDLNMAVAVKKISRGLKHGKNE-YITEVKTCSQ 249
           N  S  + LG G FG V     Y  I  D  M VAVK +       + E  ++E+K  S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------DFHLFSKKSTGT------PL 294
           L  H N++ L+G C   G  +++ E+   G L        D  + SK S          L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L    K C+ HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 355 GPRTTGLAG-TLGYMAPEYI 373
                G A   + +MAPE I
Sbjct: 200 NYVVKGNARLPVKWMAPESI 219

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 29/178 (16%)
Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGK-NEYITEVKTCSQ 249
            N    + LG+G FG V +     L        VAVK +       +  + ++E     Q
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT----------------- 292
           + H ++++L G C   G  +L+ E+   GSL   L   +  G                  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 293 ---PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
               LT       +  ++  + YL E     +VHRD+   NI+      +K+ DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS 197

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 20/166 (12%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-- 252
            ++F     LGQG FG V +      +   A+KKI R  +   +  ++EV   + L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 253 -----------RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
                      RN ++ +     +    +  E+  N +L + L   ++          ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQ--QRDEYWR 120
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +   +  AL Y+H +    ++HRD+K  NI  D   NVK+GDFGLA
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 72/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L +L     D     +V E+ P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 20  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 65
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 123
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 124 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADP 176
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 177 DHDHTGFLTEYVATRWYRAPE 197

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 24/228 (10%)
Query: 177 LSRDAGPRRFSYKDLASAT----NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           +S+     +F   ++A +T      +   + +G G  G V       L + VAVKK+SR 
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 60
Query: 233 LK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFS 286
            +   H K  Y  E+     + H+N++ L+ +   +    EF  VY  M        L  
Sbjct: 61  FQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM-------ELMD 112
Query: 287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
                         ++S  L   L  +       ++HRD+K SNI+  +D  +K+ DFGL
Sbjct: 113 ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 347 ALLVDHELGPRTTGLAGTLGYMAPEYI-STGRARLDVNFDEQQTDCLM 393
           A           T    T  Y APE I   G A    N D     C+M
Sbjct: 173 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYA---ANVDIWSVGCIM 215

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 26/141 (18%)
Query: 236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT 295
           GK  ++T++ +C Q   R                 V E++  G L +H+        P  
Sbjct: 399 GKPPFLTQLHSCFQTMDR--------------LYFVMEYVNGGDLMYHIQQVGRFKEPHA 444
Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHE 353
                +I++GL     +L     + +++RD+K  N+M D++ ++K+ DFG+    + D  
Sbjct: 445 VFYAAEIAIGL----FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 495
Query: 354 LGPRTTGLAGTLGYMAPEYIS 374
            G  T    GT  Y+APE I+
Sbjct: 496 -GVTTKXFCGTPDYIAPEIIA 515

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--GKNEYITEVKTCSQLRHRNLLQLIGL 261
           +G G +G V           VA+KKI R  +        + E+   ++L H ++++++ +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 262 C--HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL--GLASALLYLHEEW 317
               D  +F  +Y  +     DF    KK   TP+  T  +  +L   L   + Y+H   
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDF----KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
              ++HRD+K +N + + D +VK+ DFGLA  VD+
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E+ P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 20  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 65
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 123
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 124 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 176
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 177 DHDHTGFLTEYVATRWYRAPE 197

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 25/137 (18%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG+LG+F+S     +S+  V VEFD+ SN  WDP      +G             W+   
Sbjct: 102 GGYLGVFDSDVYN-NSAQTVAVEFDTLSNSGWDP--SMKHIGIDVNSIKSIATVSWD--L 156
Query: 70  HSGDTAHVKIKYNSATKNLSASW-------SY---------GETPKY-SQENTTSTGR-- 110
            +G+ A + I YN+AT  L AS        SY          E P+Y S   + +TG   
Sbjct: 157 ANGENAEILITYNAATSLLVASLVHPSRRTSYILSERVDITNELPEYVSVGFSATTGLSE 216
Query: 111 -YTERHVLKSWEFNSTL 126
            Y E H + SW F S L
Sbjct: 217 GYIETHDVLSWSFASKL 233

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 20  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 65
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 123
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 124 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 176
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 177 DHDHTGFLTEYVATRWYRAPE 197

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 26/141 (18%)
Query: 236 GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT 295
           GK  ++T++ +C Q   R                 V E++  G L +H+        P  
Sbjct: 78  GKPPFLTQLHSCFQTMDR--------------LYFVMEYVNGGDLMYHIQQVGRFKEPHA 123
Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL--LVDHE 353
                +I++GL     +L     + +++RD+K  N+M D++ ++K+ DFG+    + D  
Sbjct: 124 VFYAAEIAIGL----FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 174
Query: 354 LGPRTTGLAGTLGYMAPEYIS 374
            G  T    GT  Y+APE I+
Sbjct: 175 -GVTTKXFCGTPDYIAPEIIA 194

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 72/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L +L     D     +V E+ P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N+M D    +K+ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 22  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 67
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 68  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 125
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 126 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 178
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 179 DHDHTGFLTEYVATRWYRAPE 199

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--K 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYX 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 181 DHDHTGFLTEYVATRWYRAPE 201

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 26/193 (13%)
Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
           +++G+G +G V+ G      +AV V   +      +    TE+     +RH N+L  I  
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIA- 98
Query: 262 CHDRG-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
              +G     +  L+ ++  NGSL  +L S     T L   +  K++    S L +LH E
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 317 W-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-----DHELGPRTTGLAGTLG 366
                 K  + HRD+K  NI+   +    + D GLA+       + ++ P T    GT  
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VGTKR 211
Query: 367 YMAPEYISTGRAR 379
           YM PE +     R
Sbjct: 212 YMPPEVLDESLNR 224

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKV 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLA---------RTAGTSFMMT 183
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 184 PYVVTRYYRAPEVI 197

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 20  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 65
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 123
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 124 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 176
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 177 DHDHTGFLTEYVATRWYRAPE 197

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 74/187 (39%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    +   + +G G  G V       L + VAVKK+SR  +   H K  Y  E+     
Sbjct: 19  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKC 77
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M        L                ++S  L
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVM-------ELMDANLCQVIHMELDHERMSYLL 130
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
              L  +       ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 131 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF--MMTPYVVTRY 188
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 189 YRAPEVI 195

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 181 DHDHTGFLTEYVATRWYRAPE 201

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 85
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 146 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 194
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 195 PEYLAPEII 203

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 18  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 63
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 64  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 121
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 122 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 174
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 175 DHDHTGFLTEYVATRWYRAPE 195

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 190
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 191 YRAPEVI 197

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 25  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 70
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 71  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 128
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 129 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 181
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 182 DHDHTGFLTEYVATRWYRAPE 202

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 26  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 71
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 72  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 129
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 130 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 182
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 183 DHDHTGFLTEYVATRWYRAPE 203

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 17  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 62
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 63  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 120
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 121 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 173
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 174 DHDHTGFLTEYVATRWYRAPE 194

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 181 DHDHTGFLTEYVATRWYRAPE 201

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 28  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 73
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 74  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 131
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 132 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 184
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+     T    T  Y APE +   + 
Sbjct: 185 DHDHTGFLTEYVATRWYRAPEIMLNSKG 212

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 20  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 65
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 66  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 123
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 124 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 176
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+     T    T  Y APE +   + 
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKG 204

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 18  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 63
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 64  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 121
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 122 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 174
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+     T    T  Y APE +   + 
Sbjct: 175 DHDHTGFLTEYVATRWYRAPEIMLNSKG 202

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 204 LGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           LGQG F  +++G+  ++          V +K + +  ++    +       S+L H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
              G+C    E +LV EF+  GSLD +L  K      + W  + +++  LA+A+ +L E 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAAAMHFLEE- 131
Query: 317 WKRCVVHRDIKFSNIMPDTDFN--------VKLGDFGLALLV 350
               ++H ++   NI+   + +        +KL D G+++ V
Sbjct: 132 --NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 40  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 85
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 86  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 143
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 144 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 196
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 197 DHDHTGFLTEYVATRWYRAPE 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 177 LSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG 236
           L+    P  + Y++     +  +++ ++G+G FG V+R          AVKK+   +   
Sbjct: 58  LTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR- 113
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
               + E+  C+ L    ++ L G   +     +  E +  GSL      K+    P   
Sbjct: 114 ----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG--QLIKQMGCLPEDR 167
Query: 297 TTRYKISLGLA-SALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHE- 353
              Y   LG A   L YLH    R ++H D+K  N++  +D +   L DFG AL +  + 
Sbjct: 168 ALYY---LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 221
Query: 354 LGPR-TTG--LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           LG    TG  + GT  +MAPE +  G+   D   D   + C+M+  L   HP
Sbjct: 222 LGKSLLTGDYIPGTETHMAPEVV-MGKP-CDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 78
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 139 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGT 187
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 188 PEYLAPEII 196

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKIS-RGLKHGKNEYIT 242
           K+++ +   F  E  LG+  FG VY+G L      +   AVA+K +  +     + E+  
Sbjct: 21  KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 78
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSK------------KST 290
           E    ++L+H N++ L+G+        +++ +  +G L   L  +            ++ 
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            + L       +   +A+ + YL       VVH+D+   N++     NVK+ D GL   V
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 351 DHELGPRTTGLAGT----LGYMAPEYISTGRARLD 381
                     L G     + +MAPE I  G+  +D
Sbjct: 196 ---YAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 227

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 177 LSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG 236
           L+    P  + Y++     +  +++ ++G+G FG V+R          AVKK+   +   
Sbjct: 42  LTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR- 97
Query: 237 KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
               + E+  C+ L    ++ L G   +     +  E +  GSL      K+    P   
Sbjct: 98  ----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG--QLIKQMGCLPEDR 151
Query: 297 TTRYKISLGLA-SALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHE- 353
              Y   LG A   L YLH    R ++H D+K  N++  +D +   L DFG AL +  + 
Sbjct: 152 ALYY---LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 354 LGPR-TTG--LAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           LG    TG  + GT  +MAPE +  G+   D   D   + C+M+  L   HP
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVV-MGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 73
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G +  + 
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMT 177
Query: 367 -------YMAPEYI 373
                  Y APE I
Sbjct: 178 PYVVTRYYRAPEVI 191

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 140 K----HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF--MMTPYVVTRY 190
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 191 YRAPEVI 197

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 113
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 174 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGT 222
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 223 PEYLAPEII 231

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 30/194 (15%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 81
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTG------ 360
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA         RT G      
Sbjct: 142 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMV 185
Query: 361 -LAGTLGYMAPEYI 373
               T  Y APE I
Sbjct: 186 PFVVTRYYRAPEVI 199

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 190
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 191 YRAPEVI 197

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 22  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 67
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K     RH N++ +  +          +  +V + M      + L   +    
Sbjct: 68  QRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 125
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 126 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 178
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 179 DHDHTGFLTEYVATRWYRAPE 199

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 84
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 145 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 195
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 196 YRAPEVI 202

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 85
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 146 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGT 194
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 195 PEYLAPEII 203

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKIS-RGLKHGKNEYIT 242
           K+++ +   F  E  LG+  FG VY+G L      +   AVA+K +  +     + E+  
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSK------------KST 290
           E    ++L+H N++ L+G+        +++ +  +G L   L  +            ++ 
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            + L       +   +A+ + YL       VVH+D+   N++     NVK+ D GL   V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 351 DHELGPRTTGLAGT----LGYMAPEYISTGRARLD 381
                     L G     + +MAPE I  G+  +D
Sbjct: 179 ---YAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 74
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 123
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 180
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 181 SPPEWIRYHR 190

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 93
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 154 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 202
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 203 PEYLAPEII 211

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 79
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 190
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 191 YRAPEVI 197

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQ 249
           +    + N + +G G  G V       L   VA+KK+SR  +   H K  Y  E+     
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKC 80
Query: 250 LRHRNLLQLIGLCHDRG---EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           + H+N++ L+ +   +    EF  VY  M     +     +            Y++  G+
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
                +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T    T  
Sbjct: 141 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 191
Query: 367 YMAPEYI 373
           Y APE I
Sbjct: 192 YRAPEVI 198

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 89/219 (40%), Gaps = 51/219 (23%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKIS----RGLKHGKNEYI-TEVKTCSQLRHRNLLQL 258
           +GQG +G V   I        A+K ++    R +     E I TEV+   +L H N+ +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 259 IGLCHDRGEFMLVYEFMPNGSL--DFHLFSKKSTGT------------------------ 292
             +  D     LV E    G L    ++F   STG                         
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 293 ------PLTWTTRYK----ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD--FNVK 340
                  L +  R K    I   + SAL YLH +    + HRDIK  N +  T+  F +K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 341 LGDFGLA----LLVDHELGPRTTGLAGTLGYMAPEYIST 375
           L DFGL+     L + E    TT  AGT  ++APE ++T
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNT 248

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 88
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 89  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 137
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 194
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 195 SPPEWIRYHR 204

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 88
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 89  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 137
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 194
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 195 SPPEWIRYHR 204

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 73
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 74  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 122
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 179
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 180 SPPEWIRYHR 189

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY 240
           A P     K++     +F   + +G+G FG V    + +     A+K ++      K E 
Sbjct: 59  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN------KWEM 112
Query: 241 ITEVKTCSQLRHRNLL-----QLIGLCH----DRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
           +   +T      R++L     Q I   H    D     LV ++   G L   L SK    
Sbjct: 113 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDK 171
Query: 292 TPLTWTTRYKISLGLA-SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            P      Y   + LA  ++  LH       VHRDIK  N++ D + +++L DFG  L +
Sbjct: 172 LPEDMARFYIGEMVLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKM 225
Query: 351 DHELGPRTTGLAGTLGYMAPEYIST 375
           + +   +++   GT  Y++PE +  
Sbjct: 226 NDDGTVQSSVAVGTPDYISPEILQA 250

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 74
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 123
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 180
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 181 SPPEWIRYHR 190

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 74
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 123
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 180
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 181 SPPEWIRYHR 190

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKCQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+     T    T  Y APE +   + 
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKG 208

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 89
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 90  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 138
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 195
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 196 SPPEWIRYHR 205

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYI 241
           P+R  Y    + +++F  +  LG+G +G V           VA+KKI    K       +
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 242 TEVKTCSQLRHRNLLQLIGL-----CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
            E+K     +H N++ +  +       +  E  ++ E M     D H     ST      
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVI--STQMLSDD 112
Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP 356
             +Y I   L  A+  LH      V+HRD+K SN++ +++ ++K+ DFGLA ++D     
Sbjct: 113 HIQYFIYQTL-RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 357 RT---------TGLAGTLGYMAPEYISTG 376
            +         T    T  Y APE + T 
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTS 197

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 73
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E M      F              T R  +   LA +  + 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFI-----------TERGALQEELARSFFWQ 122
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 179
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 180 SPPEWIRYHR 189

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY 240
           A P     K++     +F   + +G+G FG V    + +     A+K ++      K E 
Sbjct: 75  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN------KWEM 128
Query: 241 ITEVKTCSQLRHRNLL-----QLIGLCH----DRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
           +   +T      R++L     Q I   H    D     LV ++   G L   L SK    
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDK 187
Query: 292 TPLTWTTRYKISLGLA-SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
            P      Y   + LA  ++  LH       VHRDIK  N++ D + +++L DFG  L +
Sbjct: 188 LPEDMARFYIGEMVLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKM 241
Query: 351 DHELGPRTTGLAGTLGYMAPEYIST 375
           + +   +++   GT  Y++PE +  
Sbjct: 242 NDDGTVQSSVAVGTPDYISPEILQA 266

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 22  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYC 67
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K     RH N++ +  +          +  +V + M      + L   +    
Sbjct: 68  QRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 125
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 126 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADP 178
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 179 DHDHTGFLTEYVATRWYRAPE 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-- 252
            ++F     LGQG FG V +      +   A+KKI R  +   +  ++EV   + L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 253 -----------RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
                      RN ++       +    +  E+  N +L + L   ++          ++
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQ--QRDEYWR 120
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA---------LLVDH 352
           +   +  AL Y+H +    ++HR++K  NI  D   NVK+GDFGLA         L +D 
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 353 ELGPRT----TGLAGTLGYMAPEYI 373
           +  P +    T   GT  Y+A E +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVL 202

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 89
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 90  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 138
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 195
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 196 SPPEWIRYHR 205

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYI 241
           P+R  Y    + +++F  +  LG+G +G V           VA+KKI    K       +
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 242 TEVKTCSQLRHRNLLQLIGL-----CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
            E+K     +H N++ +  +       +  E  ++ E M     D H     ST      
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVI--STQMLSDD 112
Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP 356
             +Y I   L  A+  LH      V+HRD+K SN++ +++ ++K+ DFGLA ++D     
Sbjct: 113 HIQYFIYQTL-RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 357 RT---------TGLAGTLGYMAPEYISTG 376
            +         T    T  Y APE + T 
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTS 197

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 89
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 90  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 138
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 195
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 196 SPPEWIRYHR 205

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 72
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 73  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 121
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 178
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 179 SPPEWIRYHR 188

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA++KIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYC 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPE 371
           DH+     T    T  Y APE
Sbjct: 181 DHDHTGFLTEYVATRWYRAPE 201

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 101
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 102 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 150
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 207
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 208 SPPEWIRYHR 217

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 102
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 103 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 151
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 208
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 209 SPPEWIRYHR 218

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 69
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 118
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 175
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 176 SPPEWIRYHR 185

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 101
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 102 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 150
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 207
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 208 SPPEWIRYHR 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 14/83 (16%)
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT-- 359
           I + +A A+ +LH    + ++HRD+K SNI    D  VK+GDFGL   +D +   +T   
Sbjct: 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 360 ---------GLAGTLGYMAPEYI 373
                    G  GT  YM+PE I
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 102
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 103 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 151
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 208
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 209 SPPEWIRYHR 218

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 102
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 103 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 151
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 208
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 209 SPPEWIRYHR 218

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 69
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 118
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 119 VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 175
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 176 SPPEWIRYHR 185

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 116
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 117 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 165
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 222
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 223 SPPEWIRYHR 232

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 204 LGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           LGQG F  +++G+  ++          V +K + +  ++    +       S+L H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
              G+C    E +LV EF+  GSLD +L  K      + W  + +++  LA A+ +L E 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAWAMHFLEE- 131
Query: 317 WKRCVVHRDIKFSNIMPDTDFN--------VKLGDFGLALLV 350
               ++H ++   NI+   + +        +KL D G+++ V
Sbjct: 132 --NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 102
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 103 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 151
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 208
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 209 SPPEWIRYHR 218

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 101
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 102 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 150
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 207
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 208 SPPEWIRYHR 217

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 116
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 117 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 165
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 222
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 223 SPPEWIRYHR 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 108
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 109 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 157
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 214
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 215 SPPEWIRYHR 224

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 69
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 118
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 175
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 176 SPPEWIRYHR 185

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 101
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 102 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 150
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 207
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 208 SPPEWIRYHR 217

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           +   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           +   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY 240
           A P     K +     +F   + +G+G FG V    L + +   A+K ++      K E 
Sbjct: 59  AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN------KWEM 112
Query: 241 ITEVKTCSQLRHRNLL-----QLIGLCH----DRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
           +   +T      R++L     + I   H    D     LV ++   G L   L SK    
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDR 171
Query: 292 TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            P      Y     LA  ++ +    +   VHRDIK  NI+ D + +++L DFG  L + 
Sbjct: 172 LPEEMARFY-----LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226
Query: 352 HELGPRTTGLAGTLGYMAPEYIST---GRAR 379
            +   +++   GT  Y++PE +     G+ R
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           +   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++P G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 10  GGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGXXXXXXXXXXYTRWNASF 69
           GG LG+F        S+ IV VEFD+FSN +WDP      +G             WN  +
Sbjct: 104 GGMLGIFKDGYFN-KSNQIVAVEFDTFSNGDWDPKG--RHLGINVNSIESIKTVPWN--W 158
Query: 70  HSGDTAHVKIKYNSATKNLSASWSY 94
            +G+ A+V I Y ++TK+L+AS  Y
Sbjct: 159 TNGEVANVFISYEASTKSLTASLVY 183

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 121
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 122 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 170
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 171 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 227
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 228 SPPEWIRYHR 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
           AGT  Y+APE I
Sbjct: 199 AGTPEYLAPEII 210

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKN---EYITEVKTCSQLRHR 253
           LG GGFG+VY GI +  N+ VA+K + +        L +G     E +   K  S     
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S 96
Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY- 312
            +++L+        F+L+ E  P    D   F           T R  +   LA +  + 
Sbjct: 97  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFI----------TERGALQEELARSFFWQ 145
Query: 313 LHEEWKRC----VVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
           + E  + C    V+HRDIK  NI+ D +   +KL DFG   L+   +    T   GT  Y
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 202
Query: 368 MAPEYISTGR 377
             PE+I   R
Sbjct: 203 SPPEWIRYHR 212

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYI 241
           P+R  Y    + +++F  +  LG+G +G V           VA+KKI    K       +
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 242 TEVKTCSQLRHRNLLQLIGL-----CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTW 296
            E+K     +H N++ +  +       +  E  ++ E M     D H     ST      
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVI--STQMLSDD 112
Query: 297 TTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP 356
             +Y I   L  A+  LH      V+HRD+K SN++ +++ ++K+ DFGLA ++D     
Sbjct: 113 HIQYFIYQTL-RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 357 RT--TG-------LAGTLGYMAPEYISTG 376
            +  TG          T  Y APE + T 
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTS 197

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 9/198 (4%)
Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR--GLKHGKN 238
           A P     K++    ++F   + +G+G F  V    +       A+K +++   LK G+ 
Sbjct: 46  AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV 105
Query: 239 EYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
               E +        R + QL     D     LV E+   G L   L SK     P    
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMA 164
Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR 357
             Y     LA  ++ +    +   VHRDIK  NI+ D   +++L DFG  L +  +   R
Sbjct: 165 RFY-----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 358 TTGLAGTLGYMAPEYIST 375
           +    GT  Y++PE +  
Sbjct: 220 SLVAVGTPDYLSPEILQA 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 16/177 (9%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG GG   V+    + L+  VAVK +   L    + Y+    E +  + L H  ++ +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDF----HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             +D GE       +P   +++     L     T  P+T     ++      AL + H+ 
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
               ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT  Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 24  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 69
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 127
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 128 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+          T  Y APE +   + 
Sbjct: 181 DHDHTGFLXEXVATRWYRAPEIMLNSKG 208

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++N   +G+G +G V         + VA+KKIS   +H    
Sbjct: 25  DVGPR-------------YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC 70
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E+K   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 71  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDL--YKLLKTQHLSN 128
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-- 350
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA +   
Sbjct: 129 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 181
Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRA 378
           DH+          T  Y APE +   + 
Sbjct: 182 DHDHTGFLXEXVATRWYRAPEIMLNSKG 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 16/177 (9%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG GG   V+    + L+  VAVK +   L    + Y+    E +  + L H  ++ +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 94
Query: 261 LCHDRGEFMLVYEFMPNGSLDF----HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             +D GE       +P   +++     L     T  P+T     ++      AL + H+ 
Sbjct: 95  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 152
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
               ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT  Y++PE
Sbjct: 153 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 32/203 (15%)
Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-- 237
           D GPR             ++  + +G+G +G V           VA+KKIS   +H    
Sbjct: 40  DVGPR-------------YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYC 85
Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRG-----EFMLVYEFMPNGSLDFHLFSKKSTGT 292
              + E++   + RH N++ +  +          +  +V + M      + L   +    
Sbjct: 86  QRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDL--YKLLKSQQLSN 143
Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD- 351
                  Y+I  GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA + D 
Sbjct: 144 DHICYFLYQILRGLK----YIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADP 196
Query: 352 -HELGPRTTGLAGTLGYMAPEYI 373
            H+     T    T  Y APE +
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIM 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKIS-RGL-KHGKNEYITEVKTCSQLRHRNLLQLI- 259
           ++G+G F  VY+G+  +  + VA  ++  R L K  +  +  E +    L+H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 260 ---GLCHDRGEFMLVYEFMPNGSLDFHL--FSKKSTGTPLTWTTRYKISLGLASALLYLH 314
                   +   +LV E   +G+L  +L  F         +W  +      +   L +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFLH 146
Query: 315 EEWKRCVVHRDIKFSNI-MPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                 ++HRD+K  NI +     +VK+GD GLA L           + GT  + APE
Sbjct: 147 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFXAPE 200

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 62/141 (43%), Gaps = 26/141 (18%)
Query: 7   NSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGXXXXXXXXXXYTRW 65
           +S GGFLGLF+S  +  S+   V VEFD++ N  + DP      +G            +W
Sbjct: 102 DSGGGFLGLFDSAVSG-STYQTVAVEFDTYENTVFTDPPYTH--IGFDVNSISSIKTVKW 158
Query: 66  NASFHSGDTAHVKIKYNSATKNLSASWSYGET----------------PKYSQ----ENT 105
             S  +G+ A V I YNSA K L AS  Y  +                P++ +      T
Sbjct: 159 --SLANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAAT 216
Query: 106 TSTGRYTERHVLKSWEFNSTL 126
            ++G   E H + SW F S L
Sbjct: 217 GASGGKIETHDVFSWSFASKL 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 76
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 136
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A      +  RT  L
Sbjct: 137 IVLTFE----YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFA----KRVKGRTWXL 185
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 186 CGTPEYLAPEII 197

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 90
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 151 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 199
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 200 CGTPEYLAPEII 211

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 196 NNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + F   + LG G FG V           Y   ++D    V +K+I   L         E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL--------NEK 92
Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +    +    L++L     D     +V E++  G +  HL        P       +I L
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
                  YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGT 201
Query: 365 LGYMAPEYI 373
             Y+APE I
Sbjct: 202 PEYLAPEII 210

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 XGTPEYLAPEII 210

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 26/141 (18%)
Query: 7   NSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGXXXXXXXXXXYTRW 65
           +S GGFLGLF+S     ++   V VEFD++ N  + DP      +G            +W
Sbjct: 102 DSGGGFLGLFDSAVGD-TTYQTVAVEFDTYENTVFTDPPYTH--IGFDVNSISSIKTVKW 158
Query: 66  NASFHSGDTAHVKIKYNSATKNLSASWSYGET----------------PKYSQ----ENT 105
             S  +G+ A V I YNSA K L AS  Y  +                P++ +      T
Sbjct: 159 --SLANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAAT 216
Query: 106 TSTGRYTERHVLKSWEFNSTL 126
            ++  Y E H + SW F S L
Sbjct: 217 GASKGYIETHDVFSWSFASKL 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 89
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 150 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 198
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 199 CGTPEYLAPEII 210

>pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 56/136 (41%), Gaps = 20/136 (14%)
Query: 10  GGFLGLF-NSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGXXXXXXXXXXYTRW-N 66
           GGFLGLF + T A  S + +V VEFD++ N +W DP      +G           TRW N
Sbjct: 106 GGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDP--PYPHIGIDVNSIVSVATTRWEN 163
Query: 67  ASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTTSTGR---------------Y 111
              +    A   I Y++ +K L+   SY     Y   +     +               Y
Sbjct: 164 DDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY 223
Query: 112 TERHVLKSWEFNSTLD 127
            E   + SW F STLD
Sbjct: 224 DEVTYILSWHFFSTLD 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 84
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 144
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 145 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 193
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 194 CGTPEYLAPEII 205

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 30/192 (15%)
Query: 193 SATNNFSNERKLGQGGFGAV-----------YRGILIDLNMAVAVKKISRGLKHGKNEYI 241
           +  + F   + LG G FG V           Y   ++D    V +K+I   L        
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-------- 110
Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
            E +    +    L++L     D     +V E++  G +  HL        P       +
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 170
Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I L       YLH      +++RD+K  N++ D    +++ DFG A  V      RT  L
Sbjct: 171 IVLTFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXL 219
Query: 362 AGTLGYMAPEYI 373
            GT  Y+APE I
Sbjct: 220 CGTPEYLAPEII 231

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 15/183 (8%)
Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
           T+ +  +  +G G +    R I    NM  AVK I +  K    E I  +    Q  H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-KRDPTEEIEILLRYGQ--HPN 77
Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++ L  +  D     +V E M  G L   +  +K           + I+      + YLH
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT----KTVEYLH 133
Query: 315 EEWKRCVVHRDIKFSNIM-PDTDFN---VKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +    VVHRD+K SNI+  D   N   +++ DFG A  +  E G   T    T  ++AP
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAP 189
Query: 371 EYI 373
           E +
Sbjct: 190 EVL 192

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 25/175 (14%)
Query: 183 PRRFSYKDLASATNNFSNE------RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG 236
           PR   Y D AS    + N+      RKLG+G +  V+  I I  N  V V KI + +K  
Sbjct: 20  PR--EYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV-KILKPVK-- 74
Query: 237 KNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEF--MLVYEFMPNGSLDFHLFSKKSTGTP 293
           KN+   E+K    LR   N++ L  +  D       LV+E + N   DF    K+   T 
Sbjct: 75  KNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT--DF----KQLYQTL 128
Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLA 347
             +  R+ +   +  AL Y H      ++HRD+K  N+M D +   ++L D+GLA
Sbjct: 129 TDYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 16/177 (9%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG GG   V+    +  +  VAVK +   L    + Y+    E +  + L H  ++ +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDF----HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             +D GE       +P   +++     L     T  P+T     ++      AL + H+ 
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
               ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT  Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 16/177 (9%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG GG   V+    +  +  VAVK +   L    + Y+    E +  + L H  ++ +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDF----HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             +D GE       +P   +++     L     T  P+T     ++      AL + H+ 
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
               ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT  Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 7/174 (4%)
Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ--LRHRNLLQLIG 260
           +LG+G +G V +   +      AVK+I   +   + + +      S   +     +   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                G+  +  E + + SLD         G  +      KI++ +  AL +LH   K  
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 157
Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           V+HRD+K SN++ +    VK  DFG++  +  ++       AG   Y APE I+
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--AGCKPYXAPERIN 209

>pdb|2PEL|A Chain A, Peanut Lectin Length = 236

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 3   QIPSNS-PGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGXXXXXXXXX 60
           QIP+ S  GG LG+ ++  A       V VEFD++SN E+ DP    D VG         
Sbjct: 95  QIPAGSIGGGTLGVSDTKGA----GHFVGVEFDTYSNSEYNDP--PTDHVGIDVNSVDSV 148
Query: 61  XYTRWNASFHSGDTAHVKIKYNSATKNLSASWS---------------YGETPKYSQENT 105
               WN+   SG    V + Y+S+TK LS + +                 + P+  +   
Sbjct: 149 KTVPWNSV--SGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGF 206
Query: 106 TSTGRYTER--HVLKSWEFNSTL 126
           +++G    R  H+++SW F STL
Sbjct: 207 SASGSLGGRQIHLIRSWSFTSTL 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 16/177 (9%)
Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRHRNLLQLIG 260
           LG GG   V+    + L+  VAVK +   L    + Y+    E +  + L H  ++ +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 261 LCHDRGEFMLVYEFMPNGSLDF----HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
             +  GE       +P   +++     L     T  P+T     ++      AL + H+ 
Sbjct: 78  --YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTLGYMAPE 371
               ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT  Y++PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 27/143 (18%)
Query: 3   QIPSNS-PGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGXXXXXXXXX 60
           QIP+ S  GG LG+ ++  A       V VEFD++SN E+ DP    D VG         
Sbjct: 95  QIPAGSIGGGTLGVSDTKGA----GHFVGVEFDTYSNSEYNDP--PTDHVGIDVNSVDSV 148
Query: 61  XYTRWNASFHSGDTAHVKIKYNSATKNLSASWS---------------YGETPKYSQENT 105
               WN+   SG    V + Y+S+TK LS + +                 + P+  +   
Sbjct: 149 KTVPWNSV--SGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGF 206
Query: 106 TSTGRYTER--HVLKSWEFNSTL 126
           +++G    R  H+++SW F STL
Sbjct: 207 SASGSLGGRQIHLIRSWSFTSTL 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	459
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-89
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-86
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-42
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-23
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	9e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-21
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	9e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-20
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	2e-20
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-20
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	5e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-20
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	5e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-19
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-19
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	6e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-19
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	7e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-18
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	6e-18
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	6e-18
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	6e-18
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	8e-18
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	8e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	2e-17
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	2e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-17
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	8e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-16
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	8e-16
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	9e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	3e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-15
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	9e-15
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-14
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  286 bits (734), Expect = 5e-94
 Identities = 95/291 (32%), Positives = 145/291 (49%), Gaps = 57/291 (19%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYI 241
            +RFS ++L  A++NFSN+  LG+GGFG VY+G L D    VAVK++      G + ++ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75

Query: 242 TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK 301
           TEV+  S   HRNLL+L G C    E +LVY +M NGS+   L  +  +  PL W  R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           I+LG A  L YLH+     ++HRD+K +NI+ D +F   +GDFGLA L+D++    TT +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 362 AGTLGYMAPEYIS---------------------TGR----------------------- 377
            GT+G++APEY+S                     TG+                       
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 378 -----------ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL 417
                        L  N+ +++ + L+ V L C       RP + + +++L
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  272 bits (698), Expect = 5e-89
 Identities = 91/309 (29%), Positives = 136/309 (44%), Gaps = 77/309 (24%)

Query: 179 RDAGPRRFSYKDLASATNNFSNER------KLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
            D     FS+ +L + TNNF          K+G+GGFG VY+G + + N  VAVKK++  
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-N-NTTVAVKKLAAM 65

Query: 233 L----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK 288
           +    +  K ++  E+K  ++ +H NL++L+G   D  +  LVY +MPNGSL   L    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 289 STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL 348
            T  PL+W  R KI+ G A+ + +LHE      +HRDIK +NI+ D  F  K+ DFGLA 
Sbjct: 126 GT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA- 180

Query: 349 LVDHELGPR------TTGLAGTLGYMAPEYIS--------------------TGRARLDV 382
                   +      T+ + GT  YMAPE +                     TG   +D 
Sbjct: 181 ----RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 383 NFDEQ------------------------------QTDCLMIVGLWCAHPDRNCRPSIRQ 412
           + + Q                                + +  V   C H  +N RP I++
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 413 AIQVLNFET 421
             Q+L   T
Sbjct: 297 VQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  267 bits (684), Expect = 1e-86
 Identities = 76/200 (38%), Positives = 112/200 (56%), Gaps = 15/200 (7%)

Query: 184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITE 243
            R    DL  ATNNF ++  +G G FG VY+G+L D    VA+K+ +     G  E+ TE
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETE 85

Query: 244 VKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
           ++T S  RH +L+ LIG C +R E +L+Y++M NG+L  HL+        ++W  R +I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR------ 357
           +G A  L YLH      ++HRD+K  NI+ D +F  K+ DFG++     + G        
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS-----KKGTELDQTHL 197

Query: 358 TTGLAGTLGYMAPEYISTGR 377
           +T + GTLGY+ PEY   GR
Sbjct: 198 STVVKGTLGYIDPEYFIKGR 217

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  197 bits (502), Expect = 1e-59
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 22/217 (10%)

Query: 173 VNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           +       +       ++L   +          +G FG V++  L  LN  VAVK     
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ 58

Query: 233 LKHG-KNEYITEVKTCSQLRHRNLLQLIGLC----HDRGEFMLVYEFMPNGSLDFHLFSK 287
            K   +NE   EV +   ++H N+LQ IG          +  L+  F   GSL   L   
Sbjct: 59  DKQSWQNE--YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--- 113

Query: 288 KSTGTPLTWTTRYKISLGLASALLYLHEE-------WKRCVVHRDIKFSNIMPDTDFNVK 340
                 ++W     I+  +A  L YLHE+        K  + HRDIK  N++   +    
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 341 LGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTG 376
           + DFGLAL  +       T G  GT  YMAPE +   
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  179 bits (456), Expect = 8e-53
 Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 31/234 (13%)

Query: 186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEV 244
            +  + +   +N      +G+G +GAVY+G L      VAVK  S   +    NE    +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINE--KNI 58

Query: 245 KTCSQLRHRNLLQLIGLC-----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
                + H N+ + I          R E++LV E+ PNGSL  +L           W + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSS 113

Query: 300 YKISLGLASALLYLHEE------WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
            +++  +   L YLH E      +K  + HRD+   N++   D    + DFGL++ +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 354 LGPR-------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLM--IVGLW 398
              R            GT+ YMAPE +       D     +Q D     ++  W
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI-YW 226

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  165 bits (421), Expect = 6e-48
 Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 7/175 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQL 258
           + K+G G FG V+R         VAVK +     H +  NE++ EV    +LRH N++  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           +G         +V E++  GSL + L  K      L    R  ++  +A  + YLH    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
             +VHR++K  N++ D  + VK+ DFGL+ L        +   AGT  +MAPE +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVL 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  156 bits (397), Expect = 1e-44
 Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 22/187 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK-------NEYITEVKTCSQLRHR 253
           E+++G+GGFG V++G L+     VA+K +  G   G+        E+  EV   S L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L GL H+     +V EF+P G L   L  K     P+ W+ + ++ L +A  + Y+
Sbjct: 84  NIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYM 138

Query: 314 HEEWKRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
                  +VHRD++  NI       +     K+ DFGL+    H      +GL G   +M
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWM 193

Query: 369 APEYIST 375
           APE I  
Sbjct: 194 APETIGA 200

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  155 bits (393), Expect = 7e-44
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
              LG+G FG   +    +    + +K++ R  +  +  ++ EVK    L H N+L+ IG
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           + +       + E++  G+L   +   KS  +   W+ R   +  +AS + YLH      
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-------------LGPRTTGLAGTLGY 367
           ++HRD+   N +   + NV + DFGLA L+  E                +   + G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 368 MAPEYI 373
           MAPE I
Sbjct: 189 MAPEMI 194

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (389), Expect = 2e-43
 Identities = 56/184 (30%), Positives = 77/184 (41%), Gaps = 22/184 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKI-SRGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
              +G+G +G V+RG        VAVK   SR  K    E  TE+     LRH N+L  I
Sbjct: 13  LECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFI 68

Query: 260 GLC----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
                  H   +  L+  +   GSL  +L       T L   +  +I L +AS L +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 316 E-----WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP---RTTGLAGTLGY 367
           E      K  + HRD+K  NI+   +    + D GLA++                GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 368 MAPE 371
           MAPE
Sbjct: 184 MAPE 187

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  152 bits (387), Expect = 6e-43
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 12/175 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E  +G+G FG V +         VA+K+I    +  +  +I E++  S++ H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
            C +     LV E+   GSL +++          T        L  +  + YLH    + 
Sbjct: 69  ACLN--PVCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 321 VVHRDIKFSNIMPDTDFNV-KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           ++HRD+K  N++      V K+ DFG A  +   +    T   G+  +MAPE   
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPEVFE 176

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (381), Expect = 2e-42
 Identities = 32/175 (18%), Positives = 64/175 (36%), Gaps = 15/175 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQL 258
             KL +   G +++G        + VK +       +   ++  E        H N+L +
Sbjct: 15  LTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 259 IGLCHD--RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +G C         L+  +MP GSL   L   + T   +  +   K +L +A  + +LH  
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLH-T 129

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            +  +    +   ++M D D   ++    +           + G      ++APE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  151 bits (383), Expect = 4e-42
 Identities = 54/184 (29%), Positives = 78/184 (42%), Gaps = 22/184 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLI 259
           +  +G+G FG V+RG        VAVK  S   +     E   E+     LRH N+L  I
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102

Query: 260 GLCHDRG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
              +       +  LV ++  +GSL F   ++      +T     K++L  AS L +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRY----TVTVEGMIKLALSTASGLAHLHM 157

Query: 316 EW-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT---TGLAGTLGY 367
           E      K  + HRD+K  NI+   +    + D GLA+  D              GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 368 MAPE 371
           MAPE
Sbjct: 218 MAPE 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  150 bits (381), Expect = 7e-42
 Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 22/184 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLLQLI 259
            +++G+G +G V+ G        VAVK      +     E  TE+     +RH N+L  I
Sbjct: 42  VKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFI 97

Query: 260 GLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
                      +  L+ ++  NGSL  +L       T L   +  K++    S L +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 316 E-----WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR---TTGLAGTLGY 367
           E      K  + HRD+K  NI+   +    + D GLA+    +            GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 368 MAPE 371
           M PE
Sbjct: 213 MPPE 216

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  148 bits (375), Expect = 1e-41
 Identities = 54/189 (28%), Positives = 78/189 (41%), Gaps = 22/189 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG----LKHGKNEYITEVKTCSQLRHRNLL 256
           E  +G GGFG VYR     +   VAVK         +         E K  + L+H N++
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L G+C       LV EF   G L+  L  K+     +        ++ +A  + YLH+E
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDE 124

Query: 317 WKRCVVHRDIKFSNI--------MPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
               ++HRD+K SNI           ++  +K+ DFGLA              AG   +M
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWM 181

Query: 369 APEYISTGR 377
           APE I    
Sbjct: 182 APEVIRASM 190

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (367), Expect = 2e-40
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 25/236 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQL 258
            +++G G FG VY+G     +  VAVK ++      +    +  EV    + RH N+L  
Sbjct: 29  GQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           +G      +  +V ++    SL  HL    ++ T         I+   A  + YLH    
Sbjct: 86  MGYS-TAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           + ++HRD+K +NI    D  VK+GDFGLA          +   L+G++ +MAPE I   R
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---R 195

Query: 378 ARLDVNFDEQQTD--CLMIVGLW----CAHPDRNCRPSIRQAIQVLNFETKMPNLP 427
            +    +   Q+D     IV L+       P  N      Q I+++   +  P+L 
Sbjct: 196 MQDSNPYSF-QSDVYAFGIV-LYELMTGQLPYSNINN-RDQIIEMVGRGSLSPDLS 248

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  145 bits (367), Expect = 6e-40
 Identities = 42/189 (22%), Positives = 73/189 (38%), Gaps = 16/189 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHRNLLQL 258
              +G+G FG VY G     +  VA++ I     +      +  EV    Q RH N++  
Sbjct: 38  GELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
           +G C       ++       +L   +   K     L      +I+  +   + YLH    
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---A 148

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR----TTGLAGTLGYMAPEYIS 374
           + ++H+D+K  N+  D +  V + DFGL  +       R         G L ++APE I 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 375 TGRARLDVN 383
                 + +
Sbjct: 208 QLSPDTEED 216

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (337), Expect = 4e-35
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 10/180 (5%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLI 259
             ++G+G FG V+ G L   N  VAVK     L    K +++ E +   Q  H N+++LI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G+C  +    +V E +  G     L   ++ G  L   T  ++    A+ + YL     +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---K 232

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY--MAPEYISTGR 377
           C +HRD+   N +      +K+ DFG++      +   + G    +     APE ++ GR
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG-LRQVPVKWTAPEALNYGR 291

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (325), Expect = 8e-34
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 11/176 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRHRNLLQL 258
           R LG+GGF   +     D     A K + +   LK  + E +  E+     L H++++  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
            G   D     +V E     SL   L  ++   T      RY +   +     YLH   +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTE--PEARYYL-RQIVLGCQYLH---R 159

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
             V+HRD+K  N+  + D  VK+GDFGLA  V+++   +   L GT  Y+APE +S
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  126 bits (319), Expect = 2e-33
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 11/176 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRHRNLLQL 258
           R LG+GGF   +     D     A K + +   LK  + E +  E+     L H++++  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
            G   D     +V E     SL   L  ++   T      RY +   +     YLH   +
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTE--PEARYYLR-QIVLGCQYLH---R 133

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
             V+HRD+K  N+  + D  VK+GDFGLA  V+++   +   L GT  Y+APE +S
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 188

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (317), Expect = 3e-33
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 12/177 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT-EVKTCSQLRHRNLLQL 258
             LG+G F  VYR   I   + VA+K I +    K G  + +  EVK   QL+H ++L+L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKISLGLASALLYLHEEW 317
                D     LV E   NG +       +    P +    R+ +   + + +LYLH   
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEM-NRYLKNR--VKPFSENEARHFMH-QIITGMLYLH--- 129

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              ++HRD+  SN++   + N+K+ DFGLA  +        T L GT  Y++PE  +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (313), Expect = 2e-32
 Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 15/187 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++   +KLG+GGF  V     +      A+K+I    +  + E   E        H N+L
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 257 QLIGLCHDRG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           +L+  C        E  L+  F   G+L   +   K  G  LT      + LG+   L  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA--------GT 364
           +H    +   HRD+K +NI+   +    L D G        +      L          T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 365 LGYMAPE 371
           + Y APE
Sbjct: 207 ISYRAPE 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  123 bits (311), Expect = 3e-32
 Identities = 49/177 (27%), Positives = 89/177 (50%), Gaps = 6/177 (3%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           + KLG G +G VY G+    ++ VAVK +         E++ E     +++H NL+QL+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL  E K  
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL--EKKNF 132

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            +HRD+   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  +
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  122 bits (308), Expect = 9e-32
 Identities = 58/181 (32%), Positives = 84/181 (46%), Gaps = 7/181 (3%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGK--NEYITEVKTCSQLRH 252
            NF  E+K+G+G F  VYR   +   + VA+KK+    L   K   + I E+    QL H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+++      +  E  +V E    G L   +   K     +   T +K  + L SAL +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           +H    R V+HRDIK +N+       VKLGD GL      +     + L GT  YM+PE 
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 207

Query: 373 I 373
           I
Sbjct: 208 I 208

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  125 bits (315), Expect = 2e-31
 Identities = 48/180 (26%), Positives = 90/180 (50%), Gaps = 12/180 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRHRNLLQ 257
           + KLG G +G VY G+    ++ VAVK     LK       E++ E     +++H NL+Q
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L+G+C     F ++ EFM  G+L  +L  ++     ++      ++  ++SA+ YL +  
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEK-- 336

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            +  +HR++   N +   +  VK+ DFGL+ L+  +      G    + + APE ++  +
Sbjct: 337 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (300), Expect = 6e-31
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            ++LG G FG V  G        VAVK I  G    ++E+  E +T  +L H  L++  G
Sbjct: 13  LKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +C       +V E++ NG L  +L   +S G  L  +   ++   +   + +L  E  + 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQF 125

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            +HRD+   N + D D  VK+ DFG+   V  +    + G    + + APE     +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (299), Expect = 1e-30
 Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 15/177 (8%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT-EVKTCSQLRHRNLLQL 258
           R LG+G FG VY          +A+K + +    K G    +  EV+  S LRH N+L+L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT-WTTRYKISLGLASALLYLHEEW 317
            G  HD     L+ E+ P G++    + +    +      T   I+  LA+AL Y H   
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITE-LANALSYCH--- 126

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            + V+HRDIK  N++  +   +K+ DFG ++        RT  L GTL Y+ PE I 
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIE 180

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (302), Expect = 2e-30
 Identities = 44/194 (22%), Positives = 81/194 (41%), Gaps = 12/194 (6%)

Query: 180 DAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGK 237
           D G     ++ +      +   +K+G+G FG        +      +K+I+        +
Sbjct: 12  DLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67

Query: 238 NEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
            E   EV   + ++H N++Q      + G   +V ++   G L   +      G      
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQED 125

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR 357
                 + +  AL ++H+   R ++HRDIK  NI    D  V+LGDFG+A +++  +   
Sbjct: 126 QILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182

Query: 358 TTGLAGTLGYMAPE 371
                GT  Y++PE
Sbjct: 183 RA-CIGTPYYLSPE 195

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  117 bits (296), Expect = 3e-30
 Identities = 40/199 (20%), Positives = 80/199 (40%), Gaps = 40/199 (20%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHR 253
              LGQG F  +++G+  ++          V +K + +  ++    +       S+L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +L+   G+C    E +LV EF+  GSLD +L   K     +    + +++  LA+A+ +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 314 HEEWKRCVVHRDIKFSNIM--------PDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGT 364
             E     +H ++   NI+              +KL D G++  ++  +           
Sbjct: 130 --EENTL-IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------- 175

Query: 365 LGY------MAPEYISTGR 377
                    + PE I   +
Sbjct: 176 -ILQERIPWVPPECIENPK 193

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (296), Expect = 3e-30
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 174 NDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL 233
            ++   ++    + Y+      +   +   LG+G +G VY G  +   + +A+K+I    
Sbjct: 5   TEEGDCESDLLEYDYE-----YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59

Query: 234 KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLD---FHLFSKKST 290
                    E+     L+H+N++Q +G   + G   +  E +P GSL       +     
Sbjct: 60  SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119

Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALL 349
                     +I  GL     YLH+     +VHRDIK  N++ +T    +K+ DFG +  
Sbjct: 120 NEQTIGFYTKQILEGLK----YLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172

Query: 350 VDHELGPRTTGLAGTLGYMAPEYI 373
           +   + P T    GTL YMAPE I
Sbjct: 173 LA-GINPCTETFTGTLQYMAPEII 195

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (295), Expect = 4e-30
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 7/185 (3%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQL 250
           S   ++     +G G +G   +         +  K++  G   +  K   ++EV    +L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 251 RHRNLLQLIGLCHDR--GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +H N+++      DR      +V E+   G L   +         L      ++   L  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 309 ALLYLHE--EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
           AL   H   +    V+HRD+K +N+  D   NVKLGDFGLA +++H+     T   GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPY 181

Query: 367 YMAPE 371
           YM+PE
Sbjct: 182 YMSPE 186

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (294), Expect = 4e-30
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            +++G G FG V+ G  ++    VA+K I  G    + ++I E +   +L H  L+QL G
Sbjct: 13  VQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +C ++    LV EFM +G L  +L   ++        T   + L +   + YL  E    
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL--EEACV 125

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            +HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S  R
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 181

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  118 bits (297), Expect = 5e-30
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 13/183 (7%)

Query: 201 ERKLGQGGFGAVYRGILID----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNL 255
            + LG G FG VY+G+ I     + + VA+K++          E + E    + + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            +L+G+C       L+ + MP G L  ++   K     +         + +A  + YL +
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIS 374
             +R  VHRD+   N++  T  +VK+ DFGLA LL   E      G    + +MA E I 
Sbjct: 136 --RRL-VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 375 TGR 377
              
Sbjct: 193 HRI 195

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (293), Expect = 7e-30
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 11/181 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLL 256
            R LG+G FG VY G+  +     + VAVK   +      K ++++E      L H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+  +     ++ E  P G L  +L   +     L   T    SL +  A+ YL  E
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL--E 130

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              CV HRDI   NI+  +   VKLGDFGL+  ++ E   + +     + +M+PE I+  
Sbjct: 131 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 377 R 377
           R
Sbjct: 190 R 190

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  116 bits (293), Expect = 8e-30
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            ++LG G FG V  G        VA+K I  G    ++E+I E K    L H  L+QL G
Sbjct: 29  LKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +C  +    ++ E+M NG L  +L   +            ++   +  A+ YL  E K+ 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQF 141

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            +HRD+   N + +    VK+ DFGL+  V  +    + G    + +  PE +   +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 1e-29
 Identities = 27/244 (11%), Positives = 60/244 (24%), Gaps = 39/244 (15%)

Query: 173 VNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           V   +             L+           L  G    V+    ++     A+K  + G
Sbjct: 40  VTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG 98

Query: 233 LKHGKNEY---ITEVKTCSQLRHRNLLQLIGLCH-------------------------- 263
            ++ ++E           ++L   +  +                                
Sbjct: 99  AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDY 158

Query: 264 DRGEFMLVYEFMP--NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
               ++L+          L   L               + ++  L      L     + +
Sbjct: 159 AVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLD 381
           VH      N+    D  + LGD         ++G R    +  + Y   E+++   A   
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFT 271

Query: 382 VNFD 385
              +
Sbjct: 272 HALN 275

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  117 bits (294), Expect = 1e-29
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 12/183 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           E+ +G G  G V  G L      ++ VA+K +  G  +  + ++++E     Q  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L G+       M+V E+M NGSLD  L   ++     T      +  G+ + + YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSD- 169

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY--MAPEYIS 374
                VHRD+   N++ D++   K+ DFGL+ +++ +     T   G +     APE I+
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 375 TGR 377
              
Sbjct: 228 FRT 230

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  116 bits (293), Expect = 2e-29
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 17/186 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNL 255
           ++ +G G FG VY+G+L   +    + VA+K +  G  +  + +++ E     Q  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++L G+       M++ E+M NG+LD  L   +      +      +  G+A+ + YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL-- 163

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGT---LGYMAPE 371
                 VHRD+   NI+ +++   K+ DFGL+ +L D      TT  +G    + + APE
Sbjct: 164 ANMNY-VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPE 220

Query: 372 YISTGR 377
            IS  +
Sbjct: 221 AISYRK 226

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (289), Expect = 3e-29
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 12/182 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLN--MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQ 257
           + +LG G FG+V +G+       + VA+K + +G  K    E + E +   QL +  +++
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+C      MLV E    G L   L  K+     +  +   ++   ++  + YL  E 
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EE 128

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GYMAPEYIST 375
           K  V HRD+   N++       K+ DFGL+  +  +    T   AG     + APE I+ 
Sbjct: 129 KNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 376 GR 377
            +
Sbjct: 188 RK 189

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  115 bits (289), Expect = 3e-29
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 12/179 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
             +LG G FG V+ G     +  VAVK + +G     + ++ E     QL+H+ L++L  
Sbjct: 18  VERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA 75

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +        ++ E+M NGSL   L  K  +G  LT      ++  +A  + ++  E +  
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI--EERNY 130

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY--MAPEYISTGR 377
           + HRD++ +NI+     + K+ DFGLA L++        G          APE I+ G 
Sbjct: 131 I-HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPEAINYGT 186

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  114 bits (288), Expect = 3e-29
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 11/181 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
            R +G+G FG V++GI +      +AVA+K          + +++ E  T  Q  H +++
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+        ++ E    G L   L   +     L   +    +  L++AL YL  E
Sbjct: 80  KLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYL--E 133

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            KR V HRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  
Sbjct: 134 SKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 377 R 377
           R
Sbjct: 193 R 193

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  115 bits (289), Expect = 4e-29
 Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
              +G+G FG VY G L+D +   +  AVK ++R       ++++TE        H N+L
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 257 QLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            L+G+C    G  ++V  +M +G L   +   ++     T        L +A  + YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL---GYMAPEY 372
             K+  VHRD+   N M D  F VK+ DFGLA  +  +         G      +MA E 
Sbjct: 147 --KKF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 373 ISTGR 377
           + T +
Sbjct: 204 LQTQK 208

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  115 bits (289), Expect = 4e-29
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHRNLL 256
           +R +G+G FG VY G  ID     +  A+K +SR  +      ++ E      L H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 257 QLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            LIG+     G   ++  +M +G L   +   +S     T        L +A  + YL  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL-- 140

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV-DHELGPRTTGLAGTL--GYMAPEY 372
             ++ V HRD+   N M D  F VK+ DFGLA  + D E           L   + A E 
Sbjct: 141 AEQKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 373 ISTGR 377
           + T R
Sbjct: 200 LQTYR 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (287), Expect = 5e-29
 Identities = 57/182 (31%), Positives = 84/182 (46%), Gaps = 13/182 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRH 252
           ++F   R LG+G FG VY          +A+K + +    K G    +  E++  S LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+L++    HDR    L+ EF P G L   L   +  G      +   +   LA AL Y
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEE-LADALHY 129

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
            H   +R V+HRDIK  N++      +K+ DFG ++        R   + GTL Y+ PE 
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEM 183

Query: 373 IS 374
           I 
Sbjct: 184 IE 185

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  113 bits (286), Expect = 6e-29
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 14/150 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHRNLLQL 258
            + +G+G FG V  G        VAVK     +K+      ++ E    +QLRH NL+QL
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKC----IKNDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 259 IGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +G+   ++G   +V E+M  GSL  +L  +    + L      K SL +  A+ YL  E 
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 135

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              V HRD+   N++   D   K+ DFGL 
Sbjct: 136 NNFV-HRDLAARNVLVSEDNVAKVSDFGLT 164

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  114 bits (287), Expect = 7e-29
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDL----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
            ++LG+G FG+V       L       VAVKK+    +    ++  E++    L+H N++
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GYMAPEY 372
              KR  +HRD+   NI+ + +  VK+GDFGL  ++  +         G     + APE 
Sbjct: 132 T--KRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 373 ISTGR 377
           ++  +
Sbjct: 189 LTESK 193

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (286), Expect = 8e-29
 Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 15/181 (8%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           ++G+G F  VY+G+  +  + VA  ++   +  K  +  +  E +    L+H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 261 ----LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
                   +   +LV E M +G+L    + K+     +           +   L +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTL--KTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 317 WKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
               ++HRD+K  NI       +VK+GD GLA L           + GT  +MAPE    
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE 204

Query: 376 G 376
            
Sbjct: 205 K 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  115 bits (290), Expect = 9e-29
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 12/183 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
           ++ +G G FG V  G L       ++VA+K +  G  +  + +++ E     Q  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L G+       M+V E+M NGSLD  L   +      T      +  G+AS + YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSD- 165

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELGPRTTGLAGTLGYMAPEYIS 374
                VHRD+   NI+ +++   K+ DFGL   L  D E    T G    + + +PE I+
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 375 TGR 377
             +
Sbjct: 224 YRK 226

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  116 bits (293), Expect = 9e-29
 Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G        VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL   L  K  TG  L       ++  +AS + Y+       
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVER---MN 300

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (285), Expect = 1e-28
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 27/192 (14%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            +F     +G GGFG V++           +K++    K+   +   EVK  ++L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 256 LQLIG----------------LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           +   G                         +  EF   G+L+  +  +K  G  L     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
            ++   +   + Y+H    + +++RD+K SNI       VK+GDFGL   + ++ G RT 
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTR 180

Query: 360 GLAGTLGYMAPE 371
              GTL YM+PE
Sbjct: 181 -SKGTLRYMSPE 191

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 1e-28
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDL----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
            ++LG+G FG+V       L       VAVKK+    +    ++  E++    L+H N++
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G+C+  G     L+ E++P GSL  +L   K     +      + +  +   + YL 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GYMAPEY 372
              KR  +HRD+   NI+ + +  VK+GDFGL  ++  +         G     + APE 
Sbjct: 163 T--KRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 373 ISTGR 377
           ++  +
Sbjct: 220 LTESK 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (284), Expect = 2e-28
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 14/183 (7%)

Query: 201 ERKLGQGGFGAVYRGILI--DLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   VAVK +         K+E + E     QL +  ++
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C +   +MLV E    G L+ +L   +     +      ++   ++  + YL  E
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL--E 134

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GYMAPEYIS 374
                VHRD+   N++  T    K+ DFGL+  +  +         G     + APE I+
Sbjct: 135 ESNF-VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 375 TGR 377
             +
Sbjct: 194 YYK 196

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  113 bits (286), Expect = 2e-28
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 13/183 (7%)

Query: 201 ERKLGQGGFGAVYRGILID----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNL 255
            + LG G FG VY+G+ I     + + VA+K++          E + E    + + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            +L+G+C       L+ + MP G L  ++   K     +         + +A  + YL +
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYIS 374
             +R V HRD+   N++  T  +VK+ DFGLA LL   E      G    + +MA E I 
Sbjct: 136 --RRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 375 TGR 377
              
Sbjct: 193 HRI 195

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (284), Expect = 2e-28
 Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 28/200 (14%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRN 254
            +F   + LG+GGFG V+       +   A+K+I     +  + + + EVK  ++L H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 255 LLQLIGLCHDRGEFM------------LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           +++      ++                +  +     +L     + + T      +    I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHI 123

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL-------- 354
            L +A A+ +LH    + ++HRD+K SNI    D  VK+GDFGL   +D +         
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 355 ---GPRTTGLAGTLGYMAPE 371
                R TG  GT  YM+PE
Sbjct: 181 MPAYARHTGQVGTKLYMSPE 200

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  116 bits (291), Expect = 3e-28
 Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E KLGQG FG V+ G        VA+K +  G       ++ E +   +LRH  L+QL  
Sbjct: 272 EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +  +     +V E+M  GSL   L  K  TG  L       ++  +AS + Y+       
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVER---MN 383

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
            VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    GR
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  115 bits (289), Expect = 4e-28
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E+KLG G FG V+       +  VAVK +  G       ++ E      L+H  L++L  
Sbjct: 193 EKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA 250

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
           +        ++ EFM  GSL   L  K   G+          S  +A  + ++  E +  
Sbjct: 251 VVTKEP-IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNY 305

Query: 321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           + HRD++ +NI+       K+ DFGLA +++        G    + + APE I+ G 
Sbjct: 306 I-HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  113 bits (285), Expect = 4e-28
 Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
              +G+G FG VY G L+D +   +  AVK ++R       ++++TE        H N+L
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 257 QLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            L+G+C    G  ++V  +M +G L   +   ++     T        L +A  + +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTL--GYMAPEY 372
             K+  VHRD+   N M D  F VK+ DFGLA  + D E           L   +MA E 
Sbjct: 211 --KKF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 373 ISTGR 377
           + T +
Sbjct: 268 LQTQK 272

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  112 bits (282), Expect = 5e-28
 Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 23/162 (14%)

Query: 202 RKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----KNEYITEVKTCSQLR 251
           R+LGQG FG VY G+   +        VA+K     +        + E++ E     +  
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEASVMKEFN 86

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DF-----HLFSKKSTGTPLTWTTRYKISLG 305
             ++++L+G+       +++ E M  G L  +        +      P + +   +++  
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +A  + YL+    +  VHRD+   N M   DF VK+GDFG+ 
Sbjct: 147 IADGMAYLNA--NKF-VHRDLAARNCMVAEDFTVKIGDFGMT 185

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (281), Expect = 6e-28
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 13/198 (6%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLR 251
           ++ + +     LGQG    V+RG         A+K  +        +    E +   +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 252 HRNLLQLIGLCHDRG--EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H+N+++L  +  +      +L+ EF P GSL + +  + S    L  +    +   +   
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           + +L    +  +VHR+IK  NIM     D     KL DFG A  ++ +     + L GT 
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS-LYGTE 179

Query: 366 GYMAPEYISTGRARLDVN 383
            Y+ P+       R D  
Sbjct: 180 EYLHPDMYERAVLRKDHQ 197

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (282), Expect = 6e-28
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 20/217 (9%)

Query: 163 QRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNM 222
           QR   ET       L+    P  + Y++     +  +++ ++G+G FG V+R        
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84

Query: 223 AVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDF 282
             AVKK+   L+  + E   E+  C+ L    ++ L G   +     +  E +  GSL  
Sbjct: 85  QCAVKKVR--LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 283 HLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKL 341
            +   K  G  L               L YLH    R ++H D+K  N++  +D     L
Sbjct: 140 LI---KQMG-CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 192

Query: 342 GDFGLALLVDHELGPRTTG----LAGTLGYMAPEYIS 374
            DFG AL +  +   ++      + GT  +MAPE + 
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (280), Expect = 7e-28
 Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 15/185 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRN 254
             KLG G FG V RG     +   ++VAVK +   +       +++I EV     L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           L++L G+        +V E  P GSL   L   +         T  + ++ +A  + YL 
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE 138

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY--MAPEY 372
               +  +HRD+   N++  T   VK+GDFGL   +              + +   APE 
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 373 ISTGR 377
           + T  
Sbjct: 196 LKTRT 200

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (282), Expect = 8e-28
 Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 12/178 (6%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY-----ITEVKTCSQLRHRNLL 256
             +G+G F  V R I  +     AVK +                  E   C  L+H +++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +L+      G   +V+EFM    L F +  +   G   +          +  AL Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148

Query: 317 WKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
               ++HRD+K   ++    +    VKLG FG+A+ +  E G    G  GT  +MAPE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPE 203

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (290), Expect = 9e-28
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 11/181 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLL 256
            R +G+G FG V++GI +      MAVA+K          + +++ E  T  Q  H +++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           +LIG+        ++ E    G L   L   +     L   +    +  L++AL YL   
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLES- 509

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
            KR V HRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE I+  
Sbjct: 510 -KRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 377 R 377
           R
Sbjct: 568 R 568

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  113 bits (286), Expect = 9e-28
 Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 10/148 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            + +G+G FG V  G        VAVK I          ++ E    +QLRH NL+QL+G
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 261 LC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           +   ++G   +V E+M  GSL  +L  +    + L      K SL +  A+ YL      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 308

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             VHRD+   N++   D   K+ DFGL 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT 336

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  111 bits (279), Expect = 9e-28
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 23/190 (12%)

Query: 201 ERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLKHG-----KNEYITEVKTCSQLR 251
            R LG+G FG V               VAVK     LK         +   E++    L 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS----LKPESGGNHIADLKKEIEILRNLY 81

Query: 252 HRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H N+++  G+C + G     L+ EF+P+GSL  +L   K+    +    + K ++ +   
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 138

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GY 367
           + YL    ++ V HRD+   N++ +++  VK+GDFGL   ++ +    T          +
Sbjct: 139 MDYLGS--RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 368 MAPEYISTGR 377
            APE +   +
Sbjct: 196 YAPECLMQSK 205

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (280), Expect = 1e-27
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVK--KISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + LG+G FG+V  G L   +   + VAVK  K+    +    E+++E        H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 256 LQLIGLCHDRG-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR--YKISLGLAS 308
           ++L+G+C +       + M++  FM  G L  +L   +    P     +   K  + +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            + YL    +   +HRD+   N M   D  V + DFGL+
Sbjct: 159 GMEYL--SNRNF-LHRDLAARNCMLRDDMTVCVADFGLS 194

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (288), Expect = 1e-27
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 12/182 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLN--MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQ 257
           + +LG G FG+V +G+       + VA+K + +G  K    E + E +   QL +  +++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           LIG+C      MLV E    G L   L  K+     +  +   ++   ++  + YL  E 
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EE 454

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY--MAPEYIST 375
           K  V HR++   N++       K+ DFGL+  +  +    T   AG       APE I+ 
Sbjct: 455 KNFV-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 376 GR 377
            +
Sbjct: 514 RK 515

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  111 bits (279), Expect = 1e-27
 Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 16/160 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLN---MAVAVK--KISRGLKHGKNEYITEVKTCSQLRHRNL 255
            R LG+G FG+V    L   +   + VAVK  K          E++ E     +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 256 LQLIGLCHDRG------EFMLVYEFMPNGSLDFHLFSKKSTGTP--LTWTTRYKISLGLA 307
            +L+G+             M++  FM +G L   L + +    P  L   T  +  + +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             + YL    +   +HRD+   N M   D  V + DFGL+
Sbjct: 148 CGMEYL--SSRNF-IHRDLAARNCMLAEDMTVCVADFGLS 184

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (277), Expect = 2e-27
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 7/182 (3%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           +    +LG G FG VY+    +     A K I    +    +YI E++  +   H  +++
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L+G  +  G+  ++ EF P G++D  +         LT      +   +  AL +LH + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
               +HRD+K  N++   + +++L DFG++      L  R +   GT  +MAPE +    
Sbjct: 138 I---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCET 193

Query: 378 AR 379
            +
Sbjct: 194 MK 195

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 2e-27
 Identities = 36/205 (17%), Positives = 61/205 (29%), Gaps = 40/205 (19%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKIS--------------------RGLKHGKNEY- 240
             LGQ    A       +   +  V                        R L+  KN+  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 241 -------ITEVKTCSQLRHRNLLQLIGLCHDRGEFM--LVYEFMPNGSLDF--HLFSKKS 289
                  I         + + ++++     D        +Y  M +    F   L S  S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 290 TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL 349
           T   L    R +++L +   L  LH      +VH  ++  +I+ D    V L  F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253

Query: 350 VDHELGPRTTGLAGTLGYMAPEYIS 374
                G R    + + G+  PE  +
Sbjct: 254 --VRDGARVV-SSVSRGFEPPELEA 275

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  110 bits (278), Expect = 2e-27
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 14/185 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
             +LG+G FG+V       L       VAVK++       + ++  E++    L    ++
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 257 QLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  G+ +  G     LV E++P+G L   L   ++    L  +     S  +   + YL 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG 144

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GYMAPEY 372
              +RC VHRD+   NI+ +++ +VK+ DFGLA L+  +         G     + APE 
Sbjct: 145 S--RRC-VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 373 ISTGR 377
           +S   
Sbjct: 202 LSDNI 206

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (277), Expect = 2e-27
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 9/180 (5%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
              F    KLG+G +G+VY+ I  +    VA+K++   ++    E I E+    Q    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++  G      +  +V E+   GS+   +   +     LT      I       L YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              K   +HRDIK  NI+ +T+ + KL DFG+A  +   +  R T + GT  +MAPE I 
Sbjct: 143 FMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQ 198

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (277), Expect = 2e-27
 Identities = 51/190 (26%), Positives = 76/190 (40%), Gaps = 25/190 (13%)

Query: 201 ERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLKHG-----KNEYITEVKTCSQLR 251
            R LG+G FG V        N      VAVK     LK       ++ +  E+     L 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA----LKADAGPQHRSGWKQEIDILRTLY 91

Query: 252 HRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H ++++  G C D G     LV E++P GSL  +L         +        +  +   
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEG 146

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL--GY 367
           + YLH   +  + HRD+   N++ D D  VK+GDFGLA  V            G     +
Sbjct: 147 MAYLHA--QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203

Query: 368 MAPEYISTGR 377
            APE +   +
Sbjct: 204 YAPECLKEYK 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 2e-27
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 9/177 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
           ++   K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +       E  +V E++  GSL   +     T T +       +      AL +LH   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH--- 133

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
              V+HRDIK  NI+   D +VKL DFG    +  E   R+T + GT  +MAPE ++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 189

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  110 bits (276), Expect = 3e-27
 Identities = 39/163 (23%), Positives = 77/163 (47%), Gaps = 19/163 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           + +LG+G FG V+     +L      M VAVK +    +  + ++  E +  + L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----------FSKKSTGTPLTWTTRYKISL 304
           ++  G+C +    ++V+E+M +G L+  L             +     PL       ++ 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
            +A+ ++YL        VHRD+   N +      VK+GDFG++
Sbjct: 166 QVAAGMVYLAG--LHF-VHRDLATRNCLVGQGLVVKIGDFGMS 205

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  110 bits (276), Expect = 4e-27
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 13/183 (7%)

Query: 201 ERKLGQGGFGAVYRGILID----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNL 255
            + LG G FG V++G+ I     + + V +K I     +         +     L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++L+GLC       LV +++P GSL  H+   +     L         + +A  + YL E
Sbjct: 78  VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEE 133

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT-LGYMAPEYIS 374
                V HR++   N++  +   V++ DFG+A L+  +        A T + +MA E I 
Sbjct: 134 --HGMV-HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 375 TGR 377
            G+
Sbjct: 191 FGK 193

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 4e-27
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 9/177 (5%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ 257
             +  K+G+G  G V           VAVK +    +  +     EV      +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +        E  ++ EF+  G+L   +     +   L       +   +  AL YLH + 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
               +HRDIK  +I+   D  VKL DFG    +  ++  R + L GT  +MAPE IS
Sbjct: 162 V---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVIS 214

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 5e-27
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 13/198 (6%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLR 251
           ++ + +     LGQG    V+RG         A+K  +        +    E +   +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 252 HRNLLQLIGLCHDRG--EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           H+N+++L  +  +      +L+ EF P GSL + +  + S    L  +    +   +   
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           + +L E     +VHR+IK  NIM     D     KL DFG A  ++ +     + L GT 
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVS-LYGTE 179

Query: 366 GYMAPEYISTGRARLDVN 383
            Y+ P+       R D  
Sbjct: 180 EYLHPDMYERAVLRKDHQ 197

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (273), Expect = 6e-27
 Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 35/207 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHR 253
            ++F     LGQG FG V +      +   A+KKI       K   I +EV   + L H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62

Query: 254 NLLQLIGLCHDRGEFM-------------LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY 300
            +++      +R  F+             +  E+  NG+L + L   +           +
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSE--NLNQQRDEYW 119

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-- 358
           ++   +  AL Y+H    + ++HRD+K  NI  D   NVK+GDFGLA  V   L      
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 359 -----------TGLAGTLGYMAPEYIS 374
                      T   GT  Y+A E + 
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLD 203

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (272), Expect = 7e-27
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 36/197 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +R+LG+G FG V+     +L      M VAVK +       + ++  E +  + L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHL------------FSKKSTGTPLTWTTRYKIS 303
           ++  G+C D    ++V+E+M +G L+  L               +     L  +    I+
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
             +AS ++YL    +   VHRD+   N +   +  VK+GDFG++  V             
Sbjct: 140 SQIASGMVYL--ASQHF-VHRDLATRNCLVGANLLVKIGDFGMSRDV------------- 183

Query: 364 TLGYMAPEYISTGRARL 380
              Y    Y   G   L
Sbjct: 184 ---YSTDYYRVGGHTML 197

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (273), Expect = 1e-26
 Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 30/201 (14%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-------RGLKHGKNEYIT------ 242
           N++   R L QG F  +        N   A+KK         R      N+ I+      
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 243 ----EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTP 293
               E++  + +++   L   G+  +  E  ++YE+M N S+           K  T   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
                +  I   + ++  Y+H   ++ + HRD+K SNI+ D +  VKL DFG +  +  +
Sbjct: 149 PIQVIKCIIK-SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 354 LGPRTTGLAGTLGYMAPEYIS 374
                    GT  +M PE+ S
Sbjct: 206 K--IKG-SRGTYEFMPPEFFS 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (272), Expect = 1e-26
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 15/159 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRN 254
            R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLASALL 311
           +++ IG+        ++ E M  G L   L     + S  + L       ++  +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 312 YLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           YL E      +HRDI   N +   P      K+GDFG+A
Sbjct: 155 YLEE--NHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (278), Expect = 1e-26
 Identities = 49/215 (22%), Positives = 82/215 (38%), Gaps = 14/215 (6%)

Query: 162 KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN 221
                +     +       A P  F        +  +   +KLG G +G V        +
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 222 MAVAVKKIS-RGLKHGKNEYI-TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGS 279
           +  A+K I    +    N  +  EV     L H N+++L     D+  + LV E    G 
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTD 336
               LF +              I   + S + YLH+     +VHRD+K  N++    + D
Sbjct: 123 ----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175

Query: 337 FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
             +K+ DFGL+ + ++    +     GT  Y+APE
Sbjct: 176 ALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPE 208

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 1e-26
 Identities = 57/305 (18%), Positives = 97/305 (31%), Gaps = 60/305 (19%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLI 259
            R L +GGF  VY    +      A+K++    +      I EV    +L  H N++Q  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 260 G--------LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
                        + EF+L+ E      ++F    K  +  PL+  T  KI      A+ 
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEF--LKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA--------- 362
           ++H + K  ++HRD+K  N++      +KL DFG A  + H      +            
Sbjct: 151 HMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 363 --GTLGYMAPEYISTGR-----ARLDV---------------NFDE-------------- 386
              T  Y  PE I          + D+                F++              
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269

Query: 387 ---QQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAP 443
               Q      +       +   R SI + +  L       N+  K P+           
Sbjct: 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYG 329

Query: 444 CSSEP 448
            ++  
Sbjct: 330 SATLS 334

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  108 bits (271), Expect = 3e-26
 Identities = 57/183 (31%), Positives = 79/183 (43%), Gaps = 15/183 (8%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK---NEYITEVKTCSQLRHRN 254
           FS+ R++G G FGAVY    +  +  VA+KK+S   K       + I EV+   +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            +Q  G         LV E+    + D      +    PL       ++ G    L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                  +HRD+K  NI+      VKLGDFG        + P  +   GT  +MAPE I 
Sbjct: 172 SHNM---IHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS-FVGTPYWMAPEVIL 223

Query: 375 TGR 377
              
Sbjct: 224 AMD 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (275), Expect = 4e-26
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 15/197 (7%)

Query: 181 AGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY 240
           A P  F     A  ++ +  +R LG+G FG V            AVK IS+     K + 
Sbjct: 11  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 70

Query: 241 ---ITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
              + EV+   QL H N+++L     D+G F LV E    G     LF +  +    +  
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEV 126

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHEL 354
              +I   + S + Y+H+     +VHRD+K  N++      D N+++ DFGL+   +   
Sbjct: 127 DAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-- 181

Query: 355 GPRTTGLAGTLGYMAPE 371
             +     GT  Y+APE
Sbjct: 182 SKKMKDKIGTAYYIAPE 198

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (266), Expect = 4e-26
 Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 29/169 (17%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
             +LG+  FG VY+G L          AVA+K     LK       + E+  E    ++L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT----LKDKAEGPLREEFRHEAMLRARL 69

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL------------FSKKSTGTPLTWTT 298
           +H N++ L+G+        +++ +  +G L   L               ++  + L    
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +   +A+ + YL        VH+D+   N++     NVK+ D GL 
Sbjct: 130 FVHLVAQIAAGMEYLSS--HHV-VHKDLATRNVLVYDKLNVKISDLGLF 175

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 5e-26
 Identities = 45/285 (15%), Positives = 82/285 (28%), Gaps = 40/285 (14%)

Query: 132 NGRETIKIKVDVGVSIGGVVIMGIL-LLWKWKQRKETETFTWVNDDLSRDAGPRRFSYKD 190
           +GRE +  +   G   G VVI  +   + +   R  +E      D L   +         
Sbjct: 9   SGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 68

Query: 191 LASATNN----FSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---------------- 230
           + S              LGQ    A       +   +  V                    
Sbjct: 69  VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128

Query: 231 ----RGLKHGKNE-----YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF--MPNGS 279
               R L+  KN+     ++  +     ++     ++I +  D  +  ++  F   P   
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188

Query: 280 LDFH-----LFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD 334
            +       L S  ST   L    R +++L +   L  LH      +VH  ++  +I+ D
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLD 245

Query: 335 TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
               V L  F   +                    A   +  G+  
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHH 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 6e-26
 Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 14/182 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRHRN 254
           F+   K+G+G FG V++GI       VA+K I   L+  ++E      E+   SQ     
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           + +  G      +  ++ E++  GS    L        PL  T    I   +   L YLH
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG----PLDETQIATILREILKGLDYLH 136

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            E K   +HRDIK +N++      VKL DFG+A  +      R T   GT  +MAPE I 
Sbjct: 137 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 192

Query: 375 TG 376
             
Sbjct: 193 QS 194

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (266), Expect = 6e-26
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 25/180 (13%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
              LG G F  V+           A+K I +      +    E+    +++H N++ L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGLASALLYLH 314
           +      + LV + +  G L F    ++           Y       +   + SA+ YLH
Sbjct: 74  IYESTTHYYLVMQLVSGGEL-FDRILER---------GVYTEKDASLVIQQVLSAVKYLH 123

Query: 315 EEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           E     +VHRD+K  N++   P+ +  + + DFGL+ +  + +    +   GT GY+APE
Sbjct: 124 E---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPE 177

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 7e-26
 Identities = 50/269 (18%), Positives = 97/269 (36%), Gaps = 28/269 (10%)

Query: 178 SRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KH 235
             D G     ++ ++     +S  +++G GG   V++ +        A+K ++       
Sbjct: 10  GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ 68

Query: 236 GKNEYITEVKTCSQLRHRNL--LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
             + Y  E+   ++L+  +   ++L           +V E   N  L      KK     
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL-NSWLKKK---KS 123

Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDH 352
           +    R      +  A+  +H+     +VH D+K +N +   D  +KL DFG+A  +   
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179

Query: 353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTD---------CLMIVGLWCAHP- 402
                     GT+ YM PE I    +  +    + +           C++   +      
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY-MTYGKTP 238

Query: 403 --DRNCRPSIRQAIQVLNFETKMPNLPSK 429
                 + S   AI   N E + P++P K
Sbjct: 239 FQQIINQISKLHAIIDPNHEIEFPDIPEK 267

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  107 bits (268), Expect = 8e-26
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 15/159 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRN 254
            R LG G FG VY G +  +      + VAVK +     +  + +++ E    S+  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS---KKSTGTPLTWTTRYKISLGLASALL 311
           +++ IG+        ++ E M  G L   L     + S  + L       ++  +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 312 YLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           YL E      +HRDI   N +   P      K+GDFG+A
Sbjct: 196 YLEE--NHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 1e-25
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 21/209 (10%)

Query: 177 LSRDAGPRRFSYKDLASATN---NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL 233
           ++ D+  R     DL++  +    F     +G G +G VY+G  +      A+K +   +
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--V 59

Query: 234 KHG-KNEYITEVKTCSQL-RHRNLLQLIG------LCHDRGEFMLVYEFMPNGSL-DFHL 284
               + E   E+    +   HRN+    G            +  LV EF   GS+ D   
Sbjct: 60  TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI- 118

Query: 285 FSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
             K + G  L       I   +   L +LH+     V+HRDIK  N++   +  VKL DF
Sbjct: 119 --KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173

Query: 345 GLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           G++  +D  +G R T   GT  +MAPE I
Sbjct: 174 GVSAQLDRTVGRRNT-FIGTPYWMAPEVI 201

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (270), Expect = 2e-25
 Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYI-TEVKTCSQLRH 252
              ++    LG+G FG V +          AVK I+    K+     I  EV+   +L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGL 306
            N+++L  +  D   F +V E    G L F    K+          R+      +I   +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKRK---------RFSEHDAARIIKQV 130

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
            S + Y+H+     +VHRD+K  NI+    + D ++K+ DFGL+         +     G
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIG 185

Query: 364 TLGYMAPE 371
           T  Y+APE
Sbjct: 186 TAYYIAPE 193

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  107 bits (268), Expect = 2e-25
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 17/177 (9%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYI-TEVKTCSQLRHRNLLQLI 259
            +LG+G F  V R + +      A   I+ + L    ++ +  E + C  L+H N+++L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYLHEEW 317
               + G   L+++ +  G L   + +++       ++          +  A+L+ H+  
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ-- 128

Query: 318 KRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              VVHR++K  N++         VKL DFGLA+ V+ E      G AGT GY++PE
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE 183

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  105 bits (263), Expect = 2e-25
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 27/167 (16%)

Query: 201 ERKLGQGGFGAVYRGILI--DLNMAVAVKKISRGLKHG-----KNEYITEVKTCSQL-RH 252
           +  +G+G FG V +  +    L M  A+K+    +K         ++  E++   +L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRDFAGELEVLCKLGHH 85

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL------------FSKKSTGTPLTWTTRY 300
            N++ L+G C  RG   L  E+ P+G+L   L                ST + L+     
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 301 KISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             +  +A  + YL +  K+  +HRD+   NI+   ++  K+ DFGL+
Sbjct: 146 HFAADVARGMDYLSQ--KQF-IHRDLAARNILVGENYVAKIADFGLS 189

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (261), Expect = 2e-25
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 30/192 (15%)

Query: 195 TNNFSNE----RKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYI-TEVKTCS 248
           +  FS+      +LG+G F  V R +     +  A K I+ + L     + +  E + C 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KI 302
           +L+H N+++L     +     LV++ +  G L F     +           Y        
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-FEDIVAR---------EFYSEADASHC 110

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTT 359
              +  ++ Y H      +VHR++K  N++         VKL DFGLA+ V+        
Sbjct: 111 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWH 165

Query: 360 GLAGTLGYMAPE 371
           G AGT GY++PE
Sbjct: 166 GFAGTPGYLSPE 177

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 3e-25
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 28/210 (13%)

Query: 173 VNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG 232
           ++      +G     ++   +    ++    LG+G FG V +          AVK I++ 
Sbjct: 1   MHHHHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58

Query: 233 LKHGKNEYI--TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKST 290
               K+      EV+   +L H N+++L  +  D   F +V E    G L F    K+  
Sbjct: 59  SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKRK- 116

Query: 291 GTPLTWTTRY------KISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKL 341
                   R+      +I   + S + Y+H+     +VHRD+K  NI+    + D ++K+
Sbjct: 117 --------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165

Query: 342 GDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            DFGL+         +     GT  Y+APE
Sbjct: 166 IDFGLSTCFQQ--NTKMKDRIGTAYYIAPE 193

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  104 bits (261), Expect = 4e-25
 Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 21/183 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLI 259
           E  LG+G    V   I +  +   AVK I +   H ++    EV+   Q + HRN+L+LI
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYLHEEW 317
               +   F LV+E M  GS+  H+  ++       +       +   +ASAL +LH   
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVVQDVASALDFLHN-- 129

Query: 318 KRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHE------LGPRTTGLAGTLGYM 368
            + + HRD+K  NI+   P+    VK+ DF L   +           P      G+  YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 369 APE 371
           APE
Sbjct: 189 APE 191

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 6e-25
 Identities = 33/204 (16%), Positives = 62/204 (30%), Gaps = 27/204 (13%)

Query: 189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHGKNEYITE 243
            +    +        LG+G F  VY     DLN         +K           E+   
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIG 114

Query: 244 VKTCSQLR---HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS-TGTPLTWTTR 299
            +   +L+       ++       +   +LV E    G+L   +   K+     +     
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIM-----------PDTDFNVKLGDFGLAL 348
              ++ +   +  +H      ++H DIK  N +            D    + L D G ++
Sbjct: 175 ISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 349 -LVDHELGPRTTGLAGTLGYMAPE 371
            +     G   T    T G+   E
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVE 255

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 8e-25
 Identities = 39/191 (20%), Positives = 63/191 (32%), Gaps = 19/191 (9%)

Query: 195 TNNFSNERKLGQG--GFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT----EVKTCS 248
              +     +G+G      V           V V++I+  L+   NE +T    E+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSK 81

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
              H N++          E  +V  FM  GS    L         +       I  G+  
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLI-CTHFMDGMNELAIAYILQGVLK 139

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT------GLA 362
           AL Y+H       VHR +K S+I+   D  V L      L +      +           
Sbjct: 140 ALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 363 GTLGYMAPEYI 373
             L +++PE +
Sbjct: 197 KVLPWLSPEVL 207

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  103 bits (258), Expect = 8e-25
 Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 12/178 (6%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQL-RHR 253
           +F    +LG G +G V++    +     AVK+     +  K+    + EV +  ++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
             ++L     + G   L  E     SL  H    ++ G  L     +        AL +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           H    + +VH D+K +NI        KLGDFGL + +            G   YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE 226

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (258), Expect = 1e-24
 Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 44/201 (21%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
            + LG G FG V       L      + VAVK     LK       K   ++E+K  S L
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM----LKSTAHADEKEALMSELKIMSHL 106

Query: 251 -RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DF---------HLFSKKSTGTPLTWTTR 299
            +H N++ L+G C   G  +++ E+   G L +F            +     +  +    
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
              S  +A  + +L    K C +HRD+   N++       K+GDFGLA  +         
Sbjct: 167 LHFSSQVAQGMAFL--ASKNC-IHRDVAARNVLLTNGHVAKIGDFGLARDI--------- 214

Query: 360 GLAGTLGYMAPEYISTGRARL 380
                       YI  G ARL
Sbjct: 215 -------MNDSNYIVKGNARL 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (258), Expect = 1e-24
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 6/186 (3%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKT-CSQLRHR 253
            +  +  ++G+G +G+V + +       +AVK+I   +   + + +  ++          
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            ++Q  G     G+  +  E M      F+ +        +      KI+L    AL +L
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
            E  K  ++HRDIK SNI+ D   N+KL DFG++  +   +       AG   YMAPE I
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERI 197

Query: 374 STGRAR 379
               +R
Sbjct: 198 DPSASR 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (259), Expect = 1e-24
 Identities = 46/196 (23%), Positives = 86/196 (43%), Gaps = 18/196 (9%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYI 241
              F        ++N+  + +LG+G F  V R +     +  A K I+ + L     + +
Sbjct: 16  GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 242 -TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY 300
             E + C +L+H N+++L     +     LV++ +  G L   + +++       ++   
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEAD 129

Query: 301 --KISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELG 355
                  +  ++ Y H      +VHR++K  N++         VKL DFGLA+ V+    
Sbjct: 130 ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--S 184

Query: 356 PRTTGLAGTLGYMAPE 371
               G AGT GY++PE
Sbjct: 185 EAWHGFAGTPGYLSPE 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  102 bits (256), Expect = 2e-24
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 19/177 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLI 259
           ++ LG+G F    + +    N A AVK IS   K  +     E+        H N+++L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYLHEEW 317
            + HD+    LV E +  G L   +  KK       ++      I   L SA+ ++H+  
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD-- 124

Query: 318 KRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              VVHRD+K  N++    + +  +K+ DFG A L   +  P  T    TL Y APE
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE 179

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  102 bits (257), Expect = 2e-24
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 25/194 (12%)

Query: 189 KDLASATNNFSNE----RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEV 244
           + L   +  F++       +G G +    R I    NM  AVK I +  +    E I  +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEIL 69

Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDF-HLFSKKSTGTPLTWTTRY--K 301
               Q  H N++ L  +  D     +V E M  G L    +  +K       ++ R    
Sbjct: 70  LRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGEL-LDKILRQKF------FSEREASA 120

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPR 357
           +   +   + YLH    + VVHRD+K SNI+         ++++ DFG A  +  E G  
Sbjct: 121 VLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177

Query: 358 TTGLAGTLGYMAPE 371
            T    T  ++APE
Sbjct: 178 MT-PCYTANFVAPE 190

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (257), Expect = 2e-24
 Identities = 47/245 (19%), Positives = 89/245 (36%), Gaps = 28/245 (11%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNL--LQ 257
           +++G GG   V++ +        A+K ++         + Y  E+   ++L+  +   ++
Sbjct: 15  KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L           +V E   N  L      KK     +    R      +  A+  +H+  
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDL-NSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ-- 126

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              +VH D+K +N +   D  +KL DFG+A  +             GT+ YM PE I   
Sbjct: 127 -HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 377 RARLDVNFDEQQTD---------CLMIVGLWCAHP---DRNCRPSIRQAIQVLNFETKMP 424
            +  +    + +           C++   +            + S   AI   N E + P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYY-MTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 425 NLPSK 429
           ++P K
Sbjct: 244 DIPEK 248

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (262), Expect = 2e-24
 Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 16/188 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNL 255
            +  + +LG GGFG V R I  D    VA+K+  + L     E    E++   +L H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 256 LQLI------GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           +                  +L  E+   G L     ++      L       +   ++SA
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
           L YLHE     ++HRD+K  NI+          K+ D G A  +D   G   T   GTL 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQ 188

Query: 367 YMAPEYIS 374
           Y+APE + 
Sbjct: 189 YLAPELLE 196

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (254), Expect = 2e-24
 Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 31/186 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISR---------GLKHGKNEYITEVKTCSQL-R 251
             LG+G    V R I        AVK I            ++  +   + EV    ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLG 305
           H N++QL         F LV++ M  G L F   ++K                  KI   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEK---------VTLSEKETRKIMRA 132

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L   +  LH+     +VHRD+K  NI+ D D N+KL DFG +  +D   G +   + GT 
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 187

Query: 366 GYMAPE 371
            Y+APE
Sbjct: 188 SYLAPE 193

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (261), Expect = 3e-24
 Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 37/211 (17%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR----------- 231
           P  +  K       ++   RKLG G +G V      + +   A+K I +           
Sbjct: 23  PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD 82

Query: 232 --GLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS 289
              ++    E   E+     L H N+++L  +  D+  F LV EF   G L F     + 
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-FEQIINRH 141

Query: 290 TGTPLTWTTRY------KISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVK 340
                    ++       I   + S + YLH+     +VHRDIK  NI+    ++  N+K
Sbjct: 142 ---------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189

Query: 341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + DFGL+         +     GT  Y+APE
Sbjct: 190 IVDFGLSSFFSK--DYKLRDRLGTAYYIAPE 218

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  101 bits (254), Expect = 3e-24
 Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 53/210 (25%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
            + LG+G FG V +     L        VAVK     LK         + ++E     Q+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LKENASPSELRDLLSEFNVLKQV 83

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DF-------------------HLFSKKST 290
            H ++++L G C   G  +L+ E+   GSL  F                           
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV 350
              LT       +  ++  + YL     +  VHRD+   NI+      +K+ DFGL+  V
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL--AEMKL-VHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 351 DHELGPRTTGLAGTLGYMAPEYISTGRARL 380
                           Y    Y+   + R+
Sbjct: 201 ----------------YEEDSYVKRSQGRI 214

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (256), Expect = 4e-24
 Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 11/199 (5%)

Query: 175 DDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK 234
           +D+ +   P+    K   S  + +    +LG G FG V+R +          K I+    
Sbjct: 31  EDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89

Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K     E+   +QL H  L+ L     D+ E +L+ EF+  G L F   + +     +
Sbjct: 90  LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL-FDRIAAE--DYKM 146

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLALLVDH 352
           +              L ++HE     +VH DIK  NIM       +VK+ DFGLA  ++ 
Sbjct: 147 SEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203

Query: 353 ELGPRTTGLAGTLGYMAPE 371
                      T  + APE
Sbjct: 204 --DEIVKVTTATAEFAAPE 220

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =   99 bits (250), Expect = 6e-24
 Identities = 46/180 (25%), Positives = 71/180 (39%), Gaps = 24/180 (13%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
           E  +G+G +G V   +     +  A KKI +      + +  E++    L H N+++L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGLASALLYLH 314
              D  +  LV E    G L F     K           +      +I   + SA+ Y H
Sbjct: 74  TFEDNTDIYLVMELCTGGEL-FERVVHKR---------VFRESDAARIMKDVLSAVAYCH 123

Query: 315 EEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +     V HRD+K  N +      D  +KL DFGLA       G       GT  Y++P+
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQ 178

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (252), Expect = 7e-24
 Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 32/172 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHG-----KNEYITEVKTCS 248
            + LG+G FG V     + +        + VAVK     LK        ++ ++E++   
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMK 95

Query: 249 QL-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL------------DFHLFSKKSTGTPLT 295
            + +H+N++ L+G C   G   ++ E+   G+L            ++     +     +T
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +      +  LA  + YL    ++C +HRD+   N++   +  +K+ DFGLA
Sbjct: 156 FKDLVSCTYQLARGMEYLAS--QKC-IHRDLAARNVLVTENNVMKIADFGLA 204

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (253), Expect = 8e-24
 Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 30/185 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI--------TEVKTCSQLR-H 252
             +G+G    V R +        AVK +    +    E +         E     Q+  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGL 306
            +++ LI          LV++ M  G L F   ++K                   I   L
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEK---------VALSEKETRSIMRSL 209

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
             A+ +LH      +VHRD+K  NI+ D +  ++L DFG +  ++   G +   L GT G
Sbjct: 210 LEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPG 264

Query: 367 YMAPE 371
           Y+APE
Sbjct: 265 YLAPE 269

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  101 bits (254), Expect = 8e-24
 Identities = 48/245 (19%), Positives = 91/245 (37%), Gaps = 28/245 (11%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNL--LQ 257
           +++G GG   V++ +        A+K ++         + Y  E+   ++L+  +   ++
Sbjct: 62  KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L           +V E   N  L+  L  KKS    +    R      +  A+  +H+  
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQ-- 173

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYISTG 376
              +VH D+K +N +   D  +KL DFG+A  +             G + YM PE I   
Sbjct: 174 -HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 377 RARLDVNFDEQQTD---------CLMIVGLWCAHP---DRNCRPSIRQAIQVLNFETKMP 424
            +  +    + +           C++   +            + S   AI   N E + P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYY-MTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290

Query: 425 NLPSK 429
           ++P K
Sbjct: 291 DIPEK 295

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (252), Expect = 1e-23
 Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 26/179 (14%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            +LG+G    VYR          A+K + +     K    TE+    +L H N+++L  +
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGLASALLYLHE 315
                E  LV E +  G L F    +K           Y           +  A+ YLHE
Sbjct: 117 FETPTEISLVLELVTGGEL-FDRIVEKG---------YYSERDAADAVKQILEAVAYLHE 166

Query: 316 EWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                +VHRD+K  N++   P  D  +K+ DFGL+ +V+H        + GT GY APE
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPE 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 19/264 (7%)

Query: 174 NDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL 233
           +    +  G      +   +  N+  N  ++G G  G V++         +AVK++ R  
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62

Query: 234 KHGKNEYIT-EVKT-CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
              +N+ I  ++           ++Q  G      +  +  E M   +       KK   
Sbjct: 63  NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL----KKRMQ 118

Query: 292 TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
            P+      K+++ +  AL YL E+    V+HRD+K SNI+ D    +KL DFG++  + 
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

Query: 352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDC--LMIVGLWCAH---PDRNC 406
            +     +  AG   YMAPE I         ++D  + D   L I  +  A    P +NC
Sbjct: 177 DDKAKDRS--AGCAAYMAPERIDPPDPT-KPDYDI-RADVWSLGISLVELATGQFPYKNC 232

Query: 407 RPSIRQAIQVLNFETKMPNLPSKM 430
           +       +VL  E   P LP  M
Sbjct: 233 KTDFEVLTKVLQEE--PPLLPGHM 254

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =   99 bits (250), Expect = 1e-23
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 14/185 (7%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQ 249
           S+++ F    KLG G +  VY+G+     + VA+K++    + G     T   E+    +
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKE 59

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPN---GSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
           L+H N+++L  + H   +  LV+EFM N     +D    +  +T   L           L
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSR--TVGNTPRGLELNLVKYFQWQL 117

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
              L + HE     ++HRD+K  N++ +    +KLGDFGLA      +   ++ +  TL 
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173

Query: 367 YMAPE 371
           Y AP+
Sbjct: 174 YRAPD 178

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 11/176 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRNLLQLI 259
           +RKLG G FG V+        +   +K I++       E I  E++    L H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFH-LFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
            +  D     +V E    G L    + S ++ G  L+     ++   + +AL Y H    
Sbjct: 87  EVFEDYHNMYIVMETCEGGEL-LERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--- 142

Query: 319 RCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + VVH+D+K  NI+         +K+ DFGLA L        +T  AGT  YMAPE
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPE 196

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 18/194 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRH 252
           +++  +  +G G    V           VA+K+I+  L+      +E + E++  SQ  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHH 72

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK----ISLGLAS 308
            N++        + E  LV + +  GS+   +    + G   +          I   +  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-----LLVDHELGPRTTGLAG 363
            L YLH+  +   +HRD+K  NI+   D +V++ DFG++              R T   G
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVG 188

Query: 364 TLGYMAPEYISTGR 377
           T  +MAPE +   R
Sbjct: 189 TPCWMAPEVMEQVR 202

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  100 bits (252), Expect = 1e-23
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 32/172 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-------MAVAVKKISRGLKHG-----KNEYITEVKTCS 248
            + LG+G FG V     I L+         VAVK     LK        ++ I+E++   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMK 129

Query: 249 QL-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL------------DFHLFSKKSTGTPLT 295
            + +H+N++ L+G C   G   ++ E+   G+L            ++      +    L+
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                  +  +A  + YL    K+C +HRD+   N++   D  +K+ DFGLA
Sbjct: 190 SKDLVSCAYQVARGMEYL--ASKKC-IHRDLAARNVLVTEDNVMKIADFGLA 238

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 19/182 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT---EVKTCSQLRH 252
             +    KLG+G +  VY+G     +  VA+K+I    + G     T   EV     L+H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPN---GSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
            N++ L  + H      LV+E++       LD         G  +           L   
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-------DCGNIINMHNVKLFLFQLLRG 112

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L Y H +    V+HRD+K  N++ +    +KL DFGLA             +  TL Y  
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168

Query: 370 PE 371
           P+
Sbjct: 169 PD 170

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 2e-23
 Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 32/172 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHG-----KNEYITEVKTCS 248
            + LG+G FG V     + +        + VAVK     LK        ++ ++E++   
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMK 141

Query: 249 QL-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL------------DFHLFSKKSTGTPLT 295
            + +H+N++ L+G C   G   ++ E+   G+L            ++     +     +T
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +      +  LA  + YL    ++C +HRD+   N++   +  +K+ DFGLA
Sbjct: 202 FKDLVSCTYQLARGMEYLAS--QKC-IHRDLAARNVLVTENNVMKIADFGLA 250

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (254), Expect = 2e-23
 Identities = 50/212 (23%), Positives = 78/212 (36%), Gaps = 28/212 (13%)

Query: 173 VNDDLSRDAGPRRFSYKDLASATNNFSN----ERKLGQGGFGAVYRGILIDLNMAVAVKK 228
            N D       +++  + +    ++  +      +LG G FG V+R          A K 
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189

Query: 229 ISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-------D 281
           +    +  K     E++T S LRH  L+ L     D  E +++YEFM  G L        
Sbjct: 190 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 249

Query: 282 FHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNV 339
             +   ++                +   L ++HE      VH D+K  NIM        +
Sbjct: 250 NKMSEDEAVEYMRQ----------VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL 296

Query: 340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           KL DFGL   +D           GT  + APE
Sbjct: 297 KLIDFGLTAHLDP--KQSVKVTTGTAEFAAPE 326

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 37/177 (20%)

Query: 201 ERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
            R +G+G FG V++     L        VAVK     LK       + ++  E    ++ 
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM----LKEEASADMQADFQREAALMAEF 107

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------------------DFHLFSKKST 290
            + N+++L+G+C       L++E+M  G L                              
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
             PL+   +  I+  +A+ + YL E  ++  VHRD+   N +   +  VK+ DFGL+
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSE--RKF-VHRDLATRNCLVGENMVVKIADFGLS 221

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 40/201 (19%), Positives = 72/201 (35%), Gaps = 30/201 (14%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY--ITEVKTCSQL-R 251
           T  F    K+G G FG+V++ +        A+K+  + L    +E   + EV   + L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++      +    ++  E+   GSL   +       +         + L +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 312 YLHEEWKRCVVHRDIKFSNIM-------------------PDTDFNVKLGDFGLALLVDH 352
           Y+H      +VH DIK SNI                           K+GD G    +  
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 353 ELGPRTTGLAGTLGYMAPEYI 373
              P+     G   ++A E +
Sbjct: 187 ---PQV--EEGDSRFLANEVL 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 3e-23
 Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 31/227 (13%)

Query: 174 NDDLS-RDAGPRRFSYKDLASATNNFSNE---------RKLGQGGFGAVYRGILIDLNMA 223
           N +++   +  + F + DL     +   +         + LG G  G V           
Sbjct: 103 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKK 162

Query: 224 VAVKKISR-------GLKHGKNEYI-TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM 275
           VA++ IS+         +      + TE++   +L H  ++++        ++ +V E M
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELM 221

Query: 276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--- 332
             G     LF K      L   T       +  A+ YLHE     ++HRD+K  N++   
Sbjct: 222 EGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSS 274

Query: 333 PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR 379
            + D  +K+ DFG + ++          L GT  Y+APE + +    
Sbjct: 275 QEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTA 319

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 51/217 (23%), Positives = 75/217 (34%), Gaps = 49/217 (22%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY-----ITEVKTCSQLRHRNL 255
           +  +GQG +G V   I        A+K +++      N        TEV+   +L H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG---------- 305
            +L  +  D     LV E    G L   L       T        K  +           
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 306 --------------------------LASALLYLHEEWKRCVVHRDIKFSNIM--PDTDF 337
                                     + SAL YLH    + + HRDIK  N +   +  F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207

Query: 338 NVKLGDFGLALLV---DHELGPRTTGLAGTLGYMAPE 371
            +KL DFGL+      ++      T  AGT  ++APE
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 20/219 (9%)

Query: 162 KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSN------ERKLGQGGFGAVYRG 215
           +   +++  + +  D+     P  F ++ + +     ++         LG G FG V++ 
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAP--FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108

Query: 216 ILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM 275
                 + +A K I       K E   E+   +QL H NL+QL      + + +LV E++
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168

Query: 276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--- 332
             G L F     +     LT          +   + ++H   +  ++H D+K  NI+   
Sbjct: 169 DGGEL-FDRIIDE--SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVN 222

Query: 333 PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
            D    +K+ DFGLA         +     GT  ++APE
Sbjct: 223 RDAK-QIKIIDFGLARRYKP--REKLKVNFGTPEFLAPE 258

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 31/170 (18%)

Query: 202 RKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHG-----KNEYITEVKTCSQL- 250
           + LG+G FG V       ++       VAVK     LK G         ++E+K    + 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIG 88

Query: 251 RHRNLLQLIGLCHDRGE-FMLVYEFMPNGSL------------DFHLFSKKSTGTPLTWT 297
            H N++ L+G C   G   M++ EF   G+L             + +  +      LT  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                S  +A  + +L    ++C +HRD+   NI+      VK+ DFGLA
Sbjct: 149 HLICYSFQVAKGMEFL--ASRKC-IHRDLAARNILLSEKNVVKICDFGLA 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 7/181 (3%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVK-TCSQLRHR 253
           ++     +LG+G +G V +   +     +AVK+I   +   + + +  ++  +   +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
             +   G     G+  +  E M + SLD         G  +      KI++ +  AL +L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H +    V+HRD+K SN++ +    VK+ DFG++  +  ++       AG   YMAPE I
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERI 181

Query: 374 S 374
           +
Sbjct: 182 N 182

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 6e-23
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 12/181 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRN 254
           ++F    +LG G  G V++       + +A K I   +K      I  E++   +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++   G  +  GE  +  E M  GSLD     KK+   P       K+S+ +   L YL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLD--QVLKKAGRIPEQILG--KVSIAVIKGLTYLR 148

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL-LVDHELGPRTTGLAGTLGYMAPEYI 373
           E+ K  ++HRD+K SNI+ ++   +KL DFG++  L+D       +   GT  YM+PE +
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS-FVGTRSYMSPERL 202

Query: 374 S 374
            
Sbjct: 203 Q 203

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score = 95.7 bits (237), Expect = 9e-23
 Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 19/148 (12%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
             +IPS S G  LGLF S+    S + +V VEFD++ N +    N    +GI+ +SI S 
Sbjct: 96  DTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNY-RHIGIDVNSIRSK 154

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN---------------- 104
             ++W+  + +G TA   I YNSA+K LS   SY  +                       
Sbjct: 155 AASKWD--WQNGKTATAHISYNSASKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGF 212

Query: 105 TTSTGRYTERHVLKSWEFNSTLDIKEIN 132
           + +TG+YT+ + + +W F S+L   + N
Sbjct: 213 SATTGQYTQTNNILAWSFRSSLMGYQAN 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 47/186 (25%), Positives = 72/186 (38%), Gaps = 19/186 (10%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNL 255
           +F  +  LG G  G +    + D N  VAVK+I        +    EV+   +   H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++      DR    +  E     +L      +K             +     S L +LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATL-QEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 316 EWKRCVVHRDIKFSNIM-----PDTDFNVKLGDFGLA--LLVDHELGPRTTGLAGTLGYM 368
                +VHRD+K  NI+             + DFGL   L V      R +G+ GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 369 APEYIS 374
           APE +S
Sbjct: 194 APEMLS 199

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 13/180 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYIT---EVKTCSQLR 251
            NF    K+G+G +G VY+         VA+KKI       G     T   E+    +L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELN 60

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L+ + H   +  LV+EF+     D   F   S  T +           L   L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + H      V+HRD+K  N++ +T+  +KL DFGLA      +   T  +  TL Y APE
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 17/189 (8%)

Query: 190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI----SRGLKHGKNEYIT--- 242
           D+ S    +     LG+G F  VY+    + N  VA+KKI        K G N   T   
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALR 61

Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E+K   +L H N++ L+     +    LV++FM    L+  +   K     LT +     
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAY 117

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
            L     L YLH+ W   ++HRD+K +N++ D +  +KL DFGLA          T  + 
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174

Query: 363 GTLGYMAPE 371
            T  Y APE
Sbjct: 175 -TRWYRAPE 182

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 44/172 (25%), Positives = 64/172 (37%), Gaps = 32/172 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
            + LG G FG V       L      M VAVK     LK       +   ++E+K  S L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM----LKPSAHLTEREALMSELKVLSYL 83

Query: 251 -RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL--------------DFHLFSKKSTGTPLT 295
             H N++ L+G C   G  +++ E+   G L                     +     L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
                  S  +A  + +L    K C +HRD+   NI+       K+ DFGLA
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNC-IHRDLAARNILLTHGRITKICDFGLA 192

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 23/192 (11%)

Query: 192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI------TEVK 245
           +   +++    +LG G F  V +          A K I +         +       EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 246 TCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
              ++RH N++ L  +  ++ + +L+ E +  G L F   ++K +      T        
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL-FDFLAEKES-----LTEDEATQFL 114

Query: 306 --LASALLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTT 359
             +   + YLH    + + H D+K  NIM       +  +KL DFG+A  ++   G    
Sbjct: 115 KQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFK 169

Query: 360 GLAGTLGYMAPE 371
            + GT  ++APE
Sbjct: 170 NIFGTPEFVAPE 181

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 37/177 (20%)

Query: 201 ERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----KNEYITEVKTCSQL 250
            + LG G FG V       +     ++ VAVK     LK       +   ++E+K  +QL
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELKMMTQL 105

Query: 251 -RHRNLLQLIGLCHDRGEFMLVYEFMPNGSL-DF------------------HLFSKKST 290
             H N++ L+G C   G   L++E+   G L ++                      ++  
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 291 GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              LT+      +  +A  + +L  E+K C VHRD+   N++      VK+ DFGLA
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFL--EFKSC-VHRDLAARNVLVTHGKVVKICDFGLA 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 31/187 (16%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKIS------RGLKHGKNEYITEVKTCSQLRHRN 254
             +LG G F  V +       +  A K I             + E   EV    Q+ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSL------DFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ L  +  +R + +L+ E +  G L         L  +++T               +  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----------ILD 126

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            + YLH    + + H D+K  NIM         ++KL DFGLA  ++   G     + GT
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGT 181

Query: 365 LGYMAPE 371
             ++APE
Sbjct: 182 PEFVAPE 188

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 43/195 (22%), Positives = 74/195 (37%), Gaps = 33/195 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISR-------GLKHGKNEYI-TEVKTCSQLRHR 253
           + LG G  G V           VA+K IS+         +      + TE++   +L H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGLA 307
            ++++        ++ +V E M  G L F                R            + 
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGEL-FDKVVGN---------KRLKEATCKLYFYQML 124

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            A+ YLHE     ++HRD+K  N++    + D  +K+ DFG + ++          L GT
Sbjct: 125 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGT 179

Query: 365 LGYMAPEYISTGRAR 379
             Y+APE + +    
Sbjct: 180 PTYLAPEVLVSVGTA 194

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 31/186 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI------TEVKTCSQLRHRNL 255
            +LG G F  V +       +  A K I +         +       EV    Q+ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSL------DFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           + L  +  +R + +L+ E +  G L         L  +++T               +   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----------ILDG 127

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           + YLH    + + H D+K  NIM         ++KL DFGLA  ++   G     + GT 
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTP 182

Query: 366 GYMAPE 371
            ++APE
Sbjct: 183 EFVAPE 188

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 36/191 (18%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY-------ITEVKTCS 248
             +    K+G+G +G V++    D    VA+KK          +        + E++   
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           QL+H NL+ L+ +   +    LV+E+  + ++   L         +       I+     
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQ 113

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG----- 363
           A+ + H+      +HRD+K  NI+      +KL DFG A         R           
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA---------RLLTGPSDYYDD 161

Query: 364 ---TLGYMAPE 371
              T  Y +PE
Sbjct: 162 EVATRWYRSPE 172

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 17/180 (9%)

Query: 200 NERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHR-NLL 256
             ++LG+G F  V + I        A K +   R  +  + E + E+      +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL--GLASALLYLH 314
            L  +  +  E +L+ E+   G + F L   +        +    I L   +   + YLH
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEI-FSLCLPELAE---MVSENDVIRLIKQILEGVYYLH 148

Query: 315 EEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +     +VH D+K  NI+        ++K+ DFG++  + H        + GT  Y+APE
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPE 203

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 55/192 (28%), Positives = 76/192 (39%), Gaps = 22/192 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT----EVKTCSQLRHRNLL 256
            R +G+GG G VY          VA+K +S  L      + T    E +T  +L+  +++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP-VFRTRMQREARTAGRLQEPHVV 97

Query: 257 QLIGLCHDRGEF----MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            +    HD GE      +    +    L   L   +  G PL       I   + SAL  
Sbjct: 98  PI----HDFGEIDGQLYVDMRLINGVDLAAML---RRQG-PLAPPRAVAIVRQIGSALDA 149

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
            H        HRD+K  NI+   D    L DFG+A     E   +     GTL YMAPE 
Sbjct: 150 AHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 373 ISTGRA--RLDV 382
            S   A  R D+
Sbjct: 207 FSESHATYRADI 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 13/173 (7%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
             LG+G FG V+R +          K +  +G    +     E+   +  RHRN+L L  
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHE 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                 E ++++EF+    + F   +       L           +  AL +LH      
Sbjct: 69  SFESMEELVMIFEFISGLDI-FERINTS--AFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 321 VVHRDIKFSNIM--PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + H DI+  NI+        +K+ +FG A  +    G     L     Y APE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPE 173

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 36/191 (18%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY-------ITEVKTCS 248
             + N   +G+G +G V +    D    VA+KK         ++        + E+K   
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLK 79

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           QLRH NL+ L+ +C  +  + LV+EF+ + ++   L   +     L +    K    + +
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIIN 135

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG----- 363
            + + H      ++HRDIK  NI+      VKL DFG A         RT    G     
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA---------RTLAAPGEVYDD 183

Query: 364 ---TLGYMAPE 371
              T  Y APE
Sbjct: 184 EVATRWYRAPE 194

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 41/180 (22%), Positives = 77/180 (42%), Gaps = 14/180 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYIT---EVKTCSQLR 251
             +    K+G+G +G V++    + +  VA+K++       G     +   E+    +L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELK 59

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H+N+++L  + H   +  LV+EF     L  +     S    L           L   L 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           + H      V+HRD+K  N++ + +  +KL +FGLA      +   +  +  TL Y  P+
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 21/184 (11%)

Query: 203 KLGQGGFGAVYRGILIDL--NMAVAVKKISR-GLKHGKNEYITEVKTCSQLRHRNLLQLI 259
           K+G+G +G VY+    D   +   A+K+I   G+         E+    +L+H N++ L 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQ 84

Query: 260 GLCHDRGE--FMLVYEFMPN---GSLDFHLFSK-KSTGTPLTWTTRYKISLGLASALLYL 313
            +     +    L++++  +     + FH  SK       L       +   +   + YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFN----VKLGDFGLALLVDHELGPRTTGLAG--TLGY 367
           H  W   V+HRD+K +NI+   +      VK+ D G A L +  L P         T  Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 368 MAPE 371
            APE
Sbjct: 202 RAPE 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 23/183 (12%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKI------SRGLKHGKNEYITEVKTCSQLRHRN 254
             +LG G F  V +       +  A K I      S      + +   EV    +++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG--LASALLY 312
           ++ L  +  ++ + +L+ E +  G L F   ++K +      T          + + + Y
Sbjct: 76  VITLHEVYENKTDVILILELVAGGEL-FDFLAEKES-----LTEEEATEFLKQILNGVYY 129

Query: 313 LHEEWKRCVVHRDIKFSNIM----PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           LH      + H D+K  NIM          +K+ DFGLA  +D   G     + GT  ++
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFV 184

Query: 369 APE 371
           APE
Sbjct: 185 APE 187

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 93.7 bits (233), Expect = 6e-21
 Identities = 43/200 (21%), Positives = 73/200 (36%), Gaps = 30/200 (15%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQL-RHR 253
           N   +E+ LG G  G V           VAVK++         +    E+K  ++   H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLID----FCDIALMEIKLLTESDDHP 69

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY---KISLGLASAL 310
           N+++            +  E   N +L   + SK  +   L     Y    +   +AS +
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 311 LYLHEEWKRCVVHRDIKFSNIM-------------PDTDFNVKLGDFGLALLVD---HEL 354
            +LH      ++HRD+K  NI+                +  + + DFGL   +D      
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 355 GPRTTGLAGTLGYMAPEYIS 374
                  +GT G+ APE + 
Sbjct: 186 RTNLNNPSGTSGWRAPELLE 205

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score = 89.8 bits (222), Expect = 9e-21
 Identities = 47/151 (31%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIVS 59
           G +IP NS GG+LG+ +S+    S +  V VEFDS  N  WDP +++   +GI+ +SI+S
Sbjct: 90  GTEIPPNSQGGYLGITDSSN---SQNQFVAVEFDSHPNV-WDPKSLRSSHIGIDVNSIMS 145

Query: 60  SVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENT-------------- 105
                WN    SG      I Y+S TK L+   ++      +                  
Sbjct: 146 LKAVNWN--RVSGSLEKATIIYDSDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVG 203

Query: 106 ---TSTGRYTERHVLKSWEFNSTLDIKEING 133
              T+     ERH + SW F STL   E   
Sbjct: 204 FSATTWNPERERHDIYSWSFTSTLKEPEEQA 234

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 36/190 (18%)

Query: 203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY----IT---EVKTCSQLRHRNL 255
           K+GQG FG V++         VA+KK+       +NE     IT   E+K    L+H N+
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQLLKHENV 78

Query: 256 LQLIGLCHDR--------GEFMLVYEFMPN---GSLDFHLFSKKSTGTPLTWTTRYKISL 304
           + LI +C  +        G   LV++F  +   G L        +     T +   ++  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQ 131

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT---TGL 361
            L + L Y+H      ++HRD+K +N++   D  +KL DFGLA         +    T  
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 362 AGTLGYMAPE 371
             TL Y  PE
Sbjct: 189 VVTLWYRPPE 198

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.2 bits (234), Expect = 1e-20
 Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 42/193 (21%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMA---VAVKKISRGLKHGKNE-----YITEVKTCSQLRH 252
           +  +  GG G +Y  +  D N+    V +K    GL H  +       + E +  +++ H
Sbjct: 85  KGCIAHGGLGWIYLAL--DRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLAEVVH 138

Query: 253 RNLLQLIGLCHDRGEFM---------LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKIS 303
            +++Q+     +  E           +V E++   SL      K+S G  L         
Sbjct: 139 PSIVQI----FNFVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYL 188

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
           L +  AL YLH      +V+ D+K  NIM   +  +KL D G    ++         L G
Sbjct: 189 LEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYG 239

Query: 364 TLGYMAPEYISTG 376
           T G+ APE + TG
Sbjct: 240 TPGFQAPEIVRTG 252

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 26/207 (12%)

Query: 178 SRDAGPRRFSYKDLASATN--NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH 235
           ++  GP   S     SAT+   +    KLG+G +G VY+ I    N  VA+K+I    + 
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RL 69

Query: 236 GKNE------YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS 289
              E       I EV    +L+HRN+++L  + H      L++E+      +  L     
Sbjct: 70  EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMD 124

Query: 290 TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-----NVKLGDF 344
               ++          L + + + H       +HRD+K  N++           +K+GDF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181

Query: 345 GLALLVDHELGPRTTGLAGTLGYMAPE 371
           GLA      +   T  +  TL Y  PE
Sbjct: 182 GLARAFGIPIRQFTHEII-TLWYRPPE 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 19/200 (9%)

Query: 179 RDAGPRRFSYKDL--ASATNNFSNERKLGQGGFGAVYRGILIDL-NMAVAVKKISRGL-K 234
                     ++L        +    K+G+G +G VY+    D     VA+K+I      
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAED 59

Query: 235 HGKNEYIT---EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG 291
            G     T   E+    +L H N++ LI + H      LV+EFM    L   L       
Sbjct: 60  EGIP--STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENK 113

Query: 292 TPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD 351
           T L  +        L   + + H+     ++HRD+K  N++ ++D  +KL DFGLA    
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170

Query: 352 HELGPRTTGLAGTLGYMAPE 371
             +   T  +  TL Y AP+
Sbjct: 171 IPVRSYTHEVV-TLWYRAPD 189

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score = 89.5 bits (221), Expect = 2e-20
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 20/155 (12%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAK-LSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIV 58
              IPS S GG LGLFN  TA   S++ ++ VEFD+F     +  +     +GI+ +SI 
Sbjct: 105 DTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIR 164

Query: 59  SSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-------------- 104
           SS   RW      G T +V + YN +T+ +    +Y +  +Y   +              
Sbjct: 165 SSKVVRWE--RREGKTLNVLVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRV 222

Query: 105 --TTSTGRYTERHVLKSWEFNSTLDIKEINGRETI 137
             + ++G   + H L+SW F STL        E +
Sbjct: 223 GFSAASGEQFQTHNLESWSFTSTLLYTAQKEDEYL 257

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 10/181 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           N F   R LG+GGFG V    +       A KK+ +     +      + E +   ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           R ++ L      +    LV   M  G L FH++     G P      Y  +  +   L  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLED 301

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH      +V+RD+K  NI+ D   ++++ D GLA  V    G    G  GT+GYMAPE 
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEV 356

Query: 373 I 373
           +
Sbjct: 357 V 357

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score = 87.4 bits (216), Expect = 2e-20
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 4   IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
               + GG+LG+FNS      ++  V VEFD+F N  WDP N    +GI+ +SI S    
Sbjct: 92  TKPQTGGGYLGVFNSAEYD-KTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK 150

Query: 64  RWNASFHSGDTAHVKIKYNSATKNLSASWSY 94
            W     +G+ A+V I +N+AT  L+ S +Y
Sbjct: 151 SWK--LQNGEEANVVIAFNAATNVLTVSLTY 179

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score = 88.3 bits (218), Expect = 3e-20
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 25/145 (17%)

Query: 4   IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
               + GG+LG+FNS      ++  V VEFD+F N  WDP N    +GI+ +SI S    
Sbjct: 92  TKPQTGGGYLGVFNSAEYD-KTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK 150

Query: 64  RWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN------------------- 104
            W     +G+ A+V I +N+AT  L+ S +Y       +                     
Sbjct: 151 SWK--LQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVR 208

Query: 105 ---TTSTGRYTERHVLKSWEFNSTL 126
              + +TG     H + SW F+S L
Sbjct: 209 IGFSATTGAEYAAHEVLSWSFHSEL 233

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 16/186 (8%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT------EVKTCS 248
            +S    LG G FG V+  +  + N  V VK I +   L+    E         E+   S
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 249 QLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           ++ H N+++++ +  ++G F LV E   +G     LF+       L       I   L S
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYM 368
           A+ YL     + ++HRDIK  NI+   DF +KL DFG A  +  E G       GT+ Y 
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYC 196

Query: 369 APEYIS 374
           APE + 
Sbjct: 197 APEVLM 202

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 41/204 (20%), Positives = 74/204 (36%), Gaps = 30/204 (14%)

Query: 183 PRRFSYKDLASATNNFSN-----ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK 237
                ++         ++     ++ LG G  G V            A+K +    K  +
Sbjct: 11  GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ 70

Query: 238 NEYITEVKTCSQL-RHRNLLQLIGLCHDRGE----FMLVYEFMPNGSLDFHLFSKKSTGT 292
                EV    Q     +++ ++ +  +        +++ E M  G     LFS+     
Sbjct: 71  -----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERG 121

Query: 293 PLTWTTRY--KISLGLASALLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
              +T R   +I   + +A+ +LH      + HRD+K  N++    + D  +KL DFG A
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

Query: 348 LLVDHELGPRTTGLAGTLGYMAPE 371
                      T    T  Y+APE
Sbjct: 179 KETTQ--NALQT-PCYTPYYVAPE 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 41/181 (22%), Positives = 72/181 (39%), Gaps = 24/181 (13%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLI 259
            + LG G  G V +          A+K +    K  +     EV+   +  +  ++++++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 121

Query: 260 GLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY--KISLGLASALLYL 313
            +  +    R   ++V E +  G L    FS+        +T R   +I   +  A+ YL
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 314 HEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
           H      + HRD+K  N++      +  +KL DFG A           T    T  Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAP 232

Query: 371 E 371
           E
Sbjct: 233 E 233

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score = 87.9 bits (217), Expect = 5e-20
 Identities = 43/146 (29%), Positives = 61/146 (41%), Gaps = 23/146 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIVS 59
             QIPS S   +LGLFN++ +  SS+ IV VEFD++    +DP +     +GI+ + I S
Sbjct: 97  DSQIPSGSVSKYLGLFNNSNSD-SSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIES 155

Query: 60  SVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQ----------------- 102
               +W+  + +G  A   I Y +  K L AS  Y                         
Sbjct: 156 IKTVQWD--WINGGVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRV 213

Query: 103 --ENTTSTGRYTERHVLKSWEFNSTL 126
                T      E H + SW F STL
Sbjct: 214 GFSAATGYPTEVETHDVLSWSFTSTL 239

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.7 bits (221), Expect = 5e-20
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 15/180 (8%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYIT---EVKTCSQLR 251
             +    K+G+G +G VY+    +     A+KKI       G     T   E+    +L+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIP--STTIREISILKELK 58

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H N+++L  + H +   +LV+E +    L   L         L   T     L L + + 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           Y H+     V+HRD+K  N++ + +  +K+ DFGLA      +   T  +  TL Y AP+
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score = 87.9 bits (217), Expect = 5e-20
 Identities = 41/144 (28%), Positives = 60/144 (41%), Gaps = 23/144 (15%)

Query: 3   QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNP--EWDPINVKDDVGINNSSIVSS 60
             P    GG+ GLFN T    SS   V VEFD+  +P   WDP      +GI+ + + S 
Sbjct: 97  DSPLRRAGGYFGLFNDTKCD-SSYQTVAVEFDTIGSPVNFWDPGF--PHIGIDVNCVKSI 153

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN---------------- 104
              RWN  +   + A+V+I Y +++K L+AS +Y                          
Sbjct: 154 NAERWNKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVG 213

Query: 105 -TTSTGR-YTERHVLKSWEFNSTL 126
            + ST       H + +W F ST 
Sbjct: 214 FSGSTYIGRQATHEVLNWYFTSTF 237

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 12/187 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLRHRNLLQ 257
             KLG GG   VY      LN+ VA+K I    +  +     +  EV   SQL H+N++ 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           +I +  +   + LV E++   +L  ++ S      PL+  T    +  +   + + H+  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD-- 129

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
              +VHRDIK  NI+ D++  +K+ DFG+A  +      +T  + GT+ Y +PE      
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 378 A--RLDV 382
                D+
Sbjct: 189 TDECTDI 195

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 11/183 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYI-TEVKTCSQLRH 252
            +F   + LG+G F  V     +  +   A+K  +    +K  K  Y+  E    S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
              ++L     D  +      +  NG L  ++   +  G+     TR+  +  + SAL Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA-EIVSALEY 145

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           LH    + ++HRD+K  NI+ + D ++++ DFG A +L       R     GT  Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 372 YIS 374
            ++
Sbjct: 203 LLT 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 20/184 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT----EVKTCSQLRHR- 253
              LG GGFG+VY GI +  N+ VA+K + +      G+    T    EV    ++    
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 254 -NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             +++L+        F+L+ E  P    D  LF   +    L           +  A+ +
Sbjct: 108 SGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGL-ALLVDHELGPRTTGLAGTLGYMAP 370
            H      V+HRDIK  NI+ D +   +KL DFG  ALL D           GT  Y  P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDF--DGTRVYSPP 217

Query: 371 EYIS 374
           E+I 
Sbjct: 218 EWIR 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 11/183 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           + F + R LG+GGFG V+   +       A KK+++     +  Y   + E K  +++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFS--KKSTGTPLTWTTRYKISLGLASAL 310
           R ++ L      + +  LV   M  G + +H+++  + + G        Y  +  + S L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGL 302

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +LH+   R +++RD+K  N++ D D NV++ D GLA+ +      +T G AGT G+MAP
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAP 358

Query: 371 EYI 373
           E +
Sbjct: 359 ELL 361

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score = 86.4 bits (213), Expect = 2e-19
 Identities = 45/141 (31%), Positives = 62/141 (43%), Gaps = 20/141 (14%)

Query: 5   PSNSPGGFLGLFNSTTAK-LSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
                GGFLGLF   TA   S + +V VEFD++ N +W+       +GI+ +SIVS   T
Sbjct: 101 SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPP-YPHIGIDVNSIVSVATT 159

Query: 64  RW-NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN----------------TT 106
           RW N   +    A   I Y++ +K L+   SY     Y   +                + 
Sbjct: 160 RWENDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSA 219

Query: 107 STGRYTERHVLKSWEFNSTLD 127
             G Y E   + SW F STLD
Sbjct: 220 GVG-YDEVTYILSWHFFSTLD 239

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 20/189 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-------RGLKHGKNE-YITEVKTC 247
           N+FS  R +G+GGFG VY     D     A+K +        +G     NE  +      
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS--LV 246

Query: 248 SQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           S      ++ +    H   +   + + M  G L +HL              R+  +  + 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAA-EII 302

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             L ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     GT GY
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGY 356

Query: 368 MAPEYISTG 376
           MAPE +  G
Sbjct: 357 MAPEVLQKG 365

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 54/189 (28%), Positives = 73/189 (38%), Gaps = 22/189 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKT--------CSQL 250
              LG+GGFG V+ G  +   + VA+K I R   L                      +  
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H  +++L+     +  FMLV E          LF   +   PL           + +A+
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQ---DLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGL-ALLVDHELGPRTTGLAGTLGYM 368
            + H    R VVHRDIK  NI+ D      KL DFG  ALL D           GT  Y 
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDF--DGTRVYS 205

Query: 369 APEYISTGR 377
            PE+IS  +
Sbjct: 206 PPEWISRHQ 214

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 13/178 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLI 259
            + LG+G +G V   +      AVAVK +         E I  E+     L H N+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G   +     L  E+   G L    F +      +      +    L + ++YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GI 124

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR---TTGLAGTLGYMAPEYIS 374
            + HRDIK  N++ D   N+K+ DFGLA +  +    R        GTL Y+APE + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK 180

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 47/192 (24%), Positives = 78/192 (40%), Gaps = 21/192 (10%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEY-------ITEV 244
            AT+ +    ++G G +G VY+         VA+K +       G           +  +
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 245 KTCSQLRHRNLLQLIGLCHDRGE-----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
           +      H N+++L+ +C            LV+E +     D   +  K+    L   T 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETI 122

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTT 359
             +       L +LH      +VHRD+K  NI+  +   VKL DFGLA +  +++    T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALT 177

Query: 360 GLAGTLGYMAPE 371
            +  TL Y APE
Sbjct: 178 PVVVTLWYRAPE 189

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score = 84.8 bits (209), Expect = 6e-19
 Identities = 40/144 (27%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSS 60
             QIP+ S GG     + T     +   V VEFD++SN E++     D VGI+ +S+ S 
Sbjct: 93  DTQIPAGSIGGGTLGVSDTK---GAGHFVGVEFDTYSNSEYNDPPT-DHVGIDVNSVDSV 148

Query: 61  VYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN---------------- 104
               WN    SG    V + Y+S+TK LS + +       +                   
Sbjct: 149 KTVPWN--SVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGF 206

Query: 105 TTSTGR-YTERHVLKSWEFNSTLD 127
           + S      + H+++SW F STL 
Sbjct: 207 SASGSLGGRQIHLIRSWSFTSTLI 230

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 39/205 (19%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT----------------- 242
            ++G+G +G V      + N   A+K +S+   ++                         
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 243 -------EVKTCSQLRHRNLLQLIGLCHD--RGEFMLVYEFMPNGSLDFHLFSKKSTGTP 293
                  E+    +L H N+++L+ +  D       +V+E +  G +        +   P
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK-P 133

Query: 294 LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL-ALLVDH 352
           L+          L   + YLH    + ++HRDIK SN++   D ++K+ DFG+       
Sbjct: 134 LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 353 ELGPRTTGLAGTLGYMAPEYISTGR 377
           +     T   GT  +MAPE +S  R
Sbjct: 191 DALLSNT--VGTPAFMAPESLSETR 213

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score = 84.8 bits (209), Expect = 7e-19
 Identities = 44/153 (28%), Positives = 62/153 (40%), Gaps = 24/153 (15%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
             +S GGFLGLF+S  +  S+   V VEFD++ N  +        +G + +SI S    +
Sbjct: 100 APDSGGGFLGLFDSAVSG-STYQTVAVEFDTYENTVFTDPPY-THIGFDVNSISSIKTVK 157

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-------------------- 104
           W  S  +G+ A V I YNSA K L AS  Y  +                           
Sbjct: 158 W--SLANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAA 215

Query: 105 TTSTGRYTERHVLKSWEFNSTLDIKEINGRETI 137
           T ++G   E H + SW F S L          +
Sbjct: 216 TGASGGKIETHDVFSWSFASKLAGXXTKDSSFL 248

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 13/178 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLI 259
            + LG+G +G V   +      AVAVK +         E I  E+     L H N+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
           G   +     L  E+   G L    F +      +      +    L + ++YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GI 124

Query: 320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR---TTGLAGTLGYMAPEYIS 374
            + HRDIK  N++ D   N+K+ DFGLA +  +    R        GTL Y+APE + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK 180

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 11/176 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYIT-EVKTCSQLRHRNLLQL 258
            + +G+G F  V     I     VA+K I +  L     + +  EV+    L H N+++L
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWK 318
             +        L+ E+   G +    F        +           + SA+ Y H   +
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---Q 132

Query: 319 RCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           + +VHRD+K  N++ D D N+K+ DFG +       G +     G   Y APE   
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPYAAPELFQ 186

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 31/193 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
             ++++ + +G G FG VY+  L D    VA+KK+   L+  + +   E++   +L H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKN-RELQIMRKLDHCN 108

Query: 255 LLQLIGLCHDRGEFM------LVYEFMPNGSLDFHLFSK--KSTGTPLTWTT----RYKI 302
           +++L    +  GE        LV +++P      +  ++        L         Y++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLALLVDHELGPRTTG 360
              LA    Y+H      + HRDIK  N++  PDT   +KL DFG A  +    G     
Sbjct: 166 FRSLA----YIH---SFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR--GEPNVS 215

Query: 361 LAGTLGYMAPEYI 373
              +  Y APE I
Sbjct: 216 YICSRYYRAPELI 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 39/186 (20%), Positives = 73/186 (39%), Gaps = 17/186 (9%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEY--ITEVKTCSQLRHRNLL 256
              LG+G +G V   +  +     AVK + +    +    E     E++   +LRH+N++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 257 QL--IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           QL  +    ++ +  +V E+   G  +  +                     L   L YLH
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH 126

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP---RTTGLAGTLGYMAPE 371
               + +VH+DIK  N++  T   +K+   G+A  +         RT+   G+  +  PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPE 181

Query: 372 YISTGR 377
             +   
Sbjct: 182 IANGLD 187

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score = 79.4 bits (195), Expect = 6e-18
 Identities = 36/132 (27%), Positives = 57/132 (43%), Gaps = 19/132 (14%)

Query: 28  IVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKN 87
           +V VEFD++ NP++   N    +GI+ +SI S V  +W+  + +G  A   I YNS +K 
Sbjct: 3   VVAVEFDTYLNPDYGDPNY-IHIGIDVNSIRSKVTAKWD--WQNGKIATAHISYNSVSKR 59

Query: 88  LSASWSYGETPKYSQEN----------------TTSTGRYTERHVLKSWEFNSTLDIKEI 131
           LS +  Y  +   +                   + STG+  ER+ + SW F S+L     
Sbjct: 60  LSVTSYYAGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLWTNVA 119

Query: 132 NGRETIKIKVDV 143
                 K     
Sbjct: 120 KKENENKYITRG 131

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score = 81.7 bits (201), Expect = 6e-18
 Identities = 44/142 (30%), Positives = 62/142 (43%), Gaps = 25/142 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                GG LG+F        S+ IV VEFD+FSN +WDP      +GIN +SI S     
Sbjct: 99  QPLDLGGMLGIFKDGYFN-KSNQIVAVEFDTFSNGDWDPKG--RHLGINVNSIESIKTVP 155

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-------------------- 104
           WN  + +G+ A+V I Y ++TK+L+AS  Y         +                    
Sbjct: 156 WN--WTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSAT 213

Query: 105 TTSTGRYTERHVLKSWEFNSTL 126
           T     Y + + + SW F S L
Sbjct: 214 TGIDKGYVQTNDVLSWSFESNL 235

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score = 82.1 bits (202), Expect = 6e-18
 Identities = 46/146 (31%), Positives = 64/146 (43%), Gaps = 25/146 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              S  GFLG+F+S     +S+  V VEFD+FSN +WDP +    +GI+ +SI S     
Sbjct: 97  EPKSNSGFLGVFDSDVYD-NSAQTVAVEFDTFSNTDWDPTS--RHIGIDVNSIKSIRTAS 153

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-----------------TTS 107
           W     +G  A + I YN+AT  L AS  +         +                 + +
Sbjct: 154 WG--LANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSAT 211

Query: 108 TGR---YTERHVLKSWEFNSTLDIKE 130
           TG    YTE H + SW F S L    
Sbjct: 212 TGLSEGYTETHDVLSWSFASKLPDDS 237

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score = 81.8 bits (201), Expect = 8e-18
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 23/148 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIVS 59
             QIPS S  G  GLF+S+ +K SS+ I+ VEFD++    ++P +     +GI+ +SI S
Sbjct: 96  NSQIPSGSSAGMFGLFSSSDSK-SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKS 154

Query: 60  SVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQ----------------- 102
               +W+  + +G+ A V I Y + TK+L+   SY      +                  
Sbjct: 155 IKTVKWD--WRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSV 212

Query: 103 --ENTTSTGRYTERHVLKSWEFNSTLDI 128
                       E H + SW F S L+ 
Sbjct: 213 GFSGGVGNAAEFETHDVLSWYFTSNLEA 240

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score = 81.8 bits (201), Expect = 8e-18
 Identities = 29/150 (19%), Positives = 52/150 (34%), Gaps = 31/150 (20%)

Query: 3   QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVY 62
             P      FLG+FN+   +  ++  V V F++F N              + + I   V 
Sbjct: 95  NSPPQKKQEFLGIFNTNNPE-PNARTVAVVFNTFKNRI----------DFDKNFIKPYVN 143

Query: 63  TRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN------------------ 104
              +   ++G+   V+I Y+S+  +L     +  +      +                  
Sbjct: 144 ENCDFHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFS 203

Query: 105 --TTSTGRYTERHVLKSWEFNSTLDIKEIN 132
             +  T   TE H + SW F+S    K  N
Sbjct: 204 PTSGLTEDTTETHDVLSWSFSSKFRNKLSN 233

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 12/177 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT-EVKTCSQLRHRNLLQ 257
              LG G FG V  G        VAVK ++R           I  E++     RH ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L  +     +F +V E++  G L    F        +      ++   + SA+ Y H   
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH--- 128

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +  VVHRD+K  N++ D   N K+ DFGL+ ++      RT+   G+  Y APE IS
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score = 81.0 bits (199), Expect = 2e-17
 Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 20/147 (13%)

Query: 5   PSNSPGGFLGLFNSTTA-KLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
                G +LGLFN +TA + S + +V VEFD+++NP +   +    +GIN +SIVS    
Sbjct: 100 DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSY-RHIGINVNSIVSVATK 158

Query: 64  RW-NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN----------------TT 106
           RW ++   SG  A  +I Y+ + + L+   SY +   Y   +                + 
Sbjct: 159 RWEDSDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISA 218

Query: 107 STGRYT-ERHVLKSWEFNSTLDIKEIN 132
           STG        + SW F+S L    + 
Sbjct: 219 STGNNQFLTVYILSWRFSSNLQSTSVK 245

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score = 80.6 bits (198), Expect = 2e-17
 Identities = 37/142 (26%), Positives = 59/142 (41%), Gaps = 25/142 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                 G+LG+FN++    +S   + VEFD+FSNP   P      +GI+ +SI S     
Sbjct: 101 KPAQGYGYLGVFNNSKQD-NSYQTLAVEFDTFSNPWDPPQV--PHIGIDVNSIRSIKTQP 157

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-----------------TTS 107
           +     +G  A+V IKY++ +K L     Y  +                        + +
Sbjct: 158 FQ--LDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGA 215

Query: 108 TGRY---TERHVLKSWEFNSTL 126
           TG      E H + SW F ++L
Sbjct: 216 TGAQRDAAETHDVYSWSFQASL 237

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 22/184 (11%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           ++F   R +G+G FG V      D     A+K +++     +NE      E++    L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLA 307
             L+ L     D  +  +V + +  G L +HL     F ++        T +  I   L 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--------TVKLFIC-ELV 125

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL YL     + ++HRD+K  NI+ D   +V + DF +A ++      + T +AGT  Y
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMAGTKPY 180

Query: 368 MAPE 371
           MAPE
Sbjct: 181 MAPE 184

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 43/248 (17%), Positives = 79/248 (31%), Gaps = 73/248 (29%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAV------------KKISRGLK--------- 234
            +F   + +G+GGFG V+       +   A+            +K+ R +K         
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 235 -------------------------------------HGKNEYITEVKTCSQLRHRNLLQ 257
                                                   +    +++       +N + 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
            +     +    +  +     +L     +++ +           I + +A A+ +LH   
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENL-KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-- 182

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-----------LLVDHELGPRTTGLAGTLG 366
            + ++HRD+K SNI    D  VK+GDFGL            +L         TG  GT  
Sbjct: 183 -KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 367 YMAPEYIS 374
           YM+PE I 
Sbjct: 242 YMSPEQIH 249

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 31/196 (15%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRH 252
            + F  ER  GQG FG V  G      M+VA+KK+   ++    +N  +  ++  + L H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHH 78

Query: 253 RNLLQLIGLCHDRGE-------FMLVYEFMPNGSLDFHLFSK--KSTGTPLTWTT----R 299
            N++QL    +  GE         +V E++P      H   +                  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLA-LLVDHELGPR 357
           +++   +      LH      V HRDIK  N++ +  D  +KL DFG A  L   E  P 
Sbjct: 136 FQLIRSIG----CLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PN 188

Query: 358 TTGLAGTLGYMAPEYI 373
              +  +  Y APE I
Sbjct: 189 VAYIC-SRYYRAPELI 203

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 20/194 (10%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT----EVKTCSQLRHRNLL 256
              LG GG   V+    +  +  VAVK +   L      +      E +  + L H  ++
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIV 75

Query: 257 QL--IGLCHDRGEFM--LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            +   G        +  +V E++   +L   + ++     P+T     ++      AL +
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNF 131

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT-TGLA-GTLGYMAP 370
            H+     ++HRD+K +NIM      VK+ DFG+A  +       T T    GT  Y++P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 371 EYISTGRA--RLDV 382
           E         R DV
Sbjct: 189 EQARGDSVDARSDV 202

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 16/178 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-EVKTCSQLRHRNLLQLI 259
            + +G G FG             VAVK I RG     +E +  E+     LRH N+++  
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFK 82

Query: 260 GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR 319
            +        ++ E+   G L    + +       +          L S + Y H     
Sbjct: 83  EVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SM 135

Query: 320 CVVHRDIKFSNIMPDTDF--NVKLGDFGL-ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
            + HRD+K  N + D      +K+ DFG     V H   P++T   GT  Y+APE + 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPEVLL 190

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 25/193 (12%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKISRGLKHGKN--------EYITE 243
            A   +    ++G+G +G V++   L +    VA+K++   ++ G+         E +  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIRE-VAV 64

Query: 244 VKTCSQLRHRNLLQLIGLCHDRGE-----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
           ++      H N+++L  +C            LV+E +     D   +  K     +   T
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTET 121

Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT 358
              +   L   L +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++    
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--AL 176

Query: 359 TGLAGTLGYMAPE 371
           T +  TL Y APE
Sbjct: 177 TSVVVTLWYRAPE 189

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score = 79.0 bits (194), Expect = 8e-17
 Identities = 44/148 (29%), Positives = 62/148 (41%), Gaps = 27/148 (18%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                GGFLGLF+ +    S+   V VEFD+  N +WDP      +GI+ +SI S   TR
Sbjct: 98  QPKDKGGFLGLFDGSN---SNFHTVAVEFDTLYNKDWDPTE--RHIGIDVNSIRSIKTTR 152

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-------------------- 104
           W+  F +G+ A V I Y+S+T  L AS  Y         +                    
Sbjct: 153 WD--FVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSAT 210

Query: 105 TTSTGRYTERHVLKSWEFNSTLDIKEIN 132
           T       E + + SW F S L  +  +
Sbjct: 211 TGINKGNVETNDVLSWSFASKLSDETTS 238

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 32/193 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
              ++N + +G G FG V++  L++ +  VA+KK+   L+  + +   E++    ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV---LQDKRFKN-RELQIMRIVKHPN 93

Query: 255 LLQLIGLCHDRGEFM------LVYEFMPNGSLDFHLFSK--KSTGTPLTWTT----RYKI 302
           ++ L    +  G+        LV E++P      +  S+        +         Y++
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSN--IMPDTDFNVKLGDFGLALLVDHELGPRTTG 360
              LA    Y+H      + HRDIK  N  + P +   +KL DFG A ++    G     
Sbjct: 151 LRSLA----YIH---SIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA--GEPNVS 200

Query: 361 LAGTLGYMAPEYI 373
              +  Y APE I
Sbjct: 201 YICSRYYRAPELI 213

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 50/192 (26%), Positives = 76/192 (39%), Gaps = 30/192 (15%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLR 251
              + N + +G G  G V       L   VA+KK+SR      H K  Y  E+     + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82

Query: 252 HRNLLQLIGL---CHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YK 301
           H+N++ L+ +        EF    +V E M     +     +      L         Y+
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---NLCQVIQM----ELDHERMSYLLYQ 135

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +  G+     +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T  
Sbjct: 136 MLCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPY 186

Query: 362 AGTLGYMAPEYI 373
             T  Y APE I
Sbjct: 187 VVTRYYRAPEVI 198

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 52/192 (27%), Positives = 75/192 (39%), Gaps = 30/192 (15%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLR 251
              + N + +G G  G V       L+  VA+KK+SR      H K  Y  E+     + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 119

Query: 252 HRN---LLQLIGLCHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YK 301
           H+N   LL +        EF    LV E M     +     +      L         Y+
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQM----ELDHERMSYLLYQ 172

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +  G+     +LH      ++HRD+K SNI+  +D  +K+ DFGLA           T  
Sbjct: 173 MLCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPY 223

Query: 362 AGTLGYMAPEYI 373
             T  Y APE I
Sbjct: 224 VVTRYYRAPEVI 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 43/177 (24%), Positives = 69/177 (38%), Gaps = 21/177 (11%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ------ 257
           +G+G F  V    +       A+K ++      K + +   +       R++L       
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMN------KWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 258 LIGLCH---DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  L     D     LV E+   G L   L SK     P      Y     +  A+  +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFY--LAEIVMAIDSVH 179

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
              +   VHRDIK  NI+ D   +++L DFG  L +  +   R+    GT  Y++PE
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 9/179 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRH 252
            +F   + +G+G FG V    L + +   A+K +++     + E   +  E         
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
           + +  L     D     LV ++   G L   L SK     P      Y     +  A+  
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFY--LAEMVIAIDS 190

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +H   +   VHRDIK  NI+ D + +++L DFG  L +  +   +++   GT  Y++PE
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score = 75.6 bits (185), Expect = 8e-16
 Identities = 34/142 (23%), Positives = 52/142 (36%), Gaps = 31/142 (21%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                G +LGLFN+T      +  V V FD+ SN           + I+ +SI       
Sbjct: 95  RPKLKGRYLGLFNTTNYD-RDAHTVAVVFDTVSN----------RIEIDVNSIRPIATES 143

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS--------------------QEN 104
            N   ++G+ A V+I Y+S   +L  S  Y  + +                         
Sbjct: 144 CNFGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSAT 203

Query: 105 TTSTGRYTERHVLKSWEFNSTL 126
           + S    TE H + SW F+S  
Sbjct: 204 SGSKKETTETHNVLSWSFSSNF 225

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score = 75.6 bits (185), Expect = 9e-16
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 33/148 (22%)

Query: 3   QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVY 62
              +   GG+ G++N      S  P V VEFD+F N  WDP      +GI+ +S++S+  
Sbjct: 98  NTQTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT-WDPQI--PHIGIDVNSVISTKT 150

Query: 63  TRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKY---------------------- 100
             +     +G  A+V IKY+++TK L     +                            
Sbjct: 151 VPFT--LDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFS 208

Query: 101 --SQENTTSTGRYTERHVLKSWEFNSTL 126
             + + +      TE H + SW F+++L
Sbjct: 209 AATGDPSGKQRNATETHDILSWSFSASL 236

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 14/215 (6%)

Query: 162 KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN 221
           K+  E E+          D   +  +     +  + F   + LG G FG V      +  
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 222 MAVAVK--KISRGLKHGKNEYI-TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG 278
              A+K     + +K  + E+   E +    +    L++L     D     +V E++  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN 338
            +  HL        P     R+  +  +     YLH      +++RD+K  N++ D    
Sbjct: 127 EMFSHLRRIGRFSEP---HARFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179

Query: 339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           +++ DFG A      +  RT  L GT   +APE I
Sbjct: 180 IQVTDFGFA----KRVKGRTWTLCGTPEALAPEII 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 14/178 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT-EVKTCSQLRHRNLLQ 257
              LG G FG V  G        VAVK ++R           I  E++     RH ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L  +     +  +V E++  G     LF        L      ++   + S + Y H   
Sbjct: 81  LYQVISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVDYCH--- 133

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGL-ALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +  VVHRD+K  N++ D   N K+ DFGL  ++ D E   RT+   G+  Y APE IS
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVIS 188

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score = 74.4 bits (182), Expect = 2e-15
 Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 26/142 (18%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              + GGFLGLF       +S   V VEFD++SN  WDP      +GI+ + I S   T 
Sbjct: 97  QPQARGGFLGLFADRAHD-ASYQTVAVEFDTYSNA-WDPNY--THIGIDTNGIESKKTTP 152

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-----------------TTS 107
           ++     G+ A++ I Y ++TK L+AS  +  +      +                 + +
Sbjct: 153 FD--MVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSAT 210

Query: 108 TGR---YTERHVLKSWEFNSTL 126
           TG      E H + SW F  +L
Sbjct: 211 TGLNAGVVETHDIVSWSFAVSL 232

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 18/217 (8%)

Query: 162 KQRKETETFTWVNDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN 221
           ++ K  + F     D        R   +D       +   + +G+G FG V         
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIGRGAFGEVQLVRHKSTR 94

Query: 222 MAVAVKKISRG--LKHGKNEYI-TEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNG 278
              A+K +S+   +K   + +   E    +      ++QL     D     +V E+MP G
Sbjct: 95  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154

Query: 279 SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN 338
            L  +L S      P  W   Y  +  +  AL  +H       +HRD+K  N++ D   +
Sbjct: 155 DL-VNLMSNY--DVPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGH 206

Query: 339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
           +KL DFG  + ++ E   R     GT  Y++PE + +
Sbjct: 207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 51/190 (26%), Positives = 76/190 (40%), Gaps = 32/190 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLR 251
              + +   +G G +G+V   I       VA+KK+SR  +     K  Y  E+     ++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQ 81

Query: 252 HRNLLQLIGL---CHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YK 301
           H N++ L+ +         F    LV  FM     D             +        Y+
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGL----KFSEEKIQYLVYQ 134

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +  GL     Y+H      VVHRD+K  N+  + D  +K+ DFGLA   D E+    TG 
Sbjct: 135 MLKGLK----YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGY 183

Query: 362 AGTLGYMAPE 371
             T  Y APE
Sbjct: 184 VVTRWYRAPE 193

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 74.1 bits (181), Expect = 3e-15
 Identities = 32/117 (27%), Positives = 46/117 (39%), Gaps = 19/117 (16%)

Query: 25  SSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA 84
           +  IV VE D++ N +    +    +GI+  S+ S    +WN    +G      I YNS 
Sbjct: 1   ADTIVAVELDTYPNTDIGDPS-YPHIGIDIKSVRSKKTAKWN--MQNGKVGTAHIIYNSV 57

Query: 85  TKNLSASWSYGETPKYSQEN----------------TTSTGRYTERHVLKSWEFNST 125
            K LSA  SY      +                   + STG Y E + + SW F S 
Sbjct: 58  DKRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 28/182 (15%), Positives = 56/182 (30%), Gaps = 23/182 (12%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG---KNEYITEVKTCSQLRHRNLLQ 257
               G       ++ +   L+  VA+  +            E ++     S++    + +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           ++ + H R   ++V E++  GSL           T  +     +    LA+A    H   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT--TGLAGTLGYMAPEYIST 375
              V       S +    D +V L           +  P+    G+  +L Y        
Sbjct: 150 ---VALSIDHPSRVRVSIDGDVVLAYPATM----PDANPQDDIRGIGASL-YAL----LV 197

Query: 376 GR 377
            R
Sbjct: 198 NR 199

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 15/179 (8%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HR 253
            +++   RKLG+G +  V+  I I  N  V VK +       K +   E+K    LR   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGP 91

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++ L  +  D         F    + DF    +  T        R+ +   +  AL Y 
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY----DIRFYM-YEILKALDYC 146

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           H      ++HRD+K  N+M D +   ++L D+GLA       G        +  +  PE
Sbjct: 147 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPE 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYIT-EVKTCSQLRHRNLLQ 257
              LG+G FG V           VA+K ISR    K   +  +  E+     LRH ++++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW 317
           L  +     + ++V E+   G L    F        +T     +    +  A+ Y H   
Sbjct: 74  LYDVITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125

Query: 318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
           +  +VHRD+K  N++ D + NVK+ DFGL+ ++      +T+   G+  Y APE I+
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN 180

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 32/161 (19%), Positives = 62/161 (38%), Gaps = 30/161 (18%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLI 259
            + LG G  G V +          A+K +    K  +     EV+   +  +  ++++++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 77

Query: 260 GLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRY------KISLGLASA 309
            +  +    R   ++V E +  G L F     +           +      +I   +  A
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGEL-FSRIQDRGD-------QAFTEREASEIMKSIGEA 129

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           + YLH      + HRD+K  N++      +  +KL DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score = 72.9 bits (178), Expect = 9e-15
 Identities = 45/147 (30%), Positives = 61/147 (41%), Gaps = 27/147 (18%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              +  G+LGLFN      S   +V VEFD+F N  WDP N    +GIN +SI S   T 
Sbjct: 100 KPQTHAGYLGLFNENE---SGDQVVAVEFDTFRNS-WDPPN--PHIGINVNSIRSIKTTS 153

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-----------------TTS 107
           W+    +   A V I Y+++T  L AS  Y      +  +                 + +
Sbjct: 154 WD--LANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAA 211

Query: 108 TGRYT--ERHVLKSWEFNSTLDIKEIN 132
           TG     E H + SW F S L     N
Sbjct: 212 TGLDIPGESHDVLSWSFASNLPHASSN 238

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score = 72.5 bits (177), Expect = 1e-14
 Identities = 40/144 (27%), Positives = 54/144 (37%), Gaps = 31/144 (21%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
           P    GG LG+F              VEFD+F N  WDP      +GI+ +SIVSS    
Sbjct: 100 PQGEDGGNLGVFKPPE----GDNAFAVEFDTFQNT-WDPQV--PHIGIDVNSIVSSKTLH 152

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS----------------------Q 102
           +     +G  A+V IKY+S TK L+   ++                              
Sbjct: 153 FQ--LENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLS 210

Query: 103 ENTTSTGRYTERHVLKSWEFNSTL 126
             T       E H + SW F S+L
Sbjct: 211 ATTGYQKNAVETHEIISWSFTSSL 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.3 bits (181), Expect = 2e-14
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 24/186 (12%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVK--KISRGLKHGKNEYI-TEVKTCSQLRH 252
            +F   R LG G FG V+           A+K  K    ++  + E+   E    S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLA 307
             ++++ G   D  +  ++ +++  G L   L     F             ++  +  + 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--------VAKFYAA-EVC 116

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
            AL YLH    + +++RD+K  NI+ D + ++K+ DFG A      +   T  L GT  Y
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA----KYVPDVTYTLCGTPDY 169

Query: 368 MAPEYI 373
           +APE +
Sbjct: 170 IAPEVV 175

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 31/190 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLR 251
              + + + +G G +GAV   +       VA+KK+ R        K  Y  E++    +R
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMR 82

Query: 252 HRNLLQLIGL---CHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YK 301
           H N++ L+ +        +F    LV  FM     D     K      L         Y+
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHE---KLGEDRIQFLVYQ 136

Query: 302 ISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGL 361
           +  GL     Y+H      ++HRD+K  N+  + D  +K+ DFGLA   D E+    TG 
Sbjct: 137 MLKGLR----YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGY 185

Query: 362 AGTLGYMAPE 371
             T  Y APE
Sbjct: 186 VVTRWYRAPE 195

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 23/164 (14%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--EVKTCSQLRH 252
            + +     +G G +G V           VA+KKI R  +   +      E+   ++L H
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111

Query: 253 RNLLQLIGLCH--DRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YKIS 303
            ++++++ +    D  +F    +V E       DF    +  T   LT        Y + 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFR--TPVYLTELHIKTLLYNLL 166

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
           +G+     Y+H      ++HRD+K +N + + D +VK+ DFGLA
Sbjct: 167 VGVK----YVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 40/164 (24%), Positives = 59/164 (35%), Gaps = 34/164 (20%)

Query: 2   FQI---PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIV 58
             I      +    L          S    V VEFD+F +           + +NN+ I 
Sbjct: 68  MNIRTHRQANSAVGLDFVLVPVQPESKGDTVTVEFDTFLSRI--------SIDVNNNDIK 119

Query: 59  SSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT------------ 106
           S     W+   + G  A V+I YNS+TK  S S S   T K +  +TT            
Sbjct: 120 S---VPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVS 176

Query: 107 -----STGRY---TERHVLKSWEFNSTLDIKEINGRETIKIKVD 142
                ++G Y    E H + SW F+S     +    E   I ++
Sbjct: 177 VGFSATSGAYQWSYETHDVLSWSFSSKFINLKDQKSERSNIVLN 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 51/186 (27%), Positives = 78/186 (41%), Gaps = 23/186 (12%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLR 251
              + N   +G G +G+V         + VAVKK+SR  +     K  Y  E++    ++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86

Query: 252 HRNLLQLIGL---CHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
           H N++ L+ +        EF    LV   M     D +   K      LT      +   
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVK---CQKLTDDHVQFLIYQ 140

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           +   L Y+H      ++HRD+K SN+  + D  +K+ DFGLA     E+    TG   T 
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATR 193

Query: 366 GYMAPE 371
            Y APE
Sbjct: 194 WYRAPE 199

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 34/197 (17%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT-----------E 243
            + ++ +R +  G +GAV  G+  +  + VA+K++   +  G+   I            E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 244 VKTCSQLRHRNLLQL--IGLCHDRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTT 298
           ++  +   H N+L L  I +  +        LV E M     D            ++   
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIH-DQRIVISPQH 135

Query: 299 R----YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                Y I LGL      LHE     VVHRD+   NI+   + ++ + DF LA     + 
Sbjct: 136 IQYFMYHILLGLH----VLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD- 187

Query: 355 GPRTTGLAGTLGYMAPE 371
               T       Y APE
Sbjct: 188 -ANKTHYVTHRWYRAPE 203

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 10/181 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           N F   + LG+G FG V            A+K + + +   K+E    +TE +     RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             L  L            V E+   G L FHL  ++          R+  +  + SAL Y
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGA-EIVSALDY 263

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH E  + VV+RD+K  N+M D D ++K+ DFGL      + G       GT  Y+APE 
Sbjct: 264 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEV 320

Query: 373 I 373
           +
Sbjct: 321 L 321

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 27/190 (14%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRH 252
              ++N   +G+G +G V         + VA+KKIS      + +     E+K   + RH
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84

Query: 253 RNLLQLIGLCH--DRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YKIS 303
            N++ +  +       +     +V + M     D +   K      L+        Y+I 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQ---HLSNDHICYFLYQIL 138

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRT--TGL 361
            GL     Y+H      V+HRD+K SN++ +T  ++K+ DFGLA + D +       T  
Sbjct: 139 RGLK----YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 362 AGTLGYMAPE 371
             T  Y APE
Sbjct: 192 VATRWYRAPE 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 29/200 (14%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISR---GLKHGKNEYITEVKTCSQLR 251
            +N+  +  +G+G +G VY     +    VA+KK++R    L   K     E+   ++L+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLK 83

Query: 252 HRNLLQLIGLCH--DRGEF---MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYK-ISLG 305
              +++L  L    D  +F    +V E   +   D     K  T   LT     K I   
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFK--TPIFLT-EEHIKTILYN 137

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTL 365
           L     ++HE     ++HRD+K +N + + D +VK+ DFGLA  ++ E            
Sbjct: 138 LLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 366 GYMAP----------EYIST 375
               P           ++ T
Sbjct: 195 EEPGPHNKNLKKQLTSHVVT 214

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 35/200 (17%)

Query: 196 NNFSNERKLGQGGFGAVY---RGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH 252
            NF   + LG G +G V+   +    D     A+K + +     K +     +T      
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT-----E 108

Query: 253 RNLLQLIG----LCH------DRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWT 297
           R +L+ I     L           +  L+ +++  G L  HL     F++          
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--------E 160

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR 357
            +  +   +  AL +LH+     +++RDIK  NI+ D++ +V L DFGL+     +   R
Sbjct: 161 VQIYVG-EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 358 TTGLAGTLGYMAPEYISTGR 377
                GT+ YMAP+ +  G 
Sbjct: 217 AYDFCGTIEYMAPDIVRGGD 236

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 40/221 (18%), Positives = 74/221 (33%), Gaps = 55/221 (24%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS----------RGLKHGKNEYITEV 244
           +  +S  + LG G FG V     I+     A+KK+             +K   +  I ++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65

Query: 245 KTC---------------------SQLRHRNLLQLIGLCHDRGEFM---LVYEFMPNGSL 280
                                       +        +  +  +     ++ E++P    
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---D 122

Query: 281 DFHLFSK--KSTGTPLTWTT----RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD 334
             H   K    +G  +         Y++   +     ++H      + HRDIK  N++ +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG----FIH---SLGICHRDIKPQNLLVN 175

Query: 335 -TDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYI 373
             D  +KL DFG A  L+  E  P    +  +  Y APE +
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSE--PSVAYIC-SRFYRAPELM 213

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 25/179 (13%)

Query: 204 LGQGGFGAVY---RGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQL 258
           LGQG FG V+   +    D     A+K + +       +     E     ++ H  +++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 259 IGLCHDRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLASALLYL 313
                  G+  L+ +F+  G L   L     F+++          ++ ++  LA AL +L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE--------DVKFYLA-ELALALDHL 142

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           H      +++RD+K  NI+ D + ++KL DFGL+   +DH    +     GT+ YMAPE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 196

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 53/185 (28%), Positives = 72/185 (38%), Gaps = 39/185 (21%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKIS-----------------RGLKHGKNEYITEVKT 246
           LG+G FG V            A+K +                  R L++ ++ ++T +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
             Q   R       LC        V E+   G L FHL   +           Y     +
Sbjct: 73  AFQTHDR-------LC-------FVMEYANGGELFFHL--SRERVFTEERARFY--GAEI 114

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
            SAL YLH    R VV+RDIK  N+M D D ++K+ DFGL        G       GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPE 170

Query: 367 YMAPE 371
           Y+APE
Sbjct: 171 YLAPE 175

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 30/196 (15%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHR 253
            + + + + LG GG G V+  +  D +  VA+KKI     +  K+    E+K   +L H 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHD 68

Query: 254 NLLQLI--------------GLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT-T 298
           N++++               G   +     +V E+M     D     ++    PL     
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQG---PLLEEHA 122

Query: 299 RYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDHELGPR 357
           R      L   L Y+H      V+HRD+K +N+  +T D  +K+GDFGLA ++D     +
Sbjct: 123 RL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 358 T--TGLAGTLGYMAPE 371
              +    T  Y +P 
Sbjct: 179 GHLSEGLVTKWYRSPR 194

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 43/189 (22%), Positives = 79/189 (41%), Gaps = 21/189 (11%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRH 252
           +++F  +  LG+G +G V           VA+KKI               E+K     +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68

Query: 253 RNLLQLIGLCH--DRGEFM---LVYEFMPNGSLDFHLFSKKSTGTPLTWT-TRYKISLGL 306
            N++ +  +        F    ++ E M     D H   +  +   L+    +Y      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT---DLH---RVISTQMLSDDHIQY-FIYQT 121

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
             A+  LH      V+HRD+K SN++ +++ ++K+ DFGLA ++D       +   G   
Sbjct: 122 LRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES-AADNSEPTGQQS 177

Query: 367 YMAPEYIST 375
            M  E+++T
Sbjct: 178 GM-VEFVAT 185

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 42/194 (21%), Positives = 79/194 (40%), Gaps = 40/194 (20%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---------------- 239
            +F+    LG+G FG V        +   AVK + + +    ++                
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 240 --YITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWT 297
             ++T++ +C Q   R       L         V E++  G L +H+  ++         
Sbjct: 401 PPFLTQLHSCFQTMDR-------LY-------FVMEYVNGGDLMYHI--QQVGRFKEPHA 444

Query: 298 TRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR 357
             Y  +  +A  L +L     + +++RD+K  N+M D++ ++K+ DFG+    +   G  
Sbjct: 445 VFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVT 498

Query: 358 TTGLAGTLGYMAPE 371
           T    GT  Y+APE
Sbjct: 499 TKTFCGTPDYIAPE 512

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.3 bits (160), Expect = 8e-12
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 24/180 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG--- 260
           +G+G +  V    L   +   A+K + + L +   + I  V+T      +++ +      
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQT-----EKHVFEQASNHP 70

Query: 261 -LCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            L      F        V E++  G L FH+  ++    P      Y  S  ++ AL YL
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFY--SAEISLALNYL 126

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+APE +
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 182

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 30/183 (16%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQLIG 260
           LG+G FG V+       N   A+K + + +    ++    + E         + +L L  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE---------KRVLSLAW 75

Query: 261 ----LCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
               L H    F        V E++  G L +H+  +      L+  T Y  +  +   L
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFY--AAEIILGL 131

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +LH    + +V+RD+K  NI+ D D ++K+ DFG+    +     +T    GT  Y+AP
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAP 187

Query: 371 EYI 373
           E +
Sbjct: 188 EIL 190

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 24/180 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG--- 260
           +G+G +  V    L   +   A++ + + L +   + I  V+T      +++ +      
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED-IDWVQT-----EKHVFEQASNHP 113

Query: 261 -LCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            L      F        V E++  G L FH+  ++    P      Y  S  ++ AL YL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFY--SAEISLALNYL 169

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           HE   R +++RD+K  N++ D++ ++KL D+G+        G  T+   GT  Y+APE +
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 225

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 42/181 (23%), Positives = 75/181 (41%), Gaps = 30/181 (16%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRNLLQLIG 260
           LG+G FG V        +   AVK + + +    ++    + E         + +L L G
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE---------KRVLALPG 78

Query: 261 ----LCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
               L      F        V E++  G L +H+  ++           Y  +  +A  L
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFY--AAEIAIGL 134

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAP 370
            +L     + +++RD+K  N+M D++ ++K+ DFG+    +   G  T    GT  Y+AP
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAP 190

Query: 371 E 371
           E
Sbjct: 191 E 191

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 24/178 (13%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG--- 260
           LG+G FG V    + +     AVK + + +    ++ +    T      + +L L     
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMT-----EKRILSLARNHP 84

Query: 261 -LCHDRGEF------MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
            L      F        V EF+  G L FH+  +KS          Y  +  + SAL++L
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFY--AAEIISALMFL 140

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           H+   + +++RD+K  N++ D + + KL DFG+        G  T    GT  Y+APE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPE 194

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 54/221 (24%)

Query: 174 NDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVY---RGILIDLNMAVAVKKIS 230
           + + S + GP +   +        F   R LG+GG+G V+   +    +     A+K + 
Sbjct: 2   SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL- 53

Query: 231 RGLKHGKNEYITEVKTCSQLRH----RNLLQ------LIGLCH----DRGEFMLVYEFMP 276
                 K   I  V+      H    RN+L+      ++ L        G+  L+ E++ 
Sbjct: 54  ------KKAMI--VRNAKDTAHTKAERNILEEVKHPFIVDL-IYAFQTGGKLYLILEYLS 104

Query: 277 NGSLDFHL-----FSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI 331
            G L   L     F +         T  + ++  ++ AL +LH+   + +++RD+K  NI
Sbjct: 105 GGELFMQLEREGIFMED--------TACFYLA-EISMALGHLHQ---KGIIYRDLKPENI 152

Query: 332 MPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           M +   +VKL DFGL    +    G  T    GT+ YMAPE
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPE 191

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 44/188 (23%)

Query: 204 LGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH----RNLLQ-- 257
           +G+G FG V         +  AVK +       + + I + K   + +H    RN+L   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKK---EEKHIMSERNVLLKN 95

Query: 258 -----LIGLCH----DRGEFMLVYEFMPNGSLDFHL-----FSKKSTGTPLTWTTRYKIS 303
                L+GL H       +   V +++  G L +HL     F +           R+  +
Sbjct: 96  VKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP--------RARFYAA 146

Query: 304 LGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAG 363
             +ASAL YLH      +V+RD+K  NI+ D+  ++ L DFGL    + E    T+   G
Sbjct: 147 -EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCG 201

Query: 364 TLGYMAPE 371
           T  Y+APE
Sbjct: 202 TPEYLAPE 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 3e-11
 Identities = 38/213 (17%), Positives = 64/213 (30%), Gaps = 59/213 (27%)

Query: 182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--- 238
           GP  FS+      T       K+G+G FG V++   I  +  VA+K I+       N   
Sbjct: 9   GPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSH 63

Query: 239 -----EYITEVKTCSQL---------RHRNLLQLIGLCHDRGEFM--------------- 269
                E + E+    +L         R    + L  +   +G +                
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 270 ---------------LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
                          +V EF   G     + +K       +  T   I   L ++L    
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAE 178

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA 347
              +    HRD+ + N++       KL      
Sbjct: 179 ASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNG 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 45/193 (23%), Positives = 70/193 (36%), Gaps = 31/193 (16%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR--------HR 253
           RKLG G F  V+    +  N  VA+ KI RG K        E+K   ++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAM-KIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 254 NLLQLIGLCHD---RGEFM----LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
               ++ L      +G       +V+E +     +     KK     +      +IS  L
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIM------PDTDFNVKLGDFGLALLVDHELGPRTTG 360
              L Y+H      ++H DIK  N++      P+    +K+ D G A   D       T 
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----TN 194

Query: 361 LAGTLGYMAPEYI 373
              T  Y +PE +
Sbjct: 195 SIQTREYRSPEVL 207

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 43/200 (21%), Positives = 83/200 (41%), Gaps = 33/200 (16%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLR 251
              +   +KLG+G +G V++ I       VAVKKI    ++    +  +  E+   ++L 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELS 66

Query: 252 -HRNLLQLIGLCH--DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR----YKISL 304
            H N++ L+ +    +  +  LV+++M     D H   +      L    +    Y++  
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET---DLHAVIR---ANILEPVHKQYVVYQLIK 120

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGT 364
            +     YLH      ++HRD+K SNI+ + + +VK+ DFGL+    +            
Sbjct: 121 VIK----YLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 365 LGYMAP---------EYIST 375
                          +Y++T
Sbjct: 174 NENTENFDDDQPILTDYVAT 193

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 8/108 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHG-KNEYITEVKTCSQ 249
           +     + LG+G FG V       ++       VAVK +  G  H      ++E+K    
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 250 L-RHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLT 295
           +  H N++ L+G C    G  M++ EF   G+L  +L SK++   P  
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 25/90 (27%), Positives = 38/90 (42%), Gaps = 19/90 (21%)

Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
            LT       S  +A  + +L    ++C+ HRD+   NI+      VK+ DFGLA  +  
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDFGLARDI-- 243

Query: 353 ELGPRTTGLAGTLGYMAPEYISTGRARLDV 382
                         Y  P+Y+  G ARL +
Sbjct: 244 --------------YKDPDYVRKGDARLPL 259

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 15/157 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RN 254
           N +   RK+G G FG +Y G  I     VA+K      KH +     E K    ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +  +     +    ++V E +  G SL+  LF         +  T   ++  + S + Y+
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL--GPSLE-DLF--NFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 314 HEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           H    +  +HRD+K  N +         V + DFGLA
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 15/157 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRN 254
           N F   RK+G G FG +Y G  I  N  VA+K  +   KH +  Y  E K    L+    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +  +     +    +LV + +  G SL+  LF+       L+  T   ++  + + + ++
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL--GPSLE-DLFNFC--SRKLSLKTVLMLADQMINRVEFV 119

Query: 314 HEEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLA 347
           H    +  +HRDIK  N +         V + DFGLA
Sbjct: 120 HS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 32/175 (18%), Positives = 53/175 (30%), Gaps = 31/175 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGI--------LIDLNMAVAVK--KISRGLKHGKNEYITEVK 245
             +  +    +   G +Y                   ++K       L + +N +    K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 246 TCSQLRHRNLLQLIGL-----CHDRGEFMLVYEFM------PNGSLDFHLFSKKSTGTPL 294
              Q+     L    L     C   G     Y F+         SL        S    L
Sbjct: 102 P-LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQ-SAL-DVSPKHVL 156

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLA 347
           +  +  +++  L  AL +LHE      VH ++   NI   P+    V L  +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 34/159 (21%), Positives = 66/159 (41%), Gaps = 17/159 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RN 254
            ++   R++G+G FG ++ G  +  N  VA+K   R     +     E +T   L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           +  +     +    +LV + +  G SL+  L      G   +  T    +  + + +  +
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLL--GPSLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 314 HEEWKRCVVHRDIKFSNIM----PDTDFN-VKLGDFGLA 347
           HE   + +V+RDIK  N +       + N + + DFG+ 
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 37/159 (23%), Positives = 64/159 (40%), Gaps = 17/159 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RN 254
            NF   +K+G G FG +  G  +  N  VA+K      +  +     E +   QL     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           + Q+           +V E +  G SL+  LF         +  T   I++ L S + Y+
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--GPSLE-DLF--DLCDRTFSLKTVLMIAIQLISRMEYV 121

Query: 314 HEEWKRCVVHRDIKFSNIM----PDTDFN-VKLGDFGLA 347
           H    + +++RD+K  N +     +     + + DF LA
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 37/184 (20%), Positives = 71/184 (38%), Gaps = 25/184 (13%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHR------NL 255
             +G+G FG V +         VA+ KI +  K   N+   EV+    +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAI-KIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + L      R    LV+E +   S + +   + +    ++     K +  + +ALL+L  
Sbjct: 119 VHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 316 EWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLALLVDHELGP----RTTGLAGTLGYMA 369
             +  ++H D+K  NI+        +K+ DFG +  +   +      R         Y +
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--------YRS 226

Query: 370 PEYI 373
           PE +
Sbjct: 227 PEVL 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 33/161 (20%), Positives = 67/161 (41%), Gaps = 15/161 (9%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHR------NL 255
           + +G+G FG V +     ++  VA+ K+ R  K    +   E++    LR +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVAL-KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + ++     R    + +E +   S++ +   KK+     +     K +  +   L  LH 
Sbjct: 162 IHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217

Query: 316 EWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLALLVDHEL 354
             K  ++H D+K  NI+        +K+ DFG +      +
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 39/181 (21%), Positives = 64/181 (35%), Gaps = 46/181 (25%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHG-------------KNEYI 241
           N +   +K+G GGFG +Y     +     A   +     ++G             K + I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 242 TEVKTCSQLRHRNLLQLI--GLCHDRGE---FM--------LVYEFMPNGSLDFHLFSKK 288
            +     QL +  +      GL   +G    FM        L      NG+     F K 
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-----FKKS 151

Query: 289 STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGL 346
           +           ++ + +   L Y+HE      VH DIK +N++        V L D+GL
Sbjct: 152 TV---------LQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGL 199

Query: 347 A 347
           +
Sbjct: 200 S 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 36/175 (20%), Positives = 59/175 (33%), Gaps = 31/175 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGLKHGKNEY-----ITEVK 245
             +     +GQGGFG +Y   +     +  +    VK           E        + +
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 246 TCSQLRHRNLLQLIGLCH-----DRGEFMLVYEFM------PNGSLDFHLFSKKSTGTPL 294
              +      L+ +G+          +    Y FM          L   ++         
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQ-KIYEA--NAKRF 149

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM--PDTDFNVKLGDFGLA 347
           +  T  ++SL +   L Y+HE      VH DIK SN++        V L D+GLA
Sbjct: 150 SRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 6e-07
 Identities = 63/406 (15%), Positives = 117/406 (28%), Gaps = 109/406 (26%)

Query: 106 TSTGRYTERHVLKSWE--FNSTLDIKEING--RETIKIK-VDVGVSIGGVVIMGILLLWK 160
           T   +Y  + +L  +E  F    D K++    +  +  + +D  +     V   + L W 
Sbjct: 11  TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70

Query: 161 WKQRKETETFTWVNDDLSRD----AGPRRFSYKDLASATNNFSNERKLGQGG---F--GA 211
              ++E     +V + L  +      P +   +  +  T  +  +R         F    
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN 130

Query: 212 VYRGILIDLNMAVAVKKISRGLKHGK-NEYITEV-------KTC---SQLRHRNLLQL-- 258
           V R             K+ + L   +  + +  +       KT           +     
Sbjct: 131 VSR--------LQPYLKLRQALLELRPAKNVL-IDGVLGSGKTWVALDVCLSYKVQCKMD 181

Query: 259 -------IGLCHDRGEFM-----LVYEFMPNGSLDFHLFSKKSTGTPL------TWTTRY 300
                  +  C+     +     L+Y+  PN    +   S  S+   L          R 
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPN----WTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 301 KISLGLASALLYL-----HEEWK----RC---VVHRDIKFSN-IMPDTDFNVKLGDFGLA 347
             S    + LL L      + W      C   +  R  + ++ +   T  ++ L    + 
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297

Query: 348 LLVDHELG-------------PR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCL 392
           L  D                 PR   T     L  +  E I  G A  D N+     D L
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-IIAESIRDGLATWD-NWKHVNCDKL 355

Query: 393 MIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKM--PVAIFE 436
             +              I  ++ VL      P    KM   +++F 
Sbjct: 356 TTI--------------IESSLNVLE-----PAEYRKMFDRLSVFP 382

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 32/143 (22%), Positives = 57/143 (39%), Gaps = 18/143 (12%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL----LQ 257
           RKLG G F  V+    I     VA+K + +  +H     + E++    +R+ +      +
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 258 LIGLCHDRGEFM--------LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           ++    D  +          +V+E +         +  KS    L      KI   +   
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL---GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 310 LLYLHEEWKRCVVHRDIKFSNIM 332
           L YLH + +  ++H DIK  NI+
Sbjct: 159 LDYLHTKCR--IIHTDIKPENIL 179

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	459
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	99.97
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	99.97
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	99.96
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	99.96
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	99.96
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	99.96
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	99.96
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	99.96
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	99.96
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	99.96
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	99.96
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	99.96
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	99.95
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	99.95
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	99.95
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	99.95
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	99.95
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	99.95
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	99.93
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	99.93
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	99.93
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.53
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.51
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.44
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.67
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.58
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.51
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	96.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.68
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	96.44
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.4
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.91
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.74
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.87
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	87.51
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.52
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.73

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-50  Score=392.67  Aligned_cols=198  Identities=22%  Similarity=0.366  Sum_probs=165.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|...++||+|+||.||+|++..     +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456677899999999999999753     578999999987766677899999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          271 VYEFMPNGSLDFHLFSKKS-----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      |||||++|+|.++|.....           ...+++|.+++.|+.|||.||+|||+   ++|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            9999999999999976432           12469999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          340 KLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ||+|||+|+.+...... ......||+.|||||++.++.  ++.++|+||+|+++++|++
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~--~~~~sDvwS~Gvvl~Ellt  255 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFT  255 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCC--CCccccccchHHHHHHHHc
Confidence            99999999876543222 234578999999999998764  5788999999999999886

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.3e-50  Score=387.78  Aligned_cols=229  Identities=23%  Similarity=0.374  Sum_probs=186.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|...+.||+|+||.||+|++..     ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            567788999999999999999753     478999999987766677899999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccC---------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          271 VYEFMPNGSLDFHLFSKK---------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                      |||||++|+|.++|....         .....++|.+++.|+.|||+||+|||+   ++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642         223469999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhc
Q 041624          342 GDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      +|||+|+......... .....||+.|||||++.++.  ++.++|+||+|+++++|++ +..|+...  +..++++.+..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~--~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~  245 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQ  245 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence            9999998765432222 23456899999999998764  5788999999999999997 56665543  34555555443


Q ss_pred             CCCCCCCCCCCCc
Q 041624          420 ETKMPNLPSKMPV  432 (459)
Q Consensus       420 ~~~~p~~p~~~p~  432 (459)
                      .. .|+.|+..|.
T Consensus       246 ~~-~~~~p~~~~~  257 (299)
T 4asz_A          246 GR-VLQRPRTCPQ  257 (299)
T ss_dssp             TC-CCCCCTTCCH
T ss_pred             CC-CCCCCccchH
Confidence            32 2334555553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-49  Score=383.19  Aligned_cols=215  Identities=25%  Similarity=0.351  Sum_probs=172.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..+++...++||+|+||+||+|++..   .||||+++...  ....++|.+|+.++++++|||||+++|+|.+ +.++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            34677888999999999999998753   59999987542  3446789999999999999999999999865 568999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||||++|+|.++|.....   .++|.+++.|+.|||.||+|||+   ++|+||||||+||||++++.+||+|||+|+...
T Consensus       110 mEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999976543   69999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HELG-PRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~~-~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .... ......+||+.|||||++.+.. ..++.++|+||+|+++|+|+++..|+.... ...++...+..
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~~  252 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGR  252 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHT
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhc
Confidence            4322 2345678999999999997542 236778999999999999999766665443 23344444433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-49  Score=383.60  Aligned_cols=229  Identities=21%  Similarity=0.312  Sum_probs=188.1

Q ss_pred             CCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +++..+.||+|+||+||+|.+.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556789999999999999974     346899999997653 3446789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          271 VYEFMPNGSLDFHLFSKKST------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      |||||++|+|.++|..+...            ...++|.++++|+.|||+||+|||+   ++|+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            99999999999999754311            2369999999999999999999999   99999999999999999999


Q ss_pred             EEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHH
Q 041624          339 VKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~  416 (459)
                      +||+|||+|+.+..... .......||+.|||||++.++.  ++.++|+||+|++++++++ +..|++..  +..++++.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~~  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEM  259 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC--CCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHHH
Confidence            99999999987654322 2245578999999999998775  5788999999999999997 57777654  45677776


Q ss_pred             HhcCCCCCCCCCCCCcc
Q 041624          417 LNFETKMPNLPSKMPVA  433 (459)
Q Consensus       417 L~~~~~~p~~p~~~p~~  433 (459)
                      +..... ++.|+..|..
T Consensus       260 i~~~~~-~~~p~~~~~~  275 (308)
T 4gt4_A          260 IRNRQV-LPCPDDCPAW  275 (308)
T ss_dssp             HHTTCC-CCCCTTCCHH
T ss_pred             HHcCCC-CCCcccchHH
Confidence            655433 4456666654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-48  Score=382.51  Aligned_cols=210  Identities=28%  Similarity=0.329  Sum_probs=185.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +.|+..+.||+|+||.||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56888899999999999999999999999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++...     .+++.++..|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+... .
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~  224 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-V  224 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-S
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCC-C
Confidence            999999988642     49999999999999999999999   99999999999999999999999999999987643 2


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ......+||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++++.+.
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~  283 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIR  283 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHH
Confidence            3345679999999999997653  688999999999999999988877654  3344444443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-48  Score=385.87  Aligned_cols=212  Identities=22%  Similarity=0.322  Sum_probs=182.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|++.+.||+|+||.||+|++..+|+.||||+++...  ....+.+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999997653  3345689999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||++|+|.++|..+..  ..+++.+++.|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999975443  258999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------------------
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------------------  398 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------------------  398 (459)
                       .......+||+.|||||++.+..  ++.++|+||+|+++|+|++                                   
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~--y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS  255 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             -cccccccCCCccccCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence             11234578999999999998653  6788999999999999987                                   


Q ss_pred             ----cCCCCCCCCCCHHHHHH
Q 041624          399 ----CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       399 ----c~~p~p~~RPs~~~v~~  415 (459)
                          |+..+|.+|||+.|+++
T Consensus       256 li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence                66678999999999876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=384.38  Aligned_cols=211  Identities=27%  Similarity=0.327  Sum_probs=186.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .+.|+..+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35699999999999999999999999999999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      |++|+|.+++...     .+++.++..|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+... 
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-  300 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  300 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence            9999999988543     49999999999999999999999   99999999999999999999999999999887643 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .......+||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++++.+.
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~  360 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIR  360 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHH
Confidence            23445678999999999997654  688999999999999999988887654  3344454443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-47  Score=365.63  Aligned_cols=222  Identities=24%  Similarity=0.330  Sum_probs=175.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|++.+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|++++++++|||||++++++.+.+.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            378999999999999999999999999999999997642   23456799999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||| +|+|.+++..+.    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        92 mEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 689999987654    59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      ..  ......+||+.|||||++.+..+ .+.++|+||+|+++|+|+++..|+...  +..++.+.+....  +++|+.++
T Consensus       164 ~~--~~~~~~~GT~~Y~APE~~~~~~y-~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~--~~~p~~~s  236 (275)
T 3hyh_A          164 DG--NFLKTSCGSPNYAAPEVISGKLY-AGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGV--YTLPKFLS  236 (275)
T ss_dssp             -------------CTTSCHHHHSSSSC-CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTC--CCCCTTSC
T ss_pred             CC--CccCCeeECcccCChhhhcCCCC-CCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCC--CCCCCCCC
Confidence            42  23445789999999999986542 456789999999999999999998764  6677766554332  33444444

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.8e-47  Score=374.16  Aligned_cols=194  Identities=25%  Similarity=0.321  Sum_probs=167.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .+.|...++||+|+||.||+|+++.+|+.||||+++....     ..+|+.++++++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4567888899999999999999999999999999975422     24799999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCcccccCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLVDHE  353 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  353 (459)
                      |++|+|.++|....    .+++.++..|+.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+|+.+...
T Consensus       132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            99999999997654    59999999999999999999998   9999999999999999987 6999999999987543


Q ss_pred             CCCc----cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          354 LGPR----TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       354 ~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ....    ....+||+.|||||++.+..  ++.++|+||+|+++|+|+++..|
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyemltG~~P  255 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKP--CDAKVDIWSSCCMMLHMLNGCHP  255 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccceecCCccccCccccCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCcCC
Confidence            2211    23468999999999998654  67889999999999999985444

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-47  Score=368.09  Aligned_cols=212  Identities=22%  Similarity=0.282  Sum_probs=188.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||+||+|++..+++.||||++++.   .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999999999999999999754   2344677999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|.++|....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999997654    59999999999999999999999   9999999999999999999999999999998754


Q ss_pred             CC-CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          353 EL-GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       353 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .. .......+||+.|||||++.+..  ++.++|+||+|+++|+|+++..||...  +..++++.+.
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~  247 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKII  247 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSC--BCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH
Confidence            32 23356789999999999998654  577899999999999999999999764  5666665443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-47  Score=377.42  Aligned_cols=240  Identities=25%  Similarity=0.311  Sum_probs=194.5

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCc-cchHHHHHHHHHHhccCc-CCceeE
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRH-RNLLQL  258 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l  258 (459)
                      ++.++++...++|+..+.||+|+||.||+|.+..+     ++.||||+++.... ...++|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            44566777788999999999999999999998754     36899999976543 345679999999999965 899999


Q ss_pred             EEEEeeC-CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecC
Q 041624          259 IGLCHDR-GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRD  325 (459)
Q Consensus       259 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD  325 (459)
                      +|+|.+. +.++||||||++|+|.++|+....            ....+++.+++.|+.|||+||+|||+   ++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence            9999764 578999999999999999975432            12358999999999999999999999   9999999


Q ss_pred             CCCCCeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          326 IKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       326 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      |||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.++.  ++.++|+||+|+++++|++ +..|+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC--CCCcccEeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999999977544332 244567999999999998764  5788999999999999997 57777


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          404 RNCRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       404 p~~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                      +..... .++.+.+..... |+.|+..|+
T Consensus       289 ~~~~~~-~~~~~~i~~g~~-~~~p~~~~~  315 (353)
T 4ase_A          289 PGVKID-EEFCRRLKEGTR-MRAPDYTTP  315 (353)
T ss_dssp             TTCCCS-HHHHHHHHHTCC-CCCCTTCCH
T ss_pred             CCCCHH-HHHHHHHHcCCC-CCCCccCCH
Confidence            765433 445555544333 344555554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-46  Score=366.25  Aligned_cols=216  Identities=25%  Similarity=0.357  Sum_probs=175.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCC-------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-------  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------  266 (459)
                      .++|+..+.||+|+||.||+|+++.+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3568899999999999999999999999999999975533 34567999999999999999999999987644       


Q ss_pred             -----eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          267 -----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       267 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                           .+|+|||||++|+|.+++..+.. ....++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence                 37999999999999999976532 1245677889999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCCCC-----------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------
Q 041624          342 GDFGLALLVDHELGP-----------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------  398 (459)
Q Consensus       342 ~DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------  398 (459)
                      +|||+|+.+......           ..+..+||+.|||||++.+..  ++.++|+||+|+++++|++            
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyell~Pf~~~~~~~~~~  237 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLYPFSTQMERVRTL  237 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC--CCCHHHHHHHHHHHHHHccCCCCccHHHHHH
Confidence            999999887543221           123467999999999998653  6788999999999998874            


Q ss_pred             -------------------------cCCCCCCCCCCHHHHHHH
Q 041624          399 -------------------------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 -------------------------c~~p~p~~RPs~~~v~~~  416 (459)
                                               |+.++|.+|||+.|+++.
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                                     888899999999988874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-46  Score=358.21  Aligned_cols=210  Identities=25%  Similarity=0.364  Sum_probs=180.3

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEFMLVY  272 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  272 (459)
                      +..+.||+|+||.||+|.+..++..||+|++...  .....+.|.+|+++|++++|||||++++++.+    .+.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556899999999999999999999999999654  23345679999999999999999999999865    35689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecC-CCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDT-DFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~-~~~~kL~DFGla~~  349 (459)
                      |||++|+|.+++....    .+++..+..|+.||+.||+|||+   ++  |+||||||+||||+. ++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999997654    59999999999999999999998   67  999999999999984 78999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                      ...   ......+||+.|||||++.+   .++.++|+||+|+++|+|+++..|+.... ...++.+.+.....
T Consensus       182 ~~~---~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~~i~~~~~  247 (290)
T 3fpq_A          182 KRA---SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVK  247 (290)
T ss_dssp             CCT---TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCC
T ss_pred             CCC---CccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-cHHHHHHHHHcCCC
Confidence            432   23456789999999998864   36889999999999999999999997654 56677777655433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2e-46  Score=365.57  Aligned_cols=225  Identities=27%  Similarity=0.293  Sum_probs=171.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC----eEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----EFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV  271 (459)
                      ++|...+.||+|+||.||+|++.  |+.||||+++... .....+..|+..+.+++|||||+++|+|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45677889999999999999984  7899999996432 11223345666777899999999999998754    58999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-----KRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ||||++|+|.++|...     .++|..+.+++.|++.||+|||+.+     +.+|+||||||+||||+.++.+||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9999999999999653     5899999999999999999999731     23999999999999999999999999999


Q ss_pred             cccccCCCCC---ccccccccccccccceeccCc----cccCCCCCHHHHHHHHHHHHhcCCCCC-------------CC
Q 041624          347 ALLVDHELGP---RTTGLAGTLGYMAPEYISTGR----ARLDVNFDEQQTDCLMIVGLWCAHPDR-------------NC  406 (459)
Q Consensus       347 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~----~~~~~~~D~~~~g~ll~~~l~c~~p~p-------------~~  406 (459)
                      |+........   .....+||+.|||||++.+..    ..++.++|+||+|+++++|+++..|+.             ..
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            9887654322   223468999999999997542    135667899999999999987654321             12


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCC
Q 041624          407 RPSIRQAIQVLNFETKMPNLPS  428 (459)
Q Consensus       407 RPs~~~v~~~L~~~~~~p~~p~  428 (459)
                      .|+..++.+.+.....-|++|.
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~  256 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPN  256 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCG
T ss_pred             cchHHHHHHHHhcccCCCCCCc
Confidence            3455666655544444444443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.2e-46  Score=360.75  Aligned_cols=211  Identities=25%  Similarity=0.281  Sum_probs=176.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|++.+.||+|+||+||+|+..   .+++.||||++++..  .....++.+|+++|.+++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999874   467899999997642  2334578899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |||||++|+|.++|.+..    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999997654    59999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ... .......+||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++++.+.
T Consensus       177 ~~~-~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~  239 (304)
T 3ubd_A          177 IDH-EKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMIL  239 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSC--CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH
T ss_pred             cCC-CccccccccCcccCCHHHhccCC--CCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHHH
Confidence            433 23345678999999999998654  578899999999999999999999764  5566665543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=355.18  Aligned_cols=200  Identities=23%  Similarity=0.311  Sum_probs=171.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEee------CCe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHD------RGE  267 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~  267 (459)
                      ++|++.+.||+|+||.||+|++..+|+.||||+++....  ...+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            579999999999999999999999999999999976532  345678899999999999999999999764      367


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      +|||||||+ |+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 68999886543    69999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCC---CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          348 LLVDHEL---GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       348 ~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      +.+....   .......+||+.|||||++.+.. .++.++|+||+||++++|+++..|++
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~DiWSlG~il~ell~G~~pF~  264 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFP  264 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCC-CCCChhheehhHHHHHHHHHCCCCCC
Confidence            8764321   22345679999999999987654 36788999999999999988766553

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7e-42  Score=360.72  Aligned_cols=198  Identities=27%  Similarity=0.324  Sum_probs=177.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999999999999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC--CCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD--FNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kL~DFGla~~~~~  352 (459)
                      |++|+|.++|.....   .+++.++..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999865543   69999999999999999999999   999999999999999854  8999999999998754


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      .  ......+||+.|||||++.+..  ++..+|+||+|+++|+|+++..|
T Consensus       310 ~--~~~~~~~GT~~y~APEv~~~~~--y~~~~DiWSlGvilyeml~G~~P  355 (573)
T 3uto_A          310 K--QSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSP  355 (573)
T ss_dssp             T--SEEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             C--CceeeeEECccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCC
Confidence            3  3345678999999999998654  57788999999999999874444

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-41  Score=333.16  Aligned_cols=243  Identities=37%  Similarity=0.625  Sum_probs=209.6

Q ss_pred             CCcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEE
Q 041624          182 GPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       182 ~~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      ..+.|++.++....++|+..+.||+|+||.||+|...+ ++.||||++..... .....+.+|++++.+++|+||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            35679999999999999999999999999999998654 89999999976532 33447899999999999999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      ++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987766556799999999999999999999992222999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------  398 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------  398 (459)
                      |+|||+++..............||+.|+|||++.++.  ++.+.|+|++|++++++++                      
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE--ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCC--CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999887655444455667999999999997664  5778899999999988875                      


Q ss_pred             -----------------------------------cCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 041624          399 -----------------------------------CAHPDRNCRPSIRQAIQVLNFETKMPNLP  427 (459)
Q Consensus       399 -----------------------------------c~~p~p~~RPs~~~v~~~L~~~~~~p~~p  427 (459)
                                                         |+.++|.+|||+.+++++|+........+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  316 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE  316 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence                                               66778999999999999999866544433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-41  Score=337.56  Aligned_cols=214  Identities=21%  Similarity=0.252  Sum_probs=180.0

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      +-...+.|++.+.||+|+||.||+|+.+   .+++.||+|++...  ....++.+|+++|.++ +||||+++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3345688999999999999999999875   45789999998654  3456788999999998 6999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFG  345 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG  345 (459)
                      .+|+|||||++|+|.+++.       .+++.++..++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            9999999999999999882       48999999999999999999999   999999999999999877 799999999


Q ss_pred             CcccccCCCC---------------------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELG---------------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +|+.......                           ......+||+.|+|||++.+.. .++.++|+||+||++++|++
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP-NQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCCccchhhhHHHHHHHHH
Confidence            9986543211                           1123467999999999997543 36788999999999999999


Q ss_pred             cCCCCCCCCCCHHHHHHHH
Q 041624          399 CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 c~~p~p~~RPs~~~v~~~L  417 (459)
                      +..|+........++.++.
T Consensus       243 G~~Pf~~~~~~~~~l~~I~  261 (361)
T 4f9c_A          243 GRYPFYKASDDLTALAQIM  261 (361)
T ss_dssp             TCSSSSCCSSHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHH
Confidence            9999977766555554443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-41  Score=358.13  Aligned_cols=211  Identities=26%  Similarity=0.362  Sum_probs=180.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHH---HHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYIT---EVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|++.++||+|+||.||+|+.+.+|+.||||++++..   ........+   ++.++..++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999999999999999996531   122233333   46677788999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      |||||||+||+|.++|....    .+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999997654    59999999999999999999998   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHH
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP-SIRQAIQV  416 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP-s~~~v~~~  416 (459)
                      .+...   .....+||+.|||||++..+. .++..+|+||+|+++|+|+++..|+....+ ...++.+.
T Consensus       341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~-~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~  405 (689)
T 3v5w_A          341 DFSKK---KPHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  405 (689)
T ss_dssp             ECSSC---CCCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH
T ss_pred             ecCCC---CCCCccCCcCccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            77543   345578999999999997543 368889999999999999999999976443 45555543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-40  Score=326.95  Aligned_cols=210  Identities=37%  Similarity=0.630  Sum_probs=182.0

Q ss_pred             CcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEE
Q 041624          183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC  262 (459)
Q Consensus       183 ~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  262 (459)
                      ..++++.++...+++|+..+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++.+++||||+++++++
T Consensus        26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             ceeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            345677788889999999999999999999999975 4899999999877666778899999999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       263 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      .+.+..++||||+++|+|.+++.........+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999997665444569999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          343 DFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       343 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |||+++....... .......||+.|+|||++.++.  ++.+.|+|++|++++++++
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~  236 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLC  236 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB--CCTHHHHHHHHHHHHHHHH
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCC--CCcccchHhHHHHHHHHHh
Confidence            9999987543222 2234456899999999997664  5778899999999998874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=322.10  Aligned_cols=218  Identities=25%  Similarity=0.376  Sum_probs=191.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|...+.||+|+||.||+|.+..+++.||+|++........+.|.+|++++.+++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45788889999999999999999999999999999776666778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++|+|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999976443   69999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CCc-------------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHH------------------------
Q 041624          355 GPR-------------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL------------------------  397 (459)
Q Consensus       355 ~~~-------------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l------------------------  397 (459)
                      ...             .....||+.|+|||++.+..  ++.+.|+|++|+++++++                        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCC--CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence            211             12467999999999998653  577899999999999876                        


Q ss_pred             -----------------hcCCCCCCCCCCHHHHHHHHhcC
Q 041624          398 -----------------WCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       398 -----------------~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                       .|+.++|.+||++.++++.|+..
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                             38888999999999999988743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-39  Score=314.95  Aligned_cols=199  Identities=24%  Similarity=0.330  Sum_probs=177.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            34689999999999999999999998999999999977666667789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++...     .+++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999998653     48999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      . .......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+
T Consensus       170 ~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf  216 (297)
T 3fxz_A          170 Q-SKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPY  216 (297)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHCSC--BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             c-cccCCccCCcCccChhhhcCCC--CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            2 2344568999999999998654  578899999999999988755544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.1e-39  Score=316.60  Aligned_cols=210  Identities=25%  Similarity=0.304  Sum_probs=183.5

Q ss_pred             CcccCHHHHHHHhcC----------CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc
Q 041624          183 PRRFSYKDLASATNN----------FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH  252 (459)
Q Consensus       183 ~~~~~~~el~~~~~~----------f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H  252 (459)
                      +..|++++++.+++.          |+..+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.++.+++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            456899999998875          6667899999999999999998899999999987766677889999999999999


Q ss_pred             CCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       253 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      +||+++++++...+..++||||+++++|.+++...     .+++..+..++.||+.||.|||+   .+|+||||||+|||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence            99999999999999999999999999999988532     59999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ++.++.+||+|||+++...... .......||+.|+|||++.++.  ++.+.|+|++|+++++++++..|+
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999998765432 2334568999999999997653  577889999999999988754443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-40  Score=336.74  Aligned_cols=216  Identities=21%  Similarity=0.231  Sum_probs=188.7

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEE
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGL  261 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~  261 (459)
                      .+.++++...+++|+..++||+|+||.||+|+++.+++.||+|++++..   ......+.+|..++.+++|+||++++++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456777788899999999999999999999999999999999997531   2233458899999999999999999999


Q ss_pred             EeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       262 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                      +.+.+.++||||||++|+|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEE
Confidence            9999999999999999999999976433   69999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCCCCccccccccccccccceecc---CccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST---GRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +|||+|+.............+||+.|+|||++..   +...++.++|+|++|+++++|+++..|+...
T Consensus       217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            9999998776543434455789999999999872   2234678899999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-39  Score=321.15  Aligned_cols=214  Identities=21%  Similarity=0.289  Sum_probs=187.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4578999999999999999999999899999999997542  23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999997654    59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..  ......+||+.|+|||++.+... .+.+.|+|++|++++++++                                 
T Consensus       166 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  242 (328)
T 3fe3_A          166 VG--GKLDAFCGAPPYAAPELFQGKKY-DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE  242 (328)
T ss_dssp             SS--CGGGTTSSSGGGCCHHHHHTCCC-CSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CC--CccccccCCcceeCcccccCCCc-CCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            43  33456789999999999986543 3467899999999999887                                 


Q ss_pred             -----cCCCCCCCCCCHHHHHHHH
Q 041624          399 -----CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L  417 (459)
                           |+..+|.+|||+.|+++.-
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCH
Confidence                 4555788888888888753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=316.44  Aligned_cols=219  Identities=28%  Similarity=0.422  Sum_probs=184.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC---cEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|.+.+.||+|+||.||+|.+..++   ..||||+++... ....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356778899999999999999997544   459999997653 3445689999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999965543   69999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          351 DHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       351 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      .......  .....+|+.|+|||++.+..  ++.+.|+|++|++++++++                              
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  279 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC  279 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCc
Confidence            5432222  23345678899999997654  5678899999999998775                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                |+.++|.+||++.++++.|+...
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      66778888888888888887543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=314.77  Aligned_cols=210  Identities=22%  Similarity=0.276  Sum_probs=176.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..++||+|+||+||+|.+..+++.||||++.....  ....++..|+..+.++ +|+||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            3679999999999999999999998899999999865432  2334566677666666 899999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+ +++|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       136 ~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 6799998876543   69999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..  .......||+.|+|||++.+   .++.+.|+|++|++++++++                                 
T Consensus       209 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          209 TA--GAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRS  283 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred             cC--CCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHH
Confidence            32  23345679999999998875   36788999999999988876                                 


Q ss_pred             ----cCCCCCCCCCCHHHHHHH
Q 041624          399 ----CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 ----c~~p~p~~RPs~~~v~~~  416 (459)
                          |+.++|.+||++.++++.
T Consensus       284 li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcCCChhhCcCHHHHHhC
Confidence                566677777777777764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-38  Score=307.49  Aligned_cols=202  Identities=27%  Similarity=0.349  Sum_probs=170.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            4678899999999999999999999999999999865432   3356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    ++++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999997654    59999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ...........||+.|+|||.+.+..  ++...|+|++|+++++++++..|+..
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             ------------CCSSCCHHHHHTCC--CCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cccccccCccccCccccCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            54333445567999999999998654  56788999999999999987666544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.8e-39  Score=315.20  Aligned_cols=227  Identities=26%  Similarity=0.370  Sum_probs=180.0

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      ++..++....++|++.+.||+|+||.||+|.+.  ++.||||++....  ....+++.+|++++.+++|+||+++++++.
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            334444456678999999999999999999874  7899999997653  233567999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecCCCCEEE
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~kL  341 (459)
                      +.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+   .+  |+||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEE
Confidence            99999999999999999999975431 1238999999999999999999998   88  999999999999999999999


Q ss_pred             eecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------
Q 041624          342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------  398 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------  398 (459)
                      +|||+++..... ........||+.|+|||++.+..  ++.+.|+|++|++++++++                       
T Consensus       181 ~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  257 (309)
T 3p86_A          181 CDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR  257 (309)
T ss_dssp             CCCC------------------CCTTSCHHHHTTCC--CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CCCCCCcccccc-ccccccCCCCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            999999865432 22234567999999999998654  5778899999999998875                       


Q ss_pred             -----------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 -----------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 -----------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                       |+..+|.+||++.++++.|+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                             77778899999999998887543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-39  Score=312.93  Aligned_cols=196  Identities=22%  Similarity=0.365  Sum_probs=165.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      .++|+..+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++.+++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788899999999999999984    557899999999876666677899999999999999999999998653  568


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999976543   59999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          349 LVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       349 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ........  ......++..|+|||.+.+..  ++.+.|+|++|++++++++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~  212 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFT  212 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCC--CChHHHHHHHHHHHHHHHh
Confidence            76543221  123445778899999998664  5778899999999998876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-38  Score=313.52  Aligned_cols=194  Identities=29%  Similarity=0.342  Sum_probs=172.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..+.||+|+||.||+|..+.+++.||+|++++.   .....+.+.+|+.++.+++||||+++++++.+.+.+++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            36788999999999999999999999999999999754   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999987654    58999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .. .......+||+.|+|||++.+..  ++...|+|++|+++++|++
T Consensus       157 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~  200 (337)
T 1o6l_A          157 SD-GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMC  200 (337)
T ss_dssp             CT-TCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHH
T ss_pred             cC-CCcccccccChhhCChhhhcCCC--CCchhhcccchhHHHHHhc
Confidence            22 23345678999999999997653  5788999999999998886

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-38  Score=312.87  Aligned_cols=218  Identities=22%  Similarity=0.264  Sum_probs=185.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999999889999999996543 2335678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++....    .+++.+++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999986543    59999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          354 LG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       354 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .. .......||+.|+|||++.+... .+.+.|+|++|++++++++                                  
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  237 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CcccccCCCccCcCccCcHHhccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence            21 22345689999999999976542 3556899999999998876                                  


Q ss_pred             -------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 -------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 -------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                             |+..+|.+||++.|+++.--..
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence                   6677899999999998865443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-38  Score=319.18  Aligned_cols=205  Identities=22%  Similarity=0.354  Sum_probs=173.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc-------CCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI-------DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      .++|...+.||+|+||.||+|.+.       .++..||||+++.... ...+++.+|+.++.++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999874       2356899999976532 3456799999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      +.+++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||+   ++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            999999999999999999976542            12358999999999999999999999   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          334 DTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      +.++.+||+|||+++.+..... .......+|+.|+|||++.+..  ++.+.|+|++|+++++|++ +..|++
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999987654322 2234456788999999997654  5778899999999999887 444444

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-39  Score=306.15  Aligned_cols=194  Identities=27%  Similarity=0.454  Sum_probs=169.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|.+.. +..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3578888999999999999999976 7789999997543 3457899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....   .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999976543   69999999999999999999999   999999999999999999999999999998765432


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ........+|+.|+|||.+.+..  ++.+.|+|++|++++++++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~  202 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFS  202 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccCcccccccCCHHHhcCCC--CCchhhhHHHHHHHHHHhc
Confidence            22334456788999999997654  5678899999999999887

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.5e-38  Score=305.24  Aligned_cols=208  Identities=37%  Similarity=0.599  Sum_probs=179.3

Q ss_pred             CcccCHHHHHHHhcCCCCC------ceeccCCceEEEEEEEcCCCcEEEEEEeccCC----ccchHHHHHHHHHHhccCc
Q 041624          183 PRRFSYKDLASATNNFSNE------RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL----KHGKNEYITEVKTCSQLRH  252 (459)
Q Consensus       183 ~~~~~~~el~~~~~~f~~~------~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H  252 (459)
                      ...|++.++..++++|...      +.||+|+||.||+|...  ++.||+|++....    ....+.+.+|+.++.+++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4679999999999999988      89999999999999863  7899999987542    2345679999999999999


Q ss_pred             CCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       253 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      |||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.||+.||.|||+   .+|+||||||+|||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence            9999999999999999999999999999999875432 2369999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.+.   ++.+.|+|++|+++++++++
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~Dv~slG~il~~l~~g  230 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITG  230 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE---ECTHHHHHHHHHHHHHHHHC
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC---CCccchhHHHHHHHHHHHHC
Confidence            999999999999999876543222 23446789999999988642   57788999999999887753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-38  Score=312.33  Aligned_cols=217  Identities=24%  Similarity=0.338  Sum_probs=182.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  266 (459)
                      ..++|+..+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3567899999999999999999999889999999997543 335678999999999999999999999986543      


Q ss_pred             ---------------------------------------------------eEEEEEEecCCCCcchhccccCCCCCCCC
Q 041624          267 ---------------------------------------------------EFMLVYEFMPNGSLDFHLFSKKSTGTPLT  295 (459)
Q Consensus       267 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~  295 (459)
                                                                         ..++||||+++|+|.+++..... ....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence                                                               38999999999999999976543 23467


Q ss_pred             HHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC-----------Ccccccccc
Q 041624          296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-----------PRTTGLAGT  364 (459)
Q Consensus       296 ~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt  364 (459)
                      +..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.......           .......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            77899999999999999999   9999999999999999999999999999987764321           122345799


Q ss_pred             ccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------------cCCCCCCCC
Q 041624          365 LGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------------CAHPDRNCR  407 (459)
Q Consensus       365 ~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------------c~~p~p~~R  407 (459)
                      +.|+|||++.+..  ++.+.|+|++|++++++++                                     |+.++|.+|
T Consensus       240 ~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          240 KLYMSPEQIHGNN--YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GGGSCHHHHHCCC--CCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             cCccChHHhcCCC--CcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            9999999998653  5788899999999988764                                     778888999


Q ss_pred             CCHHHHHHH
Q 041624          408 PSIRQAIQV  416 (459)
Q Consensus       408 Ps~~~v~~~  416 (459)
                      |++.|+++.
T Consensus       318 ps~~~~l~~  326 (332)
T 3qd2_B          318 PEATDIIEN  326 (332)
T ss_dssp             CCHHHHHHS
T ss_pred             CCHHHHhhc
Confidence            998888875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-38  Score=302.13  Aligned_cols=217  Identities=25%  Similarity=0.355  Sum_probs=186.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+.. +..||+|+++... ...+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            34678889999999999999998875 7789999997543 345779999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++.....   .+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999976543   59999999999999999999999   99999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------------------
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------------------  398 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------------------  398 (459)
                      .........+|+.|+|||.+.+..  ++.+.|+|++|++++++++                                   
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  235 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY  235 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSE--EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccC--CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence            333334456678899999997654  5778899999999998875                                   


Q ss_pred             -----cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 -----CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                           |+.++|.+||++.++++.|+..
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          236 QIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                 6666777788888887777653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1e-38  Score=313.70  Aligned_cols=199  Identities=27%  Similarity=0.371  Sum_probs=166.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC----eEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----EFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~  269 (459)
                      ..++|+..+.||+|+||.||+|++.  ++.||||++... ......+..|+.++.+++||||+++++++....    .++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            4578899999999999999999886  689999999654 233445667999999999999999999998754    479


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC----------CeeecCCCCCCeeecCCCCE
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR----------CVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~----------~iiHrDlkp~NILl~~~~~~  339 (459)
                      +||||+++|+|.+++...     .+++..++.++.|++.||+|||+   .          +|+||||||+|||++.++.+
T Consensus        99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            999999999999999653     49999999999999999999998   7          99999999999999999999


Q ss_pred             EEeecCCcccccCCCCC-ccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          340 KLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ||+|||+++.+...... ......||+.|+|||++.+..   ..++.++|+|++|+++++++++..|+
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf  238 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA  238 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence            99999999877543322 234467999999999987532   13455679999999999988754443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.1e-38  Score=313.19  Aligned_cols=198  Identities=25%  Similarity=0.318  Sum_probs=173.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc------chHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..+.|.+.+.||+|+||.||+|....+++.||+|.++.....      ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            456789999999999999999999999999999999765322      35679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEee
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGD  343 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~D  343 (459)
                      .++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999996543    59999999999999999999999   9999999999999998877    799999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ||+++.+...  .......||+.|+|||++.+..  ++...|+|++|+++++++++..|
T Consensus       163 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~~ll~g~~P  217 (361)
T 2yab_A          163 FGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP  217 (361)
T ss_dssp             CSSCEECCTT--CCCCCCCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             cCCceEcCCC--CccccCCCCccEECchHHcCCC--CCccccHHHHHHHHHHHHhCCCC
Confidence            9999876543  2334567999999999997653  57788999999999988864433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=304.79  Aligned_cols=213  Identities=23%  Similarity=0.298  Sum_probs=176.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--------------------------cchHHHHHHHHHHh
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--------------------------HGKNEYITEVKTCS  248 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  248 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|++++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999965421                          12357899999999


Q ss_pred             ccCcCCceeEEEEEee--CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCC
Q 041624          249 QLRHRNLLQLIGLCHD--RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDI  326 (459)
Q Consensus       249 ~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl  326 (459)
                      +++||||+++++++.+  .+..++||||+++++|.+++..     ..+++.+++.++.||+.||+|||+   ++|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence            9999999999999986  5689999999999999887532     269999999999999999999999   99999999


Q ss_pred             CCCCeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccc-cCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          327 KFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR-LDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       327 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+.... .+...|+|++|+++++++++..|+..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSS-SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccc-cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999999876543 2233456799999999999765421 35567999999999999999998876


Q ss_pred             CCCCHHHHHHHHh
Q 041624          406 CRPSIRQAIQVLN  418 (459)
Q Consensus       406 ~RPs~~~v~~~L~  418 (459)
                      .+  ..++...+.
T Consensus       243 ~~--~~~~~~~~~  253 (298)
T 2zv2_A          243 ER--IMCLHSKIK  253 (298)
T ss_dssp             SS--HHHHHHHHH
T ss_pred             cc--HHHHHHHHh
Confidence            53  444444443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-38  Score=305.66  Aligned_cols=201  Identities=22%  Similarity=0.308  Sum_probs=172.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+..+++.||+|+++....  ...+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            578899999999999999999999999999999976532  334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++ +|.+.+.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 56555544333   69999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                       ........||+.|+|||++.+.. .++.+.|+|++|+++++++++..|+..
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             -cccccCCccccCCcChHHHcCCC-CcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence             22334567899999999997654 367889999999999999977766433

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5e-39  Score=323.04  Aligned_cols=228  Identities=24%  Similarity=0.365  Sum_probs=184.2

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ...++|...+.||+|+||.||+|.+..+++.||||.++.... ...++|.+|++++.+++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            345678889999999999999999998899999999976532 3346789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999976543   58999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCCcc-ccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          352 HELGPRT-TGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       352 ~~~~~~~-~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                      ....... ....++..|+|||.+..+.  ++.+.|+|++|++++++++ +..|++..  +..++.+.+.....+| .|..
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~-~~~~  339 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGGRLP-CPEL  339 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHHTTCCCC-CCTT
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCCC-CCCC
Confidence            3211111 1223577899999998664  5678899999999999987 66666544  3445555554433322 2444


Q ss_pred             CC
Q 041624          430 MP  431 (459)
Q Consensus       430 ~p  431 (459)
                      .|
T Consensus       340 ~~  341 (377)
T 3cbl_A          340 CP  341 (377)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-38  Score=319.98  Aligned_cols=218  Identities=28%  Similarity=0.450  Sum_probs=177.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|++.   .++..||||+++... ....++|.+|+.++.+++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999886   457789999997653 3345689999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999976543   69999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          351 DHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       351 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      .......  .....+++.|+|||++.++.  ++.+.|+|++|++++++++                              
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  275 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC  275 (373)
T ss_dssp             ----------------CTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCC--cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            5432221  22234577899999998654  5678899999999998664                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |+..+|.+||++.++++.|+..
T Consensus       276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                      7788999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.9e-38  Score=313.45  Aligned_cols=215  Identities=24%  Similarity=0.371  Sum_probs=184.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC-----CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-----LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      .+.|+..+.||+|+||.||+|.+..+++.||||++...     .....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46789999999999999999999999999999998642     1224678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC---EEEeecCC
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGL  346 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~DFGl  346 (459)
                      +||||+++|+|.+++.........+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998887654434468999999999999999999999   99999999999999987654   99999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------  398 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------  398 (459)
                      ++..... ........||+.|+|||++.+..  ++...|+|++|++++++++                            
T Consensus       180 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          180 AIQLGES-GLVAGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CEECCTT-SCBCCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             eeEecCC-CeeecCCcCCcCccCHHHHcCCC--CCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccc
Confidence            9877543 22234567999999999998654  5788899999999998876                            


Q ss_pred             -------------cCCCCCCCCCCHHHHHH
Q 041624          399 -------------CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       399 -------------c~~p~p~~RPs~~~v~~  415 (459)
                                   |+..+|.+||++.++++
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                         55668888888888876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=323.29  Aligned_cols=217  Identities=20%  Similarity=0.170  Sum_probs=189.0

Q ss_pred             cccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEE
Q 041624          184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       184 ~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      ..+.++++....++|+..+.||+|+||.||+|+.+.+++.||+|++++..   ....+.+.+|..++.+++|+||+++++
T Consensus        49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            34566777778899999999999999999999999999999999997532   223456889999999999999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      ++.+.+.+||||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEE
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEE
Confidence            99999999999999999999999976543   59999999999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccC-----ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG-----RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      |+|||+++.............+||+.|+|||++...     ...++.++|+|++|+++++|+++..|+...
T Consensus       203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            999999987765433334457899999999998731     124678899999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-38  Score=308.92  Aligned_cols=194  Identities=22%  Similarity=0.225  Sum_probs=171.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|...+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46889999999999999999999999999999998754 33456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC--CCCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT--DFNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~  352 (459)
                      +++|+|.+++.....   .+++.++..++.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.+..
T Consensus        83 ~~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999965433   69999999999999999999999   99999999999999997  78999999999987754


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      .  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g  199 (321)
T 1tki_A          157 G--DNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSG  199 (321)
T ss_dssp             T--CEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHS
T ss_pred             C--CccccccCChhhcCcHHhcCCC--CCchhhHHHHHHHHHHHHhC
Confidence            3  2344567899999999997653  56788999999999988863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.9e-39  Score=319.02  Aligned_cols=216  Identities=26%  Similarity=0.333  Sum_probs=179.1

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEE-----cCCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCcee
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQ  257 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~  257 (459)
                      .+...++....++|...+.||+|+||.||+|.+     ..+++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            356677777889999999999999999999984     45568999999976533 3456799999999999 8999999


Q ss_pred             EEEEEeeCC-eEEEEEEecCCCCcchhccccCCC----------------------------------------------
Q 041624          258 LIGLCHDRG-EFMLVYEFMPNGSLDFHLFSKKST----------------------------------------------  290 (459)
Q Consensus       258 l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------  290 (459)
                      +++++.+.+ ..++||||+++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 489999999999999999765421                                              


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          291 ----------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       291 ----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                                      ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            1228999999999999999999999   999999999999999999999999999998764432


Q ss_pred             CC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          355 GP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       355 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      .. ......||+.|+|||++.+..  ++.+.|+|++|++++++++ +..|++.
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~  298 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPG  298 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cchhccccCCCceeEChhhhcCCC--CCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence            22 234567899999999998654  5678899999999999986 5555443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8e-38  Score=315.13  Aligned_cols=215  Identities=24%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999999999999999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC--CCCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT--DFNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~  352 (459)
                      +++|+|.+++.....   .+++.++..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999875433   59999999999999999999999   99999999999999974  47899999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .  .......||+.|+|||++.+..  ++...|+|++|+++++|++                                  
T Consensus       204 ~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          204 D--EIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             T--SCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             C--cceeeeccCCCccCchhccCCC--CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence            3  2234457999999999997654  5677899999999998875                                  


Q ss_pred             --------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 --------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 --------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                              |+..+|.+||++.++++.--.
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence                    666788889999998876433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-38  Score=313.79  Aligned_cols=219  Identities=26%  Similarity=0.332  Sum_probs=188.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999986532   23346789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+ +|+|.+++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 789988887654    59999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..  ......+||+.|+|||.+.+... .+.+.|+|++|++++++++                                 
T Consensus       160 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  236 (336)
T 3h4j_B          160 DG--NFLKTSCGSPNYAAPEVINGKLY-AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ  236 (336)
T ss_dssp             TS--BTTCCCTTSTTTSCGGGSCCSGG-GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHH
T ss_pred             CC--cccccccCCcCcCCHHHHcCCCC-CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHH
Confidence            43  23345679999999999986542 3567899999999998886                                 


Q ss_pred             -----cCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          399 -----CAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                           |+.++|.+|||+.|+++.--+...+|
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence                 66778999999999988654443333

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-38  Score=308.12  Aligned_cols=194  Identities=23%  Similarity=0.319  Sum_probs=170.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|...+.||+|+||.||+|....+++.||+|.+.....      ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4568899999999999999999999999999999976432      1357799999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEeec
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGDF  344 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DF  344 (459)
                      ++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999996543    59999999999999999999999   9999999999999999887    7999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      |+++.....  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++
T Consensus       163 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g  213 (326)
T 2y0a_A          163 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSG  213 (326)
T ss_dssp             TTCEECCTT--SCCCCCCSCTTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCeECCCC--CccccccCCcCcCCceeecCCC--CCcHHHHHHHHHHHHHHHHC
Confidence            999877533  2234567999999999987553  57788999999999988763

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-38  Score=317.25  Aligned_cols=200  Identities=18%  Similarity=0.125  Sum_probs=171.6

Q ss_pred             HhcCCCCCceeccC--CceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQG--GFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G--~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|++.+.||+|  +||.||+|.+..+++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34678999999999  99999999999999999999997553  233567888999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|||||++|+|.+++.....  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999976532  259999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCC------CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          350 VDHEL------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       350 ~~~~~------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .....      ........||+.|+|||++.+....++.+.|+|++|++++++++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~  232 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN  232 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence            43211      11123357899999999998753457888999999999987764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-38  Score=306.84  Aligned_cols=216  Identities=24%  Similarity=0.371  Sum_probs=189.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC-------cEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN-------MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      .++|...+.||+|+||.||+|.+..++       ..||+|.+........+.+.+|+.++.+++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357888899999999999999988766       4799999977666677889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC--------E
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--------V  339 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~  339 (459)
                      .++||||+++|+|.+++.....   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999976543   59999999999999999999999   99999999999999998887        9


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------  398 (459)
                      ||+|||+++....     .....||+.|+|||++.+.. .++.+.|+|++|++++++++                     
T Consensus       161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~  234 (289)
T 4fvq_A          161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPK-NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR  234 (289)
T ss_dssp             EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGG-GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             eeccCcccccccC-----ccccCCcCcccCHHHhCCCC-CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence            9999999865432     23456789999999997533 36778899999999998876                     


Q ss_pred             -----------------cCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          399 -----------------CAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       399 -----------------c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                                       |+.++|.+||++.++++.|+....
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                             778899999999999999986544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-38  Score=330.40  Aligned_cols=223  Identities=24%  Similarity=0.390  Sum_probs=190.6

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      +++...++|...+.||+|+||.||+|.+..++..||||.++... ...++|.+|+.+|.+++||||++++++|.+.+..+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            33445677888999999999999999999889999999997643 35678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      |||||+++|+|.+++.....  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999999976432  268999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------  398 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------  398 (459)
                      .............++..|+|||++..+.  ++.+.|+|++|++++++++                               
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCC--CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7543222233455678999999998664  5778899999999998875                               


Q ss_pred             ---------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ---------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ---------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                               |++.+|.+||++.++++.|+..
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                     6666777777777777777654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-38  Score=321.82  Aligned_cols=212  Identities=21%  Similarity=0.225  Sum_probs=185.0

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      .+.++....++|+..+.||+|+||.||+|+++.+++.||+|++++.   .....+.+.+|+.++..++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456667788999999999999999999999999999999999653   1233456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      +.+.+|+||||+++|+|.+++...     .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence            999999999999999999988643     48999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCcc--ccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRA--RLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ||+++.............+||+.|+|||++.....  .++.++|+|++|+++++|+++..|+...
T Consensus       212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            99998776543333456789999999999975431  2567899999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.9e-38  Score=305.29  Aligned_cols=203  Identities=25%  Similarity=0.312  Sum_probs=171.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+.. ++.||+|++.....  ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            45788999999999999999999965 89999999975432  2346788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++ +|.+++.....   .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EECCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EcCCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999974 88888765443   59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .. ........||+.|+|||++.+.. .++.+.|+|++|+++++++++..|++..
T Consensus       171 ~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          171 IP-VRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             SC-CC---CCCCCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CC-cccccCCcccCCcCCHHHhcCCC-CCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            33 22334567899999999987543 3678889999999999999888777643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-38  Score=311.73  Aligned_cols=214  Identities=26%  Similarity=0.268  Sum_probs=176.9

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC-----CccchHHHHHHHHHHhccCcCCceeEEEEEee
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-----LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      ++....++|...+.||+|+||.||+|.+..+++.||+|++...     .....+.+.+|++++.+++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            4566788999999999999999999999999999999998653     23456789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKST------------------------------------GTPLTWTTRYKISLGLAS  308 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~  308 (459)
                      .+..++||||+++|+|.+++......                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998531110                                    113467788899999999


Q ss_pred             HHHHhhhccCCCeeecCCCCCCeeecCCC--CEEEeecCCcccccCCCCC---ccccccccccccccceeccCccccCCC
Q 041624          309 ALLYLHEEWKRCVVHRDIKFSNIMPDTDF--NVKLGDFGLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRARLDVN  383 (459)
Q Consensus       309 aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~  383 (459)
                      ||+|||+   .+|+||||||+|||++.++  .+||+|||+++.+......   ......||+.|+|||.+.+....++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  8999999999876432221   234567999999999997654457788


Q ss_pred             CCHHHHHHHHHHHHhcCCCCCCC
Q 041624          384 FDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       384 ~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .|+|++|+++++++++..|++..
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~  279 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGV  279 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999877776543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.2e-38  Score=302.97  Aligned_cols=196  Identities=25%  Similarity=0.360  Sum_probs=167.7

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ...++|+..+.||+|+||.||+|.+.. +..||+|+++... ...+++.+|++++.+++|+||+++++++.+.+..++||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            456788889999999999999998875 7889999997543 34578999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.....   .+++.+++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999976443   59999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ..........+|+.|+|||.+.+..  ++.+.|+|++|++++++++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~t  216 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYS  216 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCccCcccCCHHHhccCC--CCchhhHHHHHHHHHHHHh
Confidence            3222233455678899999998654  5678899999999999885

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.1e-38  Score=306.29  Aligned_cols=208  Identities=25%  Similarity=0.372  Sum_probs=164.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999999999999999999997653 334577899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          273 EFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||++ |+|.+++....  .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 59999887542  122358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .... .......||+.|+|||++.+.. .++.+.|+|++|+++++++++..|++...
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          159 GIPV-NTFSSEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             TSCC-CCCCCCCSCCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCc-ccCCCCcccccccCchHhhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5332 2234467899999999987543 36788999999999999999988887543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=319.42  Aligned_cols=202  Identities=24%  Similarity=0.352  Sum_probs=175.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|....+++.+|+|++.....  ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            45789999999999999999999999999999999976532  3456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec---CCCCEEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD---TDFNVKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~  348 (459)
                      |||+++|+|.+.+....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||+++
T Consensus        89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999987654    59999999999999999999999   9999999999999998   46789999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ..... ........||+.|+|||++.+..  ++.+.|+||+|+++++++++..|+..
T Consensus       162 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          162 EVEGE-QQAWFGFAGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             CCCTT-CCBCCCSCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EecCC-CceeecccCCcccCCHHHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCC
Confidence            76543 22334578999999999997653  57889999999999999987766543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-38  Score=310.07  Aligned_cols=217  Identities=23%  Similarity=0.351  Sum_probs=183.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcE----EEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMA----VAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|+..+.||+|+||.||+|.+..+++.    ||+|.+.... ....+.+.+|+.++.+++|+||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            5688889999999999999999877765    7888775442 344567889999999999999999999986 457899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+
T Consensus        92 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            9999999999999976543   68999999999999999999999   89999999999999999999999999999887


Q ss_pred             cCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------
Q 041624          351 DHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------  398 (459)
Q Consensus       351 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------  398 (459)
                      ...... ......||..|+|||++.++.  ++.+.|+|++|++++++++                               
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT  243 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred             CcccccccccCCCCcccccChHHhccCC--CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence            544322 234566888999999998664  5678899999999998876                               


Q ss_pred             ---------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ---------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ---------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                               |+..+|.+||++.++++.|+...
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     66778999999999999997643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-38  Score=312.60  Aligned_cols=217  Identities=25%  Similarity=0.364  Sum_probs=178.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcE----EEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMA----VAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      .++|+..+.||+|+||.||+|.+..+++.    ||+|.++... ....++|.+|+.++.+++||||++++++|.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            35688899999999999999998776654    5888876443 345678999999999999999999999998764 78


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|+||+++|+|.+++.....   .+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999999987544   69999999999999999999999   8999999999999999999999999999988


Q ss_pred             ccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          350 VDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       350 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ........ .....+|..|+|||++.++.  ++.+.|+|++|++++++++                              
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             ccCCcccccccCCCccccccChHHhccCC--CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccC
Confidence            75443222 33456788999999998654  5678899999999998775                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |+..+|.+||++.++++.|+..
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                      6777899999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=318.41  Aligned_cols=222  Identities=23%  Similarity=0.337  Sum_probs=187.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|...+.||+|+||.||+|.+.     .+++.||||+++.. ......++.+|+.++.+++|+||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999953     45789999999754 234456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEEe
Q 041624          269 MLVYEFMPNGSLDFHLFSKKS---TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLG  342 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~  342 (459)
                      ++||||+++|+|.+++.....   ....+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999986542   22359999999999999999999999   9999999999999999555   59999


Q ss_pred             ecCCcccccCCC-CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------
Q 041624          343 DFGLALLVDHEL-GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------  398 (459)
Q Consensus       343 DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------  398 (459)
                      |||+++.+.... ........||+.|+|||++.++.  ++.+.|+|++|++++++++                       
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998654322 12234456899999999997654  5778899999999998874                       


Q ss_pred             -----------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 -----------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 -----------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                       |+..+|.+||++.++++.|+...
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                             77889999999999999997644

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=313.89  Aligned_cols=199  Identities=27%  Similarity=0.356  Sum_probs=174.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|++.+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367889999999999999999999999999999996542   33456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999997543    59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ..  ......+||+.|+|||++.... ..++...|+|++|+++++|+++..|
T Consensus       167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~P  216 (384)
T 4fr4_A          167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP  216 (384)
T ss_dssp             TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCC
Confidence            43  3345678999999999987532 2467789999999999999875444

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-38  Score=312.18  Aligned_cols=210  Identities=25%  Similarity=0.348  Sum_probs=175.8

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      ++....++|...+.||+|+||.||+|.+..     +++.||+|+++.... ...+.+.+|+.++.+++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            444567899999999999999999999973     458999999976533 34567999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeee
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKST--------------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVH  323 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH  323 (459)
                      +.+..++||||+++|+|.+++......                    ...+++.+++.++.||+.||.|||+   ++|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence            999999999999999999999764311                    1469999999999999999999999   99999


Q ss_pred             cCCCCCCeeecCCCCEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCC
Q 041624          324 RDIKFSNIMPDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAH  401 (459)
Q Consensus       324 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~  401 (459)
                      |||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.++.  ++.+.|+|++|++++++++ +..
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC--cCcccccHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999987643321 2234456889999999988654  5678899999999999987 555


Q ss_pred             CCC
Q 041624          402 PDR  404 (459)
Q Consensus       402 p~p  404 (459)
                      |+.
T Consensus       276 p~~  278 (343)
T 1luf_A          276 PYY  278 (343)
T ss_dssp             TTT
T ss_pred             cCC
Confidence            544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.9e-38  Score=310.00  Aligned_cols=218  Identities=23%  Similarity=0.314  Sum_probs=189.3

Q ss_pred             cCCCCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEe--eCCeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH--DRGEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~  269 (459)
                      ++|+..+.||+|+||.||+|.+    ..+++.||||++........+.+.+|++++.+++|+||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6788899999999999999994    5578999999998776666778999999999999999999999986  456789


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++++|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            99999999999999976543   59999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------------
Q 041624          350 VDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------------  398 (459)
Q Consensus       350 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------------  398 (459)
                      .......  ......||..|+|||++.+..  ++.+.|+|++|++++++++                             
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCC--CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            7543222  123456888999999997654  4678899999999988764                             


Q ss_pred             -------------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 -------------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 -------------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                               |+.++|.+||++.++++.|+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                     88899999999999999998653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-38  Score=306.73  Aligned_cols=206  Identities=24%  Similarity=0.402  Sum_probs=178.4

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ++....++|+..+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.++.+++|+||+++++++.+.+..+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            3344667889999999999999999999998999999999754 345678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++++|.+++.....  ..+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            99999999999999976433  369999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      .............+|+.|+|||.+.+..  ++...|+|++|++++++++ +..|+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCCccccccCCccccCcCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            7654333344556788999999997664  5678899999999999887 44443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-38  Score=322.53  Aligned_cols=195  Identities=24%  Similarity=0.303  Sum_probs=154.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee-----CCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-----RGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~  267 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ....+++.+|+.+|.+++|+||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999999999999999997543  2345678999999999999999999999844     357


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      +|+||||+ +++|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 578988886543    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCC--------------------------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          348 LLVDHELG--------------------------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       348 ~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +.......                          ......+||+.|+|||++..+. .++.++|+|++||++++|++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE-NYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-CCCcHhHHHHHHHHHHHHHH
Confidence            87653221                          1234567899999999875443 36888999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-38  Score=326.66  Aligned_cols=203  Identities=24%  Similarity=0.385  Sum_probs=172.4

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      +...+++...++|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|.+++||||+++++++. .
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            3345556677889999999999999999999976 7889999997653 45788999999999999999999999986 5


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +..++||||+++|+|.+++.....  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             CccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCC
Confidence            678999999999999999975432  258899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +++..............+|..|+|||++..+.  ++.++|+|++|++++++++
T Consensus       330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~t  380 (454)
T 1qcf_A          330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVT  380 (454)
T ss_dssp             GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             CceEcCCCceeccCCCcccccccCHHHhccCC--CCcHHHHHhHHHHHHHHHh
Confidence            99876532211223445678999999998654  5778899999999998876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=312.93  Aligned_cols=222  Identities=24%  Similarity=0.369  Sum_probs=189.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC-------CcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++|.+.+.||+|+||.||+|.+..+       +..||+|+++... ....+++.+|++++.++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            457888999999999999999997532       3679999997653 33457899999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      .+..++||||+++|+|.+++.....            ....+++.+++.|+.||+.||+|||+   .+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence            9999999999999999999976542            12359999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------
Q 041624          333 PDTDFNVKLGDFGLALLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------  398 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------  398 (459)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..  ++.+.|+|++|++++++++             
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999987654322 2234456789999999998654  5678899999999998775             


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ---------------------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ---------------------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                                 |+.++|.+||++.++++.|+..
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                       7778999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-37  Score=300.72  Aligned_cols=202  Identities=24%  Similarity=0.360  Sum_probs=171.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||.||+|.+ .+++.||+|++.....  ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5788899999999999999998 4589999999975432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++ +|.+++.....   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9975 89888875443   69999999999999999999999   99999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . .......||+.|+|||++.+.. .++.+.|+|++|+++++++++..|++...
T Consensus       154 ~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          154 V-RKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             c-cccccccccccccCchheeCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 2234457899999999987543 36788999999999999999999887653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-37  Score=310.96  Aligned_cols=201  Identities=23%  Similarity=0.377  Sum_probs=174.8

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ...++|...+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999999999999999997643  2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEEeecCCc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLGDFGLA  347 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla  347 (459)
                      ||||+++|+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999999886543    58999999999999999999999   9999999999999998654   5999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      +.....  .......||+.|+|||++.+..  ++...|+|++|+++++++++..|+.
T Consensus       179 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          179 IEVNDS--EAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             BCCTTC--CSCCCSCSCTTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eEecCC--cccccCCCCccccCHHHHccCC--CCchhhHHHHHHHHHHHHHCCCCCC
Confidence            876532  2234568999999999997653  5778999999999999998665544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.5e-37  Score=295.62  Aligned_cols=200  Identities=25%  Similarity=0.325  Sum_probs=178.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+..++..||+|++........+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            45678999999999999999999999999999999987766677889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~  350 (459)
                      |+++++|.+++....    .+++..++.++.|++.||+|||+   ++|+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999887654    58999999999999999999999   999999999999999   78899999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ...  .......||+.|+|||.+.+.   ++.+.|+|++|+++++++++..|+..
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          160 KPG--KMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             CTT--SCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCc--cchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCC
Confidence            543  233456799999999998643   67889999999999999987777654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=301.71  Aligned_cols=196  Identities=23%  Similarity=0.298  Sum_probs=164.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3678899999999999999999999999999999865532  23567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999988876543    59999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      .. .......||..|+|||.+.+.. .++.+.|+|++|+++++++++
T Consensus       155 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g  199 (311)
T 4agu_A          155 PS-DYYDDEVATRWYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSG  199 (311)
T ss_dssp             ------------GGGCCHHHHHTCS-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             cc-cccCCCcCCccccChHHHhcCC-CCCcchhhHHHHHHHHHHHhC
Confidence            32 2234567899999999987533 367889999999999887764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=311.52  Aligned_cols=197  Identities=23%  Similarity=0.269  Sum_probs=168.2

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      ..+.||+|+||.||+|....+++.||+|+++.......+++.+|++++.+++||||+++++++.+.+..+|||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            35689999999999999999999999999987665667889999999999999999999999999999999999999999


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee--cCCCCEEEeecCCcccccCCCCCc
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP--DTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||+  +.++.+||+|||+++.+...  ..
T Consensus       173 L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~  244 (373)
T 2x4f_A          173 LFDRIIDESY---NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EK  244 (373)
T ss_dssp             EHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CB
T ss_pred             HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cc
Confidence            9998876543   59999999999999999999999   999999999999999  56789999999999876543  22


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .....||+.|+|||++..+.  ++.+.|+|++|+++++|+++..|+...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCB--CCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccccCCCcEeChhhccCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            34457999999999987653  567789999999999999987776544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-38  Score=311.48  Aligned_cols=211  Identities=25%  Similarity=0.340  Sum_probs=175.9

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCc-----EEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNM-----AVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLC  262 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  262 (459)
                      ++....++|...+.||+|+||.||+|.+..++.     .||+|.+..... ...+.+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445567889999999999999999999976554     799999976532 3456799999999999 899999999999


Q ss_pred             eeCCeEEEEEEecCCCCcchhccccCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          263 HDRGEFMLVYEFMPNGSLDFHLFSKKS----------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       263 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      .+.+..++||||+++|+|.+++.....          ....+++..++.++.||+.||+|||+   ++|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence            999999999999999999999875421          12358999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      ++.++.+||+|||+++......... .....+|+.|+|||.+.+..  ++...|+|++|++++++++ +..|++.
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC--CChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999999999998765432222 23455788999999987654  5678899999999999886 4444443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4e-37  Score=305.38  Aligned_cols=214  Identities=21%  Similarity=0.334  Sum_probs=183.5

Q ss_pred             HHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCe
Q 041624          192 ASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       192 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~  267 (459)
                      ....++|...+.||+|+||.||+|+++.+++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345688999999999999999999999999999999997542   33456788899999887 99999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      +|+||||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999997654    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      +..... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+...  +..++.+.+
T Consensus       166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i  230 (345)
T 1xjd_A          166 KENMLG-DAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSI  230 (345)
T ss_dssp             BCCCCT-TCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred             hhcccC-CCcccCCCCCcccCChhhhcCCC--CCChhhhHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH
Confidence            864322 22345678999999999998654  578899999999999999999998754  344555444

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-37  Score=304.40  Aligned_cols=213  Identities=21%  Similarity=0.184  Sum_probs=185.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||+|....+++.||||.+....  ..+.+.+|+.++.++ +|+||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367899999999999999999999899999999987542  345688999999999 99999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC-----EEEeecCCcc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-----VKLGDFGLAL  348 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kL~DFGla~  348 (459)
                      |+ +++|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 9999999976533   69999999999999999999999   99999999999999999887     9999999998


Q ss_pred             cccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC--------------------
Q 041624          349 LVDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP--------------------  402 (459)
Q Consensus       349 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p--------------------  402 (459)
                      .+......      ......||+.|+|||++.+..  ++...|+|++|+++++++++..|                    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE--QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCC--CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            76543221      124568999999999998654  56788999999999999875444                    


Q ss_pred             -------------------------CCCCCCCHHHHHHHHh
Q 041624          403 -------------------------DRNCRPSIRQAIQVLN  418 (459)
Q Consensus       403 -------------------------~p~~RPs~~~v~~~L~  418 (459)
                                               +|.+||++.++.+.|+
T Consensus       237 ~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          237 RATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             ccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence                                     6789999999999886

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.9e-38  Score=308.61  Aligned_cols=216  Identities=25%  Similarity=0.313  Sum_probs=188.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--------cchHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||+++....        ...+.+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999999999999999999976531        1345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCC-CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          266 GEFMLVYEFMPNG-SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       266 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      +..++||||+.+| +|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999886543    59999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------------
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------------  398 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------------  398 (459)
                      |+++.....  .......||+.|+|||++.+... .+.+.|+|++|++++++++                          
T Consensus       175 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l  251 (335)
T 3dls_A          175 GSAAYLERG--KLFYTFCGTIEYCAPEVLMGNPY-RGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKEL  251 (335)
T ss_dssp             TTCEECCTT--CCBCEECSCGGGCCHHHHTTCCB-CSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHH
T ss_pred             ccceECCCC--CceeccCCCccccChhhhcCCCC-CCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHH
Confidence            999876543  23345679999999999976542 3567899999999998874                          


Q ss_pred             ------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                            |+.++|.+||++.++++.--.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          252 MSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCccc
Confidence                  778899999999999997543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-37  Score=301.57  Aligned_cols=195  Identities=24%  Similarity=0.371  Sum_probs=165.6

Q ss_pred             cCCCCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeE
Q 041624          196 NNFSNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEF  268 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~  268 (459)
                      +.|+..+.||+|+||.||+|.+    ..+++.||+|+++... ....+.+.+|+.++.+++|+||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999994    5578999999997543 34567899999999999999999999999876  678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999999966543   59999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          349 LVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       349 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ........  ......||..|+|||.+.+..  ++.+.|+|++|++++++++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~  224 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLT  224 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHT
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCC--CCcchhHHHHHHHHHHHHH
Confidence            77644321  233456888999999997664  4567899999999988764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=304.95  Aligned_cols=227  Identities=23%  Similarity=0.268  Sum_probs=190.2

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEF  268 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~  268 (459)
                      ...++|+..+.||+|+||.||++....+++.||+|++........+.+.+|+.++.+++||||+++++++..    ....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            345789999999999999999999988899999999977656667789999999999999999999999873    4578


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++.........+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            99999999999999998644334579999999999999999999999   899999999999999999999999999987


Q ss_pred             cccCCCCCc--------cccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHh---------------------
Q 041624          349 LVDHELGPR--------TTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLW---------------------  398 (459)
Q Consensus       349 ~~~~~~~~~--------~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~---------------------  398 (459)
                      .........        .....||+.|+|||.+.... ..++.+.|+|++|++++++++                     
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            653211110        12345799999999987543 235778899999999998875                     


Q ss_pred             --------------------cCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          399 --------------------CAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       399 --------------------c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                                          |+.++|.+||++.++++.|+...+
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                                666789999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-38  Score=303.59  Aligned_cols=204  Identities=26%  Similarity=0.369  Sum_probs=160.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..+.||+|+||.||+|.+..+   +..||+|.+.... ....+.+.+|+.++.+++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            456888999999999999999998653   4579999987643 334567999999999999999999999984 56789


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++++|.+++.....   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999976543   69999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNC  406 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~  406 (459)
                      .............+|+.|+|||.+....  ++...|+|++|++++++++ +..|+...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCcccccccccCCCcccccChhhcccCC--CCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            7554333334456788999999997654  5677899999999999986 66665543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-37  Score=303.96  Aligned_cols=207  Identities=23%  Similarity=0.309  Sum_probs=174.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..++|...+.||+|+||.||+|.+.     .++..||+|+++... ....+.+.+|++++.+++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4578889999999999999999983     345899999997653 3345788999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCC
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKS--------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK  327 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk  327 (459)
                      .++||||+++|+|.+++.....                    ....+++.+++.++.||+.||+|||+   ++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence            9999999999999999976543                    12348999999999999999999999   999999999


Q ss_pred             CCCeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          328 FSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       328 p~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      |+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..  ++...|+|++|++++++++ +..|++.
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999876543221 123456788999999997654  5678899999999999987 5555543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=301.72  Aligned_cols=204  Identities=24%  Similarity=0.282  Sum_probs=174.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC--eEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG--EFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV  271 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++.+++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357888999999999999999999999999999997543 344677889999999999999999999998765  78999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee----cCCCCEEEeecCCc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP----DTDFNVKLGDFGLA  347 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla  347 (459)
                      |||+++++|.+++...... ..+++.+++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999765431 249999999999999999999999   999999999999999    78888999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccC------ccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTG------RARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      +.....  .......||+.|+|||++...      ...++.+.|+|++|+++++++++..|+.
T Consensus       164 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  224 (319)
T 4euu_A          164 RELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (319)
T ss_dssp             EECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred             eecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            877543  233456799999999988631      2246788999999999999998877653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-37  Score=307.95  Aligned_cols=194  Identities=21%  Similarity=0.222  Sum_probs=172.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..+.||+|+||.||+|++..+++.||+|++++..   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367889999999999999999999999999999996542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999997654    59999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      ..    ....+||+.|+|||++.+..  ++...|+|++|+++++|+++..
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~  236 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYP  236 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CC----cccccCCccccCHHHhcCCC--CCCcCCEecccHhHhHHhhCCC
Confidence            32    34568999999999998653  5788999999999999887443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-37  Score=299.97  Aligned_cols=213  Identities=26%  Similarity=0.340  Sum_probs=175.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|...+.||+|+||.||+|....++..+|+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367888999999999999999999999999999997653 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~  350 (459)
                      |+++|+|.+++.........+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999987543333469999999999999999999999   999999999999999   45678999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      ...  .......||+.|+|||.+..   .++.+.|+|++|+++++++++..|+...  +..++.+..
T Consensus       178 ~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~--~~~~~~~~~  237 (285)
T 3is5_A          178 KSD--EHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGT--SLEEVQQKA  237 (285)
T ss_dssp             -----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred             CCc--ccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCC--CHHHHHhhh
Confidence            542  22345678999999999863   3567889999999999999887776543  344444443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-37  Score=300.55  Aligned_cols=193  Identities=25%  Similarity=0.323  Sum_probs=160.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhc--cCcCCceeEEEEEee----CCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ--LRHRNLLQLIGLCHD----RGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~----~~~  267 (459)
                      ..++|+..+.||+|+||.||+|.+.  ++.||||++..   ...+.+..|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3578999999999999999999883  78999999864   344556667776666  799999999999754    346


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeeecCCCCCCeeecCCCCE
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH--------EEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      .++||||+++|+|.+++...     .+++..++.++.||+.||+|||        +   ++|+||||||+|||++.++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCE
T ss_pred             eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCE
Confidence            89999999999999999432     5999999999999999999999        6   899999999999999999999


Q ss_pred             EEeecCCcccccCCCCCc---cccccccccccccceeccCcc----ccCCCCCHHHHHHHHHHHHhc
Q 041624          340 KLGDFGLALLVDHELGPR---TTGLAGTLGYMAPEYISTGRA----RLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~----~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ||+|||+++.........   .....||+.|+|||++.+...    .++.+.|+|++|+++++++++
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999999998765432221   234579999999999976532    234578999999999998876

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=307.98  Aligned_cols=210  Identities=25%  Similarity=0.333  Sum_probs=177.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..+.||+|+||.||+|+++.+++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999754   223456788999999988 7999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999997654    59999999999999999999999   9999999999999999999999999999985


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~  415 (459)
                      .... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+...  +..++.+
T Consensus       174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~  234 (353)
T 3txo_A          174 GICN-GVTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFE  234 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHH--CTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHH
T ss_pred             cccC-CccccccCCCcCeEChhhcCCCC--cCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHH
Confidence            4322 23345678999999999997553  577899999999999999999998765  3344443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-37  Score=316.69  Aligned_cols=194  Identities=26%  Similarity=0.337  Sum_probs=165.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++...  ....+.+.+|+.++.+++|+||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999999999999999997643  23456889999999999999999999999766     57


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .|+||||+. |+|.+++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999996 59999986543    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC---------------------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH
Q 041624          348 LLVDHELGP---------------------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL  397 (459)
Q Consensus       348 ~~~~~~~~~---------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l  397 (459)
                      +........                     .....+||+.|+|||++..+. .++.++|+||+||++++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE-NYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC-CCCcccccchHHHHHHHHH
Confidence            877543211                     235678999999999875443 3688899999999999887

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-37  Score=299.01  Aligned_cols=200  Identities=20%  Similarity=0.248  Sum_probs=170.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|+++...  .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4577899999999999999999999889999999997643  33456788999999999 99999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC--------------
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD--------------  336 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~--------------  336 (459)
                      ||||+++++|.+++.........+++.+++.++.||+.||+|||+   ++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997653322369999999999999999999999   999999999999999844              


Q ss_pred             -----CCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          337 -----FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       337 -----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                           ..+||+|||+++.....     ....||+.|+|||.+.+.. ..+.+.|+|++|+++++++++..+
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCC-TTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCC-CCCchhhHHHHHHHHHHHhcCCCC
Confidence                 47999999999876542     2345899999999997542 345678999999999988765443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.3e-37  Score=297.16  Aligned_cols=196  Identities=19%  Similarity=0.217  Sum_probs=170.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++...  ...+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46789999999999999999999888999999998653  2345688999999999 89999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC-----EEEeecCCcc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-----VKLGDFGLAL  348 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kL~DFGla~  348 (459)
                      |+ +++|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.     +||+|||+++
T Consensus        87 ~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 9999999976543   59999999999999999999998   99999999999999987776     9999999998


Q ss_pred             cccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          349 LVDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       349 ~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      ........      ......||+.|+|||.+.+..  ++.+.|+|++|+++++++++..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~  216 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSL  216 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCC--CChHHHHHHHHHHHHHHHcCCC
Confidence            77644321      234567999999999987654  5778899999999998886433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.4e-38  Score=321.23  Aligned_cols=222  Identities=26%  Similarity=0.371  Sum_probs=180.7

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      ..++...++|+..+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|.+++||||+++++++.+ +..
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3444566788999999999999999999986 5779999997653 346789999999999999999999999876 678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++|+|.+++.....  ..+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccce
Confidence            999999999999999975322  258999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ..............++..|+|||.+..+.  ++.++|+|++|++++++++                              
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  406 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  406 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCC--CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            76543323334456788999999998664  5778899999999988775                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |+..+|.+||++.++++.|+..
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                      6666777888888888777654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-38  Score=309.77  Aligned_cols=232  Identities=23%  Similarity=0.290  Sum_probs=174.6

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCc---EEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNM---AVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      +++....++|+..+.||+|+||.||+|.+..++.   .||||+++..  .....+++.+|++++.+++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3444566789999999999999999999877654   8999999765  3345678999999999999999999999998


Q ss_pred             eCCeE------EEEEEecCCCCcchhccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC
Q 041624          264 DRGEF------MLVYEFMPNGSLDFHLFSKKS--TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT  335 (459)
Q Consensus       264 ~~~~~------~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~  335 (459)
                      ..+..      ++||||+++|+|.+++.....  ....+++.+++.++.||+.||+|||+   ++|+||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence            77655      999999999999999875432  22358999999999999999999999   99999999999999999


Q ss_pred             CCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------
Q 041624          336 DFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------  398 (459)
Q Consensus       336 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------  398 (459)
                      ++.+||+|||+++........ ......+++.|+|||.+.+..  ++.+.|+|++|++++++++                
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCC--CCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999999876543222 223445688999999997654  5678899999999998775                


Q ss_pred             ------------------------cCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          399 ------------------------CAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       399 ------------------------c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                                              |+.++|.+||++.++++.|+....-|.
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                                    677789999999999998886543333

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-37  Score=309.34  Aligned_cols=214  Identities=21%  Similarity=0.224  Sum_probs=175.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||++....+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3568999999999999999999999999999999997543 334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC--EEEeecCCccccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALLVD  351 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~~~  351 (459)
                      |+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.  +||+|||+++...
T Consensus        97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999987654    59999999999999999999999   99999999999999987765  9999999997543


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..  .......||+.|+|||++.+... .....|+|++|++++++++                                 
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR  246 (361)
T ss_dssp             -------------CTTSCHHHHHCSSC-CHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCC-CCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence            22  22345679999999999976543 2334799999999998876                                 


Q ss_pred             -----------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 -----------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 -----------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                 |+..+|.+|||+.|+++.--
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence                       55668889999999887543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-37  Score=318.12  Aligned_cols=212  Identities=24%  Similarity=0.305  Sum_probs=186.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367889999999999999999999899999999996542   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999996543    59999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      ..  ......+||+.|+|||++.+... .+.+.|+|++|++++++++                                 
T Consensus       168 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  244 (476)
T 2y94_A          168 DG--EFLRTSCGSPNYAAPEVISGRLY-AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI  244 (476)
T ss_dssp             TT--CCBCCCCSCSTTCCHHHHTTCCB-CSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred             cc--ccccccCCCcCeEChhhccCCCC-CCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHH
Confidence            43  23445689999999999986532 3567899999999998875                                 


Q ss_pred             -----cCCCCCCCCCCHHHHHHH
Q 041624          399 -----CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~  416 (459)
                           |+..+|.+||++.++++.
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHcCCCchhCcCHHHHHhC
Confidence                 677799999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=299.06  Aligned_cols=199  Identities=25%  Similarity=0.289  Sum_probs=177.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..+.||+|+||.||+|+...+++.||+|++++..   ....+.+.+|..++..++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467889999999999999999999999999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999997654    58999999999999999999998   999999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      .    .....+||+.|+|||++.+..  ++.+.|+|++|+++++|+++..|+...
T Consensus       158 ~----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          158 D----VTYTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             S----CBCCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             C----ccccccCCccccCHhHhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            3    234568999999999997653  578899999999999999999998654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-37  Score=306.79  Aligned_cols=199  Identities=28%  Similarity=0.380  Sum_probs=163.0

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-----chHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-----GKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      +....++|...+.||+|+||.||+|.+..+++.||+|++......     ..+.+.+|+.++.+++|+||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            344567899999999999999999999988999999999754221     235788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +..++||||+++ +|.+++.....   .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999976 88888865443   68899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +++.+... ........||+.|+|||.+.+.. .++...|+|++|++++++++
T Consensus       158 ~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~  208 (346)
T 1ua2_A          158 LAKSFGSP-NRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLL  208 (346)
T ss_dssp             GGSTTTSC-CCCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeccCC-cccCCcccccccccCchHhhCCC-CCCchhhhHhHHHHHHHHHH
Confidence            99876533 22334567899999999987543 35677899999999998875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=306.41  Aligned_cols=203  Identities=27%  Similarity=0.357  Sum_probs=162.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||+++...  ..+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999999989999999997542  45678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~  350 (459)
                      |+++|+|.+++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999986543    58999999999999999999999   99999999999999975   889999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS  409 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs  409 (459)
                      ...  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+...+..
T Consensus       202 ~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~  256 (349)
T 2w4o_A          202 EHQ--VLMKTVCGTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDERGD  256 (349)
T ss_dssp             -------------CGGGSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred             Ccc--cccccccCCCCccCHHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence            532  2234567999999999998653  578899999999999999998888766543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.4e-37  Score=297.00  Aligned_cols=213  Identities=28%  Similarity=0.414  Sum_probs=184.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|...+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999999999999999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++.+++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999886543    59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      .. ........||+.|+|||.+.+..  .+.+.|+|++|++++++++                                 
T Consensus       167 ~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 2rku_A          167 YD-GERKKVLCGTPNYIAPEVLSKKG--HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA  243 (294)
T ss_dssp             ST-TCCBCCCCSCCSSCCHHHHTTSC--BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHH
T ss_pred             cC-ccccccccCCCCcCCcchhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHH
Confidence            33 22334567899999999987653  5678899999999998875                                 


Q ss_pred             -----cCCCCCCCCCCHHHHHHHH
Q 041624          399 -----CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L  417 (459)
                           |+.++|.+||++.++++.-
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHHHHHcccChhhCcCHHHHhhCh
Confidence                 6666788888888887643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.1e-37  Score=308.32  Aligned_cols=201  Identities=25%  Similarity=0.345  Sum_probs=177.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..++||+|+||.||+|+++.+++.||+|++++..   ....+.+.+|..++.++ +||||+++++++.+.+.++
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3467899999999999999999999999999999997652   23345688999999887 8999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999987654    59999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+.
T Consensus       203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~--~~~~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          203 GLRP-GDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             CCCT-TCCBCCCCBCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             cccC-CCccccccCCcccCCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCc
Confidence            3322 23455678999999999998654  5788999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.3e-37  Score=303.87  Aligned_cols=213  Identities=28%  Similarity=0.414  Sum_probs=186.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|...+.||+|+||.||++.+..+++.||+|++....   ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467888999999999999999999999999999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999886643    59999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------------------
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------------------  398 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------------------  398 (459)
                      .. ........||..|+|||++.+..  ++...|+|++|++++++++                                 
T Consensus       193 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (335)
T 2owb_A          193 YD-GERKKVLCGTPNYIAPEVLSKKG--HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA  269 (335)
T ss_dssp             ST-TCCBCCCCSCCSSCCHHHHHTSC--BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred             cC-cccccccCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHH
Confidence            33 22334567999999999997654  5678899999999988775                                 


Q ss_pred             -----cCCCCCCCCCCHHHHHHHH
Q 041624          399 -----CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L  417 (459)
                           |++++|.+||++.++++.-
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHHHHHccCChhHCcCHHHHhcCc
Confidence                 7777899999999998743

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-37  Score=306.12  Aligned_cols=208  Identities=25%  Similarity=0.345  Sum_probs=172.1

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEe
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCH  263 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~  263 (459)
                      ++...++|...+.||+|+||.||+|.+.     .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4446688999999999999999999973     356789999997542 34567899999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeec
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKST-------------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHR  324 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr  324 (459)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.||+.||+|||+   ++|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence            999999999999999999999765321                   1248999999999999999999999   999999


Q ss_pred             CCCCCCeeecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCC
Q 041624          325 DIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHP  402 (459)
Q Consensus       325 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p  402 (459)
                      ||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.++.  ++...|+|++|++++++++ +..|
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC--CChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998765433222 33456788999999997654  5678899999999999886 4444


Q ss_pred             C
Q 041624          403 D  403 (459)
Q Consensus       403 ~  403 (459)
                      +
T Consensus       275 ~  275 (344)
T 1rjb_A          275 Y  275 (344)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.1e-37  Score=296.55  Aligned_cols=219  Identities=24%  Similarity=0.356  Sum_probs=187.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee---------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD---------  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---------  264 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|+++...    +.+.+|++++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467889999999999999999999889999999996542    467789999999999999999998864         


Q ss_pred             -------CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC
Q 041624          265 -------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF  337 (459)
Q Consensus       265 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  337 (459)
                             ....++||||+++++|.+++.....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCC
Confidence                   4568999999999999999976432  269999999999999999999999   9999999999999999999


Q ss_pred             CEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------
Q 041624          338 NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------  398 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------  398 (459)
                      .+||+|||+++.....  .......||+.|+|||.+.+..  ++.+.|+|++|++++++++                   
T Consensus       160 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 2a19_B          160 QVKIGDFGLVTSLKND--GKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI  235 (284)
T ss_dssp             EEEECCCTTCEESSCC--SCCCCCCSCCTTSCHHHHHCSC--CCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTC
T ss_pred             CEEECcchhheecccc--ccccccCCcccccChhhhccCC--CcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccc
Confidence            9999999999876543  2234457899999999998653  5778899999999987763                   


Q ss_pred             ---------------cCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 041624          399 ---------------CAHPDRNCRPSIRQAIQVLNFETKMPN  425 (459)
Q Consensus       399 ---------------c~~p~p~~RPs~~~v~~~L~~~~~~p~  425 (459)
                                     |+.++|.+||++.++++.|......++
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                           888999999999999999986654443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-37  Score=295.65  Aligned_cols=200  Identities=27%  Similarity=0.430  Sum_probs=171.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|+..+.||+|+||.||+|.+.. +..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            3678888999999999999999975 7889999997653 3457899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++++|.+++.....   .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999976543   68999999999999999999999   999999999999999999999999999998764322


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      ........++..|+|||.+.+..  ++.+.|+|++|++++++++ +..|+.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~  207 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYE  207 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccccccChhhhcCCC--ccchhchhhhHHHHHHHhccCCCCCC
Confidence            22223456788999999997654  4678899999999999987 455544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.2e-37  Score=299.52  Aligned_cols=204  Identities=27%  Similarity=0.339  Sum_probs=168.7

Q ss_pred             hcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .+.|.+. +.||+|+||.||+|.+..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567764 7899999999999999988999999999876666678899999999985 7999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC---EEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~  349 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.   +||+|||+++.
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999997654    58999999999999999999999   89999999999999998776   99999999976


Q ss_pred             ccCCCC------CccccccccccccccceeccCc---cccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          350 VDHELG------PRTTGLAGTLGYMAPEYISTGR---ARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       350 ~~~~~~------~~~~~~~gt~~y~APE~~~~~~---~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ......      .......||+.|+|||++....   ..++.+.|+|++|+++++++++..|+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  228 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG  228 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence            542211      1123456999999999987421   2357789999999999998876655543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-37  Score=308.33  Aligned_cols=199  Identities=33%  Similarity=0.368  Sum_probs=171.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .+.|+..+.||+|+||.||+|....+++.||||++.....   ...+++.+|++++.+++||||+++++++.+.+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            3558888999999999999999988899999999975432   2345789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||++ |+|.+++.....   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       133 ~e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99997 688888765443   69999999999999999999999   899999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .     .....||+.|+|||++... ...++.++|+|++|+++++++++..|+..
T Consensus       206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          206 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             S-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3     2346799999999998531 22467789999999999999886666543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=294.81  Aligned_cols=203  Identities=27%  Similarity=0.426  Sum_probs=157.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|++.+.||+|+||.||+|....+++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467889999999999999999998889999999996532   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++.....   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999976543   69999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ... .......||+.|+|||.+.+..  .+.+.|+|++|+++++++++..|+...
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  215 (278)
T 3cok_A          164 MPH-EKHYTLCGTPNYISPEIATRSA--HGLESDVWSLGCMFYTLLIGRPPFDTD  215 (278)
T ss_dssp             -------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CCC-CcceeccCCCCcCCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence            322 2233467899999999987653  467889999999999999877776543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-36  Score=298.82  Aligned_cols=200  Identities=25%  Similarity=0.309  Sum_probs=174.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc------chHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|.+......      ..+++.+|+.++.+++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            346788999999999999999999999999999999764321      35679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEee
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGD  343 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~D  343 (459)
                      .++||||+++++|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999997543    58999999999999999999999   9999999999999999888    799999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ||+++.....  .......||+.|+|||.+.+..  ++.+.|+|++|+++++++++..|+.
T Consensus       163 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~  219 (321)
T 2a2a_A          163 FGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFL  219 (321)
T ss_dssp             CTTCEECCTT--CCCCCCCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CccceecCcc--ccccccCCCCCccCcccccCCC--CCCccccHHHHHHHHHHHHCCCCCC
Confidence            9999876543  2234567999999999997653  5778899999999999887655543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-37  Score=297.74  Aligned_cols=203  Identities=25%  Similarity=0.288  Sum_probs=165.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++......   ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            357899999999999999999999988999999999765322   24678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++....    .+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999997653    59999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ............||+.|+|||.+.+..  ++.+.|+|++|+++++++++..|+..
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESH--ATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cccccccccccCCCcCccCHHHHcCCC--CCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            544333344567899999999997653  57788999999999998875555443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-37  Score=304.66  Aligned_cols=195  Identities=23%  Similarity=0.308  Sum_probs=160.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccCcCCceeEEEEEeeCCe----
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE----  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----  267 (459)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.....   ..+.+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999999988999999999765332   34578899999999999999999999876543    


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+++++|.+++....    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999997654    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          348 LLVDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       348 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +.+......  ......||+.|+|||++.+..  ++.+.|+|++|++++++++
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~  214 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLT  214 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCC--CCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCC--CCchHhHHHHHHHHHHHHh
Confidence            876543222  234467899999999998653  5678899999999998776

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.2e-38  Score=300.55  Aligned_cols=206  Identities=24%  Similarity=0.316  Sum_probs=173.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEe--eCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCH--DRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|+.++.+++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468889999999999999999999889999999997543  234567899999999999999999999875  4678999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----eeecCCCCCCeeecCCCCEEEeecC
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC-----VVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+   .+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999998654444469999999999999999999999   67     9999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +++..... ........||+.|+|||.+.+..  ++...|+|++|+++++++++..|+...
T Consensus       162 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          162 LARILNHD-TSFAKTFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HHHHC----CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeeccc-cccccccCCCccccChHHhccCC--CCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            99876532 11233457899999999997653  567789999999999998866665543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-36  Score=303.29  Aligned_cols=212  Identities=22%  Similarity=0.282  Sum_probs=183.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..+.||+|+||.||+|..+.+++.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999999989999999997542   23456788999999988 8999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999997654    59999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      .... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+...  +..++.+.+
T Consensus       171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i  233 (353)
T 2i0e_A          171 NIWD-GVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSI  233 (353)
T ss_dssp             CCCT-TCCBCCCCSCGGGCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred             cccC-CcccccccCCccccChhhhcCCC--cCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHH
Confidence            4322 23345678999999999997654  578899999999999999999998754  445555443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.1e-37  Score=315.00  Aligned_cols=221  Identities=25%  Similarity=0.322  Sum_probs=178.4

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC-eEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG-EFMLV  271 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV  271 (459)
                      ...++|+..+.||+|+||.||+|.+.  ++.||||+++...  ..+.|.+|+.++.+++||||+++++++.+.+ ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            45578889999999999999999986  6799999997643  5678999999999999999999999987665 79999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999999986543  247999999999999999999999   999999999999999999999999999998543


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKM  430 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~  430 (459)
                      ..    .....++..|+|||.+.++.  ++.++|+|++|++++++++ +..|++...  ..++++.+..... ++.|...
T Consensus       341 ~~----~~~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~-~~~p~~~  411 (450)
T 1k9a_A          341 ST----QDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYK-MDAPDGC  411 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSC--CCHHHHHHHHHHHHHHHHTTTCCSSTTSC--TTTHHHHHHTTCC-CCCCTTC
T ss_pred             cc----ccCCCCCcceeCHHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-CCCCCcC
Confidence            22    22336788999999998664  5778899999999999997 666665442  2344444443322 2234444


Q ss_pred             C
Q 041624          431 P  431 (459)
Q Consensus       431 p  431 (459)
                      |
T Consensus       412 ~  412 (450)
T 1k9a_A          412 P  412 (450)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-37  Score=305.33  Aligned_cols=232  Identities=23%  Similarity=0.361  Sum_probs=195.1

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeE
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQL  258 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l  258 (459)
                      .+..+++....++|...+.||+|+||.||+|.+.     .+++.||+|.+..... ....++.+|+.++.+++|+||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3555666777889999999999999999999876     3468899999975432 345678999999999999999999


Q ss_pred             EEEEeeCCeEEEEEEecCCCCcchhccccCC------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      ++++.+.+..++||||+++|+|.+++.....      ....+++..++.++.||+.||.|||+   ++|+||||||+|||
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence            9999999999999999999999999875321      11357999999999999999999999   89999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------  398 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------  398 (459)
                      ++.++.+||+|||+++........ ......+|+.|+|||.+.++.  ++...|+|++|++++++++             
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            999999999999999866433221 123445788999999987654  5678899999999998775             


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ---------------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ---------------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                                 |+.++|.+||++.++++.|+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                                       67779999999999999997653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=295.30  Aligned_cols=220  Identities=21%  Similarity=0.236  Sum_probs=182.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC----ccchHHHHHHHHHHhccCcCCceeEEEEE--eeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL----KHGKNEYITEVKTCSQLRHRNLLQLIGLC--HDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~--~~~~~  267 (459)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|+++...    ....+.+.+|+.++.+++|+||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999999889999999996542    23457899999999999999999999998  44568


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||++++ |.+++.....  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999876 6666655332  369999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------
Q 041624          348 LLVDHELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------  398 (459)
Q Consensus       348 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------  398 (459)
                      +....... .......||+.|+|||++.+.....+.+.|+|++|++++++++                            
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  236 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC  236 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCcc
Confidence            87653222 2234567899999999987654434667899999999988775                            


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                |+.++|.+||++.++++.--.
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                      777799999999999986443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-37  Score=306.55  Aligned_cols=211  Identities=25%  Similarity=0.239  Sum_probs=183.6

Q ss_pred             CcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-----cCCcee
Q 041624          183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-----HRNLLQ  257 (459)
Q Consensus       183 ~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~  257 (459)
                      ...|++++.....++|.+.+.||+|+||.||+|.+..+++.||||+++.. ....+.+..|+.++.++.     |+||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44567777777889999999999999999999999988999999999642 334566788999999986     999999


Q ss_pred             EEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC--
Q 041624          258 LIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT--  335 (459)
Q Consensus       258 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~--  335 (459)
                      +++++...+..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccc
Confidence            999999999999999999 9999999976543  258999999999999999999999   99999999999999975  


Q ss_pred             -----------------------CCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHH
Q 041624          336 -----------------------DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCL  392 (459)
Q Consensus       336 -----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~l  392 (459)
                                             ++.+||+|||+++.....    .....||+.|+|||++.+..  ++.+.|+|++|++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~i  248 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG--WDVSSDMWSFGCV  248 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC--CCTTHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC--CCCccchHHHHHH
Confidence                                   789999999999865432    33567899999999998654  6788999999999


Q ss_pred             HHHHHhcCCCCCCC
Q 041624          393 MIVGLWCAHPDRNC  406 (459)
Q Consensus       393 l~~~l~c~~p~p~~  406 (459)
                      +++++++..|+...
T Consensus       249 l~ell~g~~pf~~~  262 (360)
T 3llt_A          249 LAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHSSCSCCCS
T ss_pred             HHHHHHCCCCCCCC
Confidence            99999998887654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-37  Score=301.16  Aligned_cols=206  Identities=25%  Similarity=0.323  Sum_probs=173.7

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEE-----cCCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGIL-----IDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      ...++|...+.||+|+||.||+|.+     ..+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3457889999999999999999986     34678999999976533 3457799999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKST--------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      +..++||||+++|+|.+++......              ...+++..++.++.||+.||.|||+   ++|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceE
Confidence            9999999999999999999765421              2258999999999999999999999   9999999999999


Q ss_pred             eecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          332 MPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       332 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      |++.++.+||+|||+++......... .....+|+.|+|||.+.+..  ++.+.|+|++|++++++++ +..|+
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999998775443222 23455788999999987654  5678899999999999986 44443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-37  Score=299.27  Aligned_cols=220  Identities=27%  Similarity=0.343  Sum_probs=170.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|++.+.||+|+||.||+|....+++.||+|+++...   ....+++.+|+.++.+++|+||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3467999999999999999999998889999999997532   2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++.........+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999987543333469999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ... ........||+.|+|||.+.+..  ++...|+|++|+++++++++..|+........++.+.+..
T Consensus       187 ~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  252 (310)
T 2wqm_A          187 SSK-TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ  252 (310)
T ss_dssp             -------------CCSSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT
T ss_pred             cCC-CccccccCCCeeEeChHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc
Confidence            533 22233457899999999987654  5677899999999999988766665555555555554443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-36  Score=300.75  Aligned_cols=201  Identities=25%  Similarity=0.337  Sum_probs=177.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|+++.+++.||+|++++...   ...+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            3578889999999999999999999999999999976532   2345688999999988 89999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999997654    59999999999999999999999   99999999999999999999999999999864


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+..
T Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          161 LRP-GDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCT-TCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCC-CCcccccCCCccccCccccCCCC--CChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            322 23345678999999999998653  57889999999999999999999853

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=292.88  Aligned_cols=205  Identities=28%  Similarity=0.362  Sum_probs=173.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|....+||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34566679999999999999999989999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-CCCEEEeecCCcccccCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~  354 (459)
                      ++++|.+++..... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++. ++.+||+|||+++..... 
T Consensus       102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-  176 (295)
T 2clq_A          102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-  176 (295)
T ss_dssp             SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence            99999999976432 2357799999999999999999999   99999999999999997 899999999999876532 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ........||+.|+|||++.++...++...|+|++|+++++++++..|+..
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            222345678999999999976544467788999999999999987766643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=309.03  Aligned_cols=202  Identities=26%  Similarity=0.311  Sum_probs=173.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      .++|+..+.||+|+||.||+|...   .+++.||||+++...    ....+.+.+|+.++.++ +|+||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            467899999999999999999984   468999999987542    23456678899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999997654    59999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ++.+............||+.|+|||++.++...++.+.|+|++|+++++++++..|+
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  262 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  262 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            987654333334456799999999999865555678899999999999988765554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.6e-37  Score=311.41  Aligned_cols=205  Identities=23%  Similarity=0.335  Sum_probs=165.6

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--------ccchHHHHHHHHHHhccCcCCceeEEEEEee
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--------KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      ...++|...+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.++.+++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            35688999999999999999999999999999999986532        122346889999999999999999999975 


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEE
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKL  341 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL  341 (459)
                      .+..++||||+++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++   .+||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence            456899999999999999886543    59999999999999999999999   8999999999999997544   5999


Q ss_pred             eecCCcccccCCCCCccccccccccccccceecc-CccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      +|||+++.....  .......||+.|+|||++.. +...++.+.|+|++|+++++++++..|+...+
T Consensus       284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            999999876532  23345789999999999863 22245678899999999999999888876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.8e-37  Score=317.12  Aligned_cols=196  Identities=27%  Similarity=0.329  Sum_probs=161.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|+..+.||+|+||.||+|....+++.||||+++..   .......+.+|+.++.+++||||+++++++.+.+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346799999999999999999999999999999999753   23345678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999987654    59999999999999999999996  278999999999999999999999999999864


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ... .......+||+.|+|||++.+..  ++...|+|++|+++++|++
T Consensus       300 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~  344 (446)
T 4ejn_A          300 IKD-GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMC  344 (446)
T ss_dssp             CC------CCSSSCGGGCCHHHHHTSC--CCTHHHHHHHHHHHHHHHH
T ss_pred             cCC-CcccccccCCccccCHhhcCCCC--CCCccchhhhHHHHHHHhh
Confidence            332 22345578999999999997654  5788999999999998886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.9e-37  Score=294.47  Aligned_cols=196  Identities=31%  Similarity=0.406  Sum_probs=167.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4567899999999999999999999999999999986532   2335678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++....    .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999999987654    58999999999999999999998   99999999999999999999999999998654


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      ...   ......||+.|+|||.+.+..  .+...|+|++|+++++++++..
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~  205 (279)
T 3fdn_A          160 PSS---RRTDLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKP  205 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSC
T ss_pred             Ccc---cccccCCCCCccCHhHhccCC--CCccchhHhHHHHHHHHHHCCC
Confidence            332   234567899999999987653  4678899999999998876433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.3e-36  Score=290.27  Aligned_cols=227  Identities=30%  Similarity=0.494  Sum_probs=191.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc-------hHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-------KNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.......       .+.+.+|+.++.+++|+||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467888999999999999999999889999999986543221       267899999999999999999999997665 


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecCCCC-----EE
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDTDFN-----VK  340 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~-----~k  340 (459)
                       ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+   ++  |+||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence             699999999999988876544   69999999999999999999998   88  999999999999988776     99


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      |+|||+++....    ......||+.|+|||.+......++...|+|++|+++++++++..|+........+....+...
T Consensus       170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            999999975432    3445679999999999865444567789999999999999999999988777766667766666


Q ss_pred             CCCCCCCCCCCcc
Q 041624          421 TKMPNLPSKMPVA  433 (459)
Q Consensus       421 ~~~p~~p~~~p~~  433 (459)
                      ...+..|...|..
T Consensus       246 ~~~~~~~~~~~~~  258 (287)
T 4f0f_A          246 GLRPTIPEDCPPR  258 (287)
T ss_dssp             CCCCCCCTTSCHH
T ss_pred             CCCCCCCcccCHH
Confidence            6666666666643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-36  Score=291.40  Aligned_cols=207  Identities=23%  Similarity=0.263  Sum_probs=177.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3467899999999999999999999889999999997543 344578899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999986543    59999999999999999999999   9999999999999999999999999999986643


Q ss_pred             CCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          353 ELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       353 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      ... .......||+.|+|||.+.+... .+.+.|+|++|+++++++++..|+.....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSB-CHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             CcchhcccCCccccCccChHHHhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            221 12345678999999999876542 35578999999999999987777654433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-36  Score=292.71  Aligned_cols=201  Identities=23%  Similarity=0.382  Sum_probs=174.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999999999999999996542  23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC---EEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~  348 (459)
                      |||+++++|.+.+....    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999998887654    59999999999999999999999   99999999999999987655   9999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .....  .......||+.|+|||.+.+..  ++.+.|+|++|+++++++++..|+..
T Consensus       157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          157 EVNDS--EAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             ECCSS--CBCCCSCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EcccC--ccccCCCCCcCCcCchhhcCCC--CCcccchHHHHHHHHHHHHCCCCCCC
Confidence            76543  2234567999999999998654  57788999999999999886665543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.7e-37  Score=301.11  Aligned_cols=199  Identities=27%  Similarity=0.359  Sum_probs=162.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEc---CCCcEEEEEEeccCC----ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGL----KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      .++|+..+.||+|+||.||+|...   .+++.||+|+++...    ......+.+|+.++.+++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            467899999999999999999985   578999999997652    2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+++|+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999997654    58999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      +..... ........||+.|+|||++.+..  ++...|+|++|+++++++++..|+
T Consensus       169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          169 KESIHD-GTVTHTFCGTIEYMAPEILMRSG--HNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSC--CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccC-CccccccCCCcCccCHhhCcCCC--CCCcccchhHHHHHHHHHHCCCCC
Confidence            765432 22334567999999999997654  577889999999999988754443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.9e-37  Score=296.45  Aligned_cols=196  Identities=26%  Similarity=0.419  Sum_probs=167.5

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ...++|+..+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++.+++|+||+++++++.+ +..++||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            345678889999999999999999875 7789999997543 356789999999999999999999999864 5689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            99999999999965421  258999999999999999999999   9999999999999999999999999999987764


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ..........++..|+|||.+.++.  ++.+.|+|++|++++++++
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~  205 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVT  205 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCccCccChhhhccCC--CCchhhhHHHHHHHHHHHh
Confidence            4322334456788999999997654  4677899999999998886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-37  Score=304.78  Aligned_cols=217  Identities=26%  Similarity=0.451  Sum_probs=177.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCC----cEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ++|...+.||+|+||.||+|.+..++    ..||+|.++.... .....+.+|+.++.+++|+||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            45667799999999999999987543    4699999976532 345678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999976543   69999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          351 DHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       351 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      .......  .....+|+.|+|||.+.+..  ++.+.|+|++|++++++++                              
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccccCCCCccccccCchhcccCC--CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            5432211  22345678999999997654  5677899999999998765                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |+.++|.+||++.++++.|+..
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      7778999999999999988753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.6e-37  Score=301.74  Aligned_cols=221  Identities=23%  Similarity=0.377  Sum_probs=184.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEc-------CCCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEEEEee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILI-------DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~  264 (459)
                      ..++|...+.||+|+||.||+|.+.       .++..||+|+++... ....+.+.+|++++.++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578899999999999999999985       346789999997653 23456789999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKST------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      .+..++||||+++|+|.+++......            ...+++.+++.++.||+.||.|||+   .+|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence            99999999999999999999765421            1248999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------  398 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------  398 (459)
                      ++.++.+||+|||+++........ ......+|+.|+|||++.+..  ++.+.|+|++|++++++++             
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC--cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999876543221 123456788999999987654  5678899999999998875             


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ---------------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ---------------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                                 |+..+|.+||++.++++.|+.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                                       666788888888888887764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-37  Score=302.64  Aligned_cols=219  Identities=25%  Similarity=0.368  Sum_probs=179.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcE----EEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMA----VAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      .++|+..+.||+|+||.||+|.+..+++.    ||+|.+... .....+++.+|+.++.+++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            36788999999999999999999877765    477777544 3445678999999999999999999999998764 78


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|+||+++|+|.+++.....   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999999976544   69999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          350 VDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       350 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ....... ......+|+.|+|||.+.+..  ++.+.|+|++|++++++++                              
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             ccCccccccccCCCccccccCHHHHcCCC--CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            6543222 233455788999999998654  5678899999999998775                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                                |+.++|.+||++.++++.|+....
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                      778899999999999999986543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-37  Score=302.95  Aligned_cols=206  Identities=25%  Similarity=0.321  Sum_probs=167.3

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      -....++|+..+.||+|+||.||+|.+..+++.||||+++....  ...+.+.+|+.++.+++|+||+++++++.+.+..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            34456789999999999999999999999999999999975532  2345678999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-----CCCCEEEee
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-----TDFNVKLGD  343 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~kL~D  343 (459)
                      ++||||++ |+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++     .++.+||+|
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            99999997 59999987654    49999999999999999999999   9999999999999994     455699999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ||+++..... ........||+.|+|||++.+.. .++.+.|+|++|+++++++++..|++..
T Consensus       181 fg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          181 FGLARAFGIP-IRQFTHEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             TTHHHHHC------------CCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCccccCCc-ccccCCCcCCccccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            9999877533 22334567899999999997644 3678899999999999999888877654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-37  Score=295.84  Aligned_cols=201  Identities=29%  Similarity=0.401  Sum_probs=166.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcC---CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILID---LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|...+.||+|+||.||+|.+..   ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            45788899999999999999998754   34569999997653 34567899999999999999999999998654 568


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++++|.+++.....   .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999999976543   58999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      .............+|+.|+|||.+.+..  ++.+.|+|++|++++++++ +..|+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cccccccccccCCCCcceeCchhhccCC--CCchhccHHHHHHHHHHHhCCCCCc
Confidence            6544333344556788999999997654  5677899999999999986 55444

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.4e-37  Score=292.20  Aligned_cols=195  Identities=30%  Similarity=0.412  Sum_probs=156.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc----cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK----HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|.+.  +..||||+++....    ...+.+.+|++++.+++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            467888999999999999999985  78999999875432    335678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC---eeecCCCCCCeeecC--------CCCE
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC---VVHRDIKFSNIMPDT--------DFNV  339 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~---iiHrDlkp~NILl~~--------~~~~  339 (459)
                      ||||+++++|.+++...     .+++..++.++.|++.||+|||+   ++   |+||||||+|||++.        ++.+
T Consensus        84 v~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence            99999999999988532     58999999999999999999999   77   999999999999986        6789


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ||+|||+++.....   ......||+.|+|||.+.+..  ++.+.|+|++|+++++++++..|+.
T Consensus       156 kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          156 KITDFGLAREWHRT---TKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             EECCCCC----------------CCGGGSCHHHHHHCC--CSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             EEccCCcccccccc---cccCCCCccceeCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999866432   223457899999999997654  5678899999999999887555544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-37  Score=308.28  Aligned_cols=200  Identities=25%  Similarity=0.362  Sum_probs=160.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccC-cCCceeEEEEEeeCC--eE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRG--EF  268 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~  268 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++.++. |+||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4678999999999999999999999999999999996542  334567889999999997 999999999997544  78


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      |+|||||+ ++|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 6898888653     58999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCC--------------------CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          349 LVDHEL--------------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       349 ~~~~~~--------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .+....                    .......+||+.|+|||++.+.. .++.++|+||+|+++++|+++..|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST-KYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC-CCCChhhHHHHHHHHHHHHhCCCCC
Confidence            764311                    11234468999999999987533 4678899999999999988765444

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.2e-37  Score=304.96  Aligned_cols=207  Identities=15%  Similarity=0.159  Sum_probs=174.1

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEE-----EcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---cCCceeEEE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGI-----LIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---HRNLLQLIG  260 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g  260 (459)
                      .++....++|...+.||+|+||.||+|.     ...+++.||+|+++..   ...++..|++++.+++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3444556789999999999999999994     5567899999999753   4557778888888876   999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC----
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKS-TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT----  335 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~----  335 (459)
                      ++...+..+||||||++|+|.+++..... ....+++..++.|+.||+.||+|||+   ++|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            99999999999999999999999975322 23469999999999999999999998   99999999999999998    


Q ss_pred             -------CCCEEEeecCCcccccCCC-CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          336 -------DFNVKLGDFGLALLVDHEL-GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       336 -------~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                             ++.+||+|||+|+.+.... .......+||+.|+|||++.+..  ++.++|+|++|+++++|+++..|+
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCcc
Confidence                   8999999999997654222 22345678999999999998654  678899999999999999998764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=293.55  Aligned_cols=203  Identities=26%  Similarity=0.319  Sum_probs=169.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-----ccchHHHHHHHHHHhccC---cCCceeEEEEEeeC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-----KHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDR  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~  265 (459)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....     ......+.+|+.++.+++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999999889999999986432     122356778888877775   99999999999875


Q ss_pred             C-----eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          266 G-----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       266 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      .     ..++||||+. ++|.+++.....  ..+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence            5     5899999997 599999876543  249999999999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          341 LGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       341 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      |+|||+++.....  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+...
T Consensus       161 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          161 LADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             ECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EeeCccccccCCC--cccCCccccccccCchHHcCCC--CCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999876533  2345568899999999998664  577899999999999988777766543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=300.92  Aligned_cols=196  Identities=24%  Similarity=0.312  Sum_probs=161.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|...+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5788899999999999999999988999999999754322 233566899999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      ++ |+|.+++.....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-  153 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence            97 589888876543   69999999999999999999999   99999999999999999999999999999865432 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      ........||+.|+|||++.+.. .++.+.|+|++|+++++++++.
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~  198 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR  198 (324)
T ss_dssp             ---------CGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccCcccccChhhhcCCC-CCCcHHHHHHHHHHHHHHHhCC
Confidence            22234457899999999987543 3678889999999998887654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.1e-37  Score=305.72  Aligned_cols=217  Identities=21%  Similarity=0.184  Sum_probs=179.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCC-----CcEEEEEEeccCCccc-----------hHHHHHHHHHHhccCcCCcee
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-----------KNEYITEVKTCSQLRHRNLLQ  257 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~  257 (459)
                      ..++|.+.+.||+|+||.||+|.+..+     ++.||||++.......           ...+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999999764     5789999987653211           123456667778889999999


Q ss_pred             EEEEEeeC----CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          258 LIGLCHDR----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       258 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      +++++...    ...+|||||+ +++|.+++.....   .+++.+++.|+.||+.||+|||+   ++|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence            99998764    4589999999 9999999976533   69999999999999999999999   899999999999999


Q ss_pred             c--CCCCEEEeecCCcccccCCCCCc------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------
Q 041624          334 D--TDFNVKLGDFGLALLVDHELGPR------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------  398 (459)
Q Consensus       334 ~--~~~~~kL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------  398 (459)
                      +  .++.+||+|||+++.+.......      .....||+.|+|||++.+..  ++.+.|+||+|++++++++       
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9  88999999999998765332111      23456999999999998654  5778899999999998876       


Q ss_pred             ------------------------------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------------------------------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------------------------------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                                                |+..+|.+||++.++++.|+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             GTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence                                                      556689999999999998864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-36  Score=314.45  Aligned_cols=217  Identities=25%  Similarity=0.371  Sum_probs=187.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|...+.||+|+||.||+|+++.+++.||+|++.+..   ....+.+.+|+.++.+++||||+++++++.+.+.+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999999999999999996542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.........+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999997655444579999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHH
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP--SIRQAIQVL  417 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP--s~~~v~~~L  417 (459)
                      ... ......+||+.|+|||++.+.  .++..+|+|++|+++++|+++..|+.....  ...++.+.+
T Consensus       341 ~~~-~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i  405 (543)
T 3c4z_A          341 AGQ-TKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV  405 (543)
T ss_dssp             TTC-CCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred             CCC-cccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence            432 223456899999999999865  357889999999999999999999976532  445555443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.4e-37  Score=291.25  Aligned_cols=222  Identities=17%  Similarity=0.226  Sum_probs=177.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC--CeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR--GEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|++.  ++.||+|+++...  ....+++.+|+.++.+++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            467888999999999999999986  7899999997653  33456799999999999999999999999887  78899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ||||+++|+|.+++.....  ..+++.+++.++.||+.||+|||+   .+  |+||||||+|||++.++.++|+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999999976543  258999999999999999999998   78  9999999999999999999999999875


Q ss_pred             cccCCCCCccccccccccccccceeccCccc-cCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRAR-LDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLP  427 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p  427 (459)
                      ...      .....||+.|+|||.+.+.... .+.+.|+|++|+++++++++..|+...  +..++...+......|..|
T Consensus       162 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          162 SFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             TTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--CHHHHHHHHHHSCCCCCCC
T ss_pred             eec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ChHHHHHHHHhcCCCCCCC
Confidence            432      2345789999999999865431 122589999999999999877666543  2233333333333334444


Q ss_pred             CCCC
Q 041624          428 SKMP  431 (459)
Q Consensus       428 ~~~p  431 (459)
                      ...|
T Consensus       234 ~~~~  237 (271)
T 3kmu_A          234 PGIS  237 (271)
T ss_dssp             TTCC
T ss_pred             CCCC
Confidence            4444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-36  Score=300.47  Aligned_cols=210  Identities=23%  Similarity=0.321  Sum_probs=180.9

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--------chHHHHHHHHHHhcc-CcCCceeE
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--------GKNEYITEVKTCSQL-RHRNLLQL  258 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~nIv~l  258 (459)
                      ........++|...+.||+|+||.||+|.+..+|+.||||+++.....        ..+.+.+|+.++.++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            344455668899999999999999999999988999999999765321        145678999999999 89999999


Q ss_pred             EEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ++++...+..++||||+++++|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCC
Confidence            999999999999999999999999997653    59999999999999999999999   89999999999999999999


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccC----ccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG----RARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +||+|||++..+...  .......||+.|+|||++.+.    ...++...|+|++|+++++++++..|+...
T Consensus       239 ikl~DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             EEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            999999999876543  234457899999999998643    223677899999999999999988877653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-36  Score=301.31  Aligned_cols=197  Identities=27%  Similarity=0.381  Sum_probs=166.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEee--------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHD--------  264 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------  264 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.++.+++|+||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999999998899999999865532  335678899999999999999999999987        


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      .+..++||||+++ +|.+.+.....   .+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence            4568999999975 77777765443   59999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCCC---CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          345 GLALLVDHELG---PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       345 Gla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      |+++.+.....   .......||+.|+|||++.+.. .++.+.|+|++|+++++++++
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g  225 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTR  225 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHS
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCC-CCCcHhHHHHHHHHHHHHHhC
Confidence            99987653221   2234567899999999987543 367889999999999887653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-36  Score=295.04  Aligned_cols=197  Identities=25%  Similarity=0.364  Sum_probs=163.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee---------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD---------  264 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---------  264 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++.+++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356789999999999999999999988999999999643 3345778999999999999999999998865         


Q ss_pred             ----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          265 ----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       265 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                          .+..++||||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL---NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG---GGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc---ccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEE
Confidence                4578999999999999999976443   58899999999999999999999   8999999999999999999999


Q ss_pred             EeecCCcccccCCC-------------CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          341 LGDFGLALLVDHEL-------------GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       341 L~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+|||+++......             ........||+.|+|||.+.+.. .++...|+|++|++++++++
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCS-CCCTHHHHHHHHHHHHHHHS
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-CCcchhhHHHHHHHHHHHHh
Confidence            99999998664321             11234457899999999987532 36778899999999998874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-36  Score=289.84  Aligned_cols=200  Identities=24%  Similarity=0.317  Sum_probs=171.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|...+.||+|+||.||+|....+++.||+|.++....      ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3568889999999999999999998899999999875422      2367899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEeec
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGDF  344 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DF  344 (459)
                      ++||||+++++|.+++....    .+++.+++.++.||+.||.|||+   .+|+||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999997643    59999999999999999999999   9999999999999999877    8999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      |+++.....  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+..
T Consensus       157 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          157 GIAHKIEAG--NEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccceeccCC--CcccccCCCcCccCcceecCCC--CCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            999876532  2234457899999999987654  57788999999999999887666554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=296.16  Aligned_cols=212  Identities=25%  Similarity=0.387  Sum_probs=174.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|+..+.||+|+||.||+|.+.  ++.||+|++...  ...+.|.+|++++.+++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            56788899999999999999986  688999998643  446789999999999999999999998874  479999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC-EEEeecCCcccccCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFGLALLVDHEL  354 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~  354 (459)
                      ++|+|.+++..... ...+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||+++..... 
T Consensus        82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            99999999975432 124789999999999999999999854468999999999999998886 799999999765432 


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------------
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------------  398 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------------  398 (459)
                         .....||+.|+|||++.+..  ++.+.|+|++|++++++++                                    
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSN--YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE  234 (307)
T ss_dssp             --------CCTTSSCHHHHTCCC--CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred             ---cccCCCCCceEChhhhCCCC--CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence               23456899999999997653  5778899999999988775                                    


Q ss_pred             -----cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 -----CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 -----c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                           |+..+|.+||++.++++.|+..
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                 7788999999999999998754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.9e-37  Score=299.91  Aligned_cols=200  Identities=23%  Similarity=0.369  Sum_probs=170.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEE----cCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC--eE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGIL----IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG--EF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~  268 (459)
                      .++|+..+.||+|+||.||+|.+    ..+++.||+|++........+.+.+|++++.+++|+||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999985    4568999999998766666778999999999999999999999987654  78


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999976543   59999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          349 LVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       349 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      .........  .....++..|+|||.+.+..  ++.+.|+|++|+++++++++..|
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~~  247 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEK  247 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHHTTCG
T ss_pred             hccccccccccccCCCCceeEECchhhcCCC--CCchhhHHHHHHHHHHHHhcCCC
Confidence            775432211  23345778899999997654  46778999999999988875443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4e-37  Score=300.54  Aligned_cols=218  Identities=26%  Similarity=0.337  Sum_probs=180.2

Q ss_pred             ccCHHHHHHHhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCcee
Q 041624          185 RFSYKDLASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQ  257 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~  257 (459)
                      .+...++....++|...+.||+|+||.||+|.+.     .+++.||||+++.... ...+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            3555666677889999999999999999999863     4578999999976533 3456789999999999 7999999


Q ss_pred             EEEEEeeCC-eEEEEEEecCCCCcchhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeec
Q 041624          258 LIGLCHDRG-EFMLVYEFMPNGSLDFHLFSKKST------------GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHR  324 (459)
Q Consensus       258 l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr  324 (459)
                      +++++...+ ..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+   .+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence            999998754 589999999999999999765431            1238999999999999999999999   999999


Q ss_pred             CCCCCCeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCC
Q 041624          325 DIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHP  402 (459)
Q Consensus       325 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p  402 (459)
                      ||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..  ++.+.|+|++|++++++++ +..|
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc--ccchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999876543222 233456789999999997654  5678899999999999997 6666


Q ss_pred             CCCCC
Q 041624          403 DRNCR  407 (459)
Q Consensus       403 ~p~~R  407 (459)
                      ++...
T Consensus       251 ~~~~~  255 (316)
T 2xir_A          251 YPGVK  255 (316)
T ss_dssp             STTCC
T ss_pred             Ccccc
Confidence            55443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-36  Score=294.32  Aligned_cols=215  Identities=27%  Similarity=0.347  Sum_probs=180.8

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCc---EEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE-EEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNM---AVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF-MLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV  271 (459)
                      .|...++||+|+||.||+|.+..++.   .||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            44556899999999999999765443   799999976433 3457899999999999999999999999876655 999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+.+|+|.+++.....   .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999976443   68999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCC---CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          352 HEL---GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       352 ~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ...   ........+|..|+|||.+.+..  ++.+.|+|++|++++++++                              
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC  253 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTC
T ss_pred             CCcccccccCcCCCCCccccChhhhccCC--CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccc
Confidence            321   11233456789999999997654  5678899999999998876                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                |+.++|.+||++.++++.|+.
T Consensus       254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                      566688888998888888864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-36  Score=299.75  Aligned_cols=193  Identities=27%  Similarity=0.322  Sum_probs=151.8

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      .+.||+|+||.||+|.+..+++.||||++..   .....+.+|+.++.++. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            4789999999999999999999999999964   34567889999999997 9999999999999999999999999999


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---CEEEeecCCcccccCCCCC
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---NVKLGDFGLALLVDHELGP  356 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~  356 (459)
                      |.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++   .+||+|||+++..... ..
T Consensus        93 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~  164 (325)
T 3kn6_A           93 LFERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQ  164 (325)
T ss_dssp             HHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CC
Confidence            999997653    59999999999999999999999   9999999999999998765   8999999999866533 22


Q ss_pred             ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          357 RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       357 ~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ......||+.|+|||++.+..  ++...|+|++|+++++++++..|+...
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNG--YDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             -------------------CC--CCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             cccccCCCcCccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            334567899999999997654  577889999999999999998887653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-36  Score=299.44  Aligned_cols=217  Identities=25%  Similarity=0.383  Sum_probs=181.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEE--EEEEeccC-CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAV--AVKKISRG-LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|+..+.||+|+||.||+|.+..++..+  |+|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67889999999999999999998877755  99998754 234566799999999999 999999999999999999999


Q ss_pred             EEecCCCCcchhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          272 YEFMPNGSLDFHLFSKK------------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      |||+++|+|.+++....            .....+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999997653            223469999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------  398 (459)
                      ||+|||+++.....  .......+++.|+|||.+.+..  ++...|+|++|++++++++                     
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhcccc--CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            99999999744321  1223345688999999987653  5678899999999998875                     


Q ss_pred             -------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 -------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 -------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                         |+.++|.+||++.++++.|+.
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                               667789999999999988864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.3e-37  Score=300.62  Aligned_cols=226  Identities=24%  Similarity=0.304  Sum_probs=175.1

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEe------
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCH------  263 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~------  263 (459)
                      +.....+|+..+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++.++. |+||+++++++.      
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3344568899999999999999999999889999999997666666778999999999996 999999999984      


Q ss_pred             --eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeecCCCCE
Q 041624          264 --DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       264 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~  339 (459)
                        .....++||||+. |+|.+++..... ...+++.+++.++.||+.||+|||+   .+  |+||||||+|||++.++.+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCE
Confidence              3456899999995 799888865322 1269999999999999999999998   78  9999999999999999999


Q ss_pred             EEeecCCcccccCCCCCc-----------cccccccccccccceecc-CccccCCCCCHHHHHHHHHHHHh---------
Q 041624          340 KLGDFGLALLVDHELGPR-----------TTGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGLW---------  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~-----------~~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l~---------  398 (459)
                      ||+|||+++.........           .....||+.|+|||++.. ....++.+.|+|++|++++++++         
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211           124568999999999842 12235678899999999998775         


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ---------------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ---------------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                                 |+.++|.+||++.++++.|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                       88889999999999999997554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.2e-37  Score=297.43  Aligned_cols=206  Identities=23%  Similarity=0.354  Sum_probs=171.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45788999999999999999999999899999999987666677889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++.....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999998876443   59999999999999999999999   99999999999999999999999999997643211


Q ss_pred             CCCccccccccccccccceecc---CccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYIST---GRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                       ........||+.|+|||++..   ....++.+.|+|++|+++++++++..|+...
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence             111234578999999999842   1223567889999999999999887776643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.8e-36  Score=290.70  Aligned_cols=215  Identities=20%  Similarity=0.224  Sum_probs=178.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEE-eeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC-HDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++....  ..+++.+|+.++.+++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999998889999999876532  334688999999999988877766665 6677889999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~  349 (459)
                      ||+ +++|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999 9999999875443   59999999999999999999999   999999999999999   7889999999999987


Q ss_pred             ccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------
Q 041624          350 VDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------  398 (459)
Q Consensus       350 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------  398 (459)
                      .......      ......||+.|+|||.+.+..  ++.+.|+|++|++++++++                         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7544321      223567999999999998654  5678899999999998876                         


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                           |+..+|.+||++.++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence                                 556688888888888888764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.7e-37  Score=295.65  Aligned_cols=217  Identities=28%  Similarity=0.417  Sum_probs=176.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEe-eCCeEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCH-DRGEFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~  269 (459)
                      ..+|+..+.||+|+||.||+|.+..+   ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            35678889999999999999997543   34689999876433 34577999999999999999999999965 456789


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +||||+++|+|.+++.....   .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999976443   68999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCC---CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------
Q 041624          350 VDHELG---PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------  398 (459)
Q Consensus       350 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------  398 (459)
                      ......   .......+|+.|+|||.+.+..  ++.+.|+|++|++++++++                            
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  255 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence            643321   1233456788999999997654  5677899999999998876                            


Q ss_pred             ------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                  |+.++|.+||++.++++.|+.
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                        556677777777777777654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-37  Score=306.97  Aligned_cols=215  Identities=27%  Similarity=0.413  Sum_probs=170.1

Q ss_pred             CCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEee-CCeEEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RGEFMLV  271 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV  271 (459)
                      .|...+.||+|+||.||+|.+..+   +..||+|.++... ....++|.+|+.++.+++||||+++++++.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            456678999999999999997543   2468999987543 3446789999999999999999999999754 5678999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999976543   58999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          352 HELGP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       352 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      .....   ......+|+.|+|||.+.++.  ++.+.|+|++|++++++++                              
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~  321 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  321 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCC--CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            33211   123456788999999998654  5678899999999998876                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                |+.++|.+||++.++++.|+.
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                      666678888888888888764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-37  Score=325.20  Aligned_cols=223  Identities=26%  Similarity=0.366  Sum_probs=186.0

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..+++...++|+..+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|.+++|+||+++++++.+ +.
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            34445566788899999999999999999986 5779999997653 346789999999999999999999999876 67


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .+|||||+++|+|.++|.....  ..+++.+++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             ceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            8999999999999999975322  258999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-----------------------------
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-----------------------------  398 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-----------------------------  398 (459)
                      +.+............++..|+|||++..+.  ++.+.|+|++|++++++++                             
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  488 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  488 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             eecCCCceecccCCcCcccccCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            876432111123345678999999998664  5778899999999988765                             


Q ss_pred             -----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 -----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 -----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                 |+..+|++||++.+|++.|+..
T Consensus       489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                       6667777788888777777654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-36  Score=305.23  Aligned_cols=191  Identities=21%  Similarity=0.273  Sum_probs=155.7

Q ss_pred             hcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee----CCeE
Q 041624          195 TNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD----RGEF  268 (459)
Q Consensus       195 ~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~  268 (459)
                      .++|... +.||+|+||.||+|.+..+++.||||+++.     ...+.+|+.++.++ +|+||+++++++..    .+.+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3556665 689999999999999999999999999853     34677888887554 89999999999875    5678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeecC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFG  345 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFG  345 (459)
                      |||||||++|+|.+++.....  ..+++.++..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999976432  259999999999999999999999   99999999999999998   7899999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +++.....  ......+||+.|+|||++.+..  ++...|+|++|+++++|+++
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g  259 (400)
T 1nxk_A          210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCG  259 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCC--SSSHHHHHHHHHHHHHHHHS
T ss_pred             cccccCCC--CccccCCCCCCccCHhhcCCCC--CCCcccHHHHHHHHHHHHhC
Confidence            99866432  2234568899999999997653  57889999999999988753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-36  Score=290.96  Aligned_cols=202  Identities=25%  Similarity=0.388  Sum_probs=168.4

Q ss_pred             hcCCCCCc-eeccCCceEEEEEEEc--CCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNER-KLGQGGFGAVYRGILI--DLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~-~Lg~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|+++... ....+++.+|++++.+++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35566665 8999999999999864  357889999997653 34567899999999999999999999999 5567999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++.....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999975433   69999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          351 DHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      .......  .....+|+.|+|||.+.+..  ++...|+|++|++++++++ +..|+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCC--CCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            5432211  23345689999999997654  5678899999999999997 5555543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=300.02  Aligned_cols=217  Identities=21%  Similarity=0.221  Sum_probs=178.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC---CCcEEEEEEeccCCcc-----------chHHHHHHHHHHhccCcCCceeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID---LNMAVAVKKISRGLKH-----------GKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      .++|...+.||+|+||.||+|.+..   ++..+|+|++......           ....+.+|+..+..++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3678999999999999999999986   6889999998765321           1234778889999999999999999


Q ss_pred             EEee----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          261 LCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       261 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      ++..    ....++||||+ +++|.+++....    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            9987    77899999999 999999997654    59999999999999999999999   899999999999999988


Q ss_pred             C--CEEEeecCCcccccCCCC------CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------
Q 041624          337 F--NVKLGDFGLALLVDHELG------PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------  398 (459)
Q Consensus       337 ~--~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------  398 (459)
                      +  .+||+|||+++.+.....      .......||+.|+|||++.+..  ++.+.|+||+|++++++++          
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA--LSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            7  999999999987643211      1124567999999999998653  5778899999999988775          


Q ss_pred             ---------------------------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ---------------------------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ---------------------------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                                             |+.++|.+||++.++++.|+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence                                                   56678999999999999997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-36  Score=312.66  Aligned_cols=198  Identities=24%  Similarity=0.362  Sum_probs=168.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..+.|+..+.||+|+||.||+|.+..++..||+|++....  ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999999999999999997653  33467899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~  348 (459)
                      ||||++|+|.+.+....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++..   +.+||+|||+++
T Consensus       115 ~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999887654    59999999999999999999999   999999999999999764   459999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .....  .......||+.|+|||++..   .++.+.|+|++|+++++++++..|+
T Consensus       188 ~~~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf  237 (494)
T 3lij_A          188 VFENQ--KKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPF  237 (494)
T ss_dssp             ECBTT--BCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECCCC--ccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCC
Confidence            77543  23445679999999999863   3678899999999999988754443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-36  Score=294.50  Aligned_cols=199  Identities=23%  Similarity=0.295  Sum_probs=160.6

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc--CcCCceeEEEEEeeC
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL--RHRNLLQLIGLCHDR  265 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~  265 (459)
                      ...-....++|++.+.||+|+||.||+|.+.  ++.||||++...   ....+..|.+++..+  +|+||+++++++...
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3334455688999999999999999999986  799999998543   334455566666554  999999999999887


Q ss_pred             ----CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC--------CeeecCCCCCCeee
Q 041624          266 ----GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR--------CVVHRDIKFSNIMP  333 (459)
Q Consensus       266 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~--------~iiHrDlkp~NILl  333 (459)
                          ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||+   .        +|+||||||+|||+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEE
Confidence                7899999999999999999643     49999999999999999999998   6        99999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCCCc---cccccccccccccceeccCccccC----CCCCHHHHHHHHHHHHhc
Q 041624          334 DTDFNVKLGDFGLALLVDHELGPR---TTGLAGTLGYMAPEYISTGRARLD----VNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~----~~~D~~~~g~ll~~~l~c  399 (459)
                      +.++.+||+|||+++.+.......   .....||+.|+|||++.+......    .+.|+|++|+++++++++
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999999999997765432221   234579999999999976543111    127999999999887644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.1e-37  Score=301.16  Aligned_cols=204  Identities=26%  Similarity=0.335  Sum_probs=171.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4678899999999999999999999999999999865533  23456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999988765443    59999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      . ........||+.|+|||++.+.. .++...|+|++|+++++++++..|++...
T Consensus       177 ~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          177 P-GEVYDDEVATRWYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             C-ccccCCCcCCccccCcccccCCC-CcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3 22234567899999999987542 36778899999999999999998887653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5e-36  Score=291.50  Aligned_cols=201  Identities=26%  Similarity=0.308  Sum_probs=175.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .+.|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999999889999999997653 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++...     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999988532     58999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      . .......||+.|+|||.+.+..  ++...|+|++|+++++++++..|+...
T Consensus       173 ~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          173 Q-IKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             B-CCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             c-cccCccCCCcCccCHHHHhcCC--CCchhhhHHHHHHHHHHccCCCCCCCc
Confidence            2 2234567899999999997654  567889999999999999876665543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=321.60  Aligned_cols=194  Identities=25%  Similarity=0.384  Sum_probs=159.6

Q ss_pred             cCCCCCc-eeccCCceEEEEEEEcC--CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNER-KLGQGGFGAVYRGILID--LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~-~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +++...+ .||+|+||.||+|.+..  ++..||||+++... ....++|.+|+++|.+++|+||++++++|.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3344444 79999999999998863  46789999998653 3456789999999999999999999999976 569999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++|+|.+++.....   .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       414 ~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EECCTTCBHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEeCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999975543   69999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          352 HELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       352 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ......  .....+|+.|+|||++.++.  ++.++|+|++|++++++++
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~--~~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             --------------CCTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCC--CCcHHHHHHHHHHHHHHHH
Confidence            432222  22334568999999997654  5778899999999999885

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-36  Score=311.99  Aligned_cols=198  Identities=25%  Similarity=0.377  Sum_probs=171.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            346799999999999999999999989999999998643  234567899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec---CCCCEEEeecCCcc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD---TDFNVKLGDFGLAL  348 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~  348 (459)
                      |||+++|+|.+.+....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||+++
T Consensus       100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999887654    59999999999999999999999   9999999999999995   45679999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      .....  .......||+.|+|||++.+.   ++.+.|+|++|+++++++++..|+
T Consensus       173 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf  222 (486)
T 3mwu_A          173 CFQQN--TKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPF  222 (486)
T ss_dssp             TBCCC------CCTTGGGGCCGGGGGSC---CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECCCC--CccCCCcCCCCCCCHHHhCCC---CCchhhHHHHHHHHHHHHhCCCCC
Confidence            76543  234456799999999998752   677889999999999998765554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-36  Score=294.15  Aligned_cols=203  Identities=25%  Similarity=0.348  Sum_probs=166.5

Q ss_pred             HHhcCCCCCc-eeccCCceEEEEEEE--cCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          193 SATNNFSNER-KLGQGGFGAVYRGIL--IDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       193 ~~~~~f~~~~-~Lg~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ...++|...+ .||+|+||.||+|.+  ..+++.||||+++....  ...+++.+|+.++.+++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3456777777 999999999999965  45678999999976532  2357899999999999999999999999 6677


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+++++|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            899999999999999997643    59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          348 LLVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       348 ~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      +.........  .....+++.|+|||.+.+..  ++.+.|+|++|++++++++ +..|+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCC--CChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            8765432221  22345678999999997654  4677899999999999987 5555443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-36  Score=296.06  Aligned_cols=224  Identities=18%  Similarity=0.274  Sum_probs=186.1

Q ss_pred             cCHHHHHHHhcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhcc-CcCCceeEEEE
Q 041624          186 FSYKDLASATNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQL-RHRNLLQLIGL  261 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~  261 (459)
                      ..++..+...+.|.+. +.||+|+||.||+|....+++.||+|+++...  .....++.+|+.++.++ +|+||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3445556667778877 89999999999999999999999999997542  33467899999999999 56999999999


Q ss_pred             EeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCC
Q 041624          262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFN  338 (459)
Q Consensus       262 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~  338 (459)
                      +.+.+..++||||+++|+|.+++.....  ..+++.+++.++.||+.||+|||+   .+|+||||||+|||++.   ++.
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999999865422  369999999999999999999999   99999999999999998   789


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------  398 (459)
                      +||+|||+++.....  .......||+.|+|||++.+..  ++.+.|+|++|++++++++                    
T Consensus       173 ~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  248 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV  248 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EEEeeCccccccCCc--cccccccCCcCccCCeeecCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence            999999999876543  2234567999999999997654  5778899999999998875                    


Q ss_pred             ----------------------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 ----------------------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 ----------------------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                            |+.++|.+||++.++++.--
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence                                  66668888888888887543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-36  Score=289.62  Aligned_cols=200  Identities=25%  Similarity=0.314  Sum_probs=165.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467889999999999999999999889999999986532   23456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999997654    58999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      ..  .......||+.|+|||.+.+... .+.+.|+|++|+++++++++..|+.
T Consensus       163 ~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          163 DG--EFLRTSCGSPNYAAPEVISGRLY-AGPEVDIWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             C---------------CCTGGGTTSCC-CHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CC--cceecccCCccccCHHHHcCCCC-CCccchHHHHHHHHHHHHhCCCCCC
Confidence            42  22334578999999999875432 3467899999999999887655543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-36  Score=293.28  Aligned_cols=215  Identities=26%  Similarity=0.378  Sum_probs=163.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..   .||+|+++...  ....+.|.+|+.++.+++|+||+++++++ ..+..++|
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            45789999999999999999998653   59999997553  23456799999999999999999999966 45578999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++.....   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999999965543   69999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCC-CCccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HEL-GPRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      ... ........||+.|+|||.+... ...++...|+|++|+++++++++..|+.... ...++.+.+..
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~  240 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGR  240 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHH
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcc
Confidence            322 2223456789999999998622 1235667899999999999998777765432 34444444443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-36  Score=311.30  Aligned_cols=200  Identities=27%  Similarity=0.377  Sum_probs=172.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-------------cchHHHHHHHHHHhccCcCCceeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-------------HGKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      ..++|...+.||+|+||.||+|.+..+++.||+|++.....             ...+.+.+|+.++.+++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            56789999999999999999999999999999999975421             33567899999999999999999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC---
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF---  337 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---  337 (459)
                      ++.+.+..++|||||++|+|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999887654    59999999999999999999999   9999999999999999776   


Q ss_pred             CEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          338 NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .+||+|||+++.....  .......||+.|+|||++..   .++.+.|+|++|+++++++++..|++.
T Consensus       187 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             SEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            6999999999877543  23445679999999999873   367889999999999999886665543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6e-36  Score=289.09  Aligned_cols=210  Identities=24%  Similarity=0.358  Sum_probs=177.2

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~l  270 (459)
                      .|...+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.++.+++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3667788999999999999999999999999987542  3345678999999999999999999999875    456899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeec-CCCCEEEeecCCc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPD-TDFNVKLGDFGLA  347 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~-~~~~~kL~DFGla  347 (459)
                      ||||+++++|.+++....    .+++..++.++.||+.||.|||+   .+  |+||||||+|||++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999997653    58999999999999999999998   77  99999999999998 7899999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      .....   .......||+.|+|||.+.+   .++.+.|+|++|++++.++++..|+.... ...++.+.+...
T Consensus       180 ~~~~~---~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~  245 (290)
T 1t4h_A          180 TLKRA---SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSG  245 (290)
T ss_dssp             GGCCT---TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTT
T ss_pred             ccccc---cccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhcc
Confidence            75543   23345679999999998864   26788999999999999999888886543 445555555443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-36  Score=297.44  Aligned_cols=206  Identities=23%  Similarity=0.316  Sum_probs=160.3

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcC---CCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEE
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILID---LNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLC  262 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~  262 (459)
                      ++++....++|...+.||+|+||.||+|.+..   ++..||+|.++...  ....+.+.+|+.++.+++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34444566788999999999999999998865   45689999997543  23456799999999999999999999999


Q ss_pred             eeCC-----eEEEEEEecCCCCcchhccccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC
Q 041624          263 HDRG-----EFMLVYEFMPNGSLDFHLFSKK--STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT  335 (459)
Q Consensus       263 ~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~  335 (459)
                      .+.+     ..++||||+++|+|.+++....  .....+++..++.++.||+.||.|||+   ++|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence            8755     3599999999999999985432  223469999999999999999999998   99999999999999999


Q ss_pred             CCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          336 DFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       336 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      ++.+||+|||+++........ ......+++.|+|||.+.+..  ++.+.|+|++|++++++++
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~  244 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIAT  244 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSC--CCHHHHHHHHHHHHHHHHT
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC--ccchhhhHHHHHHHHHHHh
Confidence            999999999999876543221 223456788999999997653  5678899999999998887

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-36  Score=300.62  Aligned_cols=201  Identities=24%  Similarity=0.312  Sum_probs=168.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHH-HhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKT-CSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|+.+.+++.||+|++++..   ....+.+..|..+ +..++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467899999999999999999999999999999997653   2234456777776 567899999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999999997654    58999999999999999999999   99999999999999999999999999999864


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+..
T Consensus       190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          190 IEH-NSTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             BCC-CCCCCSBSCCCCCCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccC-CCccccccCCccccCHHHhCCCC--CCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            332 23345678999999999998653  57889999999999999998888754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-36  Score=296.60  Aligned_cols=212  Identities=25%  Similarity=0.356  Sum_probs=180.2

Q ss_pred             CCCCceeccCCceEEEEEEEc----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEE
Q 041624          198 FSNERKLGQGGFGAVYRGILI----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFML  270 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l  270 (459)
                      |+..+.||+|+||.||++.+.    .+++.||||+++.... ...+.+.+|++++.+++|+||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            388899999999999888653    4688999999976532 345679999999999999999999999987  467899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++...     .+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999653     48999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          351 DHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       351 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ......  ......+|..|+|||.+.+..  ++.+.|+|++|++++++++                              
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            543221  123456788999999998654  4577899999999998875                              


Q ss_pred             ------------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                              |+.++|.+||++.++++.|+.
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                                    778899999999999988864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-36  Score=289.05  Aligned_cols=196  Identities=31%  Similarity=0.418  Sum_probs=171.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|++++.+++|+||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367889999999999999999999889999999986532   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||+++++|.+++....    .+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999997654    58999999999999999999998   999999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ..   ......|++.|+|||.+.+..  ++...|+|++|+++++++++..|
T Consensus       166 ~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p  211 (284)
T 2vgo_A          166 SL---RRRTMCGTLDYLPPEMIEGKT--HDEKVDLWCAGVLCYEFLVGMPP  211 (284)
T ss_dssp             SS---CBCCCCSCGGGCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cc---ccccccCCCCcCCHHHhccCC--CCcccchhhHHHHHHHHHHCCCC
Confidence            32   234567899999999998654  57788999999999988874443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-36  Score=300.77  Aligned_cols=195  Identities=25%  Similarity=0.325  Sum_probs=167.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|.++.+++.||+|++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45779999999999999999999999999999999975432    345788888888 7999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC----CCEEEeecCCcc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD----FNVKLGDFGLAL  348 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~  348 (459)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||+..+    +.+||+|||+++
T Consensus        96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999987543    59999999999999999999999   999999999999998543    359999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ...... ......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|
T Consensus       169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~P  219 (342)
T 2qr7_A          169 QLRAEN-GLLMTPCYTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTP  219 (342)
T ss_dssp             ECBCTT-CCBCCSSCCSSCCCHHHHHHHH--HHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCC-CceeccCCCccccCHHHhcCCC--CCCccCeeeHhHHHHHHhcCCCC
Confidence            765432 2344568899999999987543  56788999999999988875443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-36  Score=293.09  Aligned_cols=198  Identities=22%  Similarity=0.316  Sum_probs=170.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|...+.||+|+||.||+|....+++.||+|.++.......+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            34678899999999999999999998899999999986655556778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~  350 (459)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999987654    58999999999999999999999   999999999999999   78899999999999754


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      ...   ......||+.|+|||.+.+..  ++.+.|+|++|+++++++++..|+
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          160 QNG---IMSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             CCB---TTHHHHSCCCBCCTTTBSSCS--CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCC---ccccccCCCCccChHHhccCC--CCchhhHHHHHHHHHHHHHCCCCC
Confidence            322   234456899999999997653  567889999999999988765554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=291.38  Aligned_cols=200  Identities=26%  Similarity=0.305  Sum_probs=169.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|.+...  ...+++.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            456799999999999999999999998999999999754  345788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++++|.+++.....   .+++..++.++.||+.||.|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999874433   69999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                       ........||+.|+|||.+.+..  ++...|+|++|+++++++++..|+.
T Consensus       179 -~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          179 -MAKRNTVIGTPFWMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             -BSCBCCCCSCGGGCCHHHHSSSC--BCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -ccccCccCCCCCccChhhcCCCC--CCccccHHHHHHHHHHHHhCCCCCC
Confidence             22234567899999999997653  5778899999999999887655544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=297.96  Aligned_cols=215  Identities=26%  Similarity=0.318  Sum_probs=172.9

Q ss_pred             cccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEE
Q 041624          184 RRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLC  262 (459)
Q Consensus       184 ~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~  262 (459)
                      ..+++.++....++|+..+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++.++ +|+||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3455666677889999999999999999999999988999999999654 33457889999999999 899999999999


Q ss_pred             ee------CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC
Q 041624          263 HD------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD  336 (459)
Q Consensus       263 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~  336 (459)
                      ..      .+..++||||+++|+|.+++.....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTT
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCC
Confidence            76      4688999999999999999976432  268999999999999999999999   999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          337 FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      +.+||+|||++....... .......||+.|+|||++...   ...++.+.|+|++|+++++++++..|+..
T Consensus       166 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999999999998765321 223445789999999998632   22467788999999999999987766543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-36  Score=302.44  Aligned_cols=198  Identities=25%  Similarity=0.321  Sum_probs=172.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367889999999999999999999999999999997653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++....
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999997654    48999999999999999999998   5 899999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                      .   ......||+.|+|||++.+..  ++...|+|++|+++++++++..|++
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~  231 (360)
T 3eqc_A          185 S---MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIP  231 (360)
T ss_dssp             H---C----CCCCTTCCHHHHTTCC--CSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred             c---cccCCCCCCCeECHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2   223457899999999998653  5678899999999999987765554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=305.23  Aligned_cols=202  Identities=23%  Similarity=0.284  Sum_probs=170.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC--eEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG--EFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV  271 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++.+++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357888999999999999999999999999999997543 344677889999999999999999999998755  78999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee----cCCCCEEEeecCCc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP----DTDFNVKLGDFGLA  347 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla  347 (459)
                      |||+++|+|.+++...... ..+++..++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999765432 249999999999999999999999   999999999999999    77888999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccC------ccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTG------RARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      +.....  .......||+.|+|||++...      ...++.+.|+|++|+++++++++..|
T Consensus       164 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P  222 (396)
T 4eut_A          164 RELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP  222 (396)
T ss_dssp             EECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            876543  223456799999999998642      12356678999999999988865433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-36  Score=288.50  Aligned_cols=215  Identities=20%  Similarity=0.224  Sum_probs=181.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEE-eeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLC-HDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....  ..+++.+|+.++.+++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            3578999999999999999999998889999999986543  345688999999999988876666655 5677889999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~  349 (459)
                      ||+ +++|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 9999999975443   69999999999999999999999   999999999999999   4888999999999987


Q ss_pred             ccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------
Q 041624          350 VDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------  398 (459)
Q Consensus       350 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------  398 (459)
                      .......      ......||+.|+|||.+.+..  ++.+.|+|++|++++++++                         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            7654321      124567999999999998654  5678899999999998876                         


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                           |+.++|.+||++.++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence                                 556678888888888887764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-35  Score=311.88  Aligned_cols=215  Identities=25%  Similarity=0.377  Sum_probs=185.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|...+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+|.+++||||+++++++.+.+.+++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467899999999999999999999999999999996532   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus       262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999999876442  259999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHH
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP--SIRQAIQVL  417 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP--s~~~v~~~L  417 (459)
                      ...  ......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+.....  ...++.+.+
T Consensus       337 ~~~--~~~~~~~GT~~Y~APEvl~~~~--~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i  401 (576)
T 2acx_A          337 PEG--QTIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV  401 (576)
T ss_dssp             CTT--CCEECCCSCGGGCCHHHHTTCE--ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH
T ss_pred             ccC--ccccccCCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh
Confidence            543  2334568999999999998654  57888999999999999999999986543  344555444

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-36  Score=312.49  Aligned_cols=200  Identities=29%  Similarity=0.409  Sum_probs=176.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567899999999999999999999999999999996542   3456789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLA  347 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla  347 (459)
                      ||||+.+|+|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            999999999999887554    59999999999999999999999   999999999999999   56789999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      +.+...  .......||+.|+|||++.+   .++.+.|+||+|+++++++++..|++.
T Consensus       177 ~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          177 THFEAS--KKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             HHBCCC--CSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEcccc--cccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            877543  23445679999999999875   367889999999999999987666554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=299.10  Aligned_cols=214  Identities=22%  Similarity=0.286  Sum_probs=175.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCc--CCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|++.+.||+|+||.||++.+.. ++.||||++....  ....+.+.+|+.++.+++|  +||+++++++.+.+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            4568889999999999999998864 8999999997543  2345778999999999976  999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||| +.+++|.+++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+
T Consensus        87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56889999997653    59999999999999999999999   9999999999999997 578999999999876


Q ss_pred             cCCCCC-ccccccccccccccceeccC---------ccccCCCCCHHHHHHHHHHHHh----------------------
Q 041624          351 DHELGP-RTTGLAGTLGYMAPEYISTG---------RARLDVNFDEQQTDCLMIVGLW----------------------  398 (459)
Q Consensus       351 ~~~~~~-~~~~~~gt~~y~APE~~~~~---------~~~~~~~~D~~~~g~ll~~~l~----------------------  398 (459)
                      ...... ......||+.|+|||++.+.         ...++.+.|+|++|++++++++                      
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  237 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  237 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence            543222 23456799999999998641         1245677899999999998775                      


Q ss_pred             -------------------cCCCCCCCCCCHHHHHHHHh
Q 041624          399 -------------------CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       399 -------------------c~~p~p~~RPs~~~v~~~L~  418 (459)
                                         |+.++|.+||++.|+++...
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence                               77778999999999987544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-36  Score=302.79  Aligned_cols=200  Identities=23%  Similarity=0.288  Sum_probs=163.1

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee------
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD------  264 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------  264 (459)
                      +....++|+..+.||+|+||.||+|.+..+++.||||++.....    ...+|++++++++|+||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567889999999999999999999999999999999865422    23479999999999999999999844      


Q ss_pred             --------------------------------CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 041624          265 --------------------------------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY  312 (459)
Q Consensus       265 --------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~y  312 (459)
                                                      ....++||||++ |+|.+.+.........+++..+..++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334889999998 58888776533333479999999999999999999


Q ss_pred             hhhccCCCeeecCCCCCCeeec-CCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHH
Q 041624          313 LHEEWKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDC  391 (459)
Q Consensus       313 LH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~  391 (459)
                      ||+   .+|+||||||+|||++ .++.+||+|||+++.+...  .......||+.|+|||.+.+.. .++...|+|++|+
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGAT-EYTPSIDLWSIGC  230 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCS-SCCTHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCC-CCCcchhhhhHHH
Confidence            998   9999999999999998 6889999999999876543  2334567899999999987543 3678899999999


Q ss_pred             HHHHHHhcCC
Q 041624          392 LMIVGLWCAH  401 (459)
Q Consensus       392 ll~~~l~c~~  401 (459)
                      ++++++++..
T Consensus       231 il~ell~g~~  240 (383)
T 3eb0_A          231 VFGELILGKP  240 (383)
T ss_dssp             HHHHHHHSSC
T ss_pred             HHHHHHhCCC
Confidence            9988775433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-36  Score=298.13  Aligned_cols=223  Identities=23%  Similarity=0.331  Sum_probs=182.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEE-----EcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGI-----LIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..++|...+.||+|+||.||+|.     ...++..||||.+.... .....++.+|+.++.+++||||+++++++.+.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            34789999999999999999998     44567899999997542 3445679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEE
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKST---GTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKL  341 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL  341 (459)
                      .++||||+++++|.+++......   ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999865421   2358999999999999999999999   99999999999999994   446999


Q ss_pred             eecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------
Q 041624          342 GDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------  398 (459)
Q Consensus       342 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------  398 (459)
                      +|||+++........ ......||+.|+|||.+.++.  ++...|+|++|++++++++                      
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            999999866433221 223456789999999997654  5678899999999998875                      


Q ss_pred             ------------------cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ------------------CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ------------------c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                                        |+.++|.+||++.++++.|+...
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                              67778999999999999887543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-36  Score=293.07  Aligned_cols=221  Identities=24%  Similarity=0.265  Sum_probs=169.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cc-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|+++.... .. .+.+.++...+..++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            35788999999999999999999998899999999976532 22 23344555568888999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |||++ |+|.+++.........+++..++.++.||+.||+|||+   + +|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 58888876533333479999999999999999999998   7 9999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceecc--CccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYIST--GRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      ...  .......||+.|+|||.+..  ....++...|+|++|+++++++++..|+........++.+.+...
T Consensus       161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          161 VDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             ccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            543  22334578999999999732  122356788999999999999999988876555555665555544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-36  Score=311.07  Aligned_cols=191  Identities=26%  Similarity=0.298  Sum_probs=158.7

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeC------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  265 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.++++++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999999999999999999764  233456788999999999999999999999654      


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ...|+||||+++ +|.+.+..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            467999999976 45555532      48999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +++.....  ......+||+.|+|||++.+.  .++.+.|+|++|+++++|++
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~  258 (464)
T 3ttj_A          210 LARTAGTS--FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVR  258 (464)
T ss_dssp             CC-----C--CCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHH
T ss_pred             eeeecCCC--cccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHh
Confidence            99876542  234557899999999999875  36788999999999988763

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.3e-36  Score=305.06  Aligned_cols=197  Identities=20%  Similarity=0.245  Sum_probs=168.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc------CcCCceeEEEEEeeCCe
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL------RHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~  267 (459)
                      ...+|++.+.||+|+||.||+|.+..+++.||||+++.. ....+++.+|++++..+      .|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            346799999999999999999999999999999999653 33346778888888887      57799999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC--EEEeecC
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--VKLGDFG  345 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kL~DFG  345 (459)
                      .++||||+. ++|.+++.....  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 699998876543  258999999999999999999999   89999999999999999987  9999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      +++....    ......||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+
T Consensus       248 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf  299 (429)
T 3kvw_A          248 SSCYEHQ----RVYTYIQSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLL  299 (429)
T ss_dssp             TCEETTC----CCCSSCSCGGGCCHHHHHTBC--CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cceecCC----cccccCCCCCccChHHHhCCC--CCchHHHHhHHHHHHHHHhCCCCC
Confidence            9976543    234567899999999998654  578899999999999888654443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.1e-36  Score=288.62  Aligned_cols=214  Identities=28%  Similarity=0.327  Sum_probs=180.8

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---------cchHHHHHHHHHHhccC-cCCceeEEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---------HGKNEYITEVKTCSQLR-HRNLLQLIGLC  262 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~g~~  262 (459)
                      ...++|+..+.||+|+||.||+|.+..+++.||||.+.....         ...+.+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            345789999999999999999999999999999999975431         22456889999999995 99999999999


Q ss_pred             eeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEe
Q 041624          263 HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLG  342 (459)
Q Consensus       263 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  342 (459)
                      ...+..++||||+++++|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEe
Confidence            99999999999999999999997653    59999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCCCCccccccccccccccceeccC----ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 041624          343 DFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG----RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       343 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L  417 (459)
                      |||+++.....  .......||+.|+|||++...    ...++...|+|++|+++++++++..|+...  +..++.+.+
T Consensus       167 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~  241 (298)
T 1phk_A          167 DFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMI  241 (298)
T ss_dssp             CCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH
T ss_pred             cccchhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHHHH
Confidence            99999876543  233456789999999988531    223567889999999999999988887654  334444443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.7e-36  Score=293.36  Aligned_cols=212  Identities=24%  Similarity=0.338  Sum_probs=176.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--------ccchHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--------KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||.+....        ......+.+|++++.+++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4467999999999999999999999999999999986542        12234688999999999999999999998765


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC---EEEe
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLG  342 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~  342 (459)
                      + .++||||+++++|.+++....    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 899999999999999886543    59999999999999999999999   99999999999999987664   9999


Q ss_pred             ecCCcccccCCCCCccccccccccccccceecc-CccccCCCCCHHHHHHHHHHHHh-----------------------
Q 041624          343 DFGLALLVDHELGPRTTGLAGTLGYMAPEYIST-GRARLDVNFDEQQTDCLMIVGLW-----------------------  398 (459)
Q Consensus       343 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~~~D~~~~g~ll~~~l~-----------------------  398 (459)
                      |||+++.....  .......||+.|+|||++.. +...++.+.|+|++|++++++++                       
T Consensus       160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999876432  22345678999999999752 22246778899999999988776                       


Q ss_pred             --------------------cCCCCCCCCCCHHHHHH
Q 041624          399 --------------------CAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       399 --------------------c~~p~p~~RPs~~~v~~  415 (459)
                                          |+.++|.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                                56678899999998875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.5e-36  Score=302.90  Aligned_cols=212  Identities=22%  Similarity=0.288  Sum_probs=175.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccC--cCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLR--HRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|++.+.||+|+||.||+|.+.. ++.||||++....  ....+.+.+|+.++.+++  |+||+++++++...+.+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999999876 8999999997543  334578999999999996  59999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      || +.+++|.+++....    .+++.++..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+.
T Consensus       135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56889999997654    58999999999999999999998   9999999999999996 5799999999998765


Q ss_pred             CCCCC-ccccccccccccccceeccC---------ccccCCCCCHHHHHHHHHHHHh-----------------------
Q 041624          352 HELGP-RTTGLAGTLGYMAPEYISTG---------RARLDVNFDEQQTDCLMIVGLW-----------------------  398 (459)
Q Consensus       352 ~~~~~-~~~~~~gt~~y~APE~~~~~---------~~~~~~~~D~~~~g~ll~~~l~-----------------------  398 (459)
                      ..... .....+||+.|+|||++.+.         ...++.++|+|++|++++++++                       
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  285 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence            43222 23456799999999998652         1235678899999999998875                       


Q ss_pred             ------------------cCCCCCCCCCCHHHHHHHH
Q 041624          399 ------------------CAHPDRNCRPSIRQAIQVL  417 (459)
Q Consensus       399 ------------------c~~p~p~~RPs~~~v~~~L  417 (459)
                                        |+..+|.+||++.|+++..
T Consensus       286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                              6677888888888888754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-37  Score=310.02  Aligned_cols=200  Identities=17%  Similarity=0.153  Sum_probs=162.0

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHH---HHHhccCcCCceeEE-------E
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEV---KTCSQLRHRNLLQLI-------G  260 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g  260 (459)
                      ..++|...+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+   +++.+++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357788899999999999999999888999999999743   234457889999   555566899999998       7


Q ss_pred             EEeeCCe-----------------EEEEEEecCCCCcchhccccCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 041624          261 LCHDRGE-----------------FMLVYEFMPNGSLDFHLFSKKST---GTPLTWTTRYKISLGLASALLYLHEEWKRC  320 (459)
Q Consensus       261 ~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  320 (459)
                      ++.+.+.                 .++||||+ +|+|.+++......   ...+++..++.|+.||+.||+|||+   ++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            7665542                 79999999 68999999764321   1234568899999999999999999   99


Q ss_pred             eeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccC---------ccccCCCCCHHHHHH
Q 041624          321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG---------RARLDVNFDEQQTDC  391 (459)
Q Consensus       321 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---------~~~~~~~~D~~~~g~  391 (459)
                      |+||||||+|||++.++.+||+|||+++...    .......| +.|+|||++.+.         ...++.++|+||+|+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999998543    23445677 999999999865         113677889999999


Q ss_pred             HHHHHHhcCCC
Q 041624          392 LMIVGLWCAHP  402 (459)
Q Consensus       392 ll~~~l~c~~p  402 (459)
                      ++++++++..|
T Consensus       302 il~elltg~~P  312 (377)
T 3byv_A          302 VIYWIWCADLP  312 (377)
T ss_dssp             HHHHHHHSSCC
T ss_pred             HHHHHHHCCCC
Confidence            99998874433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=296.65  Aligned_cols=191  Identities=27%  Similarity=0.424  Sum_probs=153.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHH--HhccCcCCceeEEEEEee-----CC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKT--CSQLRHRNLLQLIGLCHD-----RG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~-----~~  266 (459)
                      ..++|+..+.||+|+||.||+|...  ++.||||+++..   ....+..|.++  +..++|+||+++++++..     ..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3478899999999999999999874  799999999643   33444555444  455899999999986543     33


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC---------CeeecCCCCCCeeecCCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR---------CVVHRDIKFSNIMPDTDF  337 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~---------~iiHrDlkp~NILl~~~~  337 (459)
                      ..++||||+++|+|.+++...     .+++..++.++.||+.||+|||+   .         +|+||||||+|||++.++
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCC
Confidence            678999999999999999654     36899999999999999999998   6         999999999999999999


Q ss_pred             CEEEeecCCcccccCCCC-------CccccccccccccccceeccCc-----cccCCCCCHHHHHHHHHHHH
Q 041624          338 NVKLGDFGLALLVDHELG-------PRTTGLAGTLGYMAPEYISTGR-----ARLDVNFDEQQTDCLMIVGL  397 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~-----~~~~~~~D~~~~g~ll~~~l  397 (459)
                      .+||+|||+++.+.....       .......||+.|+|||++.+..     ..++.++|+||+|+++++++
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            999999999987654321       1123457999999999987531     13456789999999988764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-36  Score=321.23  Aligned_cols=205  Identities=25%  Similarity=0.353  Sum_probs=164.3

Q ss_pred             ceeccCCceEEEEEEEc--CCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILI--DLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      +.||+|+||.||+|.+.  .+++.||||+++....  ...+++.+|++++.+++|+||+++++++.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999664  4568999999976532  346789999999999999999999999964 568999999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-  356 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  356 (459)
                      |+|.+++....    .+++..++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999996543    59999999999999999999999   99999999999999999999999999999877543221 


Q ss_pred             -ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHh
Q 041624          357 -RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       357 -~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~  418 (459)
                       ......+|+.|+|||++.+..  ++.+.|+|++|++++++++ +..|++..  +..++.+.+.
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~--~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~  586 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLE  586 (635)
T ss_dssp             --------CGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH
Confidence             223445788999999997654  5778899999999999987 55555433  2334444443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.8e-36  Score=299.10  Aligned_cols=202  Identities=21%  Similarity=0.284  Sum_probs=163.4

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-----------chHHHHHHHHHHhccCcCC
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-----------GKNEYITEVKTCSQLRHRN  254 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n  254 (459)
                      ....++....++|...+.||+|+||.||+|.+.. ++.||||++......           ..+.+.+|+.++.+++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            4567888999999999999999999999999876 899999998653221           1267899999999999999


Q ss_pred             ceeEEEEEee-----CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCC
Q 041624          255 LLQLIGLCHD-----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFS  329 (459)
Q Consensus       255 Iv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~  329 (459)
                      |+++++++..     ....++||||++ |+|.+++.....   .+++..+..++.||+.||.|||+   .+|+||||||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~  163 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---VISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPG  163 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChH
Confidence            9999999854     346899999997 688888875443   69999999999999999999999   89999999999


Q ss_pred             CeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          330 NIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       330 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |||++.++.+||+|||+++.....  .......||+.|+|||.+.+.. .++...|+|++|++++++++
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~  229 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFK-GFTKLVDMWSAGCVMAEMFN  229 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCC-CCCcHhHHHhHHHHHHHHHh
Confidence            999999999999999999755432  2234567899999999987533 36788899999999987764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-36  Score=294.68  Aligned_cols=210  Identities=23%  Similarity=0.268  Sum_probs=156.9

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ...++|...+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34678999999999999999999998889999999986543 34456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhcccc----CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          272 YEFMPNGSLDFHLFSK----KSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      |||+++++|.+++...    ......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999998642    1122369999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCC----CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          348 LLVDHELG----PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       348 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +.......    .......||+.|+|||.+.... .++...|+|++|+++++++++..|+...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHH-CCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhcccc-CCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence            87653211    1123457899999999986432 3577889999999999999877776543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-36  Score=297.95  Aligned_cols=194  Identities=26%  Similarity=0.354  Sum_probs=162.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCC------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  266 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.....  ...+++.+|++++.+++|+||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4678999999999999999999999999999999965432  33567889999999999999999999997653      


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+ +++|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 88999988652     58999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ++.....    .....+|+.|+|||++.+.. .++...|+|++|+++++++++..|
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCC
Confidence            9876432    34567899999999987633 367889999999999988865443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-35  Score=295.76  Aligned_cols=197  Identities=24%  Similarity=0.317  Sum_probs=167.9

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++.+++|+||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            45689999999999999999999999999999999975432 3346789999999999999999999999765     46


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+. |+|.+++...     .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            899999997 5998888543     49999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          348 LLVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       348 ~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      +.........  .....||+.|+|||++.++. .++...|+|++|+++++++++.
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~  229 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNR  229 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC-SCSTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCC-CCCcchhHHHHHHHHHHHHHCC
Confidence            8765432211  34568999999999876544 3678889999999998877543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-35  Score=317.02  Aligned_cols=213  Identities=22%  Similarity=0.272  Sum_probs=185.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  269 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++++.   .....+.+..|..++..+ +|++|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999754   234456788999999988 7999999999999999999


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      |||||+++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999997654    59999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .... .......+||+.|+|||++.+..  ++...|+|++|+++++|+++..|+...  +..++.+.+.
T Consensus       492 ~~~~-~~~~~~~~GT~~Y~APE~l~~~~--~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~  555 (674)
T 3pfq_A          492 NIWD-GVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIM  555 (674)
T ss_dssp             CCCT-TCCBCCCCSCSSSCCHHHHTCCC--BSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH
T ss_pred             cccC-CcccccccCCCcccCHhhhcCCC--CCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHHH
Confidence            4332 23355678999999999997654  578899999999999999999999865  4455555443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.5e-35  Score=291.17  Aligned_cols=228  Identities=26%  Similarity=0.323  Sum_probs=182.7

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhc--cCcCCceeEEEEEee
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQ--LRHRNLLQLIGLCHD  264 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~  264 (459)
                      +..--....++|...+.||+|+||.||+|.+.  ++.||||++..   ...+.+.+|.+++..  ++||||+++++++..
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33334456688999999999999999999984  79999999964   345677889888887  799999999999987


Q ss_pred             CC----eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeeecCCCCCCee
Q 041624          265 RG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH--------EEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       265 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDlkp~NIL  332 (459)
                      .+    ..++||||+++|+|.+++...     .+++.+++.++.|++.||.|||        +   .+|+||||||+|||
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNIL  179 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEE
Confidence            76    789999999999999999653     4899999999999999999999        6   89999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCC---ccccccccccccccceeccCcc----ccCCCCCHHHHHHHHHHHHhc------
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRA----RLDVNFDEQQTDCLMIVGLWC------  399 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~----~~~~~~D~~~~g~ll~~~l~c------  399 (459)
                      ++.++.+||+|||+++........   ......||+.|+|||++.+...    .++.+.|+|++|+++++++++      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999877544322   1244579999999999875421    123568999999999999987      


Q ss_pred             ----CCCCCCC---CCCHHHHHHHHhcCCCCCCCC
Q 041624          400 ----AHPDRNC---RPSIRQAIQVLNFETKMPNLP  427 (459)
Q Consensus       400 ----~~p~p~~---RPs~~~v~~~L~~~~~~p~~p  427 (459)
                          ..|+...   .++..++.+.+......|.+|
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP  294 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHHhCCCCc
Confidence                4455443   345666666655444444444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=300.83  Aligned_cols=194  Identities=16%  Similarity=0.149  Sum_probs=163.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC--------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCcee---------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL--------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ---------  257 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------  257 (459)
                      .++|...+.||+|+||.||+|.+..+        ++.||+|.+...     +.+.+|++++.+++|+||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            36789999999999999999999873        789999998643     46889999999999999987         


Q ss_pred             ------EEEEEee-CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          258 ------LIGLCHD-RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       258 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                            +++++.. .+..++||||+ +++|.+++.....  ..+++.+++.++.||+.||+|||+   ++|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence                  6777776 77899999999 9999999986521  269999999999999999999999   899999999999


Q ss_pred             eeecCCC--CEEEeecCCcccccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          331 IMPDTDF--NVKLGDFGLALLVDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       331 ILl~~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      ||++.++  .+||+|||+++.+......      ......||+.|+|||++.+..  ++.+.|+|++|+++++++++..
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG--PSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCC
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCC
Confidence            9999998  9999999999876533211      123457999999999998653  5778899999999998876443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-36  Score=301.62  Aligned_cols=204  Identities=13%  Similarity=0.095  Sum_probs=158.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhcc--CcCCceeEE-------EEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQL--RHRNLLQLI-------GLC  262 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------g~~  262 (459)
                      ..+|...+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4568889999999999999999998899999999987543   2345677885544444  699988865       444


Q ss_pred             eeC-----------------CeEEEEEEecCCCCcchhccccCCCCCCCCHHHH------HHHHHHHHHHHHHhhhccCC
Q 041624          263 HDR-----------------GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR------YKISLGLASALLYLHEEWKR  319 (459)
Q Consensus       263 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~  319 (459)
                      ...                 ...+|||||++ |+|.+++.....   .+.+..+      +.++.||+.||+|||+   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---K  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence            433                 34899999998 899999986533   3455556      7888999999999999   9


Q ss_pred             CeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       320 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +|+||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.++...++.++|+||+|+++++|+++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999986542    2224566799999999986445578889999999999999999


Q ss_pred             CCCCCCCCCC
Q 041624          400 AHPDRNCRPS  409 (459)
Q Consensus       400 ~~p~p~~RPs  409 (459)
                      ..|+....|.
T Consensus       290 ~~Pf~~~~~~  299 (371)
T 3q60_A          290 FLPFGLVTPG  299 (371)
T ss_dssp             SCSTTBCCTT
T ss_pred             CCCCCCcCcc
Confidence            8888776544

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4e-35  Score=288.40  Aligned_cols=204  Identities=24%  Similarity=0.317  Sum_probs=175.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEee--CCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHD--RGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV  271 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||+|+++.   ...+.+.+|+.++.+++ |+||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            3678999999999999999999999999999999964   34577899999999997 9999999999987  6678999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~  350 (459)
                      |||+++++|.+++.       .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999998873       38899999999999999999999   9999999999999999777 8999999999876


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAI  414 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~  414 (459)
                      ...  .......||..|+|||.+.+.. .++.+.|+|++|+++++++++..|+........++.
T Consensus       182 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          182 HPG--QEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             CTT--CCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             CCC--CccccccccccccChhhhcCCC-cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            543  2234567899999999987533 367889999999999999998888765544444433

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=289.05  Aligned_cols=201  Identities=24%  Similarity=0.331  Sum_probs=163.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEe-----------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCH-----------  263 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-----------  263 (459)
                      .++|...+.||+|+||.||+|.+..+++.||+|++........+++.+|++++.+++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999999999999999998766666788999999999999999999999874           


Q ss_pred             ---eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-CCCCE
Q 041624          264 ---DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TDFNV  339 (459)
Q Consensus       264 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~  339 (459)
                         +.+..++||||++ |+|.+++..     ..+++..++.++.||+.||+|||+   ++|+||||||+|||++ .++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence               3467899999997 699998853     258999999999999999999999   9999999999999997 56799


Q ss_pred             EEeecCCcccccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          340 KLGDFGLALLVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       340 kL~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ||+|||+++.......  .......+|..|+|||.+.... .++.+.|+|++|+++++++++..|+..
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcc-cCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence            9999999987653221  1223456799999999887533 367788999999999999877666544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6e-36  Score=287.29  Aligned_cols=196  Identities=28%  Similarity=0.350  Sum_probs=159.2

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC-CeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-GEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~  272 (459)
                      ..++|+..+.||+|+||.||+|.+.  ++.||+|.++..  ...+.+.+|+.++.+++|+||+++++++.+. +..++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            3578889999999999999999885  789999999753  3567899999999999999999999997654 4789999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999975432  138899999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDR  404 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p  404 (459)
                      .    .....+++.|+|||.+.+..  ++...|+|++|++++++++ +..|++
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~  216 (278)
T 1byg_A          170 T----QDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYP  216 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             c----ccCCCccccccCHHHhCCCC--CCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            2    22345788999999997654  5678899999999999986 444443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.4e-36  Score=288.54  Aligned_cols=200  Identities=26%  Similarity=0.338  Sum_probs=158.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-CC--cEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-LN--MAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|+..+.||+|+||.||+|.+.. ++  ..||+|+++...   ....+.+.+|++++.+++|+||+++++++.+.+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4678899999999999999998743 23  369999987542   334678999999999999999999999998765 8


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      ++||||+++++|.+++.....   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            999999999999999976543   58999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCC
Q 041624          349 LVDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPD  403 (459)
Q Consensus       349 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~  403 (459)
                      .........  .....+|..|+|||.+.+..  ++.+.|+|++|++++++++ +..|+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCc
Confidence            775432221  23456788999999997654  4677899999999999987 44443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=293.66  Aligned_cols=227  Identities=21%  Similarity=0.278  Sum_probs=184.2

Q ss_pred             cCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      ...+++....++|+..+.||+|+||.||+|.+..   .+|+|+++...  ....+.+.+|+.++.+++|+||+++++++.
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            3445555667889999999999999999999864   49999987542  234567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          264 DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       264 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                      +.+..++||||+++++|.+++.....   .+++..++.++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|
T Consensus       100 ~~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B          100 SPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             CSSCEEEECBCCCSEEHHHHTTSSCC---CCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECC
T ss_pred             cCCceEEEeecccCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEee
Confidence            99999999999999999999976543   68999999999999999999999   9999999999999998 67999999


Q ss_pred             cCCcccccCCC----CCccccccccccccccceeccCc-------cccCCCCCHHHHHHHHHHHHh--------------
Q 041624          344 FGLALLVDHEL----GPRTTGLAGTLGYMAPEYISTGR-------ARLDVNFDEQQTDCLMIVGLW--------------  398 (459)
Q Consensus       344 FGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~-------~~~~~~~D~~~~g~ll~~~l~--------------  398 (459)
                      ||+++......    ........||+.|+|||.+....       ..++.+.|+|++|++++++++              
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99987653211    11233456899999999987522       235667899999999998876              


Q ss_pred             --------------------------cCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          399 --------------------------CAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       399 --------------------------c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                                                |+.++|.+||++.+++++|+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                                      566689999999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.5e-35  Score=301.65  Aligned_cols=214  Identities=21%  Similarity=0.236  Sum_probs=183.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc-CCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|++.++||+|+||.||+|.+..+++.||||++....  ...++..|++++..++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999999889999999886543  33468899999999976 566666677778889999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee---cCCCCEEEeecCCcccc
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP---DTDFNVKLGDFGLALLV  350 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~  350 (459)
                      |+ +++|.+++.....   .+++.+++.|+.||+.||+|||+   ++|+||||||+|||+   +.++.+||+|||+++.+
T Consensus        84 ~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 9999999975443   69999999999999999999999   999999999999999   68899999999999877


Q ss_pred             cCCCCCc------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------------
Q 041624          351 DHELGPR------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------------  398 (459)
Q Consensus       351 ~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------------  398 (459)
                      .......      .....||..|+|||++.+..  ++.+.|+|++|+++++|++                          
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            6443211      23567999999999998664  5678899999999998875                          


Q ss_pred             --------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 --------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 --------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                          |+..+|.+||++.+|+++|+.
T Consensus       235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence                                777799999999999998863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-35  Score=296.86  Aligned_cols=196  Identities=25%  Similarity=0.340  Sum_probs=151.5

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeC------
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------  265 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------  265 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++|+||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3478999999999999999999999999999999997543  23456788999999999999999999998754      


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      ...++|+||+ +++|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CeEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            5679999999 78999888542     59999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPD  403 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~  403 (459)
                      +++....    ......||+.|+|||++.+.. .++...|+|++|+++++|+++..|+
T Consensus       178 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          178 LARHTAD----EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCC-SCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccc----cCCCcCcCcCccChHHHcCCc-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9986543    234567899999999987533 3678899999999999888755443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.4e-35  Score=292.42  Aligned_cols=207  Identities=25%  Similarity=0.280  Sum_probs=159.8

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE  267 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  267 (459)
                      ..+.....++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|++.+..++|+||+++++++...+.
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            355667789999999999999999999999998999999998654 2334567788888999999999999999976443


Q ss_pred             -------EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--hccCCCeeecCCCCCCeeecC-CC
Q 041624          268 -------FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH--EEWKRCVVHRDIKFSNIMPDT-DF  337 (459)
Q Consensus       268 -------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiHrDlkp~NILl~~-~~  337 (459)
                             .++||||+++ +|...+.........+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence                   7899999976 555554432223346899999999999999999999  7   99999999999999997 89


Q ss_pred             CEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          338 NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       338 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      .+||+|||+++.....  .......||+.|+|||++.+.. .++...|+|++|+++++++++..|
T Consensus       170 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             EEEECCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cEEEeeCCCceecCCC--CCcccccCCcceeCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999876543  2234567899999999986543 367889999999999887755433

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-35  Score=291.07  Aligned_cols=195  Identities=23%  Similarity=0.324  Sum_probs=163.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.+++|+||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999999889999999997543 23456788999999999999999999998754     67


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+. ++|.+++...     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 6898888652     58999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC---------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          348 LLVDHELGP---------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       348 ~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +........         ......||+.|+|||++..+. .++...|+|++|++++++++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~  218 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA-KYSRAMDVWSCGCILAELFL  218 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCC-CCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCC-CccchhhHHHHHHHHHHHHh
Confidence            876532211         122357899999999886533 36778899999999987653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.3e-35  Score=294.55  Aligned_cols=191  Identities=25%  Similarity=0.293  Sum_probs=155.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  266 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999999999999999997642  234567889999999999999999999997654      


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++||||+++ +|.+.+..      .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            78999999974 78777742      48999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      ++.....  .......||+.|+|||++.+..  ++.+.|+|++|+++++++++
T Consensus       174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g  222 (371)
T 2xrw_A          174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKG  222 (371)
T ss_dssp             ------------------CTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccccc--cccCCceecCCccCHHHhcCCC--CCchHhHHHHHHHHHHHHhC
Confidence            9866432  2234567899999999998653  67889999999999887754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-36  Score=291.11  Aligned_cols=221  Identities=29%  Similarity=0.341  Sum_probs=177.6

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhcc----CcCCceeE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQL----RHRNLLQL  258 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~nIv~l  258 (459)
                      ++.....++|+..+.||+|+||.||+|.+..+++.||+|++.....      .....+.+|+.++.++    +|+||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3445567889999999999999999999988899999999975432      2234567899999998    89999999


Q ss_pred             EEEEeeCCeEEEEEEe-cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-CC
Q 041624          259 IGLCHDRGEFMLVYEF-MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TD  336 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-~~  336 (459)
                      ++++...+..++|||| +.+++|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++ .+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCC
Confidence            9999999999999999 78999999997654    59999999999999999999999   8999999999999999 88


Q ss_pred             CCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------
Q 041624          337 FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------  398 (459)
Q Consensus       337 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------  398 (459)
                      +.+||+|||+++.....   ......||..|+|||++.+... ...+.|+|++|++++++++                  
T Consensus       177 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  252 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQY-HALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF  252 (312)
T ss_dssp             TEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCC
T ss_pred             CeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCC-CCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCC
Confidence            99999999999876543   2345678999999999876543 2346899999999998876                  


Q ss_pred             --------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 --------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 --------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                    |+.++|.+||++.++++.--..
T Consensus       253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence                          7778999999999999865443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=299.98  Aligned_cols=197  Identities=22%  Similarity=0.301  Sum_probs=148.1

Q ss_pred             cCCCC-CceeccCCceEEEEEEEc--CCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEE
Q 041624          196 NNFSN-ERKLGQGGFGAVYRGILI--DLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFML  270 (459)
Q Consensus       196 ~~f~~-~~~Lg~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l  270 (459)
                      +.|.. .++||+|+||.||+|.+.  .+++.||+|++...  .....+.+|+.+|.+++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34544 458999999999999976  45789999999653  334578899999999999999999999954  678999


Q ss_pred             EEEecCCCCcchhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee----cCCCCEEE
Q 041624          271 VYEFMPNGSLDFHLFSKK-----STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP----DTDFNVKL  341 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL  341 (459)
                      ||||++ |+|.+++....     .....+++..++.|+.||+.||+|||+   .+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 57877775321     112249999999999999999999999   999999999999999    77889999


Q ss_pred             eecCCcccccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          342 GDFGLALLVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       342 ~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +|||+++.+.....  .......||+.|+|||++.+.. .++.++|+|++|+++++|+++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g  232 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTS  232 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCC-SCCHHHHHHHHHHHHHHHHHS
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCC-cccchhhhHHHHHHHHHHHhC
Confidence            99999987754322  2234568999999999997643 367788999999999987753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-35  Score=318.61  Aligned_cols=230  Identities=26%  Similarity=0.357  Sum_probs=179.5

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeC
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR  265 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~  265 (459)
                      +.....++|+..+.||+|+||.||+|.+..+   +..||+|.++.... ...+.|.+|+.++.+++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            3444567888999999999999999998643   46799999875432 34578999999999999999999999985 4


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +..++||||+++|+|.+++.....   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecC
Confidence            578999999999999999976543   59999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      +++..............+|+.|+|||.+.+..  ++.+.|+|++|++++++++ +..|+...  +..++++.+..... +
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~-~  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGER-L  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCC-C
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCC--CCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCC-C
Confidence            99877544333344456788999999997653  5778899999999999986 66666543  33455554443332 2


Q ss_pred             CCCCCCC
Q 041624          425 NLPSKMP  431 (459)
Q Consensus       425 ~~p~~~p  431 (459)
                      +.|+..|
T Consensus       612 ~~~~~~~  618 (656)
T 2j0j_A          612 PMPPNCP  618 (656)
T ss_dssp             CCCTTCC
T ss_pred             CCCcccc
Confidence            2344444

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.8e-35  Score=281.87  Aligned_cols=214  Identities=23%  Similarity=0.336  Sum_probs=181.8

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ...++|++.+.||+|+||.||+|....+++.||+|++....  ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999999889999999986542  3456789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC---CCEEEeecCCc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD---FNVKLGDFGLA  347 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla  347 (459)
                      ||||+++++|.+++....    .+++.+++.++.||+.||.|||+   .+|+||||||+|||++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999887654    58999999999999999999999   999999999999999764   46999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                      +......  ......||+.|+|||.+.+.   ++.+.|+|++|+++++++++..|+...  +..++++.+...
T Consensus       172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~  237 (287)
T 2wei_A          172 TCFQQNT--KMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETG  237 (287)
T ss_dssp             GTBCCCS--SCSCHHHHHTTCCHHHHTTC---CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC
T ss_pred             eeecCCC--ccccccCcccccChHHhcCC---CCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcC
Confidence            8765432  22344689999999998743   577889999999999999988887654  445555555433

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.5e-35  Score=293.54  Aligned_cols=191  Identities=26%  Similarity=0.342  Sum_probs=161.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE---
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF---  268 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~---  268 (459)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.++.+++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            34789999999999999999999999999999999976432  2356788999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          269 ---MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       269 ---~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                         ++||||+. ++|.+++..      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999997 688777632      48999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +++....    ......||+.|+|||++.+.. .++.+.|+|++|+++++++++
T Consensus       190 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g  238 (371)
T 4exu_A          190 LARHADA----EMTGYVVTRWYRAPEVILSWM-HYNQTVDIWSVGCIMAEMLTG  238 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCS-CCCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccccc----CcCCcccCccccCHHHhcCCC-CCCcHHhHHHHHHHHHHHHhC
Confidence            9986543    234567899999999987633 367889999999999988763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.9e-35  Score=296.39  Aligned_cols=199  Identities=23%  Similarity=0.246  Sum_probs=170.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC--------cCCceeEEEEEe---
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR--------HRNLLQLIGLCH---  263 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g~~~---  263 (459)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.++.+++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999999643 334567889999999995        788999999987   


Q ss_pred             -eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCC----
Q 041624          264 -DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDF----  337 (459)
Q Consensus       264 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~----  337 (459)
                       .....++||||+ +++|.+.+.....  ..+++..++.++.||+.||+|||+   + +|+||||||+|||++.++    
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhh
Confidence             556899999999 5566666654432  269999999999999999999999   7 999999999999999775    


Q ss_pred             ---------------------------------------------CEEEeecCCcccccCCCCCccccccccccccccce
Q 041624          338 ---------------------------------------------NVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY  372 (459)
Q Consensus       338 ---------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~  372 (459)
                                                                   .+||+|||+++.....    .....||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         7999999999876532    344578999999999


Q ss_pred             eccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       373 ~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +.+..  ++.++|+|++|+++++|+++..|+...
T Consensus       265 ~~~~~--~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          265 LIGSG--YNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             HHTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             hcCCC--CCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            98654  577889999999999999999888643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-35  Score=290.63  Aligned_cols=220  Identities=24%  Similarity=0.285  Sum_probs=185.2

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc------chHHHHHHHHHHhccC--cCCceeEEE
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH------GKNEYITEVKTCSQLR--HRNLLQLIG  260 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g  260 (459)
                      ++.....++|+..+.||+|+||.||+|.+..+++.||||++......      ..+.+.+|+.++.+++  |+||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            34445667899999999999999999999988999999999764321      2356778999999996  599999999


Q ss_pred             EEeeCCeEEEEEEecCC-CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-CCCC
Q 041624          261 LCHDRGEFMLVYEFMPN-GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TDFN  338 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~  338 (459)
                      ++...+..++|||++.+ ++|.+++....    .+++..++.++.||+.||+|||+   .+|+||||||+|||++ .++.
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence            99999999999999976 89999987653    58999999999999999999999   9999999999999999 7889


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------  398 (459)
                      +||+|||+++.....   ......||+.|+|||++.+... .+...|+|++|++++++++                    
T Consensus       189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  264 (320)
T 3a99_A          189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ  264 (320)
T ss_dssp             EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSS
T ss_pred             EEEeeCccccccccc---cccCCCCCccCCChHHhccCCC-CCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccc
Confidence            999999999876532   2344678999999999876542 3566799999999998775                    


Q ss_pred             ------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                  |+.++|.+||++.++++.-..
T Consensus       265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence                        777789999999999886443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.5e-35  Score=290.81  Aligned_cols=191  Identities=24%  Similarity=0.309  Sum_probs=163.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-----------cCCceeEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-----------HRNLLQLIGLCH  263 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~  263 (459)
                      .++|...+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999999988999999999643 234567889999999886           899999999988


Q ss_pred             eCC----eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeec----
Q 041624          264 DRG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPD----  334 (459)
Q Consensus       264 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~----  334 (459)
                      ..+    ..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+   + +|+||||||+|||++    
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence            654    789999999 8899999876433  259999999999999999999999   7 999999999999994    


Q ss_pred             --CCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          335 --TDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       335 --~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                        ..+.+||+|||+++.....    .....||+.|+|||++.+..  ++.+.|+|++|++++++++
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~  230 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELIT  230 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC--CCchHhHHHHHHHHHHHHh
Confidence              4458999999999876532    33457899999999998654  5778899999999987764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-34  Score=283.49  Aligned_cols=196  Identities=26%  Similarity=0.362  Sum_probs=164.9

Q ss_pred             HHhcCCCCCceeccCCceEEEEEEEc-CCCcEEEEEEeccCC--ccchHHHHHHHHHHhcc---CcCCceeEEEEEe---
Q 041624          193 SATNNFSNERKLGQGGFGAVYRGILI-DLNMAVAVKKISRGL--KHGKNEYITEVKTCSQL---RHRNLLQLIGLCH---  263 (459)
Q Consensus       193 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~---  263 (459)
                      .+.++|+..+.||+|+||.||+|.+. .+++.||+|+++...  ......+.+|+.++.++   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45688999999999999999999995 568999999986542  22344677888877776   8999999999987   


Q ss_pred             --eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEE
Q 041624          264 --DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKL  341 (459)
Q Consensus       264 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  341 (459)
                        .....++||||++ |+|.+++.....  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence              5567899999997 699999876543  258999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          342 GDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       342 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +|||+++.....  .......||..|+|||.+.+..  ++...|+|++|++++++++
T Consensus       162 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~  214 (326)
T 1blx_A          162 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFR  214 (326)
T ss_dssp             CSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHH
T ss_pred             ecCcccccccCC--CCccccccccceeCHHHHhcCC--CCcchhHHHHHHHHHHHHc
Confidence            999999866432  2234567899999999997654  5778899999999988764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-34  Score=283.78  Aligned_cols=199  Identities=22%  Similarity=0.253  Sum_probs=171.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEE-cCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC------ceeEEEEEeeCCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGIL-IDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN------LLQLIGLCHDRGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~  267 (459)
                      .++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.++..++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46889999999999999999998 557899999999643 334567889999999997765      9999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC------------
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT------------  335 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~------------  335 (459)
                      .++||||+ +++|.+++.....  .++++..+..++.||+.||+|||+   ++|+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8899999876543  268999999999999999999999   99999999999999987            


Q ss_pred             -------CCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          336 -------DFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       336 -------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                             ++.+||+|||+++.....    .....||+.|+|||++.+..  ++...|+|++|+++++++++..|++..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG--WSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC--CCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                   668999999999865432    34567899999999998653  577889999999999998887777654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=286.18  Aligned_cols=191  Identities=27%  Similarity=0.356  Sum_probs=160.9

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCCe-----
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE-----  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  267 (459)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.++.+++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4678889999999999999999999999999999976432  235678899999999999999999999987654     


Q ss_pred             -EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          268 -FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       268 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                       .++||||++ ++|.+++..      .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 688877732      48999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      ++.....    .....||+.|+|||++.+.. .++...|+|++|+++++++++.
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~  221 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWM-HYNQTVDIWSVGCIMAEMLTGK  221 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCS-CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcC-CCCchhhHHHHHHHHHHHHhCC
Confidence            9865432    34567899999999987533 3678899999999999887643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.3e-35  Score=293.65  Aligned_cols=194  Identities=24%  Similarity=0.313  Sum_probs=156.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC------eE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------EF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  268 (459)
                      ..+|...+.||+|+||.||+|.+..++. +|+|++.....    ...+|+++++.++|+||+++++++...+      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3568889999999999999999987555 89988864322    2236999999999999999999996544      37


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec-CCCCEEEeecCCc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD-TDFNVKLGDFGLA  347 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla  347 (459)
                      ++||||++++.+ ..+.........+++..+..++.||+.||+|||+   ++|+||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            899999987544 3333221122369999999999999999999999   9999999999999999 7999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      +.....  .......||+.|+|||++.+.. .++...|+||+|+++++|+++.
T Consensus       190 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~  239 (394)
T 4e7w_A          190 KILIAG--EPNVSYICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ  239 (394)
T ss_dssp             EECCTT--CCCCSSCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCC--CCCcccccCcCccCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCC
Confidence            876443  2234567899999999987543 3678899999999999887644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.7e-35  Score=284.96  Aligned_cols=225  Identities=19%  Similarity=0.263  Sum_probs=174.5

Q ss_pred             CcccCHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccC--cCCceeE
Q 041624          183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLR--HRNLLQL  258 (459)
Q Consensus       183 ~~~~~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l  258 (459)
                      .+.+.+..+....++|++.+.||+|+||.||+|.+.. ++.||+|++....  ....+.+.+|+.++.+++  |+||+++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            3445566666677889999999999999999999865 8899999997543  234578899999999997  5999999


Q ss_pred             EEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          259 IGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       259 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      ++++.+.+..++||| +.+++|.+++....    .+++..++.++.||+.||.|||+   .+|+||||||+|||+++ +.
T Consensus        94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           94 YDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TE
T ss_pred             EEEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-Ce
Confidence            999999999999999 56889999997654    58999999999999999999999   99999999999999975 89


Q ss_pred             EEEeecCCcccccCCCCC-ccccccccccccccceeccC---------ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTG---------RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP  408 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~---------~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP  408 (459)
                      +||+|||+++........ ......||+.|+|||.+.+.         ...++.+.|+|++|+++++++++..|+.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            999999999876543221 12345789999999998752         12356678999999999999987777665544


Q ss_pred             CHHHHHHHH
Q 041624          409 SIRQAIQVL  417 (459)
Q Consensus       409 s~~~v~~~L  417 (459)
                      ....+.+.+
T Consensus       245 ~~~~~~~~~  253 (313)
T 3cek_A          245 QISKLHAII  253 (313)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            444443333

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-34  Score=283.94  Aligned_cols=205  Identities=25%  Similarity=0.300  Sum_probs=150.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-cchHHHHHHHH-HHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-HGKNEYITEVK-TCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      .++|+..+.||+|+||.||+|.+..+++.||||+++.... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            4678889999999999999999998899999999976532 33455666666 677789999999999999999999999


Q ss_pred             EecCCCCcchhcccc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          273 EFMPNGSLDFHLFSK-KSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       273 E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||+++ +|.+++... ......+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 887777531 1112369999999999999999999998   7 9999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccceeccC--ccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTG--RARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      ...  .......||+.|+|||++...  ...++.+.|+|++|+++++++++..|++.
T Consensus       177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            533  222344789999999998421  12357788999999999999987666554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-34  Score=294.29  Aligned_cols=201  Identities=23%  Similarity=0.269  Sum_probs=166.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC------CeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------GEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~  269 (459)
                      .+|...+.||+|+||.||+|.+..+++.||||++....    +.+.+|++++++++|+||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46788899999999999999999889999999986532    2334799999999999999999998542      2367


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecCCcc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLAL  348 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~  348 (459)
                      +||||+++ +|.+.+.........+++..++.++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 6666655322223469999999999999999999998   999999999999999965 568999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .+...  .......||+.|+|||++.+.. .++...|+|++|+++++|+++..|++...
T Consensus       206 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~  261 (420)
T 1j1b_A          206 QLVRG--EPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDS  261 (420)
T ss_dssp             ECCTT--CCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hcccC--CCceeeeeCCCcCCHHHHcCCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            76543  2234467899999999987543 36788999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-34  Score=283.58  Aligned_cols=191  Identities=20%  Similarity=0.266  Sum_probs=140.7

Q ss_pred             HhcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeE
Q 041624          194 ATNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEF  268 (459)
Q Consensus       194 ~~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~  268 (459)
                      ..++|.+. +.||+|+||.||+|.+..+++.||||++...    .....+....+..++|+||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            45788885 4699999999999999999999999998643    1222222334556699999999999876    4568


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeecC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFG  345 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFG  345 (459)
                      ++||||+++|+|.+++.....  ..+++.+++.++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            999999999999999976543  369999999999999999999999   89999999999999986   4559999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +++.....   ......||+.|+|||++....  ++.+.|+|++|++++++++
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~  224 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLC  224 (336)
T ss_dssp             TCEEC-------------------------CH--HHHHHHHHHHHHHHHHHHH
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCC--CCchhhHHHHHHHHHHHHH
Confidence            99865432   234567899999999997554  5678899999999998875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.6e-34  Score=282.41  Aligned_cols=198  Identities=19%  Similarity=0.249  Sum_probs=167.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC-cEEEEEEeccCCccchHHHHHHHHHHhccCcCC------ceeEEEEEeeCCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN-MAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN------LLQLIGLCHDRGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~  267 (459)
                      .++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|+.++.+++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999998766 78999999643 344567889999999998776      9999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee--------------
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP--------------  333 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl--------------  333 (459)
                      .++||||+ +++|.+++.....  ..+++.+++.++.||+.||+|||+   ++|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 6677777765432  269999999999999999999998   999999999999999              


Q ss_pred             -----cCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          334 -----DTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       334 -----~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                           +.++.+||+|||+++.....    .....||+.|+|||++.+..  ++...|+|++|+++++++++..|+..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG--WAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC--CCCccchHHHHHHHHHHHhCCCCCCC
Confidence                 66789999999999865432    34567999999999998654  57788999999999988776655543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.3e-34  Score=288.36  Aligned_cols=209  Identities=20%  Similarity=0.210  Sum_probs=175.9

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cC-----CceeEEE
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HR-----NLLQLIG  260 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g  260 (459)
                      ..++.....++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+++..|+.++..++ |+     +|+++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3344445678999999999999999999999998999999999743 234567788999888885 44     4999999


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec--CCCC
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD--TDFN  338 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~  338 (459)
                      ++...+..++||||++ |+|.+++.....  ..+++..+..++.||+.||.|||+. +.+|+||||||+|||++  .++.
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence            9999999999999996 599999876542  2589999999999999999999941 27899999999999995  5788


Q ss_pred             EEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          339 VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      +||+|||+++.....    .....||+.|+|||++.+..  ++.+.|+|++|+++++++++..|+...
T Consensus       200 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMP--YDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEeccCceecccc----cccccCCccccChHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999876432    34567899999999998664  678899999999999999999998865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.4e-34  Score=280.71  Aligned_cols=213  Identities=23%  Similarity=0.308  Sum_probs=180.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccc-----------------hHHHHHHHHHHhccCcCCcee
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-----------------KNEYITEVKTCSQLRHRNLLQ  257 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~  257 (459)
                      .++|...+.||+|+||.||+|.+  +++.||+|++.......                 .+.+.+|+.++.+++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            47899999999999999999999  58999999986542111                 178999999999999999999


Q ss_pred             EEEEEeeCCeEEEEEEecCCCCcchh------ccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCe
Q 041624          258 LIGLCHDRGEFMLVYEFMPNGSLDFH------LFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNI  331 (459)
Q Consensus       258 l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NI  331 (459)
                      +++++.+.+..++||||+++|+|.++      +....  ...+++..++.++.||+.||.|||+  .++|+||||||+||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence            99999999999999999999999998      54321  2479999999999999999999996  37999999999999


Q ss_pred             eecCCCCEEEeecCCcccccCCCCCccccccccccccccceeccCccccCC-CCCHHHHHHHHHHHHhcCCCCCCCCCCH
Q 041624          332 MPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDV-NFDEQQTDCLMIVGLWCAHPDRNCRPSI  410 (459)
Q Consensus       332 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~-~~D~~~~g~ll~~~l~c~~p~p~~RPs~  410 (459)
                      |++.++.+||+|||+++.....   ......||..|+|||.+.+... +.. ..|+|++|+++++++++..|+...... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESS-YNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCC-EEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCC-CCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            9999999999999999876432   3445678999999999986532 334 789999999999999999999876554 


Q ss_pred             HHHHHHHh
Q 041624          411 RQAIQVLN  418 (459)
Q Consensus       411 ~~v~~~L~  418 (459)
                      .++.+.+.
T Consensus       259 ~~~~~~i~  266 (348)
T 2pml_X          259 VELFNNIR  266 (348)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            44444443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-34  Score=307.18  Aligned_cols=206  Identities=22%  Similarity=0.265  Sum_probs=173.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcC-CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCe-----
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILID-LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGE-----  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----  267 (459)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999975 68999999986543 2345678999999999999999999999987665     


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .||||||+++++|.+++..      .+++.+++.|+.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence            7999999999999887643      58999999999999999999999   999999999999999986 9999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH------------------------------
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL------------------------------  397 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l------------------------------  397 (459)
                      +.....     ....||+.|+|||++.++   .+..+|+|++|+++++++                              
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~l  300 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRL  300 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHH
T ss_pred             hhcccC-----CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHH
Confidence            876532     446799999999998764   266789999999998765                              


Q ss_pred             --hcCCCCCCCCCC-HHHHHHHHh
Q 041624          398 --WCAHPDRNCRPS-IRQAIQVLN  418 (459)
Q Consensus       398 --~c~~p~p~~RPs-~~~v~~~L~  418 (459)
                        .|+.++|.+||+ +.++.+.|.
T Consensus       301 i~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          301 LRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HhhhccCChhhCCCHHHHHHHHHH
Confidence              388899999995 455555443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-34  Score=291.69  Aligned_cols=212  Identities=24%  Similarity=0.268  Sum_probs=166.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ...+|...++||+|+||.||.... .+++.||||++....   ...+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            445688889999999999664333 348999999996532   23466899999999 8999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-----CCCEEEeecCCc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-----DFNVKLGDFGLA  347 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kL~DFGla  347 (459)
                      |||. |+|.+++.....   .+.+..++.++.||+.||+|||+   .+|+||||||+|||++.     ...+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 699999976543   35555678999999999999999   99999999999999953     346889999999


Q ss_pred             ccccCCCC--CccccccccccccccceeccC-ccccCCCCCHHHHHHHHHHHHh--------------------------
Q 041624          348 LLVDHELG--PRTTGLAGTLGYMAPEYISTG-RARLDVNFDEQQTDCLMIVGLW--------------------------  398 (459)
Q Consensus       348 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~~~~~D~~~~g~ll~~~l~--------------------------  398 (459)
                      +.......  .......||+.|+|||++... ...++.++|+|++|++++++++                          
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            87754321  223456799999999998742 2235667899999999988775                          


Q ss_pred             ----------------cCCCCCCCCCCHHHHHHH
Q 041624          399 ----------------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 ----------------c~~p~p~~RPs~~~v~~~  416 (459)
                                      |+.++|.+||++.++++.
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                            667789999999998853

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.9e-34  Score=293.66  Aligned_cols=193  Identities=23%  Similarity=0.266  Sum_probs=148.6

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEEEEecC
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMP  276 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~  276 (459)
                      |...+.||+|+||+||.+... +|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++|||||.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            445688999999999876444 5899999998643   345678999999887 89999999999999999999999995


Q ss_pred             CCCcchhccccCCCCCC---CCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-------------CCEE
Q 041624          277 NGSLDFHLFSKKSTGTP---LTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-------------FNVK  340 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~k  340 (459)
                       |+|.+++.........   .++..++.++.||+.||+|||+   ++|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765432111   2344567899999999999999   999999999999999754             4899


Q ss_pred             EeecCCcccccCCCCC---ccccccccccccccceeccC-----ccccCCCCCHHHHHHHHHHHHh
Q 041624          341 LGDFGLALLVDHELGP---RTTGLAGTLGYMAPEYISTG-----RARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       341 L~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-----~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+|||+++.+......   ......||+.|+|||++.+.     ...++.++|+||+|++++++++
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence            9999999887643222   12356799999999999752     2346788999999999998886

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-33  Score=272.24  Aligned_cols=219  Identities=24%  Similarity=0.322  Sum_probs=161.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-c-hHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-G-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++...... . .+.+.++..++..++|+||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            357788899999999999999999988999999999765322 2 23344555677888999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKR-CVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |||+ ++.+..+......   .+++..+..++.||+.||.|||+   + +|+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~e~~-~~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 4455544433222   69999999999999999999998   5 9999999999999999999999999999766


Q ss_pred             cCCCCCccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      ...  .......||+.|+|||++...   ...++.+.|+|++|+++++++++..|+.........+.+.+....
T Consensus       176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (318)
T 2dyl_A          176 VDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred             cCC--ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence            432  223345789999999998632   223567889999999999999999998876555555555555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.98  E-value=2.1e-32  Score=264.39  Aligned_cols=185  Identities=15%  Similarity=0.049  Sum_probs=156.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|.+..+++.||||++......   ..+.+.+|+.++.+++|+||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            6799999999999999999999998999999999765332   3467999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+++++|.+++...      ....++.+|+.||+.||+|||+   ++|+||||||+|||++.++.+||++++..     
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~~-----  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATM-----  176 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCCC-----
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecccc-----
Confidence            999999999998431      3556788999999999999999   99999999999999999999999866533     


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHH-----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGL-----------------------------------  397 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l-----------------------------------  397 (459)
                                      +|         ++...|+|++|+++++++                                   
T Consensus       177 ----------------~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          177 ----------------PD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             ----------------TT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred             ----------------CC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence                            21         233445666666555555                                   


Q ss_pred             ----------hcCCCCCCCCCCHHHHHHHHhcC
Q 041624          398 ----------WCAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       398 ----------~c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                .|+..+|.+| |+.++++.|+..
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence                      4778899999 999999999854

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=5.5e-34  Score=281.47  Aligned_cols=190  Identities=20%  Similarity=0.194  Sum_probs=155.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--------ccchHHHHHHHHHHhccC---------cCCcee
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--------KHGKNEYITEVKTCSQLR---------HRNLLQ  257 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~  257 (459)
                      .++|+..+.||+|+||.||+|++  +++.||||+++...        ....+.+.+|+.++++++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46788899999999999999998  47999999997653        223477899999998885         888888


Q ss_pred             EEEEEe------------------------------eCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHH
Q 041624          258 LIGLCH------------------------------DRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA  307 (459)
Q Consensus       258 l~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia  307 (459)
                      +.+.+.                              +.+..+|||||+++|++.+.+..     ..+++.+++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            888753                              26789999999999977666643     2589999999999999


Q ss_pred             HHHHHhh-hccCCCeeecCCCCCCeeecCCC--------------------CEEEeecCCcccccCCCCCcccccccccc
Q 041624          308 SALLYLH-EEWKRCVVHRDIKFSNIMPDTDF--------------------NVKLGDFGLALLVDHELGPRTTGLAGTLG  366 (459)
Q Consensus       308 ~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~  366 (459)
                      .||+||| +   ++|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.
T Consensus       172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 8   8999999999999999887                    8999999999876532      3479999


Q ss_pred             ccccceeccCccccCCCCCHHHHHHH-HHHHHhcCCCC
Q 041624          367 YMAPEYISTGRARLDVNFDEQQTDCL-MIVGLWCAHPD  403 (459)
Q Consensus       367 y~APE~~~~~~~~~~~~~D~~~~g~l-l~~~l~c~~p~  403 (459)
                      |+|||++.+..   +..+|+|+++.. .+.++.+..|+
T Consensus       243 y~aPE~~~g~~---~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          243 SMDEDLFTGDG---DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             TTCSGGGCCCS---SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             ccChhhhcCCC---ccceehhhhhCCCCcccccccCCC
Confidence            99999998543   567899998665 44444344433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1.1e-31  Score=260.60  Aligned_cols=188  Identities=20%  Similarity=0.270  Sum_probs=157.2

Q ss_pred             HhcCCCCC-ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHH-hccCcCCceeEEEEEee----CCe
Q 041624          194 ATNNFSNE-RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTC-SQLRHRNLLQLIGLCHD----RGE  267 (459)
Q Consensus       194 ~~~~f~~~-~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~  267 (459)
                      ..++|... +.||+|+||.||+|.+..+++.||+|+++.     ...+.+|+.++ ..++|+||+++++++..    .+.
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34567766 789999999999999999999999999853     34677888888 55599999999999887    678


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeec
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDF  344 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DF  344 (459)
                      .++||||+++|+|.+++.....  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8999999999999999976543  369999999999999999999999   99999999999999998   789999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh--------------------------
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW--------------------------  398 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~--------------------------  398 (459)
                      |+++.....                         .++...|+|++|++++++++                          
T Consensus       165 g~a~~~~~~-------------------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  219 (299)
T 3m2w_A          165 GFAKETTGE-------------------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  219 (299)
T ss_dssp             TTCEECTTC-------------------------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred             ccccccccc-------------------------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence            999754321                         13445677777777776654                          


Q ss_pred             --------------------cCCCCCCCCCCHHHHHHH
Q 041624          399 --------------------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 --------------------c~~p~p~~RPs~~~v~~~  416 (459)
                                          |+.++|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                                777788888888888874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.1e-32  Score=278.05  Aligned_cols=212  Identities=18%  Similarity=0.124  Sum_probs=162.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCc-CCc----------ee--
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRH-RNL----------LQ--  257 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nI----------v~--  257 (459)
                      .+.+|...++||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.++..++| +|.          +.  
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            44567778899999999999999999999999999874422   336789999999999977 221          11  


Q ss_pred             ---------EEEEEee-----CCeEEEEEEecCCCCcchhcccc---CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 041624          258 ---------LIGLCHD-----RGEFMLVYEFMPNGSLDFHLFSK---KSTGTPLTWTTRYKISLGLASALLYLHEEWKRC  320 (459)
Q Consensus       258 ---------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  320 (459)
                               +..++..     ....+++|+++ +++|.+++...   ......+++..++.++.||+.||+|||+   ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence                     1111111     22457777766 68999888421   1222368899999999999999999999   99


Q ss_pred             eeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCccccccccccccccceecc--------CccccCCCCCHHHHHHH
Q 041624          321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST--------GRARLDVNFDEQQTDCL  392 (459)
Q Consensus       321 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~~~~D~~~~g~l  392 (459)
                      |+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++..        ....++.+.|+|++|++
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999999865432    445677 99999999842        12235678899999999


Q ss_pred             HHHHHh----------------------------------cCCCCCCCCCCHHHHH
Q 041624          393 MIVGLW----------------------------------CAHPDRNCRPSIRQAI  414 (459)
Q Consensus       393 l~~~l~----------------------------------c~~p~p~~RPs~~~v~  414 (459)
                      ++++++                                  |+.++|.+||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999886                                  7788999999976664

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=99.97  E-value=5e-32  Score=252.87  Aligned_cols=123  Identities=38%  Similarity=0.663  Sum_probs=107.4

Q ss_pred             CCCCCCCCCCccccccCCCCCC-CCCCEEEEEeeCC---CCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEE
Q 041624            2 FQIPSNSPGGFLGLFNSTTAKL-SSSPIVLVEFDSF---SNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHV   77 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVefdt~---~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~   77 (459)
                      +.+|.+++||||||||.+++++ +.||+|||||||+   +|.+|||++  |||||||||+.|+++++|+  +.+|+.++|
T Consensus       106 ~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~Dp~~--nHVGIdvNsi~S~~s~~~~--l~~G~~~~v  181 (261)
T 3zyr_A          106 TTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNY--QHIGIDVNSIRSSKVVRWE--RREGKTLNV  181 (261)
T ss_dssp             CCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTTSCSS--CEEEEEESSSSCSEEEECC--CCTTCCEEE
T ss_pred             CCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCCCCCC--CeEEEEcCCCCcccccccc--ccCCceEEE
Confidence            3468889999999999877643 4689999999999   998899998  9999999999999999995  569999999


Q ss_pred             EEEecCCcceEEEEEeeCCCCCcCC----------------CCcCCCCceecceecccccccccccc
Q 041624           78 KIKYNSATKNLSASWSYGETPKYSQ----------------ENTTSTGRYTERHVLKSWEFNSTLDI  128 (459)
Q Consensus        78 ~i~y~~~~~~l~v~~~~~~~~~~~~----------------~fsastG~~~~~h~i~swsfss~~~~  128 (459)
                      ||+||+.+++|+|++.+.+.+.+..                ||||+||...+.|+|++|+|++++..
T Consensus       182 ~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~l~~  248 (261)
T 3zyr_A          182 LVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFTSTLLY  248 (261)
T ss_dssp             EEEEETTTTEEEEEEECTTCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEECC
T ss_pred             EEEEcCCCCEEEEEEEcCCCCCeEEEEEechHHhCcCcEEEEEEecCCCccceEEEEEEEEEEEcCC
Confidence            9999999999999999865432211                59999999999999999999988754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=7.2e-32  Score=285.95  Aligned_cols=203  Identities=26%  Similarity=0.330  Sum_probs=173.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEee------CCe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD------RGE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~  267 (459)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|++++.+++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999988999999998764 23446679999999999999999999999765      677


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC---EEEeec
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN---VKLGDF  344 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~DF  344 (459)
                      .++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999976432 2358899999999999999999999   99999999999999997765   999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      |+++.....  .......||+.|+|||.+.+..  ++...|+|++|+++++++++..|+..
T Consensus       169 G~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          169 GYAKELDQG--ELCTEFVGTLQYLAPELLEQKK--YTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSC--CSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccc--cccccccCCcccCChHHhccCC--CCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            999876543  2234568999999999997654  57788999999999999999988854

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=99.97  E-value=1.3e-31  Score=251.96  Aligned_cols=118  Identities=41%  Similarity=0.634  Sum_probs=103.9

Q ss_pred             CCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCc
Q 041624            6 SNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSAT   85 (459)
Q Consensus         6 ~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~   85 (459)
                      ++++||||||||.+++ ++++|+|||||||++|.+|||++  |||||||||+.|+++++|+  +.+|+.++|||+||+.+
T Consensus       121 p~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~Dp~~--nHVGIDvNSi~S~~t~~~~--l~~G~~~~vwI~Yd~~t  195 (281)
T 3ujo_A          121 PKDKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGWDPTE--RHIGIDVNSIKSIKTTSWD--FANGENAEVLITYDSST  195 (281)
T ss_dssp             CCCCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSSCCSS--SEEEEEESSSCCSCEEECC--CCSSCCEEEEEEECTTT
T ss_pred             CCCCcceeeeccccCC-CccCcEEEEEEeccccccCCCCC--CeEEEEcCCCCcccccccc--ccCCCEEEEEEEEeCCC
Confidence            3478999999998766 77899999999999998899998  9999999999999999995  66999999999999999


Q ss_pred             ceEEEEEeeCCCCCcCC-----------------CCcCCCCc---eecceecccccccccccc
Q 041624           86 KNLSASWSYGETPKYSQ-----------------ENTTSTGR---YTERHVLKSWEFNSTLDI  128 (459)
Q Consensus        86 ~~l~v~~~~~~~~~~~~-----------------~fsastG~---~~~~h~i~swsfss~~~~  128 (459)
                      ++|+|++.+...++...                 ||||+||.   ..+.|++++|+|++++..
T Consensus       196 k~L~V~l~~~~~~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~IlsWSFss~l~~  258 (281)
T 3ujo_A          196 NLLVASLVHPSQKTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSFASKLSI  258 (281)
T ss_dssp             CEEEEEEECTTTCCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEEEEEEEEECS
T ss_pred             CEEEEEEecCCCCCCceEEEEechHHhccCcEEEEEEeecCCCCcccceeEEEEEEEEEEcCC
Confidence            99999999876432111                 59999996   589999999999988754

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=99.97  E-value=1.5e-31  Score=248.88  Aligned_cols=117  Identities=38%  Similarity=0.568  Sum_probs=103.6

Q ss_pred             CCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCc
Q 041624            7 NSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSAT   85 (459)
Q Consensus         7 ~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~   85 (459)
                      .+.||||||||.+++ ++++|+|||||||++|.+| ||++  |||||||||+.|+++++|+  +.+|+.++|||+||+.+
T Consensus       102 ~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~--nHVGIdvNsi~S~~t~~~~--l~~G~~~~v~I~Yd~~t  176 (251)
T 3ipv_A          102 DSGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPY--THIGFDVNSISSIKTVKWS--LANGEAAKVLITYNSAV  176 (251)
T ss_dssp             CCCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEETTT
T ss_pred             CCCCceeeeccccCC-CccCcEEEEEEecccccccCCCCC--CeEEEEcCCCcccccceeE--ecCCCEEEEEEEEeCCC
Confidence            368999999998766 6789999999999999889 9998  9999999999999999985  77999999999999999


Q ss_pred             ceEEEEEeeCCCCCcCC-----------------CCcCCCCce---ecceecccccccccccc
Q 041624           86 KNLSASWSYGETPKYSQ-----------------ENTTSTGRY---TERHVLKSWEFNSTLDI  128 (459)
Q Consensus        86 ~~l~v~~~~~~~~~~~~-----------------~fsastG~~---~~~h~i~swsfss~~~~  128 (459)
                      ++|+|+|.+...+....                 ||||+||..   .+.|+|++|+|++++..
T Consensus       177 k~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF~s~l~~  239 (251)
T 3ipv_A          177 KLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFASKLAG  239 (251)
T ss_dssp             TEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEECC
T ss_pred             CEEEEEEecCCCCccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEEEEECCC
Confidence            99999999876532111                 599999998   89999999999988654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9.7e-32  Score=283.30  Aligned_cols=208  Identities=17%  Similarity=0.082  Sum_probs=144.7

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeccCC----------ccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          203 KLGQGGFGAVYRGILIDLNMAVAVKKISRGL----------KHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       203 ~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..+.|++|.+..++..-.|+.+|+|.+....          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3556777777766666668999999997542          12345799999999999 799999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||++|++|.++|....    +++..   +|+.||+.||+|||+   +|||||||||+||||+.++.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999997653    46654   588999999999999   999999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------cCCCCCCCCCCHHHHHHHHhcCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------CAHPDRNCRPSIRQAIQVLNFETKMP  424 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------c~~p~p~~RPs~~~v~~~L~~~~~~p  424 (459)
                      .. .......+||+.|||||++.+.   .....|+|++|++.+.+..       .....|..++++..+.+.+....+.|
T Consensus       391 ~~-~~~~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~  466 (569)
T 4azs_A          391 QD-CSWPTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWSNWLYAVWQEPVERWNFVLLLALFEKKAKLP  466 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC--------------------CCCCTTHHHHHHHHHTSCGGGCSHHHHHHHHHTGGGSC
T ss_pred             CC-CccccCceechhhccHHHhCCC---CCCcccccccccchhhhccccchhHHHhhcCCCCCCcHHHHHHHHhCCCCCC
Confidence            43 2334567899999999999753   3456799999886653321       12234556677888777776544443

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=99.97  E-value=6.8e-31  Score=244.04  Aligned_cols=118  Identities=37%  Similarity=0.578  Sum_probs=104.2

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCC---CCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEE
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSN---PEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKI   79 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~---~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i   79 (459)
                      ++|.++.||||||||.++ +++++|+|||||||++|   .+|||++  |||||||||+.|+++++|+  |.+|+.++|||
T Consensus        99 ~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~g~~~~v~I  173 (239)
T 1dbn_A           99 QIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNY--RHIGIDVNGIESIKTVQWD--WINGGVAFATI  173 (239)
T ss_dssp             CCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSS--CEEEEEESSSSCSEEEECC--CCTTCCEEEEE
T ss_pred             CCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccccCCCC--CcEEEecCCccccceEccc--ccCCCEEEEEE
Confidence            478889999999999764 46789999999999999   7899998  9999999999999999985  88999999999


Q ss_pred             EecCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCce--ecceeccccccccc
Q 041624           80 KYNSATKNLSASWSYGETPKYSQ-----------------ENTTSTGRY--TERHVLKSWEFNST  125 (459)
Q Consensus        80 ~y~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~~--~~~h~i~swsfss~  125 (459)
                      +||+.+++|+|+|.+...+....                 ||||+||..  .+.|+|++|+|+++
T Consensus       174 ~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~  238 (239)
T 1dbn_A          174 TYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             EEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             EEeCCCcEEEEEEccCCCCCcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEEeEec
Confidence            99999999999999865432110                 699999998  99999999999864

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=99.96  E-value=6.9e-31  Score=243.46  Aligned_cols=117  Identities=38%  Similarity=0.581  Sum_probs=101.2

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.||||||||.++ +++++|+|||||||++|.+|||++  |||||||||+.|+++++|+  |.+|+.++|||+||+.
T Consensus        99 ~~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~Dp~~--nHVGIdvNsi~S~~~~~~~--l~~G~~~~v~I~Yd~~  173 (237)
T 1fny_A           99 QPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKG--RHLGINVNSIESIKTVPWN--WTNGEVANVFISYEAS  173 (237)
T ss_dssp             CCCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSS--SEEEEEESSSSCSEEEECC--CCTTCCEEEEEEEEGG
T ss_pred             CCCCCCCcccccccCC-CCccccEEEEEeecccCcccCCCC--CceEEecCCcccccccccc--ccCCCEEEEEEEEeCC
Confidence            4558999999999764 477899999999999998899998  9999999999999999984  8899999999999999


Q ss_pred             cceEEEEEeeCCCCCcCC-----------------CCcCCCCce---ecceecccccccccc
Q 041624           85 TKNLSASWSYGETPKYSQ-----------------ENTTSTGRY---TERHVLKSWEFNSTL  126 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~~-----------------~fsastG~~---~~~h~i~swsfss~~  126 (459)
                      +++|+|+|.+...+....                 ||||+||..   .+.|+|++|+|++++
T Consensus       174 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~l  235 (237)
T 1fny_A          174 TKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             GTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             CcEEEEEEecCCCCCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEec
Confidence            999999999865432110                 699999998   999999999998764

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=99.96  E-value=5.9e-30  Score=237.92  Aligned_cols=117  Identities=38%  Similarity=0.596  Sum_probs=102.3

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCC--CCCCCCCCceeEecCCceeeeeeecccCCCCC--ceEEEEEE
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPE--WDPINVKDDVGINNSSIVSSVYTRWNASFHSG--DTAHVKIK   80 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~--~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g--~~~~~~i~   80 (459)
                      ++++.||||||||.++ +++++|+|||||||++|.+  |||++  |||||||||+.|.++++|+  +.+|  +.++|||+
T Consensus        99 ~~~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~G~~~~~~v~I~  173 (242)
T 1fx5_A           99 PLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGF--PHIGIDVNCVKSINAERWN--KRYGLNNVANVEII  173 (242)
T ss_dssp             CCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSS--CEEEEEESSSSCSEEEECC--CCCSGGGCEEEEEE
T ss_pred             CCCCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCC--CeEEEecCCccccceeccc--ccCCCceeEEEEEE
Confidence            4558999999999764 4778999999999999988  89998  9999999999999999984  7899  99999999


Q ss_pred             ecCCcceEEEEEeeCCCCCcC-----------------CCCcCCC--Cceecceeccccccccccc
Q 041624           81 YNSATKNLSASWSYGETPKYS-----------------QENTTST--GRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        81 y~~~~~~l~v~~~~~~~~~~~-----------------~~fsast--G~~~~~h~i~swsfss~~~  127 (459)
                      ||+.+++|+|+|.+...+...                 +||||+|  |.. +.|+|++|+|++++.
T Consensus       174 Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l~  238 (242)
T 1fx5_A          174 YEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWYFTSTFI  238 (242)
T ss_dssp             EETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEEEEEESS
T ss_pred             EeCCCCEEEEEEecCCCCccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEEeEeecc
Confidence            999999999999986543211                 0599999  998 999999999988764

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=99.96  E-value=8.3e-30  Score=236.94  Aligned_cols=119  Identities=39%  Similarity=0.662  Sum_probs=104.4

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCC----CCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEE
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSF----SNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK   78 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~----~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~   78 (459)
                      ++|.++.||||||||.++ +++.+|+|||||||+    +|. |||++  |||||||||+.|.++++|+  +.+|+.++||
T Consensus        98 ~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~-~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~G~~~~v~  171 (242)
T 1qnw_A           98 QIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP-WDPDF--KHIGIDVNSIKSIKTVKWD--WRNGEVADVV  171 (242)
T ss_dssp             CCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT-TSCSS--CEEEEEESSSSCSEEEECC--CCTTCCEEEE
T ss_pred             CCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC-CCCCC--CcEEEecCCccccceeccc--ccCCCEEEEE
Confidence            578889999999999764 467899999999999    997 99998  9999999999999999984  7799999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCce--ecceeccccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYSQ-----------------ENTTSTGRY--TERHVLKSWEFNSTLD  127 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~~--~~~h~i~swsfss~~~  127 (459)
                      |+||+.+++|+|+|.+...+....                 ||||+||..  .+.|+|++|+|++++.
T Consensus       172 I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~l~  239 (242)
T 1qnw_A          172 ITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSNLE  239 (242)
T ss_dssp             EEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEEEC-
T ss_pred             EEEeCCCcEEEEEEecCCCCcceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEEeEeecC
Confidence            999999999999999865432111                 699999999  9999999999988754

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=99.96  E-value=8.5e-30  Score=238.42  Aligned_cols=118  Identities=38%  Similarity=0.575  Sum_probs=103.7

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.|+||||||.++ ++.++|+|||||||++|.+|||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.
T Consensus        97 ~~~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~Dp~~--nHVGIdvns~~S~~t~~~~--l~~g~~~~v~I~Yd~~  171 (253)
T 1g7y_A           97 EPKSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTDWDPTS--RHIGIDVNSIKSIRTASWG--LANGQNAEILITYNAA  171 (253)
T ss_dssp             CCCCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTCCSS--CEEEEEESSSSCSEEEECC--CCTTSEEEEEEEEETT
T ss_pred             CCCCCCCcccccccCC-CCccCceEEEEecceeccCcCCCC--CcEeeccCCccccceeccc--cCCCCeEEEEEEEeCC
Confidence            4568899999999764 467899999999999998899998  9999999999999999995  7899999999999999


Q ss_pred             cceEEEEEeeCCCCCcCC-----------------CCcCCCCce---ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPKYSQ-----------------ENTTSTGRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~~-----------------~fsastG~~---~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+...+....                 ||||+||..   .+.|+|++|+|++++.
T Consensus       172 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l~  234 (253)
T 1g7y_A          172 TSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKLP  234 (253)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEEC
T ss_pred             CCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEEeeCC
Confidence            999999999875432110                 699999998   9999999999998764

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=99.96  E-value=1.4e-29  Score=235.23  Aligned_cols=116  Identities=34%  Similarity=0.560  Sum_probs=100.4

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCC-CCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWD-PINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNS   83 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d-~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~   83 (459)
                      ++++.||||||||.++ +++++|+|||||||++|. || |++  |||||||||+.|.++++|+  |.+|+.++|||+||+
T Consensus       101 ~~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~--nHVGIdvns~~S~~~~~~~--l~~G~~~~v~I~Yd~  174 (239)
T 1gzc_A          101 KPAQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQV--PHIGIDVNSIRSIKTQPFQ--LDNGQVANVVIKYDA  174 (239)
T ss_dssp             CCCCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSS--SEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEET
T ss_pred             CCCCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCC--CeEEEecCCcccccccccc--ccCCCEEEEEEEEeC
Confidence            4558999999999764 467899999999999998 95 887  9999999999999999984  889999999999999


Q ss_pred             CcceEEEEEeeCCCCCcCC-----------------CCcCCCCc---eecceecccccccccc
Q 041624           84 ATKNLSASWSYGETPKYSQ-----------------ENTTSTGR---YTERHVLKSWEFNSTL  126 (459)
Q Consensus        84 ~~~~l~v~~~~~~~~~~~~-----------------~fsastG~---~~~~h~i~swsfss~~  126 (459)
                      .+++|+|+|.+...+....                 ||||+||.   ..+.|+|++|+|++++
T Consensus       175 ~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~l  237 (239)
T 1gzc_A          175 PSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQASL  237 (239)
T ss_dssp             TTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             CCcEEEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEeEEec
Confidence            9999999999865432111                 69999997   4899999999998764

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=99.96  E-value=1.8e-29  Score=236.11  Aligned_cols=116  Identities=39%  Similarity=0.621  Sum_probs=102.4

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.||||||||.+   ++.+|+|||||||++|.+|||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.
T Consensus        98 ~~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~G~~~~v~I~Yd~~  170 (252)
T 1fat_A           98 QPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTE--RHIGIDVNSIRSIKTTRWD--FVNGENAEVLITYDSS  170 (252)
T ss_dssp             CCCCSGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSS--CEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEETT
T ss_pred             CCCCCCccccccccC---CccCcEEEEEeecccCCCCCCCC--CeEEEecCCccccceeccc--ccCCCEEEEEEEEeCC
Confidence            456889999999975   56789999999999998899998  9999999999999999985  7799999999999999


Q ss_pred             cceEEEEEeeCCCCCcCC-----------------CCcCCCCce---ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPKYSQ-----------------ENTTSTGRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~~-----------------~fsastG~~---~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+...+....                 ||||+||..   .+.|+|++|+|++++.
T Consensus       171 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l~  233 (252)
T 1fat_A          171 TNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKLS  233 (252)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEEEC
T ss_pred             CCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEEeeCC
Confidence            999999999875532110                 699999998   9999999999998764

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.96  E-value=1.4e-29  Score=211.40  Aligned_cols=99  Identities=37%  Similarity=0.604  Sum_probs=87.7

Q ss_pred             CCEEEEEeeCCCCCC-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcceEEEEEeeCCCCCcCC--
Q 041624           26 SPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQ--  102 (459)
Q Consensus        26 ~~~~aVefdt~~~~~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~--  102 (459)
                      ||+|||||||++|.+ |||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.+++|+|++.+...+.+..  
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~--nHVGIdvNsi~S~~s~~~~--l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~~~p~ls~   76 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNY--IHIGIDVNSIRSKVTAKWD--WQNGKIATAHISYNSVSKRLSVTSYYAGSKPATLSY   76 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECC--CCTTSCEEEEEEEETTTTEEEEEEECSSSCCEEEEE
T ss_pred             CCEEEEEEeCCcCccccCCCC--CeeEEecccccccceeeeE--EcCCCEEEEEEEEeCCCcEEEEEEccCCCccceEEE
Confidence            589999999999988 79998  9999999999999999985  7799999999999999999999998864422211  


Q ss_pred             --------------CCcCCCCceecceecccccccccccc
Q 041624          103 --------------ENTTSTGRYTERHVLKSWEFNSTLDI  128 (459)
Q Consensus       103 --------------~fsastG~~~~~h~i~swsfss~~~~  128 (459)
                                    ||||+||...+.|++++|+|++++..
T Consensus        77 ~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l~~  116 (133)
T 1qmo_E           77 DIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLWT  116 (133)
T ss_dssp             ECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEEEE
T ss_pred             eechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeCCC
Confidence                          69999999999999999999987643

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=99.96  E-value=1.2e-29  Score=237.96  Aligned_cols=121  Identities=36%  Similarity=0.621  Sum_probs=104.0

Q ss_pred             CCCCCCCccccccCCC-CCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecccC-CCCCceEEEEEEe
Q 041624            5 PSNSPGGFLGLFNSTT-AKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNAS-FHSGDTAHVKIKY   81 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~-~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~~-~~~g~~~~~~i~y   81 (459)
                      ++++.|+||||||.++ +++.++|+|||||||++|.+| ||++  |||||||||+.|.++++|+.. |.+|+.++|||+|
T Consensus       100 ~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~--nHVGIdvNs~~S~~s~~~~~~~l~~g~~~~v~I~Y  177 (257)
T 1hql_A          100 DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSY--RHIGINVNSIVSVATKRWEDSDIFSGKIATARISY  177 (257)
T ss_dssp             CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSS--CEEEEEESSSSCSEEEECCHHHHTSCSCEEEEEEE
T ss_pred             CCCCCCccccccccccccCCccCceEEEEecccccccccCCCC--CceeeeeCCccccceeccCcccccCCceEEEEEEE
Confidence            4568899999999765 367789999999999999999 9988  999999999999999999754 5569999999999


Q ss_pred             cCCcceEEEEEeeCCCCCcC----------------CCCcCCCC-ceecceeccccccccccc
Q 041624           82 NSATKNLSASWSYGETPKYS----------------QENTTSTG-RYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        82 ~~~~~~l~v~~~~~~~~~~~----------------~~fsastG-~~~~~h~i~swsfss~~~  127 (459)
                      |+.+++|+|+|.+.....+.                +||||+|| ...+.|+|++|+|+++++
T Consensus       178 d~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s~~~  240 (257)
T 1hql_A          178 DGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSNLQ  240 (257)
T ss_dssp             ETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEEC-
T ss_pred             eCCCCEEEEEEecCCCCceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEEeEecCC
Confidence            99999999999886431111                16999999 899999999999998765

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=99.96  E-value=2.1e-29  Score=235.46  Aligned_cols=115  Identities=38%  Similarity=0.605  Sum_probs=101.5

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.||||||||.+   ++++|+|||||||++|. |||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.
T Consensus       100 ~~~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~-~Dp~~--nHVGIdvNs~~S~~t~~~~--l~~G~~~~v~I~Yd~~  171 (253)
T 1sbf_A          100 KPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS-WDPPN--PHIGINVNSIRSIKTTSWD--LANNKVAKVLITYDAS  171 (253)
T ss_dssp             CCCCCGGGTTTCCTT---SCCCSCEEEEEECSCCT-TCCSS--SEEEEEESSSSCSEEEECC--CCTTCCEEEEEEEETT
T ss_pred             CCCCCCCccccccCC---CcccceEEEEeccccCC-CCCCC--CcEEEEcCCccccceeccc--ccCCCeeEEEEEEeCC
Confidence            445899999999965   56789999999999998 99998  9999999999999999985  7899999999999999


Q ss_pred             cceEEEEEeeCCCCCcCC-----------------CCcCCCCce--ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPKYSQ-----------------ENTTSTGRY--TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~~-----------------~fsastG~~--~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+...+....                 ||||+||..  .+.|+|++|+|++.+.
T Consensus       172 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~l~  233 (253)
T 1sbf_A          172 TSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNLP  233 (253)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEEC
T ss_pred             CcEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEeecC
Confidence            999999999875542110                 699999998  9999999999998764

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=99.96  E-value=4e-29  Score=230.95  Aligned_cols=117  Identities=38%  Similarity=0.619  Sum_probs=101.3

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCC-CCceeEecCCceeeeeeecccCCCCCceEEEEEEe
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINV-KDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKY   81 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~-~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y   81 (459)
                      ++|.++.||||||||.+   ++++|+|||||||++|. |||++. +|||||||||+.|.++++|+  +.+|+.++|||+|
T Consensus        92 ~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~-~Dp~~~~~nHVGIdvNsi~S~~~~~~~--l~~g~~~~v~I~Y  165 (234)
T 2eig_A           92 EIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV-WDPKSLRSSHIGIDVNSIMSLKAVNWN--RVSGSLEKATIIY  165 (234)
T ss_dssp             CCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT-TSCTTTCSSEEEEEESSSSCSEEEECC--CCTTCCEEEEEEE
T ss_pred             CCCcCCCCCccccccCC---CccccEEEEEeccccCc-cCCCCCCCCceEEecCCccccceeccc--ccCCCEEEEEEEE
Confidence            57888999999999865   56789999999999998 999741 18999999999999999984  7799999999999


Q ss_pred             cCCcceEEEEEeeCCCCCcCC-----------------CCcCCC--Cceecceeccccccccccc
Q 041624           82 NSATKNLSASWSYGETPKYSQ-----------------ENTTST--GRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        82 ~~~~~~l~v~~~~~~~~~~~~-----------------~fsast--G~~~~~h~i~swsfss~~~  127 (459)
                      |+.+++|+|+|.+ ..+....                 ||||+|  |.. +.|+|++|+|++++.
T Consensus       166 d~~~~~L~V~l~~-~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l~  228 (234)
T 2eig_A          166 DSDTKILTVVMTH-QNGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTLK  228 (234)
T ss_dssp             ETTTTEEEEEEEE-TTSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEECC
T ss_pred             eCCCcEEEEEEec-CCCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEecCC
Confidence            9999999999998 4432111                 599999  988 999999999988764

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=99.95  E-value=2.1e-29  Score=232.78  Aligned_cols=114  Identities=38%  Similarity=0.592  Sum_probs=100.2

Q ss_pred             CCCCCC-CCCccccccCCCCCCCCCCEEEEEeeCCCCCC-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEE
Q 041624            3 QIPSNS-PGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIK   80 (459)
Q Consensus         3 ~~~~~~-~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~   80 (459)
                      ++|.++ .||||||||.    ++++|+|||||||++|.+ |||++  |||||||||+.|.++++|+  +.+|+.++|||+
T Consensus        95 ~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~--nHVGIdvns~~S~~~~~~~--l~~G~~~~v~I~  166 (232)
T 1v6i_A           95 QIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPT--DHVGIDVNSVDSVKTVPWN--SVSGAVVKVTVI  166 (232)
T ss_dssp             CCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSS--CEEEEEEEESSCSEEEECC--CCTTCEEEEEEE
T ss_pred             CCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCC--CeEEEEcCCcccccccccc--ccCCCEEEEEEE
Confidence            578888 9999999986    457899999999999988 79998  9999999999999999995  889999999999


Q ss_pred             ecCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCc--eecceecccccccccc
Q 041624           81 YNSATKNLSASWSYGETPKYSQ-----------------ENTTSTGR--YTERHVLKSWEFNSTL  126 (459)
Q Consensus        81 y~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~--~~~~h~i~swsfss~~  126 (459)
                      ||+.+++|+|+|.+ ..+....                 ||| +||.  ..+.|+|++|+|++++
T Consensus       167 Yd~~~~~L~V~l~~-~~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~l  229 (232)
T 1v6i_A          167 YDSSTKTLSVAVTN-DNGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTSTL  229 (232)
T ss_dssp             EETTTTEEEEEEEC-TTSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred             EeCCCcEEEEEEec-CCCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEeec
Confidence            99999999999998 4332110                 599 9998  5899999999998765

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=99.95  E-value=1.5e-29  Score=235.68  Aligned_cols=118  Identities=39%  Similarity=0.643  Sum_probs=102.7

Q ss_pred             CCCCCCCccccccCCCC-CCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecccCCCC---CceEEEEE
Q 041624            5 PSNSPGGFLGLFNSTTA-KLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNASFHS---GDTAHVKI   79 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~-~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~~~~~---g~~~~~~i   79 (459)
                      ++++.|+||||||.+++ +++.+|+|||||||++|.+| ||++  |||||||||+.|.++++|+  +.+   |+.++|||
T Consensus       101 ~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~--nHvGIdvns~~S~~~~~~~--l~~~~~g~~~~v~I  176 (243)
T 1gsl_A          101 SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPY--PHIGIDVNSIVSVATTRWE--NDDAYGSSIATAHI  176 (243)
T ss_dssp             CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECC--HHHHTSCCEEEEEE
T ss_pred             CCCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCC--CceeeccCCccccceeeeE--EeccCCCcEEEEEE
Confidence            45588999999997654 67789999999999999989 9988  9999999999999999985  667   99999999


Q ss_pred             EecCCcceEEEEEeeCCCCCcCC----------------CCcCCCCceecceeccccccccccc
Q 041624           80 KYNSATKNLSASWSYGETPKYSQ----------------ENTTSTGRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        80 ~y~~~~~~l~v~~~~~~~~~~~~----------------~fsastG~~~~~h~i~swsfss~~~  127 (459)
                      +||+.+++|+|+|.+.....+..                ||||+|| ..+.|+|++|+|++++.
T Consensus       177 ~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~l~  239 (243)
T 1gsl_A          177 TYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHFFSTLD  239 (243)
T ss_dssp             EEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEEEEEEEEEECT
T ss_pred             EEeCCCCEEEEEEecCCCCceeEEEEechHHhCCCceEEEEEeccC-CcceeEEEEEEEEeecc
Confidence            99999999999998865422111                6999999 99999999999998764

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=99.95  E-value=4.1e-29  Score=231.43  Aligned_cols=114  Identities=36%  Similarity=0.622  Sum_probs=100.1

Q ss_pred             CCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcc
Q 041624            7 NSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATK   86 (459)
Q Consensus         7 ~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~   86 (459)
                      ++.|+||||||.++ ++..+|+|||||||++|. |||++  |||||||||+.|.++++|  ++.+|+.++|||+||+.++
T Consensus        99 ~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~-~Dp~~--nHvGIdvns~~S~~~~~~--~l~~g~~~~v~I~Yd~~~~  172 (233)
T 1n47_A           99 QARGGFLGLFADRA-HDASYQTVAVEFDTYSNA-WDPNY--THIGIDTNGIESKKTTPF--DMVYGEKANIVITYQASTK  172 (233)
T ss_dssp             CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSS--CEEEEEESSSSCSEEEEC--CCCTTSCEEEEEEEETTTT
T ss_pred             CCCCCcccccccCC-CCccCceEEEEeccccCC-CCCCC--CcEEEccCCccccccccc--cccCCCEEEEEEEEeCCCC
Confidence            38899999999764 467899999999999998 99998  999999999999999998  4779999999999999999


Q ss_pred             eEEEEEeeCCCCC-cCC----------------CCcCCCCce---ecceecccccccccc
Q 041624           87 NLSASWSYGETPK-YSQ----------------ENTTSTGRY---TERHVLKSWEFNSTL  126 (459)
Q Consensus        87 ~l~v~~~~~~~~~-~~~----------------~fsastG~~---~~~h~i~swsfss~~  126 (459)
                      +|+|+|.+...+. +..                ||||+||..   .+.|+|++|+|++++
T Consensus       173 ~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~l  232 (233)
T 1n47_A          173 ALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL  232 (233)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             EEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEeec
Confidence            9999999865431 110                599999998   999999999998753

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=99.95  E-value=6.8e-29  Score=230.50  Aligned_cols=116  Identities=36%  Similarity=0.660  Sum_probs=100.4

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCC--CCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPI--NVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~--~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      |. +.|+||||||.++ ++..+|+|||||||++|.+|||+  +  |||||||||+.|.++++|+  +.+|+.++|||+||
T Consensus        94 p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~~Dp~~~~--nHVgIdvns~~S~~s~~~~--l~~g~~~~v~I~Yd  167 (234)
T 2bqp_A           94 PQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAAWDPSNRD--RHIGIDVNSIKSVNTKSWK--LQNGEEANVVIAFN  167 (234)
T ss_dssp             CC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTSCTTCC--CEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEE
T ss_pred             CC-CCCCccccccccC-CCCCCcEEEEEEecccCcccCCCCCC--CceeEeeCCccccceEeeE--EcCCCEEEEEEEEe
Confidence            44 8899999999764 46789999999999999889998  7  9999999999999999984  77999999999999


Q ss_pred             CCcceEEEEEeeCCCC---CcCC-------------------CCcCCCCceecceecccccccccc
Q 041624           83 SATKNLSASWSYGETP---KYSQ-------------------ENTTSTGRYTERHVLKSWEFNSTL  126 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~---~~~~-------------------~fsastG~~~~~h~i~swsfss~~  126 (459)
                      +.+++|+|++.+...+   +|..                   ||||+||...+.|+|++|+|++++
T Consensus       168 ~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~l  233 (234)
T 2bqp_A          168 AATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL  233 (234)
T ss_dssp             TTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             CCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEEeec
Confidence            9999999999886543   1111                   599999999999999999998753

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=99.95  E-value=7.6e-29  Score=230.84  Aligned_cols=119  Identities=36%  Similarity=0.595  Sum_probs=101.3

Q ss_pred             CCC-CCCCccccccCCCCCCCCCCEEEEEeeCCCCCC-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            5 PSN-SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         5 ~~~-~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      |.+ +.|+||||||.+++++..+|+|||||||++|.+ |||++  |||||||||+.|.++++|+  +.+|+.++|||+||
T Consensus        99 p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~--nHvgIdvns~~S~~s~~~~--l~~g~~~~v~I~Yd  174 (240)
T 2fmd_A           99 IPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNY--RHIGIDVNSIRSKAASKWD--WQNGKTATAHISYN  174 (240)
T ss_dssp             CCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECC--CCSSCEEEEEEEEE
T ss_pred             CCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCC--CceeeccccccccceeEEE--eeCCCEEEEEEEEe
Confidence            554 889999999987767788999999999999988 79998  9999999999999999984  77999999999999


Q ss_pred             CCcceEEEEEeeCCCCCcC----------------CCCcCCCCceecceeccccccccccc
Q 041624           83 SATKNLSASWSYGETPKYS----------------QENTTSTGRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~~~----------------~~fsastG~~~~~h~i~swsfss~~~  127 (459)
                      +.+++|+|++.+.....+.                +||||+||...+.|+|++|+|++++.
T Consensus       175 ~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~~~  235 (240)
T 2fmd_A          175 SASKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRSSLM  235 (240)
T ss_dssp             TTTTEEEEEEECTTSCCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEEEEE
T ss_pred             CCCCEEEEEEecCCCCceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEecCC
Confidence            9999999999886432211                06999999999999999999988754

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=99.95  E-value=1e-28  Score=229.65  Aligned_cols=114  Identities=33%  Similarity=0.627  Sum_probs=100.0

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.|+||||||.+    +++|+|||||||++|. |||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.
T Consensus       100 ~~~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~-~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~G~~~~v~I~Yd~~  170 (242)
T 1wbf_A          100 QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT-WDPQI--PHIGIDVNSVISTKTVPFT--LDNGGIANVVIKYDAS  170 (242)
T ss_dssp             CCCCCGGGTTTCCTT----SCCCCEEEEEECSCCT-TCCSS--SEEEEEESSSSCSEEEECC--CCTTSCEEEEEEEETT
T ss_pred             CCCCCCCccccccCC----CcCcEEEEEeccccCC-CCCCC--CeEEEECCCccccceeeeE--ecCCCEEEEEEEEeCC
Confidence            455899999999864    5789999999999998 99998  9999999999999999984  8899999999999999


Q ss_pred             cceEEEEEeeCCCCCcCC-----------------CCcCCC----Cce---ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPKYSQ-----------------ENTTST----GRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~~-----------------~fsast----G~~---~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+...+....                 ||||+|    |..   .+.|+|++|+|++++.
T Consensus       171 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWsF~s~l~  237 (242)
T 1wbf_A          171 TKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFSASLP  237 (242)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEEEECC
T ss_pred             CCEEEEEEccCCCCCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEEEeEecCC
Confidence            999999999875432110                 599999    888   8999999999988764

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=99.95  E-value=2.4e-28  Score=226.99  Aligned_cols=114  Identities=36%  Similarity=0.600  Sum_probs=99.2

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      ++++.|+||||||.+   ++ +|+|||||||++|. |||++  |||||||||+.|.++++|+  +.+|+.++|||+||+.
T Consensus       100 ~~~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~-~Dp~~--nHVgIdvns~~S~~s~~~~--l~~g~~~~v~I~Yd~~  170 (238)
T 1f9k_A          100 PQGEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT-WDPQV--PHIGIDVNSIVSSKTLHFQ--LENGGVANVVIKYDSP  170 (238)
T ss_dssp             CCCCSGGGTTTCCSS---CC-SCCEEEEEECSCCT-TCCSS--SEEEEEESSSSCSEEEECC--CCTTCCEEEEEEEETT
T ss_pred             CCCCCCCcccccccC---CC-CcEEEEEEecccCC-CCCCC--CeEEEecCCccccceEeec--ccCCCEEEEEEEEeCC
Confidence            456889999999875   45 89999999999997 99998  9999999999999999984  7899999999999999


Q ss_pred             cceEEEEEeeCCCCCc--------------C-----CCCcCCCCce---ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPKY--------------S-----QENTTSTGRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~--------------~-----~~fsastG~~---~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+...+..              .     +||||+||..   .+.|+|++|+|++++.
T Consensus       171 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~~~  235 (238)
T 1f9k_A          171 TKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSSLQ  235 (238)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEEEC-
T ss_pred             CCEEEEEEecCCCCCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEeEeecc
Confidence            9999999988654311              1     1599999998   9999999999988754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.7e-28  Score=253.79  Aligned_cols=183  Identities=14%  Similarity=0.120  Sum_probs=138.7

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--------chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--------GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      ...++||+|+||.||+|...  +..+++|+.......        ..+++.+|++++.+++|+||+++..++...+..+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            44678999999999999543  688999987543211        13458999999999999999966666667778899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++++|.+++..            +..++.|+++||+|||+   ++|+||||||+|||++.  .+||+|||+++..
T Consensus       417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            9999999999999854            46899999999999999   99999999999999999  9999999999887


Q ss_pred             cCCCCCc------cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          351 DHELGPR------TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       351 ~~~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      .......      .....||+.|||||++......++..+|.|+...-........
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r  535 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR  535 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence            5431111      2356899999999999864445677789998765554444433

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=99.93  E-value=3e-27  Score=217.71  Aligned_cols=109  Identities=30%  Similarity=0.487  Sum_probs=95.5

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      |+ +.|+||||||.+ ++++.+|+|||||||+        +  |||||||||+.|.++++|+..+.+|+.++|||+||+.
T Consensus        96 p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~--------~--nHVGIdvNs~~S~~t~~~~~~l~~g~~~~v~I~Yd~~  163 (226)
T 1avb_A           96 PK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV--------S--NRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSP  163 (226)
T ss_dssp             CC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT--------T--TEEEEEESSSSCSEEEECCSGGGTTCEEEEEEEEEGG
T ss_pred             CC-CCCCcccccccC-CCCCcccEEEEEecCc--------C--CccceeecCcccCccccCCccccCCCeEEEEEEEeCC
Confidence            55 889999999975 4467799999999998        2  7999999999999999998888899999999999999


Q ss_pred             cceEEEEEeeCCCCC-cCC----------------CCcCCCCce---ecceeccccccccc
Q 041624           85 TKNLSASWSYGETPK-YSQ----------------ENTTSTGRY---TERHVLKSWEFNST  125 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~-~~~----------------~fsastG~~---~~~h~i~swsfss~  125 (459)
                      +++|+|++.+...++ +..                ||||+||..   .+.|+|++|+|+++
T Consensus       164 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~  224 (226)
T 1avb_A          164 KNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             GTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             CcEEEEEEeecCCCccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence            999999999865542 110                699999998   99999999999875

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=99.93  E-value=3.4e-26  Score=202.63  Aligned_cols=85  Identities=40%  Similarity=0.739  Sum_probs=78.2

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCC--CCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPI--NVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~--~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      |. +.||||||||.+ ++++.+|+|||||||++|.+|||+  +  |||||||||+.|+++++|+  +.+|+.++|||+||
T Consensus        94 p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~~Dp~~~~--nHVGIdvNs~~S~~t~~~~--l~~G~~~~v~I~Yd  167 (181)
T 2ltn_A           94 PQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRD--RHIGIDVNSIKSVNTKSWK--LQNGEEANVVIAFN  167 (181)
T ss_dssp             CC-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTTTSCTTCC--CEEEEEESSSSCSEEEECC--CCTTCCEEEEEEEE
T ss_pred             CC-CCCccccccccC-CCCccccEEEEEeccccccccCCCCCC--CEEEEEcCCccccceeccc--cCCCCEEEEEEEEE
Confidence            55 899999999976 457789999999999999889999  7  9999999999999999995  77999999999999


Q ss_pred             CCcceEEEEEeeC
Q 041624           83 SATKNLSASWSYG   95 (459)
Q Consensus        83 ~~~~~l~v~~~~~   95 (459)
                      +.+++|+|+|+|+
T Consensus       168 ~~~~~L~V~l~~~  180 (181)
T 2ltn_A          168 AATNVLTVSLTYP  180 (181)
T ss_dssp             TTTTEEEEEEEEC
T ss_pred             CCCCEEEEEEecC
Confidence            9999999999885

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=99.93  E-value=4.7e-27  Score=218.15  Aligned_cols=111  Identities=24%  Similarity=0.425  Sum_probs=96.5

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      |+ +.||||||||.+ ++++.+|+|||||||+        +  |||||||||+.|.++++|+..+.+|+.++|||+||+.
T Consensus        98 p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~--------~--nHVGIdvNs~~S~~t~~~~~~l~~g~~~~v~I~Yd~~  165 (240)
T 1ioa_A           98 PQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF--------K--NRIDFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSS  165 (240)
T ss_dssp             CC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT--------T--TEEEEEESSSSCSEEEECCHHHHCSSCEEEEEEEETT
T ss_pred             CC-CCCCcccccccC-CCCCcCcEEEEEecCc--------C--CceeeeeCCccccccccCCccccCCCEEEEEEEEeCC
Confidence            55 889999999975 4467899999999998        2  7999999999999999998777799999999999999


Q ss_pred             cceEEEEEeeCCCCC-cCC----------------CCcCCCCce---ecceeccccccccccc
Q 041624           85 TKNLSASWSYGETPK-YSQ----------------ENTTSTGRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~-~~~----------------~fsastG~~---~~~h~i~swsfss~~~  127 (459)
                      +++|+|++.+.+.++ +..                ||||+||..   .+.|+|++|+|+++++
T Consensus       166 ~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s~~~  228 (240)
T 1ioa_A          166 NNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKFR  228 (240)
T ss_dssp             TTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEEEC
T ss_pred             CcEEEEEEecCCCCccceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEeeCC
Confidence            999999999865432 110                599999998   9999999999988754

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.92  E-value=4e-26  Score=210.83  Aligned_cols=99  Identities=35%  Similarity=0.584  Sum_probs=87.7

Q ss_pred             CCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcceEEEEEeeCCCCCcC--
Q 041624           25 SSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS--  101 (459)
Q Consensus        25 ~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~~~~~~~~~~~--  101 (459)
                      +||+|||||||++|.+| ||++  |||||||||+.|+++++|+  +.+|+.++|||+||+.+++|+|++.+.....+.  
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~--nHVGIdvNs~~S~~~~~~~--l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls   76 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSY--PHIGIDIKSVRSKKTAKWN--MQNGKVGTAHIIYNSVDKRLSAVVSYPNADSATVS   76 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEETTTTEEEEEEECTTSCCEEEE
T ss_pred             CCCEEEEEEeCCCCcccCCCCC--CeeeEecCCcccccccccc--ccCCCEEEEEEEEeCCCCEEEEEEecCCCCcceEE
Confidence            47899999999999999 9988  9999999999999999985  779999999999999999999999875432111  


Q ss_pred             --------------CCCcCCCCceecceeccccccccccc
Q 041624          102 --------------QENTTSTGRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus       102 --------------~~fsastG~~~~~h~i~swsfss~~~  127 (459)
                                    +||||+||...+.|+|++|+|++.+.
T Consensus        77 ~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           77 YDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             EECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             EeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence                          16999999999999999999988764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.1e-24  Score=206.57  Aligned_cols=152  Identities=14%  Similarity=0.080  Sum_probs=121.0

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------------------cchHHHHHHHHHHhcc
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------------------HGKNEYITEVKTCSQL  250 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  250 (459)
                      ..+......|...+.||+|+||.||+|.+ .+++.||+|.++....                  .....+.+|+.++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34444555666779999999999999999 6799999999965321                  1245688999999999


Q ss_pred             CcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       251 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      +|   +++.+++. .+..++||||+++|+|.+ +..          .....++.|++.||.|||+   .+|+||||||+|
T Consensus       162 ~~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N  223 (282)
T 1zar_A          162 QG---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN  223 (282)
T ss_dssp             TT---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred             cC---CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence            84   55555443 356699999999999988 421          1245799999999999998   999999999999


Q ss_pred             eeecCCCCEEEeecCCcccccCCCCCccccccccccccccceec
Q 041624          331 IMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS  374 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~  374 (459)
                      ||++ ++.+||+|||+|+..              ..|+|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV--------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence            9999 999999999999633              3478999875

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=99.84  E-value=9e-22  Score=180.23  Aligned_cols=109  Identities=29%  Similarity=0.373  Sum_probs=84.7

Q ss_pred             CCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcce
Q 041624            8 SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKN   87 (459)
Q Consensus         8 ~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~   87 (459)
                      .+|.-|.+|=......+.+++|||||||+        +  |||||||||+ |+++++|+..+.+|+.++|||+||+.+++
T Consensus        77 ~~gdGlAF~l~p~~~~p~~~~vAVEFDT~--------~--nHVGIdvNsi-S~~~~~~~~~l~~g~~~~v~I~Yd~~~~~  145 (223)
T 1dhk_B           77 NSAVGLDFVLVPVQPESKGDTVTVEFDTF--------L--SRISIDVNNN-DIKSVPWDVHDYDGQNAEVRITYNSSTKV  145 (223)
T ss_dssp             -CCSEEEEEEEEC------CCEEEEEETT--------T--TEEEEEETTE-EEEEEECCGGGTTTSCEEEEEEEETTTTE
T ss_pred             CCCCceEEEEecCCCCCCccEEEEEecCC--------C--CcccccCCcc-ccccccCCccccCCCEEEEEEEEeCCCCE
Confidence            34555655532211224467999999998        2  7999999999 99999998888899999999999999999


Q ss_pred             EEEEEeeCCCCC-cCC----------------CCcCCCCce---ecceeccccccccccc
Q 041624           88 LSASWSYGETPK-YSQ----------------ENTTSTGRY---TERHVLKSWEFNSTLD  127 (459)
Q Consensus        88 l~v~~~~~~~~~-~~~----------------~fsastG~~---~~~h~i~swsfss~~~  127 (459)
                      |+|++.+.+.++ +..                ||||+||..   .+.|+|++|+|++++.
T Consensus       146 L~V~l~~~~~~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~~  205 (223)
T 1dhk_B          146 FSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFI  205 (223)
T ss_dssp             EEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC-
T ss_pred             EEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEeccc
Confidence            999999865432 110                699999998   9999999999998765

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=2.6e-21  Score=183.66  Aligned_cols=138  Identities=18%  Similarity=0.030  Sum_probs=107.5

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcE--EEEEEeccCCcc------------------------chHHHHHHHHHHhccC
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMA--VAVKKISRGLKH------------------------GKNEYITEVKTCSQLR  251 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  251 (459)
                      |...+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999999556888  999987543211                        0135789999999998


Q ss_pred             cCCc--eeEEEEEeeCCeEEEEEEecCC-C----CcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCeee
Q 041624          252 HRNL--LQLIGLCHDRGEFMLVYEFMPN-G----SLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH-EEWKRCVVH  323 (459)
Q Consensus       252 H~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH  323 (459)
                      |+++  +.++.+    +..+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| +   .+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence            8864  445543    356899999942 4    55544321       234567889999999999999 7   99999


Q ss_pred             cCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          324 RDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       324 rDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      |||||+|||++.  .++|+|||+|....
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=5.7e-18  Score=168.08  Aligned_cols=136  Identities=14%  Similarity=0.098  Sum_probs=100.4

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc--------------chHH--------HHHHHHHHhccCcCCc
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH--------------GKNE--------YITEVKTCSQLRHRNL  255 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~H~nI  255 (459)
                      |.+...||+|+||.||+|.... |+.||||+++.....              ....        ..+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            8899999999999999999865 899999988643110              0111        2346667777755443


Q ss_pred             e--eEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          256 L--QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       256 v--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      .  ..+++  .  ..+|||||+++++|.++...          .....++.||+.+|.|||.   .+||||||||.|||+
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILI  238 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEE
Confidence            2  22322  1  23799999999888665421          1335678999999999998   899999999999999


Q ss_pred             cCCC----------CEEEeecCCccccc
Q 041624          334 DTDF----------NVKLGDFGLALLVD  351 (459)
Q Consensus       334 ~~~~----------~~kL~DFGla~~~~  351 (459)
                      ++++          .+.|+||+-+-...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             eCCCCcccccccccceEEEEeCCcccCC
Confidence            8876          38999999875443

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.53  E-value=4.2e-15  Score=139.73  Aligned_cols=104  Identities=16%  Similarity=0.264  Sum_probs=76.4

Q ss_pred             CCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecc--------------cCCC-CC
Q 041624            8 SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWN--------------ASFH-SG   72 (459)
Q Consensus         8 ~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~--------------~~~~-~g   72 (459)
                      ..|++||+.+       .++.|||||||++|.+| +    .|+|+|||++++..++.|+              ..+. +|
T Consensus        95 ~~G~~lG~~~-------~~~gvAVefDT~~n~~~-~----~~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n~g  162 (253)
T 2dur_A           95 VPGPVFGSKD-------NFHGLAIFLDTYPNDET-T----ERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRD  162 (253)
T ss_dssp             CEETBTEECS-------SCEEEEEEEECSCCCTT-C----CSCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBTCS
T ss_pred             CCCcccCcCC-------CCCEEEEEEECCCCCCC-C----CCCCcEEEEEecCCceeeeccCCCcccccccccHhhccCC
Confidence            4678899643       25789999999999744 2    2666777776666555442              2443 48


Q ss_pred             ceEEEEEEecCCcceEEEEEeeCCCCCc------------C---CCCcCCCCceecceeccccccccc
Q 041624           73 DTAHVKIKYNSATKNLSASWSYGETPKY------------S---QENTTSTGRYTERHVLKSWEFNST  125 (459)
Q Consensus        73 ~~~~~~i~y~~~~~~l~v~~~~~~~~~~------------~---~~fsastG~~~~~h~i~swsfss~  125 (459)
                      ..++|||+|++.  +|+|++.+.+....            .   .||||+||...+.|+|++|+|.+-
T Consensus       163 ~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          163 HDTFLAVRYSRG--RLTVMTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             SCEEEEEEEETT--EEEEEEECSSSSCCEEEEEECCEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             CCeEEEEEEECC--EEEEEEeCCCCCCceEEEEeCCcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence            899999999976  89999987543210            0   169999999999999999999764

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.51  E-value=4.7e-15  Score=139.79  Aligned_cols=107  Identities=21%  Similarity=0.229  Sum_probs=77.7

Q ss_pred             CCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC--CC------CCCCCceeEecCC-ceeeeeeecccCCC-CCceEEE
Q 041624            8 SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW--DP------INVKDDVGINNSS-IVSSVYTRWNASFH-SGDTAHV   77 (459)
Q Consensus         8 ~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~--d~------~~~~~hvgid~ns-~~s~~~~~~~~~~~-~g~~~~~   77 (459)
                      ..|++||+.+       .++.|||||||++|.+|  +|      ++  +|+|||+|+ +.|...+.|...+. +|..++|
T Consensus       117 ~~g~~~G~~~-------~~~gvaVefDT~~N~~~~~~p~I~~~ind--g~~~~d~~~d~~s~~~~~c~~~~~n~g~~~~~  187 (260)
T 1gv9_A          117 LDGPVFGSAD-------MWNGVGIFFDSFDNDGKKNNPAIVVVGNN--GQINYDHQNDGATQALASCQRDFRNKPYPVRA  187 (260)
T ss_dssp             CEEEETTECS-------CCEEEEEEEECCCC-----CCEEEEEEEE--SCCCCCHHHHHHHHCSEEECCCCBSCSSCEEE
T ss_pred             CCCCccCCCC-------CCCEEEEEEECCCCCCCCCCCceEEEeCC--CceEeecCCCcccceeeccChhhccCCCcEEE
Confidence            3567777732       35679999999999754  33      34  799999986 66666566655554 5999999


Q ss_pred             EEEecCCcceEEEEEeeCCCC---C------------cC---CCCcCCCCceecceeccccccccc
Q 041624           78 KIKYNSATKNLSASWSYGETP---K------------YS---QENTTSTGRYTERHVLKSWEFNST  125 (459)
Q Consensus        78 ~i~y~~~~~~l~v~~~~~~~~---~------------~~---~~fsastG~~~~~h~i~swsfss~  125 (459)
                      ||+|++.  +|+|.+.+...+   .            |.   .+|||+||...+.|+|++|+|..-
T Consensus       188 ~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd~~~LP~~~~vGfSAaTG~~~e~hdIlsw~~~~l  251 (260)
T 1gv9_A          188 KITYYQK--TLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLTFQL  251 (260)
T ss_dssp             EEEEETT--EEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEEEEEE
T ss_pred             EEEEECC--EEEEEEeeccCCCCCcceEEEEEcccccCCCcEEEEEEeCCCCcceEEEEEEEEEEe
Confidence            9999986  799999863111   0            00   169999999999999999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=4e-13  Score=127.03  Aligned_cols=149  Identities=14%  Similarity=0.006  Sum_probs=117.7

Q ss_pred             HHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeE
Q 041624          190 DLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       190 el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~  268 (459)
                      .+.....+|.....++.|+.+.||++...  +..+++|............+.+|++++..+. +..+.++++++.+.+..
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            34556678888888999999999998754  6789999987533234457889999999984 67788999999998999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE--------------------------------  316 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------  316 (459)
                      |+||||++|.+|.+.+.         +......++.+++++|..||+.                                
T Consensus        86 ~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             EEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            99999999999877642         1123357889999999999981                                


Q ss_pred             ------------------------cCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          317 ------------------------WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       317 ------------------------~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                                              ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    014599999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=5.7e-12  Score=118.35  Aligned_cols=140  Identities=20%  Similarity=0.081  Sum_probs=102.4

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV  271 (459)
                      ...++....+.+.|..+.||++... +|..+++|.....   ....+..|+.++..+.+.+  +.+++++....+..++|
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            3444554333345666999999754 3678999997543   3356788999999986545  55689988888889999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW----------------------------------  317 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------  317 (459)
                      |||++|.+|.  ..       ..+   ...++.+++..|..||+..                                  
T Consensus        94 ~e~i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           94 LGEVPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EECCSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEecCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            9999998884  21       122   2356788888888888621                                  


Q ss_pred             ---------------------CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          318 ---------------------KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       318 ---------------------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                                           ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 12399999999999998876677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=2.2e-10  Score=113.33  Aligned_cols=142  Identities=15%  Similarity=0.206  Sum_probs=108.0

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEec--cCC-ccchHHHHHHHHHHhccC--cCCceeEEEEEeeC---CeEEEE
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGL-KHGKNEYITEVKTCSQLR--HRNLLQLIGLCHDR---GEFMLV  271 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lV  271 (459)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|..++..+.  +..+++++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998765  4678888875  332 123457888999999996  45688999998876   458999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW----------------------------------  317 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------  317 (459)
                      |||++|..+.+...      ..++..++..++.+++..|..||...                                  
T Consensus       120 me~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999988854221      14788889999999999999999720                                  


Q ss_pred             ---------------------CCCeeecCCCCCCeeecCCCC--EEEeecCCccc
Q 041624          318 ---------------------KRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALL  349 (459)
Q Consensus       318 ---------------------~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~  349 (459)
                                           ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 257999999999999997753  68999999864

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=98.73  E-value=3.8e-09  Score=98.93  Aligned_cols=108  Identities=10%  Similarity=0.121  Sum_probs=78.7

Q ss_pred             CCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCC------CCCCceeEecCCceeeeeeecccCCC-CCceEEEEEE
Q 041624            8 SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPI------NVKDDVGINNSSIVSSVYTRWNASFH-SGDTAHVKIK   80 (459)
Q Consensus         8 ~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~------~~~~hvgid~ns~~s~~~~~~~~~~~-~g~~~~~~i~   80 (459)
                      ..|+.+|.++       ..+-+||||||+.|.  .|.      +  .|+++|.+++.+...+.|...+. +|..+++||+
T Consensus       101 ~~g~~~G~~~-------~f~GlaV~fDT~~n~--~p~i~~~~Nd--g~~~~d~~~~~~~~~~~c~~~~rn~~~~~~v~I~  169 (256)
T 2a6y_A          101 RDKQLYNGPV-------NYDGLQLLVDNNGPL--GPTLRGQLND--GQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVT  169 (256)
T ss_dssp             CCCTBTTBCT-------TCEEEEEEEESCSTT--CSEEEEEEEE--SSSCCCGGGHHHHCSEEEECCCTTCSSCEEEEEE
T ss_pred             cCCcccCcCC-------CCCEEEEEEECCCCC--CceEEEEECC--CceecccCCCcccceecceeecccCCCcEEEEEE
Confidence            3556666653       123499999999874  232      5  69999999866666666655555 7899999999


Q ss_pred             ec-CCcceEEEEEee------CC--CCCc--CCCCcCCCC---ceecceecccccccccc
Q 041624           81 YN-SATKNLSASWSY------GE--TPKY--SQENTTSTG---RYTERHVLKSWEFNSTL  126 (459)
Q Consensus        81 y~-~~~~~l~v~~~~------~~--~~~~--~~~fsastG---~~~~~h~i~swsfss~~  126 (459)
                      |+ +.++.|+|.+.+      ..  .|..  ..+|||+||   ...+.|.+++|+|....
T Consensus       170 Y~~~~~~~L~V~i~~~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~~  229 (256)
T 2a6y_A          170 YDLEDDNLLKVQVDNKVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNGV  229 (256)
T ss_dssp             EEGGGTSEEEEEETTEEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEESC
T ss_pred             EecCCCcEEEEEEcCEEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEecc
Confidence            99 778889998742      11  1222  247999999   77899999999998743

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.70  E-value=3.8e-08  Score=94.88  Aligned_cols=137  Identities=18%  Similarity=0.179  Sum_probs=102.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCC--ceeEEEEEeeCC---eEEEEEEe
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRN--LLQLIGLCHDRG---EFMLVYEF  274 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~E~  274 (459)
                      .+.++.|....||+..     ..+++|+....  .....+.+|.+++..+ .+..  +.+++......+   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863     46888886432  3456788999999888 3333  456665544433   34899999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE--------------------------------------  316 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------  316 (459)
                      ++|.+|......      .++..++..++.+++..|+.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888754321      477888888999999999999961                                      


Q ss_pred             -----------------cCCCeeecCCCCCCeeecC--CCCEEEeecCCcccc
Q 041624          317 -----------------WKRCVVHRDIKFSNIMPDT--DFNVKLGDFGLALLV  350 (459)
Q Consensus       317 -----------------~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~  350 (459)
                                       ....++|+|++|.||+++.  ...+.|+||+.+..-
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                             0145899999999999998  456889999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=1.3e-07  Score=89.14  Aligned_cols=144  Identities=17%  Similarity=0.072  Sum_probs=104.2

Q ss_pred             HhcCCCCCceeccCCce-EEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFG-AVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ...+|+. +.+..|..+ .||+......+..+.+|+-...   ...++.+|...|..+. +--+.++++++.+.+..++|
T Consensus        23 ~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           23 DLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             HHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             cccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            3344443 345556555 6999887766778999986532   3456788999998883 44477899999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW----------------------------------  317 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------  317 (459)
                      ||++++.++.+....        .......+..+++..|.-||...                                  
T Consensus        99 me~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            999999887665422        12234456677777777777510                                  


Q ss_pred             ---------------------CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          318 ---------------------KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       318 ---------------------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                                           ...++|+|+.+.|||++.++.+-|.||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                 12489999999999999887778999998854

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=4.4e-07  Score=87.58  Aligned_cols=137  Identities=18%  Similarity=0.164  Sum_probs=98.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcC---CceeEEEEEe-eCCeEEEEEEecC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHR---NLLQLIGLCH-DRGEFMLVYEFMP  276 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~E~~~  276 (459)
                      .+.++.|....||+.     +..+++|+...  ......+.+|.++|..+.+.   .+.+++.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888999999997     45688887532  23456788999999999653   3667777774 4556789999999


Q ss_pred             CCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 041624          277 NGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE----------------------------------------  316 (459)
Q Consensus       277 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------  316 (459)
                      |.+|......      .++..++..++.+++..|..||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9888663211      245556666666666666666641                                        


Q ss_pred             -----------------cCCCeeecCCCCCCeeecC---CCC-EEEeecCCcccc
Q 041624          317 -----------------WKRCVVHRDIKFSNIMPDT---DFN-VKLGDFGLALLV  350 (459)
Q Consensus       317 -----------------~~~~iiHrDlkp~NILl~~---~~~-~kL~DFGla~~~  350 (459)
                                       ....++|+|+++.|||++.   ++. ..|.||+.+..-
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             1235799999999999997   455 489999988654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.44  E-value=9e-07  Score=87.04  Aligned_cols=81  Identities=4%  Similarity=-0.061  Sum_probs=58.0

Q ss_pred             cee-ccCCceEEEEEEEc---C---CCcEEEEEEeccCC---ccchHHHHHHHHHHhccC-c--CCceeEEEEEeeC---
Q 041624          202 RKL-GQGGFGAVYRGILI---D---LNMAVAVKKISRGL---KHGKNEYITEVKTCSQLR-H--RNLLQLIGLCHDR---  265 (459)
Q Consensus       202 ~~L-g~G~fg~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~---  265 (459)
                      +.| +.|....+|+....   +   .+..+++|......   ......+.+|+.++..+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998764   1   15678888765432   112356788999998884 3  3577888888765   


Q ss_pred             CeEEEEEEecCCCCcch
Q 041624          266 GEFMLVYEFMPNGSLDF  282 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~  282 (459)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999887764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=3.9e-06  Score=83.84  Aligned_cols=76  Identities=13%  Similarity=0.048  Sum_probs=51.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCc-------cchHHHHHHHHHHhccCc--C-CceeEEEEEeeCCeEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK-------HGKNEYITEVKTCSQLRH--R-NLLQLIGLCHDRGEFML  270 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-nIv~l~g~~~~~~~~~l  270 (459)
                      .+.||.|.++.||++.....++.+++|.......       ...+++..|.+++..+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4578999999999997665578899998654321       234567789998887742  3 44566654  3445689


Q ss_pred             EEEecCCC
Q 041624          271 VYEFMPNG  278 (459)
Q Consensus       271 V~E~~~~g  278 (459)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=2e-05  Score=76.52  Aligned_cols=142  Identities=12%  Similarity=0.158  Sum_probs=81.4

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcC--CceeEEE------EEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHR--NLLQLIG------LCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~E  273 (459)
                      +.|+.|..+.||+....+  ..+++|+....    ..+...|..++..|...  .+.+++.      +....+..++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS--GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETT--EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCC--CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            446567789999987753  45889988652    23344555655555321  2333332      1234667899999


Q ss_pred             ecCCCCcch--------------hcccc-CCC--C-------CCCCHHHHH-----------------------------
Q 041624          274 FMPNGSLDF--------------HLFSK-KST--G-------TPLTWTTRY-----------------------------  300 (459)
Q Consensus       274 ~~~~gsL~~--------------~l~~~-~~~--~-------~~l~~~~~~-----------------------------  300 (459)
                      |++|.++..              .++.. ...  .       ..-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999876531              11110 000  0       011232210                             


Q ss_pred             --HHHHHHHHHHHHhhh----------ccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          301 --KISLGLASALLYLHE----------EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       301 --~i~~~ia~aL~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              111223445666653          1247899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.88  E-value=9.6e-05  Score=71.24  Aligned_cols=139  Identities=17%  Similarity=0.191  Sum_probs=93.2

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      .+.|+.|....+|+....  +..+++|+....   ....+..|...|+.|.   ...+++++.++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            467899999999998753  578889987532   3567889999998884   35688999998888899999999998


Q ss_pred             CCcch-----------hccccCC---CC---------------CCCCHHHHH---HHHH----------------HHHHH
Q 041624          278 GSLDF-----------HLFSKKS---TG---------------TPLTWTTRY---KISL----------------GLASA  309 (459)
Q Consensus       278 gsL~~-----------~l~~~~~---~~---------------~~l~~~~~~---~i~~----------------~ia~a  309 (459)
                      ..+..           .|+....   .+               ..-+|....   ++..                .++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            87632           1111111   00               012455432   1111                11111


Q ss_pred             H-HHhhh-ccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          310 L-LYLHE-EWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       310 L-~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      + ..|.. ..+..++|+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 23321 1247899999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.80  E-value=0.00011  Score=69.77  Aligned_cols=78  Identities=17%  Similarity=0.126  Sum_probs=58.0

Q ss_pred             CCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-c--CCceeEEEEEeeCCeEEEEEEe
Q 041624          198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-H--RNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       198 f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ....+.+|.|..+.||+.+..+ |+.+.+|+...........|..|...|+.|. .  --+.+++++.    .-++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3445789999999999999876 8899999876554444567889999998884 2  2355666553    24789999


Q ss_pred             cCCCCc
Q 041624          275 MPNGSL  280 (459)
Q Consensus       275 ~~~gsL  280 (459)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.67  E-value=0.00012  Score=73.71  Aligned_cols=73  Identities=10%  Similarity=0.164  Sum_probs=46.1

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCC-------c--cchHHHHHHHHHHhc-cCcCCceeEEEEEeeCCeEEE
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-------K--HGKNEYITEVKTCSQ-LRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~--~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .+.||.|..+.||++..  .+..++||......       .  .....+..|+..+.. .....+.+++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            46789999999999864  36789999532211       1  122334444433322 2335677787775  466799


Q ss_pred             EEEec-CC
Q 041624          271 VYEFM-PN  277 (459)
Q Consensus       271 V~E~~-~~  277 (459)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.00023  Score=68.48  Aligned_cols=161  Identities=13%  Similarity=0.100  Sum_probs=91.1

Q ss_pred             ccCHHHHHHHhcCCCCC-----ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--cee
Q 041624          185 RFSYKDLASATNNFSNE-----RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQ  257 (459)
Q Consensus       185 ~~~~~el~~~~~~f~~~-----~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~  257 (459)
                      .++.+++......|...     +.|+.|....+|+....+ + .+++|.....  ...+++..|+.++..+...+  +.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence            35666777776667552     346678889999987754 3 6889988652  12345566777777764322  233


Q ss_pred             EEEE------EeeCCeEEEEEEecCCCCcchh--------------ccccC-CCCC----CC---CHHHHHH--------
Q 041624          258 LIGL------CHDRGEFMLVYEFMPNGSLDFH--------------LFSKK-STGT----PL---TWTTRYK--------  301 (459)
Q Consensus       258 l~g~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~-~~~~----~l---~~~~~~~--------  301 (459)
                      ++..      ....+..+++|+|++|..+...              ++... ....    ..   .|...+.        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            3321      1224567899999998665321              11100 0000    01   1222111        


Q ss_pred             ----HHHHHHHHHHHhhhc----cCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          302 ----ISLGLASALLYLHEE----WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       302 ----i~~~ia~aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                          +...+...+++++..    ...+++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                011244455555532    135799999999999999876668999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.58  E-value=0.00019  Score=72.45  Aligned_cols=74  Identities=16%  Similarity=0.224  Sum_probs=51.9

Q ss_pred             ceeccCCceEEEEEEEcC-------CCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILID-------LNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  273 (459)
                      +.|+.|....+|++...+       .+..+++|+....  ...+.+..|..++..+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            568888889999998753       2468889987431  112566689999988854444 677776543    28999


Q ss_pred             ecCCCCcc
Q 041624          274 FMPNGSLD  281 (459)
Q Consensus       274 ~~~~gsL~  281 (459)
                      |+++.+|.
T Consensus       153 ~l~G~~l~  160 (429)
T 1nw1_A          153 YIPSRPLS  160 (429)
T ss_dssp             CCCEEECC
T ss_pred             EeCCcccC
Confidence            99875553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.57  E-value=0.00034  Score=66.82  Aligned_cols=73  Identities=8%  Similarity=0.106  Sum_probs=46.9

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEec-CC
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEFM-PN  277 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~-~~  277 (459)
                      ..+.|+.|....+|+.      ..+++|+....... .....+|+.++..+...++ .++++++  .+.-++++||+ ++
T Consensus        22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             ceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            3678999999999998      45888887654221 1233568888877743333 4666553  33357899999 66


Q ss_pred             CCcc
Q 041624          278 GSLD  281 (459)
Q Consensus       278 gsL~  281 (459)
                      .+|.
T Consensus        93 ~~l~   96 (301)
T 3dxq_A           93 QTMS   96 (301)
T ss_dssp             EECC
T ss_pred             ccCC
Confidence            5553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.51  E-value=0.00052  Score=69.72  Aligned_cols=75  Identities=12%  Similarity=0.045  Sum_probs=49.9

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEEecCCCCc
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYEFMPNGSL  280 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL  280 (459)
                      +.|+.|-...+|+....+.+..+++|+........ -.-..|..++..|...++ .++++.+.  +  .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            57888888999999886545788898875432221 122578888888865555 57777763  2  259999998665


Q ss_pred             c
Q 041624          281 D  281 (459)
Q Consensus       281 ~  281 (459)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0022  Score=61.69  Aligned_cols=159  Identities=13%  Similarity=0.082  Sum_probs=89.9

Q ss_pred             cCHHHHHHHhcCCCC-----CceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCC--ceeE
Q 041624          186 FSYKDLASATNNFSN-----ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN--LLQL  258 (459)
Q Consensus       186 ~~~~el~~~~~~f~~-----~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l  258 (459)
                      .+.+++......|..     ...|+ |....||+....+ |+.+++|...... .....+..|..++..+....  ++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCC-CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            455566555555532     23566 8888999876543 5679999986432 23456777888887774322  3444


Q ss_pred             EEE-----EeeCCeEEEEEEecCCCCcch----h----------cccc--C-C--CCCCCCHHHH----HHH--------
Q 041624          259 IGL-----CHDRGEFMLVYEFMPNGSLDF----H----------LFSK--K-S--TGTPLTWTTR----YKI--------  302 (459)
Q Consensus       259 ~g~-----~~~~~~~~lV~E~~~~gsL~~----~----------l~~~--~-~--~~~~l~~~~~----~~i--------  302 (459)
                      +..     ....+..+++||+++|..+..    .          ++..  . .  ....+++...    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            432     122456688999998865531    0          1100  0 0  0011222211    000        


Q ss_pred             -------HHHHHHHHHHhhhc----cCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          303 -------SLGLASALLYLHEE----WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       303 -------~~~ia~aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                             ...+...++.+...    ....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   11111122232211    236789999999999999 4 899999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.0013  Score=65.12  Aligned_cols=143  Identities=17%  Similarity=0.137  Sum_probs=85.5

Q ss_pred             ceeccCCceEEEEEEEcC-------CCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILID-------LNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      +.|..|-...+|+....+       .+..+.+|+.... ........+|.++++.|. +.-..++++++.+.    +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            467778888899988742       3478889886332 234556678999998884 33336777766542    9999


Q ss_pred             ecCCCCcchh-cc----------------ccC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 041624          274 FMPNGSLDFH-LF----------------SKK-STGTPL--TWTTRYKISLGLAS-------------------ALLYLH  314 (459)
Q Consensus       274 ~~~~gsL~~~-l~----------------~~~-~~~~~l--~~~~~~~i~~~ia~-------------------aL~yLH  314 (459)
                      |++|.+|..- +.                ... ..+...  -|.+..++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421 10                000 001122  24455555544322                   223332


Q ss_pred             h-----ccCCCeeecCCCCCCeeecCC----CCEEEeecCCccc
Q 041624          315 E-----EWKRCVVHRDIKFSNIMPDTD----FNVKLGDFGLALL  349 (459)
Q Consensus       315 ~-----~~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~  349 (459)
                      .     .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1     123579999999999999876    7899999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.19  E-value=0.002  Score=62.19  Aligned_cols=143  Identities=17%  Similarity=0.051  Sum_probs=73.4

Q ss_pred             ceeccCCceE-EEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc--CCceeEEEEEeeCCeEEEEEEecCCC
Q 041624          202 RKLGQGGFGA-VYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRGEFMLVYEFMPNG  278 (459)
Q Consensus       202 ~~Lg~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~g  278 (459)
                      +.|+.|+... +|+....+ +..+++|.......   .++..|+.++..+..  -.+.+++.+..+.+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~-~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPT-GAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTT-CCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCC-CCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            3465555544 66765432 56677776543221   334556777776642  23567777654443  7899999776


Q ss_pred             CcchhccccC---------------------CC-CCCCCHHHHH-------H-------------HHHHHHHHHHHhh--
Q 041624          279 SLDFHLFSKK---------------------ST-GTPLTWTTRY-------K-------------ISLGLASALLYLH--  314 (459)
Q Consensus       279 sL~~~l~~~~---------------------~~-~~~l~~~~~~-------~-------------i~~~ia~aL~yLH--  314 (459)
                      .+.+++....                     .. -..++.....       .             ....+...++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6643332110                     00 0112221100       0             0011112222221  


Q ss_pred             -hccCCCeeecCCCCCCeeecCC----CCEEEeecCCcccc
Q 041624          315 -EEWKRCVVHRDIKFSNIMPDTD----FNVKLGDFGLALLV  350 (459)
Q Consensus       315 -~~~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~~  350 (459)
                       ......++|+|+.+.|||++.+    ..+.|.||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             1124689999999999999875    68999999988643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.0014  Score=64.37  Aligned_cols=74  Identities=12%  Similarity=0.103  Sum_probs=45.5

Q ss_pred             ceeccCCceEEEEEEEcCC--------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCC-ceeEEEEEeeCCeEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDL--------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN-LLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  272 (459)
                      +.|+.|....+|+....+.        +..+++|+...... .......|..++..+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            4677788889999887531        26788887754322 1223467888888885444 44777554  2  26899


Q ss_pred             EecCCCCc
Q 041624          273 EFMPNGSL  280 (459)
Q Consensus       273 E~~~~gsL  280 (459)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988654

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=96.83  E-value=0.00043  Score=63.06  Aligned_cols=93  Identities=11%  Similarity=0.150  Sum_probs=55.2

Q ss_pred             EEEEeeCCCCCC--C--CCCCCCCceeEecCCceeeeeeecccCCC-CCceEEEEEEec-CCcceEEEEEee------CC
Q 041624           29 VLVEFDSFSNPE--W--DPINVKDDVGINNSSIVSSVYTRWNASFH-SGDTAHVKIKYN-SATKNLSASWSY------GE   96 (459)
Q Consensus        29 ~aVefdt~~~~~--~--d~~~~~~hvgid~ns~~s~~~~~~~~~~~-~g~~~~~~i~y~-~~~~~l~v~~~~------~~   96 (459)
                      +||+|||+.|..  .  ..+|  .|..+|.++..+.....+...++ ++...+++|+|+ .....|+|.+..      ..
T Consensus       108 L~I~~Dt~~n~~p~i~~~~nd--G~~~yd~~~~~~~~~~~C~~~~rn~~~~~~~rI~Y~~~~~~~l~v~id~~~C~~~~~  185 (222)
T 2a6z_A          108 LQLLVDNNGPLGPTLRGQLND--GQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNKVCFQTRK  185 (222)
T ss_dssp             EEEEEESCSTTSSEEEEEEEE--SSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTEEEEEESC
T ss_pred             EEEEEECCCCCCceEEEEECC--CCeeeccCCCccccccccceeccCCCCcEEEEEEEEcCCCcEEEEEEcCeEEEEeCC
Confidence            799999998831  0  1122  23333333211111122223343 477899999998 666778877632      11


Q ss_pred             --CCCc--CCCCcCCCC---ceecceeccccccc
Q 041624           97 --TPKY--SQENTTSTG---RYTERHVLKSWEFN  123 (459)
Q Consensus        97 --~~~~--~~~fsastG---~~~~~h~i~swsfs  123 (459)
                        .|..  ..+|||+||   ...+.|.+++|.+.
T Consensus       186 v~LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~  219 (222)
T 2a6z_A          186 VRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF  219 (222)
T ss_dssp             CCCCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred             eecCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence              1211  236899999   77888999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.68  E-value=0.0074  Score=58.57  Aligned_cols=33  Identities=21%  Similarity=0.372  Sum_probs=28.9

Q ss_pred             CCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          318 KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       318 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ...++|+|+.+.||+++.++.+.|.||+.+..-
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            367999999999999998888999999887653

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=96.44  E-value=0.00032  Score=47.90  Aligned_cols=26  Identities=31%  Similarity=0.466  Sum_probs=23.1

Q ss_pred             CCCcCCCCceecceeccccccccccc
Q 041624          102 QENTTSTGRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus       102 ~~fsastG~~~~~h~i~swsfss~~~  127 (459)
                      +||+|+||...+.|++++|+|+++.+
T Consensus        22 VGFSAsTG~~~~~h~IlsWsF~s~~~   47 (52)
T 2ltn_B           22 IGFSATTGAEYAAHEVLSWSFHSELS   47 (52)
T ss_dssp             EEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred             EEEEeccCCcceeEEEEEeEEEeecc
Confidence            37999999999999999999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.91  E-value=0.068  Score=53.41  Aligned_cols=142  Identities=14%  Similarity=0.180  Sum_probs=85.6

Q ss_pred             ceeccCCceEEEEEEEcCC-------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCC-ceeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN-LLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E  273 (459)
                      +.|..|-...+|+......       +..+++|+....... .-...+|..++..+.-.+ ..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            5677788889999987631       477888886543222 223457888888884333 456665432    278999


Q ss_pred             ecCCCCcchh-cc----------------c--c-----CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 041624          274 FMPNGSLDFH-LF----------------S--K-----KS--TGTPLTWTTRYKISLGL-------------------AS  308 (459)
Q Consensus       274 ~~~~gsL~~~-l~----------------~--~-----~~--~~~~l~~~~~~~i~~~i-------------------a~  308 (459)
                      |++|.+|..- +.                .  .     ..  ...+.-|.+..++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998765321 10                0  0     00  11122244444443322                   22


Q ss_pred             HHHHhhh---------------------ccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          309 ALLYLHE---------------------EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       309 aL~yLH~---------------------~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      .+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2333321                     11356899999999999 8888999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.74  E-value=0.11  Score=51.51  Aligned_cols=30  Identities=23%  Similarity=0.282  Sum_probs=25.3

Q ss_pred             CeeecCCCCCCeee------cCCCCEEEeecCCccc
Q 041624          320 CVVHRDIKFSNIMP------DTDFNVKLGDFGLALL  349 (459)
Q Consensus       320 ~iiHrDlkp~NILl------~~~~~~kL~DFGla~~  349 (459)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567799999998854

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.87  E-value=0.043  Score=55.62  Aligned_cols=61  Identities=7%  Similarity=0.022  Sum_probs=17.8

Q ss_pred             CCceeccCCceEEEEEEEcCCCcEEEE------EEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEe
Q 041624          200 NERKLGQGGFGAVYRGILIDLNMAVAV------KKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCH  263 (459)
Q Consensus       200 ~~~~Lg~G~fg~Vy~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~  263 (459)
                      ..+.||   ||.||+|.+.....+||+      |..+...  .+....|.+|..++..++|+|+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345566   999999999765578888      7665432  233457889999999999999999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=87.51  E-value=0.8  Score=41.10  Aligned_cols=121  Identities=16%  Similarity=0.029  Sum_probs=75.0

Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      -||.+.|.....   ++++.+++.++.|.+.+|.-+-.  +..-..+=+.|..|++..+|.+.+.+ ..+.         
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            378888887665   89999999999999999877621  01111233456889999999888764 2110         


Q ss_pred             cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHHHHhcC
Q 041624          358 TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR---NCRPSIRQAIQVLNFE  420 (459)
Q Consensus       358 ~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p---~~RPs~~~v~~~L~~~  420 (459)
                          .....+.|||....+   ...+.-++++|.++|.++.---+.-   .--|.+.+++..+...
T Consensus        98 ----~~~~~~~~pe~~~~~---~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 ----AGEPPPVAGKLGYSQ---CMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -------------CCSSSS---SCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTC
T ss_pred             ----ccccCCCChhhcccc---chHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhc
Confidence                112346688876421   2344568999999999886444432   3446777777766433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.52  E-value=2  Score=38.34  Aligned_cols=85  Identities=12%  Similarity=-0.003  Sum_probs=61.9

Q ss_pred             CcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCC
Q 041624          251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSN  330 (459)
Q Consensus       251 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~N  330 (459)
                      .||+.+.. .+-.+.+.+.+.|+.-+  +...+-.-+     .++...+++++..|+....+++.     =+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            68888877 46666676666666543  222222111     47889999999999988866664     4688899999


Q ss_pred             eeecCCCCEEEeecCCcc
Q 041624          331 IMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       331 ILl~~~~~~kL~DFGla~  348 (459)
                      ++++.++.+++.-.|+-.
T Consensus       110 L~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             EEECTTSCEEESCCEETT
T ss_pred             EEEcCCCCEEEEEccCcc
Confidence            999999999999877643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.73  E-value=5  Score=35.84  Aligned_cols=83  Identities=11%  Similarity=-0.028  Sum_probs=59.6

Q ss_pred             CcCCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHH-HhhhccCCCeeecCCCCC
Q 041624          251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL-YLHEEWKRCVVHRDIKFS  329 (459)
Q Consensus       251 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~iiHrDlkp~  329 (459)
                      .||++  -...-.+.+.+.+.++.-+++.=...+.       .++...+++++..|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67887  3344466777777777653332222221       4788999999999988777 5553     567889999


Q ss_pred             CeeecCCCCEEEeecCCc
Q 041624          330 NIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       330 NILl~~~~~~kL~DFGla  347 (459)
                      |+++|.++.+++.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999977764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	459
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-42
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-41
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	5e-22
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	1e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-21
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	4e-21
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	5e-21
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	7e-21
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	8e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	3e-19
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	9e-19
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	2e-18
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	5e-18
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	6e-18
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	7e-18
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	1e-17
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	1e-16
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	2e-16
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	2e-16
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-15
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	1e-15
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	8e-15
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-12
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	5e-10
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	1e-06

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 6e-53
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 10/185 (5%)

Query: 194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRH 252
             ++F    +LG G  G V++       + +A K I   +K   +N+ I E++   +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             ++   G  +  GE  +  E M  GSLD  L         +      K+S+ +   L Y
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTY 119

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           L E+ K  ++HRD+K SNI+ ++   +KL DFG++  +            GT  YM+PE 
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPER 174

Query: 373 ISTGR 377
           +    
Sbjct: 175 LQGTH 179

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 1e-51
 Identities = 67/295 (22%), Positives = 109/295 (36%), Gaps = 61/295 (20%)

Query: 186 FSYKDLASATNNFSNE---------RKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL 233
           F+++D   A   F+ E         + +G G FG V  G L       + VA+K +  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 234 -KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT 292
            +  + ++++E     Q  H N++ L G+       M++ EFM NGSLD  L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123

Query: 293 PLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH 352
             T      +  G+A+ + YL        VHRD+   NI+ +++   K+ DFGL+  ++ 
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 353 ELGP----RTTGLAGTLGYMAPEYISTGR--ARLDV------------------------ 382
           +          G    + + APE I   +  +  DV                        
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 383 ------------NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPN 425
                                L  + L C   DRN RP   Q +  L+   + PN
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-49
 Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 56/278 (20%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
              +  +++G G FG VY+G     ++AV +  ++         +  EV    + RH N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           L  +G      +  +V ++    SL  HL   +   T         I+   A  + YLH 
Sbjct: 67  LLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH- 121

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYIS 374
              + ++HRD+K +NI    D  VK+GDFGLA +     G  +   L+G++ +MAPE I 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 375 TG------------------------------------------RARLDVNFDEQQTDC- 391
                                                       R  L  +  + +++C 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 392 --LMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLP 427
             +  +   C    R+ RP   Q +  +    +  +LP
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR--SLP 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (425), Expect = 3e-49
 Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 44/273 (16%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT 242
           P   +Y        + + + KLG G +G VY G+    ++ VAVK +       + E++ 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 62

Query: 243 EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
           E     +++H NL+QL+G+C     F ++ EFM  G+L  +L         ++      +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYM 120

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
           +  ++SA+ YL    K+  +HRD+   N +   +  VK+ DFGL+ L+  +      G  
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 363 GTLGYMAPEYISTGR--------------------------------------ARLDVNF 384
             + + APE ++  +                                          +  
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237

Query: 385 DEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL 417
            E   + +  +   C   + + RPS  +  Q  
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (425), Expect = 5e-49
 Identities = 64/215 (29%), Positives = 88/215 (40%), Gaps = 16/215 (7%)

Query: 198 FSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRHRN 254
           FS+ R++G G FGAVY    +  +  VA+KK+S   K    ++   I EV+   +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
            +Q  G         LV E+    + D     KK    PL       ++ G    L YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 ++HRD+K  NI+      VKLGDFG A ++            GT  +MAPE I 
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 375 T-GRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP 408
                + D   D        I       P  N   
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 11/233 (4%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGL 261
            +LG G FG VY+    + ++  A K I    +    +Y+ E+   +   H N+++L+  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 262 CHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCV 321
            +      ++ EF   G++D  +   +    PLT +    +      AL YLH+     +
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131

Query: 322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRAR-- 379
           +HRD+K  NI+   D ++KL DFG++      +  R +   GT  +MAPE +    ++  
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190

Query: 380 -LDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP 431
             D   D       +I  +    P  +    +R  +++   E      PS+  
Sbjct: 191 PYDYKADVWSLGITLIE-MAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 51/260 (19%), Positives = 96/260 (36%), Gaps = 46/260 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            + +  ++LG G FG V  G        VA+K I  G    ++E+I E K    L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKL 61

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL G+C  +    ++ E+M NG L  +L   +            ++   +  A+ YL  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE- 117

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
              +  +HRD+   N + +    VK+ DFGL+  V  +    + G    + +  PE +  
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 376 GR--ARLDVN------------------------------------FDEQQTDCLMIVGL 397
            +  ++ D+                                          ++ +  +  
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235

Query: 398 WCAHPDRNCRPSIRQAIQVL 417
            C H   + RP+ +  +  +
Sbjct: 236 SCWHEKADERPTFKILLSNI 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-47
 Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 7/191 (3%)

Query: 193 SATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQL 250
           S   ++     +G G +G   +         +  K++  G   +  K   ++EV    +L
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 251 RHRNLLQLIGLCHDR--GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLAS 308
           +H N+++      DR      +V E+   G L   +         L      ++   L  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 309 ALLYLHE--EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
           AL   H   +    V+HRD+K +N+  D   NVKLGDFGLA +++H+         GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 367 YMAPEYISTGR 377
           YM+PE ++   
Sbjct: 180 YMSPEQMNRMS 190

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-47
 Identities = 57/260 (21%), Positives = 97/260 (37%), Gaps = 46/260 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
                  +LG G FG V+ G     +  VAVK + +G     + ++ E     QL+H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRL 70

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           ++L  +        ++ E+M NGSL   L +    G  LT      ++  +A  + ++ E
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
              R  +HRD++ +NI+     + K+ DFGLA L++        G    + + APE I+ 
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 376 GR--ARLDVN------------------------------------FDEQQTDCLMIVGL 397
           G    + DV                                       +   + L  +  
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244

Query: 398 WCAHPDRNCRPSIRQAIQVL 417
            C       RP+      VL
Sbjct: 245 LCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 5e-47
 Identities = 53/260 (20%), Positives = 103/260 (39%), Gaps = 46/260 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +  +  +++G G FG V+ G  ++ +  VA+K I  G    + ++I E +   +L H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREG-AMSEEDFIEEAEVMMKLSHPKL 62

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL G+C ++    LV+EFM +G L  +L +++         T   + L +   +     
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGM---AY 116

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             + CV+HRD+   N +   +  +K+ DFG+   V  +    +TG    + + +PE  S 
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 376 GR--ARLDV------------------------------------NFDEQQTDCLMIVGL 397
            R  ++ DV                                          +  +  +  
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236

Query: 398 WCAHPDRNCRPSIRQAIQVL 417
            C       RP+  + ++ L
Sbjct: 237 HCWKERPEDRPAFSRLLRQL 256

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-46
 Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 13/185 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRH 252
            +F   R LG+G FG VY          +A+K + +        +++   EV+  S LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N+L+L G  HD     L+ E+ P G++   L                     LA+AL Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 121

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
            H    + V+HRDIK  N++  +   +K+ DFG ++        R T L GTL Y+ PE 
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEM 175

Query: 373 ISTGR 377
           I    
Sbjct: 176 IEGRM 180

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-45
 Identities = 57/274 (20%), Positives = 98/274 (35%), Gaps = 51/274 (18%)

Query: 189 KDLASATNNFS-NERKLGQGGFGAVYRGILIDLN--MAVAVKKISRGLKHG-KNEYITEV 244
           K L    +N    + +LG G FG+V +G+       + VA+K + +G +     E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 245 KTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISL 304
           +   QL +  +++LIG+C      MLV E    G L   L  K+     +  +   ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116

Query: 305 GLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELGPRTTGLA 362
            ++  + YL    ++  VHRD+   N++       K+ DFGL+  L  D       +   
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 363 GTLGYMAPEYISTGR--ARLDV------------------------------------NF 384
             L + APE I+  +  +R DV                                      
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233

Query: 385 DEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN 418
             +    L  +   C       RP      Q + 
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 6e-45
 Identities = 52/242 (21%), Positives = 89/242 (36%), Gaps = 19/242 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKTCSQLRHRN 254
            ++   + LG+G +G V   +      AVAVK +         E I  E+     L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++  G   +     L  E+   G L   +         +      +    L + ++YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYI 373
                 + HRDIK  N++ D   N+K+ DFGLA +  +    R    + GTL Y+APE +
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 374 STGRARLDVNFDEQQTD----CLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK 429
                     F  +  D     +++  +       +      Q       +    N   K
Sbjct: 178 KRRE------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231

Query: 430 MP 431
           + 
Sbjct: 232 ID 233

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 3e-44
 Identities = 51/238 (21%), Positives = 92/238 (38%), Gaps = 19/238 (7%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKIS--RGLKHGKNEYITEVKTCSQLRHRNLLQL 258
           + ++G+G F  VY+G+  +  + VA  ++   +  K  +  +  E +    L+H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 259 IGLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
                     +   +LV E M +G+L  +L   K     +           +   L +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 315 EEWKRCVVHRDIKFSNIM-PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 ++HRD+K  NI       +VK+GD GLA L           + GT  +MAPE  
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMY 185

Query: 374 STGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP 431
                + D + D       M+      +P   C+    Q  + +    K  +      
Sbjct: 186 ---EEKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPASFDKVAI 239

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  156 bits (394), Expect = 4e-44
 Identities = 68/302 (22%), Positives = 108/302 (35%), Gaps = 59/302 (19%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           +++    +LG G FG V+R          A K +    +  K     E++T S LRH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           + L     D  E +++YEFM  G L   +  + +    ++     +    +   L ++HE
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE 142

Query: 316 EWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                 VH D+K  NIM  T  +  +KL DFGL   +D +   + T   GT  + APE  
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197

Query: 374 S---------------------TGR---------------ARLDVNFDEQQTDCL----- 392
                                 +G                   D N D+     +     
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 393 -MIVGLWCAHPDRNCRPSIRQA-----IQVLNFETKMPNLPSKMPVAIFEAPASSAPCSS 446
             I  L  A P+   R +I QA     +   N   +   +PS     I ++  +      
Sbjct: 258 DFIRKLLLADPNT--RMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315

Query: 447 EP 448
           EP
Sbjct: 316 EP 317

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 5e-44
 Identities = 57/289 (19%), Positives = 96/289 (33%), Gaps = 69/289 (23%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRGLKHG-KNEYITEVKTCSQ 249
            N    + LG G FG V       ++     + VAVK +        +   ++E+K  +Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK-------------------S 289
           L  H N++ L+G C   G   L++E+   G L  +L SK+                    
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 290 TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-L 348
               LT+      +  +A  + +L     +  VHRD+   N++      VK+ DFGLA  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 349 LVDHELGPRTTGLAGTLGYMAPEYISTG-------------------------------- 376
           ++              + +MAPE +  G                                
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 377 -------RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN 418
                  +    ++     T+ + I+   C   D   RPS       L 
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 7e-44
 Identities = 59/260 (22%), Positives = 94/260 (36%), Gaps = 46/260 (17%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            +   E KLGQG FG V+ G        VA+K +  G       ++ E +   +LRH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKL 74

Query: 256 LQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
           +QL  +        +V E+M  GSL   L  +   G  L       ++  +AS + Y+  
Sbjct: 75  VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE- 130

Query: 316 EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIST 375
             +   VHRD++ +NI+   +   K+ DFGLA L++        G    + + APE    
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 376 GR--ARLDV------------------------------------NFDEQQTDCLMIVGL 397
           GR   + DV                                        +  + L  +  
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248

Query: 398 WCAHPDRNCRPSIRQAIQVL 417
            C   +   RP+       L
Sbjct: 249 QCWRKEPEERPTFEYLQAFL 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 9e-44
 Identities = 55/200 (27%), Positives = 82/200 (41%), Gaps = 22/200 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKIS-RGLKHGKNEYITEVKTCSQLRHRNLLQLI 259
           +  +G+G FG V+RG        VAVK  S R  +    E   E+     LRH N+L  I
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63

Query: 260 GLCHDRG----EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
              +       +  LV ++  +GSL  +L         +T     K++L  AS L +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 118

Query: 316 E-----WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE---LGPRTTGLAGTLGY 367
           E      K  + HRD+K  NI+   +    + D GLA+  D     +        GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 368 MAPEYISTGRARLDVNFDEQ 387
           MAPE +            ++
Sbjct: 179 MAPEVLDDSINMKHFESFKR 198

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-43
 Identities = 63/261 (24%), Positives = 94/261 (36%), Gaps = 52/261 (19%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
                 + +G+G FG V  G        VAVK I          ++ E    +QLRH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNL 62

Query: 256 LQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +QL+G+   ++G   +V E+M  GSL  +L S+    + L      K SL +  A+ YL 
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                  VHRD+   N++   D   K+ DFGL      E           + + APE + 
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALR 173

Query: 375 TGR--ARLDV------------------------------------NFDEQQTDCLMIVG 396
             +   + DV                                    +  +     +  V 
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233

Query: 397 LWCAHPDRNCRPSIRQAIQVL 417
             C H D   RPS  Q  + L
Sbjct: 234 KNCWHLDAAMRPSFLQLREQL 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 7e-43
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 9/183 (4%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRN 254
              ++   K+GQG  G VY  + +     VA+++++   +  K   I E+    + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           ++  +       E  +V E++  GSL   +         +       +      AL +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH 133

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 V+HRDIK  NI+   D +VKL DFG    +  E   + + + GT  +MAPE ++
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVT 189

Query: 375 TGR 377
              
Sbjct: 190 RKA 192

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (385), Expect = 7e-43
 Identities = 65/306 (21%), Positives = 108/306 (35%), Gaps = 55/306 (17%)

Query: 175 DDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK 234
           +D+ +   P+    K   S  + +    +LG G FG V+R +          K I+    
Sbjct: 9   EDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 67

Query: 235 HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPL 294
             K     E+   +QL H  L+ L     D+ E +L+ EF+  G L   +    +    +
Sbjct: 68  LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKM 124

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN--VKLGDFGLALLVDH 352
           +              L ++HE     +VH DIK  NIM +T     VK+ DFGLA  ++ 
Sbjct: 125 SEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181

Query: 353 ELGPRTTGLAGTLGYMAPEYIS---------------------TGRA------------- 378
                      T  + APE +                      +G +             
Sbjct: 182 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239

Query: 379 --RLDVNFDEQQTDCL------MIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKM 430
             R D  FDE     +       I  L    P +  R ++  A++    +    NL S++
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK--RLTVHDALEHPWLKGDHSNLTSRI 297

Query: 431 PVAIFE 436
           P + + 
Sbjct: 298 PSSRYN 303

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 51/281 (18%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLKHG-KNEYITEVKTCSQL 250
           +  + ++ +G G FG VY+G+L   +    + VA+K +  G     + +++ E     Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 251 RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
            H N+++L G+       M++ E+M NG+LD  L  K       +      +  G+A+ +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGM 123

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYM 368
            YL        VHRD+   NI+ +++   K+ DFGL+ ++  D E    T+G    + + 
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 369 APEYISTGR--------------------------------------ARLDVNFDEQQTD 390
           APE IS  +                                          +        
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 391 CLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP 431
            +  + + C   +R  RP     + +L+   + P+    + 
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 14/183 (7%)

Query: 201 ERKLGQGGFGAVYRGILID--LNMAVAVKKISRGLKHG--KNEYITEVKTCSQLRHRNLL 256
           +++LG G FG V +G      +   VAVK +         K+E + E     QL +  ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
           ++IG+C     +MLV E    G L+ +L   +     +      ++   ++  + YL   
Sbjct: 72  RMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLE-- 124

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPEYIS 374
            +   VHRD+   N++  T    K+ DFGL+  +  D       T     + + APE I+
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 375 TGR 377
             +
Sbjct: 184 YYK 186

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 7e-42
 Identities = 60/296 (20%), Positives = 98/296 (33%), Gaps = 68/296 (22%)

Query: 187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-KNEY 240
               L    NN    R +G+G FG V++     L        VAVK +        + ++
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 241 ITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS----------- 289
             E    ++  + N+++L+G+C       L++E+M  G L+  L S              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 290 ---------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK 340
                       PL+   +  I+  +A+ + YL E   R  VHRD+   N +   +  VK
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 341 LGDFGLA-LLVDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDV--------------- 382
           + DFGL+  +   +        A  + +M PE I   R     DV               
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 383 ---------------------NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVL 417
                                   E     L  +   C       RPS     ++L
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 9e-42
 Identities = 55/263 (20%), Positives = 94/263 (35%), Gaps = 28/263 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISRGLKHG-KNEYITEVKTCSQ 249
           N  S  + LG G FG V       L      M VAVK +        +   ++E+K  S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 250 L-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGT--------------PL 294
           L  H N++ L+G C   G  +++ E+   G L   L  K+ +                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
                   S  +A  + +L     +  +HRD+   NI+       K+ DFGLA  + ++ 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 355 GPRTTGLA-GTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQA 413
                G A   + +MAPE I       + +         +              P   + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVW--SYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 414 IQVLNFETKMPNLPSKMPVAIFE 436
            +++    +M   P   P  +++
Sbjct: 258 YKMIKEGFRML-SPEHAPAEMYD 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-41
 Identities = 62/320 (19%), Positives = 113/320 (35%), Gaps = 66/320 (20%)

Query: 183 PRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILID--LNMAVAVKKISRGL-KHGKNE 239
           P  +   D     N+   +  +G+G FG V +  +    L M  A+K++     K    +
Sbjct: 1   PTIYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 240 YITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSK----------- 287
           +  E++   +L  H N++ L+G C  RG   L  E+ P+G+L   L              
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 288 -KSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL 346
             ST + L+       +  +A  + YL    ++  +HRD+   NI+   ++  K+ DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGR--ARLDV---------------------- 382
           +     E+  + T     + +MA E ++        DV                      
Sbjct: 174 S--RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231

Query: 383 --------------NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPS 428
                                D +  +   C       RPS  Q +  L     +    +
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL--NRMLEERKT 289

Query: 429 KMPVAIFEAPASS-APCSSE 447
            +   ++E    +   CS+E
Sbjct: 290 YVNTTLYEKFTYAGIDCSAE 309

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-41
 Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 57/291 (19%)

Query: 174 NDDLSRDAGPRRFSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKIS 230
           N +L +           L     +F     +G+G FG VY G L+D +   +  AVK ++
Sbjct: 10  NPELVQAVQHVVIGPSSL---IVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 231 RGLKHGK-NEYITEVKTCSQLRHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKK 288
           R    G+ ++++TE        H N+L L+G+C    G  ++V  +M +G L   + ++ 
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124

Query: 289 STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL 348
                 T        L +A  +        +  VHRD+   N M D  F VK+ DFGLA 
Sbjct: 125 H---NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 349 LV---DHELGPRTTGLAGTLGYMAPEYISTGR--ARLDV--------------------- 382
            +   + +     TG    + +MA E + T +   + DV                     
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

Query: 383 ---------------NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN 418
                             E   D L  V L C HP    RPS  + +  ++
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 42/185 (22%), Positives = 77/185 (41%), Gaps = 11/185 (5%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHR 253
           +F   + LG+G F  V     +  +   A+K + +     ++       E    S+L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
             ++L     D  +      +  NG L  ++            T     +  + SAL YL
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYL 124

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE-LGPRTTGLAGTLGYMAPEY 372
           H    + ++HRD+K  NI+ + D ++++ DFG A ++  E    R     GT  Y++PE 
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 373 ISTGR 377
           ++   
Sbjct: 182 LTEKS 186

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-41
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 15/240 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGLKHGKNE-YITEVKTCSQLR 251
                 R +G+G FG V++GI +      +AVA+K           E ++ E  T  Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H ++++LIG+  +     ++ E    G L   L  +K     L   +    +  L++AL 
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALA 122

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           YL     +  VHRDI   N++  ++  VKLGDFGL+  ++     + +     + +MAPE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 372 YISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP 431
            I+  R       D       M   L           +     ++ N E     +P   P
Sbjct: 180 SINFRRFTSAS--DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--LPMPPNCP 235

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 56/249 (22%), Positives = 92/249 (36%), Gaps = 18/249 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN---MAVAVKKISRGL---KHGKNEYITEVKTCSQ 249
            +     KLG G FG V RG     +   ++VAVK +   +       +++I EV     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
           L HRNL++L G+        +V E  P GSL   L   +         T  + ++ +A  
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEG 123

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA--LLVDHELGPRTTGLAGTLGY 367
           + YL     +  +HRD+   N++  T   VK+GDFGL   L  + +             +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLP 427
            APE + T         D       +                 +   ++     ++P  P
Sbjct: 181 CAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-RP 237

Query: 428 SKMPVAIFE 436
              P  I+ 
Sbjct: 238 EDCPQDIYN 246

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 61/296 (20%), Positives = 105/296 (35%), Gaps = 54/296 (18%)

Query: 198 FSNERKLGQGGFGAVYRGILID----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRH 252
           F   + LG G FG VY+G+ I     + + VA+K++          E + E    + + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            ++ +L+G+C       L+ + MP G L  ++   K     +         + +A  + Y
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNY 126

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA-LLVDHELGPRTTGLAGTLGYMAPE 371
           L     R +VHRD+   N++  T  +VK+ DFGLA LL   E      G    + +MA E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 372 YISTGR--------------------------------------ARLDVNFDEQQTDCLM 393
            I                                              +      T  + 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243

Query: 394 IVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVAIFEAPASSAPCSSEPF 449
           ++ + C   D + RP  R+ I   +   KM   P +  V   +        +   F
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSPTDSNF 296

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (355), Expect = 6e-39
 Identities = 41/191 (21%), Positives = 73/191 (38%), Gaps = 7/191 (3%)

Query: 188 YKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-TEVKT 246
           +K      + +     LG G F  V           VA+K I++    GK   +  E+  
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 247 CSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
             +++H N++ L  +    G   L+ + +  G L   +  K       T     ++   +
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQV 116

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
             A+ YLH+        +         D D  + + DFGL+ + D   G   +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 174

Query: 367 YMAPEYISTGR 377
           Y+APE ++   
Sbjct: 175 YVAPEVLAQKP 185

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 18/242 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN------EYITEVKTCSQ 249
           N+FS  R +G+GGFG VY     D     A+K + +     K            +   S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 250 LRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASA 309
                ++ +    H   +   + + M  G L +HL          +       +  +   
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 310 LLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
           L ++H    R VV+RD+K +NI+ D   +V++ D GLA     +   +     GT GYMA
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMA 173

Query: 370 PEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK 429
           PE +  G A  D + D     C++   L    P R  +   +  I  +        LP  
Sbjct: 174 PEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDS 231

Query: 430 MP 431
             
Sbjct: 232 FS 233

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-38
 Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 60/292 (20%)

Query: 183 PRRFSYKDLASA------TNNFSNERKLGQGGFGAVYRGILIDL-----NMAVAVKKISR 231
           P  FS  D+             +  R+LGQG FG VY G+   +        VA+K ++ 
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 232 GLKHG-KNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKK-- 288
                 + E++ E     +    ++++L+G+       +++ E M  G L  +L S +  
Sbjct: 61  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120

Query: 289 ----STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF 344
                   P + +   +++  +A  + YL        VHRD+   N M   DF VK+GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF 177

Query: 345 GLA-LLVDHELGPRTTGLAGTLGYMAPEYISTG--------------------------- 376
           G+   + + +   +       + +M+PE +  G                           
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237

Query: 377 --------RARLDVNFDEQQTDC---LMIVGLWCAHPDRNCRPSIRQAIQVL 417
                   R  ++    ++  +C   L  +   C   +   RPS  + I  +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 19/200 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKIS---------RGLKHGKNEYITEVKTC 247
           N+  +  LG+G    V R I        AVK I            ++  +   + EV   
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 248 SQLR-HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGL 306
            ++  H N++QL         F LV++ M  G L  +L  K      L+     KI   L
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRAL 119

Query: 307 ASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLG 366
              +  LH+     +VHRD+K  NI+ D D N+KL DFG +  +D   G +   + GT  
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPS 174

Query: 367 YMAPEYISTGRARLDVNFDE 386
           Y+APE I          + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGK 194

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-36
 Identities = 41/186 (22%), Positives = 75/186 (40%), Gaps = 12/186 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCS-QLR 251
            +F   + LG+G FG V+       N   A+K + + +    ++    + E +  S    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 252 HRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALL 311
           H  L  +      +     V E++  G L +H+ S          +     +  +   L 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 312 YLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
           +L     + +V+RD+K  NI+ D D ++K+ DFG+            T   GT  Y+APE
Sbjct: 118 FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 372 YISTGR 377
            +   +
Sbjct: 174 ILLGQK 179

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-36
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 8/211 (3%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHG-KNEYITEVKTCSQLRHR 253
              ++N   +G+G +G V         + VA+KKIS           + E+K   + RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N++ +  +        +   ++    +   L+    T   L+          +   L Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV--DHELGPRTTGLAGTLGYMAPE 371
           H      V+HRD+K SN++ +T  ++K+ DFGLA +   DH+     T    T  Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 372 YISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
            +   +     + D     C++   L     
Sbjct: 183 IMLNSKGY-TKSIDIWSVGCILAEMLSNRPI 212

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-35
 Identities = 61/283 (21%), Positives = 100/283 (35%), Gaps = 63/283 (22%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMA-----VAVKKISRGLKHGKN-EYITEVKTCSQ 249
           +     + LG+G FG V       ++       VAVK +  G  H ++   ++E+K    
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 250 -LRHRNLLQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTP------------LT 295
              H N++ L+G C    G  M++ EF   G+L  +L SK++   P            LT
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 296 WTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG 355
                  S  +A  + +L     R  +HRD+   NI+      VK+ DFGLA  +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 356 P-RTTGLAGTLGYMAPEYISTGR------------------ARLDVNFDEQQTDCLMI-- 394
             R       L +MAPE I                      +     +   + D      
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 395 -------------------VGLWCAHPDRNCRPSIRQAIQVLN 418
                                L C H + + RP+  + ++ L 
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 54/255 (21%), Positives = 87/255 (34%), Gaps = 49/255 (19%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE------YITEVKTCSQLR--H 252
              LG GGFG+VY GI +  N+ VA+K + +       E         EV    ++    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             +++L+        F+L+ E        F   +++     L           +  A+ +
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRH 125

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPE 371
                   V+HRDIK  NI+ D +   +KL DFG   L+        T   GT  Y  PE
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179

Query: 372 YISTGRA-------------------------------RLDVNFDEQQTDCLMIVGLWCA 400
           +I   R                                R  V F ++ +     +  WC 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239

Query: 401 HPDRNCRPSIRQAIQ 415
               + RP+  +   
Sbjct: 240 ALRPSDRPTFEEIQN 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 48/241 (19%), Positives = 92/241 (38%), Gaps = 23/241 (9%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN---EYITEVKTCSQLR 251
           ++ +     LG GG   V+    + L+  VAVK +   L    +    +  E +  + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 252 HRNLLQLIGLCHDRGE----FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           H  ++ +               +V E++   +L   + ++     P+T     ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP--RTTGLAGTL 365
            AL +     +  ++HRD+K +NIM      VK+ DFG+A  +        +T  + GT 
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 366 GYMAPEYISTGR--ARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKM 423
            Y++PE        AR DV      +   ++  +    P       +  A Q +  +   
Sbjct: 179 QYLSPEQARGDSVDARSDVY-----SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233

Query: 424 P 424
           P
Sbjct: 234 P 234

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-35
 Identities = 56/283 (19%), Positives = 108/283 (38%), Gaps = 63/283 (22%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLN-------MAVAVKKISRGL-KHGKNEYITEVKTC 247
           +     + LG+G FG V     I L+         VAVK +     +   ++ I+E++  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 248 SQL-RHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTG------------TPL 294
             + +H+N++ L+G C   G   ++ E+   G+L  +L +++  G              L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 295 TWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL 354
           +       +  +A  + YL     +  +HRD+   N++   D  +K+ DFGLA  + H  
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 355 GPRTT-GLAGTLGYMAPEYISTGR--ARLDV----------------------------- 382
             + T      + +MAPE +       + DV                             
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 383 -------NFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN 418
                  +     T+ L ++   C H   + RP+ +Q ++ L+
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-35
 Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 11/179 (6%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
              LG+G FG V+R +          K +       +     E+   +  RHRN+L L  
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHE 68

Query: 261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC 320
                 E ++++EF+    +   +    ++   L           +  AL +LH      
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 321 VVHRDIKFSNIMPDTDFN--VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGR 377
           + H DI+  NI+  T  +  +K+ +FG A  +    G     L     Y APE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDV 179

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (327), Expect = 6e-35
 Identities = 48/237 (20%), Positives = 96/237 (40%), Gaps = 17/237 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRH 252
            +F   R LG G FG V+           A+K + + +     +      E    S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             ++++ G   D  +  ++ +++  G L   L   +    P+      ++        L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-------CLA 116

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           L     + +++RD+K  NI+ D + ++K+ DFG A      +   T  L GT  Y+APE 
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA----KYVPDVTYTLCGTPDYIAPEV 172

Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK 429
           +ST     + + D      L+   +   +       +++   ++LN E + P   ++
Sbjct: 173 VSTK--PYNKSIDWWSFGILIYE-MLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 13/181 (7%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI-----TEVKTCSQLRHRNLL 256
             LG+G F  VY+    + N  VA+KKI  G +    + I      E+K   +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 257 QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE 316
            L+     +    LV++FM          +       LT +      L     L YLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 317 WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTG 376
           W   ++HRD+K +N++ D +  +KL DFGLA           T    T  Y APE +   
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGA 175

Query: 377 R 377
           R
Sbjct: 176 R 176

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-33
 Identities = 49/260 (18%), Positives = 97/260 (37%), Gaps = 25/260 (9%)

Query: 186 FSYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYIT--- 242
           F  +++    + +    +LG G F  V +       +  A K I +         ++   
Sbjct: 3   FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 243 ---EVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTR 299
              EV    +++H N++ L  +  ++ + +L+ E +  G L   L  K+     LT    
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEA 115

Query: 300 YKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD----FNVKLGDFGLALLVDHELG 355
            +    + +    ++      + H D+K  NIM          +K+ DFGLA  +D   G
Sbjct: 116 TEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--G 170

Query: 356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPS-IRQAI 414
                + GT  ++APE ++     L +  D      +  + L  A P            +
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228

Query: 415 QVLNFETKMPNLPSKMPVAI 434
             +N+E +     +   +A 
Sbjct: 229 SAVNYEFEDEYFSNTSALAK 248

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 7e-33
 Identities = 63/237 (26%), Positives = 90/237 (37%), Gaps = 14/237 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNE---YITEVKTCSQLRH 252
           N+F   + LG+G FG V            A+K + + +   K+E    +TE +     RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             L  L            V E+   G L FHL  ++      T          + SAL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH    R VV+RDIK  N+M D D ++K+ DFGL      + G       GT  Y+APE 
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEV 176

Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK 429
           +           D      +M   + C       +   R    +L  E + P   S 
Sbjct: 177 LEDN--DYGRAVDWWGLGVVMYE-MMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-32
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 17/184 (9%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL 256
           ++++ + +G G FG VY+  L D    VA+KK+ +  +        E++   +L H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76

Query: 257 QLIGLCHDRGE------FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASAL 310
           +L    +  GE        LV +++P           ++    L           L  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSL 135

Query: 311 LYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFGLALLVDHELGPRTTGLAGTLGYMA 369
            Y+H      + HRDIK  N++ D D   +KL DFG A  +       +     +  Y A
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRA 190

Query: 370 PEYI 373
           PE I
Sbjct: 191 PELI 194

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 9/183 (4%)

Query: 197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRN 254
           NF    K+G+G +G VY+         VA+KKI      +   +  I E+    +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +++L+ + H   +  LV+EF+      F      S  T +           L   L +  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFC- 118

Query: 315 EEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYIS 374
                 V+HRD+K  N++ +T+  +KL DFGLA      +   T     TL Y APE + 
Sbjct: 119 --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTLWYRAPEILL 175

Query: 375 TGR 377
             +
Sbjct: 176 GCK 178

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-32
 Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 27/241 (11%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLI 259
            + LG G  G V +          A+K +         +   EV+   +  +  ++++++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71

Query: 260 GLCHD----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHE 315
            +  +    R   ++V E +  G L   +  +       T     +I   +  A+ YLH 
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH- 128

Query: 316 EWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
                + HRD+K  N++      +  +KL DFG A           T    T  Y+APE 
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEV 184

Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP-----DRNCRPSIRQAIQVLNFETKMPNLP 427
           +     + D + D      +M + L    P          P ++  I++  +E   P   
Sbjct: 185 LGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 428 S 428
            
Sbjct: 243 E 243

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  118 bits (296), Expect = 8e-31
 Identities = 40/248 (16%), Positives = 84/248 (33%), Gaps = 23/248 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
            ++   R++G+G FG ++ G  +  N  VA+K   R  +    +   E +T   L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 256 L-QLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  +     +    +LV + +     D         G   +  T    +  + + +  +H
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 315 EEWKRCVVHRDIKFSNIMPD-----TDFNVKLGDFGLALLVDHELG------PRTTGLAG 363
           E   + +V+RDIK  N +           + + DFG+       +            L+G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 364 TLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKM 423
           T  YM+               D +    + +  L  + P +  + +  +       E K 
Sbjct: 176 TARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 424 PNLPSKMP 431
                ++ 
Sbjct: 234 STPLRELC 241

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (296), Expect = 9e-31
 Identities = 42/192 (21%), Positives = 67/192 (34%), Gaps = 19/192 (9%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL 255
           N +   RK+G G FG +Y G  I     VA+K      KH   +   E K    ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 256 LQLIGLC-HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLH 314
           +  I  C  +    ++V E +     D   F  +      +  T   ++  + S + Y+H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIH 120

Query: 315 EEWKRCVVHRDIKFSNIM---PDTDFNVKLGDFGLALLVDHELG------PRTTGLAGTL 365
               +  +HRD+K  N +         V + DFGLA                   L GT 
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 366 GYMAPEYISTGR 377
            Y +        
Sbjct: 178 RYASINTHLGIE 189

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-30
 Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 20/195 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGK--NEYITEVKTCSQLRHR 253
           + +    K+GQG FG V++         VA+KK+    +        + E+K    L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 254 NLLQLIGLCHD--------RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLG 305
           N++ LI +C          +G   LV++F  +                 T +   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRV--- 122

Query: 306 LASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD---HELGPRTTGLA 362
           +   L  L+   +  ++HRD+K +N++   D  +KL DFGLA       +    R T   
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 363 GTLGYMAPEYISTGR 377
            TL Y  PE +   R
Sbjct: 183 VTLWYRPPELLLGER 197

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 22/215 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHR 253
             + + + +G G +GAV   +       VA+KK+ R    +        E++    +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 254 NLLQLIGLCHDRG------EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           N++ L+ +           +F LV  FM  G+    L   +     L       +   + 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----KLGEDRIQFLVYQML 131

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             L Y+H      ++HRD+K  N+  + D  +K+ DFGLA     +     TG   T  Y
Sbjct: 132 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYVVTRWY 184

Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
            APE I     R     D     C+M   +     
Sbjct: 185 RAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 42/195 (21%), Positives = 77/195 (39%), Gaps = 19/195 (9%)

Query: 194 ATNNFSNERKLGQGGFGAVYRGI-LIDLNMAVAVKKISRGLKHGKNEY-----ITEVKTC 247
           A   +    ++G+G +G V++   L +    VA+K++                +  ++  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 248 SQLRHRNLLQLIGLCHD-----RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKI 302
               H N+++L  +C         +  LV+E +      +     +     +   T   +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121

Query: 303 SLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLA 362
              L   L +LH      VVHRD+K  NI+  +   +KL DFGLA +   ++   +    
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--V 176

Query: 363 GTLGYMAPEYISTGR 377
            TL Y APE +    
Sbjct: 177 VTLWYRAPEVLLQSS 191

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  113 bits (282), Expect = 5e-29
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 12/209 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKI--SRGLKHGKNEYITEVKTCSQLRHR 253
             +    K+G+G +G VY+          A+KKI   +  +   +  I E+    +L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L  + H +   +LV+E +           +      L   T     L L + + Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYC 116

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
           H+   R V+HRD+K  N++ + +  +K+ DFGLA         + T    TL Y AP+ +
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVL 172

Query: 374 STGRARLDVNFDEQQTDCLMIVGLWCAHP 402
             G  +     D     C+    +     
Sbjct: 173 -MGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-28
 Identities = 41/209 (19%), Positives = 81/209 (38%), Gaps = 11/209 (5%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHR 253
             +    K+G+G +G V++    + +  VA+K++      +   +  + E+    +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 254 NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYL 313
           N+++L  + H   +  LV+EF       +                   +   L   L  L
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGL 114

Query: 314 HEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYI 373
                R V+HRD+K  N++ + +  +KL +FGLA           +    TL Y  P+ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVL 173

Query: 374 STGRARLDVNFDEQQTDCLMIVGLWCAHP 402
              +     + D     C+         P
Sbjct: 174 FGAK-LYSTSIDMWSAGCIFAELANAGRP 201

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (282), Expect = 2e-28
 Identities = 40/185 (21%), Positives = 70/185 (37%), Gaps = 14/185 (7%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEY---ITEVKTCSQLRH 252
           + F   + LG G FG V      +     A+K + +       +    + E +    +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
             L++L     D     +V E++  G +  HL          +       +  +     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEY 156

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           LH      +++RD+K  N++ D    +++ DFG A  V      RT  L GT   +APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEI 209

Query: 373 ISTGR 377
           I +  
Sbjct: 210 ILSKG 214

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-28
 Identities = 59/244 (24%), Positives = 92/244 (37%), Gaps = 15/244 (6%)

Query: 196 NNFSNERKLGQGGFGAVYRGILI---DLNMAVAVKKISRGLKHGKNEYI----TEVKTCS 248
            NF   + LG G +G V+    I   D     A+K + +     K +      TE +   
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 249 QLRHR-NLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            +R    L+ L        +  L+ +++  G L  HL  ++            +I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             +L L    K  +++RDIK  NI+ D++ +V L DFGL+     +   R     GT+ Y
Sbjct: 139 --VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 368 MAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLP 427
           MAP+ +  G +  D   D      LM   L  A P         QA          P  P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 428 SKMP 431
            +M 
Sbjct: 257 QEMS 260

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  108 bits (271), Expect = 4e-27
 Identities = 49/207 (23%), Positives = 76/207 (36%), Gaps = 22/207 (10%)

Query: 173 VNDDLSRDAGPRRFSYKDLASATNNFSN---ERKLGQGGFGAVYRGILIDLNMAVAVKKI 229
           V  D++       + Y+       N  +    RKLG+G +  V+  I I  N  V VK +
Sbjct: 9   VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68

Query: 230 SRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGE--FMLVYEFMPNGSLDFHLFS 286
                  K +   E+K    LR   N++ L  +  D       LV+E + N         
Sbjct: 69  K---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-- 123

Query: 287 KKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN-VKLGDFG 345
                  LT          +  AL Y H      ++HRD+K  N+M D +   ++L D+G
Sbjct: 124 -----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175

Query: 346 LALLVDHELGPRTTGLAGTLGYMAPEY 372
           LA       G        +  +  PE 
Sbjct: 176 LAEFYHP--GQEYNVRVASRYFKGPEL 200

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 46/210 (21%), Positives = 75/210 (35%), Gaps = 10/210 (4%)

Query: 195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRH 252
              + N   +G G +G+V         + VAVKK+SR  +   +      E++    ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLY 312
            N++ L+ +           +      L     +       LT      +   +   L Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 313 LHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEY 372
           +H        HRD+K SN+  + D  +K+ DFGLA           TG   T  Y APE 
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEI 189

Query: 373 ISTGRARLDVNFDEQQTDCLMIVGLWCAHP 402
           +       +   D     C+M   L     
Sbjct: 190 ML-NWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 3e-25
 Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 20/187 (10%)

Query: 196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKN--EYITEVKTCSQLRHR 253
             + N + +G G  G V       L+  VA+KK+SR  ++  +      E+     + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 254 NLLQLIGLCHDRG------EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
           N++ L+ +   +       +  LV E M                  L       +   + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQML 129

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPRTTGLAGTLGY 367
             + +LH       +HRD+K SNI+  +D  +K+ DFGLA           T    T  Y
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYY 184

Query: 368 MAPEYIS 374
            APE I 
Sbjct: 185 RAPEVIL 191

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score = 92.5 bits (229), Expect = 5e-22
 Identities = 38/140 (27%), Positives = 57/140 (40%), Gaps = 19/140 (13%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
           P    GG+ GLFN T    SS   V VEFD+  +P          +GI+ + + S    R
Sbjct: 99  PLRRAGGYFGLFNDTKCD-SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER 157

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
           WN  +   + A+V+I Y +++K L+AS +Y          +                  S
Sbjct: 158 WNKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGS 217

Query: 108 TGR-YTERHVLKSWEFNSTL 126
           T       H + +W F ST 
Sbjct: 218 TYIGRQATHEVLNWYFTSTF 237

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score = 91.3 bits (226), Expect = 1e-21
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 20/141 (14%)

Query: 5   PSNSPGGFLGLFNSTTA-KLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
                G +LGLFN +TA + S + +V VEFD+++NP +   +    +GIN +SIVS    
Sbjct: 97  DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSY-RHIGINVNSIVSVATK 155

Query: 64  RW-NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS-----------QEN-----TT 106
           RW ++   SG  A  +I Y+ + + L+   SY +   Y             E+     + 
Sbjct: 156 RWEDSDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISA 215

Query: 107 STGRYT-ERHVLKSWEFNSTL 126
           STG        + SW F+S L
Sbjct: 216 STGNNQFLTVYILSWRFSSNL 236

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.8 bits (229), Expect = 2e-21
 Identities = 45/246 (18%), Positives = 80/246 (32%), Gaps = 21/246 (8%)

Query: 201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIG 260
            RKLG G F  V+    +  N  VA+K + RG K        E+K   ++   +  +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 261 LCHDRG-EFMLVYEFMPNGSLDFHL-----------FSKKSTGTPLTWTTRYKISLGLAS 308
           +  +   + +  +       +   +             KK     +      +IS  L  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 309 ALLYLHEEWKRCVVHRDIKFSNIMPDT-DFNVKLGDFGLALLVDH-ELGPRTTGLAGTLG 366
            L Y+H   +  ++H DIK  N++ +  D    L    +A L +        T    T  
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 367 YMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP--DRNCRPSIRQAIQVLNFETKMP 424
           Y +PE +           D   T CL+   +               +    +      + 
Sbjct: 195 YRSPEVLLGAPW--GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 425 NLPSKM 430
            LPS +
Sbjct: 253 ELPSYL 258

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score = 89.4 bits (221), Expect = 5e-21
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 23/147 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIVS 59
             QIPS S  G  GLF+S+ +K SS+ I+ VEFD++    ++P +     +GI+ +SI S
Sbjct: 94  NSQIPSGSSAGMFGLFSSSDSK-SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKS 152

Query: 60  SVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT------------- 106
               +W+  + +G+ A V I Y + TK+L+   SY      +    +             
Sbjct: 153 IKTVKWD--WRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSV 210

Query: 107 ----STGRYT--ERHVLKSWEFNSTLD 127
                 G     E H + SW F S L+
Sbjct: 211 GFSGGVGNAAEFETHDVLSWYFTSNLE 237

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score = 89.0 bits (220), Expect = 7e-21
 Identities = 43/147 (29%), Positives = 60/147 (40%), Gaps = 27/147 (18%)

Query: 2   FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSV 61
           F +P NSP G  G                VEFD+F N  WDP      +GI+ +SIVSS 
Sbjct: 93  FMVPPNSPQGEDGGNLGVFKPPEGDNAFAVEFDTFQNT-WDPQV--PHIGIDVNSIVSSK 149

Query: 62  YTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKY--------------SQEN--- 104
              +     +G  A+V IKY+S TK L+   ++                    + E    
Sbjct: 150 TLHFQ--LENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNV 207

Query: 105 --TTSTG---RYTERHVLKSWEFNSTL 126
             + +TG      E H + SW F S+L
Sbjct: 208 GLSATTGYQKNAVETHEIISWSFTSSL 234

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score = 89.0 bits (220), Expect = 8e-21
 Identities = 45/141 (31%), Positives = 62/141 (43%), Gaps = 20/141 (14%)

Query: 5   PSNSPGGFLGLFNSTTA-KLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT 63
                GGFLGLF   TA   S + +V VEFD++ N +W+       +GI+ +SIVS   T
Sbjct: 101 SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPY-PHIGIDVNSIVSVATT 159

Query: 64  RW-NASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS-----------QEN-----TT 106
           RW N   +    A   I Y++ +K L+   SY     Y             +      + 
Sbjct: 160 RWENDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSA 219

Query: 107 STGRYTERHVLKSWEFNSTLD 127
             G Y E   + SW F STLD
Sbjct: 220 GVG-YDEVTYILSWHFFSTLD 239

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 2e-19
 Identities = 24/166 (14%), Positives = 52/166 (31%), Gaps = 30/166 (18%)

Query: 202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRGL----------KHGKNEYITEVKTCSQLR 251
           + +G+G   AV+            VK    G            +G   +       ++  
Sbjct: 6   KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 252 HRNLLQLIGLC----HDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLA 307
            R L +L GL     +      ++ E +    L                    ++   + 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMIL 113

Query: 308 SALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE 353
             +   +    R +VH D+   N++  ++  + + DF  ++ V  E
Sbjct: 114 EEVAKFYH---RGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEE 155

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score = 84.3 bits (208), Expect = 3e-19
 Identities = 37/142 (26%), Positives = 58/142 (40%), Gaps = 25/142 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                 G+LG+FN++    +S   + VEFD+FSNP   P      +GI+ +SI S     
Sbjct: 101 KPAQGYGYLGVFNNSKQD-NSYQTLAVEFDTFSNPWDPPQV--PHIGIDVNSIRSIKTQP 157

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
           +     +G  A+V IKY++ +K L     Y  +                          +
Sbjct: 158 FQ--LDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGA 215

Query: 108 TGRY---TERHVLKSWEFNSTL 126
           TG      E H + SW F ++L
Sbjct: 216 TGAQRDAAETHDVYSWSFQASL 237

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 82.3 bits (203), Expect = 2e-18
 Identities = 35/135 (25%), Positives = 51/135 (37%), Gaps = 21/135 (15%)

Query: 25  SSPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNS 83
           +  IV VE D++ N +  DP      +GI+  S+ S    +WN    +G      I YNS
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSY--PHIGIDIKSVRSKKTAKWN--MQNGKVGTAHIIYNS 56

Query: 84  ATKNLSASWSYGETPKYSQEN----------------TTSTGRYTERHVLKSWEFNSTLD 127
             K LSA  SY      +                   + STG Y E + + SW F S L 
Sbjct: 57  VDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK 116

Query: 128 IKEINGRETIKIKVD 142
               +    +    +
Sbjct: 117 SNSTHETNALHFMFN 131

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.5 bits (198), Expect = 5e-18
 Identities = 46/142 (32%), Positives = 63/142 (44%), Gaps = 27/142 (19%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                GGFLGLF+ +    S+   V VEFD+  N +WDP      +GI+ +SI S   TR
Sbjct: 98  QPKDKGGFLGLFDGSN---SNFHTVAVEFDTLYNKDWDPTE--RHIGIDVNSIRSIKTTR 152

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
           W+  F +G+ A V I Y+S+T  L AS  Y         + T                 +
Sbjct: 153 WD--FVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSAT 210

Query: 108 TG---RYTERHVLKSWEFNSTL 126
           TG      E + + SW F S L
Sbjct: 211 TGINKGNVETNDVLSWSFASKL 232

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score = 81.0 bits (199), Expect = 6e-18
 Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 20/144 (13%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSS-PIVLVEFDSFSNPEWDPINVKDD-VGINNSSIV 58
              IPS S GG LGLF   TA+ +S+  ++ VEFD+F   + +  +     +GI+ +SI 
Sbjct: 96  DTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIR 155

Query: 59  SSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQEN-------------- 104
           S    +W+     G + +V + +N +T+NL    +Y +  +Y                  
Sbjct: 156 SVKTVKWD--RRDGQSLNVLVTFNPSTRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRV 213

Query: 105 --TTSTGRYTERHVLKSWEFNSTL 126
             + ++G   + H L+SW F STL
Sbjct: 214 GFSAASGEQYQTHTLESWSFTSTL 237

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score = 80.5 bits (198), Expect = 7e-18
 Identities = 47/142 (33%), Positives = 64/142 (45%), Gaps = 25/142 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              S  GFLG+F+S     +S+  V VEFD+FSN +WDP +    +GI+ +SI S     
Sbjct: 97  EPKSNSGFLGVFDSDVYD-NSAQTVAVEFDTFSNTDWDPTS--RHIGIDVNSIKSIRTAS 153

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPK------------YSQEN-----TTS 107
           W     +G  A + I YN+AT  L AS  +                    E      + +
Sbjct: 154 WG--LANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSAT 211

Query: 108 TGR---YTERHVLKSWEFNSTL 126
           TG    YTE H + SW F S L
Sbjct: 212 TGLSEGYTETHDVLSWSFASKL 233

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score = 79.8 bits (196), Expect = 1e-17
 Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 20/136 (14%)

Query: 8   SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNA 67
             G   G     +    +   V VEFD++SN E++     D VGI+ +S+ S     WN 
Sbjct: 97  PAGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPP-TDHVGIDVNSVDSVKTVPWN- 154

Query: 68  SFHSGDTAHVKIKYNSATKNLSASWSYGETPKYS-----------QEN-----TTSTGR- 110
              SG    V + Y+S+TK LS + +       +            E      + S    
Sbjct: 155 -SVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLG 213

Query: 111 YTERHVLKSWEFNSTL 126
             + H+++SW F STL
Sbjct: 214 GRQIHLIRSWSFTSTL 229

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score = 77.1 bits (189), Expect = 1e-16
 Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 29/146 (19%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
           P N+  G  G +      LS  P V VEFD+F N     I     +GI+ +S++S+    
Sbjct: 95  PPNTQTGEGGGYFGIYNPLSPYPFVAVEFDTFRNTWDPQIP---HIGIDVNSVISTKTVP 151

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPK------------YSQEN-----TTS 107
           +     +G  A+V IKY+++TK L     +                    E+     + +
Sbjct: 152 FT--LDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAA 209

Query: 108 TG-------RYTERHVLKSWEFNSTL 126
           TG         TE H + SW F+++L
Sbjct: 210 TGDPSGKQRNATETHDILSWSFSASL 235

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score = 76.3 bits (187), Expect = 2e-16
 Identities = 45/146 (30%), Positives = 65/146 (44%), Gaps = 23/146 (15%)

Query: 1   GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDD-VGINNSSIVS 59
             QIPS S   +LGLFN++ +  SS+ IV VEFD++    +DP +     +GI+ + I S
Sbjct: 97  DSQIPSGSVSKYLGLFNNSNSD-SSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIES 155

Query: 60  SVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT------------- 106
               +W+  + +G  A   I Y +  K L AS  Y           +             
Sbjct: 156 IKTVQWD--WINGGVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRV 213

Query: 107 ----STGRYT--ERHVLKSWEFNSTL 126
               +TG  T  E H + SW F STL
Sbjct: 214 GFSAATGYPTEVETHDVLSWSFTSTL 239

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 76.7 bits (188), Expect = 2e-16
 Identities = 42/146 (28%), Positives = 54/146 (36%), Gaps = 24/146 (16%)

Query: 6   SNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRW 65
              P    G         S   +V VEFD+F N  WDP N    +GIN +SI S   T W
Sbjct: 98  DTKPQTHAGYLGLFNENESGDQVVAVEFDTFRNS-WDPPN--PHIGINVNSIRSIKTTSW 154

Query: 66  NASFHSGDTAHVKIKYNSATKNLSASWSYGETP------------KYSQEN-----TTST 108
           +    +   A V I Y+++T  L AS  Y                    E      + +T
Sbjct: 155 D--LANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAAT 212

Query: 109 GRYT--ERHVLKSWEFNSTLDIKEIN 132
           G     E H + SW F S L     N
Sbjct: 213 GLDIPGESHDVLSWSFASNLPHASSN 238

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 73.6 bits (180), Expect = 1e-15
 Identities = 30/142 (21%), Positives = 52/142 (36%), Gaps = 31/142 (21%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                G +LGLFN+T            + D+ +          + + I+ +SI       
Sbjct: 95  RPKLKGRYLGLFNTTN----------YDRDAHTVAVVFDTV-SNRIEIDVNSIRPIATES 143

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
            N   ++G+ A V+I Y+S   +L  S  Y  + +    + T                 +
Sbjct: 144 CNFGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSAT 203

Query: 108 TG---RYTERHVLKSWEFNSTL 126
           +G     TE H + SW F+S  
Sbjct: 204 SGSKKETTETHNVLSWSFSSNF 225

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score = 73.7 bits (180), Expect = 1e-15
 Identities = 45/142 (31%), Positives = 64/142 (45%), Gaps = 25/142 (17%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
                GG LG+F        S+ IV VEFD+FSN +WDP      +GIN +SI S     
Sbjct: 99  QPLDLGGMLGIFKDGYFN-KSNQIVAVEFDTFSNGDWDPKG--RHLGINVNSIESIKTVP 155

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
           WN  + +G+ A+V I Y ++TK+L+AS  Y         +                   +
Sbjct: 156 WN--WTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSAT 213

Query: 108 TG---RYTERHVLKSWEFNSTL 126
           TG    Y + + + SW F S L
Sbjct: 214 TGIDKGYVQTNDVLSWSFESNL 235

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score = 71.3 bits (174), Expect = 8e-15
 Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 26/142 (18%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              + GGFLGLF       +S   V VEFD++SN  WDP      +GI+ + I S   T 
Sbjct: 97  QPQARGGFLGLFADRAHD-ASYQTVAVEFDTYSNA-WDPNY--THIGIDTNGIESKKTTP 152

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPK------------YSQEN-----TTS 107
           ++     G+ A++ I Y ++TK L+AS  +  +                 E      + +
Sbjct: 153 FD--MVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSAT 210

Query: 108 TGR---YTERHVLKSWEFNSTL 126
           TG      E H + SW F  +L
Sbjct: 211 TGLNAGVVETHDIVSWSFAVSL 232

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score = 65.2 bits (158), Expect = 1e-12
 Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 31/142 (21%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
           P      FLG+FN+   +  ++  V V F++F          K+ +  + + I   V   
Sbjct: 97  PPQKKQEFLGIFNTNNPE-PNARTVAVVFNTF----------KNRIDFDKNFIKPYVNEN 145

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
            +   ++G+   V+I Y+S+  +L     +  +      + T                 +
Sbjct: 146 CDFHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPT 205

Query: 108 TG---RYTERHVLKSWEFNSTL 126
           +G     TE H + SW F+S  
Sbjct: 206 SGLTEDTTETHDVLSWSFSSKF 227

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.7 bits (136), Expect = 5e-10
 Identities = 37/141 (26%), Positives = 51/141 (36%), Gaps = 31/141 (21%)

Query: 5   PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTR 64
              +    L          S    V VEFD+F +          DV  N+   V      
Sbjct: 74  RQANSAVGLDFVLVPVQPESKGDTVTVEFDTFLSRISI------DVNNNDIKSVP----- 122

Query: 65  WNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQENTT-----------------S 107
           W+   + G  A V+I YNS+TK  S S S   T K +  +TT                 +
Sbjct: 123 WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSAT 182

Query: 108 TGRY---TERHVLKSWEFNST 125
           +G Y    E H + SW F+S 
Sbjct: 183 SGAYQWSYETHDVLSWSFSSK 203

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 1e-06
 Identities = 24/148 (16%), Positives = 37/148 (25%), Gaps = 33/148 (22%)

Query: 2   FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSV 61
           +       G   G              V + FDSF N +    N    V  NN  I    
Sbjct: 86  YTENQGLDGPVFGS-------ADMWNGVGIFFDSFDN-DGKKNNPAIVVVGNNGQINYDH 137

Query: 62  YTRWNASFHS-------GDTAHVKIKYNSATKNLSASWSYGETPKYSQEN---------- 104
                    +            V+ K     K L+   + G TP  +             
Sbjct: 138 QNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVI 197

Query: 105 --------TTSTGRYTERHVLKSWEFNS 124
                   + +TG   + H + S+    
Sbjct: 198 PTQGHFGISAATGGLADDHDVLSFLTFQ 225

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	459
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	99.92
d1leda_	243	Legume lectin {West-central african legume (Griffo	99.92
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	99.91
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	99.9
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	99.9
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	99.89
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	99.89
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	99.87
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	99.87
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.86
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	99.86
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	99.85
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	99.85
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	99.85
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	99.84
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	99.83
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	99.81
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.68
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.67
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.89
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.03
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	97.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.45

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-48  Score=374.89  Aligned_cols=204  Identities=25%  Similarity=0.417  Sum_probs=179.8

Q ss_pred             CHHHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCC
Q 041624          187 SYKDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG  266 (459)
Q Consensus       187 ~~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~  266 (459)
                      .+++++...++|+..+.||+|+||+||+|++..+++.||||+++.. ....++|.+|+++|++++|||||+++++|.+.+
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            3344555567888899999999999999999998999999999764 345678999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      ..++|||||++|+|.+++.....  ..+++..++.|+.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             eeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccc
Confidence            99999999999999999875433  369999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+..............||+.|+|||++.++.  ++.++|+||+|++++++++
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~  211 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIAT  211 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHT
T ss_pred             eeecCCCCceeeccccccccccChHHHcCCC--CCchhhhhhHHHHHHHHHh
Confidence            9987655444445566899999999998764  5778999999999999887

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=366.37  Aligned_cols=216  Identities=22%  Similarity=0.252  Sum_probs=183.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++... ....+++.+|++++++++||||+++++++.+++..|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357899999999999999999999999999999997653 3345679999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ||++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999996543    59999999999999999999999   99999999999999999999999999999877543


Q ss_pred             CC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          354 LG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       354 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      .. ......+||+.|||||++.+... .+.++|+||+|+++++|+++..|+...............
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~  221 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE  221 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT
T ss_pred             CccccccceeeCcCccCHhHhcCCCC-CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence            22 22456789999999999986543 356689999999999999988888776655554444433

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=364.93  Aligned_cols=193  Identities=27%  Similarity=0.458  Sum_probs=160.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|+..+.||+|+||.||+|.+.+ +..||||+++.. ....++|.+|++++.+++||||++++|+|.+++..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            567888999999999999999976 678999999764 345678999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.....   .+++..++.|+.|||.||+|||+   ++|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            99999999876544   68999999999999999999999   9999999999999999999999999999988765544


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .......||+.|+|||++.++.  ++.++|+||+|++++++++
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t  197 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFS  197 (263)
T ss_dssp             --------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             eeecceecCcccCChHHhcCCC--CCchhhhcchHHHHHHHHH
Confidence            4445567999999999998764  5778999999999999887

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-47  Score=369.66  Aligned_cols=224  Identities=25%  Similarity=0.409  Sum_probs=170.3

Q ss_pred             cCHHHHHHHhcCC---------CCCceeccCCceEEEEEEEcCCCc---EEEEEEeccCC-ccchHHHHHHHHHHhccCc
Q 041624          186 FSYKDLASATNNF---------SNERKLGQGGFGAVYRGILIDLNM---AVAVKKISRGL-KHGKNEYITEVKTCSQLRH  252 (459)
Q Consensus       186 ~~~~el~~~~~~f---------~~~~~Lg~G~fg~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H  252 (459)
                      |+|+++..++.+|         +..++||+|+||+||+|.++.+++   .||||++.... ....++|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            5566666665444         456899999999999999976553   68999987653 3456789999999999999


Q ss_pred             CCceeEEEEEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCee
Q 041624          253 RNLLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIM  332 (459)
Q Consensus       253 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NIL  332 (459)
                      ||||+++|+|.+.+..++|||||++|+|.+++.....   .+++.+++.|+.|||+||+|||+   ++|+||||||+|||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL  160 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence            9999999999999999999999999999998876543   69999999999999999999999   99999999999999


Q ss_pred             ecCCCCEEEeecCCcccccCCCCCc----cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCC
Q 041624          333 PDTDFNVKLGDFGLALLVDHELGPR----TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCR  407 (459)
Q Consensus       333 l~~~~~~kL~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~R  407 (459)
                      |+.++.+||+|||+|+.+.......    .....||+.|||||.+.++.  ++.++|+||+|++++++++ +..|+... 
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-  237 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDM-  237 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTC-
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC--CCcccccccchHHHHHHHhCCCCCCCCC-
Confidence            9999999999999998775432222    22345799999999998764  5778899999999999987 34444433 


Q ss_pred             CCHHHHHHHHhc
Q 041624          408 PSIRQAIQVLNF  419 (459)
Q Consensus       408 Ps~~~v~~~L~~  419 (459)
                       +..++++.+..
T Consensus       238 -~~~~~~~~i~~  248 (299)
T d1jpaa_         238 -TNQDVINAIEQ  248 (299)
T ss_dssp             -CHHHHHHHHHT
T ss_pred             -CHHHHHHHHHc
Confidence             23444444443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=365.62  Aligned_cols=215  Identities=25%  Similarity=0.380  Sum_probs=179.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ..++|+..+.||+|+||.||+|.+++ ++.||||+++.. ....++|.+|++++.+++|||||+++|++.+ +..++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            34678888999999999999999875 788999999754 3456789999999999999999999998855 56799999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+++|+|.+++.....  ..+++.++++|+.||++||+|||+   ++|+||||||+||||++++.+||+|||+|+.+...
T Consensus        88 y~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999998765432  259999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .........||+.|+|||++.++.  ++.++|+||+|+++++|+++..|.... .+..++++.+..
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~-~~~~~~~~~i~~  225 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLER  225 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHT
T ss_pred             ccccccccCCcccccChHHHhCCC--CCchhhhhhhHHHHHHHHhCCCCCCCC-CCHHHHHHHHHh
Confidence            434445677999999999998764  577889999999999999844433222 244555555543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=361.46  Aligned_cols=200  Identities=25%  Similarity=0.327  Sum_probs=179.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|+..+.||+|+||.||+|.+..+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999998765566778999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++...     .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~  170 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-Q  170 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-T
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccc-c
Confidence            999999887542     59999999999999999999999   99999999999999999999999999999887543 2


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ......+||+.|+|||++.++.  ++.++|+||+|+++|+|+++..|+...
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccccccccCCCccChhhhcCCC--CCchhceehHhHHHHHHhhCCCCCCCC
Confidence            3345678999999999998754  578899999999999999987777543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=363.83  Aligned_cols=215  Identities=26%  Similarity=0.381  Sum_probs=173.6

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ..++|...+.||+|+||.||+|+++   ..||||+++..  .....++|.+|+.++.+++|||||++++++.+ +.+++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            3578899999999999999999864   35999999754  34456789999999999999999999998754 568999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||||++|+|.+++.....   .+++..++.|+.|||+||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999976543   69999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCC-CccccccccccccccceeccCcc-ccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HELG-PRTTGLAGTLGYMAPEYISTGRA-RLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~~-~~~~~~~gt~~y~APE~~~~~~~-~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .... .......||+.|||||++.+... .++.++|+||+|+++++|+++..|++... ...++...+..
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~  224 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGR  224 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHH
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhc
Confidence            4322 23456789999999999975432 35778899999999999999777766543 33344444443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=355.99  Aligned_cols=221  Identities=28%  Similarity=0.366  Sum_probs=190.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.+.   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688999999999999999999999999999998643   2334667899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999997654    59999999999999999999999   9999999999999999999999999999986653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                      .   ......||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++++.+....  +.+|+..|.
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~  229 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVE--FTFPDFVTE  229 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTC--CCCCTTSCH
T ss_pred             C---cccccCCCCcccCHHHHcCCC--CCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC--CCCCccCCH
Confidence            2   344578999999999998753  578899999999999999999998654  6677776654332  234444553

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=362.55  Aligned_cols=229  Identities=24%  Similarity=0.354  Sum_probs=193.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      +.|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888899999999999999999999999999998776777789999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.+...   .+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus        92 ~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~  164 (288)
T d2jfla1          92 AGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I  164 (288)
T ss_dssp             TTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence            99999998876543   69999999999999999999999   99999999999999999999999999999765432 1


Q ss_pred             CccccccccccccccceeccC---ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          356 PRTTGLAGTLGYMAPEYISTG---RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~---~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                      .......||+.|+|||++...   ...++.++|+||+|+++++|+++..|+....+ ...+.+.+....+....|...+.
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-GGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCCCCCccccCCH
Confidence            123457899999999998532   22467789999999999999999998876543 33444555555544444555553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=361.38  Aligned_cols=231  Identities=23%  Similarity=0.294  Sum_probs=179.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee--CCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--RGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV  271 (459)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|+++...  ....+.+.+|++++.+++||||+++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999999999999999997653  2345678999999999999999999999864  4568999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW--KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      ||||++|+|.+++.........+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998764333347999999999999999999999821  12499999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                      +... ........||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++.+.+... ..+++|..
T Consensus       164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~~-~~~~~~~~  237 (269)
T d2java1         164 LNHD-TSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREG-KFRRIPYR  237 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHT-CCCCCCTT
T ss_pred             cccC-CCccccCCCCcccCCHHHHcCCC--CChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHcC-CCCCCCcc
Confidence            7643 22345678999999999997654  578899999999999999999998754  556666665433 33455656


Q ss_pred             CCc
Q 041624          430 MPV  432 (459)
Q Consensus       430 ~p~  432 (459)
                      .+.
T Consensus       238 ~s~  240 (269)
T d2java1         238 YSD  240 (269)
T ss_dssp             SCH
T ss_pred             cCH
Confidence            553

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=349.88  Aligned_cols=223  Identities=23%  Similarity=0.314  Sum_probs=189.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      ++|+..++||+|+||+||+|+++ +++.||||+++... ...++|++|+.++.+++||||++++|+|.+++.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            68899999999999999999996 47899999998653 45678999999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.....   .+++..+.+++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999999876654   68999999999999999999999   9999999999999999999999999999987765544


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      .......||+.|+|||.+.++.  ++.++|+||+|+++++|++ +..|+...  +..++.+.+..... ++.|...|
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~-~~~p~~~~  227 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLR-LYRPHLAS  227 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCC-CCCCTTCC
T ss_pred             eeecccCCCCCcCCcHHhcCCC--CCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCC-CCCccccc
Confidence            4455677999999999998765  5778999999999999986 55555433  56666666554333 33455555

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-46  Score=356.31  Aligned_cols=217  Identities=26%  Similarity=0.451  Sum_probs=178.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCC----cEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLN----MAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      +.|+..++||+|+||.||+|.++.++    ..||||+++.... ....+|.+|++++.+++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            56778899999999999999987644    4799999976533 345679999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      |||||.+|+|.+++.....   .+++.+++.++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999988876544   69999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------
Q 041624          351 DHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------  398 (459)
Q Consensus       351 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------  398 (459)
                      ......  ......||+.|+|||++.++.  ++.++|+||+|+++++|++                              
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  238 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  238 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCC--CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhh
Confidence            543222  233457899999999998764  5778899999999998876                              


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ----------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ----------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                |++++|.+||+|.+|+++|+..
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence                      7788888888888888877653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=364.25  Aligned_cols=203  Identities=25%  Similarity=0.308  Sum_probs=179.3

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|+++... ....+++.+|+.+|++++|||||+++++|.+.+.+++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999999999999999997653 334567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|.+++.+..    .+++..+..++.||+.||.|||+  +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999997654    59999999999999999999997  24899999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      .   .....+||+.|+|||++.+..  ++.++|+||+||++++|+++..|++...
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             C---ccccccCCccccCchHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            2   234578999999999998764  6888999999999999999998886543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=353.29  Aligned_cols=226  Identities=23%  Similarity=0.354  Sum_probs=183.8

Q ss_pred             cCCCCCce-eccCCceEEEEEEEcC--CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERK-LGQGGFGAVYRGILID--LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~-Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|...+. ||+|+||.||+|.++.  ++..||||+++... ....++|.+|+++|.+++|||||+++|++.+ +.++||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45556664 9999999999998764  35589999997654 3446789999999999999999999999865 568999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||||++|+|.+++.....   .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999998865543   69999999999999999999999   999999999999999999999999999999875


Q ss_pred             CCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 041624          352 HELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPS  428 (459)
Q Consensus       352 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~  428 (459)
                      ......  .....||+.|+|||++.++.  ++.++|+||+|++++++++ +..|++...  ..++++.+.... .|+.|+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~-~~~~p~  235 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGK-RMECPP  235 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTC-CCCCCT
T ss_pred             ccccccccccccccCccccChHHHhCCC--CCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCCC
Confidence            432222  23456899999999998764  5778899999999999997 677777653  456666665433 344566


Q ss_pred             CCCcc
Q 041624          429 KMPVA  433 (459)
Q Consensus       429 ~~p~~  433 (459)
                      ..|..
T Consensus       236 ~~~~~  240 (285)
T d1u59a_         236 ECPPE  240 (285)
T ss_dssp             TCCHH
T ss_pred             cCCHH
Confidence            66643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-46  Score=355.36  Aligned_cols=217  Identities=26%  Similarity=0.378  Sum_probs=182.0

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|+++++ ..||||+++.. ....++|.+|+.++.+++|+|||+++|+|.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            35788999999999999999999874 67999999754 4456789999999999999999999999854 568999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      |++|+|..++.....  ..++|.+++.|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus        93 ~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          93 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             cCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999988876432  259999999999999999999999   999999999999999999999999999998876544


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh------------------------------------
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW------------------------------------  398 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~------------------------------------  398 (459)
                      ........||+.|+|||++..+.  ++.++|+||+|++++++++                                    
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             --------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             ceeeccccccccccChHHHhCCC--CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence            44445567999999999998765  4678899999999998775                                    


Q ss_pred             ----cCCCCCCCCCCHHHHHHHHhcCC
Q 041624          399 ----CAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       399 ----c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                          |++.+|++||+|.+|+++|+...
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                88999999999999999998644

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=356.56  Aligned_cols=199  Identities=32%  Similarity=0.371  Sum_probs=174.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc---cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK---HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      +.|+..+.||+|+||.||+|++..+++.||||+++....   ...+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            458889999999999999999999999999999976543   23457899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|..++..+.    .+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999976665443    69999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccceeccCc-cccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGR-ARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                           .....||+.|||||++.+.. ..++.++|+||+|+++++|+++..|+...
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~  217 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence                 23467999999999986532 24678899999999999999977776554

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.3e-45  Score=358.31  Aligned_cols=212  Identities=27%  Similarity=0.326  Sum_probs=189.1

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|.+++|||||++++++.+.+.+||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999999999999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC--CCCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT--DFNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~  352 (459)
                      |++|+|.+++.....   .+++.++..|+.||+.||+|||+   ++|+||||||+|||++.  ++.+||+|||+|+.+..
T Consensus       105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999865443   69999999999999999999999   99999999999999964  57899999999987754


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .  .......||+.|||||++.+..  ++.++|+||+|+++++|++                                  
T Consensus       179 ~--~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         179 K--QSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             T--SCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             c--cccceecCcccccCHHHHcCCC--CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            3  3345578999999999998654  5678899999999999886                                  


Q ss_pred             --------cCCCCCCCCCCHHHHHHH
Q 041624          399 --------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 --------c~~p~p~~RPs~~~v~~~  416 (459)
                              |+.++|.+|||+.|+++.
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    667789999999998875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-44  Score=357.06  Aligned_cols=212  Identities=24%  Similarity=0.285  Sum_probs=188.6

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.+|++++||||+++++++.+++.+||||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999999999999999876655667889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec--CCCCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD--TDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~~~~  352 (459)
                      |++|+|.+++.....   .+++.+++.|+.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+|+.+..
T Consensus       108 ~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999888765443   69999999999999999999999   9999999999999998  578999999999988754


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .  .......||+.|+|||++.+..  ++.++|+||+|+++|+|++                                  
T Consensus       182 ~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         182 D--EIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             T--SCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             C--CceeeccCcccccCHHHHcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            3  3345578999999999998654  5778899999999999887                                  


Q ss_pred             --------cCCCCCCCCCCHHHHHHH
Q 041624          399 --------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 --------c~~p~p~~RPs~~~v~~~  416 (459)
                              |+.++|.+|||+.|+++.
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    667788888888888775

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=347.89  Aligned_cols=219  Identities=24%  Similarity=0.326  Sum_probs=178.8

Q ss_pred             ceeccCCceEEEEEEEcC--CCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEecCC
Q 041624          202 RKLGQGGFGAVYRGILID--LNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFMPN  277 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  277 (459)
                      ++||+|+||.||+|.+..  +++.||||+++...  ....++|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998754  45789999997543  2335689999999999999999999999965 467899999999


Q ss_pred             CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc
Q 041624          278 GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR  357 (459)
Q Consensus       278 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  357 (459)
                      |+|.+++....    .+++.+++.|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999987654    59999999999999999999999   999999999999999999999999999998775443222


Q ss_pred             --cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 041624          358 --TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMPVA  433 (459)
Q Consensus       358 --~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p~~  433 (459)
                        .....||+.|+|||.+.++.  ++.++|+||+|++++++++ +..|+...  +..++.+.+.... .|+.|...|..
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~-~~~~p~~~~~~  238 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGE-RMGCPAGCPRE  238 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred             ccccccCCCceecCchhhcCCC--CCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCC-CCCCCcccCHH
Confidence              23457899999999998765  5678899999999999997 67787765  4567777766543 34556666654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=357.70  Aligned_cols=232  Identities=24%  Similarity=0.312  Sum_probs=186.8

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCC-----cEEEEEEeccC-CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCC
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLN-----MAVAVKKISRG-LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRG  266 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~  266 (459)
                      ..++|+..++||+|+||+||+|++..++     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            4468889999999999999999987544     36999998654 334567899999999998 8999999999999999


Q ss_pred             eEEEEEEecCCCCcchhccccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKS-------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK  327 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk  327 (459)
                      .+++|||||++|+|.++|..+..                   ....+++..++.|+.||+.||+|||+   ++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence            99999999999999999976532                   12358999999999999999999999   999999999


Q ss_pred             CCCeeecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCC
Q 041624          328 FSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRN  405 (459)
Q Consensus       328 p~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~  405 (459)
                      |+|||++.++.+||+|||+|+......... .....||+.|||||++.++.  ++.++|+||+|+++++|++ +..|++.
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC--CCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999998765443322 34567899999999998765  5778899999999999997 5777765


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          406 CRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       406 ~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                      . +...++.+.++.... ++.|...|.
T Consensus       270 ~-~~~~~~~~~~~~~~~-~~~p~~~~~  294 (325)
T d1rjba_         270 I-PVDANFYKLIQNGFK-MDQPFYATE  294 (325)
T ss_dssp             C-CCSHHHHHHHHTTCC-CCCCTTCCH
T ss_pred             C-CHHHHHHHHHhcCCC-CCCCCcCCH
Confidence            3 344556666655543 344555664

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-45  Score=355.42  Aligned_cols=202  Identities=22%  Similarity=0.313  Sum_probs=161.1

Q ss_pred             HhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          194 ATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       194 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ..+.|+..+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.+|.+++||||+++++++.+++.+||||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3466899999999999999999999999999999997653 233456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec---CCCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD---TDFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~  349 (459)
                      |||++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+.
T Consensus        87 E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999997543    59999999999999999999999   9999999999999994   578999999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNC  406 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~  406 (459)
                      ....  ......+||+.|||||++.++.  ++.++|+||+|+++|+|+++..|+...
T Consensus       160 ~~~~--~~~~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         160 EDPG--SVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             ---------------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccCC--CeeeeeeeCccccCcHHHcCCC--CCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence            6543  2334578999999999998654  578899999999999999977776654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=345.23  Aligned_cols=212  Identities=22%  Similarity=0.286  Sum_probs=182.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|.+..+++.||||++++.   .....+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999999999999999999753   2334567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|.+++....    .+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999887654    59999999999999999999999   9999999999999999999999999999998754


Q ss_pred             CCC-CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 041624          353 ELG-PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       353 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~  418 (459)
                      ... ......+||+.|+|||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++.+.+.
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~  223 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKII  223 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCC--CCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHH
Confidence            322 2345578999999999998664  577899999999999999999999865  5566665543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-44  Score=343.69  Aligned_cols=197  Identities=24%  Similarity=0.330  Sum_probs=173.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++++...      ...+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3679999999999999999999999999999999965421      2357899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC----CEEEeec
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF----NVKLGDF  344 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DF  344 (459)
                      |||||||++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999997654    59999999999999999999999   9999999999999998876    4999999


Q ss_pred             CCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          345 GLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       345 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      |+|+.....  .......||+.|+|||++.+..  ++.++|+||+|+++++|+++..|
T Consensus       162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhhhhcCCC--ccccccCCCCcccCHHHHcCCC--CCCcccchhhhHHHHHHHcCCCC
Confidence            999877543  2344567999999999998653  57889999999999999874433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-45  Score=351.24  Aligned_cols=207  Identities=25%  Similarity=0.342  Sum_probs=175.4

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEE
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGL  261 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~  261 (459)
                      +.+|+...++|+..+.||+|+||.||+|+++.     +++.||||+++.... ...++|.+|+.++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            34566677899999999999999999999863     457899999976543 345679999999999999999999999


Q ss_pred             EeeCCeEEEEEEecCCCCcchhccccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 041624          262 CHDRGEFMLVYEFMPNGSLDFHLFSKKS--------------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCV  321 (459)
Q Consensus       262 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i  321 (459)
                      |.+.+..++||||+++|+|.+++.....                    ....+++..++.|+.||+.||+|||+   ++|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence            9999999999999999999999864321                    12358999999999999999999999   999


Q ss_pred             eecCCCCCCeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          322 VHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       322 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      +||||||+|||++.++.+||+|||+|+.+...... ......||+.|+|||.+.+..  ++.++|+||+|+++++|+++
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTT
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHHHHcc
Confidence            99999999999999999999999999876543222 234567899999999998664  57889999999999998874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=337.82  Aligned_cols=210  Identities=25%  Similarity=0.365  Sum_probs=179.6

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee----CCeEEEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD----RGEFMLVY  272 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  272 (459)
                      +..+.||+|+||+||+|++..+++.||+|++....  ....+.|.+|+++|++++||||+++++++.+    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999999999999999987542  3345679999999999999999999999865    35689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCCeeec-CCCCEEEeecCCccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRC--VVHRDIKFSNIMPD-TDFNVKLGDFGLALL  349 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDlkp~NILl~-~~~~~kL~DFGla~~  349 (459)
                      ||+++|+|.+++....    .+++.+++.++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||+|+.
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999999999997654    59999999999999999999998   67  99999999999996 578999999999986


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETK  422 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~  422 (459)
                      ...   ......+||+.|||||++.+   .++.++|+||+|+++++|+++..|+.... +..++.+.+.....
T Consensus       165 ~~~---~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~  230 (270)
T d1t4ha_         165 KRA---SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVK  230 (270)
T ss_dssp             CCT---TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCC
T ss_pred             ccC---CccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCC
Confidence            543   23456789999999999864   36788999999999999999999998665 56677776655433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=345.54  Aligned_cols=213  Identities=27%  Similarity=0.316  Sum_probs=187.7

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      .++|++.+.||+|+||.||+|+++.+++.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999999999999999999754   233467789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||||++|+|.+++....    .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999987665    58999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~  419 (459)
                      .. .......+||+.|+|||++.+..  ++..+|+||+|+++|+|+++..|+...  +..++.+....
T Consensus       157 ~~-~~~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~  219 (337)
T d1o6la_         157 SD-GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILM  219 (337)
T ss_dssp             CT-TCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHH
T ss_pred             cC-CcccccceeCHHHhhhhhccCCC--CChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhc
Confidence            33 23345678999999999998764  578899999999999999999988765  45666655443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=345.27  Aligned_cols=226  Identities=25%  Similarity=0.360  Sum_probs=170.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCCc-cchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGLK-HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .++|+..+.||+|+||.||+|++..+   +..||||.++.... ...+.|.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            46788899999999999999998653   35799999875533 34567999999999999999999999996 467899


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ||||+++|+|.+++.....   .+++..++.++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999998766544   69999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 041624          351 DHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNLPSK  429 (459)
Q Consensus       351 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~  429 (459)
                      ............||+.|+|||++.++.  ++.++|+||+|+++++|++ +..|+....  ..++++.+..... ++.|+.
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~~~~~-~~~~~~  233 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGER-LPMPPN  233 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC-CCCCTT
T ss_pred             cCCcceeccceecCcccchhhHhccCC--CCCccccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC-CCCCCC
Confidence            655444556677899999999998664  5778899999999999887 555555443  2445544433322 334555


Q ss_pred             CCc
Q 041624          430 MPV  432 (459)
Q Consensus       430 ~p~  432 (459)
                      .|.
T Consensus       234 ~~~  236 (273)
T d1mp8a_         234 CPP  236 (273)
T ss_dssp             CCH
T ss_pred             CCH
Confidence            554

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=347.06  Aligned_cols=215  Identities=26%  Similarity=0.372  Sum_probs=181.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc----EEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM----AVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFML  270 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  270 (459)
                      .+|+..++||+|+||+||+|.+..+|+    .||+|+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358889999999999999999987665    6899988654 345577899999999999999999999999865 5678


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLV  350 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~  350 (459)
                      ++||+.+|+|.+++.....   .+++..+++|+.|||.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            8999999999998876654   69999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------------------
Q 041624          351 DHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------------------  398 (459)
Q Consensus       351 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------------------  398 (459)
                      ....... .....||+.|+|||++.++.  ++.++|+||+|+++++|++                               
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~  239 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  239 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred             ccccccccccccccCccccChHHHhcCC--CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence            6543332 34457899999999998764  5788999999999998875                               


Q ss_pred             ---------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 ---------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 ---------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                               |+..+|.+|||+.||++.|+.
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                     888999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-43  Score=341.26  Aligned_cols=212  Identities=25%  Similarity=0.290  Sum_probs=185.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5788999999999999999999999999999999754   2344678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      |||++|+|..++....    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999998887654    48899999999999999999998   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHhcCCC
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ-VLNFETK  422 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~-~L~~~~~  422 (459)
                      .    ....+||+.|||||++.+..  ++.++|+||+|+++|+|+++..|+...  +..++.+ .++....
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~  219 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELR  219 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCC
T ss_pred             c----cccccCcccccCHHHHcCCC--CCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHHHHcCCCC
Confidence            2    34578999999999998654  578899999999999999999999865  4455554 3444433

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=344.81  Aligned_cols=238  Identities=24%  Similarity=0.291  Sum_probs=177.9

Q ss_pred             HHHHHHHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCC-ccchHHHHHHHHHHhcc-CcCCceeEEE
Q 041624          188 YKDLASATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQL-RHRNLLQLIG  260 (459)
Q Consensus       188 ~~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g  260 (459)
                      ..+++...++|+..+.||+|+||.||+|.+..     +++.||||+++... ....+++.+|...+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            34444455789999999999999999999764     34789999997653 34456788899888887 6899999999


Q ss_pred             EEeeC-CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCC
Q 041624          261 LCHDR-GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIK  327 (459)
Q Consensus       261 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk  327 (459)
                      ++.+. +.+++|||||++|+|.++|.....            ....+++.+++.++.||++||+|||+   ++|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCC
Confidence            98764 468999999999999999975432            12358999999999999999999999   999999999


Q ss_pred             CCCeeecCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC-CCCC
Q 041624          328 FSNIMPDTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH-PDRN  405 (459)
Q Consensus       328 p~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~-p~p~  405 (459)
                      |+||||+.++.+||+|||+|+........ ......||+.|+|||++.++.  ++.++|+||+|+++++|+++.. |++.
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC--CCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999876543332 244568999999999998764  5778899999999999998644 4443


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 041624          406 CRPSIRQAIQVLNFETKMPNLPSKMPV  432 (459)
Q Consensus       406 ~RPs~~~v~~~L~~~~~~p~~p~~~p~  432 (459)
                      . ....++.+.+..... |+.|+..|+
T Consensus       240 ~-~~~~~~~~~~~~~~~-~~~~~~~~~  264 (299)
T d1ywna1         240 V-KIDEEFCRRLKEGTR-MRAPDYTTP  264 (299)
T ss_dssp             C-CCSHHHHHHHHHTCC-CCCCTTCCH
T ss_pred             C-CHHHHHHHHHhcCCC-CCCCccCCH
Confidence            3 334455555544332 344554543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=341.36  Aligned_cols=193  Identities=28%  Similarity=0.321  Sum_probs=162.9

Q ss_pred             CceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc-----chHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEec
Q 041624          201 ERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH-----GKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEFM  275 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  275 (459)
                      .++||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999999999999999999654321     2356899999999999999999999999999999999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      .++++..++...    ..+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            988776665433    258999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          356 PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       356 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      ......+||+.|+|||++..+. .++.++|+||+|+++++|+++..|
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~p  200 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPF  200 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccceecChhhccHHHHccCC-CCChhhhhhhcchHHHHHHhCcCC
Confidence            2334568999999999987554 367789999999999998875433

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.1e-43  Score=336.18  Aligned_cols=215  Identities=27%  Similarity=0.327  Sum_probs=184.9

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---------chHHHHHHHHHHhccC-cCCceeEEEEEeeC
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---------GKNEYITEVKTCSQLR-HRNLLQLIGLCHDR  265 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~  265 (459)
                      ++|+..+.||+|+||+||+|++..+++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999999999999999999765321         1346889999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecC
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFG  345 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  345 (459)
                      +..|||||||++|+|.++|..+.    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999997654    59999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccC----ccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHhcC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTG----RARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ-VLNFE  420 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~-~L~~~  420 (459)
                      +++.+...  .......||+.|+|||.+.+.    ...++.++|+||+|+++++|+++..|+....  ..++.+ .+++.
T Consensus       156 ~a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i~~~~  231 (277)
T d1phka_         156 FSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGN  231 (277)
T ss_dssp             TCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC
T ss_pred             heeEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHHHhCC
Confidence            99887643  234557899999999998743    2235678899999999999999999998763  344554 44444


Q ss_pred             C
Q 041624          421 T  421 (459)
Q Consensus       421 ~  421 (459)
                      .
T Consensus       232 ~  232 (277)
T d1phka_         232 Y  232 (277)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=343.44  Aligned_cols=217  Identities=25%  Similarity=0.381  Sum_probs=184.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCc--EEEEEEeccC-CccchHHHHHHHHHHhcc-CcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNM--AVAVKKISRG-LKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|+..++||+|+||.||+|+++.++.  .||||+++.. .....++|.+|+++|.++ +||||++++|+|.+.+.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678888999999999999999988765  5788888654 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCCcchhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCE
Q 041624          272 YEFMPNGSLDFHLFSKK------------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNV  339 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  339 (459)
                      |||+++|+|.++|....            .....+++.++..++.|||.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            99999999999997542            223479999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh---------------------
Q 041624          340 KLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW---------------------  398 (459)
Q Consensus       340 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~---------------------  398 (459)
                      ||+|||+|+.....  .......||..|+|||.+..+.  ++.++|+||+|+++++|++                     
T Consensus       167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             EEcccccccccccc--ccccceecCCcccchHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            99999999865432  2233456899999999998765  5778899999999998876                     


Q ss_pred             -------------------cCCCCCCCCCCHHHHHHHHhc
Q 041624          399 -------------------CAHPDRNCRPSIRQAIQVLNF  419 (459)
Q Consensus       399 -------------------c~~p~p~~RPs~~~v~~~L~~  419 (459)
                                         |++++|++||||.+|++.|+.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                               888899999999999998865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-42  Score=340.58  Aligned_cols=190  Identities=22%  Similarity=0.238  Sum_probs=172.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  272 (459)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++++.   .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999999999999999999643   2234567899999999999999999999999999999999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccC
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDH  352 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~  352 (459)
                      ||+.+|+|.+++....    .+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999997654    59999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      .    .....||+.|||||++.+..  ++.++|+||+|+++|+|++
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemlt  233 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAA  233 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHH
T ss_pred             c----cccccCccccCCHHHHcCCC--CCccccccchhHHHHHHHh
Confidence            2    34568999999999998654  5788999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=336.04  Aligned_cols=206  Identities=27%  Similarity=0.360  Sum_probs=163.4

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEee-CCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~  274 (459)
                      ++|+..+.||+|+||.||+|.++  |..||||+++..  ...++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            56777899999999999999985  678999999653  456789999999999999999999999865 4678999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHEL  354 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  354 (459)
                      +++|+|.++|..+..  ..+++..+++|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        83 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--  155 (262)
T ss_dssp             CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC--
Confidence            999999999976432  158999999999999999999999   9999999999999999999999999999986543  


Q ss_pred             CCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc-CCCCCCCCCCHHHHHHHHh
Q 041624          355 GPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC-AHPDRNCRPSIRQAIQVLN  418 (459)
Q Consensus       355 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c-~~p~p~~RPs~~~v~~~L~  418 (459)
                        ......+|..|+|||++.++.  ++.++|+||+|+++++++++ ..|+.  +.+..++.+.+.
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~--~~~~~~~~~~i~  214 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVE  214 (262)
T ss_dssp             --------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCT--TSCGGGHHHHHT
T ss_pred             --CCccccccccCCChHHHhCCC--CChHHHHHhHHHHHHHHHHCCCCCCC--CCCHHHHHHHHH
Confidence              233456789999999998764  57889999999999999873 33222  234445554443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=342.10  Aligned_cols=211  Identities=25%  Similarity=0.340  Sum_probs=177.2

Q ss_pred             CcccCHHH-HHHHhcCCCCCceeccCCceEEEEEEEc-----CCCcEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCC
Q 041624          183 PRRFSYKD-LASATNNFSNERKLGQGGFGAVYRGILI-----DLNMAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRN  254 (459)
Q Consensus       183 ~~~~~~~e-l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~n  254 (459)
                      |.+++++. ++...++|+..++||+|+||.||+|++.     .+++.||||+++.... ....+|.+|+.++.++ +|||
T Consensus         9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn   88 (311)
T d1t46a_           9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN   88 (311)
T ss_dssp             TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence            44455432 3345578888999999999999999874     3567999999976543 3456799999999999 6999


Q ss_pred             ceeEEEEEeeCCeEEEEEEecCCCCcchhccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 041624          255 LLQLIGLCHDRGEFMLVYEFMPNGSLDFHLFSKKS--------------TGTPLTWTTRYKISLGLASALLYLHEEWKRC  320 (459)
Q Consensus       255 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  320 (459)
                      ||+++++|.+.+..++|||||++|+|.+++.....              ....+++..+..++.||+.||+|||+   ++
T Consensus        89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~  165 (311)
T d1t46a_          89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KN  165 (311)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence            99999999999999999999999999999976432              12358999999999999999999999   99


Q ss_pred             eeecCCCCCCeeecCCCCEEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          321 VVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       321 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      |+||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.++.  ++.++|+||+|+++++|++
T Consensus       166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ellt  242 (311)
T d1t46a_         166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFS  242 (311)
T ss_dssp             CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC--CCCcccccchHHHHHHHHh
Confidence            9999999999999999999999999999876543322 34567899999999998764  5778899999999999886

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=338.29  Aligned_cols=211  Identities=22%  Similarity=0.225  Sum_probs=185.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEEe
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      .++|.+.+.||+|+||+||+|.++.+++.||||.++... .....+.+|+++|.+++||||+++++++.+.+.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999999999999999997643 3345688999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC--CCEEEeecCCcccccC
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD--FNVKLGDFGLALLVDH  352 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kL~DFGla~~~~~  352 (459)
                      |++|+|.+++.....   .+++.++..|+.||+.||+|||+   ++|+||||||+|||++.+  ..+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999976543   59999999999999999999999   999999999999999854  5899999999987643


Q ss_pred             CCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          353 ELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       353 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      .  .......+|+.|+|||.+.+..  ++.++|+||+|+++|+|++                                  
T Consensus       157 ~--~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         157 G--DNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             T--CEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             C--CcccccccccccccchhccCCC--CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence            2  3344567899999999987654  5778899999999999887                                  


Q ss_pred             --------cCCCCCCCCCCHHHHHHH
Q 041624          399 --------CAHPDRNCRPSIRQAIQV  416 (459)
Q Consensus       399 --------c~~p~p~~RPs~~~v~~~  416 (459)
                              |+.++|.+|||+.|+++.
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    677799999999999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=336.73  Aligned_cols=212  Identities=28%  Similarity=0.421  Sum_probs=181.7

Q ss_pred             CceeccCCceEEEEEEEcCCC---cEEEEEEeccC-CccchHHHHHHHHHHhccCcCCceeEEEEEee-CCeEEEEEEec
Q 041624          201 ERKLGQGGFGAVYRGILIDLN---MAVAVKKISRG-LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD-RGEFMLVYEFM  275 (459)
Q Consensus       201 ~~~Lg~G~fg~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~  275 (459)
                      .++||+|+||+||+|++..++   ..||||+++.. .....++|.+|+++|.+++||||++++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999986543   46999999754 34456789999999999999999999999876 46899999999


Q ss_pred             CCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCCCC
Q 041624          276 PNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHELG  355 (459)
Q Consensus       276 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  355 (459)
                      ++|+|.+++.....   .+++..+++++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999876544   58899999999999999999999   9999999999999999999999999999987754322


Q ss_pred             Cc---cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh----------------------------------
Q 041624          356 PR---TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW----------------------------------  398 (459)
Q Consensus       356 ~~---~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~----------------------------------  398 (459)
                      ..   .....||+.|+|||.+.++.  ++.+.|+||+|++++++++                                  
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l  263 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  263 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccceecccccccccccChHHHhcCC--CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHH
Confidence            22   33467899999999998765  5778899999999998875                                  


Q ss_pred             ------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                            |++.+|++||+|.||++.|+..
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                  8888999999999999988753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-42  Score=332.25  Aligned_cols=217  Identities=22%  Similarity=0.288  Sum_probs=176.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc---chHHHHHHHHHHhccCcCCceeEEEEEeeCC----e
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH---GKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----E  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~  267 (459)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.....   ..+.|.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999999999999999999765332   3457899999999999999999999987654    4


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .||||||+++|+|.+++....    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence            799999999999999887654    59999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC--CccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 041624          348 LLVDHELG--PRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFET  421 (459)
Q Consensus       348 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~  421 (459)
                      +.......  ......+||+.|+|||++.+..  ++.++|+||+|+++++|+++..|+.... .+..+.+.+....
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~~~~~~~  231 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDP  231 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCC--CCcceecccchHHHHHHHhCCCCCCCcC-HHHHHHHHHhcCC
Confidence            76643322  2345578999999999998654  5778999999999999999999997653 2334445555543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-43  Score=334.89  Aligned_cols=227  Identities=25%  Similarity=0.309  Sum_probs=178.7

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCC---CcEEEEEEeccCC---ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDL---NMAVAVKKISRGL---KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  269 (459)
                      ++|+..+.||+|+||.||+|++...   ...||||++++..   .+..++|.+|+.+|.+++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5688889999999999999987532   2478999987642   3345689999999999999999999999976 4678


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +|||||++|+|.+++..+..   .+++..++.++.|||.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999998876554   69999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCc--cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-cCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 041624          350 VDHELGPR--TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-CAHPDRNCRPSIRQAIQVLNFETKMPNL  426 (459)
Q Consensus       350 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-c~~p~p~~RPs~~~v~~~L~~~~~~p~~  426 (459)
                      +.......  .....|+..|+|||.+.+..  ++.++|+||+|+++++|++ +..|++.  .+..++++.+......|+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~--~~~~~~~~~i~~~~~~~~~  236 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKEGERLPR  236 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTSCCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCC--CCcchhhhhhHHHHHHHHhCCCCCCCC--cCHHHHHHHHHhCCCCCCC
Confidence            75443222  23456889999999998764  5777899999999999997 7777654  4777777776655555666


Q ss_pred             CCCCCcc
Q 041624          427 PSKMPVA  433 (459)
Q Consensus       427 p~~~p~~  433 (459)
                      |+..|..
T Consensus       237 ~~~~~~~  243 (273)
T d1u46a_         237 PEDCPQD  243 (273)
T ss_dssp             CTTCCHH
T ss_pred             cccccHH
Confidence            6666654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-43  Score=340.68  Aligned_cols=225  Identities=24%  Similarity=0.366  Sum_probs=189.7

Q ss_pred             HHHHhcCCCCCceeccCCceEEEEEEEcC-----CCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEee
Q 041624          191 LASATNNFSNERKLGQGGFGAVYRGILID-----LNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD  264 (459)
Q Consensus       191 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~  264 (459)
                      ++...++|...+.||+|+||.||+|.+..     ++..||||+++... .+....|.+|+.++.+++||||++++|+|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            33345778888999999999999998853     35789999997543 3344578999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcchhccccC------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKK------STGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN  338 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  338 (459)
                      .+..++|||||++|+|.+++....      .....+++..+.+++.|+|+||.|||+   ++|+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCce
Confidence            999999999999999999987432      122357999999999999999999999   89999999999999999999


Q ss_pred             EEEeecCCcccccCCCCCc-cccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh-------------------
Q 041624          339 VKLGDFGLALLVDHELGPR-TTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW-------------------  398 (459)
Q Consensus       339 ~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~-------------------  398 (459)
                      +||+|||+|+.+....... .....||+.|+|||.+.++.  ++.++|+||+|+++++|++                   
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC--CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999998775433222 34456899999999998765  4678899999999998886                   


Q ss_pred             ---------------------cCCCCCCCCCCHHHHHHHHhcC
Q 041624          399 ---------------------CAHPDRNCRPSIRQAIQVLNFE  420 (459)
Q Consensus       399 ---------------------c~~p~p~~RPs~~~v~~~L~~~  420 (459)
                                           |++.+|.+||||.+|+++|+..
T Consensus       250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                                 7788888888888888888765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-42  Score=333.00  Aligned_cols=201  Identities=25%  Similarity=0.314  Sum_probs=170.2

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...  ....+++.+|+++|++++||||+++++++.+.+.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999996543  2346789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+.++.+ +++.....  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~-~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLK-KFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHH-HHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchh-hhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            9976444 44433222  269999999999999999999999   99999999999999999999999999999877543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDR  404 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p  404 (459)
                       ........||+.|+|||.+..... .+.++|+||+|+++++|+++..|++
T Consensus       156 -~~~~~~~~gt~~y~apE~~~~~~~-~~~~~DiwSlGvily~m~~G~~Pf~  204 (298)
T d1gz8a_         156 -VRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFP  204 (298)
T ss_dssp             -SBCTTCCBCCCTTCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -cccceeecccceeeehhhhccccC-CCccccccccchhhhHHhhCCCCCC
Confidence             233445689999999998876543 5678999999999999998776653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.2e-42  Score=340.74  Aligned_cols=210  Identities=26%  Similarity=0.361  Sum_probs=179.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC---ccchHHHHH---HHHHHhccCcCCceeEEEEEeeCCeE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL---KHGKNEYIT---EVKTCSQLRHRNLLQLIGLCHDRGEF  268 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~  268 (459)
                      .++|++.++||+|+||.||+|++..+|+.||||++.+..   ......+.+   |+.++..++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367999999999999999999999999999999986431   122333444   46777888999999999999999999


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                      |+|||||++|+|.++|....    .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999997654    58999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHH
Q 041624          349 LVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRP-SIRQAIQ  415 (459)
Q Consensus       349 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RP-s~~~v~~  415 (459)
                      .+...   ......||+.|+|||++..+. .++.++|+||+|+++|+|+++..|+....+ ...++.+
T Consensus       156 ~~~~~---~~~~~~GT~~y~APE~~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~  219 (364)
T d1omwa3         156 DFSKK---KPHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR  219 (364)
T ss_dssp             ECSSS---CCCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH
T ss_pred             ecCCC---cccccccccccchhHHhhcCC-CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            76543   334568999999999997654 367889999999999999999999987654 3444443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=335.01  Aligned_cols=217  Identities=23%  Similarity=0.357  Sum_probs=174.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCC-------cEEEEEEeccCCc-cchHHHHHHHHHHhcc-CcCCceeEEEEEeeC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLN-------MAVAVKKISRGLK-HGKNEYITEVKTCSQL-RHRNLLQLIGLCHDR  265 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~  265 (459)
                      .++|.+.+.||+|+||.||+|+...++       ..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467888899999999999999986543       4799999977643 4457899999999998 899999999999999


Q ss_pred             CeEEEEEEecCCCCcchhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeee
Q 041624          266 GEFMLVYEFMPNGSLDFHLFSKKS------------TGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMP  333 (459)
Q Consensus       266 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl  333 (459)
                      +..++|||||++|+|.++|..+..            ....+++.++++++.||+.||+|||+   ++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence            999999999999999999976542            12468999999999999999999999   999999999999999


Q ss_pred             cCCCCEEEeecCCcccccCCCCC-ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc-CCCCCCCCCCHH
Q 041624          334 DTDFNVKLGDFGLALLVDHELGP-RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC-AHPDRNCRPSIR  411 (459)
Q Consensus       334 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c-~~p~p~~RPs~~  411 (459)
                      +.++.+||+|||+++........ ......||+.|+|||.+.++.  ++.++|+||+|+++++|+++ ..|++..  +..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~~g~~p~~~~--~~~  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC--CCchhhhHHhHHHHHHhccCCCCCCCCC--CHH
Confidence            99999999999999877654332 244567899999999998764  57889999999999999863 3333322  344


Q ss_pred             HHHHHHh
Q 041624          412 QAIQVLN  418 (459)
Q Consensus       412 ~v~~~L~  418 (459)
                      ++.+.+.
T Consensus       245 ~~~~~i~  251 (299)
T d1fgka_         245 ELFKLLK  251 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            5555444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=332.30  Aligned_cols=222  Identities=22%  Similarity=0.355  Sum_probs=188.8

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC---CccchHHHHHHHHHHh-ccCcCCceeEEEEEeeCCeEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG---LKHGKNEYITEVKTCS-QLRHRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV  271 (459)
                      ++|.+.+.||+|+||+||+|+++.+++.||||++++.   .....+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5788999999999999999999999999999999754   2344566778887766 58999999999999999999999


Q ss_pred             EEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccccc
Q 041624          272 YEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVD  351 (459)
Q Consensus       272 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~  351 (459)
                      ||||++|+|.+++....    .+++.++..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999997654    48999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQVLNFETKMPNLPSKMP  431 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~~L~~~~~~p~~p~~~p  431 (459)
                      .. ........||+.|+|||++.++.  ++.++|+||+|+++++|+++..|+...  +..++.+.+....  |..|+..|
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~--~~~p~~~s  227 (320)
T d1xjda_         155 LG-DAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDN--PFYPRWLE  227 (320)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCC--CCCCTTSC
T ss_pred             cc-cccccccCCCCCcCCHHHHcCCC--CCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCccCC
Confidence            43 23345578999999999998764  578899999999999999999998754  6677776654332  33444444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=336.61  Aligned_cols=190  Identities=22%  Similarity=0.275  Sum_probs=163.8

Q ss_pred             hcCCCCCc-eeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhcc-CcCCceeEEEEEee----CCeE
Q 041624          195 TNNFSNER-KLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQL-RHRNLLQLIGLCHD----RGEF  268 (459)
Q Consensus       195 ~~~f~~~~-~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~  268 (459)
                      .++|.+.. .||+|+||.||+|++..+++.||||+++.     .+.+.+|+.++.++ +||||+++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788764 69999999999999999999999999853     35677899987665 89999999999875    4678


Q ss_pred             EEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC---CCCEEEeecC
Q 041624          269 MLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT---DFNVKLGDFG  345 (459)
Q Consensus       269 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFG  345 (459)
                      |+|||||++|+|.++|..+..  ..+++.++..|+.||+.||+|||+   ++|+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccc
Confidence            999999999999999976432  369999999999999999999999   99999999999999986   4679999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                      +|+.....  .......||+.|+|||++.+..  ++.++|+||+|+++|+|++
T Consensus       160 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~llt  208 (335)
T d2ozaa1         160 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLC  208 (335)
T ss_dssp             TCEECCCC--CCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTT
T ss_pred             eeeeccCC--CccccccCCcccCCcHHHcCCC--CCHHHHHHhhchhHHHHhh
Confidence            99877543  2345578999999999997653  6788999999999998876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-42  Score=332.02  Aligned_cols=196  Identities=28%  Similarity=0.326  Sum_probs=158.5

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHH--HHHHHHhccCcCCceeEEEEEeeCC----eEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYI--TEVKTCSQLRHRNLLQLIGLCHDRG----EFM  269 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~g~~~~~~----~~~  269 (459)
                      +.|...+.||+|+||.||+|++.  |+.||||+++..   ..+++.  .|+..+.+++||||++++++|.+.+    .++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            35667789999999999999974  789999999643   233443  4555566789999999999998654    689


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW-----KRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      +|||||++|+|.++|.+.     .++|.++++++.|+|.||+|||+..     +++|+||||||+||||+.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            999999999999999753     4899999999999999999999631     369999999999999999999999999


Q ss_pred             CCcccccCCCCC---ccccccccccccccceeccCcc----ccCCCCCHHHHHHHHHHHHhcCC
Q 041624          345 GLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRA----RLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       345 Gla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~----~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      |+++........   ......||+.|+|||++.+...    .++.++|+||+|+++++++++..
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~  216 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  216 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence            999887544322   2345789999999999875422    24567899999999999886543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=330.55  Aligned_cols=195  Identities=25%  Similarity=0.288  Sum_probs=166.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc------cchHHHHHHHHHHhccC--cCCceeEEEEEeeCCe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK------HGKNEYITEVKTCSQLR--HRNLLQLIGLCHDRGE  267 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~  267 (459)
                      ++|++.++||+|+||.||+|++..+++.||||+++....      ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999975421      12345778999999996  8999999999999999


Q ss_pred             EEEEEEecCC-CCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCC-CCEEEeecC
Q 041624          268 FMLVYEFMPN-GSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTD-FNVKLGDFG  345 (459)
Q Consensus       268 ~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG  345 (459)
                      .++||||+.+ +++.+++....    .+++.+++.++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 56777776543    59999999999999999999999   999999999999999854 799999999


Q ss_pred             CcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCC
Q 041624          346 LALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAH  401 (459)
Q Consensus       346 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~  401 (459)
                      +|+.....   ..+...||+.|+|||++.+... .+.++|+||+|+++++|+++..
T Consensus       157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~-~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             TCEECCSS---CBCCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             cceecccc---cccccccCCCcCCHHHHcCCCC-CCcccccccceeeehhHhhCCC
Confidence            99876432   3445789999999999986543 4566899999999999987433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.8e-41  Score=320.57  Aligned_cols=202  Identities=23%  Similarity=0.336  Sum_probs=171.6

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|+..+.||+|+||+||+|+++ +++.||||+++...  ....+.+.+|+.+|++++||||+++++++...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            57889999999999999999997 48999999997653  2336789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      |+.++.+..+.....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|......
T Consensus        81 ~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            998877766654332    69999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                       ........|++.|+|||.+.... .++.++|+||+|+++++|+++..|+....
T Consensus       154 -~~~~~~~~~~~~y~~pE~~~~~~-~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         154 -VRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -ccccceecccchhhhHHHHhCCC-CCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence             22334557899999999997554 36788999999999999999999987653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-40  Score=318.97  Aligned_cols=197  Identities=26%  Similarity=0.375  Sum_probs=162.8

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccC--CccchHHHHHHHHHHhccCcCCceeEEEEEee--------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRG--LKHGKNEYITEVKTCSQLRHRNLLQLIGLCHD--------  264 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------  264 (459)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+.+|++++|+||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999999999999998654  23446778999999999999999999999855        


Q ss_pred             CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeec
Q 041624          265 RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDF  344 (459)
Q Consensus       265 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  344 (459)
                      .+..++||||++++.+.......    ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence            34689999999887776544332    258999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCCCC---ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          345 GLALLVDHELGP---RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       345 Gla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      |+++.+......   .....+||+.|+|||++.+.. .++.++|+||+|+++++|+++
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~~~~k~DiwSlGvil~el~~g  218 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTR  218 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHS
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCC-CCCcHHHcccCCceeeeHhhC
Confidence            999876533211   233467999999999987654 367889999999999988744

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-40  Score=316.88  Aligned_cols=203  Identities=24%  Similarity=0.327  Sum_probs=169.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCC-CcEEEEEEeccCC--ccchHHHHHHHHHHhcc---CcCCceeEEEEEee----
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDL-NMAVAVKKISRGL--KHGKNEYITEVKTCSQL---RHRNLLQLIGLCHD----  264 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~----  264 (459)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999654 6789999986542  22344677888877766   79999999999853    


Q ss_pred             -CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEee
Q 041624          265 -RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGD  343 (459)
Q Consensus       265 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  343 (459)
                       ....+++|||+.++++.........   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence             3478999999998777554443332   68999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC
Q 041624          344 FGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR  407 (459)
Q Consensus       344 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R  407 (459)
                      ||+++.....  .......||+.|+|||++.+..  ++.++|+||+|+++++|+++..|++...
T Consensus       160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhhhhhccc--ccCCCcccChhhcCcchhcCCC--CChhehhhchHHHHHHHHHCCCCCCCCC
Confidence            9999765432  2345678999999999998654  6788999999999999999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-40  Score=322.05  Aligned_cols=191  Identities=27%  Similarity=0.365  Sum_probs=159.4

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeCC------
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG------  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  266 (459)
                      .++|+..+.||+|+||+||+|.+..+|+.||||+++....  ...+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4689999999999999999999999999999999975432  33567899999999999999999999997654      


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      .+++||||+ +.+|..++...     .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence            579999999 55777665432     59999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhc
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWC  399 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c  399 (459)
                      |+.....    .+...||+.|+|||.+.+.. ..+.++|+||+|+++++|+++
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~ell~g  215 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITG  215 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHS
T ss_pred             eeccCCc----cccccccccccCHHHHcCCC-CCCccchhhcchHHHHHHHHC
Confidence            9876543    34568999999999987644 367889999999999987654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=320.69  Aligned_cols=199  Identities=23%  Similarity=0.281  Sum_probs=164.5

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC-ccchHHHHHHHHHHhccCcCCceeEEEEEeeCC----eEE
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL-KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRG----EFM  269 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~  269 (459)
                      +.+|++.+.||+|+||+||+|++..+|+.||||+++... ....+++++|+.+|.+++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457889999999999999999999999999999997543 334568899999999999999999999997643    234


Q ss_pred             EEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          270 LVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       270 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      ++++|+.+|+|.+++..+     .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            555667799999998643     49999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCC--ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCC
Q 041624          350 VDHELGP--RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHP  402 (459)
Q Consensus       350 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p  402 (459)
                      .......  .....+||+.|+|||++..+. .++.++|+||+|+++++|+++..|
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~eml~g~~p  212 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPI  212 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-SCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCccceeeccccccceechHHHhhcCC-CCCchhhhhccCceehHHhhCCCC
Confidence            6443222  235567999999999987654 367888999999999998765433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=318.29  Aligned_cols=203  Identities=26%  Similarity=0.303  Sum_probs=175.8

Q ss_pred             cCCCCCceeccCCceEEEEEEE---cCCCcEEEEEEeccCC----ccchHHHHHHHHHHhccCc-CCceeEEEEEeeCCe
Q 041624          196 NNFSNERKLGQGGFGAVYRGIL---IDLNMAVAVKKISRGL----KHGKNEYITEVKTCSQLRH-RNLLQLIGLCHDRGE  267 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~  267 (459)
                      ++|+..+.||+|+||+||+|..   +.+|+.||||.++...    ....+.+.+|++++.+++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6699999999999999999987   3468999999986542    2345678899999999976 899999999999999


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .++||||+.+|+|.+++....    .+++.....++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999997665    47889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      +.+............|++.|+|||.+......++.++|+||+|+++++|+++..|+..
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~  234 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  234 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            8776544444556789999999999987766677889999999999999997777644

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-39  Score=310.29  Aligned_cols=207  Identities=20%  Similarity=0.293  Sum_probs=179.1

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEeeCCeEEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  273 (459)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999999999999999997553  2346789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCcccccCC
Q 041624          274 FMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALLVDHE  353 (459)
Q Consensus       274 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  353 (459)
                      ++.+++|..++....    .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.|+.....
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999887775443    58999999999999999999999   99999999999999999999999999999877543


Q ss_pred             CCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 041624          354 LGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIR  411 (459)
Q Consensus       354 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~  411 (459)
                      . .......++..|+|||.+..... ++.++|+||+|+++++|+++..|+...+....
T Consensus       155 ~-~~~~~~~~~~~~~~pe~~~~~~~-~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  210 (292)
T d1unla_         155 V-RCYSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGNDVDD  210 (292)
T ss_dssp             C-SCCCSCCSCGGGCCHHHHTTCSC-CCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred             C-ccceeeccccchhhhhHhccCCC-CCchhhccccchHHHHHhhCCCCCCCCCCHHH
Confidence            2 23344567889999999876543 57789999999999999998888665554333

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=320.08  Aligned_cols=193  Identities=24%  Similarity=0.314  Sum_probs=158.7

Q ss_pred             CCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCceeEEEEEeeC------CeEEE
Q 041624          197 NFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQLIGLCHDR------GEFML  270 (459)
Q Consensus       197 ~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l  270 (459)
                      .|+..++||+|+||+||+|++..+++.||||+++....    .+.+|+++|++++|+||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            56777899999999999999999999999999975432    234799999999999999999998543      35799


Q ss_pred             EEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCccc
Q 041624          271 VYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALL  349 (459)
Q Consensus       271 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~  349 (459)
                      |||||+++.+.. +.........+++.+++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998764433 33222222369999999999999999999998   9999999999999999775 899999999987


Q ss_pred             ccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          350 VDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       350 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      +...  .......||..|+|||.+.+.. .++.++|+||+|+++++|+++.
T Consensus       173 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DIwSlG~il~el~~g~  220 (350)
T d1q5ka_         173 LVRG--EPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ  220 (350)
T ss_dssp             CCTT--SCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHTS
T ss_pred             ccCC--cccccccccccccChHHhhccc-CCCcceeecccceEEEehhhCC
Confidence            7543  2234468999999999887543 4788899999999999887643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-38  Score=305.40  Aligned_cols=209  Identities=19%  Similarity=0.215  Sum_probs=177.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc-CCceeEEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH-RNLLQLIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~  274 (459)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...  ....+.+|++.+..++| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            67999999999999999999999999999999986542  34567789999999965 8999999999999999999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecC-----CCCEEEeecCCccc
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDT-----DFNVKLGDFGLALL  349 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kL~DFGla~~  349 (459)
                      + +++|.+++.....   .+++.++..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+|+.
T Consensus        83 ~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          83 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             c-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9 6899998876543   69999999999999999999998   99999999999999974     57899999999988


Q ss_pred             ccCCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHH
Q 041624          350 VDHELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCR-PSIRQAIQ  415 (459)
Q Consensus       350 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~R-Ps~~~v~~  415 (459)
                      +......      ......||+.|||||++.+..  ++.+.|+||+|+++++|+++..|++... .+..+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~  226 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  226 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC--CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence            7543221      234567999999999998653  5778899999999999999999997544 34444433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-38  Score=306.80  Aligned_cols=199  Identities=20%  Similarity=0.192  Sum_probs=163.3

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCcee-EEEEEeeCCeEEEEEEe
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLLQ-LIGLCHDRGEFMLVYEF  274 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lV~E~  274 (459)
                      ++|++.+.||+|+||.||+|++..+++.||||++....  ..+++..|++++++++|+|++. +.++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46999999999999999999999999999999987543  3356889999999998776554 55556778889999999


Q ss_pred             cCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeec---CCCCEEEeecCCccccc
Q 041624          275 MPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPD---TDFNVKLGDFGLALLVD  351 (459)
Q Consensus       275 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~  351 (459)
                      + +++|...+.....   .+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+.+.
T Consensus        85 ~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 5577666654433   69999999999999999999999   9999999999999875   45679999999999876


Q ss_pred             CCCCC------ccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCC
Q 041624          352 HELGP------RTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRN  405 (459)
Q Consensus       352 ~~~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~  405 (459)
                      .....      ......||+.|+|||.+.+..  ++.+.|+||+|+++++++++..|++.
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCC--CCChhhEEecCHHHHHHHhCCCcccc
Confidence            43322      234567999999999998654  57788999999999999886555443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-37  Score=303.85  Aligned_cols=204  Identities=24%  Similarity=0.317  Sum_probs=176.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEee--CCeEEEEE
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHD--RGEFMLVY  272 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  272 (459)
                      ++|++.++||+|+||+||+|++..+++.||||+++..   ..+++.+|+.+|.+++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999999999999999999643   3567899999999995 9999999999874  45689999


Q ss_pred             EecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCC-CEEEeecCCccccc
Q 041624          273 EFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDF-NVKLGDFGLALLVD  351 (459)
Q Consensus       273 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~  351 (459)
                      |||++++|..+..       .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+...
T Consensus       112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999976641       59999999999999999999999   9999999999999998765 69999999998765


Q ss_pred             CCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 041624          352 HELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCAHPDRNCRPSIRQAIQ  415 (459)
Q Consensus       352 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~~p~p~~RPs~~~v~~  415 (459)
                      ..  .......+|+.|+|||.+.+.. .++.++|+||+|+++++++++..|+........+...
T Consensus       182 ~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         182 PG--QEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             TT--CCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CC--CcccccccCccccCcccccCCC-CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence            43  2345567899999999987654 3678889999999999999999999877765554443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-38  Score=310.29  Aligned_cols=193  Identities=24%  Similarity=0.335  Sum_probs=162.2

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCc--cchHHHHHHHHHHhccCcCCceeEEEEEeeC-----Ce
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLK--HGKNEYITEVKTCSQLRHRNLLQLIGLCHDR-----GE  267 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~  267 (459)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+++.+|+++|++++|+||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5679999999999999999999999999999999976532  3346788999999999999999999998643     34


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCCc
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLA  347 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla  347 (459)
                      .+++++|+.+|+|.+++..+     .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence            56777888899999988532     59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          348 LLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       348 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      .....    ......||+.|+|||.+.+.. ..+.++|+||+|+++++|+++.
T Consensus       169 ~~~~~----~~~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~  216 (348)
T d2gfsa1         169 RHTDD----EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGR  216 (348)
T ss_dssp             -CCTG----GGSSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cccCc----ccccccccccccCchhhcCCc-cCCcccchhhhhHHHHHHHhCC
Confidence            75432    345567899999999877544 3677899999999999887644

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=306.93  Aligned_cols=192  Identities=25%  Similarity=0.291  Sum_probs=153.3

Q ss_pred             hcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCC--ccchHHHHHHHHHHhccCcCCceeEEEEEee------CC
Q 041624          195 TNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGL--KHGKNEYITEVKTCSQLRHRNLLQLIGLCHD------RG  266 (459)
Q Consensus       195 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~  266 (459)
                      .++|++.++||+|+||+||+|.+..+|+.||||+++...  ....+++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999999999999999997653  2334578899999999999999999999964      36


Q ss_pred             eEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEEEeecCC
Q 041624          267 EFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVKLGDFGL  346 (459)
Q Consensus       267 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl  346 (459)
                      .+|+|||||.++.+. .+.   .   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~iv~Ey~~~~l~~-~~~---~---~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VIQ---M---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHHH-HHT---S---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchHHHH-hhh---c---CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence            889999999765554 332   1   48999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHhcC
Q 041624          347 ALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLWCA  400 (459)
Q Consensus       347 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~c~  400 (459)
                      ++.....  .......+|+.|+|||++.+.  .++.++|+||+||++++++++.
T Consensus       166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~  215 (355)
T d2b1pa1         166 ARTAGTS--FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK  215 (355)
T ss_dssp             -----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             hhccccc--cccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCC
Confidence            8866542  334556789999999999865  4678899999999999877433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.4e-32  Score=270.19  Aligned_cols=193  Identities=23%  Similarity=0.251  Sum_probs=154.0

Q ss_pred             cCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-----------cCCceeEEEEEee
Q 041624          196 NNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-----------HRNLLQLIGLCHD  264 (459)
Q Consensus       196 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~  264 (459)
                      ++|++.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            34899999999999999999999999999999997542 23467788999888875           5789999988764


Q ss_pred             --CCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCC----
Q 041624          265 --RGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFN----  338 (459)
Q Consensus       265 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~----  338 (459)
                        ....+++|+++..+......... .....+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence              45677788877665443332222 122368999999999999999999997  478999999999999987653    


Q ss_pred             --EEEeecCCcccccCCCCCccccccccccccccceeccCccccCCCCCHHHHHHHHHHHHh
Q 041624          339 --VKLGDFGLALLVDHELGPRTTGLAGTLGYMAPEYISTGRARLDVNFDEQQTDCLMIVGLW  398 (459)
Q Consensus       339 --~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~D~~~~g~ll~~~l~  398 (459)
                        ++++|||.++....    ......||+.|+|||.+....  ++.++|+||+|+++++|++
T Consensus       169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~  224 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELIT  224 (362)
T ss_dssp             EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHH
T ss_pred             ceeeEeeccccccccc----ccccccccccccChhhccccC--CCccccccchHHHHHHHHH
Confidence              99999999976543    234567999999999998654  5788999999999887664

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=99.92  E-value=1.9e-26  Score=212.31  Aligned_cols=123  Identities=35%  Similarity=0.596  Sum_probs=102.0

Q ss_pred             CCCCCCCCCCccccccCCCCC-CCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecc-cCCCCCceEEEE
Q 041624            2 FQIPSNSPGGFLGLFNSTTAK-LSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWN-ASFHSGDTAHVK   78 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~-~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~-~~~~~g~~~~~~   78 (459)
                      ...+.++.|+||||+|..+++ ...+++|||||||++|.++ ||++  ||||||+||+.|.++.+|. .++.+|+.++||
T Consensus        94 ~~~~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~--nHIgIdvns~~s~~~~~~~~~~l~~G~~~~v~  171 (236)
T d1hqla_          94 PDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSY--RHIGINVNSIVSVATKRWEDSDIFSGKIATAR  171 (236)
T ss_dssp             TTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSS--CEEEEEESSSSCSEEEECCHHHHTSCSCEEEE
T ss_pred             CCCCCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCC--CEEEEEcCCcccccccccccccccCCCEEEEE
Confidence            344566899999999976543 3568999999999999875 9988  9999999999999998874 478899999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcCC----------------CCcCCCCc-eecceecccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYSQ----------------ENTTSTGR-YTERHVLKSWEFNSTL  126 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~~----------------~fsastG~-~~~~h~i~swsfss~~  126 (459)
                      |+||+.+++|+|+|.+.....+..                +|+|+||. ..+.|+|++|+|++++
T Consensus       172 I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~l  236 (236)
T d1hqla_         172 ISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSNL  236 (236)
T ss_dssp             EEEETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEEC
T ss_pred             EEEeCCCcEEEEEEecCCCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeEecC
Confidence            999999999999998754322211                59999996 4678999999998753

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=99.92  E-value=1.7e-26  Score=213.45  Aligned_cols=123  Identities=37%  Similarity=0.565  Sum_probs=103.5

Q ss_pred             CCCCCCCCCccccccCCCCCC-CCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeeccc-CCCCCceEEEEE
Q 041624            3 QIPSNSPGGFLGLFNSTTAKL-SSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNA-SFHSGDTAHVKI   79 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~-~~~~g~~~~~~i   79 (459)
                      ..+.+..|+||||++..++++ ..+++|||||||++|.+| ||++  ||||||+|++.|..++.|.. ++.+|+.++|||
T Consensus        99 ~~~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~--nHVgIdvns~~s~~~~~~~~~~~~~g~~~~v~I  176 (243)
T d1leda_          99 DSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPY--PHIGIDVNSIVSVATTRWENDDAYGSSIATAHI  176 (243)
T ss_dssp             TCCCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEECCHHHHTSCCEEEEEE
T ss_pred             CCCCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCC--CceEEEecCcccccccccccCCcccCceeEEEE
Confidence            345567899999999776543 468999999999999876 8887  99999999999999998853 788999999999


Q ss_pred             EecCCcceEEEEEeeCCCCCcCC----------------CCcCCCCceecceecccccccccccc
Q 041624           80 KYNSATKNLSASWSYGETPKYSQ----------------ENTTSTGRYTERHVLKSWEFNSTLDI  128 (459)
Q Consensus        80 ~y~~~~~~l~v~~~~~~~~~~~~----------------~fsastG~~~~~h~i~swsfss~~~~  128 (459)
                      +||+.+++|.|+|.+.....+..                +|||+||. .+.|+|++|+|+++++.
T Consensus       177 ~Yd~~~~~L~V~l~~~~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~h~I~sWsF~s~l~~  240 (243)
T d1leda_         177 TYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSWHFFSTLDG  240 (243)
T ss_dssp             EEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEEEEEEEEEEEEECTT
T ss_pred             EEECCCCEEEEEEeeCCCCCceEEEecCHHHhcCCcEEEEEEcccCC-cceeeEEEEEEEeeCCC
Confidence            99999999999998764333221                59999995 69999999999988754

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=99.91  E-value=1.1e-25  Score=208.15  Aligned_cols=123  Identities=33%  Similarity=0.522  Sum_probs=105.1

Q ss_pred             CCCCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCC-C-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEE
Q 041624            1 GFQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNP-E-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK   78 (459)
Q Consensus         1 ~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~-~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~   78 (459)
                      |+..|.++.|+||||+|.++ +.+.+++|||||||++|+ + +||++  ||||||+||+.|..+..++..+.+|+.++||
T Consensus        95 p~~~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~--nHIgid~ns~~s~~~~~~~~~~~~g~~~~v~  171 (240)
T d1fx5a_          95 PPDSPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGF--PHIGIDVNCVKSINAERWNKRYGLNNVANVE  171 (240)
T ss_dssp             CTTCCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSS--CEEEEEESSSSCSEEEECCCCCSGGGCEEEE
T ss_pred             CCCCCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCC--CceEEccCCcccccccccccccCCCCeEEEE
Confidence            34567789999999999754 445689999999999985 3 69988  9999999999999999998889999999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCc-eecceecccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYSQ-----------------ENTTSTGR-YTERHVLKSWEFNSTL  126 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~-~~~~h~i~swsfss~~  126 (459)
                      |+||+.+++|.|++.+...+....                 +|+|+||. ..+.|+|++|+|++++
T Consensus       172 I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst~  237 (240)
T d1fx5a_         172 IIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTSTF  237 (240)
T ss_dssp             EEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEEEES
T ss_pred             EEEcCCCCEEEEEEecCCCceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeEEec
Confidence            999999999999998865432111                 59999985 6789999999999875

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=99.90  E-value=9.7e-25  Score=201.34  Aligned_cols=117  Identities=32%  Similarity=0.593  Sum_probs=98.5

Q ss_pred             CCCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEe
Q 041624            2 FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKY   81 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y   81 (459)
                      +..+.++.|++||+++..    ..+++|||||||++|. |||++  ||||||+|++.|.++..+  .+.+|+.++|||+|
T Consensus        96 ~~~~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~-~d~~~--nHvgI~vns~~s~~~~~~--~l~~G~~~~v~I~Y  166 (237)
T d2d3sa1          96 PNTQTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT-WDPQI--PHIGIDVNSVISTKTVPF--TLDNGGIANVVIKY  166 (237)
T ss_dssp             SSCCCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT-TCCSS--SEEEEEESSSSCSEEEEC--CCCTTCEEEEEEEE
T ss_pred             CCccCCccccccccccCC----CcCceEEEEEEeecCC-CCCCC--CcEEEEcCCCccccccce--eecCCCEEEEEEEE
Confidence            345667899999999753    3468899999999996 89988  999999999999988877  47799999999999


Q ss_pred             cCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCc-------eecceeccccccccccc
Q 041624           82 NSATKNLSASWSYGETPKYSQ-----------------ENTTSTGR-------YTERHVLKSWEFNSTLD  127 (459)
Q Consensus        82 ~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~-------~~~~h~i~swsfss~~~  127 (459)
                      |+.+++|.|+|.+...+....                 ||||+||.       ..+.|+|++|+|+++++
T Consensus       167 d~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsFss~lp  236 (237)
T d2d3sa1         167 DASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFSASLP  236 (237)
T ss_dssp             ETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEEEECC
T ss_pred             ECCCCEEEEEEEcCCCCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEeEeEeeCC
Confidence            999999999998866533221                 69999985       46899999999998764

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=99.90  E-value=3e-24  Score=198.29  Aligned_cols=120  Identities=36%  Similarity=0.586  Sum_probs=100.2

Q ss_pred             CCCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC---CCCCCCCceeEecCCceeeeeeecccCCCCCceEEEE
Q 041624            2 FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW---DPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK   78 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~---d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~   78 (459)
                      +.+|.++.|++||++|.. +....+++|||||||++|.++   ||++  ||||||+|++.|..++.++  +.+|+.++||
T Consensus        95 ~~~~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~--nHvgid~ns~~s~~~~~~~--~~~G~~~~v~  169 (237)
T d1qnwa_          95 SQIPSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDF--KHIGIDVNSIKSIKTVKWD--WRNGEVADVV  169 (237)
T ss_dssp             CCCCTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSS--CEEEEEESSSSCSEEEECC--CCTTCCEEEE
T ss_pred             CCCCCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCC--CeEEEECCCCCcccccccc--cCCCcEEEEE
Confidence            456788899999999864 346678999999999999754   5777  9999999999999888874  6799999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcCC-----------------CCcCCCCcee--cceecccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYSQ-----------------ENTTSTGRYT--ERHVLKSWEFNSTL  126 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~~-----------------~fsastG~~~--~~h~i~swsfss~~  126 (459)
                      |+||+.+++|.|++.+...+....                 +|||+||...  |.|+|++|+|++++
T Consensus       170 I~Yd~~~~~L~V~l~~~~~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s~l  236 (237)
T d1qnwa_         170 ITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSNL  236 (237)
T ss_dssp             EEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred             EEEcCCCcEEEEEEecCCCCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEEec
Confidence            999999999999998765432111                 5999999754  89999999999865

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=99.89  E-value=3.6e-24  Score=197.88  Aligned_cols=120  Identities=31%  Similarity=0.460  Sum_probs=98.9

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      ..++++.|++||+++..+.+ ..++.|||||||++|..+||++  +|||||+|++.|..++++  ++.+|+.++|||+||
T Consensus        99 ~~~~~~~~g~lg~~~~~~~~-~~~~~vaVEFDT~~n~~~d~~~--~HvgI~vn~~~s~~t~~~--~l~~G~~~~v~I~Yd  173 (239)
T d1gzca_          99 KSKPAQGYGYLGVFNNSKQD-NSYQTLAVEFDTFSNPWDPPQV--PHIGIDVNSIRSIKTQPF--QLDNGQVANVVIKYD  173 (239)
T ss_dssp             SCCCCCCGGGTTTCSSSSCC-GGGCCEEEEEECSCCTTSCSSS--SEEEEEESSSSCSEEEEC--CCCTTCEEEEEEEEE
T ss_pred             CCCCCCCcccccccccCCCC-CccceEEEEEEccccCCCCCCC--CEEEEEECCccccccCCc--cccCCCEEEEEEEEe
Confidence            33456788999999875543 4678899999999996458887  999999999999988887  577999999999999


Q ss_pred             CCcceEEEEEeeCCCCCcC-----------------CCCcCCCCc---eecceeccccccccccc
Q 041624           83 SATKNLSASWSYGETPKYS-----------------QENTTSTGR---YTERHVLKSWEFNSTLD  127 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~~~-----------------~~fsastG~---~~~~h~i~swsfss~~~  127 (459)
                      +.+++|.|++.+...+...                 ++|||+||.   ..+.|+|++|+|+++++
T Consensus       174 ~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF~s~lp  238 (239)
T d1gzca_         174 APSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQASLP  238 (239)
T ss_dssp             TTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEEC
T ss_pred             CCCcEEEEEEecCCCCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEeEeeCC
Confidence            9999999999876543211                 159999994   56899999999998764

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=99.89  E-value=5.7e-24  Score=195.87  Aligned_cols=116  Identities=35%  Similarity=0.571  Sum_probs=97.3

Q ss_pred             CCCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEe
Q 041624            2 FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKY   81 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y   81 (459)
                      +..|.++.|+++|+++..    ..++.|||||||++|. |||++  ||||||+|++.|.++..|  ++.+|+.++|||+|
T Consensus        97 ~~~~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~-~Dp~~--nHvgi~~ns~~s~~~~~~--~l~~G~~~~v~I~Y  167 (234)
T d1f9ka_          97 PNSPQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT-WDPQV--PHIGIDVNSIVSSKTLHF--QLENGGVANVVIKY  167 (234)
T ss_dssp             TTCCCCCSGGGTTTCCSS----CCSCCEEEEEECSCCT-TCCSS--SEEEEEESSSSCSEEEEC--CCCTTCCEEEEEEE
T ss_pred             CCCCcccccccccccCCC----CccceEEEEEeccccC-CCCCC--CcEeEecCCccccccccc--cccCCCEEEEEEEE
Confidence            445677899999998753    3467899999999996 89998  999999999999988887  57799999999999


Q ss_pred             cCCcceEEEEEeeCCCCCcC-------------------CCCcCCCCc---eecceecccccccccc
Q 041624           82 NSATKNLSASWSYGETPKYS-------------------QENTTSTGR---YTERHVLKSWEFNSTL  126 (459)
Q Consensus        82 ~~~~~~l~v~~~~~~~~~~~-------------------~~fsastG~---~~~~h~i~swsfss~~  126 (459)
                      |+.+++|.|++.+...+...                   .+|||+||.   ..+.|+|++|+|++++
T Consensus       168 d~~~~~l~V~l~~~~~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~s~l  234 (234)
T d1f9ka_         168 DSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSSL  234 (234)
T ss_dssp             ETTTTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEEEC
T ss_pred             cCCCcEEEEEEEeCCCCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEeEEeC
Confidence            99999999999986543211                   159999984   5689999999998753

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.88  E-value=1e-23  Score=192.27  Aligned_cols=101  Identities=34%  Similarity=0.552  Sum_probs=87.7

Q ss_pred             CCCEEEEEeeCCCCCC-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcceEEEEEeeCCCCCcCC-
Q 041624           25 SSPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETPKYSQ-  102 (459)
Q Consensus        25 ~~~~~aVefdt~~~~~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~-  102 (459)
                      .|++|||||||++|.+ |||++  ||||||+|++.|.+++.|  ++.+|+.++|||+||+.+++|.|++.+.....+.. 
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~--nHIgIdvns~~S~~~~~~--~l~~G~~~~v~I~Yd~~~~~L~V~~~~~~~~~~~ls   76 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSY--PHIGIDIKSVRSKKTAKW--NMQNGKVGTAHIIYNSVDKRLSAVVSYPNADSATVS   76 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSS--CEEEEEESSSSCSEEEEC--CCCTTCEEEEEEEEETTTTEEEEEEECTTSCCEEEE
T ss_pred             CCCEEEEEEECCcCCCCCCCCC--CEEEEEeCCCCccceecc--cccCCCEEEEEEEEecCCcEEEEEEecCCCCCeEEE
Confidence            4789999999999977 69998  999999999999998888  57799999999999999999999998654322221 


Q ss_pred             ---------------CCcCCCCceecceeccccccccccccc
Q 041624          103 ---------------ENTTSTGRYTERHVLKSWEFNSTLDIK  129 (459)
Q Consensus       103 ---------------~fsastG~~~~~h~i~swsfss~~~~~  129 (459)
                                     ||+|+||...+.|+|++|+|++++...
T Consensus        77 ~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~~~  118 (237)
T d1nlsa_          77 YDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKSN  118 (237)
T ss_dssp             EECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEES
T ss_pred             EEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeecccc
Confidence                           699999999999999999999886543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=5.8e-23  Score=183.93  Aligned_cols=134  Identities=14%  Similarity=0.121  Sum_probs=105.8

Q ss_pred             CCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCcc------------------chHHHHHHHHHHhccCcCCceeEEE
Q 041624          199 SNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKH------------------GKNEYITEVKTCSQLRHRNLLQLIG  260 (459)
Q Consensus       199 ~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~nIv~l~g  260 (459)
                      .+.++||+|+||.||+|.+.+ |+.||||+++.....                  .......|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356899999999999999865 899999987543110                  0123456888999999999999886


Q ss_pred             EEeeCCeEEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeecCCCCCCeeecCCCCEE
Q 041624          261 LCHDRGEFMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEWKRCVVHRDIKFSNIMPDTDFNVK  340 (459)
Q Consensus       261 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  340 (459)
                      +..    .+++|||+++..+.+           ++......++.|++.+|+|||+   ++|+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence            632    379999998765532           3334557899999999999999   999999999999999965 589


Q ss_pred             EeecCCcccccC
Q 041624          341 LGDFGLALLVDH  352 (459)
Q Consensus       341 L~DFGla~~~~~  352 (459)
                      |+|||+|....+
T Consensus       143 liDFG~a~~~~~  154 (191)
T d1zara2         143 IIDFPQSVEVGE  154 (191)
T ss_dssp             ECCCTTCEETTS
T ss_pred             EEECCCcccCCC
Confidence            999999976543

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.87  E-value=3.3e-23  Score=192.77  Aligned_cols=119  Identities=37%  Similarity=0.583  Sum_probs=96.8

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      ..+++..||+||+++..+   ..++.|||||||++|. |||++  +|||||+|++.|..++.+  ++.+|+.++|||+||
T Consensus        98 ~~~~~~~~g~lG~~~~~~---~~~~~vaVEFDT~~n~-~D~~~--~Hvgi~~n~~~s~~~~~~--~l~~g~~~~v~I~Yd  169 (251)
T d1g9fa_          98 DTKPQTHAGYLGLFNENE---SGDQVVAVEFDTFRNS-WDPPN--PHIGINVNSIRSIKTTSW--DLANNKVAKVLITYD  169 (251)
T ss_dssp             TCCCCCCGGGTTTCCTTS---CCCSCEEEEEECC-CT-TSCSS--SEEEEEESSSSCSEEEEC--CCCTTCCEEEEEEEE
T ss_pred             CCCCCCccCccCcccccC---CCcceEEEEEecccCC-CCCCC--CcEeEEecCcccccccce--EecCCCEEEEEEEEE
Confidence            345667899999998643   3468899999999995 89988  999999999999988887  577999999999999


Q ss_pred             CCcceEEEEEeeCCCCCcC-----------------CCCcCCCCcee--cceeccccccccccccc
Q 041624           83 SATKNLSASWSYGETPKYS-----------------QENTTSTGRYT--ERHVLKSWEFNSTLDIK  129 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~~~-----------------~~fsastG~~~--~~h~i~swsfss~~~~~  129 (459)
                      +.+++|.|++.+...+...                 .+|||+||...  |.|+|++|+|+++.+++
T Consensus       170 ~~~~~L~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s~~~~~  235 (251)
T d1g9fa_         170 ASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNLPHA  235 (251)
T ss_dssp             TTTTEEEEEEEEGGGTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEECC-
T ss_pred             CCccEEEEEEecCCCCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeECCCCCC
Confidence            9999999999875432111                 16999999754  78999999999876543

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=99.87  E-value=4.9e-23  Score=192.13  Aligned_cols=119  Identities=39%  Similarity=0.590  Sum_probs=99.3

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSA   84 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~   84 (459)
                      +.++.||+|||++..+. ...++.+||||||++|.+|||++  +|||||+|++.|..++.+  .+.+|+.++|||+||+.
T Consensus        97 ~~~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~--~Hvgi~~ns~~s~~~~~~--~~~~g~~~~v~I~Yd~~  171 (253)
T d1g7ya_          97 EPKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDWDPTS--RHIGIDVNSIKSIRTASW--GLANGQNAEILITYNAA  171 (253)
T ss_dssp             CCCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTTCCSS--CEEEEEESSSSCSEEEEC--CCCTTSEEEEEEEEETT
T ss_pred             CCCCCcccccccccCCC-CCcCceEEEEEeceecCCCCCCC--CcEEEeeCCcccccccCC--CccCCCEEEEEEEEeCC
Confidence            34568899999986543 34578899999999998899988  999999999999988877  57799999999999999


Q ss_pred             cceEEEEEeeCCCCCcC-----------------CCCcCCCC---ceecceecccccccccccc
Q 041624           85 TKNLSASWSYGETPKYS-----------------QENTTSTG---RYTERHVLKSWEFNSTLDI  128 (459)
Q Consensus        85 ~~~l~v~~~~~~~~~~~-----------------~~fsastG---~~~~~h~i~swsfss~~~~  128 (459)
                      +++|.|++.+...+...                 .||||+||   .+.+.|+|++|+|+++++.
T Consensus       172 ~~~L~v~l~~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~lp~  235 (253)
T d1g7ya_         172 TSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKLPD  235 (253)
T ss_dssp             TTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEECS
T ss_pred             cEEEEEEEecCCCCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEeEEeCCC
Confidence            99999999876443211                 16999999   4679999999999987643

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.86  E-value=1.6e-22  Score=186.05  Aligned_cols=116  Identities=39%  Similarity=0.610  Sum_probs=97.2

Q ss_pred             CCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecC
Q 041624            4 IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNS   83 (459)
Q Consensus         4 ~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~   83 (459)
                      .++++.|++||+++..   +..++.|||||||++|.+|||++  +|||||+|++.|..+..+  ++.+|+.+.|||+||+
T Consensus        97 ~~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~d~~~--~Hvgi~~n~~~s~~~~~~--~~~~g~~~~~~I~yd~  169 (233)
T d1g8wa_          97 SQPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTE--RHIGIDVNSIRSIKTTRW--DFVNGENAEVLITYDS  169 (233)
T ss_dssp             CCCCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSS--CEEEEEESSSSCSEEEEC--CCCTTCCEEEEEEEET
T ss_pred             CCCCcccccCCccccC---CCcccEEEEEeecccCCCCCCCC--CeEEEECCCcceeeeccc--cccCCcEEEEEEEEeC
Confidence            3556889999999753   33568899999999998899988  999999999999888877  4779999999999999


Q ss_pred             CcceEEEEEeeCCCCCcCC-----------------CCcCCCCc---eecceecccccccccc
Q 041624           84 ATKNLSASWSYGETPKYSQ-----------------ENTTSTGR---YTERHVLKSWEFNSTL  126 (459)
Q Consensus        84 ~~~~l~v~~~~~~~~~~~~-----------------~fsastG~---~~~~h~i~swsfss~~  126 (459)
                      .+++|.|++.+...+....                 +|||+||.   ..+.|+|++|+|++++
T Consensus       170 ~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsFss~l  232 (233)
T d1g8wa_         170 STNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKL  232 (233)
T ss_dssp             TTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred             CCcEEEEEEEeCCCCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEEEEEc
Confidence            9999999998865432111                 59999994   4577999999999864

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=99.86  E-value=1.8e-22  Score=186.00  Aligned_cols=118  Identities=34%  Similarity=0.570  Sum_probs=98.0

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      ..+.++.|++||||+..+. +..++.|||||||++|. +||++  ||||||+|++.|..+.++  .+.+|+.++|||+||
T Consensus        95 ~~~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~-~d~~~--~higi~~n~~~s~~~~~~--~l~~g~~~~v~I~Y~  168 (233)
T d1n47a_          95 DTQPQARGGFLGLFADRAH-DASYQTVAVEFDTYSNA-WDPNY--THIGIDTNGIESKKTTPF--DMVYGEKANIVITYQ  168 (233)
T ss_dssp             TCCCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT-TSCSS--CEEEEEESSSSCSEEEEC--CCCTTSCEEEEEEEE
T ss_pred             CCCCCCCCCccccccccCC-CCcCceEEEEEEeeecC-CCCCC--CceeEccCCccccccccc--eecCCCEEEEEEEEc
Confidence            3455678999999986543 45678899999999996 89988  999999999999888877  577999999999999


Q ss_pred             CCcceEEEEEeeCCCCCcCC-----------------CCcCCCC---ceecceecccccccccc
Q 041624           83 SATKNLSASWSYGETPKYSQ-----------------ENTTSTG---RYTERHVLKSWEFNSTL  126 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~~~~-----------------~fsastG---~~~~~h~i~swsfss~~  126 (459)
                      +.+++|.|++.+...+....                 +|||+||   ...+.|+|++|+|++++
T Consensus       169 ~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~l  232 (233)
T d1n47a_         169 ASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL  232 (233)
T ss_dssp             TTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             CCCeEEEEEEEeCCCCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEEc
Confidence            99999999998765432111                 5999999   45788999999999864

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=99.85  E-value=5.3e-22  Score=183.62  Aligned_cols=119  Identities=37%  Similarity=0.593  Sum_probs=98.1

Q ss_pred             CCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecC
Q 041624            4 IPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNS   83 (459)
Q Consensus         4 ~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~   83 (459)
                      .+.+..||+||+++... ....++.+||||||++|.+|||++  +|||||+|++.|..+...  ++.+|+.++|||+||+
T Consensus        98 ~~~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~d~~~--~Higi~~n~~~s~~~~~~--~~~~g~~~~v~I~Y~~  172 (237)
T d1fnya_          98 TQPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKG--RHLGINVNSIESIKTVPW--NWTNGEVANVFISYEA  172 (237)
T ss_dssp             CCCCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSS--SEEEEEESSSSCSEEEEC--CCCTTCCEEEEEEEEG
T ss_pred             CCcccccCcccccCCCC-ccCccceEEEEeccccccCCCCCC--ceEEEecCCCcccccccc--cccCCcEEEEEEEEeC
Confidence            34567889999998643 345678999999999998899998  999999999999887766  5679999999999999


Q ss_pred             CcceEEEEEeeCCCCCcCC-----------------CCcCCCC---ceecceeccccccccccc
Q 041624           84 ATKNLSASWSYGETPKYSQ-----------------ENTTSTG---RYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        84 ~~~~l~v~~~~~~~~~~~~-----------------~fsastG---~~~~~h~i~swsfss~~~  127 (459)
                      .+++|.|++.+...+....                 +|||+||   ...+.|+|++|+|++++|
T Consensus       173 ~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~lp  236 (237)
T d1fnya_         173 STKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESNLP  236 (237)
T ss_dssp             GGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEEC
T ss_pred             CccEEEEEEEeCCCCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEEeCC
Confidence            9999999998865432211                 5999999   466899999999998764

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=99.85  E-value=5.7e-22  Score=183.85  Aligned_cols=121  Identities=36%  Similarity=0.666  Sum_probs=100.0

Q ss_pred             CCCCCCCCCccccccCCC-CCCCCCCEEEEEeeCCCCCC---CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEE
Q 041624            3 QIPSNSPGGFLGLFNSTT-AKLSSSPIVLVEFDSFSNPE---WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK   78 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~-~~~~~~~~~aVefdt~~~~~---~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~   78 (459)
                      ..|.++.|+++|+++... .+...++.+||||||++|.+   +||++  +|||||+|++.|.++..+  ++.+|..++||
T Consensus        98 ~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~--~Higid~n~~~s~~~~~~--~~~~g~~~~v~  173 (241)
T d1ukga_          98 TIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNY--PHIGIDVNSIRSVKTVKW--DRRDGQSLNVL  173 (241)
T ss_dssp             CCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSS--CEEEEEESSSSCSEEEEC--CCCTTCCEEEE
T ss_pred             CcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCC--ccEeeecCCccccccccc--ccCCCcEEEEE
Confidence            456778899999997543 34567899999999999865   35666  999999999999887766  57799999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcCC----------------CCcCCCCceecceeccccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYSQ----------------ENTTSTGRYTERHVLKSWEFNSTLD  127 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~~----------------~fsastG~~~~~h~i~swsfss~~~  127 (459)
                      |+||+.+++|.|++.+.....+..                +|||+||...+.|+|++|+|++++.
T Consensus       174 I~Yd~~~~~L~v~~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsFss~l~  238 (241)
T d1ukga_         174 VTFNPSTRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTSTLL  238 (241)
T ss_dssp             EEEETTTTEEEEEEEETTCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEEE
T ss_pred             EEEeCCCcEEEEEEccCCCCceEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEEEEEee
Confidence            999999999999998764433221                5999999999999999999998753

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=99.84  E-value=1.5e-21  Score=180.68  Aligned_cols=120  Identities=37%  Similarity=0.535  Sum_probs=98.5

Q ss_pred             CCCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCC---CCCCCCCceeEecCCceeeeeeecccCCCCCceEEEE
Q 041624            2 FQIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEW---DPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVK   78 (459)
Q Consensus         2 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~---d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~   78 (459)
                      +.+++++.|++|||++..+ .+..++.+||||||++|.++   ||+.  +|||||+|++.|..+..+  .+.+|+..+||
T Consensus        98 ~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~--~hvgid~n~~~s~~~~~~--~~~~g~~~~~~  172 (239)
T d1dbna_          98 SQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNY--RHIGIDVNGIESIKTVQW--DWINGGVAFAT  172 (239)
T ss_dssp             CCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSS--CEEEEEESSSSCSEEEEC--CCCTTCCEEEE
T ss_pred             ccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCC--ceeeEEcCCccccccccc--eEeCCceeEEE
Confidence            3467778899999998653 45678999999999999764   6666  899999999999887776  46689999999


Q ss_pred             EEecCCcceEEEEEeeCCCCCcC-----------------CCCcCCCCce--ecceecccccccccc
Q 041624           79 IKYNSATKNLSASWSYGETPKYS-----------------QENTTSTGRY--TERHVLKSWEFNSTL  126 (459)
Q Consensus        79 i~y~~~~~~l~v~~~~~~~~~~~-----------------~~fsastG~~--~~~h~i~swsfss~~  126 (459)
                      |+|++.+++|.|.+.+...+...                 .+|||+||..  .+.|+|++|+|++++
T Consensus       173 i~y~~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWsFss~l  239 (239)
T d1dbna_         173 ITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFTSTL  239 (239)
T ss_dssp             EEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEEEEC
T ss_pred             EEEcCCCCEEEEEEEecCCCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEEeEEeC
Confidence            99999999999999886544321                 1699999964  578999999998763

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=99.81  E-value=9.3e-21  Score=174.31  Aligned_cols=104  Identities=33%  Similarity=0.471  Sum_probs=85.9

Q ss_pred             CCCCCCCCEEEEEeeCCCCCCC-CCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcceEEEEEeeCCCC
Q 041624           20 TAKLSSSPIVLVEFDSFSNPEW-DPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKNLSASWSYGETP   98 (459)
Q Consensus        20 ~~~~~~~~~~aVefdt~~~~~~-d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~~~~~~~~   98 (459)
                      .+....++.|||||||++|.++ ||++  +|||||+|++.|.....+  ++.+|+.++|||+||+.+++|.|++.+....
T Consensus       109 ~~~~~~~~~~aVEfDT~~n~~~~d~~~--~Higid~n~~~s~~~~~~--~~~~g~~~~v~I~Yd~~~~~L~V~~~~~~~~  184 (232)
T d1v6ia_         109 SDTKGAGHFVGVEFDTYSNSEYNDPPT--DHVGIDVNSVDSVKTVPW--NSVSGAVVKVTVIYDSSTKTLSVAVTNDNGD  184 (232)
T ss_dssp             SCTTSEEEEEEEEEECSCCGGGTCCSS--CEEEEEEEESSCSEEEEC--CCCTTCEEEEEEEEETTTTEEEEEEECTTSC
T ss_pred             ccCCCCCceEEEEEEeEecCCCCCCCC--ccEeEeeCCccccccccc--ccCCCCEEEEEEEEeCCceEEEEEEecCCCC
Confidence            3345567899999999999865 8887  999999999998877665  5779999999999999999999999875433


Q ss_pred             CcCC----------------CCcCCCCc-eecceeccccccccccc
Q 041624           99 KYSQ----------------ENTTSTGR-YTERHVLKSWEFNSTLD  127 (459)
Q Consensus        99 ~~~~----------------~fsastG~-~~~~h~i~swsfss~~~  127 (459)
                      .+..                +|||+||. ..+.|+|++|+|++++.
T Consensus       185 ~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~l~  230 (232)
T d1v6ia_         185 ITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLI  230 (232)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEEEC
T ss_pred             cceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEeee
Confidence            2211                59999996 46899999999998764

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=99.68  E-value=7.3e-18  Score=154.44  Aligned_cols=113  Identities=23%  Similarity=0.356  Sum_probs=87.9

Q ss_pred             CCCCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEec
Q 041624            3 QIPSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYN   82 (459)
Q Consensus         3 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~   82 (459)
                      ..+.++.|++|||++.+. ++..++.|||||||++|. +|++.  +|+|+++++.       ....+.+|+.++|||+||
T Consensus        95 ~~~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~-~~~~~--~~~~~~~~~~-------~~~~~~~g~~~~v~I~Yd  163 (228)
T d1ioaa_          95 NSPPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR-IDFDK--NFIKPYVNEN-------CDFHKYNGEKTDVQITYD  163 (228)
T ss_dssp             TCCCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE-EEEEE--SSSSCSEEEE-------CCHHHHCSSCEEEEEEEE
T ss_pred             CCCCCCCccccccccccC-CCCcceeEEEEecCcccc-ccCCC--Cccceecccc-------cccccccCcEEEEEEEEc
Confidence            345678899999998643 455678999999999884 56665  6777777643       334567899999999999


Q ss_pred             CCcceEEEEEeeCCCCCcC-----------------CCCcCCCC---ceecceecccccccccc
Q 041624           83 SATKNLSASWSYGETPKYS-----------------QENTTSTG---RYTERHVLKSWEFNSTL  126 (459)
Q Consensus        83 ~~~~~l~v~~~~~~~~~~~-----------------~~fsastG---~~~~~h~i~swsfss~~  126 (459)
                      +.+++|.|++.+...+...                 .+|||+||   ...|.|+|++|+|++++
T Consensus       164 ~~~~~l~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFss~~  227 (228)
T d1ioaa_         164 SSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKF  227 (228)
T ss_dssp             TTTTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred             CCCCEEEEEEEeCCCCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeEEec
Confidence            9999999999886543211                 05999999   45688999999999864

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.67  E-value=2.5e-18  Score=157.48  Aligned_cols=110  Identities=26%  Similarity=0.463  Sum_probs=91.7

Q ss_pred             CCCCCCCccccccCCCCCCCCCCEEEEEeeCCCCCC-CCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecC
Q 041624            5 PSNSPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPE-WDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNS   83 (459)
Q Consensus         5 ~~~~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~-~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~   83 (459)
                      +.+..|+++||++.          ++|||||+.|.. +|+.+  ||||||+|+..+..++.....+.+|+.++|||+||+
T Consensus        95 ~~g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~--nhi~i~~n~~~s~~~~~~~~~~~~g~~~~v~I~Yd~  162 (226)
T d1avba_          95 RPKLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVS--NRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDS  162 (226)
T ss_dssp             CCCCCGGGTTTCSC----------SSCCGGGCCEEEEEETTT--TEEEEEESSSSCSEEEECCSGGGTTCEEEEEEEEEG
T ss_pred             CCCCccccCCcccc----------ccccccceeccccccCCC--CEEEEeCCCCccccccccccccCCCeEEEEEEEEcC
Confidence            34578889999863          468999998853 68887  999999999999998888888999999999999999


Q ss_pred             CcceEEEEEeeCCCCCcCC-----------------CCcCCCCc---eecceecccccccccc
Q 041624           84 ATKNLSASWSYGETPKYSQ-----------------ENTTSTGR---YTERHVLKSWEFNSTL  126 (459)
Q Consensus        84 ~~~~l~v~~~~~~~~~~~~-----------------~fsastG~---~~~~h~i~swsfss~~  126 (459)
                      .+++|+|++.+...+....                 +|||+||.   ..+.|+|++|+|++++
T Consensus       163 ~~~~L~V~l~~~~~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~~  225 (226)
T d1avba_         163 PKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF  225 (226)
T ss_dssp             GGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEEE
T ss_pred             CCcEEEEEEEeCCCCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEec
Confidence            9999999998865432211                 59999995   4568999999999864

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.55  E-value=1.8e-15  Score=135.86  Aligned_cols=107  Identities=30%  Similarity=0.385  Sum_probs=79.1

Q ss_pred             CCCCccccccCCCCCCCCCCEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeeeecccCCCCCceEEEEEEecCCcce
Q 041624            8 SPGGFLGLFNSTTAKLSSSPIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYTRWNASFHSGDTAHVKIKYNSATKN   87 (459)
Q Consensus         8 ~~g~~lGl~~~~~~~~~~~~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~~~~~~~~~g~~~~~~i~y~~~~~~   87 (459)
                      ..|.-|+++-....+...++.+||||||++|          |+++|+|+.. +....+...+.+|+.++|||+||+.+++
T Consensus        77 ~~gdGlaf~~~~~~~~~~~~~~~vefDt~~n----------~~~~d~~~~~-~~~~~~~~~~~~g~~~~v~I~Yd~~~~~  145 (204)
T d1dhkb_          77 NSAVGLDFVLVPVQPESKGDTVTVEFDTFLS----------RISIDVNNND-IKSVPWDVHDYDGQNAEVRITYNSSTKV  145 (204)
T ss_dssp             -CCSEEEEEEEEC------CCEEEEEETTTT----------EEEEEETTEE-EEEEECCGGGTTTSCEEEEEEEETTTTE
T ss_pred             CCCceEEEEecCCCCCCCCcEeeEeeEcccc----------cccCcccccc-ccccccccEecCCCEEEEEEEEcCCCEE
Confidence            3566677765545556778999999999765          7888888854 3444566678899999999999999999


Q ss_pred             EEEEEeeCCCCCcCC-----------------CCcCCCCce---ecceeccccccccc
Q 041624           88 LSASWSYGETPKYSQ-----------------ENTTSTGRY---TERHVLKSWEFNST  125 (459)
Q Consensus        88 l~v~~~~~~~~~~~~-----------------~fsastG~~---~~~h~i~swsfss~  125 (459)
                      |.|++.+...+....                 ||||+||..   .+.|+|++|+|+++
T Consensus       146 L~V~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss~  203 (204)
T d1dhkb_         146 FSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK  203 (204)
T ss_dssp             EEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred             EEEEEecCCCCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEec
Confidence            999998876543210                 599999965   46799999999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=1.8e-08  Score=92.39  Aligned_cols=150  Identities=14%  Similarity=0.016  Sum_probs=106.6

Q ss_pred             HHHHHHhcCCCCCceeccCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccC-cCCceeEEEEEeeCCe
Q 041624          189 KDLASATNNFSNERKLGQGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLR-HRNLLQLIGLCHDRGE  267 (459)
Q Consensus       189 ~el~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~  267 (459)
                      .|+.....+|+..+..+.++.+.||+...  .+..+.+|+...........+.+|...+..+. +--+.+++.++.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            46777777787665544445578998764  35678899887655555566788988888773 4446788888888899


Q ss_pred             EEEEEEecCCCCcchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------
Q 041624          268 FMLVYEFMPNGSLDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEEW------------------------------  317 (459)
Q Consensus       268 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------  317 (459)
                      .++||+++++.++.+.....         .....++.++++.|+.||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            99999999998775543211         122334566666666666410                              


Q ss_pred             --------------------------CCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          318 --------------------------KRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       318 --------------------------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                                                ...++|+|+.|.|||+++++..-|.||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                      12489999999999999876677999998854

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.47  E-value=3.2e-08  Score=89.11  Aligned_cols=92  Identities=22%  Similarity=0.180  Sum_probs=56.0

Q ss_pred             CEEEEEeeCCCCCCCCCCCCCCceeEecCCceeeeee----------ecccCC-CCCceEEEEEEecCCcceEEEEEeeC
Q 041624           27 PIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSVYT----------RWNASF-HSGDTAHVKIKYNSATKNLSASWSYG   95 (459)
Q Consensus        27 ~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~~~----------~~~~~~-~~g~~~~~~i~y~~~~~~l~v~~~~~   95 (459)
                      +-+||||||+.|. +|++.  +|+.+++|........          .+.... .++..+++|++|+  .+.|.|.+...
T Consensus       104 ~glaVefDt~~n~-~~~~~--~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~  178 (228)
T d1gv9a_         104 NGVGIFFDSFDND-GKKNN--PAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYY--QKTLTVMINNG  178 (228)
T ss_dssp             EEEEEEEECCCC------C--CEEEEEEEESCCCCCHHHHHHHHCSEEECCCCBSCSSCEEEEEEEE--TTEEEEEEECS
T ss_pred             ceEEEEEEccccc-CCCCC--CcEEEEecCCcceeeecCCCccccccceeeeecCCceEEEEEEEec--CCEEEEEEecc
Confidence            4589999999995 67666  7888887754311111          111111 2455666777776  46677777543


Q ss_pred             CCCCcC------------------CCCcCCCCceecceeccccccc
Q 041624           96 ETPKYS------------------QENTTSTGRYTERHVLKSWEFN  123 (459)
Q Consensus        96 ~~~~~~------------------~~fsastG~~~~~h~i~swsfs  123 (459)
                      ......                  .+|||+||...+.|.|++|.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~~  224 (228)
T d1gv9a_         179 FTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLTF  224 (228)
T ss_dssp             SCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEEEE
T ss_pred             ccCCCcceeEEEEecccccCCCEEEEEEEeCCCCcCeEEEEEEEEE
Confidence            221111                  1599999999999999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=4.1e-06  Score=75.68  Aligned_cols=131  Identities=22%  Similarity=0.109  Sum_probs=87.2

Q ss_pred             eeccCCc-eEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCc--CCceeEEEEEeeCCeEEEEEEecCCCC
Q 041624          203 KLGQGGF-GAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRH--RNLLQLIGLCHDRGEFMLVYEFMPNGS  279 (459)
Q Consensus       203 ~Lg~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gs  279 (459)
                      .+..|.. +.||+..... +..+.+|......   ...+..|...++.+..  -.+.+++.+..+.+..++||+++++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444443 6789987654 6678888765432   3356778888877743  335778888888889999999999876


Q ss_pred             cchhccccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 041624          280 LDFHLFSKKSTGTPLTWTTRYKISLGLASALLYLHEE-------------------------------------------  316 (459)
Q Consensus       280 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------------  316 (459)
                      +.+..         +..   ...+.+++..|.-||+.                                           
T Consensus        93 ~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          93 LLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             TTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             ccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            64321         111   11223344444444420                                           


Q ss_pred             ------------cCCCeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          317 ------------WKRCVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       317 ------------~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                                  ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                        013489999999999999876778999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.89  E-value=2.2e-05  Score=76.00  Aligned_cols=77  Identities=12%  Similarity=0.059  Sum_probs=50.2

Q ss_pred             ceeccCCceEEEEEEEcCCCcEEEEEEeccC-------CccchHHHHHHHHHHhccC---cCCceeEEEEEeeCCeEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDLNMAVAVKKISRG-------LKHGKNEYITEVKTCSQLR---HRNLLQLIGLCHDRGEFMLV  271 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV  271 (459)
                      +.||.|....||+.....+++.++||.-...       .....++...|.+.|..+.   ...+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            4689999999999988777888999975431       1123345566888777662   2456677765  44456899


Q ss_pred             EEecCCCCc
Q 041624          272 YEFMPNGSL  280 (459)
Q Consensus       272 ~E~~~~gsL  280 (459)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.26  E-value=9.1e-05  Score=65.32  Aligned_cols=90  Identities=7%  Similarity=-0.004  Sum_probs=56.5

Q ss_pred             EEEEeeCCCCCCCCCCCCCCceeEecCCcee-------eeeeeccc-CCCCCceEEEEEEecCCcc-eEEEEEee-----
Q 041624           29 VLVEFDSFSNPEWDPINVKDDVGINNSSIVS-------SVYTRWNA-SFHSGDTAHVKIKYNSATK-NLSASWSY-----   94 (459)
Q Consensus        29 ~aVefdt~~~~~~d~~~~~~hvgid~ns~~s-------~~~~~~~~-~~~~g~~~~~~i~y~~~~~-~l~v~~~~-----   94 (459)
                      +||||||+.|.     .  +||.+.+|.-..       ..-..+.. ...++...+++|.|+..+. .|.|.+..     
T Consensus       106 laV~fDt~~n~-----~--~~i~~~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~~~i~Y~~~~~~~l~v~id~~~c~~  178 (218)
T d2a6va1         106 LMILLRLDDKL-----G--ESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDNRVCFQ  178 (218)
T ss_dssp             EEEEEEEETTT-----E--EEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETTEEEEE
T ss_pred             EEEEEECCCCC-----C--CeEEEEeCCCCccccccCCcccceEEecccCCCCcEEEEEEEECcccceEEEEeCCcEEEE
Confidence            89999999884     1  577776653211       00011111 2335788999999987554 36665421     


Q ss_pred             -CCC--CCc---CCCCcCCCCceecceeccccccccc
Q 041624           95 -GET--PKY---SQENTTSTGRYTERHVLKSWEFNST  125 (459)
Q Consensus        95 -~~~--~~~---~~~fsastG~~~~~h~i~swsfss~  125 (459)
                       ...  +..   ..+|||+||...+.|.|++|.+...
T Consensus       179 t~~i~lp~~~~~yfG~SA~Tg~~~d~~dIls~~~~~~  215 (218)
T d2a6va1         179 TRKVKFMGSSPFRIGTSAINDASKESFEILKMKLYDG  215 (218)
T ss_dssp             ESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEESS
T ss_pred             ECCeecCCCCcEEEEEEECCCCCcCcEEEEEEEEEec
Confidence             111  111   1269999999999999999987553

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.03  E-value=0.0011  Score=61.74  Aligned_cols=137  Identities=14%  Similarity=0.108  Sum_probs=78.8

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCce--eEEE-----EEeeCCeEEEEEEecCCCCcc
Q 041624          209 FGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL--QLIG-----LCHDRGEFMLVYEFMPNGSLD  281 (459)
Q Consensus       209 fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~g-----~~~~~~~~~lV~E~~~~gsL~  281 (459)
                      --.||++...+ |..+++|..+.. ....+++..|...+..|....+.  ..+.     .....+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35899998866 788999998754 33456788888888887533321  1111     123456788999999875442


Q ss_pred             hh-----------c---c----ccC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHhh----hccCC
Q 041624          282 FH-----------L---F----SKK-STGTPLTWT-------------------TRYKISLGLASALLYLH----EEWKR  319 (459)
Q Consensus       282 ~~-----------l---~----~~~-~~~~~l~~~-------------------~~~~i~~~ia~aL~yLH----~~~~~  319 (459)
                      ..           +   +    ... .....+++.                   .+..+...+...++.+.    +....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            10           0   0    000 000112211                   11112222222233332    22246


Q ss_pred             CeeecCCCCCCeeecCCCCEEEeecCCccc
Q 041624          320 CVVHRDIKFSNIMPDTDFNVKLGDFGLALL  349 (459)
Q Consensus       320 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~  349 (459)
                      +++|+|+.+.|||++++  ..+.||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999754  46899998864

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.01  E-value=0.00022  Score=62.92  Aligned_cols=89  Identities=11%  Similarity=0.057  Sum_probs=50.5

Q ss_pred             CEEEEEeeCCCCCCCCCCCCCCceeEecCCceeee-------eeecccCC-CCCceEEEEEEecCCcce-EEEEEe----
Q 041624           27 PIVLVEFDSFSNPEWDPINVKDDVGINNSSIVSSV-------YTRWNASF-HSGDTAHVKIKYNSATKN-LSASWS----   93 (459)
Q Consensus        27 ~~~aVefdt~~~~~~d~~~~~~hvgid~ns~~s~~-------~~~~~~~~-~~g~~~~~~i~y~~~~~~-l~v~~~----   93 (459)
                      .-+||||||+.|..  +.   .|+.++-++..-..       ...+...+ .++...+++|+|++.++. |.|.+.    
T Consensus       105 ~GlaV~fDt~~n~~--~~---~~~~~ndgt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~~c  179 (221)
T d2a6za1         105 DGLQLLVDNNGPLG--PT---LRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNKVC  179 (221)
T ss_dssp             EEEEEEEESCSTTS--SE---EEEEEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTEEE
T ss_pred             ceEEEEEECCCCCC--Cc---eEEEecCCCccccccCCcccccceeeecccCCCCCEEEEEEEecCccceEEEEecCcEe
Confidence            35999999998841  11   23444433322111       11122233 357778999999876544 677652    


Q ss_pred             --eCCCCCcC----CCCcCCCCceecceecccc
Q 041624           94 --YGETPKYS----QENTTSTGRYTERHVLKSW  120 (459)
Q Consensus        94 --~~~~~~~~----~~fsastG~~~~~h~i~sw  120 (459)
                        .....-+.    .+|||+||...+.|.++.+
T Consensus       180 ~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i  212 (221)
T d2a6za1         180 FQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEI  212 (221)
T ss_dssp             EEESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred             EEECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence              11111111    2699999998888876543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.96  E-value=0.0015  Score=62.47  Aligned_cols=74  Identities=16%  Similarity=0.249  Sum_probs=50.6

Q ss_pred             ceeccCCceEEEEEEEcCC-------CcEEEEEEeccCCccchHHHHHHHHHHhccCcCCc-eeEEEEEeeCCeEEEEEE
Q 041624          202 RKLGQGGFGAVYRGILIDL-------NMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNL-LQLIGLCHDRGEFMLVYE  273 (459)
Q Consensus       202 ~~Lg~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  273 (459)
                      +.|+.|-.-.+|++.....       .+.|.+++.. . ........+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5788888899999987642       3556666654 2 2233445689998888853344 578887753    58999


Q ss_pred             ecCCCCcc
Q 041624          274 FMPNGSLD  281 (459)
Q Consensus       274 ~~~~gsL~  281 (459)
                      |+++.+|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.45  E-value=0.0035  Score=57.69  Aligned_cols=159  Identities=13%  Similarity=0.009  Sum_probs=85.0

Q ss_pred             cCHHHHHHHhcCCCCCceec-----cCCceEEEEEEEcCCCcEEEEEEeccCCccchHHHHHHHHHHhccCcCCce--eE
Q 041624          186 FSYKDLASATNNFSNERKLG-----QGGFGAVYRGILIDLNMAVAVKKISRGLKHGKNEYITEVKTCSQLRHRNLL--QL  258 (459)
Q Consensus       186 ~~~~el~~~~~~f~~~~~Lg-----~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l  258 (459)
                      .+.+|++....+|...+...     .|---+.|+....+ | .+++|+.....  ..++...|++++..|...++.  ..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            56788998889997755443     45557889987764 4 58899885432  234455566677766433321  11


Q ss_pred             EE------EEeeCCeEEEEEEecCCCCcchhcc--------------c---cCC-C-CCCCCH-----------------
Q 041624          259 IG------LCHDRGEFMLVYEFMPNGSLDFHLF--------------S---KKS-T-GTPLTW-----------------  296 (459)
Q Consensus       259 ~g------~~~~~~~~~lV~E~~~~gsL~~~l~--------------~---~~~-~-~~~l~~-----------------  296 (459)
                      +.      +.........++.++.+......-.              .   ... . ......                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            10      1122345666777776643321100              0   000 0 000000                 


Q ss_pred             -HHHHHHHHHHHHHHHHhhh-ccCCCeeecCCCCCCeeecCCCCEEEeecCCcc
Q 041624          297 -TTRYKISLGLASALLYLHE-EWKRCVVHRDIKFSNIMPDTDFNVKLGDFGLAL  348 (459)
Q Consensus       297 -~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~  348 (459)
                       ......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             0011112222222222221 124689999999999999998877899999885